1	OPEN	NN	MISC	open	nn	3	SENT_1	[p1l187t137r269b160],
2	8	CD	NUMBER	8	num	3	SENT_1	[p1l279t118r311b169],
3	ACCESS	NNP	O	ACCESS	_	0	SENT_1	[p1l319t137r431b161],
4	Freely	RB	O	freely	advmod	3	SENT_1	[p1l447t136r536b168],
5	available	JJ	O	available	dep	6	SENT_1	[p1l544t136r677b161],
6	online	NN	O	online	amod	3	SENT_1	[p1l685t136r777b161],
7	.	.	O	.	_	0	SENT_1	[p1l1981t118r2095b161],

1	;	:	O	;	_	0	SENT_2	[p1l1981t118r2095b161],
2	@	SYM	O	@	_	0	SENT_2	[p1l1981t118r2095b161],
3	,	,	O	,	_	0	SENT_2	[p1l1981t118r2095b161],
4	PATHOGENS	NNS	O	pathogen	appos	2	SENT_2	[p1l2106t138r2286b161],

1	Doxycycline	NNP	O	Doxycycline	nsubj	2	SENT_3	[p1l195t215r704b312],
2	Reduces	VBZ	O	reduce	_	0	SENT_3	[p1l751t215r1103b290],
3	Plasma	NN	O	plasma	dobj	2	SENT_3	[p1l1149t215r1441b290],

1	VEGF-C/sVEGFR	NN	O	vegf-c/svegfr	_	0	SENT_4	[p1l188t342r945b417],
2	-3	CD	NUMBER	-3	num	1	SENT_4	[p1l188t342r945b417],
3	and	CC	O	and	_	0	SENT_4	[p1l989t339r1144b414],
4	Improves	VBZ	O	improve	conj_and	1	SENT_4	[p1l1193t343r1586b434],
5	Pathology	NN	O	pathology	dobj	4	SENT_4	[p1l1632t339r2066b436],
6	in	IN	O	in	_	0	SENT_4	[p1l193t467r262b538],
7	Lymphatic	JJ	MISC	lymphatic	amod	8	SENT_4	[p1l311t464r755b561],
8	Filariasis	NN	MISC	filariasis	prep_in	5	SENT_4	[p1l801t464r1150b539],

1	Alexander	NNP	PERSON	Alexander	nn	3	SENT_5	[p1l188t611r362b638],
2	Yaw	NNP	PERSON	Yaw	nn	3	SENT_5	[p1l376t612r447b638],
3	Debrahl	NNP	PERSON	Debrahl	dep	8	SENT_5	[p1l463t599r693b643],
4	’	NN	O	’	dep	3	SENT_5	[p1l463t599r693b643],
5	2	CD	NUMBER	2	num	4	SENT_5	[p1l463t599r693b643],
6	’	CD	NUMBER	’	dep	8	SENT_5	[p1l463t599r693b643],
7	3	CD	NUMBER	3	num	8	SENT_5	[p1l463t599r693b643],
8	®	NN	O	®	dep	41	SENT_5	[p1l463t599r693b643],
9	,	,	O	,	_	0	SENT_5	[p1l463t599r693b643],
10	Sabine	NNP	PERSON	Sabine	nn	11	SENT_5	[p1l709t611r823b638],
11	Mandle	NNP	PERSON	Mandle	appos	8	SENT_5	[p1l838t599r988b643],
12	,	,	O	,	_	0	SENT_5	[p1l838t599r988b643],
13	Sabine	NNP	PERSON	Sabine	nn	14	SENT_5	[p1l1004t611r1118b638],
14	Spechtl	NNP	PERSON	Spechtl	appos	8	SENT_5	[p1l1133t601r1275b646],
15	,	,	O	,	_	0	SENT_5	[p1l1133t601r1275b646],
16	Yeboah	NNP	PERSON	Yeboah	nn	17	SENT_5	[p1l1289t611r1417b639],
17	Marfo-Debrekyeiz	NNP	PERSON	Marfo-Debrekyeiz	appos	8	SENT_5	[p1l1433t600r1747b646],
18	,	,	O	,	_	0	SENT_5	[p1l1433t600r1747b646],
19	Linda	NNP	PERSON	Linda	nn	20	SENT_5	[p1l1763t611r1854b638],
20	Batsaz	NNP	PERSON	Batsaz	appos	8	SENT_5	[p1l1871t600r1989b643],
21	,	,	O	,	_	0	SENT_5	[p1l1871t600r1989b643],
22	Kenneth	NNP	PERSON	Kenneth	nn	23	SENT_5	[p1l2006t611r2146b638],
23	Pfarrl	NNP	PERSON	Pfarrl	appos	8	SENT_5	[p1l2163t601r2271b643],
24	,	,	O	,	_	0	SENT_5	[p1l2163t601r2271b643],
25	John	NNP	PERSON	John	nn	26	SENT_5	[p1l187t669r267b697],
26	Larbiz	NNP	PERSON	Larbiz	appos	8	SENT_5	[p1l284t658r395b701],
27	,	,	O	,	_	0	SENT_5	[p1l284t658r395b701],
28	Bernard	NNP	PERSON	Bernard	nn	29	SENT_5	[p1l412t669r545b697],
29	Lawson3	NNP	PERSON	Lawson3	appos	8	SENT_5	[p1l561t658r715b701],
30	,	,	O	,	_	0	SENT_5	[p1l561t658r715b701],
31	Mark	NNP	PERSON	Mark	nn	32	SENT_5	[p1l731t669r817b697],
32	TayIor4	NNP	PERSON	TayIor4	appos	8	SENT_5	[p1l830t659r963b704],
33	,	,	O	,	_	0	SENT_5	[p1l830t659r963b704],
34	Ohene	NNP	PERSON	Ohene	nn	35	SENT_5	[p1l978t669r1089b697],
35	Adjei2	NNP	O	Adjei2	appos	8	SENT_5	[p1l1103t658r1244b704],
36	'	POS	O	'	_	0	SENT_5	[p1l1103t658r1244b704],
37	5	CD	NUMBER	5	dep	35	SENT_5	[p1l1103t658r1244b704],
38	,	,	O	,	_	0	SENT_5	[p1l1103t658r1244b704],
39	Achim	NNP	PERSON	Achim	nn	40	SENT_5	[p1l1258t669r1363b697],
40	Hoeraufl	NNP	PERSON	Hoeraufl	appos	8	SENT_5	[p1l1381t658r1548b697],
41	*	NN	O	*	_	0	SENT_5	[p1l1381t658r1548b697],

1	1	CD	NUMBER	1	_	0	SENT_6	[p1l190t735r199b754],
2	Institute	NNP	ORGANIZATION	Institute	rcmod	1	SENT_6	[p1l215t734r313b754],
3	for	IN	ORGANIZATION	for	_	0	SENT_6	[p1l323t733r357b754],
4	Medical	NNP	ORGANIZATION	Medical	nn	5	SENT_6	[p1l368t733r459b754],
5	Microbiology	NNP	ORGANIZATION	Microbiology	prep_for	2	SENT_6	[p1l472t733r635b760],
6	,	,	O	,	_	0	SENT_6	[p1l472t733r635b760],
7	Immunology	NNP	O	Immunology	prep_for	2	SENT_6	[p1l648t733r807b760],
8	,	,	O	,	_	0	SENT_6	[p1l648t733r807b760],
9	and	CC	O	and	_	0	SENT_6	[p1l819t733r862b754],
10	Parasitology	NNP	O	Parasitology	prep_for	2	SENT_6	[p1l876t733r1027b760],
11	,	,	O	,	_	0	SENT_6	[p1l876t733r1027b760],
12	University	NNP	ORGANIZATION	University	appos	2	SENT_6	[p1l1040t734r1159b760],
13	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1169t733r1194b754],
14	Bonn	NNP	ORGANIZATION	Bonn	prep_of	12	SENT_6	[p1l1204t734r1271b758],
15	,	,	O	,	_	0	SENT_6	[p1l1204t734r1271b758],
16	Bonn	NNP	LOCATION	Bonn	appos	2	SENT_6	[p1l1283t734r1350b758],
17	,	,	O	,	_	0	SENT_6	[p1l1283t734r1350b758],
18	Germany	NNP	LOCATION	Germany	appos	2	SENT_6	[p1l1362t734r1476b760],
19	,	,	O	,	_	0	SENT_6	[p1l1362t734r1476b760],
20	2	CD	NUMBER	2	num	22	SENT_6	[p1l1488t735r1501b754],
21	Kumasi	NNP	ORGANIZATION	Kumasi	nn	22	SENT_6	[p1l1514t734r1599b754],
22	Centre	NNP	ORGANIZATION	Centre	appos	2	SENT_6	[p1l1610t734r1690b754],
23	for	IN	ORGANIZATION	for	_	0	SENT_6	[p1l1700t733r1734b754],
24	Collaborative	NNP	ORGANIZATION	Collaborative	nn	25	SENT_6	[p1l1744t733r1903b754],
25	Research	NNP	ORGANIZATION	Research	prep_for	22	SENT_6	[p1l1916t733r2020b754],
26	in	IN	ORGANIZATION	in	_	0	SENT_6	[p1l2034t734r2053b754],
27	Tropical	NNP	ORGANIZATION	Tropical	nn	28	SENT_6	[p1l2064t733r2159b760],
28	Medicine	NNP	ORGANIZATION	Medicine	prep_in	25	SENT_6	[p1l2172t733r2286b758],
29	,	,	O	,	_	0	SENT_6	[p1l2172t733r2286b758],
30	Kumasi	NNP	LOCATION	Kumasi	appos	2	SENT_6	[p1l190t775r280b799],
31	,	,	O	,	_	0	SENT_6	[p1l190t775r280b799],
32	Ghana	NNP	LOCATION	Ghana	appos	2	SENT_6	[p1l292t774r375b799],
33	,	,	O	,	_	0	SENT_6	[p1l292t774r375b799],
34	3	CD	NUMBER	3	num	35	SENT_6	[p1l387t776r400b795],
35	Department	NN	ORGANIZATION	department	appos	2	SENT_6	[p1l413t775r559b801],
36	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l570t774r595b795],
37	Theoretical	JJ	ORGANIZATION	theoretical	prep_of	35	SENT_6	[p1l603t774r736b795],
38	and	CC	ORGANIZATION	and	_	0	SENT_6	[p1l749t774r792b795],
39	Applied	NNP	ORGANIZATION	Applied	nn	40	SENT_6	[p1l804t774r897b801],
40	Biology	NNP	ORGANIZATION	Biology	prep_of	35	SENT_6	[p1l911t774r1005b801],
41	,	,	O	,	_	0	SENT_6	[p1l911t774r1005b801],
42	Kwame	NNP	ORGANIZATION	Kwame	nn	44	SENT_6	[p1l1018t775r1104b795],
43	Nkrumah	NNP	ORGANIZATION	Nkrumah	nn	44	SENT_6	[p1l1117t774r1226b795],
44	University	NNP	ORGANIZATION	University	appos	2	SENT_6	[p1l1239t775r1357b801],
45	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1368t774r1393b795],
46	Science	NNP	ORGANIZATION	Science	prep_of	44	SENT_6	[p1l1403t775r1493b795],
47	and	CC	ORGANIZATION	and	_	0	SENT_6	[p1l1504t774r1547b795],
48	Technology	NNP	ORGANIZATION	Technology	conj_and	46	SENT_6	[p1l1559t774r1707b801],
49	,	,	O	,	_	0	SENT_6	[p1l1559t774r1707b801],
50	Kumasi	NNP	LOCATION	Kumasi	appos	2	SENT_6	[p1l1720t775r1811b799],
51	,	,	O	,	_	0	SENT_6	[p1l1720t775r1811b799],
52	Ghana	NNP	LOCATION	Ghana	appos	2	SENT_6	[p1l1822t774r1905b799],
53	,	,	O	,	_	0	SENT_6	[p1l1822t774r1905b799],
54	4	CD	NUMBER	4	num	56	SENT_6	[p1l1917t776r1932b795],
55	Liverpool	NNP	ORGANIZATION	Liverpool	nn	56	SENT_6	[p1l1944t774r2053b801],
56	School	NNP	ORGANIZATION	School	appos	2	SENT_6	[p1l2066t774r2145b795],
57	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l2157t774r2182b795],
58	Tropical	NNP	ORGANIZATION	Tropical	nn	59	SENT_6	[p1l2190t774r2286b801],
59	Medicine	NNP	ORGANIZATION	Medicine	prep_of	56	SENT_6	[p1l189t816r303b841],
60	,	,	O	,	_	0	SENT_6	[p1l189t816r303b841],
61	Liverpool	NNP	ORGANIZATION	Liverpool	appos	2	SENT_6	[p1l317t816r433b843],
62	,	,	O	,	_	0	SENT_6	[p1l317t816r433b843],
63	United	NNP	LOCATION	United	nn	64	SENT_6	[p1l446t816r524b837],
64	Kingdom	NNP	LOCATION	Kingdom	appos	2	SENT_6	[p1l538t816r652b843],
65	,	,	O	,	_	0	SENT_6	[p1l538t816r652b843],
66	5	CD	NUMBER	5	num	67	SENT_6	[p1l664t818r678b837],
67	School	NN	ORGANIZATION	school	appos	2	SENT_6	[p1l690t816r769b837],
68	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l782t816r806b837],
69	Medical	NNP	ORGANIZATION	Medical	nn	70	SENT_6	[p1l817t816r908b837],
70	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	67	SENT_6	[p1l920t817r1027b841],
71	,	,	O	,	_	0	SENT_6	[p1l920t817r1027b841],
72	Kwame	NNP	ORGANIZATION	Kwame	nn	74	SENT_6	[p1l1041t817r1128b837],
73	Nkrumah	NNP	ORGANIZATION	Nkrumah	nn	74	SENT_6	[p1l1140t816r1249b837],
74	University	NNP	ORGANIZATION	University	appos	2	SENT_6	[p1l1263t817r1381b843],
75	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1392t816r1417b837],
76	Science	NNP	ORGANIZATION	Science	prep_of	74	SENT_6	[p1l1427t817r1516b837],
77	and	CC	ORGANIZATION	and	_	0	SENT_6	[p1l1528t816r1571b837],
78	Technology	NNP	ORGANIZATION	Technology	prep_of	74	SENT_6	[p1l1583t816r1731b843],
79	,	,	O	,	_	0	SENT_6	[p1l1583t816r1731b843],
80	Kumasi	NNP	LOCATION	Kumasi	appos	2	SENT_6	[p1l1744t817r1835b841],
81	,	,	O	,	_	0	SENT_6	[p1l1744t817r1835b841],
82	Ghana	NNP	LOCATION	Ghana	dep	1	SENT_6	[p1l1847t816r1923b837],

1	Lymphatic	JJ	MISC	lymphatic	amod	2	SENT_7	[p1l190t917r371b954],
2	filariasis	NN	O	filariasis	nsubj	5	SENT_7	[p1l385t916r530b946],
3	is	VBZ	O	be	cop	5	SENT_7	[p1l546t917r570b946],
4	a	DT	O	a	det	5	SENT_7	[p1l585t925r603b946],
5	disease	NN	O	disease	_	0	SENT_7	[p1l618t917r747b946],
6	of	IN	O	of	_	0	SENT_7	[p1l761t916r797b946],
7	considerable	JJ	O	considerable	amod	9	SENT_7	[p1l809t917r1033b946],
8	socioeconomic	JJ	O	socioeconomic	amod	9	SENT_7	[p1l1048t917r1305b946],
9	burden	NN	O	burden	prep_of	5	SENT_7	[p1l1320t917r1445b946],
10	in	IN	O	in	_	0	SENT_7	[p1l1461t917r1490b945],
11	the	DT	O	the	det	12	SENT_7	[p1l1505t917r1562b946],
12	tropics	NNS	O	tropics	prep_in	9	SENT_7	[p1l1576t917r1705b953],
13	.	.	O	.	_	0	SENT_7	[p1l1576t917r1705b953],

1	Presently	RB	O	presently	advmod	2	SENT_8	[p1l1720t917r1883b954],
2	used	VBN	O	use	amod	4	SENT_8	[p1l1898t917r1978b946],
3	antifilarial	JJ	O	antifilarial	amod	4	SENT_8	[p1l1993t916r2172b946],
4	drugs	NNS	O	drug	nsubj	6	SENT_8	[p1l2187t917r2286b953],
5	are	VBP	O	be	cop	6	SENT_8	[p1l189t970r243b991],
6	able	JJ	O	able	_	0	SENT_8	[p1l259t962r333b991],
7	to	TO	O	to	aux	9	SENT_8	[p1l348t966r383b991],
8	strongly	RB	O	strongly	advmod	9	SENT_8	[p1l399t962r544b999],
9	reduce	VB	O	reduce	xcomp	6	SENT_8	[p1l560t962r677b991],
10	transmission	NN	O	transmission	dobj	9	SENT_8	[p1l693t962r916b991],
11	and	CC	O	and	_	0	SENT_8	[p1l933t962r997b991],
12	will	MD	O	will	conj_and	6	SENT_8	[p1l1013t962r1072b990],
13	thus	RB	O	thus	advmod	12	SENT_8	[p1l1089t962r1165b991],
14	ultimately	RB	O	ultimately	advmod	15	SENT_8	[p1l1181t962r1359b999],
15	lower	JJR	O	lower	amod	17	SENT_8	[p1l1376t962r1472b991],
16	the	DT	O	the	det	17	SENT_8	[p1l1486t962r1543b991],
17	burden	NN	O	burden	dobj	6	SENT_8	[p1l1560t962r1684b991],
18	of	IN	O	of	_	0	SENT_8	[p1l1701t961r1737b991],
19	morbidity	NN	O	morbidity	prep_of	17	SENT_8	[p1l1752t962r1924b999],
20	associated	VBN	O	associate	partmod	19	SENT_8	[p1l1939t962r2122b991],
21	with	IN	O	with	_	0	SENT_8	[p1l2138t962r2213b991],
22	the	DT	O	the	det	23	SENT_8	[p1l2230t962r2286b991],
23	infection	NN	O	infection	prep_with	20	SENT_8	[p1l189t1007r353b1041],
24	,	,	O	,	_	0	SENT_8	[p1l189t1007r353b1041],
25	however	RB	O	however	advmod	20	SENT_8	[p1l367t1008r526b1041],
26	,	,	O	,	_	0	SENT_8	[p1l367t1008r526b1041],
27	a	DT	O	a	det	29	SENT_8	[p1l539t1016r557b1037],
28	chemotherapeutic	JJ	O	chemotherapeutic	amod	29	SENT_8	[p1l571t1008r891b1044],
29	principle	NN	O	principle	appos	17	SENT_8	[p1l904t1008r1056b1044],
30	that	WDT	O	that	nsubj	32	SENT_8	[p1l1068t1008r1140b1037],
31	directly	RB	O	directly	advmod	32	SENT_8	[p1l1152t1008r1284b1045],
32	induces	VBZ	O	induce	rcmod	29	SENT_8	[p1l1296t1008r1429b1037],
33	a	DT	O	a	det	34	SENT_8	[p1l1442t1016r1459b1037],
34	halt	NN	O	halt	nsubj	48	SENT_8	[p1l1474t1008r1540b1037],
35	or	CC	O	or	_	0	SENT_8	[p1l1552t1016r1588b1037],
36	improvement	NN	O	improvement	nsubj	48	SENT_8	[p1l1601t1008r1838b1044],
37	in	IN	O	in	_	0	SENT_8	[p1l1851t1008r1881b1036],
38	the	DT	O	the	det	39	SENT_8	[p1l1894t1008r1950b1037],
39	progression	NN	O	progression	prep_in	34	SENT_8	[p1l1964t1008r2170b1044],
40	of	IN	O	of	_	0	SENT_8	[p1l2184t1007r2219b1037],
41	the	DT	O	the	det	42	SENT_8	[p1l2230t1008r2286b1037],
42	morbidity	NN	O	morbidity	prep_of	39	SENT_8	[p1l190t1054r362b1091],
43	in	IN	O	in	_	0	SENT_8	[p1l379t1054r409b1082],
44	already	RB	O	already	advmod	45	SENT_8	[p1l427t1054r558b1091],
45	infected	JJ	O	infected	amod	46	SENT_8	[p1l575t1053r715b1083],
46	individuals	NNS	O	individual	prep_in	42	SENT_8	[p1l734t1054r926b1083],
47	would	MD	O	would	aux	48	SENT_8	[p1l943t1054r1049b1083],
48	constitute	VB	O	constitute	ccomp	32	SENT_8	[p1l1068t1054r1244b1083],
49	a	DT	O	a	det	51	SENT_8	[p1l1261t1062r1279b1083],
50	major	JJ	O	major	amod	51	SENT_8	[p1l1298t1054r1399b1091],
51	lead	NN	O	lead	dobj	48	SENT_8	[p1l1417t1054r1500b1083],
52	.	.	O	.	_	0	SENT_8	[p1l1417t1054r1500b1083],

1	In	IN	O	in	_	0	SENT_9	[p1l1518t1055r1548b1082],
2	search	NN	O	search	prep_in	30	SENT_9	[p1l1566t1054r1677b1083],
3	of	IN	O	of	_	0	SENT_9	[p1l1696t1053r1731b1083],
4	such	PDT	O	such	predet	7	SENT_9	[p1l1747t1054r1824b1083],
5	a	DT	O	a	det	7	SENT_9	[p1l1843t1062r1860b1083],
6	more-effective	JJ	O	more-effective	amod	7	SENT_9	[p1l1880t1053r2135b1083],
7	drug	NN	O	drug	prep_of	2	SENT_9	[p1l2152t1054r2233b1090],
8	to	TO	O	to	aux	9	SENT_9	[p1l2251t1058r2286b1083],
9	complement	VB	O	complement	infmod	2	SENT_9	[p1l189t1099r408b1135],
10	the	DT	O	the	det	12	SENT_9	[p1l429t1099r486b1128],
11	existing	VBG	O	exist	amod	12	SENT_9	[p1l507t1099r644b1135],
12	ones	NNS	O	one	dobj	9	SENT_9	[p1l667t1107r759b1132],
13	,	,	O	,	_	0	SENT_9	[p1l667t1107r759b1132],
14	in	IN	O	in	_	0	SENT_9	[p1l781t1099r811b1127],
15	an	DT	O	a	det	16	SENT_9	[p1l833t1107r874b1128],
16	area	NN	O	area	prep_in	12	SENT_9	[p1l897t1107r971b1128],
17	endemic	JJ	O	endemic	amod	16	SENT_9	[p1l994t1099r1143b1128],
18	for	IN	O	for	_	0	SENT_9	[p1l1163t1098r1213b1128],
19	bancroftian	JJ	O	bancroftian	amod	20	SENT_9	[p1l1235t1098r1436b1128],
20	filariasis	NN	O	filariasis	prep_for	17	SENT_9	[p1l1457t1098r1603b1128],
21	in	IN	O	in	_	0	SENT_9	[p1l1626t1099r1655b1127],
22	Ghana	NNP	LOCATION	Ghana	prep_in	20	SENT_9	[p1l1678t1099r1800b1132],
23	,	,	O	,	_	0	SENT_9	[p1l1678t1099r1800b1132],
24	33	CD	NUMBER	33	num	29	SENT_9	[p1l1823t1101r1862b1128],
25	microfilaremic	JJ	O	microfilaremic	amod	29	SENT_9	[p1l1886t1098r2137b1128],
26	and	CC	O	and	_	0	SENT_9	[p1l2158t1099r2222b1128],
27	18	CD	NUMBER	18	num	28	SENT_9	[p1l2247t1101r2286b1128],
28	lymphedema	NN	O	lymphedema	conj_and	25	SENT_9	[p1l190t1145r417b1182],
29	patients	NNS	O	patient	nsubj	30	SENT_9	[p1l445t1145r586b1181],
30	took	VBD	O	take	_	0	SENT_9	[p1l611t1145r691b1174],
31	part	NN	O	part	dobj	30	SENT_9	[p1l716t1149r787b1181],
32	in	IN	O	in	_	0	SENT_9	[p1l813t1145r842b1173],
33	a	DT	O	a	det	37	SENT_9	[p1l868t1153r886b1174],
34	double-blind	JJ	O	double-blind	amod	37	SENT_9	[p1l912t1145r1148b1178],
35	,	,	O	,	_	0	SENT_9	[p1l912t1145r1148b1178],
36	placebo-controlled	JJ	O	placebo-controlled	amod	37	SENT_9	[p1l1174t1145r1503b1181],
37	trial	NN	O	trial	prep_in	30	SENT_9	[p1l1529t1145r1598b1174],
38	of	IN	O	of	_	0	SENT_9	[p1l1624t1144r1659b1174],
39	a	DT	O	a	det	41	SENT_9	[p1l1683t1153r1701b1174],
40	6-wk	JJ	DURATION	6-wk	amod	41	SENT_9	[p1l1727t1145r1812b1174],
41	regimen	NN	O	regimen	prep_of	37	SENT_9	[p1l1837t1145r1980b1181],
42	of	IN	O	of	_	0	SENT_9	[p1l2006t1144r2041b1174],
43	200	CD	NUMBER	200	num	45	SENT_9	[p1l2065t1147r2128b1174],
44	mg/day	JJ	O	mg/day	amod	45	SENT_9	[p1l2154t1145r2287b1182],
45	doxycycline	NN	O	doxycycline	prep_of	41	SENT_9	[p1l189t1191r405b1228],
46	.	.	O	.	_	0	SENT_9	[p1l189t1191r405b1228],

1	Four	CD	DURATION	four	num	2	SENT_10	[p1l424t1192r502b1220],
2	months	NNS	DURATION	month	npadvmod	9	SENT_10	[p1l520t1191r651b1220],
3	after	IN	O	after	_	0	SENT_10	[p1l669t1190r752b1220],
4	doxycycline	NN	O	doxycycline	nn	5	SENT_10	[p1l769t1191r975b1228],
5	treatment	NN	O	treatment	prep_after	9	SENT_10	[p1l992t1195r1178b1224],
6	,	,	O	,	_	0	SENT_10	[p1l992t1195r1178b1224],
7	all	DT	O	all	det	8	SENT_10	[p1l1196t1191r1236b1220],
8	patients	NNS	O	patient	nsubj	9	SENT_10	[p1l1255t1191r1397b1227],
9	received	VBD	O	receive	_	0	SENT_10	[p1l1416t1191r1562b1220],
10	150-200	CD	NUMBER	150-200	num	12	SENT_10	[p1l1583t1193r1729b1220],
11	pg/kg	NN	O	pg/kg	nn	12	SENT_10	[p1l1747t1191r1845b1227],
12	ivermectin	NN	O	ivermectin	dobj	9	SENT_10	[p1l1865t1191r2049b1220],
13	and	CC	O	and	_	0	SENT_10	[p1l2068t1191r2132b1220],
14	400	CD	NUMBER	400	num	16	SENT_10	[p1l2150t1193r2214b1220],
15	mg	NN	O	mg	nn	16	SENT_10	[p1l2232t1199r2285b1227],
16	albendazole	NN	O	albendazole	dobj	9	SENT_10	[p1l189t1236r412b1265],
17	.	.	O	.	_	0	SENT_10	[p1l189t1236r412b1265],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_11	[p1l433t1236r574b1265],
2	were	VBD	O	be	auxpass	3	SENT_11	[p1l593t1244r677b1264],
3	monitored	VBN	O	monitor	dep	49	SENT_11	[p1l697t1236r880b1265],
4	for	IN	O	for	_	0	SENT_11	[p1l899t1235r949b1265],
5	Wolbachia	NNP	LOCATION	Wolbachia	prep_for	3	SENT_11	[p1l970t1236r1148b1265],
6	and	CC	O	and	_	0	SENT_11	[p1l1166t1236r1230b1265],
7	microfilaria	NN	O	microfilarium	nn	8	SENT_11	[p1l1251t1235r1449b1265],
8	loads	NNS	O	load	prep_for	3	SENT_11	[p1l1470t1236r1572b1269],
9	,	,	O	,	_	0	SENT_11	[p1l1470t1236r1572b1269],
10	antigenemia	NN	O	antigenemia	appos	8	SENT_11	[p1l1591t1236r1821b1272],
11	,	,	O	,	_	0	SENT_11	[p1l1591t1236r1821b1272],
12	filarial	JJ	O	filarial	amod	17	SENT_11	[p1l1840t1235r1950b1265],
13	dance	NN	O	dance	nn	17	SENT_11	[p1l1970t1236r2074b1265],
14	sign	NN	O	sign	nn	17	SENT_11	[p1l2093t1236r2164b1272],
15	(	CD	NUMBER	(	num	17	SENT_11	[p1l2185t1237r2286b1269],
16	FDS	NN	O	fd	nn	17	SENT_11	[p1l2185t1237r2286b1269],
17	)	NN	O	)	appos	8	SENT_11	[p1l2185t1237r2286b1269],
18	,	,	O	,	_	0	SENT_11	[p1l2185t1237r2286b1269],
19	dilation	NN	O	dilation	appos	8	SENT_11	[p1l189t1282r322b1311],
20	of	IN	O	of	_	0	SENT_11	[p1l344t1281r380b1311],
21	supratesticular	JJ	O	supratesticular	amod	23	SENT_11	[p1l400t1282r662b1318],
22	lymphatic	JJ	O	lymphatic	amod	23	SENT_11	[p1l685t1282r857b1319],
23	vessels	NNS	O	vessel	prep_of	19	SENT_11	[p1l877t1282r1011b1315],
24	,	,	O	,	_	0	SENT_11	[p1l877t1282r1011b1315],
25	and	CC	O	and	_	0	SENT_11	[p1l1033t1282r1097b1311],
26	plasma	NN	O	plasma	nn	27	SENT_11	[p1l1120t1282r1244b1318],
27	levels	NNS	O	level	nsubj	31	SENT_11	[p1l1267t1282r1365b1311],
28	of	IN	O	of	_	0	SENT_11	[p1l1387t1281r1422b1311],
29	lymphangiogenic	JJ	O	lymphangiogenic	amod	30	SENT_11	[p1l1444t1282r1747b1319],
30	factors	NNS	O	factor	prep_of	27	SENT_11	[p1l1768t1281r1888b1311],
31	(	VBP	O	(	dep	49	SENT_11	[p1l1910t1282r2066b1315],
32	vascular	JJ	O	vascular	amod	38	SENT_11	[p1l1910t1282r2066b1315],
33	endothelial	JJ	O	endothelial	amod	38	SENT_11	[p1l2087t1282r2285b1311],
34	growth	NN	O	growth	nn	38	SENT_11	[p1l189t1328r313b1364],
35	factor-C	NN	O	factor-c	nn	38	SENT_11	[p1l337t1327r476b1357],
36	[	CD	NUMBER	[	num	38	SENT_11	[p1l501t1329r650b1361],
37	VEGF-C	NN	O	vegf-c	nn	38	SENT_11	[p1l501t1329r650b1361],
38	]	NN	O	]	dobj	31	SENT_11	[p1l501t1329r650b1361],
39	and	CC	O	and	_	0	SENT_11	[p1l675t1328r739b1357],
40	soluble	JJ	O	soluble	amod	45	SENT_11	[p1l765t1328r890b1357],
41	vascular	JJ	O	vascular	amod	42	SENT_11	[p1l914t1328r1059b1357],
42	endothelial	JJ	O	endothelial	amod	45	SENT_11	[p1l1082t1328r1280b1357],
43	growth	NN	O	growth	nn	45	SENT_11	[p1l1305t1328r1429b1364],
44	factor	NN	O	factor	nn	45	SENT_11	[p1l1453t1327r1556b1357],
45	receptor-3	NN	O	receptor-3	dobj	31	SENT_11	[p1l1580t1330r1760b1364],
46	[	CD	NUMBER	[	num	48	SENT_11	[p1l1786t1329r2023b1361],
47	(	NN	O	(	nn	48	SENT_11	[p1l1786t1329r2023b1361],
48	s	NNS	O	s	dep	38	SENT_11	[p1l1786t1329r2023b1361],
49	)	VBP	O	)	_	0	SENT_11	[p1l1786t1329r2023b1361],
50	VEGFR-3	NN	O	vegfr-3	dobj	49	SENT_11	[p1l1786t1329r2023b1361],
51	]	CD	NUMBER	]	num	52	SENT_11	[p1l1786t1329r2023b1361],
52	)	NN	O	)	nsubj	49	SENT_11	[p1l1786t1329r2023b1361],
53	.	.	O	.	_	0	SENT_11	[p1l1786t1329r2023b1361],

1	Lymphedema	NN	O	lymphedema	nn	2	SENT_12	[p1l2048t1328r2285b1365],
2	patients	NNS	O	patient	nsubjpass	5	SENT_12	[p1l190t1373r331b1409],
3	were	VBD	O	be	auxpass	5	SENT_12	[p1l352t1381r437b1401],
4	additionally	RB	O	additionally	advmod	5	SENT_12	[p1l459t1373r669b1410],
5	monitored	VBN	O	monitor	_	0	SENT_12	[p1l691t1373r873b1402],
6	for	IN	O	for	_	0	SENT_12	[p1l895t1372r945b1402],
7	stage	NN	O	stage	nn	10	SENT_12	[p1l966t1377r1060b1409],
8	(	CD	NUMBER	(	num	10	SENT_12	[p1l1083t1373r1206b1409],
9	grade	NN	O	grade	nn	10	SENT_12	[p1l1083t1373r1206b1409],
10	)	NN	O	)	prep_for	5	SENT_12	[p1l1083t1373r1206b1409],
11	of	IN	O	of	_	0	SENT_12	[p1l1229t1372r1264b1402],
12	lymphedema	NN	O	lymphedema	prep_of	10	SENT_12	[p1l1286t1373r1513b1410],
13	and	CC	O	and	_	0	SENT_12	[p1l1536t1373r1600b1402],
14	the	DT	O	the	det	15	SENT_12	[p1l1622t1373r1678b1402],
15	circumferences	NNS	O	circumference	conj_and	10	SENT_12	[p1l1700t1372r1964b1402],
16	of	IN	O	of	_	0	SENT_12	[p1l1986t1372r2022b1402],
17	affected	VBN	O	affect	amod	18	SENT_12	[p1l2042t1372r2184b1402],
18	legs	NNS	O	leg	prep_of	15	SENT_12	[p1l2207t1373r2286b1409],
19	.	.	O	.	_	0	SENT_12	[p1l2207t1373r2286b1409],

1	Wolbachia	JJ	O	wolbachia	amod	2	SENT_13	[p1l191t1419r369b1448],
2	load	NN	O	load	nsubjpass	14	SENT_13	[p1l392t1419r476b1452],
3	,	,	O	,	_	0	SENT_13	[p1l392t1419r476b1452],
4	microfilaremia	NN	O	microfilaremia	appos	2	SENT_13	[p1l500t1418r764b1452],
5	,	,	O	,	_	0	SENT_13	[p1l500t1418r764b1452],
6	antigenemia	NN	O	antigenemia	conj_and	4	SENT_13	[p1l787t1419r1017b1455],
7	,	,	O	,	_	0	SENT_13	[p1l787t1419r1017b1455],
8	and	CC	O	and	_	0	SENT_13	[p1l1040t1419r1104b1448],
9	frequency	NN	O	frequency	conj_and	4	SENT_13	[p1l1127t1418r1304b1456],
10	of	IN	O	of	_	0	SENT_13	[p1l1326t1418r1362b1448],
11	FDS	NN	O	fd	prep_of	4	SENT_13	[p1l1384t1420r1450b1448],
12	were	VBD	O	be	auxpass	14	SENT_13	[p1l1472t1427r1557b1447],
13	significantly	RB	O	significantly	advmod	14	SENT_13	[p1l1580t1418r1794b1456],
14	reduced	VBN	O	reduce	_	0	SENT_13	[p1l1817t1419r1957b1448],
15	in	IN	O	in	_	0	SENT_13	[p1l1981t1419r2011b1447],
16	microfilaremic	JJ	O	microfilaremic	amod	17	SENT_13	[p1l2036t1418r2286b1448],
17	patients	NNS	O	patient	prep_in	14	SENT_13	[p1l190t1465r331b1501],
18	up	IN	DURATION	up	advmod	14	SENT_13	[p1l347t1473r391b1501],
19	to	TO	DURATION	to	_	0	SENT_13	[p1l405t1469r441b1494],
20	24	CD	DURATION	24	num	21	SENT_13	[p1l456t1467r498b1493],
21	mo	NN	DURATION	mo	prep_to	18	SENT_13	[p1l513t1473r567b1494],
22	in	IN	O	in	_	0	SENT_13	[p1l583t1465r612b1493],
23	the	DT	O	the	det	25	SENT_13	[p1l628t1465r685b1494],
24	doxycycline	NN	O	doxycycline	nn	25	SENT_13	[p1l700t1465r906b1502],
25	group	NN	O	group	prep_in	21	SENT_13	[p1l921t1473r1026b1501],
26	compared	VBN	O	compare	_	0	SENT_13	[p1l1041t1465r1215b1501],
27	to	TO	O	to	prepc_compared_to	25	SENT_13	[p1l1231t1469r1267b1494],
28	the	DT	O	the	det	30	SENT_13	[p1l1281t1465r1338b1494],
29	placebo	NN	O	placebo	nn	30	SENT_13	[p1l1354t1465r1490b1501],
30	group	NN	O	group	pobj	25	SENT_13	[p1l1505t1473r1620b1501],
31	.	.	O	.	_	0	SENT_13	[p1l1505t1473r1620b1501],

1	The	DT	O	the	det	3	SENT_14	[p1l1635t1465r1699b1493],
2	mean	NN	O	mean	nn	3	SENT_14	[p1l1715t1473r1810b1494],
3	dilation	NN	O	dilation	nsubjpass	12	SENT_14	[p1l1826t1465r1959b1494],
4	of	IN	O	of	_	0	SENT_14	[p1l1975t1464r2011b1494],
5	supratesticular	JJ	O	supratesticular	amod	7	SENT_14	[p1l2025t1465r2287b1501],
6	lymphatic	JJ	O	lymphatic	amod	7	SENT_14	[p1l190t1510r362b1547],
7	vessels	NNS	O	vessel	prep_of	3	SENT_14	[p1l388t1510r511b1539],
8	in	IN	O	in	_	0	SENT_14	[p1l539t1510r568b1538],
9	doxycycline-treated	JJ	O	doxycycline-treated	amod	10	SENT_14	[p1l596t1510r943b1547],
10	patients	NNS	O	patient	prep_in	7	SENT_14	[p1l972t1510r1113b1546],
11	was	VBD	O	be	auxpass	12	SENT_14	[p1l1140t1518r1206b1539],
12	reduced	VBN	O	reduce	_	0	SENT_14	[p1l1233t1510r1373b1539],
13	significantly	RB	O	significantly	advmod	12	SENT_14	[p1l1401t1509r1615b1547],
14	at	IN	O	at	_	0	SENT_14	[p1l1641t1514r1674b1539],
15	24	CD	DURATION	24	num	16	SENT_14	[p1l1701t1512r1743b1538],
16	mo	NN	DURATION	mo	prep_at	12	SENT_14	[p1l1770t1518r1833b1543],
17	,	,	O	,	_	0	SENT_14	[p1l1770t1518r1833b1543],
18	whereas	IN	O	whereas	mark	20	SENT_14	[p1l1859t1510r2005b1539],
19	there	EX	O	there	expl	20	SENT_14	[p1l2031t1510r2124b1539],
20	was	VBD	O	be	advcl	12	SENT_14	[p1l2150t1518r2216b1539],
21	no	DT	O	no	det	22	SENT_14	[p1l2244t1518r2286b1539],
22	improvement	NN	O	improvement	nsubj	20	SENT_14	[p1l189t1556r426b1592],
23	in	IN	O	in	_	0	SENT_14	[p1l441t1556r470b1584],
24	the	DT	O	the	det	26	SENT_14	[p1l485t1556r541b1585],
25	placebo	NN	O	placebo	nn	26	SENT_14	[p1l556t1556r693b1592],
26	group	NN	O	group	prep_in	22	SENT_14	[p1l706t1564r821b1592],
27	.	.	O	.	_	0	SENT_14	[p1l706t1564r821b1592],

1	Preceding	VBG	O	precede	partmod	17	SENT_15	[p1l836t1556r1009b1592],
2	clinical	JJ	O	clinical	amod	3	SENT_15	[p1l1024t1556r1142b1585],
3	improvement	NN	O	improvement	dobj	1	SENT_15	[p1l1158t1556r1405b1592],
4	,	,	O	,	_	0	SENT_15	[p1l1158t1556r1405b1592],
5	at	IN	O	at	_	0	SENT_15	[p1l1419t1560r1452b1585],
6	12	CD	DURATION	12	num	7	SENT_15	[p1l1468t1558r1506b1584],
7	mo	NN	DURATION	mo	prep_at	1	SENT_15	[p1l1522t1564r1585b1589],
8	,	,	O	,	_	0	SENT_15	[p1l1522t1564r1585b1589],
9	the	DT	O	the	det	12	SENT_15	[p1l1599t1556r1656b1585],
10	mean	NN	O	mean	nn	12	SENT_15	[p1l1671t1564r1765b1585],
11	plasma	NN	O	plasma	nn	12	SENT_15	[p1l1781t1556r1904b1592],
12	levels	NNS	O	level	nsubj	17	SENT_15	[p1l1920t1556r2018b1585],
13	of	IN	O	of	_	0	SENT_15	[p1l2032t1555r2067b1585],
14	VEGF-C	NN	O	vegf-c	prep_of	12	SENT_15	[p1l2079t1557r2207b1585],
15	and	CC	O	and	_	0	SENT_15	[p1l2221t1556r2285b1585],
16	sVEGFR-3	NN	O	svegfr-3	conj_and	14	SENT_15	[p1l189t1603r354b1631],
17	decreased	VBD	O	decrease	_	0	SENT_15	[p1l368t1602r545b1631],
18	significantly	RB	O	significantly	advmod	17	SENT_15	[p1l559t1601r773b1639],
19	in	IN	O	in	_	0	SENT_15	[p1l786t1602r816b1630],
20	the	DT	O	the	det	22	SENT_15	[p1l829t1602r886b1631],
21	doxycycline-treated	JJ	O	doxycycline-treated	amod	22	SENT_15	[p1l898t1602r1246b1639],
22	patients	NNS	O	patient	prep_in	17	SENT_15	[p1l1261t1602r1402b1638],
23	to	TO	O	to	_	0	SENT_15	[p1l1415t1606r1450b1631],
24	a	DT	O	a	det	26	SENT_15	[p1l1463t1610r1481b1631],
25	level	NN	O	level	nn	26	SENT_15	[p1l1496t1602r1575b1630],
26	close	NN	O	close	prep_to	22	SENT_15	[p1l1589t1602r1676b1631],
27	to	TO	O	to	_	0	SENT_15	[p1l1688t1606r1724b1631],
28	that	DT	O	that	prep_to	17	SENT_15	[p1l1736t1602r1807b1631],
29	of	IN	O	of	_	0	SENT_15	[p1l1820t1601r1855b1631],
30	endemic	JJ	O	endemic	amod	32	SENT_15	[p1l1867t1602r2015b1631],
31	normal	JJ	O	normal	amod	32	SENT_15	[p1l2029t1602r2150b1631],
32	values	NNS	O	value	prep_of	28	SENT_15	[p1l2164t1602r2286b1635],
33	,	,	O	,	_	0	SENT_15	[p1l2164t1602r2286b1635],
34	whereas	IN	O	whereas	mark	36	SENT_15	[p1l188t1647r334b1676],
35	there	EX	O	there	expl	36	SENT_15	[p1l351t1647r443b1676],
36	was	VBD	O	be	advcl	17	SENT_15	[p1l461t1655r527b1676],
37	no	DT	O	no	det	39	SENT_15	[p1l545t1655r588b1676],
38	significant	JJ	O	significant	amod	39	SENT_15	[p1l606t1646r788b1683],
39	reduction	NN	O	reduction	nsubj	36	SENT_15	[p1l806t1647r972b1676],
40	in	IN	O	in	_	0	SENT_15	[p1l992t1647r1021b1675],
41	the	DT	O	the	det	43	SENT_15	[p1l1039t1647r1096b1676],
42	placebo	NN	O	placebo	nn	43	SENT_15	[p1l1114t1647r1251b1683],
43	patients	NNS	O	patient	prep_in	39	SENT_15	[p1l1269t1647r1421b1683],
44	.	.	O	.	_	0	SENT_15	[p1l1269t1647r1421b1683],

1	The	DT	O	the	det	2	SENT_16	[p1l1438t1647r1502b1675],
2	extent	NN	O	extent	nsubj	9	SENT_16	[p1l1520t1651r1632b1676],
3	of	IN	O	of	_	0	SENT_16	[p1l1649t1646r1685b1676],
4	disease	NN	O	disease	prep_of	2	SENT_16	[p1l1701t1647r1830b1676],
5	in	IN	O	in	_	0	SENT_16	[p1l1848t1647r1878b1675],
6	lymphedema	NN	O	lymphedema	nn	7	SENT_16	[p1l1897t1647r2125b1684],
7	patients	NNS	O	patient	prep_in	4	SENT_16	[p1l2144t1647r2286b1683],
8	significantly	RB	O	significantly	advmod	9	SENT_16	[p1l189t1692r403b1730],
9	improved	VBD	O	improve	_	0	SENT_16	[p1l416t1693r583b1729],
10	following	VBG	O	follow	_	0	SENT_16	[p1l596t1692r760b1729],
11	doxycycline	NN	O	doxycycline	prep_following	9	SENT_16	[p1l774t1693r990b1730],
12	,	,	O	,	_	0	SENT_16	[p1l774t1693r990b1730],
13	with	IN	O	with	_	0	SENT_16	[p1l1003t1693r1078b1722],
14	the	DT	O	the	det	16	SENT_16	[p1l1092t1693r1149b1722],
15	mean	JJ	O	mean	amod	16	SENT_16	[p1l1163t1701r1257b1722],
16	stage	NN	O	stage	prep_with	9	SENT_16	[p1l1272t1697r1366b1729],
17	of	IN	O	of	_	0	SENT_16	[p1l1379t1692r1414b1722],
18	lymphedema	NN	O	lymphedema	prep_of	16	SENT_16	[p1l1427t1693r1654b1730],
19	in	IN	O	in	_	0	SENT_16	[p1l1669t1693r1699b1721],
20	the	DT	O	the	det	22	SENT_16	[p1l1712t1693r1769b1722],
21	doxycycline-treated	JJ	O	doxycycline-treated	amod	22	SENT_16	[p1l1782t1693r2129b1730],
22	patients	NNS	O	patient	prep_in	18	SENT_16	[p1l2144t1693r2286b1729],
23	being	VBG	O	be	cop	25	SENT_16	[p1l190t1739r286b1775],
24	significantly	RB	O	significantly	advmod	25	SENT_16	[p1l301t1738r515b1776],
25	lower	JJR	O	lower	partmod	22	SENT_16	[p1l528t1739r624b1768],
26	compared	VBN	O	compare	_	0	SENT_16	[p1l636t1739r811b1775],
27	to	TO	O	to	prepc_compared_to	25	SENT_16	[p1l824t1743r860b1768],
28	placebo	NN	O	placebo	nn	29	SENT_16	[p1l874t1739r1010b1775],
29	patients	NNS	O	patient	pobj	25	SENT_16	[p1l1024t1739r1165b1775],
30	12	CD	DURATION	12	num	31	SENT_16	[p1l1181t1741r1219b1767],
31	mo	NN	DURATION	mo	dep	29	SENT_16	[p1l1234t1747r1287b1768],
32	after	IN	O	after	_	0	SENT_16	[p1l1300t1738r1383b1768],
33	treatment	NN	O	treatment	prep_after	31	SENT_16	[p1l1395t1743r1581b1768],
34	.	.	O	.	_	0	SENT_16	[p1l1395t1743r1581b1768],

1	The	DT	O	the	det	2	SENT_17	[p1l1593t1739r1657b1767],
2	reduction	NN	O	reduction	nsubj	22	SENT_17	[p1l1672t1739r1838b1768],
3	in	IN	O	in	_	0	SENT_17	[p1l1852t1739r1882b1767],
4	the	DT	O	the	det	5	SENT_17	[p1l1895t1739r1952b1768],
5	stages	NNS	O	stage	prep_in	2	SENT_17	[p1l1965t1743r2076b1775],
6	manifested	VBN	O	manifest	partmod	5	SENT_17	[p1l2090t1738r2285b1768],
7	as	IN	O	as	_	0	SENT_17	[p1l189t1792r225b1813],
8	better	JJR	O	better	amod	10	SENT_17	[p1l238t1784r344b1813],
9	skin	NN	O	skin	nn	10	SENT_17	[p1l355t1784r424b1813],
10	texture	NN	O	texture	prep_as	6	SENT_17	[p1l437t1788r574b1817],
11	,	,	O	,	_	0	SENT_17	[p1l437t1788r574b1817],
12	a	DT	O	a	det	13	SENT_17	[p1l586t1792r604b1813],
13	reduction	NN	O	reduction	conj_and	2	SENT_17	[p1l618t1784r784b1813],
14	of	IN	O	of	_	0	SENT_17	[p1l797t1783r833b1813],
15	deep	JJ	O	deep	prep_of	13	SENT_17	[p1l843t1784r930b1820],
16	folds	VBZ	O	fold	dep	15	SENT_17	[p1l941t1783r1037b1817],
17	,	,	O	,	_	0	SENT_17	[p1l941t1783r1037b1817],
18	and	CC	O	and	_	0	SENT_17	[p1l1049t1784r1114b1813],
19	fewer	JJR	O	fewer	amod	21	SENT_17	[p1l1126t1783r1225b1812],
20	deep	JJ	O	deep	amod	21	SENT_17	[p1l1237t1784r1323b1820],
21	skin	NN	O	skin	conj_and	2	SENT_17	[p1l1335t1784r1404b1813],
22	folds	VBZ	O	fold	_	0	SENT_17	[p1l1417t1783r1513b1813],
23	.	.	O	.	_	0	SENT_17	[p1l1417t1783r1513b1813],

1	In	IN	O	in	_	0	SENT_18	[p1l1526t1785r1556b1812],
2	conclusion	NN	O	conclusion	prep_in	15	SENT_18	[p1l1569t1784r1764b1817],
3	,	,	O	,	_	0	SENT_18	[p1l1569t1784r1764b1817],
4	a	DT	O	a	det	6	SENT_18	[p1l1777t1792r1795b1813],
5	6-wk	JJ	DURATION	6-wk	amod	6	SENT_18	[p1l1808t1784r1893b1813],
6	regimen	NN	O	regimen	nsubj	15	SENT_18	[p1l1904t1784r2047b1820],
7	of	IN	O	of	_	0	SENT_18	[p1l2060t1783r2096b1813],
8	antifilarial	JJ	O	antifilarial	amod	9	SENT_18	[p1l2107t1783r2285b1813],
9	treatment	NN	O	treatment	prep_of	6	SENT_18	[p1l188t1834r365b1859],
10	with	IN	O	with	_	0	SENT_18	[p1l382t1830r457b1859],
11	doxycycline	NN	O	doxycycline	prep_with	9	SENT_18	[p1l477t1830r683b1867],
12	against	IN	O	against	_	0	SENT_18	[p1l701t1830r829b1866],
13	W.	NNP	O	W.	nn	14	SENT_18	[p1l850t1831r889b1858],
14	bancrofti	NN	O	bancroftus	prep_against	11	SENT_18	[p1l909t1829r1066b1859],
15	showed	VBD	O	show	_	0	SENT_18	[p1l1082t1830r1216b1859],
16	a	DT	O	a	det	19	SENT_18	[p1l1235t1838r1253b1859],
17	strong	JJ	O	strong	amod	18	SENT_18	[p1l1273t1834r1384b1866],
18	macrofilaricidal	JJ	O	macrofilaricidal	amod	19	SENT_18	[p1l1405t1829r1675b1859],
19	activity	NN	O	activity	dobj	15	SENT_18	[p1l1695t1830r1823b1867],
20	and	CC	O	and	_	0	SENT_18	[p1l1841t1830r1905b1859],
21	reduction	NN	O	reduction	conj_and	19	SENT_18	[p1l1926t1830r2092b1859],
22	in	IN	O	in	_	0	SENT_18	[p1l2112t1830r2142b1858],
23	plasma	NN	O	plasma	nn	24	SENT_18	[p1l2162t1830r2285b1866],
24	levels	NNS	O	level	prep_in	15	SENT_18	[p1l190t1876r288b1905],
25	of	IN	O	of	_	0	SENT_18	[p1l303t1875r339b1905],
26	VEGF-C/sVEGFR	NN	O	vegf-c/svegfr	prep_of	24	SENT_18	[p1l352t1877r672b1909],
27	-3	CD	NUMBER	-3	num	26	SENT_18	[p1l352t1877r672b1909],
28	,	,	O	,	_	0	SENT_18	[p1l352t1877r672b1909],
29	the	DT	O	the	det	31	SENT_18	[p1l687t1876r743b1905],
30	latter	JJ	O	latter	amod	31	SENT_18	[p1l760t1876r853b1905],
31	being	NN	O	being	appos	26	SENT_18	[p1l869t1876r965b1912],
32	associated	VBN	O	associate	partmod	31	SENT_18	[p1l982t1876r1164b1905],
33	with	IN	O	with	_	0	SENT_18	[p1l1180t1876r1255b1905],
34	amelioration	NN	O	amelioration	prep_with	32	SENT_18	[p1l1272t1876r1495b1905],
35	of	IN	O	of	_	0	SENT_18	[p1l1511t1875r1547b1905],
36	supratesticular	JJ	O	supratesticular	amod	39	SENT_18	[p1l1560t1876r1822b1912],
37	dilated	JJ	O	dilated	amod	39	SENT_18	[p1l1837t1876r1958b1905],
38	lymphatic	JJ	O	lymphatic	amod	39	SENT_18	[p1l1976t1876r2148b1913],
39	vessels	NNS	O	vessel	prep_of	34	SENT_18	[p1l2163t1876r2286b1905],
40	and	CC	O	and	_	0	SENT_18	[p1l189t1921r253b1950],
41	with	IN	O	with	_	0	SENT_18	[p1l268t1921r344b1950],
42	an	DT	O	a	det	43	SENT_18	[p1l360t1929r401b1950],
43	improvement	NN	O	improvement	conj_and	34	SENT_18	[p1l418t1921r655b1957],
44	of	IN	O	of	_	0	SENT_18	[p1l670t1920r706b1950],
45	pathology	NN	O	pathology	prep_of	43	SENT_18	[p1l720t1921r899b1958],
46	in	IN	O	in	_	0	SENT_18	[p1l914t1921r944b1949],
47	lymphatic	JJ	O	lymphatic	amod	49	SENT_18	[p1l962t1921r1134b1958],
48	filariasis	NN	O	filariasis	nn	49	SENT_18	[p1l1148t1920r1294b1950],
49	patients	NNS	O	patient	prep_in	32	SENT_18	[p1l1310t1921r1462b1957],
50	.	.	O	.	_	0	SENT_18	[p1l1310t1921r1462b1957],

1	Citation	NNP	O	Citation	_	0	SENT_19	[p1l188t2000r288b2020],
2	:	:	O	:	_	0	SENT_19	[p1l188t2000r288b2020],
3	Debrah	NNP	ORGANIZATION	Debrah	nn	4	SENT_19	[p1l299t1999r385b2020],
4	AY	NNP	O	AY	dep	1	SENT_19	[p1l395t2000r432b2024],
5	,	,	O	,	_	0	SENT_19	[p1l395t2000r432b2024],
6	Mand	NNP	LOCATION	Mand	nn	7	SENT_19	[p1l442t1999r508b2020],
7	S	NNP	LOCATION	S	appos	4	SENT_19	[p1l519t2000r537b2024],
8	,	,	O	,	_	0	SENT_19	[p1l519t2000r537b2024],
9	Specht	NNP	PERSON	Specht	nn	10	SENT_19	[p1l546t1999r628b2026],
10	S	NNP	O	S	appos	4	SENT_19	[p1l638t2000r656b2024],
11	,	,	O	,	_	0	SENT_19	[p1l638t2000r656b2024],
12	Marfo	NNP	PERSON	Marfo	appos	4	SENT_19	[p1l666t1999r865b2026],
13	.	.	O	.	_	0	SENT_19	[p1l666t1999r865b2026],

1	—	NN	O	—	_	0	SENT_20	[p1l666t1999r865b2026],
2	.	.	O	.	_	0	SENT_20	[p1l666t1999r865b2026],

1	Debrekyei	FW	MISC	debrekyei	nsubj	13	SENT_21	[p1l666t1999r865b2026],
2	Y	NN	O	y	nn	1	SENT_21	[p1l875t2000r895b2024],
3	,	,	O	,	_	0	SENT_21	[p1l875t2000r895b2024],
4	Batsa	NNP	ORGANIZATION	Batsa	nn	5	SENT_21	[p1l905t2000r966b2020],
5	L	NNP	ORGANIZATION	L	appos	1	SENT_21	[p1l977t2000r994b2024],
6	,	,	O	,	_	0	SENT_21	[p1l977t2000r994b2024],
7	et	FW	O	et	dep	1	SENT_21	[p1l1003t2003r1026b2020],
8	al.	FW	O	al.	nn	9	SENT_21	[p1l1034t1999r1059b2020],
9	(	FW	O	(	dep	1	SENT_21	[p1l1069t2000r1141b2024],
10	2006	CD	DATE	2006	num	11	SENT_21	[p1l1069t2000r1141b2024],
11	)	CD	NUMBER	)	dep	1	SENT_21	[p1l1069t2000r1141b2024],
12	Doxycycline	NNP	O	Doxycycline	dep	1	SENT_21	[p1l1153t1999r1295b2026],
13	reduces	VBZ	O	reduce	_	0	SENT_21	[p1l1306t1999r1398b2020],
14	plasma	NN	O	plasma	nn	15	SENT_21	[p1l1408t1999r1492b2026],
15	VEGF-C/sVEGFR	NN	O	vegf-c/svegfr	dobj	13	SENT_21	[p1l1501t2000r1713b2021],
16	-3	CD	NUMBER	-3	num	15	SENT_21	[p1l1501t2000r1713b2021],
17	and	CC	O	and	_	0	SENT_21	[p1l1723t1999r1766b2020],
18	improves	VBZ	O	improve	conj_and	13	SENT_21	[p1l1777t2000r1887b2026],
19	pathology	NN	O	pathology	dobj	18	SENT_21	[p1l1897t1999r2020b2026],
20	in	IN	O	in	_	0	SENT_21	[p1l2029t2000r2049b2020],
21	lymphatic	JJ	O	lymphatic	amod	22	SENT_21	[p1l2060t1999r2178b2026],
22	ﬁlariasis	NN	O	ﬁlariasis	prep_in	18	SENT_21	[p1l2186t1999r2286b2020],
23	.	.	O	.	_	0	SENT_21	[p1l2186t1999r2286b2020],

1	PLoS	NN	O	plo	nn	2	SENT_22	[p1l190t2033r246b2053],
2	Pathog	NN	O	pathog	_	0	SENT_22	[p1l259t2032r342b2059],
3	2	CD	NUMBER	2	number	4	SENT_22	[p1l355t2033r405b2057],
4	(	CD	NUMBER	(	dep	2	SENT_22	[p1l355t2033r405b2057],
5	9	CD	NUMBER	9	num	6	SENT_22	[p1l355t2033r405b2057],
6	)	NN	O	)	dep	4	SENT_22	[p1l355t2033r405b2057],
7	:	:	O	:	_	0	SENT_22	[p1l355t2033r405b2057],
8	e92	NN	O	e92	dep	2	SENT_22	[p1l417t2034r465b2053],
9	.	.	O	.	_	0	SENT_22	[p1l417t2034r465b2053],

1	DOI	NNP	O	DOI	_	0	SENT_23	[p1l478t2033r527b2053],
2	:	:	O	:	_	0	SENT_23	[p1l478t2033r527b2053],
3	10.1371	CD	NUMBER	10.1371	dep	1	SENT_23	[p1l541t2032r900b2059],
4	/	:	O	/	punct	6	SENT_23	[p1l541t2032r900b2059],
5	journa	NN	O	journa	nn	6	SENT_23	[p1l541t2032r900b2059],
6	|	NN	O	|	dep	3	SENT_23	[p1l541t2032r900b2059],
7	.	.	O	.	_	0	SENT_23	[p1l541t2032r900b2059],

1	ppat	NN	O	ppat	_	0	SENT_24	[p1l541t2032r900b2059],
2	.0020092	CD	NUMBER	.0020092	num	1	SENT_24	[p1l541t2032r900b2059],

1	Introduction	NN	O	introduction	_	0	SENT_25	[p1l190t2151r429b2183],

1	Bancroftian	JJ	O	bancroftian	amod	2	SENT_26	[p1l226t2231r421b2257],
2	ﬁlariasis	NN	O	ﬁlariasis	nsubj	6	SENT_26	[p1l442t2231r575b2257],
3	is	VBZ	O	be	cop	6	SENT_26	[p1l598t2232r620b2257],
4	a	DT	O	a	dep	6	SENT_26	[p1l642t2240r658b2257],
5	mosquito-transmitted	JJ	O	mosquito-transmitted	amod	6	SENT_26	[p1l680t2231r1038b2266],
6	parasitic	JJ	O	parasitic	_	0	SENT_26	[p1l1060t2232r1198b2266],

1	Editor	NNP	O	Editor	_	0	SENT_27	[p1l1277t2277r1361b2298],
2	:	:	O	:	_	0	SENT_27	[p1l1277t2277r1361b2298],
3	Kasturi	NNP	PERSON	Kasturi	nn	4	SENT_27	[p1l1375t2278r1454b2298],
4	Haldar	NNP	PERSON	Haldar	dep	1	SENT_27	[p1l1470t2277r1552b2302],
5	,	,	O	,	_	0	SENT_27	[p1l1470t2277r1552b2302],
6	Northwestern	NNP	ORGANIZATION	Northwestern	nn	9	SENT_27	[p1l1567t2277r1731b2298],
7	University	NNP	ORGANIZATION	University	nn	9	SENT_27	[p1l1747t2278r1865b2304],
8	Medical	NNP	ORGANIZATION	Medical	nn	9	SENT_27	[p1l1879t2277r1970b2298],
9	School	NNP	ORGANIZATION	School	appos	4	SENT_27	[p1l1985t2277r2070b2302],
10	,	,	O	,	_	0	SENT_27	[p1l1985t2277r2070b2302],
11	United	NNP	LOCATION	United	nn	12	SENT_27	[p1l2086t2277r2164b2298],
12	States	NNPS	LOCATION	States	nsubj	17	SENT_27	[p1l2179t2278r2250b2298],
13	of	IN	O	of	_	0	SENT_27	[p1l2264t2277r2289b2298],
14	disease	NN	O	disease	prep_of	12	SENT_27	[p1l189t2278r302b2304],
15	of	IN	O	of	_	0	SENT_27	[p1l318t2278r353b2304],
16	humans	NNS	O	human	prep_of	14	SENT_27	[p1l365t2278r492b2304],
17	characterized	VBN	O	characterize	dep	4	SENT_27	[p1l508t2278r728b2304],
18	by	IN	O	by	_	0	SENT_27	[p1l744t2278r781b2313],
19	lymphangitis	NN	O	lymphangitis	prep_by	17	SENT_27	[p1l796t2278r1014b2313],
20	,	,	O	,	_	0	SENT_27	[p1l796t2278r1014b2313],
21	hydrocele	NN	O	hydrocele	prep_by	17	SENT_27	[p1l1031t2278r1198b2313],
22	,	,	O	,	_	0	SENT_27	[p1l1031t2278r1198b2313],
23	A	DT	O	a	det	26	SENT_27	[p1l1276t2311r1292b2331],
24	_	NN	O	_	nn	26	SENT_27	[p1l1343t2311r1346b2314],
25	merlca	NN	O	merlca	nn	26	SENT_27	[p1l1295t2316r1373b2331],
26	lymphedema	NN	O	lymphedema	prep_by	17	SENT_27	[p1l189t2326r406b2361],
27	,	,	O	,	_	0	SENT_27	[p1l189t2326r406b2361],
28	and	CC	O	and	_	0	SENT_27	[p1l434t2326r493b2352],
29	elephantiasis	NN	O	elephantiasis	prep_by	17	SENT_27	[p1l519t2326r738b2361],
30	,	,	O	,	_	0	SENT_27	[p1l519t2326r738b2361],
31	and	CC	O	and	_	0	SENT_27	[p1l765t2326r824b2352],
32	is	VBZ	O	be	auxpass	49	SENT_27	[p1l852t2327r873b2352],
33	one	CD	NUMBER	one	nsubjpass	49	SENT_27	[p1l901t2335r959b2352],
34	of	IN	O	of	_	0	SENT_27	[p1l986t2326r1021b2352],
35	the	DT	O	the	prep_of	33	SENT_27	[p1l1045t2326r1094b2352],
36	most	RBS	O	most	advmod	35	SENT_27	[p1l1122t2331r1199b2352],
37	Received	VBN	O	receive	partmod	35	SENT_27	[p1l1277t2368r1391b2389],
38	December	NNP	DATE	December	dobj	37	SENT_27	[p1l1404t2368r1528b2389],
39	30	CD	DATE	30	num	38	SENT_27	[p1l1540t2370r1573b2393],
40	,	,	DATE	,	_	0	SENT_27	[p1l1540t2370r1573b2393],
41	2005	CD	DATE	2005	num	38	SENT_27	[p1l1585t2370r1648b2393],
42	;	:	O	;	_	0	SENT_27	[p1l1585t2370r1648b2393],
43	Accepted	JJ	O	accepted	amod	38	SENT_27	[p1l1660t2368r1779b2395],
44	July	NNP	DATE	July	tmod	43	SENT_27	[p1l1790t2368r1837b2395],
45	28	CD	DATE	28	num	44	SENT_27	[p1l1848t2370r1882b2393],
46	,	,	DATE	,	_	0	SENT_27	[p1l1848t2370r1882b2393],
47	2006	CD	DATE	2006	num	44	SENT_27	[p1l1894t2370r1957b2393],
48	;	:	O	;	_	0	SENT_27	[p1l1894t2370r1957b2393],
49	Published	VBN	O	publish	conj_and	17	SENT_27	[p1l1970t2368r2096b2389],
50	September	NNP	DATE	September	tmod	49	SENT_27	[p1l2109t2368r2241b2395],
51	15	CD	DATE	15	num	50	SENT_27	[p1l2255t2370r2286b2393],
52	,	,	O	,	_	0	SENT_27	[p1l2255t2370r2286b2393],

1	common	JJ	O	common	amod	2	SENT_28	[p1l189t2383r332b2400],
2	causes	NNS	O	cause	_	0	SENT_28	[p1l347t2383r448b2400],
3	of	IN	O	of	_	0	SENT_28	[p1l464t2374r499b2400],
4	global	JJ	O	global	amod	8	SENT_28	[p1l510t2374r608b2409],
5	disability	NN	O	disability	nn	8	SENT_28	[p1l623t2374r771b2409],
6	[	NN	O	[	nn	8	SENT_28	[p1l788t2374r833b2406],
7	1	CD	NUMBER	1	num	8	SENT_28	[p1l788t2374r833b2406],
8	]	NN	O	]	prep_of	2	SENT_28	[p1l788t2374r833b2406],
9	.	.	O	.	_	0	SENT_28	[p1l788t2374r833b2406],

1	The	DT	O	the	det	2	SENT_29	[p1l849t2374r911b2400],
2	disease	NN	O	disease	nsubj	5	SENT_29	[p1l927t2374r1039b2400],
3	has	VBZ	O	have	aux	5	SENT_29	[p1l1055t2374r1106b2400],
4	been	VBN	O	be	cop	5	SENT_29	[p1l1121t2374r1199b2400],
5	2006	CD	DATE	2006	_	0	SENT_29	[p1l1276t2403r1334b2422],
6	considered	VBN	O	consider	partmod	5	SENT_29	[p1l189t2421r368b2447],
7	to	TO	O	to	aux	10	SENT_29	[p1l386t2426r416b2447],
8	be	VB	O	be	cop	10	SENT_29	[p1l434t2421r471b2447],
9	potentially	RB	O	potentially	advmod	10	SENT_29	[p1l488t2421r664b2456],
10	eradicable	JJ	O	eradicable	xcomp	6	SENT_29	[p1l681t2421r849b2447],
11	due	JJ	O	due	_	0	SENT_29	[p1l866t2421r925b2447],
12	to	TO	O	to	_	0	SENT_29	[p1l943t2426r973b2447],
13	the	DT	O	the	det	14	SENT_29	[p1l992t2421r1041b2447],
14	fact	NN	O	fact	prep_due_to	10	SENT_29	[p1l1059t2421r1118b2447],
15	that	IN	O	that	complm	21	SENT_29	[p1l1136t2421r1199b2447],
16	antiﬁlarial	JJ	O	antiﬁlarial	amod	17	SENT_29	[p1l189t2469r358b2495],
17	drugs	NNS	O	drug	nsubj	21	SENT_29	[p1l382t2469r471b2504],
18	currently	RB	DATE	currently	advmod	19	SENT_29	[p1l495t2469r645b2504],
19	used	VBN	O	use	partmod	17	SENT_29	[p1l668t2469r741b2495],
20	could	MD	O	could	aux	21	SENT_29	[p1l764t2469r853b2495],
21	break	VB	O	break	ccomp	10	SENT_29	[p1l877t2469r968b2495],
22	the	DT	O	the	det	23	SENT_29	[p1l992t2469r1041b2495],
23	cycle	NN	O	cycle	dobj	21	SENT_29	[p1l1065t2469r1144b2504],
24	of	IN	O	of	_	0	SENT_29	[p1l1168t2469r1202b2495],
25	Dol	NN	O	dol	nn	28	SENT_29	[p1l1277t2460r1331b2480],
26	’	CD	NUMBER	’	num	28	SENT_29	[p1l1277t2460r1331b2480],
27	l	NN	O	l	nn	28	SENT_29	[p1l1345t2459r1704b2486],
28	°	NN	O	°	prep_of	23	SENT_29	[p1l1345t2459r1704b2486],
29	'	''	O	'	_	0	SENT_29	[p1l1345t2459r1704b2486],
30	l37l/l	NN	O	l37l/l	dep	23	SENT_29	[p1l1345t2459r1704b2486],
31	°	CD	NUMBER	°	num	32	SENT_29	[p1l1345t2459r1704b2486],
32	”	NN	O	”	dep	30	SENT_29	[p1l1345t2459r1704b2486],
33	'	''	O	'	_	0	SENT_29	[p1l1345t2459r1704b2486],
34	”	CD	NUMBER	”	dep	23	SENT_29	[p1l1345t2459r1704b2486],
35	al	NNP	O	al	nn	37	SENT_29	[p1l1345t2459r1704b2486],
36	‘	NNP	O	‘	nn	37	SENT_29	[p1l1345t2459r1704b2486],
37	ppat	NN	O	ppat	poss	39	SENT_29	[p1l1345t2459r1704b2486],
38	'	POS	O	'	_	0	SENT_29	[p1l1345t2459r1704b2486],
39	0	CD	NUMBER	0	dep	34	SENT_29	[p1l1345t2459r1704b2486],
40	°	CD	NUMBER	°	number	41	SENT_29	[p1l1345t2459r1704b2486],
41	20092	CD	NUMBER	20092	num	42	SENT_29	[p1l1345t2459r1704b2486],
42	tran5mi55i0n	NN	O	tran5mi55i0n	npadvmod	39	SENT_29	[p1l190t2517r396b2542],
43	in	IN	O	in	_	0	SENT_29	[p1l421t2517r451b2541],
44	endemic	JJ	O	endemic	amod	45	SENT_29	[p1l476t2516r613b2542],
45	31rea5	NN	O	31rea5	prep_in	39	SENT_29	[p1l639t2525r729b2542],
46	-	:	O	-	_	0	SENT_29	[p1l639t2525r729b2542],
47	The	DT	O	the	det	48	SENT_29	[p1l754t2516r816b2542],
48	S0315	NN	O	s0315	dep	34	SENT_29	[p1l841t2516r921b2551],
49	of	IN	O	of	_	0	SENT_29	[p1l946t2516r981b2542],
50	the	DT	O	the	det	52	SENT_29	[p1l1003t2516r1052b2542],
51	Current	JJ	DATE	current	amod	52	SENT_29	[p1l1077t2521r1199b2542],
52	Copyright	NN	O	copyright	prep_of	48	SENT_29	[p1l1276t2526r1411b2553],
53	:	:	O	:	_	0	SENT_29	[p1l1276t2526r1411b2553],
54	©	CD	NUMBER	©	num	55	SENT_29	[p1l1424t2527r1444b2548],
55	2006	CD	DATE	2006	dep	34	SENT_29	[p1l1457t2528r1515b2547],
56	Debrah	NNP	ORGANIZATION	Debrah	dep	55	SENT_29	[p1l1528t2526r1614b2547],
57	et	FW	O	et	nn	58	SENT_29	[p1l1627t2530r1650b2547],
58	al.	FW	O	al.	dep	55	SENT_29	[p1l1662t2526r1687b2547],
59	.	.	O	.	_	0	SENT_29	[p1l1662t2526r1687b2547],

1	This	DT	O	this	nsubj	7	SENT_30	[p1l1698t2526r1746b2547],
2	is	VBZ	O	be	cop	7	SENT_30	[p1l1759t2527r1774b2547],
3	an	DT	O	a	det	7	SENT_30	[p1l1787t2532r1814b2547],
4	open	JJ	O	open	amod	7	SENT_30	[p1l1827t2532r1975b2553],
5	—	NN	O	—	nn	7	SENT_30	[p1l1827t2532r1975b2553],
6	access	NN	O	access	nn	7	SENT_30	[p1l1827t2532r1975b2553],
7	article	NN	O	article	_	0	SENT_30	[p1l1987t2526r2059b2547],
8	distributed	VBN	O	distribute	partmod	7	SENT_30	[p1l2072t2526r2203b2547],
9	under	IN	O	under	_	0	SENT_30	[p1l2217t2526r2287b2547],
10	the	DT	O	the	det	11	SENT_30	[p1l1275t2559r1314b2580],
11	terms	NNS	O	term	prep_under	8	SENT_30	[p1l1323t2563r1391b2580],
12	of	IN	O	of	_	0	SENT_30	[p1l1400t2559r1424b2580],
13	the	DT	O	the	det	17	SENT_30	[p1l1430t2559r1469b2580],
14	Creative	NNP	O	Creative	nn	17	SENT_30	[p1l1478t2560r1576b2580],
15	Commons	NNPS	O	Commons	nn	17	SENT_30	[p1l1585t2560r1708b2580],
16	Attribution	NNP	O	Attribution	nn	17	SENT_30	[p1l1717t2559r1849b2580],
17	License	NNP	O	License	prep_of	11	SENT_30	[p1l1859t2560r1952b2584],
18	,	,	O	,	_	0	SENT_30	[p1l1859t2560r1952b2584],
19	which	WDT	O	which	nsubj	20	SENT_30	[p1l1961t2559r2032b2580],
20	permits	VBZ	O	permit	rcmod	11	SENT_30	[p1l2042t2560r2132b2586],
21	unrestricted	JJ	O	unrestricted	amod	22	SENT_30	[p1l2142t2559r2285b2580],
22	use	NN	O	use	dobj	20	SENT_30	[p1l1277t2598r1322b2617],
23	,	,	O	,	_	0	SENT_30	[p1l1277t2598r1322b2617],
24	distribution	NN	O	distribution	dobj	20	SENT_30	[p1l1335t2592r1480b2617],
25	,	,	O	,	_	0	SENT_30	[p1l1335t2592r1480b2617],
26	and	CC	O	and	_	0	SENT_30	[p1l1494t2592r1538b2613],
27	reproduction	NN	O	reproduction	conj_and	22	SENT_30	[p1l1553t2592r1709b2619],
28	in	IN	O	in	_	0	SENT_30	[p1l1724t2593r1743b2613],
29	any	DT	O	any	det	30	SENT_30	[p1l1757t2598r1799b2619],
30	medium	NN	O	medium	prep_in	27	SENT_30	[p1l1813t2592r1918b2617],
31	,	,	O	,	_	0	SENT_30	[p1l1813t2592r1918b2617],
32	provided	VBD	O	provide	prep	20	SENT_30	[p1l1932t2592r2038b2619],
33	the	DT	O	the	det	35	SENT_30	[p1l2052t2592r2091b2613],
34	original	JJ	O	original	amod	35	SENT_30	[p1l2104t2592r2193b2619],
35	author	NN	O	author	nsubjpass	39	SENT_30	[p1l2207t2592r2287b2613],
36	and	CC	O	and	_	0	SENT_30	[p1l1276t2625r1319b2646],
37	source	NN	O	source	nsubjpass	39	SENT_30	[p1l1332t2631r1411b2646],
38	are	VBP	O	be	auxpass	39	SENT_30	[p1l1422t2632r1458b2646],
39	credited	VBN	O	credit	dep	32	SENT_30	[p1l1470t2625r1575b2646],
40	.	.	O	.	_	0	SENT_30	[p1l1470t2625r1575b2646],

1	global	JJ	O	global	amod	4	SENT_31	[p1l189t2564r286b2599],
2	lymphatic	JJ	O	lymphatic	amod	4	SENT_31	[p1l299t2564r460b2599],
3	filariasis	NN	O	filariasis	nn	4	SENT_31	[p1l473t2564r606b2590],
4	(	NN	O	(	nsubj	12	SENT_31	[p1l621t2565r683b2596],
5	LF	NN	O	lf	nn	8	SENT_31	[p1l621t2565r683b2596],
6	)	CD	NUMBER	)	num	8	SENT_31	[p1l621t2565r683b2596],
7	elimination	NN	O	elimination	nn	8	SENT_31	[p1l696t2564r885b2590],
8	program	NN	O	program	dep	4	SENT_31	[p1l898t2573r1039b2599],
9	are	VBP	O	be	cop	12	SENT_31	[p1l1052t2573r1102b2590],
10	(	CD	NUMBER	(	number	11	SENT_31	[p1l1116t2564r1154b2596],
11	1	CD	NUMBER	1	num	12	SENT_31	[p1l1116t2564r1154b2596],
12	)	NN	O	)	_	0	SENT_31	[p1l1116t2564r1154b2596],
13	to	TO	O	to	aux	14	SENT_31	[p1l1168t2569r1198b2590],
14	reduce	VB	O	reduce	infmod	12	SENT_31	[p1l190t2611r299b2637],
15	microﬁlaremia	NN	O	microﬁlaremia	nn	16	SENT_31	[p1l317t2611r559b2637],
16	levels	NNS	O	level	dobj	14	SENT_31	[p1l576t2611r662b2637],
17	with	IN	O	with	_	0	SENT_31	[p1l679t2611r749b2637],
18	ﬁlaricidal	JJ	O	ﬁlaricidal	amod	19	SENT_31	[p1l766t2611r920b2637],
19	drugs	NNS	O	drug	prep_with	14	SENT_31	[p1l938t2611r1026b2646],
20	to	TO	O	to	_	0	SENT_31	[p1l1045t2616r1075b2637],
21	a	DT	O	a	det	22	SENT_31	[p1l1094t2620r1110b2637],
22	level	NN	O	level	prep_to	14	SENT_31	[p1l1126t2611r1199b2637],
23	that	WDT	O	that	nsubj	26	SENT_31	[p1l190t2659r253b2685],
24	is	VBZ	O	be	cop	26	SENT_31	[p1l269t2660r291b2685],
25	too	RB	O	too	advmod	26	SENT_31	[p1l308t2664r359b2685],
26	low	JJ	O	low	rcmod	22	SENT_31	[p1l375t2659r430b2685],
27	to	TO	O	to	aux	28	SENT_31	[p1l446t2665r476b2685],
28	Sustain	VB	O	sustain	xcomp	26	SENT_31	[p1l492t2660r604b2685],
29	transmission	NN	O	transmission	dobj	28	SENT_31	[p1l621t2660r826b2685],
30	of	IN	O	of	_	0	SENT_31	[p1l842t2659r877b2685],
31	ﬁlarial	JJ	O	ﬁlarial	amod	32	SENT_31	[p1l889t2659r993b2685],
32	parasites	NNS	O	parasite	prep_of	29	SENT_31	[p1l1009t2660r1151b2694],
33	to	TO	O	to	_	0	SENT_31	[p1l1168t2664r1198b2685],
34	Abbreviations	NNPS	O	Abbreviations	prep_to	28	SENT_31	[p1l1276t2684r1465b2705],
35	:	:	O	:	_	0	SENT_31	[p1l1276t2684r1465b2705],
36	ADL	NNP	ORGANIZATION	ADL	conj_and	12	SENT_31	[p1l1483t2685r1538b2709],
37	,	,	O	,	_	0	SENT_31	[p1l1483t2685r1538b2709],
38	adenolymphangitis	NN	O	adenolymphangitis	appos	36	SENT_31	[p1l1556t2684r1796b2711],
39	;	:	O	;	_	0	SENT_31	[p1l1556t2684r1796b2711],
40	CFA	NNP	O	CFA	dep	38	SENT_31	[p1l1813t2685r1866b2709],
41	,	,	O	,	_	0	SENT_31	[p1l1813t2685r1866b2709],
42	circulating	VBG	O	circulate	partmod	36	SENT_31	[p1l1884t2684r2009b2711],
43	ﬁlarial	JJ	O	ﬁlarial	amod	44	SENT_31	[p1l2027t2684r2097b2705],
44	antigen	NN	O	antigen	dobj	42	SENT_31	[p1l2116t2685r2214b2711],
45	;	:	O	;	_	0	SENT_31	[p1l2116t2685r2214b2711],
46	DEC	NNP	ORGANIZATION	DEC	dep	36	SENT_31	[p1l2233t2685r2286b2709],
47	,	,	O	,	_	0	SENT_31	[p1l2233t2685r2286b2709],
48	humans	NNS	O	human	appos	46	SENT_31	[p1l189t2707r324b2738],
49	;	:	O	;	_	0	SENT_31	[p1l189t2707r324b2738],
50	and	CC	O	and	_	0	SENT_31	[p1l348t2707r407b2733],
51	(	NN	O	(	nn	53	SENT_31	[p1l432t2707r470b2739],
52	2	CD	NUMBER	2	num	53	SENT_31	[p1l432t2707r470b2739],
53	)	NN	O	)	conj_and	12	SENT_31	[p1l432t2707r470b2739],
54	to	TO	O	to	aux	55	SENT_31	[p1l494t2712r524b2733],
55	reduce	VB	O	reduce	infmod	53	SENT_31	[p1l549t2707r659b2733],
56	the	DT	O	the	det	57	SENT_31	[p1l683t2707r732b2733],
57	morbidity	NN	O	morbidity	dobj	55	SENT_31	[p1l757t2707r919b2742],
58	associated	VBN	O	associate	partmod	57	SENT_31	[p1l942t2707r1106b2733],
59	with	IN	O	with	_	0	SENT_31	[p1l1129t2707r1199b2733],
60	chronic	JJ	O	chronic	amod	65	SENT_31	[p1l189t2754r312b2780],
61	ﬁlarial	JJ	O	ﬁlarial	amod	65	SENT_31	[p1l328t2754r432b2780],
62	disease	NN	O	disease	nn	65	SENT_31	[p1l448t2754r561b2780],
63	[	NN	O	[	nn	65	SENT_31	[p1l578t2754r623b2786],
64	2	CD	NUMBER	2	num	65	SENT_31	[p1l578t2754r623b2786],
65	]	NN	O	]	prep_with	58	SENT_31	[p1l578t2754r623b2786],
66	.	.	O	.	_	0	SENT_31	[p1l578t2754r623b2786],

1	The	DT	O	the	det	3	SENT_32	[p1l226t2803r288b2829],
2	antiﬁlarial	JJ	O	antiﬁlarial	amod	3	SENT_32	[p1l309t2803r478b2829],
3	drugs	NNS	O	drug	nsubj	16	SENT_32	[p1l499t2803r587b2838],
4	currently	RB	DATE	currently	advmod	5	SENT_32	[p1l608t2803r758b2838],
5	used	VBN	O	use	partmod	3	SENT_32	[p1l777t2803r858b2834],
6	,	,	O	,	_	0	SENT_32	[p1l777t2803r858b2834],
7	diethylcarbamazine	NN	O	diethylcarbamazine	nn	9	SENT_32	[p1l879t2803r1198b2838],
8	(	CD	NUMBER	(	num	9	SENT_32	[p1l190t2851r284b2883],
9	DEC	NNP	ORGANIZATION	DEC	appos	3	SENT_32	[p1l190t2851r284b2883],
10	)	NN	O	)	dep	9	SENT_32	[p1l190t2851r284b2883],
11	and	CC	O	and	_	0	SENT_32	[p1l313t2851r372b2877],
12	ivermectin	NN	O	ivermectin	dep	9	SENT_32	[p1l401t2852r584b2882],
13	,	,	O	,	_	0	SENT_32	[p1l401t2852r584b2882],
14	are	VBP	O	be	cop	16	SENT_32	[p1l613t2860r662b2877],
15	predominantly	RB	O	predominantly	advmod	16	SENT_32	[p1l691t2851r935b2886],
16	active	JJ	O	active	_	0	SENT_32	[p1l963t2852r1057b2877],
17	against	IN	O	against	_	0	SENT_32	[p1l1085t2852r1199b2886],
18	microﬁlariae	FW	O	microﬁlariae	nn	21	SENT_32	[p1l189t2898r399b2924],
19	(	FW	O	(	nn	21	SENT_32	[p1l415t2899r495b2930],
20	MF	NN	O	mf	nn	21	SENT_32	[p1l415t2899r495b2930],
21	)	NN	O	)	prep_against	16	SENT_32	[p1l415t2899r495b2930],
22	,	,	O	,	_	0	SENT_32	[p1l415t2899r495b2930],
23	with	IN	O	with	mark	31	SENT_32	[p1l511t2898r580b2924],
24	DEC	NNP	DATE	DEC	nsubj	31	SENT_32	[p1l595t2898r668b2924],
25	showing	VBG	O	show	partmod	24	SENT_32	[p1l684t2898r816b2933],
26	partial	JJ	O	partial	amod	27	SENT_32	[p1l831t2898r938b2933],
27	activity	NN	O	activity	dobj	25	SENT_32	[p1l953t2899r1070b2933],
28	against	IN	O	against	_	0	SENT_32	[p1l1086t2899r1199b2933],
29	adult	JJ	O	adult	amod	30	SENT_32	[p1l189t2946r272b2972],
30	worms	NNS	O	worm	prep_against	25	SENT_32	[p1l282t2955r388b2972],
31	[	VBP	O	[	dep	21	SENT_32	[p1l402t2946r447b2978],
32	3	CD	NUMBER	3	num	33	SENT_32	[p1l402t2946r447b2978],
33	]	NN	O	]	dobj	31	SENT_32	[p1l402t2946r447b2978],
34	.	.	O	.	_	0	SENT_32	[p1l402t2946r447b2978],

1	Mass	JJ	O	mass	amod	3	SENT_33	[p1l459t2947r535b2972],
2	drug	NN	O	drug	nn	3	SENT_33	[p1l547t2946r622b2981],
3	applications	NNS	O	application	_	0	SENT_33	[p1l633t2946r831b2981],
4	using	VBG	O	use	partmod	3	SENT_33	[p1l843t2947r929b2981],
5	DEC	NNP	DATE	DEC	dobj	4	SENT_33	[p1l939t2946r1020b2977],
6	,	,	O	,	_	0	SENT_33	[p1l939t2946r1020b2977],
7	which	WDT	O	which	nsubj	8	SENT_33	[p1l1032t2946r1127b2972],
8	acts	VBZ	O	act	rcmod	5	SENT_33	[p1l1139t2951r1198b2972],
9	on	IN	O	on	_	0	SENT_33	[p1l189t3002r230b3019],
10	the	DT	O	the	det	12	SENT_33	[p1l244t2993r293b3019],
11	adult	JJ	O	adult	amod	12	SENT_33	[p1l308t2993r390b3019],
12	worms	NNS	O	worm	prep_on	8	SENT_33	[p1l402t3002r508b3019],
13	that	WDT	O	that	nsubjpass	15	SENT_33	[p1l523t2993r586b3019],
14	are	VBP	O	be	auxpass	15	SENT_33	[p1l600t3002r649b3019],
15	believed	VBN	O	believe	rcmod	12	SENT_33	[p1l662t2993r797b3019],
16	to	TO	O	to	aux	19	SENT_33	[p1l812t2998r842b3019],
17	be	VB	O	be	cop	19	SENT_33	[p1l855t2993r892b3019],
18	major	JJ	O	major	amod	19	SENT_33	[p1l906t2993r1002b3028],
19	inducers	NNS	O	inducer	xcomp	15	SENT_33	[p1l1015t2993r1154b3019],
20	of	IN	O	of	prep	19	SENT_33	[p1l1168t2993r1202b3019],

1	W	NN	O	w	_	0	SENT_34	[p1l188t3077r261b3136],
2	?	.	O	?	_	0	SENT_34	[p1l188t3077r261b3136],

1	,	,	O	,	_	0	SENT_35	[p1l188t3077r261b3136],
2	PLoS	NN	O	plo	nsubj	3	SENT_35	[p1l288t3093r352b3116],
3	Pathogens	VBD	O	pathogen	_	0	SENT_35	[p1l367t3092r511b3123],
4	|	CD	NUMBER	|	num	5	SENT_35	[p1l526t3091r528b3124],
5	www	NN	O	www	dep	3	SENT_35	[p1l543t3092r882b3123],
6	.	.	O	.	_	0	SENT_35	[p1l543t3092r882b3123],

1	p	NN	O	p	nn	4	SENT_36	[p1l543t3092r882b3123],
2	|	CD	NUMBER	|	num	4	SENT_36	[p1l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	nn	4	SENT_36	[p1l543t3092r882b3123],
4	diethylcarbamazine	NN	O	diethylcarbamazine	_	0	SENT_36	[p1l1276t2717r1519b2744],
5	;	:	O	;	_	0	SENT_36	[p1l1276t2717r1519b2744],
6	ELISA	NN	LOCATION	elisa	dep	4	SENT_36	[p1l1529t2718r1598b2742],
7	,	,	O	,	_	0	SENT_36	[p1l1529t2718r1598b2742],
8	enzyme	NN	O	enzyme	nn	9	SENT_36	[p1l1607t2717r1782b2744],
9	—	NN	O	—	appos	4	SENT_36	[p1l1607t2717r1782b2744],
10	linked	VBN	O	link	partmod	9	SENT_36	[p1l1607t2717r1782b2744],
11	immunosorbent	JJ	O	immunosorbent	amod	12	SENT_36	[p1l1793t2717r1988b2738],
12	assay	NN	O	assay	dobj	10	SENT_36	[p1l1997t2723r2065b2744],
13	;	:	O	;	_	0	SENT_36	[p1l1997t2723r2065b2744],
14	FDS	NNP	O	FDS	dep	9	SENT_36	[p1l2075t2718r2126b2742],
15	,	,	O	,	_	0	SENT_36	[p1l2075t2718r2126b2742],
16	ﬁlarial	JJ	O	ﬁlarial	amod	18	SENT_36	[p1l2134t2717r2205b2738],
17	dance	NN	O	dance	nn	18	SENT_36	[p1l2214t2717r2286b2738],
18	sign	NN	O	sign	appos	14	SENT_36	[p1l1276t2751r1331b2777],
19	;	:	O	;	_	0	SENT_36	[p1l1276t2751r1331b2777],
20	GM	NNP	ORGANIZATION	GM	dep	14	SENT_36	[p1l1342t2751r1388b2775],
21	,	,	O	,	_	0	SENT_36	[p1l1342t2751r1388b2775],
22	geometric	JJ	O	geometric	amod	23	SENT_36	[p1l1399t2751r1522b2777],
23	means	NNS	O	means	appos	20	SENT_36	[p1l1534t2756r1618b2775],
24	;	:	O	;	_	0	SENT_36	[p1l1534t2756r1618b2775],
25	IL	NN	O	il	dep	14	SENT_36	[p1l1630t2751r1653b2775],
26	,	,	O	,	_	0	SENT_36	[p1l1630t2751r1653b2775],
27	interleukin	NN	O	interleukin	appos	25	SENT_36	[p1l1665t2750r1799b2775],
28	;	:	O	;	_	0	SENT_36	[p1l1665t2750r1799b2775],
29	LF	NNP	O	LF	dep	14	SENT_36	[p1l1811t2751r1842b2775],
30	,	,	O	,	_	0	SENT_36	[p1l1811t2751r1842b2775],
31	lymphatic	JJ	O	lymphatic	amod	32	SENT_36	[p1l1854t2750r1972b2777],
32	ﬁlariasis	NN	O	ﬁlariasis	appos	29	SENT_36	[p1l1983t2750r2083b2775],
33	;	:	O	;	_	0	SENT_36	[p1l1983t2750r2083b2775],
34	MF	NN	O	mf	dep	14	SENT_36	[p1l2095t2751r2136b2775],
35	,	,	O	,	_	0	SENT_36	[p1l2095t2751r2136b2775],
36	microﬁlaria	NN	O	microﬁlaria	appos	34	SENT_36	[p1l2148t2750r2286b2775],
37	;	:	O	;	_	0	SENT_36	[p1l2148t2750r2286b2775],
38	SD	NN	O	sd	dep	14	SENT_36	[p1l1276t2784r1314b2808],
39	,	,	O	,	_	0	SENT_36	[p1l1276t2784r1314b2808],
40	standard	JJ	O	standard	amod	41	SENT_36	[p1l1332t2783r1436b2804],
41	deviations	NNS	O	deviation	appos	38	SENT_36	[p1l1455t2783r1585b2808],
42	;	:	O	;	_	0	SENT_36	[p1l1455t2783r1585b2808],
43	sVEGFR-3	NN	O	svegfr-3	dep	14	SENT_36	[p1l1603t2784r1722b2808],
44	,	,	O	,	_	0	SENT_36	[p1l1603t2784r1722b2808],
45	soluble	JJ	O	soluble	amod	50	SENT_36	[p1l1740t2783r1826b2804],
46	vascular	JJ	O	vascular	amod	47	SENT_36	[p1l1844t2783r1941b2804],
47	endothelial	JJ	O	endothelial	amod	50	SENT_36	[p1l1959t2783r2093b2804],
48	growth	NN	O	growth	nn	50	SENT_36	[p1l2112t2783r2198b2810],
49	factor	NN	O	factor	nn	50	SENT_36	[p1l2217t2783r2287b2804],
50	receptor-3	NN	O	receptor-3	appos	43	SENT_36	[p1l1277t2818r1407b2843],
51	;	:	O	;	_	0	SENT_36	[p1l1277t2818r1407b2843],
52	TNF	NN	O	tnf	dep	14	SENT_36	[p1l1425t2817r1478b2841],
53	,	,	O	,	_	0	SENT_36	[p1l1425t2817r1478b2841],
54	tumor	NN	O	tumor	nn	56	SENT_36	[p1l1498t2820r1572b2837],
55	necrosis	NN	O	necrosis	nn	56	SENT_36	[p1l1592t2817r1688b2837],
56	factor	NN	O	factor	appos	52	SENT_36	[p1l1707t2816r1782b2841],
57	;	:	O	;	_	0	SENT_36	[p1l1707t2816r1782b2841],
58	USG	NNP	O	USG	dep	14	SENT_36	[p1l1803t2817r1857b2841],
59	,	,	O	,	_	0	SENT_36	[p1l1803t2817r1857b2841],
60	ultrasonography	NN	O	ultrasonography	appos	58	SENT_36	[p1l1878t2816r2083b2843],
61	;	:	O	;	_	0	SENT_36	[p1l1878t2816r2083b2843],
62	VEGF	NN	O	vegf	dep	14	SENT_36	[p1l2102t2817r2170b2841],
63	,	,	O	,	_	0	SENT_36	[p1l2102t2817r2170b2841],
64	vascular	JJ	O	vascular	amod	67	SENT_36	[p1l2190t2816r2287b2837],
65	endothelial	JJ	O	endothelial	amod	67	SENT_36	[p1l1276t2850r1410b2871],
66	growth	NN	O	growth	nn	67	SENT_36	[p1l1423t2850r1509b2877],
67	factor	NN	O	factor	appos	62	SENT_36	[p1l1521t2850r1597b2875],
68	;	:	O	;	_	0	SENT_36	[p1l1521t2850r1597b2875],
69	VEGFR	NNP	O	VEGFR	dep	14	SENT_36	[p1l1608t2851r1715b2875],
70	»	CD	NUMBER	»	number	71	SENT_36	[p1l1608t2851r1715b2875],
71	3	CD	NUMBER	3	num	78	SENT_36	[p1l1608t2851r1715b2875],
72	,	,	O	,	_	0	SENT_36	[p1l1608t2851r1715b2875],
73	vascular	JJ	O	vascular	amod	78	SENT_36	[p1l1727t2850r1824b2871],
74	endothelial	JJ	O	endothelial	amod	78	SENT_36	[p1l1835t2850r1970b2871],
75	growth	NN	O	growth	nn	78	SENT_36	[p1l1982t2850r2068b2877],
76	factor	NN	O	factor	nn	78	SENT_36	[p1l2080t2850r2150b2871],
77	receptor	NN	O	receptor	nn	78	SENT_36	[p1l2162t2852r2285b2877],
78	»	NN	O	»	dep	69	SENT_36	[p1l2162t2852r2285b2877],
79	3	CD	NUMBER	3	dep	69	SENT_36	[p1l2162t2852r2285b2877],

1	*	NN	O	*	_	0	SENT_37	[p1l1276t2908r1286b2918],
2	To	TO	O	to	_	0	SENT_37	[p1l1297t2908r1326b2928],
3	whom	WP	O	whom	dobj	7	SENT_37	[p1l1338t2907r1413b2928],
4	correspondence	NN	O	correspondence	nsubjpass	7	SENT_37	[p1l1425t2907r1621b2934],
5	should	MD	O	should	aux	7	SENT_37	[p1l1633t2907r1712b2928],
6	be	VB	O	be	auxpass	7	SENT_37	[p1l1726t2907r1754b2928],
7	addressed	VBN	O	address	prepc_to	1	SENT_37	[p1l1766t2907r1895b2928],
8	.	.	O	.	_	0	SENT_37	[p1l1766t2907r1895b2928],

1	E	NN	O	e	_	0	SENT_38	[p1l1907t2907r1985b2928],
2	»	CD	NUMBER	»	num	1	SENT_38	[p1l1907t2907r1985b2928],
3	mai	FW	O	mai	nn	4	SENT_38	[p1l1907t2907r1985b2928],
4	|	FW	O	|	dep	1	SENT_38	[p1l1907t2907r1985b2928],
5	:	:	O	:	_	0	SENT_38	[p1l1907t2907r1985b2928],
6	hoerauf@parasit.meb	NN	O	hoerauf@parasit.meb	dep	1	SENT_38	[p1l1998t2907r2260b2934],
7	.	.	O	.	_	0	SENT_38	[p1l1998t2907r2260b2934],

1	uni	FW	O	uni	_	0	SENT_39	[p1l1277t2940r1423b2961],
2	—	FW	O	—	nn	3	SENT_39	[p1l1277t2940r1423b2961],
3	bonn	FW	O	bonn	dep	1	SENT_39	[p1l1277t2940r1423b2961],
4	.	.	O	.	_	0	SENT_39	[p1l1277t2940r1423b2961],

1	de	IN	O	de	_	0	SENT_40	[p1l1277t2940r1423b2961],

1	9	CD	NUMBER	9	nsubj	4	SENT_41	[p1l1277t2997r1299b3018],
2	These	DT	O	these	det	3	SENT_41	[p1l1310t2997r1381b3018],
3	authors	NNS	O	author	dep	1	SENT_41	[p1l1392t2997r1483b3018],
4	contributed	VBD	O	contribute	_	0	SENT_41	[p1l1495t2997r1636b3018],
5	equally	RB	O	equally	advmod	4	SENT_41	[p1l1649t2997r1735b3024],
6	to	TO	O	to	_	0	SENT_41	[p1l1746t3001r1770b3018],
7	this	DT	O	this	det	8	SENT_41	[p1l1781t2997r1824b3018],
8	work	NN	O	work	prep_to	4	SENT_41	[p1l1835t2997r1900b3018],
9	.	.	O	.	_	0	SENT_41	[p1l1835t2997r1900b3018],

1	the	DT	O	the	det	3	SENT_42	[p2l190t1514r239b1540],
2	lymphatic	JJ	O	lymphatic	amod	3	SENT_42	[p2l258t1514r419b1549],
3	pathology	NN	O	pathology	dep	7	SENT_42	[p2l438t1514r607b1549],
4	,	,	O	,	_	0	SENT_42	[p2l438t1514r607b1549],
5	have	VBP	O	have	aux	7	SENT_42	[p2l626t1514r699b1540],
6	been	VBN	O	be	auxpass	7	SENT_42	[p2l717t1514r795b1540],
7	reported	VBN	O	report	_	0	SENT_42	[p2l814t1514r957b1549],
8	to	TO	O	to	aux	9	SENT_42	[p2l977t1519r1007b1540],
9	lead	VB	O	lead	xcomp	7	SENT_42	[p2l1026t1514r1092b1540],
10	to	TO	O	to	_	0	SENT_42	[p2l1112t1519r1142b1540],
11	an	DT	O	a	det	12	SENT_42	[p2l1161t1523r1199b1540],
12	improvement	NN	O	improvement	prep_to	9	SENT_42	[p2l189t1561r411b1596],
13	of	IN	O	of	_	0	SENT_42	[p2l437t1561r472b1587],
14	pre-existing	JJ	O	pre-existing	amod	15	SENT_42	[p2l496t1561r692b1596],
15	lymphedema	NN	O	lymphedema	prep_of	12	SENT_42	[p2l717t1561r927b1596],
16	and	CC	O	and	_	0	SENT_42	[p2l954t1561r1013b1587],
17	hydrocele	NN	O	hydrocele	prep_of	12	SENT_42	[p2l1039t1561r1199b1596],
18	[	CD	NUMBER	[	number	19	SENT_42	[p2l191t1607r265b1639],
19	4,5	CD	NUMBER	4,5	num	20	SENT_42	[p2l191t1607r265b1639],
20	]	NN	O	]	dobj	9	SENT_42	[p2l191t1607r265b1639],
21	;	:	O	;	_	0	SENT_42	[p2l191t1607r265b1639],
22	similar	JJ	O	similar	amod	23	SENT_42	[p2l277t1607r389b1633],
23	ﬁndings	NNS	O	ﬁndings	dep	20	SENT_42	[p2l399t1607r528b1642],
24	were	VBD	O	be	auxpass	25	SENT_42	[p2l540t1616r616b1633],
25	observed	VBN	O	observe	rcmod	23	SENT_42	[p2l628t1607r773b1633],
26	in	IN	O	in	_	0	SENT_42	[p2l786t1607r816b1632],
27	a	DT	O	a	det	30	SENT_42	[p2l829t1616r845b1633],
28	controlled	JJ	O	controlled	amod	30	SENT_42	[p2l856t1607r1025b1633],
29	treatment	NN	O	treatment	nn	30	SENT_42	[p2l1038t1612r1199b1633],
30	study	NN	O	study	prep_in	25	SENT_42	[p2l189t1653r275b1688],
31	using	VBG	O	use	partmod	30	SENT_42	[p2l293t1653r380b1688],
32	different	JJ	O	different	amod	33	SENT_42	[p2l399t1653r543b1679],
33	regimens	NNS	O	regimen	dobj	31	SENT_42	[p2l563t1653r710b1688],
34	of	IN	O	of	_	0	SENT_42	[p2l731t1653r766b1679],
35	DEC	NNP	DATE	DEC	prep_of	33	SENT_42	[p2l781t1653r854b1679],
36	[	CD	NUMBER	[	num	35	SENT_42	[p2l877t1653r922b1685],
37	6	CD	NUMBER	6	num	38	SENT_42	[p2l877t1653r922b1685],
38	]	NN	O	]	nsubjpass	7	SENT_42	[p2l877t1653r922b1685],
39	.	.	O	.	_	0	SENT_42	[p2l877t1653r922b1685],

1	However	RB	O	however	advmod	7	SENT_43	[p2l943t1654r1095b1684],
2	,	,	O	,	_	0	SENT_43	[p2l943t1654r1095b1684],
3	these	DT	O	these	det	4	SENT_43	[p2l1117t1653r1199b1679],
4	results	NNS	O	result	nsubj	7	SENT_43	[p2l189t1699r293b1725],
5	are	VBP	O	be	cop	7	SENT_43	[p2l309t1708r358b1725],
6	not	RB	O	not	neg	7	SENT_43	[p2l373t1704r427b1725],
7	unequivocal	JJ	O	unequivocal	dep	15	SENT_43	[p2l441t1699r647b1734],
8	,	,	O	,	_	0	SENT_43	[p2l441t1699r647b1734],
9	since	IN	O	since	_	0	SENT_43	[p2l662t1699r743b1725],
10	several	JJ	O	several	amod	12	SENT_43	[p2l757t1699r868b1725],
11	other	JJ	O	other	amod	12	SENT_43	[p2l882t1699r970b1725],
12	studies	NNS	O	study	prep_since	7	SENT_43	[p2l984t1699r1095b1725],
13	could	MD	O	could	aux	15	SENT_43	[p2l1110t1699r1199b1725],
14	not	RB	O	not	neg	15	SENT_43	[p2l189t1750r243b1771],
15	conﬁrm	VB	O	conﬁrm	_	0	SENT_43	[p2l257t1745r386b1771],
16	these	DT	O	these	det	17	SENT_43	[p2l400t1745r482b1771],
17	ﬁndings	NNS	O	ﬁndings	dobj	15	SENT_43	[p2l496t1745r625b1780],
18	even	RB	O	even	advmod	15	SENT_43	[p2l640t1754r714b1771],
19	when	WRB	O	when	advmod	22	SENT_43	[p2l727t1745r813b1771],
20	DEC	NNP	ORGANIZATION	DEC	nsubjpass	22	SENT_43	[p2l826t1745r899b1771],
21	was	VBD	O	be	auxpass	22	SENT_43	[p2l913t1754r969b1771],
22	administered	VBN	O	administer	advcl	15	SENT_43	[p2l984t1745r1199b1771],
23	for	IN	O	for	_	0	SENT_43	[p2l189t1792r237b1818],
24	12	CD	NUMBER	12	num	25	SENT_43	[p2l258t1792r291b1819],
25	d	NN	O	d	prep_for	22	SENT_43	[p2l311t1792r330b1818],
26	instead	RB	O	instead	_	0	SENT_43	[p2l349t1792r465b1818],
27	of	IN	O	of	_	0	SENT_43	[p2l484t1792r519b1818],
28	the	DT	O	the	det	31	SENT_43	[p2l535t1792r585b1818],
29	usual	JJ	O	usual	amod	31	SENT_43	[p2l603t1792r687b1818],
30	single	JJ	O	single	amod	31	SENT_43	[p2l706t1792r799b1827],
31	dose	NN	O	dose	prep_instead_of	25	SENT_43	[p2l818t1792r890b1818],
32	of	IN	O	of	_	0	SENT_43	[p2l909t1792r944b1818],
33	the	DT	O	the	det	36	SENT_43	[p2l960t1792r1010b1818],
34	mass	NN	O	mass	nn	36	SENT_43	[p2l1030t1801r1104b1818],
35	drug	NN	O	drug	nn	36	SENT_43	[p2l1124t1792r1200b1827],
36	administration	NN	O	administration	prep_of	31	SENT_43	[p2l189t1838r432b1864],
37	(	CD	NUMBER	(	num	38	SENT_43	[p2l458t1838r563b1871],
38	MDA	NN	ORGANIZATION	mda	tmod	22	SENT_43	[p2l458t1838r563b1871],
39	)	CD	NUMBER	)	num	40	SENT_43	[p2l458t1838r563b1871],
40	[	NN	O	[	dep	38	SENT_43	[p2l590t1835r693b1870],
41	7	CD	NUMBER	7	num	44	SENT_43	[p2l590t1835r693b1870],
42	—	NN	O	—	nn	44	SENT_43	[p2l590t1835r693b1870],
43	12	CD	NUMBER	12	num	44	SENT_43	[p2l590t1835r693b1870],
44	]	NN	O	]	nsubj	15	SENT_43	[p2l590t1835r693b1870],
45	.	.	O	.	_	0	SENT_43	[p2l590t1835r693b1870],

1	This	DT	O	this	det	2	SENT_44	[p2l719t1838r788b1864],
2	inconsistency	NN	O	inconsistency	nsubjpass	5	SENT_44	[p2l813t1838r1033b1873],
3	was	VBD	O	be	auxpass	5	SENT_44	[p2l1056t1847r1112b1864],
4	also	RB	O	also	advmod	5	SENT_44	[p2l1138t1838r1198b1864],
5	acknowledged	VBN	O	acknowledge	_	0	SENT_44	[p2l189t1884r419b1919],
6	in	IN	O	in	_	0	SENT_44	[p2l439t1884r469b1909],
7	a	DT	O	a	det	8	SENT_44	[p2l489t1893r505b1910],
8	conference	NN	O	conference	prep_in	5	SENT_44	[p2l523t1884r704b1910],
9	by	IN	O	by	_	0	SENT_44	[p2l723t1884r760b1919],
10	experts	NNS	O	expert	prep_by	8	SENT_44	[p2l779t1889r897b1919],
11	of	IN	O	of	_	0	SENT_44	[p2l917t1884r952b1910],
12	the	DT	O	the	det	15	SENT_44	[p2l968t1884r1018b1910],
13	“	CD	NUMBER	“	num	15	SENT_44	[p2l1037t1883r1198b1910],
14	Filariasis	NNP	ORGANIZATION	Filariasis	nn	15	SENT_44	[p2l1037t1883r1198b1910],
15	Community	NNP	ORGANIZATION	Community	prep_of	10	SENT_44	[p2l189t1930r383b1965],
16	of	IN	ORGANIZATION	of	_	0	SENT_44	[p2l398t1930r432b1956],
17	Scientists	NNS	ORGANIZATION	scientist	prep_of	15	SENT_44	[p2l444t1930r596b1956],
18	in	IN	ORGANIZATION	in	_	0	SENT_44	[p2l611t1930r642b1955],
19	Association	NNP	ORGANIZATION	Association	prep_in	17	SENT_44	[p2l656t1930r845b1956],
20	with	IN	O	with	_	0	SENT_44	[p2l859t1930r929b1956],
21	an	DT	O	a	det	24	SENT_44	[p2l944t1939r982b1956],
22	LF	NNP	O	LF	nn	24	SENT_44	[p2l996t1931r1038b1955],
23	Research	NNP	O	Research	nn	24	SENT_44	[p2l1052t1930r1199b1956],
24	Forum	NNP	O	Forum	prep_with	5	SENT_44	[p2l188t1975r315b2002],
25	”	CD	NUMBER	”	num	24	SENT_44	[p2l188t1975r315b2002],
26	convened	VBN	O	convene	partmod	24	SENT_44	[p2l332t1976r487b2002],
27	in	IN	O	in	_	0	SENT_44	[p2l503t1976r533b2001],
28	Philadelphia	NNP	LOCATION	Philadelphia	prep_in	26	SENT_44	[p2l548t1976r760b2011],
29	,	,	O	,	_	0	SENT_44	[p2l548t1976r760b2011],
30	December	NNP	DATE	December	appos	28	SENT_44	[p2l775t1976r943b2002],
31	2003	CD	DATE	2003	num	30	SENT_44	[p2l958t1976r1032b2003],
32	[	CD	NUMBER	[	number	33	SENT_44	[p2l1050t1976r1114b2008],
33	13	CD	NUMBER	13	num	34	SENT_44	[p2l1050t1976r1114b2008],
34	]	NN	O	]	dep	30	SENT_44	[p2l1050t1976r1114b2008],
35	.	.	O	.	_	0	SENT_44	[p2l1050t1976r1114b2008],

1	Thus	RB	O	thus	advmod	25	SENT_45	[p2l226t2023r314b2054],
2	,	,	O	,	_	0	SENT_45	[p2l226t2023r314b2054],
3	a	DT	O	a	det	4	SENT_45	[p2l334t2032r351b2049],
4	drug	NN	O	drug	nsubj	25	SENT_45	[p2l370t2023r446b2058],
5	with	IN	O	with	_	0	SENT_45	[p2l464t2023r534b2049],
6	stronger	JJR	O	stronger	amod	8	SENT_45	[p2l553t2028r691b2058],
7	macroﬁlaricidal	NN	O	macroﬁlaricidal	nn	8	SENT_45	[p2l710t2023r969b2049],
8	activity	NN	O	activity	prep_with	4	SENT_45	[p2l989t2023r1107b2058],
9	than	IN	O	than	advmod	10	SENT_45	[p2l1127t2023r1199b2049],
10	reported	VBN	O	report	partmod	8	SENT_45	[p2l189t2069r333b2104],
11	for	IN	O	for	_	0	SENT_45	[p2l356t2069r404b2095],
12	DEC	NNP	ORGANIZATION	DEC	prep_for	10	SENT_45	[p2l426t2069r507b2100],
13	,	,	O	,	_	0	SENT_45	[p2l426t2069r507b2100],
14	which	WDT	O	which	nsubj	16	SENT_45	[p2l531t2069r626b2095],
15	simultaneously	RB	O	simultaneously	advmod	16	SENT_45	[p2l650t2069r893b2104],
16	has	VBZ	O	have	rcmod	4	SENT_45	[p2l915t2069r967b2095],
17	ameliorating	JJ	O	ameliorating	amod	18	SENT_45	[p2l991t2069r1200b2104],
18	effects	NNS	O	effect	dobj	16	SENT_45	[p2l189t2115r293b2141],
19	on	IN	O	on	_	0	SENT_45	[p2l309t2124r350b2141],
20	lymphatic	JJ	O	lymphatic	amod	21	SENT_45	[p2l365t2115r526b2150],
21	vessels	NNS	O	vessel	prep_on	18	SENT_45	[p2l541t2115r654b2146],
22	,	,	O	,	_	0	SENT_45	[p2l541t2115r654b2146],
23	could	MD	O	could	aux	25	SENT_45	[p2l671t2115r760b2141],
24	considerably	RB	O	considerably	advmod	25	SENT_45	[p2l775t2115r982b2150],
25	improve	VB	O	improve	_	0	SENT_45	[p2l998t2115r1133b2150],
26	the	DT	O	the	det	27	SENT_45	[p2l1149t2115r1199b2141],
27	prospect	NN	O	prospect	dobj	25	SENT_45	[p2l189t2166r331b2196],
28	of	IN	O	of	_	0	SENT_45	[p2l346t2161r380b2187],
29	developing	VBG	O	develop	prepc_of	27	SENT_45	[p2l391t2161r571b2196],
30	a	DT	O	a	det	31	SENT_45	[p2l585t2170r601b2187],
31	treatment	NN	O	treatment	dobj	29	SENT_45	[p2l616t2166r777b2187],
32	for	IN	O	for	_	0	SENT_45	[p2l791t2161r840b2187],
33	lymphatic	JJ	O	lymphatic	amod	34	SENT_45	[p2l853t2161r1014b2196],
34	pathology	NN	O	pathology	prep_for	31	SENT_45	[p2l1029t2161r1198b2196],
35	.	.	O	.	_	0	SENT_45	[p2l1029t2161r1198b2196],

1	One	CD	NUMBER	one	num	2	SENT_46	[p2l189t2208r257b2234],
2	aspect	NN	O	aspect	nsubj	23	SENT_46	[p2l272t2213r373b2243],
3	of	IN	O	of	_	0	SENT_46	[p2l386t2208r421b2234],
4	the	DT	O	the	det	5	SENT_46	[p2l432t2208r481b2234],
5	biology	NN	O	biology	prep_of	2	SENT_46	[p2l495t2208r615b2243],
6	of	IN	O	of	_	0	SENT_46	[p2l628t2208r663b2234],
7	ﬁlarial	JJ	O	ﬁlarial	amod	8	SENT_46	[p2l673t2208r778b2234],
8	nematodes	NNS	O	nematode	prep_of	5	SENT_46	[p2l792t2208r967b2234],
9	that	WDT	O	that	nsubjpass	12	SENT_46	[p2l982t2208r1045b2234],
10	could	MD	O	could	aux	12	SENT_46	[p2l1059t2208r1148b2234],
11	be	VB	O	be	auxpass	12	SENT_46	[p2l1162t2208r1199b2234],
12	exploited	VBN	O	exploit	rcmod	5	SENT_46	[p2l189t2254r342b2289],
13	in	IN	O	in	_	0	SENT_46	[p2l355t2254r386b2279],
14	the	DT	O	the	det	15	SENT_46	[p2l400t2254r449b2280],
15	effort	NN	O	effort	prep_in	12	SENT_46	[p2l463t2254r555b2280],
16	to	TO	O	to	aux	17	SENT_46	[p2l568t2259r599b2280],
17	advance	VB	O	advance	xcomp	12	SENT_46	[p2l612t2254r743b2280],
18	the	DT	O	the	det	20	SENT_46	[p2l757t2254r806b2280],
19	elimination	NN	O	elimination	nn	20	SENT_46	[p2l820t2254r1009b2280],
20	program	NN	O	program	dobj	17	SENT_46	[p2l1022t2263r1163b2289],
21	is	VBZ	O	be	cop	23	SENT_46	[p2l1176t2254r1198b2280],
22	the	DT	O	the	det	23	SENT_46	[p2l190t2300r239b2326],
23	presence	NN	O	presence	_	0	SENT_46	[p2l257t2309r401b2335],
24	of	IN	O	of	_	0	SENT_46	[p2l419t2300r453b2326],
25	the	DT	O	the	det	27	SENT_46	[p2l468t2300r517b2326],
26	endosymbiotic	JJ	O	endosymbiotic	amod	27	SENT_46	[p2l535t2300r773b2335],
27	Wolbachiu	NNP	O	Wolbachiu	prep_of	23	SENT_46	[p2l794t2300r942b2326],
28	found	VBN	O	find	partmod	27	SENT_46	[p2l959t2300r1056b2326],
29	in	IN	O	in	_	0	SENT_46	[p2l1073t2300r1104b2325],
30	most	JJS	O	most	amod	32	SENT_46	[p2l1122t2305r1199b2326],
31	ﬁlarial	JJ	O	ﬁlarial	amod	32	SENT_46	[p2l189t2346r294b2372],
32	species	NNS	O	species	prep_in	28	SENT_46	[p2l312t2346r432b2381],
33	,	,	O	,	_	0	SENT_46	[p2l312t2346r432b2381],
34	including	VBG	O	include	_	0	SENT_46	[p2l451t2346r606b2381],
35	W.	NNP	O	W.	nn	36	SENT_46	[p2l626t2347r661b2372],
36	bzmcrofti	NNS	O	bzmcroftus	prep_including	27	SENT_46	[p2l680t2346r806b2381],
37	[	CD	NUMBER	[	num	39	SENT_46	[p2l825t2346r890b2378],
38	14	CD	NUMBER	14	num	39	SENT_46	[p2l825t2346r890b2378],
39	]	NN	O	]	dep	36	SENT_46	[p2l825t2346r890b2378],
40	.	.	O	.	_	0	SENT_46	[p2l825t2346r890b2378],

1	Recent	JJ	O	recent	amod	2	SENT_47	[p2l908t2347r1021b2372],
2	studies	NNS	O	study	nsubj	7	SENT_47	[p2l1039t2346r1149b2372],
3	of	IN	O	of	_	0	SENT_47	[p2l1168t2346r1203b2372],
4	symbiotic	JJ	O	symbiotic	amod	6	SENT_47	[p2l189t2392r345b2427],
5	Wolbachia	JJ	O	wolbachia	amod	6	SENT_47	[p2l362t2392r510b2418],
6	organisms	NNS	O	organism	prep_of	2	SENT_47	[p2l523t2392r687b2427],
7	suggest	VBP	O	suggest	_	0	SENT_47	[p2l701t2397r817b2427],
8	that	IN	O	that	complm	12	SENT_47	[p2l831t2392r894b2418],
9	these	DT	O	these	det	10	SENT_47	[p2l908t2392r990b2418],
10	bacteria	NNS	O	bacterium	nsubj	12	SENT_47	[p2l1003t2392r1136b2418],
11	are	VBP	O	be	cop	12	SENT_47	[p2l1149t2401r1199b2418],
12	important	JJ	O	important	ccomp	7	SENT_47	[p2l189t2439r356b2474],
13	both	CC	O	both	dep	12	SENT_47	[p2l380t2439r454b2465],
14	as	IN	O	as	mark	20	SENT_47	[p2l479t2448r508b2465],
15	chemotherapeutic	JJ	O	chemotherapeutic	amod	16	SENT_47	[p2l533t2439r830b2474],
16	targets	NNS	O	target	nsubj	20	SENT_47	[p2l857t2444r965b2474],
17	and	CC	O	and	_	0	SENT_47	[p2l990t2439r1049b2465],
18	diseasecausing	NN	O	diseasecausing	nn	19	SENT_47	[p2l1073t2439r1198b2465, p2l189t2485r311b2520],
19	organisms	NNS	O	organism	conj_and	16	SENT_47	[p2l323t2485r488b2520],
20	[	VBP	O	[	conj	12	SENT_47	[p2l504t2485r568b2517],
21	14	CD	NUMBER	14	num	22	SENT_47	[p2l504t2485r568b2517],
22	]	CD	NUMBER	]	dobj	20	SENT_47	[p2l504t2485r568b2517],
23	.	.	O	.	_	0	SENT_47	[p2l504t2485r568b2517],

1	In	IN	O	in	_	0	SENT_48	[p2l582t2486r615b2510],
2	a	DT	O	a	det	4	SENT_48	[p2l629t2494r645b2511],
3	laboratory	NN	O	laboratory	nn	4	SENT_48	[p2l658t2485r829b2520],
4	model	NN	O	model	prep_in	11	SENT_48	[p2l842t2485r942b2511],
5	of	IN	O	of	_	0	SENT_48	[p2l956t2485r990b2511],
6	onchocercal	JJ	O	onchocercal	amod	7	SENT_48	[p2l1000t2485r1199b2511],
7	keratitis	NN	O	keratitis	prep_of	4	SENT_48	[p2l188t2531r329b2562],
8	,	,	O	,	_	0	SENT_48	[p2l188t2531r329b2562],
9	Wolbachiu	NNP	PERSON	Wolbachiu	nsubjpass	11	SENT_48	[p2l347t2531r495b2557],
10	was	VBD	O	be	auxpass	11	SENT_48	[p2l508t2540r564b2557],
11	shown	VBN	O	show	_	0	SENT_48	[p2l579t2531r681b2557],
12	to	TO	O	to	aux	13	SENT_48	[p2l696t2536r726b2557],
13	mediate	VB	O	mediate	xcomp	11	SENT_48	[p2l741t2531r871b2557],
14	neutrophil	NN	O	neutrophil	nn	15	SENT_48	[p2l886t2531r1060b2566],
15	inﬁltration	NN	O	inﬁltration	dobj	13	SENT_48	[p2l1075t2531r1198b2557, p2l190t2577r255b2603],
16	and	CC	O	and	_	0	SENT_48	[p2l283t2577r343b2603],
17	stromal	JJ	O	stromal	amod	18	SENT_48	[p2l371t2577r495b2603],
18	haze	NN	O	haze	conj_and	15	SENT_48	[p2l522t2577r594b2603],
19	when	WRB	O	when	advmod	27	SENT_48	[p2l621t2577r708b2603],
20	a	DT	O	a	det	22	SENT_48	[p2l736t2586r752b2603],
21	worm	NN	O	worm	nn	22	SENT_48	[p2l779t2586r873b2603],
22	extract	NN	O	extract	nsubjpass	27	SENT_48	[p2l900t2582r1015b2603],
23	including	VBG	O	include	_	0	SENT_48	[p2l1043t2577r1200b2612],
24	Wolbuchia	JJ	O	wolbuchia	amod	25	SENT_48	[p2l192t2623r340b2649],
25	antigens	NNS	O	antigen	prep_including	22	SENT_48	[p2l353t2623r488b2658],
26	was	VBD	O	be	auxpass	27	SENT_48	[p2l501t2632r557b2649],
27	injected	VBN	O	inject	advcl	13	SENT_48	[p2l572t2623r702b2658],
28	into	IN	O	into	_	0	SENT_48	[p2l716t2623r780b2649],
29	the	DT	O	the	det	30	SENT_48	[p2l795t2623r844b2649],
30	eyes	NNS	O	eye	prep_into	27	SENT_48	[p2l859t2632r924b2658],
31	of	IN	O	of	_	0	SENT_48	[p2l938t2623r973b2649],
32	mice	NNS	O	mouse	prep_of	30	SENT_48	[p2l983t2623r1059b2649],
33	[	RB	O	[	advmod	32	SENT_48	[p2l1075t2620r1198b2655],
34	15	CD	NUMBER	15	number	35	SENT_48	[p2l1075t2620r1198b2655],
35	—	CD	NUMBER	—	dep	32	SENT_48	[p2l1075t2620r1198b2655],
36	17	CD	NUMBER	17	num	37	SENT_48	[p2l1075t2620r1198b2655],
37	]	NN	O	]	dep	35	SENT_48	[p2l1075t2620r1198b2655],
38	.	.	O	.	_	0	SENT_48	[p2l1075t2620r1198b2655],

1	The	DT	O	the	det	2	SENT_49	[p2l226t2670r288b2696],
2	events	NNS	O	event	nsubjpass	16	SENT_49	[p2l317t2675r418b2696],
3	that	WDT	O	that	nsubj	4	SENT_49	[p2l448t2670r511b2696],
4	lead	VBP	O	lead	rcmod	2	SENT_49	[p2l539t2670r606b2696],
5	to	TO	O	to	_	0	SENT_49	[p2l634t2675r664b2696],
6	the	DT	O	the	det	7	SENT_49	[p2l694t2670r744b2696],
7	development	NN	O	development	prep_to	4	SENT_49	[p2l772t2670r986b2705],
8	of	IN	O	of	_	0	SENT_49	[p2l1014t2670r1049b2696],
9	chronic	JJ	O	chronic	amod	10	SENT_49	[p2l1073t2670r1198b2696],
10	pathology	NN	O	pathology	prep_of	7	SENT_49	[p2l189t2716r351b2751],
11	in	IN	O	in	_	0	SENT_49	[p2l369t2716r400b2741],
12	LF	NN	O	lf	prep_in	4	SENT_49	[p2l418t2717r460b2741],
13	are	VBP	O	be	auxpass	16	SENT_49	[p2l479t2725r528b2742],
14	not	RB	O	not	neg	16	SENT_49	[p2l548t2721r602b2742],
15	fully	RB	O	fully	advmod	16	SENT_49	[p2l620t2716r691b2751],
16	understood	VBN	O	understand	dep	46	SENT_49	[p2l708t2716r904b2747],
17	,	,	O	,	_	0	SENT_49	[p2l708t2716r904b2747],
18	but	CC	O	but	_	0	SENT_49	[p2l923t2716r977b2742],
19	the	DT	O	the	det	21	SENT_49	[p2l996t2716r1046b2742],
20	immune	JJ	O	immune	amod	21	SENT_49	[p2l1065t2716r1199b2742],
21	responses	NNS	O	response	nsubjpass	30	SENT_49	[p2l189t2771r346b2797],
22	of	IN	O	of	_	0	SENT_49	[p2l362t2762r396b2788],
23	the	DT	O	the	det	25	SENT_49	[p2l409t2762r458b2788],
24	human	JJ	O	human	amod	25	SENT_49	[p2l473t2762r586b2788],
25	host	NN	O	host	prep_of	21	SENT_49	[p2l600t2762r668b2788],
26	to	TO	O	to	_	0	SENT_49	[p2l684t2767r714b2788],
27	the	DT	O	the	det	28	SENT_49	[p2l731t2762r780b2788],
28	parasites	NNS	O	parasite	prep_to	25	SENT_49	[p2l795t2762r938b2797],
29	are	VBP	O	be	auxpass	30	SENT_49	[p2l953t2771r1003b2788],
30	believed	VBN	O	believe	conj_but	16	SENT_49	[p2l1017t2762r1152b2788],
31	to	TO	O	to	aux	32	SENT_49	[p2l1168t2767r1198b2788],
32	play	VB	O	play	xcomp	30	SENT_49	[p2l189t2808r257b2843],
33	a	DT	O	a	det	35	SENT_49	[p2l285t2817r301b2834],
34	signiﬁcant	JJ	O	signiﬁcant	amod	35	SENT_49	[p2l328t2808r500b2843],
35	role	NN	O	role	dobj	32	SENT_49	[p2l528t2808r592b2834],
36	in	IN	O	in	_	0	SENT_49	[p2l621t2808r652b2833],
37	determining	VBG	O	determine	prepc_in	32	SENT_49	[p2l680t2808r887b2843],
38	the	DT	O	the	det	40	SENT_49	[p2l915t2808r965b2834],
39	pathological	JJ	O	pathological	amod	40	SENT_49	[p2l993t2808r1199b2843],
40	manifestations	NNS	O	manifestation	dobj	37	SENT_49	[p2l189t2855r428b2881],
41	of	IN	O	of	_	0	SENT_49	[p2l444t2855r478b2881],
42	disease	NN	O	disease	prep_of	40	SENT_49	[p2l490t2855r603b2881],
43	in	IN	O	in	_	0	SENT_49	[p2l618t2855r649b2880],
44	infected	JJ	O	infected	amod	45	SENT_49	[p2l664t2855r796b2881],
45	individuals	NNS	O	individual	prep_in	37	SENT_49	[p2l812t2855r989b2881],
46	[	VBP	O	[	_	0	SENT_49	[p2l1006t2855r1129b2887],
47	18	CD	NUMBER	18	num	48	SENT_49	[p2l1006t2855r1129b2887],
48	—	CD	NUMBER	—	dobj	46	SENT_49	[p2l1006t2855r1129b2887],
49	21	CD	NUMBER	21	num	50	SENT_49	[p2l1006t2855r1129b2887],
50	]	NN	O	]	nsubj	46	SENT_49	[p2l1006t2855r1129b2887],
51	.	.	O	.	_	0	SENT_49	[p2l1006t2855r1129b2887],

1	The	DT	O	the	det	4	SENT_50	[p2l226t2901r288b2927],
2	lymphatic	JJ	O	lymphatic	amod	4	SENT_50	[p2l308t2901r469b2936],
3	vascular	JJ	O	vascular	amod	4	SENT_50	[p2l489t2901r622b2927],
4	system	NN	O	system	nsubj	6	SENT_50	[p2l641t2906r748b2936],
5	is	VBZ	O	be	cop	6	SENT_50	[p2l768t2901r790b2927],
6	important	JJ	O	important	_	0	SENT_50	[p2l811t2901r977b2936],
7	for	IN	O	for	_	0	SENT_50	[p2l997t2901r1045b2927],
8	immune	JJ	O	immune	amod	9	SENT_50	[p2l1065t2901r1199b2927],
9	surveillance	NN	O	surveillance	prep_for	6	SENT_50	[p2l189t2947r394b2978],
10	,	,	O	,	_	0	SENT_50	[p2l189t2947r394b2978],
11	tissue	NN	O	tissue	nn	13	SENT_50	[p2l420t2947r510b2973],
12	ﬂuid	NN	O	ﬂuid	nn	13	SENT_50	[p2l535t2947r610b2973],
13	homeostasis	NN	O	homeostasis	appos	9	SENT_50	[p2l634t2947r842b2978],
14	,	,	O	,	_	0	SENT_50	[p2l634t2947r842b2978],
15	and	CC	O	and	_	0	SENT_50	[p2l867t2947r927b2973],
16	fat	JJ	O	fat	amod	17	SENT_50	[p2l951t2947r994b2973],
17	absorption	NN	O	absorption	conj_and	6	SENT_50	[p2l1019t2947r1199b2982],
18	[	CD	NUMBER	[	number	19	SENT_50	[p2l191t2993r303b3025],
19	22,23	CD	NUMBER	22,23	num	20	SENT_50	[p2l191t2993r303b3025],
20	]	NN	O	]	dep	6	SENT_50	[p2l191t2993r303b3025],
21	.	.	O	.	_	0	SENT_50	[p2l191t2993r303b3025],

1	Perturbations	NNS	O	perturbation	_	0	SENT_51	[p2l316t2993r541b3019],
2	in	IN	O	in	_	0	SENT_51	[p2l554t2993r585b3018],
3	the	DT	O	the	det	4	SENT_51	[p2l598t2993r647b3019],
4	maintenance	NN	O	maintenance	prep_in	1	SENT_51	[p2l660t2993r870b3019],
5	and	CC	O	and	_	0	SENT_51	[p2l883t2993r942b3019],
6	function	NN	O	function	prep_in	1	SENT_51	[p2l953t2993r1093b3019],
7	of	IN	O	of	_	0	SENT_51	[p2l1105t2993r1140b3019],
8	the	DT	O	the	prep_of	4	SENT_51	[p2l1149t2993r1199b3019],

1	&	CC	O	&	cc	2	SENT_52	[p2l188t3077r261b3136],
2	PLoS	NNP	O	PLoS	nsubj	4	SENT_52	[p2l288t3093r352b3116],
3	Pathogens	NNPS	O	Pathogens	dep	2	SENT_52	[p2l367t3092r511b3123],
4	|	VBP	O	|	_	0	SENT_52	[p2l526t3091r528b3124],
5	www	NN	O	www	dobj	4	SENT_52	[p2l543t3092r882b3123],
6	.	.	O	.	_	0	SENT_52	[p2l543t3092r882b3123],

1	p	NN	O	p	nn	3	SENT_53	[p2l543t3092r882b3123],
2	|	CD	NUMBER	|	num	3	SENT_53	[p2l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	nsubj	7	SENT_53	[p2l543t3092r882b3123],
4	lymphatic	JJ	O	lymphatic	amod	5	SENT_53	[p2l1276t206r1437b241],
5	system	NN	O	system	dep	3	SENT_53	[p2l1446t211r1553b241],
6	can	MD	O	can	aux	7	SENT_53	[p2l1560t215r1616b232],
7	lead	VB	O	lead	_	0	SENT_53	[p2l1623t206r1690b232],
8	to	TO	O	to	_	0	SENT_53	[p2l1698t211r1729b232],
9	avariety	JJ	O	avariety	amod	11	SENT_53	[p2l1738t206r1871b241],
10	ofpathological	JJ	O	ofpathological	amod	11	SENT_53	[p2l1879t206r2119b241],
11	disorders	NNS	O	disorder	prep_to	7	SENT_53	[p2l2127t206r2286b237],
12	,	,	O	,	_	0	SENT_53	[p2l2127t206r2286b237],
13	including	VBG	O	include	_	0	SENT_53	[p2l1277t253r1432b288],
14	lymphatic	JJ	O	lymphatic	amod	15	SENT_53	[p2l1442t253r1602b288],
15	dilation	NN	O	dilation	prep_including	7	SENT_53	[p2l1615t253r1741b279],
16	and	CC	O	and	_	0	SENT_53	[p2l1753t253r1812b279],
17	lymphedema	NN	O	lymphedema	prep_including	7	SENT_53	[p2l1824t253r2033b288],
18	[	CD	NUMBER	[	number	19	SENT_53	[p2l2046t253r2169b285],
19	24	CD	NUMBER	24	num	20	SENT_53	[p2l2046t253r2169b285],
20	—	NN	O	—	dep	15	SENT_53	[p2l2046t253r2169b285],
21	26	CD	NUMBER	26	num	22	SENT_53	[p2l2046t253r2169b285],
22	]	NN	O	]	dep	20	SENT_53	[p2l2046t253r2169b285],
23	.	.	O	.	_	0	SENT_53	[p2l2046t253r2169b285],

1	Recent	JJ	O	recent	amod	2	SENT_54	[p2l1314t300r1426b325],
2	studies	NNS	O	study	nsubj	56	SENT_54	[p2l1445t299r1556b325],
3	on	IN	O	on	_	0	SENT_54	[p2l1576t308r1617b325],
4	the	DT	O	the	det	6	SENT_54	[p2l1636t299r1686b325],
5	molecular	JJ	O	molecular	amod	6	SENT_54	[p2l1706t299r1869b325],
6	mechanisms	NNS	O	mechanism	prep_on	2	SENT_54	[p2l1888t299r2085b325],
7	controlling	VBG	O	control	partmod	6	SENT_54	[p2l2105t299r2288b334],
8	the	DT	O	the	det	10	SENT_54	[p2l1277t346r1327b372],
9	lymphatic	JJ	O	lymphatic	amod	10	SENT_54	[p2l1347t346r1508b381],
10	vessels	NNS	O	vessel	nsubj	12	SENT_54	[p2l1528t346r1632b372],
11	have	VBP	O	have	aux	12	SENT_54	[p2l1652t346r1725b372],
12	shown	VBN	O	show	ccomp	7	SENT_54	[p2l1746t346r1848b372],
13	that	IN	O	that	complm	29	SENT_54	[p2l1868t346r1932b372],
14	vascular	JJ	O	vascular	amod	17	SENT_54	[p2l1951t346r2083b372],
15	endothelial	JJ	O	endothelial	amod	17	SENT_54	[p2l2103t346r2286b372],
16	growth	NN	O	growth	nn	17	SENT_54	[p2l1276t392r1390b427],
17	factors	NNS	O	factor	nsubj	29	SENT_54	[p2l1406t392r1516b418],
18	C	NN	O	c	nn	21	SENT_54	[p2l1534t392r1556b418],
19	(	CD	NUMBER	(	num	21	SENT_54	[p2l1574t392r1729b425],
20	VEGF-C	NN	O	vegf-c	nn	21	SENT_54	[p2l1574t392r1729b425],
21	)	NN	O	)	dep	17	SENT_54	[p2l1574t392r1729b425],
22	and	CC	O	and	_	0	SENT_54	[p2l1746t392r1805b418],
23	VEGF-D	NN	O	vegf-d	nsubj	29	SENT_54	[p2l1821t392r1956b418],
24	speciﬁcally	RB	O	speciﬁcally	advmod	26	SENT_54	[p2l1974t392r2151b427],
25	control	JJ	O	control	amod	26	SENT_54	[p2l2168t392r2286b418],
26	lymphangiogenesis	NN	O	lymphangiogenesis	rcmod	23	SENT_54	[p2l1276t439r1585b474],
27	in	IN	O	in	_	0	SENT_54	[p2l1600t439r1631b464],
28	humans	NNS	O	human	prep_in	26	SENT_54	[p2l1644t439r1770b465],
29	[	VBP	O	[	ccomp	12	SENT_54	[p2l1787t436r1890b471],
30	27,28	CD	NUMBER	27,28	number	31	SENT_54	[p2l1787t436r1890b471],
31	]	CD	NUMBER	]	dobj	29	SENT_54	[p2l1787t436r1890b471],
32	by	IN	O	by	_	0	SENT_54	[p2l1904t439r1942b474],
33	activating	VBG	O	activate	prepc_by	31	SENT_54	[p2l1955t439r2115b474],
34	the	DT	O	the	det	44	SENT_54	[p2l2128t439r2178b465],
35	VEGF	NN	O	vegf	nn	44	SENT_54	[p2l2190t439r2286b465],
36	receptor-3	NN	O	receptor-3	nn	44	SENT_54	[p2l1277t485r1448b520],
37	(	CD	NUMBER	(	num	44	SENT_54	[p2l1464t485r1637b518],
38	VEGFR-3	NN	O	vegfr-3	nn	44	SENT_54	[p2l1464t485r1637b518],
39	)	CD	NUMBER	)	num	44	SENT_54	[p2l1464t485r1637b518],
40	[	CD	NUMBER	[	num	44	SENT_54	[p2l1654t485r1777b517],
41	29	CD	NUMBER	29	num	44	SENT_54	[p2l1654t485r1777b517],
42	—	NN	O	—	nn	44	SENT_54	[p2l1654t485r1777b517],
43	32	CD	NUMBER	32	num	44	SENT_54	[p2l1654t485r1777b517],
44	]	NN	O	]	dobj	33	SENT_54	[p2l1654t485r1777b517],
45	,	,	O	,	_	0	SENT_54	[p2l1654t485r1777b517],
46	which	WDT	O	which	nsubj	49	SENT_54	[p2l1791t485r1887b511],
47	is	VBZ	O	be	cop	49	SENT_54	[p2l1902t485r1924b511],
48	principally	RB	O	principally	advmod	49	SENT_54	[p2l1939t485r2116b520],
49	restricted	JJ	O	restricted	rcmod	31	SENT_54	[p2l2130t485r2286b511],
50	to	TO	O	to	_	0	SENT_54	[p2l1277t537r1308b558],
51	the	DT	O	the	det	53	SENT_54	[p2l1331t532r1380b558],
52	lymphatic	JJ	O	lymphatic	amod	53	SENT_54	[p2l1402t532r1562b567],
53	endothelium	NN	O	endothelium	prep_to	49	SENT_54	[p2l1585t532r1793b558],
54	in	IN	O	in	_	0	SENT_54	[p2l1815t532r1846b557],
55	adults	NNS	O	adult	prep_in	53	SENT_54	[p2l1868t532r1963b558],
56	[	VBP	O	[	_	0	SENT_54	[p2l1987t532r2099b564],
57	33,34	CD	NUMBER	33,34	number	58	SENT_54	[p2l1987t532r2099b564],
58	]	CD	NUMBER	]	dobj	56	SENT_54	[p2l1987t532r2099b564],
59	.	.	O	.	_	0	SENT_54	[p2l1987t532r2099b564],

1	In	IN	O	in	_	0	SENT_55	[p2l2121t533r2155b557],
2	animal	NN	O	animal	nn	3	SENT_55	[p2l2177t532r2286b558],
3	models	NNS	O	model	prep_in	14	SENT_55	[p2l1277t578r1399b609],
4	,	,	O	,	_	0	SENT_55	[p2l1277t578r1399b609],
5	overexpression	NN	O	overexpression	nsubj	14	SENT_55	[p2l1416t578r1663b613],
6	of	IN	O	of	_	0	SENT_55	[p2l1679t578r1714b604],
7	VEGF-C	NN	O	vegf-c	prep_of	5	SENT_55	[p2l1725t578r1859b604],
8	in	IN	O	in	_	0	SENT_55	[p2l1876t578r1907b603],
9	the	DT	O	the	det	10	SENT_55	[p2l1924t578r1973b604],
10	skin	NN	O	skin	prep_in	7	SENT_55	[p2l1989t578r2054b604],
11	of	IN	O	of	_	0	SENT_55	[p2l2070t578r2105b604],
12	transgenic	JJ	O	transgenic	amod	13	SENT_55	[p2l2118t578r2286b613],
13	mice	NNS	O	mouse	prep_of	10	SENT_55	[p2l1277t624r1353b650],
14	resulted	VBD	O	result	_	0	SENT_55	[p2l1379t624r1510b650],
15	in	IN	O	in	_	0	SENT_55	[p2l1536t624r1567b649],
16	lymphatic	JJ	O	lymphatic	amod	18	SENT_55	[p2l1592t624r1753b659],
17	endothelial	JJ	O	endothelial	amod	18	SENT_55	[p2l1780t624r1964b650],
18	proliferation	NN	O	proliferation	prep_in	14	SENT_55	[p2l1990t624r2201b659],
19	and	CC	O	and	_	0	SENT_55	[p2l2227t624r2287b650],
20	dilation	NN	O	dilation	nsubj	24	SENT_55	[p2l1277t671r1407b697],
21	of	IN	O	of	_	0	SENT_55	[p2l1439t671r1474b697],
22	lymph	NN	O	lymph	nn	23	SENT_55	[p2l1501t671r1605b706],
23	vessels	NNS	O	vessel	prep_of	20	SENT_55	[p2l1634t671r1742b697],
24	[	VBP	O	[	conj_and	14	SENT_55	[p2l1776t671r1833b703],
25	32	CD	NUMBER	32	number	26	SENT_55	[p2l1776t671r1833b703],
26	]	CD	NUMBER	]	nsubj	36	SENT_55	[p2l1776t671r1833b703],
27	with	IN	O	with	_	0	SENT_55	[p2l1864t671r1936b697],
28	a	DT	O	a	det	29	SENT_55	[p2l1967t680r1983b697],
29	resemblance	NN	O	resemblance	prep_with	26	SENT_55	[p2l2014t671r2223b697],
30	to	TO	O	to	_	0	SENT_55	[p2l2255t676r2286b697],
31	lymphatics	NNS	O	lymphatic	prep_to	29	SENT_55	[p2l1276t717r1451b752],
32	infected	VBN	O	infect	partmod	31	SENT_55	[p2l1476t717r1608b743],
33	with	IN	O	with	_	0	SENT_55	[p2l1631t717r1701b743],
34	ﬁlarial	JJ	O	ﬁlarial	amod	35	SENT_55	[p2l1725t717r1830b743],
35	parasites	NNS	O	parasite	prep_with	32	SENT_55	[p2l1854t717r1996b752],
36	[	VBP	O	[	ccomp	24	SENT_55	[p2l2022t717r2087b749],
37	35	CD	NUMBER	35	num	38	SENT_55	[p2l2022t717r2087b749],
38	]	CD	NUMBER	]	dobj	36	SENT_55	[p2l2022t717r2087b749],
39	.	.	O	.	_	0	SENT_55	[p2l2022t717r2087b749],

1	Additional	JJ	O	additional	amod	2	SENT_56	[p2l2111t717r2286b743],
2	evidence	NN	O	evidence	nsubj	17	SENT_56	[p2l1277t764r1419b790],
3	for	IN	O	for	_	0	SENT_56	[p2l1440t764r1489b790],
4	the	DT	O	the	det	5	SENT_56	[p2l1510t764r1559b790],
5	role	NN	O	role	prep_for	2	SENT_56	[p2l1582t764r1644b790],
6	of	IN	O	of	_	0	SENT_56	[p2l1666t764r1701b790],
7	VEGF-CIVEGF-D/VEGFR	NN	O	vegf-civegf-d/vegfr	prep_of	5	SENT_56	[p2l1718t764r2161b790],
8	-3	CD	NUMBER	-3	num	7	SENT_56	[p2l1718t764r2161b790],
9	in	IN	O	in	_	0	SENT_56	[p2l2184t764r2215b789],
10	the	DT	O	the	det	11	SENT_56	[p2l2237t764r2286b790],
11	pathogenesis	NN	O	pathogenesis	prep_in	7	SENT_56	[p2l1277t810r1486b845],
12	of	IN	O	of	_	0	SENT_56	[p2l1507t810r1542b836],
13	lymphatic	JJ	O	lymphatic	amod	14	SENT_56	[p2l1559t810r1720b845],
14	dilation	NN	O	dilation	prep_of	11	SENT_56	[p2l1741t810r1868b836],
15	and	CC	O	and	_	0	SENT_56	[p2l1888t810r1948b836],
16	lymphedema	NN	O	lymphedema	prep_of	11	SENT_56	[p2l1968t810r2178b845],
17	stems	VBZ	O	stem	_	0	SENT_56	[p2l2198t815r2286b836],
18	from	IN	O	from	_	0	SENT_56	[p2l1276t857r1356b883],
19	experimental	JJ	O	experimental	amod	20	SENT_56	[p2l1383t857r1600b892],
20	studies	NNS	O	study	prep_from	17	SENT_56	[p2l1628t857r1738b883],
21	in	IN	O	in	_	0	SENT_56	[p2l1767t857r1798b882],
22	transgenic	JJ	O	transgenic	amod	23	SENT_56	[p2l1826t857r1993b892],
23	mice	NNS	O	mouse	prep_in	20	SENT_56	[p2l2022t857r2098b883],
24	with	IN	O	with	_	0	SENT_56	[p2l2125t857r2195b883],
25	skin	NN	O	skin	nn	27	SENT_56	[p2l2222t857r2286b883],
26	speciﬁc	NN	O	speciﬁc	nn	27	SENT_56	[p2l1277t903r1397b938],
27	overexpression	NN	O	overexpression	prep_with	17	SENT_56	[p2l1428t903r1677b938],
28	of	IN	O	of	_	0	SENT_56	[p2l1707t903r1742b929],
29	soluble	JJ	O	soluble	amod	33	SENT_56	[p2l1768t903r1883b929],
30	VEGFR-3	NN	O	vegfr-3	nn	33	SENT_56	[p2l1912t903r2066b929],
31	(	CD	NUMBER	(	num	33	SENT_56	[p2l2098t903r2286b936],
32	sVEGFR-3	NN	O	svegfr-3	nn	33	SENT_56	[p2l2098t903r2286b936],
33	)	NN	O	)	nsubj	34	SENT_56	[p2l2098t903r2286b936],
34	using	VBG	O	use	prepc_of	27	SENT_56	[p2l1276t949r1363b984],
35	a	DT	O	a	det	37	SENT_56	[p2l1381t958r1397b975],
36	keratin	NN	O	keratin	nn	37	SENT_56	[p2l1415t949r1516b975],
37	I4	NN	O	i4	nsubj	40	SENT_56	[p2l1536t949r1571b974],
38	transgenic	JJ	O	transgenic	amod	40	SENT_56	[p2l1591t949r1759b984],
39	promoter	NN	O	promoter	nn	40	SENT_56	[p2l1778t954r1936b984],
40	[	NN	O	[	xcomp	34	SENT_56	[p2l1957t949r2021b981],
41	36	CD	NUMBER	36	num	42	SENT_56	[p2l1957t949r2021b981],
42	]	NN	O	]	dep	40	SENT_56	[p2l1957t949r2021b981],
43	.	.	O	.	_	0	SENT_56	[p2l1957t949r2021b981],

1	In	IN	O	in	_	0	SENT_57	[p2l2040t950r2074b974],
2	this	DT	O	this	det	4	SENT_57	[p2l2094t949r2150b975],
3	genetic	JJ	O	genetic	amod	4	SENT_57	[p2l2169t949r2286b984],
4	model	NN	O	model	prep_in	8	SENT_57	[p2l1277t996r1389b1027],
5	,	,	O	,	_	0	SENT_57	[p2l1277t996r1389b1027],
6	SVEGFR-3	NN	O	svegfr-3	nsubj	17	SENT_57	[p2l1421t996r1592b1022],
7	is	VBZ	O	be	auxpass	8	SENT_57	[p2l1624t996r1647b1022],
8	secreted	VBN	O	secrete	_	0	SENT_57	[p2l1679t996r1818b1022],
9	at	IN	O	at	_	0	SENT_57	[p2l1850t1001r1879b1022],
10	high	JJ	O	high	amod	11	SENT_57	[p2l1910t996r1983b1031],
11	levels	NNS	O	level	prep_at	8	SENT_57	[p2l2014t996r2104b1022],
12	by	IN	O	by	_	0	SENT_57	[p2l2135t996r2173b1031],
13	basal	JJ	O	basal	amod	15	SENT_57	[p2l2203t996r2287b1022],
14	epidermal	JJ	O	epidermal	amod	15	SENT_57	[p2l1277t1042r1442b1077],
15	keratinocytes	NNS	O	keratinocyte	agent	8	SENT_57	[p2l1465t1042r1683b1077],
16	and	CC	O	and	_	0	SENT_57	[p2l1708t1042r1767b1068],
17	binds	VBZ	O	bind	conj_and	8	SENT_57	[p2l1791t1042r1878b1068],
18	the	DT	O	the	det	21	SENT_57	[p2l1904t1042r1953b1068],
19	lymphangiogenesis	NN	O	lymphangiogenesis	nn	21	SENT_57	[p2l1977t1042r2286b1077],
20	factors	NNS	O	factor	nn	21	SENT_57	[p2l1276t1089r1386b1115],
21	VEGF-C	NN	O	vegf-c	dobj	17	SENT_57	[p2l1400t1089r1534b1115],
22	and	CC	O	and	_	0	SENT_57	[p2l1549t1089r1608b1115],
23	VEGF-D	NN	O	vegf-d	conj_and	21	SENT_57	[p2l1622t1089r1766b1120],
24	,	,	O	,	_	0	SENT_57	[p2l1622t1089r1766b1120],
25	thereby	RB	O	thereby	advmod	26	SENT_57	[p2l1782t1089r1905b1124],
26	preventing	VBG	O	prevent	conj_and	21	SENT_57	[p2l1919t1089r2097b1124],
27	them	PRP	O	they	dobj	26	SENT_57	[p2l2111t1089r2193b1115],
28	from	IN	O	from	_	0	SENT_57	[p2l2207t1089r2287b1115],
29	activating	VBG	O	activate	prepc_from	26	SENT_57	[p2l1277t1135r1437b1170],
30	membrane-bound	JJ	O	membrane-bound	amod	31	SENT_57	[p2l1458t1135r1752b1161],
31	VEGFR-3	NN	O	vegfr-3	dobj	29	SENT_57	[p2l1773t1135r1926b1161],
32	on	IN	O	on	_	0	SENT_57	[p2l1948t1144r1988b1161],
33	lymphatic	JJ	O	lymphatic	amod	34	SENT_57	[p2l2010t1135r2171b1170],
34	endothelium	NN	O	endothelium	prep_on	29	SENT_57	[p2l2193t1135r2286b1161, p2l1278t1182r1403b1208],
35	[	CD	NUMBER	[	number	36	SENT_57	[p2l1424t1182r1489b1214],
36	36	CD	NUMBER	36	num	37	SENT_57	[p2l1424t1182r1489b1214],
37	]	NN	O	]	dobj	8	SENT_57	[p2l1424t1182r1489b1214],
38	.	.	O	.	_	0	SENT_57	[p2l1424t1182r1489b1214],

1	These	DT	O	these	det	4	SENT_58	[p2l1509t1182r1604b1208],
2	K14	NN	O	k14	nn	4	SENT_58	[p2l1624t1182r1697b1208],
3	]	CD	NUMBER	]	num	4	SENT_58	[p2l1624t1182r1697b1208],
4	SVEGFR-3	NN	O	svegfr-3	nsubjpass	15	SENT_58	[p2l1716t1182r1881b1208],
5	transgenic	JJ	O	transgenic	amod	6	SENT_58	[p2l1902t1182r2070b1217],
6	mice	NNS	O	mouse	dep	4	SENT_58	[p2l2091t1182r2167b1208],
7	lack	VBP	O	lack	_	0	SENT_58	[p2l2187t1182r2251b1208],
8	a	DT	O	a	det	12	SENT_58	[p2l2271t1191r2287b1208],
9	functional	JJ	O	functional	amod	10	SENT_58	[p2l1276t1228r1444b1254],
10	cutaneous	JJ	O	cutaneous	amod	12	SENT_58	[p2l1467t1233r1631b1254],
11	lymphatic	JJ	O	lymphatic	amod	12	SENT_58	[p2l1653t1228r1814b1263],
12	system	NN	O	system	dobj	7	SENT_58	[p2l1837t1233r1944b1263],
13	and	CC	O	and	_	0	SENT_58	[p2l1966t1228r2025b1254],
14	are	VBP	O	be	auxpass	15	SENT_58	[p2l2048t1237r2097b1254],
15	characterized	VBN	O	characterize	conj_and	7	SENT_58	[p2l2120t1228r2285b1254, p2l1277t1274r1341b1300],
16	by	IN	O	by	_	0	SENT_58	[p2l1358t1274r1395b1309],
17	lymphedema	NN	O	lymphedema	nn	18	SENT_58	[p2l1413t1274r1623b1309],
18	formation	NN	O	formation	agent	15	SENT_58	[p2l1640t1274r1805b1300],
19	in	IN	O	in	_	0	SENT_58	[p2l1824t1274r1855b1299],
20	the	DT	O	the	det	21	SENT_58	[p2l1873t1274r1923b1300],
21	skin	NN	O	skin	prep_in	18	SENT_58	[p2l1941t1274r2013b1300],
22	.	.	O	.	_	0	SENT_58	[p2l1941t1274r2013b1300],

1	The	DT	O	the	det	2	SENT_59	[p2l2032t1274r2094b1300],
2	expression	NN	O	expression	nsubjpass	7	SENT_59	[p2l2112t1274r2286b1309],
3	of	IN	O	of	_	0	SENT_59	[p2l1277t1321r1311b1347],
4	VEGF-C	NN	O	vegf-c	prep_of	2	SENT_59	[p2l1329t1321r1462b1347],
5	has	VBZ	O	have	aux	7	SENT_59	[p2l1484t1321r1536b1347],
6	been	VBN	O	be	auxpass	7	SENT_59	[p2l1558t1321r1636b1347],
7	shown	VBN	O	show	_	0	SENT_59	[p2l1657t1321r1759b1347],
8	to	TO	O	to	aux	10	SENT_59	[p2l1782t1326r1812b1347],
9	be	VB	O	be	auxpass	10	SENT_59	[p2l1834t1321r1871b1347],
10	up-regulated	VBN	O	up-regulate	xcomp	7	SENT_59	[p2l1893t1321r2104b1356],
11	by	IN	O	by	_	0	SENT_59	[p2l2125t1321r2162b1356],
12	proinﬂammatory	JJ	O	proinﬂammatory	amod	13	SENT_59	[p2l2183t1321r2286b1356, p2l1276t1367r1465b1402],
13	cytokines	NNS	O	cytokine	agent	10	SENT_59	[p2l1491t1367r1642b1402],
14	like	IN	O	like	_	0	SENT_59	[p2l1669t1367r1726b1393],
15	interleukin	NN	O	interleukin	nn	17	SENT_59	[p2l1753t1367r1934b1393],
16	(	CD	NUMBER	(	num	17	SENT_59	[p2l1962t1367r2072b1400],
17	IL	NN	O	il	prep_like	13	SENT_59	[p2l1962t1367r2072b1400],
18	)	CD	NUMBER	)	num	17	SENT_59	[p2l1962t1367r2072b1400],
19	-1	CD	NUMBER	-1	num	20	SENT_59	[p2l1962t1367r2072b1400],
20	B	NN	O	b	dep	7	SENT_59	[p2l1962t1367r2072b1400],
21	and	CC	O	and	_	0	SENT_59	[p2l2100t1367r2159b1393],
22	tumor	NN	O	tumor	nn	27	SENT_59	[p2l2186t1372r2288b1393],
23	necrosis	NN	O	necrosis	nn	27	SENT_59	[p2l1277t1414r1410b1440],
24	factor	NN	O	factor	nn	27	SENT_59	[p2l1441t1414r1540b1440],
25	(	CD	NUMBER	(	num	27	SENT_59	[p2l1571t1415r1674b1447],
26	TNF	NN	O	tnf	nn	27	SENT_59	[p2l1571t1415r1674b1447],
27	)	NN	O	)	conj_and	20	SENT_59	[p2l1571t1415r1674b1447],
28	,	,	O	,	_	0	SENT_59	[p2l1571t1415r1674b1447],
29	suggesting	VBG	O	suggest	partmod	7	SENT_59	[p2l1705t1414r1877b1449],
30	that	IN	O	that	complm	34	SENT_59	[p2l1907t1414r1972b1440],
31	proinﬂammatory	JJ	O	proinﬂammatory	amod	32	SENT_59	[p2l2002t1414r2287b1449],
32	cytokines	NNS	O	cytokine	nsubj	34	SENT_59	[p2l1277t1460r1428b1495],
33	could	MD	O	could	aux	34	SENT_59	[p2l1443t1460r1533b1486],
34	affect	VB	O	affect	ccomp	29	SENT_59	[p2l1547t1460r1638b1486],
35	the	DT	O	the	det	37	SENT_59	[p2l1653t1460r1702b1486],
36	lymphatic	JJ	O	lymphatic	amod	37	SENT_59	[p2l1717t1460r1878b1495],
37	vessels	NNS	O	vessel	dobj	34	SENT_59	[p2l1892t1460r1997b1486],
38	via	IN	O	via	_	0	SENT_59	[p2l2011t1460r2057b1486],
39	VEGF-C	NN	O	vegf-c	prep_via	37	SENT_59	[p2l2070t1460r2203b1486],
40	[	CD	NUMBER	[	num	39	SENT_59	[p2l2221t1458r2285b1492],
41	37	CD	NUMBER	37	num	42	SENT_59	[p2l2221t1458r2285b1492],
42	]	NN	O	]	dep	39	SENT_59	[p2l2221t1458r2285b1492],
43	.	.	O	.	_	0	SENT_59	[p2l2221t1458r2285b1492],

1	Studies	NNS	O	study	nsubj	6	SENT_60	[p2l1314t1507r1431b1533],
2	in	IN	O	in	_	0	SENT_60	[p2l1459t1507r1490b1532],
3	animal	NN	O	animal	nn	4	SENT_60	[p2l1517t1507r1627b1533],
4	models	NNS	O	model	prep_in	1	SENT_60	[p2l1655t1507r1768b1533],
5	have	VBP	O	have	aux	6	SENT_60	[p2l1796t1507r1869b1533],
6	shown	VBN	O	show	_	0	SENT_60	[p2l1897t1507r1999b1533],
7	that	IN	O	that	_	0	SENT_60	[p2l2027t1507r2090b1533],
8	Wolbuchia	NNP	O	Wolbuchia	prep_that	6	SENT_60	[p2l2120t1507r2286b1533],
9	—	CD	NUMBER	—	num	8	SENT_60	[p2l2120t1507r2286b1533],

1	derived	VBN	O	derive	_	0	SENT_61	[p2l1277t1553r1398b1579],
2	molecules	NNS	O	molecule	dobj	1	SENT_61	[p2l1411t1553r1571b1579],
3	from	IN	O	from	_	0	SENT_61	[p2l1584t1553r1664b1579],
4	Brugiu	NNP	LOCATION	Brugiu	nn	5	SENT_61	[p2l1674t1554r1774b1588],
5	spp	NN	O	spp	prep_from	1	SENT_61	[p2l1786t1562r1849b1588],
6	.	.	O	.	_	0	SENT_61	[p2l1786t1562r1849b1588],

1	induced	VBN	O	induce	_	0	SENT_62	[p2l1863t1553r1994b1579],
2	proinﬂammatory	JJ	O	proinﬂammatory	amod	3	SENT_62	[p2l2006t1553r2287b1588],
3	cytokines	NNS	O	cytokine	dobj	1	SENT_62	[p2l1277t1600r1436b1635],
4	,	,	O	,	_	0	SENT_62	[p2l1277t1600r1436b1635],
5	including	VBG	O	include	_	0	SENT_62	[p2l1453t1600r1608b1635],
6	TNF	NN	O	tnf	prep_including	1	SENT_62	[p2l1622t1601r1695b1626],
7	and	CC	O	and	_	0	SENT_62	[p2l1711t1600r1770b1626],
8	IL-1B	NN	O	il-1b	prep_including	1	SENT_62	[p2l1785t1600r1875b1625],
9	[	CD	NUMBER	[	number	10	SENT_62	[p2l1894t1600r1958b1632],
10	38	CD	NUMBER	38	num	11	SENT_62	[p2l1894t1600r1958b1632],
11	]	NN	O	]	dep	8	SENT_62	[p2l1894t1600r1958b1632],
12	.	.	O	.	_	0	SENT_62	[p2l1894t1600r1958b1632],

1	Soluble	JJ	O	soluble	amod	2	SENT_63	[p2l1976t1600r2095b1626],
2	extracts	NNS	O	extract	nsubjpass	14	SENT_63	[p2l2112t1605r2239b1626],
3	of	IN	O	of	_	0	SENT_63	[p2l2255t1600r2290b1626],
4	Brugiu	NNP	LOCATION	Brugiu	nn	8	SENT_63	[p2l1275t1647r1375b1681],
5	and	CC	O	and	_	0	SENT_63	[p2l1392t1646r1451b1672],
6	Onchocercu	NNP	O	Onchocercu	nn	8	SENT_63	[p2l1470t1646r1630b1672],
7	volvulus	NN	O	volvulus	nn	8	SENT_63	[p2l1646t1646r1767b1672],
8	adult	NN	O	adult	prep_of	2	SENT_63	[p2l1785t1646r1867b1672],
9	and	CC	O	and	_	0	SENT_63	[p2l1885t1646r1944b1672],
10	microﬁlarial	JJ	O	microﬁlarial	amod	11	SENT_63	[p2l1961t1646r2163b1672],
11	worms	NNS	O	worm	prep_of	2	SENT_63	[p2l2179t1655r2286b1672],
12	were	VBD	O	be	auxpass	14	SENT_63	[p2l1276t1702r1352b1719],
13	also	RB	O	also	advmod	14	SENT_63	[p2l1366t1693r1426b1719],
14	found	VBN	O	find	_	0	SENT_63	[p2l1440t1693r1537b1719],
15	to	TO	O	to	aux	16	SENT_63	[p2l1551t1698r1581b1719],
16	stimulate	VB	O	stimulate	xcomp	14	SENT_63	[p2l1595t1693r1744b1719],
17	human	JJ	O	human	amod	20	SENT_63	[p2l1757t1693r1871b1719],
18	peripheral	JJ	O	peripheral	amod	20	SENT_63	[p2l1884t1693r2055b1728],
19	mononuclear	JJ	O	mononuclear	amod	20	SENT_63	[p2l2069t1693r2287b1719],
20	cells	NNS	O	cell	dobj	16	SENT_63	[p2l1277t1739r1344b1765],
21	in	FW	O	in	nn	22	SENT_63	[p2l1371t1739r1402b1764],
22	vitro	FW	O	vitro	advmod	16	SENT_63	[p2l1426t1739r1511b1770],
23	,	,	O	,	_	0	SENT_63	[p2l1426t1739r1511b1770],
24	resulting	VBG	O	result	xcomp	14	SENT_63	[p2l1538t1739r1682b1774],
25	in	IN	O	in	_	0	SENT_63	[p2l1707t1739r1737b1764],
26	the	DT	O	the	det	27	SENT_63	[p2l1764t1739r1813b1765],
27	production	NN	O	production	prep_in	24	SENT_63	[p2l1839t1739r2023b1774],
28	of	IN	O	of	_	0	SENT_63	[p2l2049t1739r2084b1765],
29	TNF	NN	MISC	tnf	nn	38	SENT_63	[p2l2106t1740r2186b1770],
30	,	,	O	,	_	0	SENT_63	[p2l2106t1740r2186b1770],
31	IL-1	NN	O	il-1	dep	38	SENT_63	[p2l2211t1739r2286b1770],
32	,	,	O	,	_	0	SENT_63	[p2l2211t1739r2286b1770],
33	granulocyte-macrophage	JJ	O	granulocyte-macrophage	amod	38	SENT_63	[p2l1277t1786r1699b1821],
34	colony-stimulating	JJ	O	colony-stimulating	amod	38	SENT_63	[p2l1728t1786r2047b1821],
35	factor	NN	O	factor	nn	38	SENT_63	[p2l2074t1786r2175b1812],
36	(	CD	NUMBER	(	num	38	SENT_63	[p2l2204t1786r2286b1819, p2l1277t1832r1360b1865],
37	GMCSF	NN	O	gmcsf	nn	38	SENT_63	[p2l2204t1786r2286b1819, p2l1277t1832r1360b1865],
38	)	NN	O	)	prep_of	27	SENT_63	[p2l2204t1786r2286b1819, p2l1277t1832r1360b1865],
39	,	,	O	,	_	0	SENT_63	[p2l2204t1786r2286b1819, p2l1277t1832r1360b1865],
40	and	CC	O	and	_	0	SENT_63	[p2l1381t1832r1440b1858],
41	IL-10	NN	O	il-10	prep_of	27	SENT_63	[p2l1460t1832r1545b1857],
42	[	CD	NUMBER	[	number	43	SENT_63	[p2l1568t1832r1679b1864],
43	39,40	CD	NUMBER	39,40	num	44	SENT_63	[p2l1568t1832r1679b1864],
44	]	NN	O	]	dep	41	SENT_63	[p2l1568t1832r1679b1864],
45	.	.	O	.	_	0	SENT_63	[p2l1568t1832r1679b1864],

1	This	DT	O	this	det	2	SENT_64	[p2l1700t1832r1769b1858],
2	stimulation	NN	O	stimulation	nsubjpass	5	SENT_64	[p2l1790t1832r1976b1858],
3	was	VBD	O	be	auxpass	5	SENT_64	[p2l1995t1841r2051b1858],
4	not	RB	O	not	neg	5	SENT_64	[p2l2071t1837r2125b1858],
5	achieved	VBN	O	achieve	ccomp	42	SENT_64	[p2l2145t1832r2286b1858],
6	using	VBG	O	use	xcomp	5	SENT_64	[p2l1276t1879r1363b1914],
7	extracts	NNS	O	extract	dobj	6	SENT_64	[p2l1379t1884r1506b1905],
8	from	IN	O	from	_	0	SENT_64	[p2l1524t1879r1604b1905],
9	Aamthocheilonemu	FW	O	aamthocheilonemu	nn	10	SENT_64	[p2l1617t1879r1895b1905],
10	viteae	FW	O	viteae	prep_from	6	SENT_64	[p2l1912t1880r2000b1910],
11	,	,	O	,	_	0	SENT_64	[p2l1912t1880r2000b1910],
12	a	DT	O	a	det	14	SENT_64	[p2l2019t1888r2035b1905],
13	ﬁlarial	JJ	O	ﬁlarial	amod	14	SENT_64	[p2l2051t1879r2156b1905],
14	species	NNS	O	species	nn	27	SENT_64	[p2l2174t1879r2286b1914],
15	naturally	RB	O	naturally	advmod	16	SENT_64	[p2l1277t1925r1423b1960],
16	devoid	JJ	O	devoid	amod	14	SENT_64	[p2l1450t1925r1559b1951],
17	of	IN	O	of	_	0	SENT_64	[p2l1586t1925r1621b1951],
18	Wolbachia	NNP	LOCATION	Wolbachia	prep_of	14	SENT_64	[p2l1648t1925r1803b1956],
19	,	,	O	,	_	0	SENT_64	[p2l1648t1925r1803b1956],
20	and	CC	O	and	_	0	SENT_64	[p2l1832t1925r1899b1956],
21	,	,	O	,	_	0	SENT_64	[p2l1832t1925r1899b1956],
22	importantly	RB	O	importantly	conj_and	14	SENT_64	[p2l1927t1925r2130b1960],
23	,	,	O	,	_	0	SENT_64	[p2l1927t1925r2130b1960],
24	with	IN	O	with	_	0	SENT_64	[p2l2158t1925r2228b1951],
25	o.	NN	O	o.	prep_with	22	SENT_64	[p2l2256t1925r2285b1951],
26	volvulus	JJ	O	volvulus	amod	27	SENT_64	[p2l1276t1971r1397b1997],
27	extracts	NNS	O	extract	nsubj	42	SENT_64	[p2l1418t1976r1545b1997],
28	from	IN	O	from	_	0	SENT_64	[p2l1566t1971r1646b1997],
29	patients	NNS	O	patient	prep_from	27	SENT_64	[p2l1666t1971r1796b2006],
30	that	WDT	O	that	nsubjpass	33	SENT_64	[p2l1818t1971r1881b1997],
31	had	VBD	O	have	aux	33	SENT_64	[p2l1902t1971r1961b1997],
32	been	VBN	O	be	auxpass	33	SENT_64	[p2l1981t1971r2059b1997],
33	treated	VBN	O	treat	rcmod	29	SENT_64	[p2l2081t1971r2196b1997],
34	with	IN	O	with	_	0	SENT_64	[p2l2217t1971r2287b1997],
35	doxycycline	NN	O	doxycycline	prep_with	33	SENT_64	[p2l1277t2018r1468b2053],
36	to	TO	O	to	aux	37	SENT_64	[p2l1482t2023r1512b2044],
37	deplete	VB	O	deplete	xcomp	33	SENT_64	[p2l1525t2018r1644b2053],
38	Wolbuchia	NNP	O	Wolbuchia	dobj	37	SENT_64	[p2l1660t2018r1808b2044],
39	from	IN	O	from	_	0	SENT_64	[p2l1819t2018r1899b2044],
40	the	DT	O	the	det	41	SENT_64	[p2l1912t2018r1962b2044],
41	worms	NNS	O	worm	prep_from	37	SENT_64	[p2l1973t2027r2080b2044],
42	[	VBP	O	[	_	0	SENT_64	[p2l2095t2018r2159b2050],
43	41	CD	NUMBER	41	num	44	SENT_64	[p2l2095t2018r2159b2050],
44	]	CD	NUMBER	]	dobj	42	SENT_64	[p2l2095t2018r2159b2050],
45	.	.	O	.	_	0	SENT_64	[p2l2095t2018r2159b2050],

1	Thus	RB	O	thus	advmod	4	SENT_65	[p2l2172t2018r2252b2044],
2	it	PRP	O	it	nsubjpass	4	SENT_65	[p2l2265t2018r2287b2044],
3	was	VBD	O	be	auxpass	4	SENT_65	[p2l1276t2073r1332b2090],
4	concluded	VBN	O	conclude	_	0	SENT_65	[p2l1345t2064r1514b2090],
5	that	IN	O	that	complm	20	SENT_65	[p2l1528t2064r1591b2090],
6	in	IN	O	in	_	0	SENT_65	[p2l1604t2064r1635b2089],
7	those	DT	O	those	det	9	SENT_65	[p2l1649t2064r1733b2090],
8	ﬁlarial	JJ	O	ﬁlarial	amod	9	SENT_65	[p2l1746t2064r1851b2090],
9	species	NNS	O	species	prep_in	20	SENT_65	[p2l1864t2064r1977b2099],
10	that	WDT	O	that	nsubj	11	SENT_65	[p2l1991t2064r2055b2090],
11	contain	VBP	O	contain	rcmod	9	SENT_65	[p2l2067t2064r2191b2090],
12	these	DT	O	these	det	13	SENT_65	[p2l2205t2064r2286b2090],
13	endosymbionts	NNS	O	endosymbiont	dobj	11	SENT_65	[p2l1277t2111r1531b2146],
14	,	,	O	,	_	0	SENT_65	[p2l1277t2111r1531b2146],
15	Wolbachiu	NNP	PERSON	Wolbachiu	nsubj	20	SENT_65	[p2l1547t2111r1695b2137],
16	are	VBP	O	be	cop	20	SENT_65	[p2l1708t2120r1757b2137],
17	the	DT	O	the	det	20	SENT_65	[p2l1771t2111r1820b2137],
18	major	JJ	O	major	amod	20	SENT_65	[p2l1834t2111r1930b2146],
19	stimulating	NN	O	stimulating	nn	20	SENT_65	[p2l1941t2111r2126b2146],
20	principle	NN	O	principle	ccomp	4	SENT_65	[p2l2138t2111r2286b2146],
21	for	IN	O	for	_	0	SENT_65	[p2l1276t2157r1325b2183],
22	proinﬂammatory	JJ	O	proinﬂammatory	amod	23	SENT_65	[p2l1338t2157r1619b2192],
23	cytokines	NNS	O	cytokine	prep_for	20	SENT_65	[p2l1632t2157r1783b2192],
24	such	JJ	O	such	_	0	SENT_65	[p2l1798t2157r1870b2183],
25	as	IN	O	as	_	0	SENT_65	[p2l1884t2166r1913b2183],
26	TNF	NN	O	tnf	prep_such_as	23	SENT_65	[p2l1927t2158r2007b2183],
27	.	.	O	.	_	0	SENT_65	[p2l1927t2158r2007b2183],

1	From	IN	O	from	_	0	SENT_66	[p2l2021t2158r2110b2183],
2	this	DT	O	this	prep_from	6	SENT_66	[p2l2124t2157r2180b2183],
3	it	PRP	O	it	nsubj	6	SENT_66	[p2l2195t2157r2217b2183],
4	can	MD	O	can	aux	6	SENT_66	[p2l2231t2166r2286b2183],
5	be	VB	O	be	cop	6	SENT_66	[p2l1276t2204r1314b2230],
6	further	JJ	O	further	_	0	SENT_66	[p2l1341t2204r1461b2230],
7	hypothesized	VBD	O	hypothesize	ccomp	6	SENT_66	[p2l1487t2204r1703b2239],
8	that	IN	O	that	complm	41	SENT_66	[p2l1732t2204r1796b2230],
9	exposure	NN	O	exposure	nsubj	41	SENT_66	[p2l1824t2213r1974b2239],
10	of	IN	O	of	_	0	SENT_66	[p2l2002t2204r2037b2230],
11	host	NN	O	host	nn	12	SENT_66	[p2l2061t2204r2129b2230],
12	cells	NNS	O	cell	prep_of	9	SENT_66	[p2l2157t2204r2226b2230],
13	to	TO	O	to	_	0	SENT_66	[p2l2255t2209r2286b2230],
14	Wolbachiu	JJ	O	wolbachiu	amod	39	SENT_66	[p2l1279t2250r1427b2276],
15	from	IN	O	from	_	0	SENT_66	[p2l1448t2250r1528b2276],
16	worms	NNS	O	worm	prep_from	14	SENT_66	[p2l1549t2259r1656b2276],
17	(	CD	NUMBER	(	dep	16	SENT_66	[p2l1679t2250r1786b2282],
18	either	CC	O	either	dep	17	SENT_66	[p2l1679t2250r1786b2282],
19	from	IN	O	from	_	0	SENT_66	[p2l1807t2250r1887b2276],
20	dying	VBG	O	die	amod	22	SENT_66	[p2l1909t2250r1998b2285],
21	adult	JJ	O	adult	amod	22	SENT_66	[p2l2020t2250r2102b2276],
22	worms	NNS	O	worm	prep_from	17	SENT_66	[p2l2123t2259r2229b2276],
23	or	CC	O	or	_	0	SENT_66	[p2l2252t2259r2287b2276],
24	incoming	JJ	O	incoming	amod	26	SENT_66	[p2l1277t2296r1431b2331],
25	L3/4	NN	O	l3/4	nn	26	SENT_66	[p2l1441t2296r1510b2322],
26	larvae	NNS	O	larva	prep_from	17	SENT_66	[p2l1520t2296r1625b2327],
27	,	,	O	,	_	0	SENT_66	[p2l1520t2296r1625b2327],
28	or	CC	O	or	_	0	SENT_66	[p2l1637t2305r1672b2322],
29	from	IN	O	from	_	0	SENT_66	[p2l1682t2296r1762b2322],
30	the	DT	O	the	det	31	SENT_66	[p2l1774t2296r1823b2322],
31	proportion	NN	O	proportion	prep_from	32	SENT_66	[p2l1835t2296r2018b2331],
32	of	IN	O	of	conj_or	16	SENT_66	[p2l2030t2296r2064b2322],
33	degenerating	VBG	O	degenerate	pcomp	32	SENT_66	[p2l2072t2296r2287b2331],
34	embryos	NNS	O	embryo	dobj	33	SENT_66	[p2l1277t2343r1417b2378],
35	that	WDT	O	that	nsubjpass	38	SENT_66	[p2l1447t2343r1512b2369],
36	are	VBP	O	be	auxpass	38	SENT_66	[p2l1540t2352r1591b2369],
37	constantly	RB	O	constantly	advmod	38	SENT_66	[p2l1620t2343r1793b2378],
38	released	VBN	O	release	rcmod	34	SENT_66	[p2l1821t2343r1969b2376],
39	)	NN	O	)	prep_to	12	SENT_66	[p2l1821t2343r1969b2376],
40	may	MD	O	may	aux	41	SENT_66	[p2l1998t2352r2065b2378],
41	induce	VB	O	induce	ccomp	7	SENT_66	[p2l2094t2343r2206b2369],
42	the	DT	O	the	det	43	SENT_66	[p2l2235t2343r2286b2369],
43	production	NN	O	production	dobj	41	SENT_66	[p2l1277t2389r1461b2424],
44	of	IN	O	of	_	0	SENT_66	[p2l1480t2389r1515b2415],
45	lymphangiogenic	JJ	O	lymphangiogenic	amod	46	SENT_66	[p2l1530t2389r1810b2424],
46	factors	NNS	O	factor	prep_of	43	SENT_66	[p2l1829t2389r1939b2415],
47	such	JJ	O	such	_	0	SENT_66	[p2l1959t2389r2031b2415],
48	as	IN	O	as	_	0	SENT_66	[p2l2050t2398r2079b2415],
49	VEGF-C	NN	O	vegf-c	prep_such_as	46	SENT_66	[p2l2097t2389r2230b2415],
50	by	IN	O	by	_	0	SENT_66	[p2l2250t2389r2287b2424],
51	endothelial	JJ	O	endothelial	amod	52	SENT_66	[p2l1277t2436r1460b2462],
52	cells	NNS	O	cell	prep_by	41	SENT_66	[p2l1475t2436r1543b2462],
53	in	IN	O	in	_	0	SENT_66	[p2l1559t2436r1590b2461],
54	LF	NN	O	lf	nn	55	SENT_66	[p2l1604t2437r1646b2461],
55	patients	NNS	O	patient	prep_in	52	SENT_66	[p2l1661t2436r1799b2471],
56	.	.	O	.	_	0	SENT_66	[p2l1661t2436r1799b2471],

1	Treatment	NN	O	treatment	nsubjpass	14	SENT_67	[p2l1314t2484r1488b2509],
2	with	IN	O	with	_	0	SENT_67	[p2l1505t2483r1575b2509],
3	doxycycline	NN	O	doxycycline	prep_with	1	SENT_67	[p2l1594t2483r1785b2518],
4	for	IN	O	for	_	0	SENT_67	[p2l1804t2483r1853b2509],
5	8	CD	DURATION	8	num	6	SENT_67	[p2l1871t2483r1887b2508],
6	wk	NN	DURATION	wk	prep_for	9	SENT_67	[p2l1905t2483r1949b2508],
7	is	VBZ	O	be	auxpass	9	SENT_67	[p2l1967t2483r1989b2509],
8	well	RB	O	well	advmod	9	SENT_67	[p2l2007t2483r2071b2509],
9	tolerated	VBN	O	tolerate	_	0	SENT_67	[p2l2090t2483r2237b2509],
10	in	IN	O	in	_	0	SENT_67	[p2l2256t2483r2287b2508],
11	humans	NNS	O	human	prep_in	9	SENT_67	[p2l1276t2529r1403b2555],
12	and	CC	O	and	_	0	SENT_67	[p2l1417t2529r1476b2555],
13	has	VBZ	O	have	aux	14	SENT_67	[p2l1489t2529r1541b2555],
14	shown	VBN	O	show	conj_and	9	SENT_67	[p2l1555t2529r1657b2555],
15	macroﬁlaricidal	JJ	O	macroﬁlaricidal	amod	16	SENT_67	[p2l1670t2529r1929b2555],
16	activity	NN	O	activity	dobj	14	SENT_67	[p2l1944t2529r2061b2564],
17	[	CD	NUMBER	[	number	18	SENT_67	[p2l2076t2529r2141b2561],
18	42	CD	NUMBER	42	num	19	SENT_67	[p2l2076t2529r2141b2561],
19	]	NN	O	]	dobj	9	SENT_67	[p2l2076t2529r2141b2561],
20	.	.	O	.	_	0	SENT_67	[p2l2076t2529r2141b2561],

1	Doxycycline	NNP	O	Doxycycline	nsubj	4	SENT_68	[p2l2155t2530r2286b2564, p2l1277t2575r1354b2601],
2	is	VBZ	O	be	cop	4	SENT_68	[p2l1365t2575r1387b2601],
3	also	RB	O	also	advmod	4	SENT_68	[p2l1400t2575r1460b2601],
4	effective	JJ	O	effective	_	0	SENT_68	[p2l1472t2575r1609b2601],
5	in	IN	O	in	_	0	SENT_68	[p2l1621t2575r1652b2600],
6	depleting	VBG	O	deplete	prepc_in	4	SENT_68	[p2l1663t2575r1817b2610],
7	Wolbachiu	NNP	PERSON	Wolbachiu	dobj	6	SENT_68	[p2l1830t2575r1978b2601],
8	from	IN	O	from	_	0	SENT_68	[p2l1989t2575r2069b2601],
9	both	DT	O	both	det	10	SENT_68	[p2l2079t2575r2154b2601],
10	MF	NN	O	mf	prep_from	6	SENT_68	[p2l2165t2576r2216b2600],
11	and	CC	O	and	_	0	SENT_68	[p2l2228t2575r2287b2601],
12	adult	JJ	O	adult	amod	14	SENT_68	[p2l1277t2622r1359b2648],
13	ﬁlarial	JJ	O	ﬁlarial	amod	14	SENT_68	[p2l1374t2622r1479b2648],
14	worms	NNS	O	worm	prep_from	6	SENT_68	[p2l1494t2631r1600b2648],
15	of	IN	O	of	_	0	SENT_68	[p2l1616t2622r1651b2648],
16	W.	NNP	O	W.	nn	17	SENT_68	[p2l1665t2623r1701b2648],
17	bzmcrofti	NNS	O	bzmcroftus	prep_of	14	SENT_68	[p2l1718t2622r1844b2657],
18	and	CC	O	and	_	0	SENT_68	[p2l1859t2622r1918b2648],
19	o.	NN	O	o.	nn	20	SENT_68	[p2l1934t2622r1963b2648],
20	volvulus	NN	O	volvulus	conj_and	10	SENT_68	[p2l1979t2622r2100b2648],
21	[	CD	NUMBER	[	number	22	SENT_68	[p2l2117t2622r2229b2654],
22	43,44	CD	NUMBER	43,44	num	23	SENT_68	[p2l2117t2622r2229b2654],
23	]	NN	O	]	dep	20	SENT_68	[p2l2117t2622r2229b2654],
24	.	.	O	.	_	0	SENT_68	[p2l2117t2622r2229b2654],

1	Of	IN	O	of	_	0	SENT_69	[p2l2246t2622r2290b2648],
2	importance	NN	O	importance	prep_of	13	SENT_69	[p2l1277t2668r1466b2703],
3	for	IN	O	for	_	0	SENT_69	[p2l1489t2668r1538b2694],
4	the	DT	O	the	det	6	SENT_69	[p2l1561t2668r1611b2694],
5	present	JJ	DATE	present	amod	6	SENT_69	[p2l1635t2673r1757b2703],
6	study	NN	O	study	prep_for	2	SENT_69	[p2l1780t2668r1873b2703],
7	,	,	O	,	_	0	SENT_69	[p2l1780t2668r1873b2703],
8	Wolbuchia	JJ	O	wolbuchia	amod	9	SENT_69	[p2l1900t2668r2048b2694],
9	depletion	NN	O	depletion	nsubjpass	13	SENT_69	[p2l2071t2668r2227b2703],
10	by	IN	O	by	_	0	SENT_69	[p2l2250t2668r2287b2703],
11	doxycycline	NN	O	doxycycline	prep_by	9	SENT_69	[p2l1277t2715r1468b2750],
12	was	VBD	O	be	auxpass	13	SENT_69	[p2l1482t2724r1538b2741],
13	associated	VBN	O	associate	_	0	SENT_69	[p2l1554t2715r1718b2741],
14	with	IN	O	with	_	0	SENT_69	[p2l1732t2715r1802b2741],
15	a	DT	O	a	det	16	SENT_69	[p2l1817t2724r1833b2741],
16	reduction	NN	O	reduction	prep_with	13	SENT_69	[p2l1848t2715r2007b2741],
17	of	IN	O	of	_	0	SENT_69	[p2l2022t2715r2057b2741],
18	pretreatment	NN	O	pretreatment	nn	20	SENT_69	[p2l2068t2720r2287b2750],
19	elevated	JJ	O	elevated	amod	20	SENT_69	[p2l1277t2761r1410b2787],
20	levels	NNS	O	level	prep_of	16	SENT_69	[p2l1431t2761r1518b2787],
21	of	IN	O	of	_	0	SENT_69	[p2l1540t2761r1575b2787],
22	proinﬂammatory	JJ	O	proinﬂammatory	amod	23	SENT_69	[p2l1593t2761r1874b2796],
23	cytokines	NNS	O	cytokine	prep_of	20	SENT_69	[p2l1896t2761r2047b2796],
24	such	JJ	O	such	_	0	SENT_69	[p2l2069t2761r2141b2787],
25	as	IN	O	as	_	0	SENT_69	[p2l2163t2770r2192b2787],
26	TNF	NN	O	tnf	prep_such_as	23	SENT_69	[p2l2214t2762r2286b2787],
27	from	IN	O	from	_	0	SENT_69	[p2l1276t2808r1356b2834],
28	plasma	NN	O	plasma	prep_from	13	SENT_69	[p2l1373t2808r1486b2843],
29	[	CD	NUMBER	[	number	30	SENT_69	[p2l1504t2808r1569b2840],
30	45	CD	NUMBER	45	num	31	SENT_69	[p2l1504t2808r1569b2840],
31	]	NN	O	]	dep	13	SENT_69	[p2l1504t2808r1569b2840],
32	.	.	O	.	_	0	SENT_69	[p2l1504t2808r1569b2840],

1	Together	RB	O	together	advmod	5	SENT_70	[p2l1586t2808r1744b2843],
2	,	,	O	,	_	0	SENT_70	[p2l1586t2808r1744b2843],
3	these	DT	O	these	det	4	SENT_70	[p2l1762t2808r1844b2834],
4	data	NNS	O	datum	nsubj	5	SENT_70	[p2l1861t2808r1931b2834],
5	allow	VBP	O	allow	_	0	SENT_70	[p2l1947t2808r2031b2834],
6	the	DT	O	the	det	7	SENT_70	[p2l2048t2808r2098b2834],
7	hypothesis	NN	O	hypothesis	dobj	5	SENT_70	[p2l2114t2808r2286b2843],
8	that	IN	O	that	complm	14	SENT_70	[p2l1278t2854r1342b2880],
9	targeting	VBG	O	target	csubj	14	SENT_70	[p2l1370t2854r1520b2889],
10	Wolbachia	JJ	PERSON	wolbachia	dobj	9	SENT_70	[p2l1550t2854r1701b2880],
11	by	IN	O	by	_	0	SENT_70	[p2l1727t2854r1765b2889],
12	doxycycline	NN	O	doxycycline	prep_by	9	SENT_70	[p2l1792t2854r1987b2889],
13	may	MD	O	may	aux	14	SENT_70	[p2l2015t2863r2081b2889],
14	ameliorate	VB	O	ameliorate	ccomp	5	SENT_70	[p2l2109t2854r2286b2880],
15	ﬁlarial	JJ	O	ﬁlarial	amod	16	SENT_70	[p2l1276t2900r1381b2926],
16	pathology	NN	O	pathology	dobj	14	SENT_70	[p2l1398t2900r1560b2935],
17	through	IN	O	through	_	0	SENT_70	[p2l1577t2900r1707b2935],
18	down-regulation	NN	O	down-regulation	prep_through	14	SENT_70	[p2l1724t2900r1995b2935],
19	of	IN	O	of	_	0	SENT_70	[p2l2013t2900r2047b2926],
20	proinﬂammatory	JJ	O	proinﬂammatory	amod	21	SENT_70	[p2l2061t2900r2286b2935, p2l1277t2952r1342b2982],
21	cytokines	NNS	O	cytokine	prep_of	18	SENT_70	[p2l1355t2947r1506b2982],
22	and	CC	O	and	_	0	SENT_70	[p2l1520t2947r1579b2973],
23	VEGF-CIVEGFR-3	NN	O	vegf-civegfr-3	prep_of	18	SENT_70	[p2l1591t2947r1896b2973],
24	.	.	O	.	_	0	SENT_70	[p2l1591t2947r1896b2973],

1	However	RB	O	however	advmod	8	SENT_71	[p2l1910t2948r2063b2978],
2	,	,	O	,	_	0	SENT_71	[p2l1910t2948r2063b2978],
3	no	DT	O	no	det	4	SENT_71	[p2l2077t2956r2117b2973],
4	studies	NNS	O	study	nsubj	8	SENT_71	[p2l2131t2947r2241b2973],
5	to	TO	O	to	_	0	SENT_71	[p2l2256t2952r2286b2973],
6	date	NN	O	date	prep_to	4	SENT_71	[p2l1277t2993r1345b3019],
7	have	VBP	O	have	aux	8	SENT_71	[p2l1365t2993r1438b3019],
8	analyzed	VBN	O	analyze	_	0	SENT_71	[p2l1459t2993r1598b3028],
9	Wolbachiu-induced	JJ	MISC	wolbachiu-induced	amod	10	SENT_71	[p2l1620t2993r1913b3019],
10	secretion	NN	O	secretion	dobj	8	SENT_71	[p2l1933t2993r2082b3019],
11	of	IN	O	of	_	0	SENT_71	[p2l2102t2993r2137b3019],
12	VEGF-C	NN	O	vegf-c	prep_of	10	SENT_71	[p2l2152t2993r2286b3019],

1	Table	NNP	O	Table	_	0	SENT_72	[p3l188t247r279b274],
2	1	CD	NUMBER	1	dep	1	SENT_72	[p3l296t250r322b274],
3	.	.	O	.	_	0	SENT_72	[p3l296t250r322b274],

1	Primary	JJ	O	primary	amod	2	SENT_73	[p3l338t248r454b282],
2	Variables	NNS	O	variable	nsubj	3	SENT_73	[p3l467t247r606b274],
3	Measured	VBN	O	measure	conj_and	3	SENT_73	[p3l622t247r771b274],
4	before	IN	O	before	_	0	SENT_73	[p3l789t247r887b274],
5	and	CC	O	and	_	0	SENT_73	[p3l902t247r958b274],
6	after	IN	O	after	_	0	SENT_73	[p3l974t247r1045b274],
7	Treatment	NN	O	treatment	prep_before	3	SENT_73	[p3l1057t249r1219b274],
8	in	IN	O	in	_	0	SENT_73	[p3l1235t248r1259b274],
9	Microfilaremic	JJ	O	microfilaremic	amod	10	SENT_73	[p3l1276t247r1494b274],
10	Patients	NNS	O	patient	prep_in	3	SENT_73	[p3l1510t248r1631b274],

1	Treatment	NNP	O	Treatment	nn	2	SENT_74	[p3l188t345r342b368],
2	Group	NNP	O	Group	_	0	SENT_74	[p3l355t345r446b375],

1	Time	NNP	O	Time	nn	2	SENT_75	[p3l1048t344r1120b368],
2	Point	NNP	O	Point	_	0	SENT_75	[p3l1134t344r1210b368],
3	after	IN	O	after	_	0	SENT_75	[p3l1223t344r1293b368],
4	Treatment	NN	O	treatment	prep_after	2	SENT_75	[p3l1304t345r1459b368],

1	Before	IN	O	before	dep	8	SENT_76	[p3l1050t403r1145b427],
2	Treatment	NN	O	treatment	amod	6	SENT_76	[p3l1157t404r1311b427],
3	4	CD	DURATION	4	number	2	SENT_76	[p3l1421t405r1438b427],
4	mo	NN	DURATION	mo	nn	6	SENT_76	[p3l1452t410r1497b427],
5	12	CD	DURATION	12	num	6	SENT_76	[p3l1727t405r1759b427],
6	mo	NN	DURATION	mo	pobj	1	SENT_76	[p3l1774t410r1819b427],
7	24	CD	DURATION	24	num	8	SENT_76	[p3l2061t405r2096b427],
8	mo	NN	DURATION	mo	_	0	SENT_76	[p3l2110t410r2155b427],

1	Doxycycline	NNP	O	Doxycycline	nn	2	SENT_77	[p3l189t492r343b519],
2	GM	NNP	O	GM	dep	11	SENT_77	[p3l454t493r493b513],
3	of	IN	O	of	_	0	SENT_77	[p3l505t492r530b513],
4	Wolbachia	NNP	O	Wolbachia	nn	5	SENT_77	[p3l541t492r664b513],
5	load/MF	NNP	O	load/MF	prep_of	2	SENT_77	[p3l677t492r774b514],
6	89	CD	NUMBER	89	number	7	SENT_77	[p3l1048t494r1076b513],
7	(	CD	NUMBER	(	num	5	SENT_77	[p3l1088t493r1190b517],
8	67-184	CD	NUMBER	67-184	num	9	SENT_77	[p3l1088t493r1190b517],
9	)	NN	O	)	dep	11	SENT_77	[p3l1088t493r1190b517],
10	4	CD	NUMBER	4	num	11	SENT_77	[p3l1421t494r1435b513],
11	(	NN	O	(	dep	15	SENT_77	[p3l1447t493r1540b517],
12	0.8-10	CD	NUMBER	0.8-10	dep	11	SENT_77	[p3l1447t493r1540b517],
13	)	CD	NUMBER	)	number	14	SENT_77	[p3l1447t493r1540b517],
14	16	CD	NUMBER	16	dep	12	SENT_77	[p3l1727t494r1753b513],
15	(	NN	O	(	dep	17	SENT_77	[p3l1765t493r1781b517],
16	1	CD	NUMBER	1	num	15	SENT_77	[p3l1765t493r1781b517],
17	patient	NN	O	patient	dep	20	SENT_77	[p3l1798t493r1890b519],
18	)	CD	NUMBER	)	num	17	SENT_77	[p3l1798t493r1890b519],
19	33	CD	NUMBER	33	num	20	SENT_77	[p3l2061t494r2088b513],
20	(	NN	O	(	dep	22	SENT_77	[p3l2101t493r2188b517],
21	14-69	CD	NUMBER	14-69	num	22	SENT_77	[p3l2101t493r2188b517],
22	)	NN	O	)	_	0	SENT_77	[p3l2101t493r2188b517],

1	(	NN	O	(	nn	3	SENT_78	[p3l454t529r584b554],
2	10th	JJ	ORDINAL	10th	amod	3	SENT_78	[p3l454t529r584b554],
3	—	NN	O	—	_	0	SENT_78	[p3l454t529r584b554],
4	90th	JJ	ORDINAL	90th	amod	7	SENT_78	[p3l454t529r584b554],
5	percentile	NN	O	percentile	nn	7	SENT_78	[p3l598t529r724b556],
6	)	NN	O	)	nn	7	SENT_78	[p3l598t529r724b556],
7	p	NN	O	p	dep	3	SENT_78	[p3l452t564r554b593],
8	.	.	O	.	_	0	SENT_78	[p3l452t564r554b593],

1	—	NN	O	—	_	0	SENT_79	[p3l452t564r554b593],
2	.	.	O	.	_	0	SENT_79	[p3l452t564r554b593],

1	Valuea	NN	PERSON	valuea	nn	2	SENT_80	[p3l452t564r554b593],
2	p	NN	O	p	_	0	SENT_80	[p3l1047t572r1062b593],
3	=	JJ	O	=	amod	6	SENT_80	[p3l1074t576r1094b583],
4	0.0418	CD	NUMBER	0.0418	num	5	SENT_80	[p3l1106t568r1184b587],
5	p	NN	O	p	dep	3	SENT_80	[p3l1420t573r1435b593],
6	<	JJR	O	<	dep	2	SENT_80	[p3l1448t570r1468b586],
7	0.0001	CD	NUMBER	0.0001	num	8	SENT_80	[p3l1481t568r1554b587],
8	p	NN	O	p	dep	6	SENT_80	[p3l1724t572r1739b593],
9	=	JJ	O	=	amod	11	SENT_80	[p3l1751t576r1770b583],
10	0.1266	CD	NUMBER	0.1266	tmod	9	SENT_80	[p3l1782t568r1861b587],
11	p	NN	O	p	dep	2	SENT_80	[p3l2060t573r2075b593],
12	=	JJ	O	=	amod	11	SENT_80	[p3l2087t576r2106b583],
13	0.0330	CD	NUMBER	0.0330	tmod	12	SENT_80	[p3l2118t568r2197b587],
14	GM	NNP	O	GM	dep	2	SENT_80	[p3l454t605r493b625],
15	of	IN	O	of	_	0	SENT_80	[p3l505t604r530b625],
16	microﬁlaremia	NN	O	microﬁlaremia	nn	18	SENT_80	[p3l541t604r711b625],
17	734	CD	NUMBER	734	num	18	SENT_80	[p3l1049t606r1091b625],
18	(	NN	O	(	prep_of	14	SENT_80	[p3l1103t605r1241b629],
19	2l8	CD	NUMBER	2l8	num	18	SENT_80	[p3l1103t605r1241b629],
20	—	CD	NUMBER	—	number	21	SENT_80	[p3l1103t605r1241b629],
21	3,650	CD	NUMBER	3,650	num	22	SENT_80	[p3l1103t605r1241b629],
22	)	NN	O	)	dep	2	SENT_80	[p3l1103t605r1241b629],
23	550	CD	NUMBER	550	num	24	SENT_80	[p3l1422t606r1464b625],
24	(	NN	O	(	dep	22	SENT_80	[p3l1476t605r1599b629],
25	88	CD	NUMBER	88	number	26	SENT_80	[p3l1476t605r1599b629],
26	—	CD	NUMBER	—	dep	2	SENT_80	[p3l1476t605r1599b629],
27	4,682	CD	NUMBER	4,682	num	28	SENT_80	[p3l1476t605r1599b629],
28	)	NN	O	)	dep	26	SENT_80	[p3l1476t605r1599b629],
29	0.10	CD	NUMBER	0.10	num	31	SENT_80	[p3l1725t606r1774b625],
30	(	CD	NUMBER	(	num	31	SENT_80	[p3l1786t605r1843b629],
31	o-o	NN	O	o-o	dep	2	SENT_80	[p3l1786t605r1843b629],
32	)	CD	NUMBER	)	number	33	SENT_80	[p3l1786t605r1843b629],
33	1.3	CD	NUMBER	1.3	num	34	SENT_80	[p3l2063t606r2094b625],
34	(	NN	O	(	dep	31	SENT_80	[p3l2107t605r2152b629],
35	0-1	CD	NUMBER	0-1	dep	2	SENT_80	[p3l2107t605r2152b629],
36	1	CD	NUMBER	1	number	37	SENT_80	[p3l2161t606r2167b625],
37	1	CD	NUMBER	1	num	38	SENT_80	[p3l2176t605r2194b629],
38	)	NN	O	)	dep	35	SENT_80	[p3l2176t605r2194b629],
39	(	CD	NUMBER	(	num	41	SENT_80	[p3l454t641r584b666],
40	10th	JJ	ORDINAL	10th	amod	41	SENT_80	[p3l454t641r584b666],
41	—	NN	O	—	dep	2	SENT_80	[p3l454t641r584b666],
42	90th	JJ	ORDINAL	90th	amod	45	SENT_80	[p3l454t641r584b666],
43	percentile	NN	O	percentile	nn	45	SENT_80	[p3l598t641r724b668],
44	)	NN	O	)	nn	45	SENT_80	[p3l598t641r724b668],
45	p	NN	O	p	dep	41	SENT_80	[p3l452t676r554b705],
46	.	.	O	.	_	0	SENT_80	[p3l452t676r554b705],

1	—	NN	O	—	_	0	SENT_81	[p3l452t676r554b705],
2	.	.	O	.	_	0	SENT_81	[p3l452t676r554b705],

1	Valuea	NN	PERSON	valuea	nn	2	SENT_82	[p3l452t676r554b705],
2	p	NN	O	p	_	0	SENT_82	[p3l1047t684r1062b705],
3	=	JJ	O	=	amod	5	SENT_82	[p3l1074t688r1094b695],
4	0.0293	CD	NUMBER	0.0293	tmod	3	SENT_82	[p3l1106t680r1183b699],
5	p	NN	O	p	dep	2	SENT_82	[p3l1420t685r1435b705],
6	=	JJ	O	=	amod	5	SENT_82	[p3l1447t688r1467b695],
7	0.4749	CD	NUMBER	0.4749	tmod	6	SENT_82	[p3l1479t680r1557b699],
8	p	NN	O	p	dep	2	SENT_82	[p3l1724t684r1739b705],
9	=	JJ	O	=	amod	11	SENT_82	[p3l1751t688r1770b695],
10	0.0029	CD	NUMBER	0.0029	tmod	9	SENT_82	[p3l1782t680r1861b699],
11	p	NN	O	p	dep	8	SENT_82	[p3l2060t685r2075b705],
12	=	JJ	O	=	amod	14	SENT_82	[p3l2087t688r2106b695],
13	0.0211	CD	NUMBER	0.0211	tmod	12	SENT_82	[p3l2118t680r2192b699],
14	Number	NN	O	number	dep	2	SENT_82	[p3l455t716r552b737],
15	of	IN	O	of	_	0	SENT_82	[p3l563t716r588b737],
16	MF-positive	JJ	O	mf-positive	amod	17	SENT_82	[p3l598t717r738b743],
17	individuals	NNS	O	individual	prep_of	14	SENT_82	[p3l750t716r878b737],
18	(	CD	PERCENT	(	num	19	SENT_82	[p3l891t717r927b741],
19	%	NN	PERCENT	%	dep	2	SENT_82	[p3l891t717r927b741],
20	)	CD	NUMBER	)	number	21	SENT_82	[p3l891t717r927b741],
21	17/17	CD	NUMBER	17/17	num	22	SENT_82	[p3l1050t717r1115b738],
22	(	NN	O	(	dep	19	SENT_82	[p3l1128t717r1208b741],
23	100	CD	PERCENT	100	num	24	SENT_82	[p3l1128t717r1208b741],
24	%	NN	PERCENT	%	dep	2	SENT_82	[p3l1128t717r1208b741],
25	)	CD	NUMBER	)	number	26	SENT_82	[p3l1128t717r1208b741],
26	15/17	CD	NUMBER	15/17	num	27	SENT_82	[p3l1424t717r1489b738],
27	(	NN	O	(	dep	24	SENT_82	[p3l1501t717r1567b741],
28	88	CD	PERCENT	88	num	29	SENT_82	[p3l1501t717r1567b741],
29	%	NN	PERCENT	%	dep	2	SENT_82	[p3l1501t717r1567b741],
30	)	CD	NUMBER	)	number	31	SENT_82	[p3l1501t717r1567b741],
31	1/17	CD	NUMBER	1/17	num	32	SENT_82	[p3l1727t717r1777b738],
32	(	NN	O	(	dep	29	SENT_82	[p3l1790t717r1841b741],
33	6	CD	PERCENT	6	num	34	SENT_82	[p3l1790t717r1841b741],
34	%	NN	PERCENT	%	dep	2	SENT_82	[p3l1790t717r1841b741],
35	)	CD	NUMBER	)	number	36	SENT_82	[p3l1790t717r1841b741],
36	3/17	CD	NUMBER	3/17	num	37	SENT_82	[p3l2061t717r2113b738],
37	(	NN	O	(	dep	34	SENT_82	[p3l2126t717r2191b741],
38	18	CD	PERCENT	18	num	39	SENT_82	[p3l2126t717r2191b741],
39	%	NN	PERCENT	%	dep	2	SENT_82	[p3l2126t717r2191b741],
40	)	CD	NUMBER	)	num	41	SENT_82	[p3l2126t717r2191b741],
41	p	NN	O	p	dep	39	SENT_82	[p3l452t751r554b780],
42	.	.	O	.	_	0	SENT_82	[p3l452t751r554b780],

1	—	NN	O	—	_	0	SENT_83	[p3l452t751r554b780],
2	.	.	O	.	_	0	SENT_83	[p3l452t751r554b780],

1	Valuea	NN	PERSON	valuea	nn	2	SENT_84	[p3l452t751r554b780],
2	p	NN	O	p	_	0	SENT_84	[p3l1047t759r1062b780],
3	>	JJR	O	>	dep	2	SENT_84	[p3l1075t756r1095b773],
4	0.9999	CD	NUMBER	0.9999	num	5	SENT_84	[p3l1107t755r1186b774],
5	p	NN	O	p	npadvmod	6	SENT_84	[p3l1420t760r1435b780],
6	=	JJ	O	=	amod	3	SENT_84	[p3l1447t763r1467b770],
7	0.6562	CD	NUMBER	0.6562	num	8	SENT_84	[p3l1479t755r1556b774],
8	p	NN	O	p	dep	2	SENT_84	[p3l1724t759r1739b780],
9	=	JJ	O	=	amod	11	SENT_84	[p3l1751t763r1770b770],
10	0.0066	CD	NUMBER	0.0066	tmod	9	SENT_84	[p3l1782t755r1861b774],
11	p	NN	O	p	dep	8	SENT_84	[p3l2060t760r2075b780],
12	=	JJ	O	=	dep	2	SENT_84	[p3l2087t763r2106b770],
13	0.0134	CD	NUMBER	0.0134	tmod	12	SENT_84	[p3l2118t755r2197b774],
14	Median	JJ	MISC	median	amod	12	SENT_84	[p3l454t790r542b811],
15	of	IN	O	of	_	0	SENT_84	[p3l554t790r579b811],
16	antigenemia	NN	O	antigenemia	prep_of	12	SENT_84	[p3l589t791r739b817],
17	in	IN	O	in	_	0	SENT_84	[p3l752t791r771b811],
18	units	NNS	O	unit	prep_in	16	SENT_84	[p3l784t791r841b811],
19	(	CD	PERCENT	(	num	20	SENT_84	[p3l854t791r890b815],
20	%	NN	PERCENT	%	dep	2	SENT_84	[p3l854t791r890b815],
21	)	CD	NUMBER	)	number	22	SENT_84	[p3l854t791r890b815],
22	724,844	CD	NUMBER	724,844	num	23	SENT_84	[p3l1049t792r1142b815],
23	(	NN	O	(	dep	20	SENT_84	[p3l1154t791r1234b815],
24	100	CD	PERCENT	100	num	25	SENT_84	[p3l1154t791r1234b815],
25	%	NN	PERCENT	%	dep	2	SENT_84	[p3l1154t791r1234b815],
26	)	CD	PERCENT	)	number	27	SENT_84	[p3l1154t791r1234b815],
27	—	CD	PERCENT	—	dep	25	SENT_84	[p3l1421t803r1449b805],
28	137,265	CD	PERCENT	137,265	number	29	SENT_84	[p3l1727t792r1818b815],
29	(	CD	PERCENT	(	dep	2	SENT_84	[p3l1831t791r1896b815],
30	19	CD	PERCENT	19	num	31	SENT_84	[p3l1831t791r1896b815],
31	%	NN	PERCENT	%	dep	29	SENT_84	[p3l1831t791r1896b815],
32	)	CD	PERCENT	)	number	33	SENT_84	[p3l1831t791r1896b815],
33	43,622	CD	PERCENT	43,622	dep	2	SENT_84	[p3l2060t792r2139b815],
34	(	CD	PERCENT	(	num	36	SENT_84	[p3l2152t791r2202b815],
35	6	CD	PERCENT	6	num	36	SENT_84	[p3l2152t791r2202b815],
36	%	NN	PERCENT	%	dep	33	SENT_84	[p3l2152t791r2202b815],
37	)	CD	NUMBER	)	number	38	SENT_84	[p3l2152t791r2202b815],
38	(	CD	NUMBER	(	dep	2	SENT_84	[p3l454t828r584b853],
39	10th	JJ	ORDINAL	10th	amod	40	SENT_84	[p3l454t828r584b853],
40	—	NN	O	—	dep	38	SENT_84	[p3l454t828r584b853],
41	90th	JJ	ORDINAL	90th	amod	43	SENT_84	[p3l454t828r584b853],
42	percentile	NN	O	percentile	nn	43	SENT_84	[p3l598t828r724b855],
43	)	NN	O	)	dep	2	SENT_84	[p3l598t828r724b855],
44	(	CD	NUMBER	(	number	45	SENT_84	[p3l1049t829r1273b853],
45	74,512	CD	NUMBER	74,512	dep	43	SENT_84	[p3l1049t829r1273b853],
46	—	CD	NUMBER	—	number	47	SENT_84	[p3l1049t829r1273b853],
47	9,596,258	CD	NUMBER	9,596,258	dep	2	SENT_84	[p3l1049t829r1273b853],
48	)	NN	O	)	dep	47	SENT_84	[p3l1049t829r1273b853],
49	(	CD	NUMBER	(	num	48	SENT_84	[p3l1726t829r1950b853],
50	13,318	CD	NUMBER	13,318	number	51	SENT_84	[p3l1726t829r1950b853],
51	—	CD	NUMBER	—	dep	2	SENT_84	[p3l1726t829r1950b853],
52	1,468,456	CD	NUMBER	1,468,456	num	53	SENT_84	[p3l1726t829r1950b853],
53	)	NN	O	)	dep	51	SENT_84	[p3l1726t829r1950b853],
54	(	CD	NUMBER	(	number	55	SENT_84	[p3l2062t829r2250b853],
55	2,965	CD	NUMBER	2,965	num	56	SENT_84	[p3l2062t829r2250b853],
56	—	NN	O	—	dep	2	SENT_84	[p3l2062t829r2250b853],
57	163,273	CD	NUMBER	163,273	number	58	SENT_84	[p3l2062t829r2250b853],
58	)	CD	NUMBER	)	num	60	SENT_84	[p3l2062t829r2250b853],
59	p-Valuea	NN	O	p-valuea	nn	60	SENT_84	[p3l452t863r554b892],
60	p	NN	O	p	npadvmod	61	SENT_84	[p3l1047t871r1062b892],
61	=	JJ	O	=	amod	56	SENT_84	[p3l1074t875r1094b882],
62	0.5718	CD	NUMBER	0.5718	num	63	SENT_84	[p3l1106t867r1184b886],
63	p	NN	O	p	dep	2	SENT_84	[p3l1724t871r1739b892],
64	=	JJ	O	=	amod	66	SENT_84	[p3l1751t875r1770b882],
65	0.1748	CD	NUMBER	0.1748	tmod	64	SENT_84	[p3l1782t867r1861b886],
66	p	NN	O	p	dep	63	SENT_84	[p3l2060t872r2075b892],
67	=	JJ	O	=	amod	69	SENT_84	[p3l2087t875r2106b882],
68	0.0382	CD	NUMBER	0.0382	tmod	67	SENT_84	[p3l2118t867r2196b886],
69	Number	NN	O	number	dep	2	SENT_84	[p3l455t902r552b923],
70	of	IN	O	of	_	0	SENT_84	[p3l563t902r588b923],
71	FDS	NN	O	fd	prep_of	69	SENT_84	[p3l599t903r748b929],
72	—	CD	NUMBER	—	num	74	SENT_84	[p3l599t903r748b929],
73	positive	JJ	O	positive	amod	74	SENT_84	[p3l599t903r748b929],
74	individuals	NNS	O	individual	dep	2	SENT_84	[p3l761t902r888b923],
75	(	CD	PERCENT	(	num	76	SENT_84	[p3l901t903r937b927],
76	%	NN	PERCENT	%	dep	74	SENT_84	[p3l901t903r937b927],
77	)	CD	NUMBER	)	number	78	SENT_84	[p3l901t903r937b927],
78	11/17	CD	NUMBER	11/17	num	79	SENT_84	[p3l1050t903r1115b924],
79	(	NN	O	(	dep	2	SENT_84	[p3l1128t903r1194b927],
80	65	CD	PERCENT	65	number	81	SENT_84	[p3l1128t903r1194b927],
81	%	NN	PERCENT	%	amod	79	SENT_84	[p3l1128t903r1194b927],
82	)	CD	NUMBER	)	number	83	SENT_84	[p3l1128t903r1194b927],
83	—	CD	NUMBER	—	dep	2	SENT_84	[p3l1421t915r1449b917],
84	3/17	CD	NUMBER	3/17	num	85	SENT_84	[p3l1725t903r1777b924],
85	(	NN	O	(	dep	83	SENT_84	[p3l1790t903r1855b927],
86	18	CD	PERCENT	18	num	87	SENT_84	[p3l1790t903r1855b927],
87	%	NN	PERCENT	%	dep	2	SENT_84	[p3l1790t903r1855b927],
88	)	CD	NUMBER	)	number	89	SENT_84	[p3l1790t903r1855b927],
89	1/17	CD	NUMBER	1/17	num	90	SENT_84	[p3l2063t903r2113b924],
90	(	NN	O	(	dep	87	SENT_84	[p3l2126t903r2177b927],
91	6	CD	PERCENT	6	num	92	SENT_84	[p3l2126t903r2177b927],
92	%	NN	PERCENT	%	dep	2	SENT_84	[p3l2126t903r2177b927],
93	)	CD	NUMBER	)	num	94	SENT_84	[p3l2126t903r2177b927],
94	p	NN	O	p	dep	92	SENT_84	[p3l452t934r556b967],
95	.	.	O	.	_	0	SENT_84	[p3l452t934r556b967],

1	—	NN	O	—	_	0	SENT_85	[p3l452t934r556b967],
2	.	.	O	.	_	0	SENT_85	[p3l452t934r556b967],

1	Valueb	NN	PERSON	valueb	nn	2	SENT_86	[p3l452t934r556b967],
2	p	NN	O	p	_	0	SENT_86	[p3l1047t946r1062b967],
3	=	JJ	O	=	amod	5	SENT_86	[p3l1074t950r1094b957],
4	0.4384	CD	NUMBER	0.4384	tmod	3	SENT_86	[p3l1106t942r1184b961],
5	p	NN	O	p	dep	2	SENT_86	[p3l1724t946r1739b967],
6	=	JJ	O	=	quantmod	7	SENT_86	[p3l1751t950r1770b957],
7	0.0004	CD	NUMBER	0.0004	num	8	SENT_86	[p3l1782t942r1861b961],
8	p	NN	O	p	npadvmod	9	SENT_86	[p3l2060t947r2075b967],
9	=	JJ	O	=	amod	5	SENT_86	[p3l2087t950r2106b957],
10	0.0002	CD	NUMBER	0.0002	num	11	SENT_86	[p3l2118t942r2196b961],
11	Number	NN	O	number	dep	2	SENT_86	[p3l455t977r552b998],
12	of	IN	O	of	_	0	SENT_86	[p3l563t977r588b998],
13	only	RB	O	only	advmod	14	SENT_86	[p3l598t977r649b1004],
14	male	JJ	O	male	prep_of	11	SENT_86	[p3l661t977r717b998],
15	9/13	CD	PERCENT	9/13	number	16	SENT_86	[p3l1049t978r1100b999],
16	(	CD	PERCENT	(	amod	14	SENT_86	[p3l1113t978r1179b1002],
17	69	CD	PERCENT	69	num	18	SENT_86	[p3l1113t978r1179b1002],
18	%	NN	PERCENT	%	dep	16	SENT_86	[p3l1113t978r1179b1002],
19	)	CD	NUMBER	)	number	20	SENT_86	[p3l1113t978r1179b1002],
20	—	CD	NUMBER	—	dep	2	SENT_86	[p3l1421t990r1449b992],
21	3/13	CD	NUMBER	3/13	num	22	SENT_86	[p3l1725t978r1777b999],
22	(	NN	O	(	dep	20	SENT_86	[p3l1790t978r1856b1002],
23	23	CD	PERCENT	23	num	24	SENT_86	[p3l1790t978r1856b1002],
24	%	NN	PERCENT	%	dep	2	SENT_86	[p3l1790t978r1856b1002],
25	)	CD	NUMBER	)	number	26	SENT_86	[p3l1790t978r1856b1002],
26	1/13	CD	NUMBER	1/13	num	27	SENT_86	[p3l2063t978r2113b999],
27	(	NN	O	(	dep	24	SENT_86	[p3l2126t978r2177b1002],
28	8	CD	PERCENT	8	number	29	SENT_86	[p3l2126t978r2177b1002],
29	%	NN	PERCENT	%	amod	27	SENT_86	[p3l2126t978r2177b1002],
30	)	CD	NUMBER	)	num	31	SENT_86	[p3l2126t978r2177b1002],
31	FDS	NN	O	fd	dep	2	SENT_86	[p3l455t1016r604b1042],
32	—	CD	NUMBER	—	num	34	SENT_86	[p3l455t1016r604b1042],
33	positive	JJ	O	positive	amod	34	SENT_86	[p3l455t1016r604b1042],
34	individuals	NNS	O	individual	dep	31	SENT_86	[p3l616t1015r745b1036],
35	(	CD	PERCENT	(	num	36	SENT_86	[p3l757t1016r793b1040],
36	%	NN	PERCENT	%	dep	2	SENT_86	[p3l757t1016r793b1040],
37	)	CD	NUMBER	)	num	38	SENT_86	[p3l757t1016r793b1040],
38	p	NN	O	p	dep	36	SENT_86	[p3l452t1046r556b1079],
39	.	.	O	.	_	0	SENT_86	[p3l452t1046r556b1079],

1	—	NN	O	—	_	0	SENT_87	[p3l452t1046r556b1079],
2	.	.	O	.	_	0	SENT_87	[p3l452t1046r556b1079],

1	Valueb	NNP	O	Valueb	_	0	SENT_88	[p3l452t1046r556b1079],
2	0.3271	CD	NUMBER	0.3271	number	3	SENT_88	[p3l1048t1054r1122b1073],
3	0.0013	CD	NUMBER	0.0013	dep	1	SENT_88	[p3l1725t1054r1803b1073],
4	0.0022	CD	NUMBER	0.0022	dep	3	SENT_88	[p3l2061t1054r2139b1073],

1	Placebo	NN	O	placebo	_	0	SENT_89	[p3l189t1089r289b1110],
2	GM	NNP	O	GM	dep	1	SENT_89	[p3l454t1090r493b1110],
3	of	IN	O	of	dep	2	SENT_89	[p3l505t1089r530b1110],
4	Wolbachia	NNP	O	Wolbachia	nn	21	SENT_89	[p3l541t1089r664b1110],
5	load/MF	NNP	O	load/MF	nn	21	SENT_89	[p3l677t1089r774b1111],
6	66	CD	NUMBER	66	num	21	SENT_89	[p3l1048t1091r1076b1110],
7	(	CD	NUMBER	(	num	21	SENT_89	[p3l1088t1090r1190b1114],
8	30-135	CD	NUMBER	30-135	num	21	SENT_89	[p3l1088t1090r1190b1114],
9	)	NN	O	)	nn	21	SENT_89	[p3l1088t1090r1190b1114],
10	127	CD	NUMBER	127	num	21	SENT_89	[p3l1424t1091r1464b1110],
11	(	CD	NUMBER	(	num	21	SENT_89	[p3l1476t1090r1578b1114],
12	73-206	CD	NUMBER	73-206	num	21	SENT_89	[p3l1476t1090r1578b1114],
13	)	NN	O	)	nn	21	SENT_89	[p3l1476t1090r1578b1114],
14	113	CD	NUMBER	113	num	21	SENT_89	[p3l1727t1091r1767b1110],
15	(	NN	O	(	nn	21	SENT_89	[p3l1780t1090r1882b1114],
16	33-327	CD	NUMBER	33-327	num	21	SENT_89	[p3l1780t1090r1882b1114],
17	)	CD	NUMBER	)	num	21	SENT_89	[p3l1780t1090r1882b1114],
18	91	CD	NUMBER	91	num	21	SENT_89	[p3l2061t1091r2084b1110],
19	(	NN	O	(	nn	21	SENT_89	[p3l2101t1090r2203b1114],
20	43-680	CD	NUMBER	43-680	num	21	SENT_89	[p3l2101t1090r2203b1114],
21	)	NN	O	)	dep	3	SENT_89	[p3l2101t1090r2203b1114],

1	(	NN	O	(	dep	161	SENT_90	[p3l454t1127r584b1152],
2	10th	JJ	ORDINAL	10th	dep	161	SENT_90	[p3l454t1127r584b1152],
3	—	NN	O	—	dep	161	SENT_90	[p3l454t1127r584b1152],
4	90th	JJ	ORDINAL	90th	dep	161	SENT_90	[p3l454t1127r584b1152],
5	percentile	NN	O	percentile	dep	161	SENT_90	[p3l598t1127r724b1154],
6	)	CD	NUMBER	)	dep	161	SENT_90	[p3l598t1127r724b1154],
7	GM	NNP	O	GM	dep	161	SENT_90	[p3l454t1165r493b1185],
8	of	IN	O	of	dep	161	SENT_90	[p3l505t1164r530b1185],
9	microﬁlaremia	NN	O	microﬁlaremia	dep	161	SENT_90	[p3l541t1164r711b1185],
10	319	CD	NUMBER	319	dep	161	SENT_90	[p3l1049t1166r1091b1185],
11	(	NN	O	(	dep	161	SENT_90	[p3l1103t1165r1226b1189],
12	73	CD	NUMBER	73	dep	161	SENT_90	[p3l1103t1165r1226b1189],
13	—	CD	NUMBER	—	dep	161	SENT_90	[p3l1103t1165r1226b1189],
14	2,109	CD	NUMBER	2,109	dep	161	SENT_90	[p3l1103t1165r1226b1189],
15	)	NN	O	)	dep	161	SENT_90	[p3l1103t1165r1226b1189],
16	590	CD	NUMBER	590	dep	161	SENT_90	[p3l1422t1166r1464b1185],
17	(	NN	O	(	dep	161	SENT_90	[p3l1476t1165r1614b1189],
18	169	CD	NUMBER	169	dep	161	SENT_90	[p3l1476t1165r1614b1189],
19	—	NN	O	—	dep	161	SENT_90	[p3l1476t1165r1614b1189],
20	3,884	CD	NUMBER	3,884	dep	161	SENT_90	[p3l1476t1165r1614b1189],
21	)	CD	NUMBER	)	dep	161	SENT_90	[p3l1476t1165r1614b1189],
22	8	CD	NUMBER	8	dep	161	SENT_90	[p3l1725t1166r1738b1185],
23	(	NN	O	(	dep	161	SENT_90	[p3l1750t1165r1837b1189],
24	0	CD	NUMBER	0	dep	161	SENT_90	[p3l1750t1165r1837b1189],
25	—	NN	O	—	dep	161	SENT_90	[p3l1750t1165r1837b1189],
26	359	CD	NUMBER	359	dep	161	SENT_90	[p3l1750t1165r1837b1189],
27	)	CD	NUMBER	)	dep	161	SENT_90	[p3l1750t1165r1837b1189],
28	22	CD	NUMBER	22	dep	161	SENT_90	[p3l2061t1165r2199b1189],
29	(	NN	O	(	dep	161	SENT_90	[p3l2061t1165r2199b1189],
30	0	CD	NUMBER	0	dep	161	SENT_90	[p3l2061t1165r2199b1189],
31	—	CD	NUMBER	—	dep	161	SENT_90	[p3l2061t1165r2199b1189],
32	1,700	CD	NUMBER	1,700	dep	161	SENT_90	[p3l2061t1165r2199b1189],
33	)	NN	O	)	dep	161	SENT_90	[p3l2061t1165r2199b1189],
34	(	CD	NUMBER	(	dep	161	SENT_90	[p3l454t1201r584b1226],
35	10th	JJ	ORDINAL	10th	dep	161	SENT_90	[p3l454t1201r584b1226],
36	—	NN	O	—	dep	161	SENT_90	[p3l454t1201r584b1226],
37	90th	JJ	ORDINAL	90th	dep	161	SENT_90	[p3l454t1201r584b1226],
38	percentile	NN	O	percentile	dep	161	SENT_90	[p3l598t1201r724b1228],
39	)	NN	O	)	dep	161	SENT_90	[p3l598t1201r724b1228],
40	Number	NN	O	number	dep	161	SENT_90	[p3l455t1239r552b1260],
41	of	IN	O	of	dep	161	SENT_90	[p3l563t1239r588b1260],
42	MF-positive	JJ	O	mf-positive	dep	161	SENT_90	[p3l598t1240r738b1266],
43	individuals	NNS	O	individual	dep	161	SENT_90	[p3l750t1239r878b1260],
44	(	CD	PERCENT	(	dep	161	SENT_90	[p3l891t1240r927b1264],
45	%	NN	PERCENT	%	dep	161	SENT_90	[p3l891t1240r927b1264],
46	)	CD	NUMBER	)	dep	161	SENT_90	[p3l891t1240r927b1264],
47	16/16	CD	NUMBER	16/16	dep	161	SENT_90	[p3l1050t1240r1116b1261],
48	(	NN	O	(	dep	161	SENT_90	[p3l1128t1240r1208b1264],
49	100	CD	PERCENT	100	dep	161	SENT_90	[p3l1128t1240r1208b1264],
50	%	NN	PERCENT	%	dep	161	SENT_90	[p3l1128t1240r1208b1264],
51	)	CD	NUMBER	)	dep	161	SENT_90	[p3l1128t1240r1208b1264],
52	13/16	CD	NUMBER	13/16	dep	161	SENT_90	[p3l1424t1240r1489b1261],
53	(	NN	O	(	dep	161	SENT_90	[p3l1501t1240r1567b1264],
54	81	CD	PERCENT	81	dep	161	SENT_90	[p3l1501t1240r1567b1264],
55	%	NN	PERCENT	%	dep	161	SENT_90	[p3l1501t1240r1567b1264],
56	)	CD	NUMBER	)	dep	161	SENT_90	[p3l1501t1240r1567b1264],
57	8/16	CD	NUMBER	8/16	dep	161	SENT_90	[p3l1725t1240r1778b1261],
58	(	NN	O	(	dep	161	SENT_90	[p3l1790t1240r1855b1264],
59	50	CD	PERCENT	50	dep	161	SENT_90	[p3l1790t1240r1855b1264],
60	%	NN	PERCENT	%	dep	161	SENT_90	[p3l1790t1240r1855b1264],
61	)	CD	NUMBER	)	dep	161	SENT_90	[p3l1790t1240r1855b1264],
62	10/16	CD	NUMBER	10/16	dep	161	SENT_90	[p3l2063t1240r2128b1261],
63	(	NN	O	(	dep	161	SENT_90	[p3l2141t1240r2206b1264],
64	63	CD	PERCENT	63	dep	161	SENT_90	[p3l2141t1240r2206b1264],
65	%	NN	PERCENT	%	dep	161	SENT_90	[p3l2141t1240r2206b1264],
66	)	CD	NUMBER	)	dep	161	SENT_90	[p3l2141t1240r2206b1264],
67	Median	JJ	MISC	median	dep	161	SENT_90	[p3l454t1276r542b1297],
68	of	IN	O	of	dep	161	SENT_90	[p3l554t1276r579b1297],
69	antigenemia	NN	O	antigenemia	dep	161	SENT_90	[p3l589t1277r739b1303],
70	in	IN	O	in	dep	161	SENT_90	[p3l752t1277r771b1297],
71	units	NNS	O	unit	dep	161	SENT_90	[p3l784t1277r841b1297],
72	(	CD	PERCENT	(	dep	161	SENT_90	[p3l854t1277r890b1301],
73	%	NN	PERCENT	%	dep	161	SENT_90	[p3l854t1277r890b1301],
74	)	CD	NUMBER	)	dep	161	SENT_90	[p3l854t1277r890b1301],
75	452,085	CD	NUMBER	452,085	dep	161	SENT_90	[p3l1048t1278r1141b1301],
76	(	NN	O	(	dep	161	SENT_90	[p3l1154t1277r1234b1301],
77	100	CD	PERCENT	100	dep	161	SENT_90	[p3l1154t1277r1234b1301],
78	%	NN	PERCENT	%	dep	161	SENT_90	[p3l1154t1277r1234b1301],
79	)	CD	PERCENT	)	dep	161	SENT_90	[p3l1154t1277r1234b1301],
80	—	CD	PERCENT	—	dep	161	SENT_90	[p3l1421t1289r1449b1291],
81	313,605	CD	PERCENT	313,605	dep	161	SENT_90	[p3l1726t1278r1818b1301],
82	(	CD	PERCENT	(	dep	161	SENT_90	[p3l1831t1277r1896b1301],
83	69	CD	PERCENT	69	dep	161	SENT_90	[p3l1831t1277r1896b1301],
84	%	NN	PERCENT	%	dep	161	SENT_90	[p3l1831t1277r1896b1301],
85	)	CD	PERCENT	)	dep	161	SENT_90	[p3l1831t1277r1896b1301],
86	236,055	CD	PERCENT	236,055	dep	161	SENT_90	[p3l2061t1278r2154b1301],
87	(	CD	PERCENT	(	dep	161	SENT_90	[p3l2167t1277r2232b1301],
88	52	CD	PERCENT	52	dep	161	SENT_90	[p3l2167t1277r2232b1301],
89	%	NN	PERCENT	%	dep	161	SENT_90	[p3l2167t1277r2232b1301],
90	)	CD	NUMBER	)	dep	161	SENT_90	[p3l2167t1277r2232b1301],
91	(	CD	NUMBER	(	dep	161	SENT_90	[p3l454t1313r584b1338],
92	10th	JJ	ORDINAL	10th	dep	161	SENT_90	[p3l454t1313r584b1338],
93	—	NN	O	—	dep	161	SENT_90	[p3l454t1313r584b1338],
94	90th	JJ	ORDINAL	90th	dep	161	SENT_90	[p3l454t1313r584b1338],
95	percentile	NN	O	percentile	dep	161	SENT_90	[p3l598t1313r724b1340],
96	)	NN	O	)	dep	161	SENT_90	[p3l598t1313r724b1340],
97	(	CD	NUMBER	(	dep	161	SENT_90	[p3l1049t1314r1273b1338],
98	40,807	CD	NUMBER	40,807	dep	161	SENT_90	[p3l1049t1314r1273b1338],
99	—	CD	NUMBER	—	dep	161	SENT_90	[p3l1049t1314r1273b1338],
100	6,384,750	CD	NUMBER	6,384,750	dep	161	SENT_90	[p3l1049t1314r1273b1338],
101	)	NN	O	)	dep	161	SENT_90	[p3l1049t1314r1273b1338],
102	(	CD	NUMBER	(	dep	161	SENT_90	[p3l1726t1314r1950b1338],
103	20,607	CD	NUMBER	20,607	dep	161	SENT_90	[p3l1726t1314r1950b1338],
104	—	CD	NUMBER	—	dep	161	SENT_90	[p3l1726t1314r1950b1338],
105	1,906,708	CD	NUMBER	1,906,708	dep	161	SENT_90	[p3l1726t1314r1950b1338],
106	)	NN	O	)	dep	161	SENT_90	[p3l1726t1314r1950b1338],
107	(	CD	NUMBER	(	dep	161	SENT_90	[p3l2062t1314r2285b1338],
108	12,455	CD	NUMBER	12,455	dep	161	SENT_90	[p3l2062t1314r2285b1338],
109	—	CD	NUMBER	—	dep	161	SENT_90	[p3l2062t1314r2285b1338],
110	2,634,917	CD	NUMBER	2,634,917	dep	161	SENT_90	[p3l2062t1314r2285b1338],
111	)	NN	O	)	dep	161	SENT_90	[p3l2062t1314r2285b1338],
112	Number	NN	O	number	dep	161	SENT_90	[p3l455t1351r552b1372],
113	of	IN	O	of	dep	161	SENT_90	[p3l563t1351r588b1372],
114	FDS	NN	O	fd	dep	161	SENT_90	[p3l599t1352r748b1378],
115	—	CD	NUMBER	—	dep	161	SENT_90	[p3l599t1352r748b1378],
116	positive	JJ	O	positive	dep	161	SENT_90	[p3l599t1352r748b1378],
117	individuals	NNS	O	individual	dep	161	SENT_90	[p3l761t1351r888b1372],
118	(	CD	PERCENT	(	dep	161	SENT_90	[p3l901t1352r937b1376],
119	%	NN	PERCENT	%	dep	161	SENT_90	[p3l901t1352r937b1376],
120	)	CD	NUMBER	)	dep	161	SENT_90	[p3l901t1352r937b1376],
121	13/16	CD	NUMBER	13/16	dep	161	SENT_90	[p3l1050t1352r1116b1373],
122	(	NN	O	(	dep	161	SENT_90	[p3l1128t1352r1194b1376],
123	81	CD	PERCENT	81	dep	161	SENT_90	[p3l1128t1352r1194b1376],
124	%	NN	PERCENT	%	dep	161	SENT_90	[p3l1128t1352r1194b1376],
125	)	CD	NUMBER	)	dep	161	SENT_90	[p3l1128t1352r1194b1376],
126	—	CD	NUMBER	—	dep	161	SENT_90	[p3l1421t1364r1449b1366],
127	13/16	CD	NUMBER	13/16	dep	161	SENT_90	[p3l1727t1352r1793b1373],
128	(	NN	O	(	dep	161	SENT_90	[p3l1805t1352r1870b1376],
129	81	CD	PERCENT	81	dep	161	SENT_90	[p3l1805t1352r1870b1376],
130	%	NN	PERCENT	%	dep	161	SENT_90	[p3l1805t1352r1870b1376],
131	)	CD	NUMBER	)	dep	161	SENT_90	[p3l1805t1352r1870b1376],
132	11/16	CD	NUMBER	11/16	dep	161	SENT_90	[p3l2063t1352r2128b1373],
133	(	NN	O	(	dep	161	SENT_90	[p3l2141t1352r2206b1376],
134	69	CD	PERCENT	69	dep	161	SENT_90	[p3l2141t1352r2206b1376],
135	%	NN	PERCENT	%	dep	161	SENT_90	[p3l2141t1352r2206b1376],
136	)	CD	NUMBER	)	dep	161	SENT_90	[p3l2141t1352r2206b1376],
137	Number	NN	O	number	dep	161	SENT_90	[p3l455t1388r552b1409],
138	of	IN	O	of	dep	161	SENT_90	[p3l563t1388r588b1409],
139	only	RB	O	only	dep	161	SENT_90	[p3l598t1388r649b1415],
140	male	JJ	O	male	dep	161	SENT_90	[p3l661t1388r717b1409],
141	10/11	CD	PERCENT	10/11	dep	161	SENT_90	[p3l1051t1389r1111b1410],
142	(	CD	PERCENT	(	dep	161	SENT_90	[p3l1128t1389r1194b1413],
143	91	CD	PERCENT	91	dep	161	SENT_90	[p3l1128t1389r1194b1413],
144	%	NN	PERCENT	%	dep	161	SENT_90	[p3l1128t1389r1194b1413],
145	)	CD	NUMBER	)	dep	161	SENT_90	[p3l1128t1389r1194b1413],
146	—	CD	NUMBER	—	dep	161	SENT_90	[p3l1421t1401r1449b1403],
147	10/11	CD	NUMBER	10/11	dep	161	SENT_90	[p3l1727t1389r1788b1410],
148	(	NN	O	(	dep	161	SENT_90	[p3l1805t1389r1870b1413],
149	91	CD	PERCENT	91	dep	161	SENT_90	[p3l1805t1389r1870b1413],
150	%	NN	PERCENT	%	dep	161	SENT_90	[p3l1805t1389r1870b1413],
151	)	CD	NUMBER	)	dep	161	SENT_90	[p3l1805t1389r1870b1413],
152	8/11	CD	NUMBER	8/11	dep	161	SENT_90	[p3l2061t1389r2109b1410],
153	(	NN	O	(	dep	161	SENT_90	[p3l2126t1389r2191b1413],
154	73	CD	PERCENT	73	dep	161	SENT_90	[p3l2126t1389r2191b1413],
155	%	NN	PERCENT	%	dep	161	SENT_90	[p3l2126t1389r2191b1413],
156	)	CD	NUMBER	)	dep	161	SENT_90	[p3l2126t1389r2191b1413],
157	FDS-positive	JJ	O	fds-positive	dep	161	SENT_90	[p3l455t1427r604b1453],
158	individuals	NNS	O	individual	dep	161	SENT_90	[p3l616t1426r745b1447],
159	(	CD	PERCENT	(	dep	161	SENT_90	[p3l757t1427r793b1451],
160	%	NN	PERCENT	%	dep	161	SENT_90	[p3l757t1427r793b1451],
161	)	CD	NUMBER	)	_	0	SENT_90	[p3l757t1427r793b1451],

1	Only	RB	O	only	advmod	3	SENT_91	[p3l188t1531r240b1556],
2	33	CD	NUMBER	33	num	3	SENT_91	[p3l250t1532r275b1550],
3	patients	NNS	O	patient	nsubjpass	17	SENT_91	[p3l287t1531r376b1555],
4	(	IN	O	(	_	0	SENT_91	[p3l387t1531r419b1553],
5	17	CD	NUMBER	17	num	6	SENT_91	[p3l387t1531r419b1553],
6	doxycycline	NN	O	doxycycline	prep_(	17	SENT_91	[p3l430t1531r561b1556],
7	and	CC	O	and	_	0	SENT_91	[p3l572t1531r612b1550],
8	16	CD	NUMBER	16	num	9	SENT_91	[p3l626t1532r650b1550],
9	placebo	NN	O	placebo	prep_(	17	SENT_91	[p3l661t1531r756b1555],
10	)	CD	NUMBER	)	num	15	SENT_91	[p3l661t1531r756b1555],
11	present	JJ	DATE	present	amod	15	SENT_91	[p3l768t1534r851b1555],
12	at	IN	O	at	_	0	SENT_91	[p3l861t1534r882b1550],
13	all	DT	O	all	prep_at	11	SENT_91	[p3l892t1531r915b1550],
14	time	NN	O	time	nn	15	SENT_91	[p3l926t1531r976b1550],
15	points	NNS	O	point	nsubjpass	17	SENT_91	[p3l988t1531r1056b1555],
16	were	VBD	O	be	auxpass	17	SENT_91	[p3l1066t1537r1120b1550],
17	included	VBN	O	include	_	0	SENT_91	[p3l1132t1531r1226b1550],
18	in	IN	O	in	_	0	SENT_91	[p3l1239t1531r1256b1550],
19	the	DT	O	the	det	20	SENT_91	[p3l1267t1531r1303b1550],
20	analyses	NNS	O	analysis	prep_in	17	SENT_91	[p3l1314t1531r1412b1556],
21	.	.	O	.	_	0	SENT_91	[p3l1314t1531r1412b1556],

1	aChanges	NNS	O	achange	nsubjpass	23	SENT_92	[p3l188t1563r294b1590],
2	in	IN	O	in	_	0	SENT_92	[p3l304t1565r322b1584],
3	Geometric	JJ	O	geometric	amod	6	SENT_92	[p3l332t1565r448b1584],
4	mean	JJ	O	mean	amod	6	SENT_92	[p3l459t1571r519b1584],
5	(	NN	O	(	nn	6	SENT_92	[p3l530t1565r581b1587],
6	GM	NNP	ORGANIZATION	GM	prep_in	1	SENT_92	[p3l530t1565r581b1587],
7	)	CD	NUMBER	)	num	6	SENT_92	[p3l530t1565r581b1587],
8	of	IN	O	of	_	0	SENT_92	[p3l591t1564r614b1584],
9	Wolbachia	JJ	LOCATION	wolbachia	amod	10	SENT_92	[p3l624t1565r737b1584],
10	load	NN	O	load	prep_of	1	SENT_92	[p3l748t1565r793b1584],
11	per	IN	O	per	_	0	SENT_92	[p3l805t1571r840b1589],
12	microfilaria	NN	O	microfilarium	nn	14	SENT_92	[p3l850t1564r978b1587],
13	,	,	O	,	_	0	SENT_92	[p3l850t1564r978b1587],
14	microﬁlaremia	NN	O	microﬁlaremia	prep_per	10	SENT_92	[p3l988t1564r1152b1587],
15	,	,	O	,	_	0	SENT_92	[p3l988t1564r1152b1587],
16	and	CC	O	and	_	0	SENT_92	[p3l1162t1565r1202b1584],
17	antigenemia	NN	O	antigenemia	nn	18	SENT_92	[p3l1213t1565r1352b1590],
18	values	NNS	O	value	conj_and	14	SENT_92	[p3l1362t1565r1431b1584],
19	from	IN	O	from	_	0	SENT_92	[p3l1440t1564r1492b1584],
20	doxycycline	NN	O	doxycycline	nn	21	SENT_92	[p3l1503t1565r1633b1590],
21	group	NN	O	group	prep_from	10	SENT_92	[p3l1643t1571r1710b1590],
22	were	VBD	O	be	auxpass	23	SENT_92	[p3l1719t1571r1773b1584],
23	compared	VBN	O	compare	_	0	SENT_92	[p3l1783t1565r1896b1589],
24	to	TO	O	to	_	0	SENT_92	[p3l1905t1568r1928b1584],
25	those	DT	O	those	prep_to	23	SENT_92	[p3l1937t1565r1999b1584],
26	from	IN	O	from	_	0	SENT_92	[p3l2008t1564r2060b1584],
27	placebo	NN	O	placebo	nn	28	SENT_92	[p3l2071t1565r2158b1589],
28	group	NN	O	group	prep_from	25	SENT_92	[p3l2168t1571r2235b1590],
29	and	CC	O	and	_	0	SENT_92	[p3l2245t1565r2285b1584],
30	assessed	VBN	O	assess	conj_and	23	SENT_92	[p3l188t1598r283b1617],
31	by	IN	O	by	_	0	SENT_92	[p3l296t1598r322b1623],
32	Mann-Whitney	NNP	PERSON	Mann-Whitney	nn	34	SENT_92	[p3l333t1598r497b1623],
33	U	NNP	O	U	nn	34	SENT_92	[p3l508t1599r523b1617],
34	tests	NNS	O	test	prep_by	30	SENT_92	[p3l532t1601r584b1617],
35	of	IN	O	of	_	0	SENT_92	[p3l594t1597r617b1617],
36	raw	JJ	O	raw	amod	37	SENT_92	[p3l627t1604r666b1617],
37	data	NNS	O	datum	prep_of	34	SENT_92	[p3l677t1598r730b1617],
38	.	.	O	.	_	0	SENT_92	[p3l677t1598r730b1617],

1	bChanges	NNS	O	bchange	nsubjpass	28	SENT_93	[p3l189t1625r296b1656],
2	in	IN	O	in	_	0	SENT_93	[p3l307t1631r324b1650],
3	the	DT	O	the	det	4	SENT_93	[p3l335t1631r371b1650],
4	number	NN	O	number	prep_in	1	SENT_93	[p3l383t1631r471b1650],
5	of	IN	O	of	_	0	SENT_93	[p3l480t1630r503b1650],
6	MF-positive	JJ	O	mf-positive	amod	7	SENT_93	[p3l512t1631r641b1655],
7	individuals	NNS	O	individual	prep_of	4	SENT_93	[p3l652t1631r771b1650],
8	and	CC	O	and	_	0	SENT_93	[p3l781t1631r821b1650],
9	filarial	JJ	O	filarial	amod	11	SENT_93	[p3l832t1630r897b1650],
10	dance	NN	O	dance	nn	11	SENT_93	[p3l908t1631r975b1650],
11	sign	NN	O	sign	conj_and	7	SENT_93	[p3l985t1631r1029b1656],
12	(	CD	NUMBER	(	num	13	SENT_93	[p3l1041t1631r1195b1655],
13	FDS	NN	O	fd	dep	11	SENT_93	[p3l1041t1631r1195b1655],
14	)	SYM	O	)	dep	4	SENT_93	[p3l1041t1631r1195b1655],
15	-	:	O	-	_	0	SENT_93	[p3l1041t1631r1195b1655],
16	positive	JJ	O	positive	amod	17	SENT_93	[p3l1041t1631r1195b1655],
17	individuals	NNS	O	individual	dep	4	SENT_93	[p3l1206t1631r1325b1650],
18	from	IN	O	from	_	0	SENT_93	[p3l1334t1630r1386b1650],
19	doxycycline	NN	O	doxycycline	nn	20	SENT_93	[p3l1397t1631r1528b1656],
20	group	NN	O	group	prep_from	17	SENT_93	[p3l1538t1637r1605b1656],
21	were	VBD	O	be	auxpass	22	SENT_93	[p3l1615t1637r1670b1650],
22	compared	VBN	O	compare	_	0	SENT_93	[p3l1680t1631r1792b1655],
23	to	TO	O	to	_	0	SENT_93	[p3l1803t1634r1825b1650],
24	those	DT	O	those	prep_to	22	SENT_93	[p3l1835t1631r1897b1650],
25	from	IN	O	from	_	0	SENT_93	[p3l1907t1630r1959b1650],
26	placebo	NN	O	placebo	prep_from	24	SENT_93	[p3l1971t1631r2058b1655],
27	and	CC	O	and	_	0	SENT_93	[p3l2069t1631r2109b1650],
28	assessed	VBN	O	assess	conj_and	22	SENT_93	[p3l2120t1631r2215b1650],
29	using	VBG	O	use	xcomp	28	SENT_93	[p3l2228t1631r2286b1656],
30	Fisher	NNP	PERSON	Fisher	dobj	29	SENT_93	[p3l189t1664r260b1683],
31	’	CD	NUMBER	’	num	33	SENT_93	[p3l189t1664r260b1683],
32	exact	JJ	O	exact	amod	33	SENT_93	[p3l270t1667r328b1683],
33	tests	NNS	O	test	dobj	22	SENT_93	[p3l338t1667r395b1683],
34	.	.	O	.	_	0	SENT_93	[p3l338t1667r395b1683],

1	DOI	NNP	O	DOI	_	0	SENT_94	[p3l189t1697r235b1716],
2	:	:	O	:	_	0	SENT_94	[p3l189t1697r235b1716],
3	10.1371	CD	NUMBER	10.1371	dep	1	SENT_94	[p3l248t1697r632b1722],
4	/	:	O	/	punct	5	SENT_94	[p3l248t1697r632b1722],
5	journal	NN	O	journal	dep	3	SENT_94	[p3l248t1697r632b1722],
6	.	.	O	.	_	0	SENT_94	[p3l248t1697r632b1722],

1	ppat	NN	O	ppat	_	0	SENT_95	[p3l248t1697r632b1722],
2	.0020092	CD	NUMBER	.0020092	dep	1	SENT_95	[p3l248t1697r632b1722],
3	.	.	O	.	_	0	SENT_95	[p3l248t1697r632b1722],

1	t001	NN	O	t001	_	0	SENT_96	[p3l248t1697r632b1722],

1	and	CC	O	and	dep	3	SENT_97	[p3l189t1778r248b1804],
2	its	PRP$	O	its	poss	3	SENT_97	[p3l266t1779r301b1804],
3	receptor	NN	O	receptor	_	0	SENT_97	[p3l318t1783r459b1813],
4	on	IN	O	on	_	0	SENT_97	[p3l474t1787r515b1804],
5	lymphatic	JJ	O	lymphatic	amod	7	SENT_97	[p3l532t1778r692b1813],
6	vessel	NN	O	vessel	nn	7	SENT_97	[p3l709t1778r800b1804],
7	dilation	NN	O	dilation	prep_on	3	SENT_97	[p3l817t1778r943b1804],
8	among	IN	O	among	_	0	SENT_97	[p3l960t1787r1070b1813],
9	human	JJ	O	human	amod	10	SENT_97	[p3l1086t1778r1199b1804],
10	populations	NNS	O	population	prep_among	7	SENT_97	[p3l189t1824r383b1859],
11	with	IN	O	with	_	0	SENT_97	[p3l398t1824r468b1850],
12	lymphatic	JJ	O	lymphatic	amod	14	SENT_97	[p3l483t1824r643b1859],
13	ﬁlarial	JJ	O	ﬁlarial	amod	14	SENT_97	[p3l659t1824r763b1850],
14	disease	NN	O	disease	prep_with	3	SENT_97	[p3l778t1824r899b1850],
15	.	.	O	.	_	0	SENT_97	[p3l778t1824r899b1850],

1	The	DT	O	the	det	2	SENT_98	[p3l226t1871r288b1897],
2	aims	NNS	O	aim	nsubj	6	SENT_98	[p3l305t1872r378b1897],
3	of	IN	O	of	_	0	SENT_98	[p3l395t1871r430b1897],
4	this	DT	O	this	det	5	SENT_98	[p3l444t1871r499b1897],
5	study	NN	O	study	prep_of	2	SENT_98	[p3l517t1871r602b1906],
6	were	VBD	O	be	_	0	SENT_98	[p3l618t1880r694b1897],
7	to	TO	O	to	aux	8	SENT_98	[p3l711t1876r741b1897],
8	assess	VB	O	assess	xcomp	6	SENT_98	[p3l759t1880r848b1897],
9	(	NN	O	(	dobj	8	SENT_98	[p3l866t1872r904b1903],
10	1	CD	NUMBER	1	number	11	SENT_98	[p3l866t1872r904b1903],
11	)	CD	NUMBER	)	num	14	SENT_98	[p3l866t1872r904b1903],
12	a	DT	O	a	det	14	SENT_98	[p3l922t1880r938b1897],
13	6-wk	JJ	DURATION	6-wk	amod	14	SENT_98	[p3l955t1871r1029b1896],
14	course	NN	O	course	dep	9	SENT_98	[p3l1045t1880r1151b1897],
15	of	IN	O	of	_	0	SENT_98	[p3l1168t1871r1202b1897],
16	doxycycline	NN	O	doxycycline	prep_of	14	SENT_98	[p3l189t1917r380b1952],
17	for	IN	O	for	_	0	SENT_98	[p3l405t1917r454b1943],
18	macroﬁlaricidal	JJ	O	macroﬁlaricidal	amod	19	SENT_98	[p3l478t1917r737b1943],
19	activity	NN	O	activity	prep_for	16	SENT_98	[p3l762t1918r887b1952],
20	;	:	O	;	_	0	SENT_98	[p3l762t1918r887b1952],
21	(	NN	O	(	dep	9	SENT_98	[p3l914t1917r952b1949],
22	2	CD	NUMBER	2	number	23	SENT_98	[p3l914t1917r952b1949],
23	)	CD	NUMBER	)	num	25	SENT_98	[p3l914t1917r952b1949],
24	the	DT	O	the	det	25	SENT_98	[p3l978t1917r1027b1943],
25	effect	NN	O	effect	dep	21	SENT_98	[p3l1052t1917r1143b1943],
26	of	IN	O	of	_	0	SENT_98	[p3l1168t1917r1202b1943],
27	targeting	VBG	O	target	prepc_of	8	SENT_98	[p3l190t1965r337b1999],
28	the	DT	O	the	det	30	SENT_98	[p3l349t1964r398b1990],
29	endosymbiotic	JJ	O	endosymbiotic	amod	30	SENT_98	[p3l410t1964r647b1999],
30	Wolbachia	NNP	O	Wolbachia	dobj	27	SENT_98	[p3l662t1964r811b1990],
31	in	IN	O	in	_	0	SENT_98	[p3l822t1965r852b1989],
32	ﬁlarial	JJ	O	ﬁlarial	amod	33	SENT_98	[p3l863t1964r968b1990],
33	worms	NNS	O	worm	prep_in	27	SENT_98	[p3l979t1973r1085b1990],
34	on	IN	O	on	_	0	SENT_98	[p3l1097t1973r1137b1990],
35	the	DT	O	the	det	36	SENT_98	[p3l1150t1964r1199b1990],
36	levels	NNS	O	level	prep_on	33	SENT_98	[p3l189t2010r275b2036],
37	of	IN	O	of	_	0	SENT_98	[p3l293t2010r328b2036],
38	VEGF	NN	O	vegf	prep_of	36	SENT_98	[p3l341t2010r474b2036],
39	.	.	O	.	_	0	SENT_98	[p3l341t2010r474b2036],

1	—	NN	O	—	_	0	SENT_99	[p3l341t2010r474b2036],
2	.	.	O	.	_	0	SENT_99	[p3l341t2010r474b2036],

1	C	NN	O	c	nsubj	31	SENT_100	[p3l341t2010r474b2036],
2	and	CC	O	and	_	0	SENT_100	[p3l493t2010r552b2036],
3	its	PRP$	O	its	poss	6	SENT_100	[p3l570t2011r605b2036],
4	soluble	JJ	O	soluble	amod	6	SENT_100	[p3l623t2010r737b2036],
5	receptor	NN	O	receptor	nn	6	SENT_100	[p3l755t2015r895b2045],
6	VEGFR-3	NN	O	vegfr-3	nsubj	31	SENT_100	[p3l911t2010r1064b2036],
7	and	CC	O	and	_	0	SENT_100	[p3l1082t2010r1141b2036],
8	on	IN	O	on	dep	27	SENT_100	[p3l1158t2019r1199b2036],
9	dilation	NN	O	dilation	pobj	8	SENT_100	[p3l189t2056r316b2082],
10	of	IN	O	of	_	0	SENT_100	[p3l338t2056r372b2082],
11	the	DT	O	the	det	14	SENT_100	[p3l392t2056r441b2082],
12	supratesticular	JJ	O	supratesticular	amod	14	SENT_100	[p3l464t2056r707b2091],
13	lymphatic	JJ	O	lymphatic	amod	14	SENT_100	[p3l728t2056r889b2091],
14	vessels	NNS	O	vessel	prep_of	9	SENT_100	[p3l911t2056r1015b2082],
15	in	IN	O	in	_	0	SENT_100	[p3l1039t2057r1069b2081],
16	microfilaremic	JJ	O	microfilaremic	amod	17	SENT_100	[p3l1091t2057r1198b2082, p3l189t2102r331b2128],
17	patients	NNS	O	patient	prep_in	14	SENT_100	[p3l346t2103r484b2137],
18	;	:	O	;	_	0	SENT_100	[p3l346t2103r484b2137],
19	and	CC	O	and	_	0	SENT_100	[p3l497t2102r556b2128],
20	(	NN	O	(	nn	22	SENT_100	[p3l570t2102r608b2134],
21	3	CD	NUMBER	3	num	22	SENT_100	[p3l570t2102r608b2134],
22	)	NN	O	)	conj_and	8	SENT_100	[p3l570t2102r608b2134],
23	the	DT	O	the	det	24	SENT_100	[p3l623t2102r672b2128],
24	effect	NN	O	effect	dep	22	SENT_100	[p3l685t2102r776b2128],
25	of	IN	O	of	_	0	SENT_100	[p3l788t2102r823b2128],
26	doxycycline	NN	O	doxycycline	prep_of	24	SENT_100	[p3l832t2102r1023b2137],
27	treatment	NN	O	treatment	conj_and	1	SENT_100	[p3l1038t2107r1199b2128],
28	on	IN	O	on	_	0	SENT_100	[p3l189t2158r230b2175],
29	clinical	JJ	O	clinical	amod	30	SENT_100	[p3l247t2149r363b2175],
30	manifestations	NNS	O	manifestation	prep_on	27	SENT_100	[p3l381t2149r620b2175],
31	associated	VBN	O	associate	_	0	SENT_100	[p3l637t2149r802b2175],
32	with	IN	O	with	_	0	SENT_100	[p3l819t2149r888b2175],
33	ﬁlarial	JJ	O	ﬁlarial	amod	34	SENT_100	[p3l905t2149r1010b2175],
34	lymphedema	NN	O	lymphedema	prep_with	31	SENT_100	[p3l1027t2149r1198b2184, p3l189t2204r244b2221],
35	.	.	O	.	_	0	SENT_100	[p3l1027t2149r1198b2184, p3l189t2204r244b2221],

1	To	TO	O	to	aux	2	SENT_101	[p3l261t2196r305b2221],
2	address	VB	O	address	purpcl	7	SENT_101	[p3l322t2195r442b2221],
3	these	DT	O	these	det	4	SENT_101	[p3l460t2195r542b2221],
4	aims	NNS	O	aim	dobj	2	SENT_101	[p3l559t2196r639b2226],
5	,	,	O	,	_	0	SENT_101	[p3l559t2196r639b2226],
6	we	PRP	O	we	nsubj	19	SENT_101	[p3l656t2204r698b2221],
7	recruited	VBD	O	recruit	_	0	SENT_101	[p3l715t2195r865b2221],
8	microﬁlaremic	JJ	O	microﬁlaremic	amod	11	SENT_101	[p3l882t2195r1122b2221],
9	and	CC	O	and	_	0	SENT_101	[p3l1140t2195r1199b2221],
10	lymphedema	NN	O	lymphedema	amod	11	SENT_101	[p3l189t2241r399b2276],
11	patients	NNS	O	patient	dobj	7	SENT_101	[p3l423t2242r553b2276],
12	in	IN	O	in	_	0	SENT_101	[p3l579t2242r609b2266],
13	an	DT	O	a	det	15	SENT_101	[p3l634t2250r672b2267],
14	endemic	JJ	O	endemic	amod	15	SENT_101	[p3l697t2241r834b2267],
15	area	NN	O	area	prep_in	7	SENT_101	[p3l861t2250r929b2267],
16	in	IN	O	in	_	0	SENT_101	[p3l954t2242r984b2266],
17	Ghana	NNP	LOCATION	Ghana	prep_in	15	SENT_101	[p3l1010t2241r1115b2267],
18	and	CC	O	and	_	0	SENT_101	[p3l1140t2241r1199b2267],
19	treated	VBN	O	treat	conj_and	7	SENT_101	[p3l190t2287r305b2313],
20	them	PRP	O	they	dobj	19	SENT_101	[p3l324t2287r405b2313],
21	with	IN	O	with	_	0	SENT_101	[p3l422t2287r491b2313],
22	200	CD	NUMBER	200	num	24	SENT_101	[p3l510t2287r564b2314],
23	mg/d	JJ	O	mg/d	amod	24	SENT_101	[p3l582t2287r660b2322],
24	doxycycline	NN	O	doxycycline	prep_with	19	SENT_101	[p3l678t2287r869b2322],
25	for	IN	O	for	_	0	SENT_101	[p3l886t2287r935b2313],
26	6	CD	DURATION	6	num	27	SENT_101	[p3l952t2287r968b2312],
27	wk	NN	DURATION	wk	prep_for	24	SENT_101	[p3l985t2287r1036b2313],
28	.	.	O	.	_	0	SENT_101	[p3l985t2287r1036b2313],

1	Lymphedema	NN	O	lymphedema	nn	2	SENT_102	[p3l1054t2287r1198b2322, p3l189t2333r277b2359],
2	patients	NNS	O	patient	nsubjpass	4	SENT_102	[p3l297t2334r427b2368],
3	were	VBD	O	be	auxpass	4	SENT_102	[p3l447t2342r523b2359],
4	followed	VBN	O	follow	_	0	SENT_102	[p3l544t2333r683b2359],
5	up	RP	O	up	prt	4	SENT_102	[p3l703t2342r744b2368],
6	at	IN	O	at	quantmod	7	SENT_102	[p3l766t2338r795b2359],
7	4	CD	NUMBER	4	num	10	SENT_102	[p3l815t2334r833b2358],
8	and	CC	O	and	_	0	SENT_102	[p3l853t2333r912b2359],
9	12	CD	DURATION	12	num	10	SENT_102	[p3l936t2333r969b2360],
10	mo	NN	DURATION	mo	dobj	4	SENT_102	[p3l990t2342r1048b2364],
11	,	,	O	,	_	0	SENT_102	[p3l990t2342r1048b2364],
12	whereas	IN	O	whereas	mark	16	SENT_102	[p3l1069t2333r1198b2359],
13	microﬁlaremic	JJ	O	microﬁlaremic	amod	14	SENT_102	[p3l189t2380r429b2406],
14	patients	NNS	O	patient	nsubjpass	16	SENT_102	[p3l443t2381r572b2415],
15	were	VBD	O	be	auxpass	16	SENT_102	[p3l584t2389r660b2406],
16	re-examined	VBN	O	re-examine	advcl	4	SENT_102	[p3l674t2380r878b2406],
17	at	IN	O	at	_	0	SENT_102	[p3l892t2385r921b2406],
18	4	CD	NUMBER	4	prep_at	16	SENT_102	[p3l933t2381r957b2411],
19	,	,	O	,	_	0	SENT_102	[p3l933t2381r957b2411],
20	12	CD	NUMBER	12	conj_and	18	SENT_102	[p3l973t2380r1015b2411],
21	,	,	O	,	_	0	SENT_102	[p3l973t2380r1015b2411],
22	and	CC	DURATION	and	_	0	SENT_102	[p3l1028t2380r1087b2406],
23	24	CD	DURATION	24	num	24	SENT_102	[p3l1100t2380r1137b2407],
24	mo	NN	DURATION	mo	prep_at	16	SENT_102	[p3l1149t2389r1198b2406],
25	after	IN	O	after	_	0	SENT_102	[p3l189t2426r266b2452],
26	the	DT	O	the	det	27	SENT_102	[p3l280t2426r329b2452],
27	start	NN	O	start	prep_after	16	SENT_102	[p3l343t2431r416b2452],
28	of	IN	O	of	_	0	SENT_102	[p3l430t2426r464b2452],
29	doxycycline	NN	O	doxycycline	nn	30	SENT_102	[p3l475t2426r666b2461],
30	treatment	NN	O	treatment	prep_of	27	SENT_102	[p3l681t2431r850b2452],
31	.	.	O	.	_	0	SENT_102	[p3l681t2431r850b2452],

1	We	PRP	O	we	nsubj	2	SENT_103	[p3l864t2427r916b2452],
2	report	VBP	O	report	_	0	SENT_103	[p3l930t2431r1034b2461],
3	that	IN	O	that	complm	8	SENT_103	[p3l1049t2426r1112b2452],
4	6	CD	DURATION	6	num	5	SENT_103	[p3l1126t2426r1142b2451],
5	wk	NN	DURATION	wk	nsubj	8	SENT_103	[p3l1156t2426r1199b2451],
6	of	IN	O	of	_	0	SENT_103	[p3l189t2472r224b2498],
7	doxycycline	NN	O	doxycycline	prep_of	5	SENT_103	[p3l244t2472r435b2507],
8	had	VBD	O	have	ccomp	2	SENT_103	[p3l459t2472r518b2498],
9	a	DT	O	a	det	12	SENT_103	[p3l542t2481r558b2498],
10	strong	JJ	O	strong	amod	12	SENT_103	[p3l581t2477r684b2507],
11	macroﬁlaricidal	JJ	O	macroﬁlaricidal	amod	12	SENT_103	[p3l707t2472r966b2498],
12	activity	NN	O	activity	dobj	8	SENT_103	[p3l990t2473r1116b2507],
13	;	:	O	;	_	0	SENT_103	[p3l990t2473r1116b2507],
14	and	CC	O	and	_	0	SENT_103	[p3l1140t2472r1199b2498],
15	targeting	VBG	O	target	csubj	22	SENT_103	[p3l190t2519r340b2553],
16	the	DT	O	the	det	18	SENT_103	[p3l368t2518r418b2544],
17	endosymbiotic	JJ	O	endosymbiotic	amod	18	SENT_103	[p3l446t2518r688b2553],
18	Wolbachia	NNP	LOCATION	Wolbachia	dobj	15	SENT_103	[p3l720t2518r871b2544],
19	in	IN	O	in	_	0	SENT_103	[p3l898t2519r929b2543],
20	filarial	JJ	O	filarial	amod	21	SENT_103	[p3l957t2518r1063b2544],
21	worms	NNS	O	worm	prep_in	15	SENT_103	[p3l1091t2527r1198b2544],
22	resulted	VBD	O	result	conj_and	2	SENT_103	[p3l190t2564r321b2590],
23	in	IN	O	in	_	0	SENT_103	[p3l350t2565r381b2589],
24	the	DT	O	the	det	25	SENT_103	[p3l410t2564r460b2590],
25	reduction	NN	O	reduction	prep_in	22	SENT_103	[p3l488t2564r650b2590],
26	of	IN	O	of	_	0	SENT_103	[p3l678t2564r713b2590],
27	plasma	NN	O	plasma	nn	28	SENT_103	[p3l738t2564r852b2599],
28	levels	NNS	O	level	prep_of	25	SENT_103	[p3l880t2564r967b2590],
29	of	IN	O	of	_	0	SENT_103	[p3l996t2564r1031b2590],
30	VEGF-C	NN	O	vegf-c	prep_of	22	SENT_103	[p3l1054t2564r1200b2590],
31	/	:	O	/	punct	32	SENT_103	[p3l1054t2564r1200b2590],
32	sVEGFR-3	NN	O	svegfr-3	dep	22	SENT_103	[p3l189t2611r367b2642],
33	,	,	O	,	_	0	SENT_103	[p3l189t2611r367b2642],
34	which	WDT	O	which	nsubjpass	36	SENT_103	[p3l395t2611r492b2637],
35	were	VBD	O	be	auxpass	36	SENT_103	[p3l520t2620r598b2637],
36	associated	VBN	O	associate	rcmod	32	SENT_103	[p3l626t2611r795b2637],
37	with	IN	O	with	_	0	SENT_103	[p3l823t2611r894b2637],
38	amelioration	NN	O	amelioration	prep_with	36	SENT_103	[p3l923t2611r1138b2637],
39	of	IN	O	of	_	0	SENT_103	[p3l1167t2611r1202b2637],
40	dilated	JJ	O	dilated	amod	43	SENT_103	[p3l189t2657r301b2683],
41	supratesticular	JJ	O	supratesticular	amod	43	SENT_103	[p3l323t2657r567b2692],
42	lymphatic	JJ	O	lymphatic	amod	43	SENT_103	[p3l587t2657r748b2692],
43	vessels	NNS	O	vessel	prep_of	38	SENT_103	[p3l770t2657r874b2683],
44	and	CC	O	and	_	0	SENT_103	[p3l897t2657r956b2683],
45	improvement	NN	O	improvement	dep	22	SENT_103	[p3l978t2658r1199b2692],
46	of	IN	O	of	_	0	SENT_103	[p3l189t2703r224b2729],
47	lymphedema	NN	O	lymphedema	prep_of	45	SENT_103	[p3l235t2703r445b2738],
48	in	IN	O	in	_	0	SENT_103	[p3l460t2704r490b2728],
49	lymphatic	JJ	O	lymphatic	amod	51	SENT_103	[p3l505t2703r666b2738],
50	ﬁlariasis	NN	O	ﬁlariasis	nn	51	SENT_103	[p3l681t2703r814b2729],
51	patients	NNS	O	patient	prep_in	22	SENT_103	[p3l830t2704r968b2738],
52	.	.	O	.	_	0	SENT_103	[p3l830t2704r968b2738],

1	Results	NNS	O	result	_	0	SENT_104	[p3l190t2777r326b2809],

1	We	PRP	O	we	nsubj	2	SENT_105	[p3l226t2856r277b2881],
2	treated	VBD	O	treat	_	0	SENT_105	[p3l290t2855r405b2881],
3	a	DT	O	a	det	6	SENT_105	[p3l418t2864r434b2881],
4	total	JJ	O	total	amod	6	SENT_105	[p3l446t2855r519b2881],
5	95	CD	NUMBER	95	num	6	SENT_105	[p3l532t2855r568b2880],
6	patients	NNS	O	patient	dobj	2	SENT_105	[p3l580t2856r709b2890],
7	with	IN	O	with	_	0	SENT_105	[p3l721t2855r791b2881],
8	bancroftian	JJ	O	bancroftian	amod	10	SENT_105	[p3l802t2855r994b2881],
9	ﬁlariasis	NN	O	ﬁlariasis	nn	10	SENT_105	[p3l1006t2855r1139b2881],
10	(	NN	O	(	prep_with	6	SENT_105	[p3l1152t2853r1199b2887],
11	76	CD	NUMBER	76	npadvmod	12	SENT_105	[p3l1152t2853r1199b2887],
12	microﬁlaremic	JJ	O	microﬁlaremic	amod	10	SENT_105	[p3l189t2901r433b2927],
13	and	CC	O	and	_	0	SENT_105	[p3l458t2901r518b2927],
14	19	CD	NUMBER	19	num	16	SENT_105	[p3l545t2901r579b2926],
15	lymphedema	NN	O	lymphedema	nn	16	SENT_105	[p3l603t2901r826b2936],
16	)	NN	O	)	conj_and	6	SENT_105	[p3l603t2901r826b2936],
17	with	IN	O	with	_	0	SENT_105	[p3l850t2901r921b2927],
18	doxycycline	NN	O	doxycycline	nn	21	SENT_105	[p3l945t2901r1140b2936],
19	or	CC	O	or	_	0	SENT_105	[p3l1164t2910r1200b2927],
20	matching	VBG	O	match	conj_or	18	SENT_105	[p3l189t2947r342b2982],
21	placebo	NN	O	placebo	prep_with	16	SENT_105	[p3l355t2947r480b2982],
22	for	IN	O	for	_	0	SENT_105	[p3l493t2947r542b2973],
23	6	CD	DURATION	6	num	24	SENT_105	[p3l555t2947r571b2972],
24	wk	NN	DURATION	wk	prep_for	21	SENT_105	[p3l583t2947r634b2973],
25	.	.	O	.	_	0	SENT_105	[p3l583t2947r634b2973],

1	The	DT	O	the	det	2	SENT_106	[p3l648t2947r710b2973],
2	treatment	NN	O	treatment	nsubjpass	5	SENT_106	[p3l724t2952r886b2973],
3	was	VBD	O	be	auxpass	5	SENT_106	[p3l898t2956r954b2973],
4	well	RB	O	well	advmod	5	SENT_106	[p3l966t2947r1029b2973],
5	tolerated	VBN	O	tolerate	_	0	SENT_106	[p3l1044t2947r1198b2978],
6	,	,	O	,	_	0	SENT_106	[p3l1044t2947r1198b2978],
7	with	IN	O	with	_	0	SENT_106	[p3l188t2993r258b3019],
8	eight	CD	NUMBER	eight	num	9	SENT_106	[p3l271t2993r352b3028],
9	doxycycline	NN	O	doxycycline	prep_with	5	SENT_106	[p3l364t2993r555b3028],
10	and	CC	O	and	_	0	SENT_106	[p3l569t2993r627b3019],
11	ten	CD	NUMBER	ten	num	13	SENT_106	[p3l641t2998r691b3019],
12	placebo	NN	O	placebo	nn	13	SENT_106	[p3l704t2993r829b3028],
13	patients	NNS	O	patient	prep_with	5	SENT_106	[p3l843t2994r973b3028],
14	experiencing	VBG	O	experience	partmod	9	SENT_106	[p3l986t2994r1199b3028],

1	@r	NN	O	@r	nn	3	SENT_107	[p3l188t3077r261b3136],
2	O	NN	O	o	nn	3	SENT_107	[p3l188t3077r261b3136],
3	PLoS	NN	O	plo	nsubj	4	SENT_107	[p3l288t3093r352b3116],
4	Pathogens	VBD	O	pathogen	_	0	SENT_107	[p3l367t3092r511b3123],
5	|	CD	NUMBER	|	num	6	SENT_107	[p3l526t3091r528b3124],
6	www	NN	O	www	dobj	4	SENT_107	[p3l543t3092r882b3123],
7	.	.	O	.	_	0	SENT_107	[p3l543t3092r882b3123],

1	p	NN	O	p	_	0	SENT_108	[p3l543t3092r882b3123],
2	|	CD	NUMBER	|	num	3	SENT_108	[p3l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	dep	1	SENT_108	[p3l543t3092r882b3123],
4	0831	CD	DATE	0831	dep	1	SENT_108	[p3l1205t3094r1265b3116],

1	adverse	JJ	O	adverse	amod	2	SENT_109	[p3l1277t1778r1398b1804],
2	reactions	NNS	O	reaction	nsubj	8	SENT_109	[p3l1410t1779r1566b1809],
3	,	,	O	,	_	0	SENT_109	[p3l1410t1779r1566b1809],
4	which	WDT	O	which	dep	5	SENT_109	[p3l1578t1778r1673b1804],
5	in	IN	O	in	rcmod	2	SENT_109	[p3l1685t1779r1716b1803],
6	no	DT	O	no	det	7	SENT_109	[p3l1728t1787r1767b1804],
7	case	NN	O	case	pobj	5	SENT_109	[p3l1780t1787r1845b1804],
8	required	VBD	O	require	_	0	SENT_109	[p3l1857t1778r1997b1813],
9	a	DT	O	a	det	11	SENT_109	[p3l2009t1787r2025b1804],
10	treatment	NN	O	treatment	nn	11	SENT_109	[p3l2038t1783r2199b1804],
11	stop	NN	O	stop	dobj	8	SENT_109	[p3l2210t1784r2285b1813],
12	.	.	O	.	_	0	SENT_109	[p3l2210t1784r2285b1813],

1	The	DT	O	the	det	3	SENT_110	[p3l1276t1825r1338b1851],
2	adverse	JJ	O	adverse	amod	3	SENT_110	[p3l1351t1825r1472b1851],
3	reactions	NNS	O	reaction	nsubj	4	SENT_110	[p3l1485t1826r1633b1851],
4	arose	VBD	O	arise	_	0	SENT_110	[p3l1647t1834r1731b1851],
5	on	IN	O	on	_	0	SENT_110	[p3l1744t1834r1785b1851],
6	days	NNS	DURATION	day	prep_on	4	SENT_110	[p3l1797t1825r1865b1860],
7	2	CD	NUMBER	2	num	6	SENT_110	[p3l1879t1825r1895b1852],
8	and	CC	O	and	_	0	SENT_110	[p3l1908t1825r1967b1851],
9	3	CD	NUMBER	3	prep_on	4	SENT_110	[p3l1980t1825r1996b1850],
10	after	IN	O	after	_	0	SENT_110	[p3l2009t1825r2086b1851],
11	commencement	NN	O	commencement	prep_after	4	SENT_110	[p3l2097t1834r2285b1851, p3l1277t1878r1360b1899],
12	of	IN	O	of	_	0	SENT_110	[p3l1382t1873r1417b1899],
13	treatment	NN	O	treatment	prep_of	11	SENT_110	[p3l1436t1878r1597b1899],
14	in	IN	O	in	_	0	SENT_110	[p3l1620t1874r1650b1898],
15	both	DT	O	both	det	16	SENT_110	[p3l1672t1873r1746b1899],
16	groups	NNS	O	group	prep_in	13	SENT_110	[p3l1768t1882r1887b1908],
17	.	.	O	.	_	0	SENT_110	[p3l1768t1882r1887b1908],

1	The	DT	O	the	det	3	SENT_111	[p3l1909t1873r1972b1899],
2	adverse	JJ	O	adverse	amod	3	SENT_111	[p3l1994t1873r2115b1899],
3	reactions	NNS	O	reaction	nsubj	10	SENT_111	[p3l2138t1874r2286b1899],
4	experienced	VBN	O	experience	partmod	3	SENT_111	[p3l1277t1920r1477b1955],
5	by	IN	O	by	_	0	SENT_111	[p3l1485t1920r1521b1955],
6	the	DT	O	the	det	9	SENT_111	[p3l1530t1920r1579b1946],
7	eight	CD	NUMBER	eight	num	9	SENT_111	[p3l1588t1920r1668b1955],
8	doxycycline-treated	JJ	O	doxycycline-treated	amod	9	SENT_111	[p3l1676t1920r1999b1955],
9	patients	NNS	O	patient	agent	4	SENT_111	[p3l2007t1921r2137b1955],
10	included	VBD	O	include	_	0	SENT_111	[p3l2145t1920r2286b1946],
11	headache	NN	O	headache	dobj	10	SENT_111	[p3l1276t1967r1437b1998],
12	,	,	O	,	_	0	SENT_111	[p3l1276t1967r1437b1998],
13	dizziness	NN	O	dizziness	conj_and	11	SENT_111	[p3l1457t1967r1606b1998],
14	,	,	O	,	_	0	SENT_111	[p3l1457t1967r1606b1998],
15	diarrhea	NN	O	diarrhea	conj_and	11	SENT_111	[p3l1627t1967r1773b1998],
16	,	,	O	,	_	0	SENT_111	[p3l1627t1967r1773b1998],
17	and	CC	O	and	_	0	SENT_111	[p3l1794t1967r1853b1993],
18	itching	VBG	O	itch	amod	19	SENT_111	[p3l1873t1967r1987b2002],
19	skin	NN	O	skin	dobj	10	SENT_111	[p3l2006t1967r2077b1993],
20	.	.	O	.	_	0	SENT_111	[p3l2006t1967r2077b1993],

1	No	DT	O	no	det	3	SENT_112	[p3l2098t1968r2145b1993],
2	adverse	JJ	O	adverse	amod	3	SENT_112	[p3l2166t1967r2286b1993],
3	event	NN	O	event	nsubj	9	SENT_112	[p3l1277t2020r1364b2040],
4	went	VBD	O	go	_	0	SENT_112	[p3l1380t2020r1458b2040],
5	beyond	IN	O	beyond	_	0	SENT_112	[p3l1474t2014r1594b2049],
6	3	CD	NUMBER	3	num	7	SENT_112	[p3l1611t2014r1627b2039],
7	d	NN	O	d	prep_beyond	4	SENT_112	[p3l1645t2014r1664b2040],
8	or	CC	O	or	_	0	SENT_112	[p3l1681t2023r1717b2040],
9	required	VBN	O	require	conj_or	4	SENT_112	[p3l1733t2014r1873b2049],
10	more	RBR	O	more	advmod	9	SENT_112	[p3l1891t2023r1975b2040],
11	intervention	NN	O	intervention	dobj	9	SENT_112	[p3l1993t2015r2196b2040],
12	than	IN	O	than	_	0	SENT_112	[p3l2215t2014r2286b2040],
13	application	NN	O	application	prep_than	11	SENT_112	[p3l1277t2061r1462b2096],
14	of	IN	O	of	_	0	SENT_112	[p3l1475t2061r1510b2087],
15	paracetamol	NNP	O	paracetamol	nn	16	SENT_112	[p3l1520t2061r1722b2096],
16	tablets	NNS	O	tablet	prep_of	9	SENT_112	[p3l1736t2061r1849b2092],
17	,	,	O	,	_	0	SENT_112	[p3l1736t2061r1849b2092],
18	oral	JJ	O	oral	amod	20	SENT_112	[p3l1863t2061r1926b2087],
19	dehydration	NN	O	dehydration	nn	20	SENT_112	[p3l1939t2061r2139b2096],
20	salt	NN	O	salt	prep_of	9	SENT_112	[p3l2152t2061r2213b2092],
21	,	,	O	,	_	0	SENT_112	[p3l2152t2061r2213b2092],
22	and	CC	O	and	_	0	SENT_112	[p3l2227t2061r2286b2087],
23	ointment	NN	O	ointment	prep_of	9	SENT_112	[p3l1277t2109r1437b2134],
24	.	.	O	.	_	0	SENT_112	[p3l1277t2109r1437b2134],

1	The	DT	O	the	det	3	SENT_113	[p3l1462t2108r1524b2134],
2	adverse	JJ	O	adverse	amod	3	SENT_113	[p3l1549t2108r1671b2134],
3	reactions	NNS	O	reaction	nsubj	10	SENT_113	[p3l1697t2109r1847b2134],
4	experienced	VBN	O	experience	partmod	3	SENT_113	[p3l1872t2108r2074b2143],
5	by	IN	O	by	_	0	SENT_113	[p3l2098t2108r2135b2143],
6	the	DT	O	the	det	9	SENT_113	[p3l2161t2108r2210b2134],
7	ten	CD	NUMBER	ten	num	9	SENT_113	[p3l2236t2113r2286b2134],
8	placebo	NN	O	placebo	nn	9	SENT_113	[p3l1277t2156r1402b2191],
9	patients	NNS	O	patient	agent	4	SENT_113	[p3l1425t2157r1554b2191],
10	included	VBD	O	include	_	0	SENT_113	[p3l1576t2156r1717b2182],
11	headache	NN	O	headache	dobj	10	SENT_113	[p3l1738t2156r1899b2187],
12	,	,	O	,	_	0	SENT_113	[p3l1738t2156r1899b2187],
13	diarrhea	NN	O	diarrhea	conj_and	11	SENT_113	[p3l1921t2156r2067b2187],
14	,	,	O	,	_	0	SENT_113	[p3l1921t2156r2067b2187],
15	and	CC	O	and	_	0	SENT_113	[p3l2090t2156r2149b2182],
16	painful	JJ	O	painful	amod	17	SENT_113	[p3l2170t2156r2286b2191],
17	scrotum	NN	O	scrotum	conj_and	11	SENT_113	[p3l1277t2208r1417b2229],
18	.	.	O	.	_	0	SENT_113	[p3l1277t2208r1417b2229],

1	Again	RB	O	again	advmod	4	SENT_114	[p3l1424t2203r1519b2238],
2	no	DT	O	no	det	3	SENT_114	[p3l1528t2212r1567b2229],
3	event	NN	O	event	nsubj	4	SENT_114	[p3l1576t2209r1663b2229],
4	lasted	VBD	O	last	ccomp	33	SENT_114	[p3l1670t2203r1763b2229],
5	for	IN	O	for	_	0	SENT_114	[p3l1771t2203r1820b2229],
6	more	JJR	O	more	mwe	7	SENT_114	[p3l1826t2212r1910b2229],
7	than	IN	O	than	quantmod	8	SENT_114	[p3l1919t2203r1991b2229],
8	3	CD	NUMBER	3	num	9	SENT_114	[p3l1999t2203r2015b2228],
9	d	NN	O	d	prep_for	4	SENT_114	[p3l2023t2203r2050b2234],
10	,	,	O	,	_	0	SENT_114	[p3l2023t2203r2050b2234],
11	except	IN	O	except	_	0	SENT_114	[p3l2059t2208r2165b2238],
12	for	IN	O	for	_	0	SENT_114	[p3l2172t2203r2221b2229],
13	one	CD	NUMBER	one	num	15	SENT_114	[p3l2228t2212r2286b2229],
14	microﬁlaremic	JJ	O	microﬁlaremic	amod	15	SENT_114	[p3l1277t2250r1517b2276],
15	patient	NN	O	patient	prep_except_for	4	SENT_114	[p3l1532t2251r1648b2285],
16	who	WP	O	who	nsubj	17	SENT_114	[p3l1661t2250r1727b2276],
17	had	VBD	O	have	rcmod	15	SENT_114	[p3l1741t2250r1800b2276],
18	a	DT	O	a	det	20	SENT_114	[p3l1814t2259r1830b2276],
19	painful	JJ	O	painful	amod	20	SENT_114	[p3l1844t2250r1959b2285],
20	scrotum	NN	O	scrotum	dobj	17	SENT_114	[p3l1973t2256r2106b2276],
21	for	IN	O	for	_	0	SENT_114	[p3l2120t2250r2168b2276],
22	6	CD	NUMBER	6	num	23	SENT_114	[p3l2182t2250r2198b2275],
23	d.	NN	O	d.	prep_for	20	SENT_114	[p3l2212t2250r2239b2276],
24	In	IN	O	in	_	0	SENT_114	[p3l2253t2251r2286b2275],
25	this	DT	O	this	det	26	SENT_114	[p3l1278t2297r1334b2323],
26	group	NN	O	group	prep_in	17	SENT_114	[p3l1345t2306r1450b2332],
27	,	,	O	,	_	0	SENT_114	[p3l1345t2306r1450b2332],
28	the	DT	O	the	det	30	SENT_114	[p3l1464t2297r1513b2323],
29	side	JJ	O	side	amod	30	SENT_114	[p3l1525t2297r1587b2323],
30	effects	NNS	O	effect	nsubjpass	33	SENT_114	[p3l1599t2297r1703b2323],
31	were	VBD	O	be	auxpass	33	SENT_114	[p3l1714t2306r1790b2323],
32	also	RB	O	also	advmod	33	SENT_114	[p3l1802t2297r1863b2323],
33	treated	VBN	O	treat	_	0	SENT_114	[p3l1876t2297r1991b2323],
34	with	IN	O	with	_	0	SENT_114	[p3l2002t2297r2072b2323],
35	paracetamol	NNP	O	paracetamol	nn	36	SENT_114	[p3l2084t2297r2286b2332],
36	tablets	NNS	O	tablet	prep_with	33	SENT_114	[p3l1278t2344r1382b2370],
37	and	CC	O	and	_	0	SENT_114	[p3l1403t2344r1462b2370],
38	oral	JJ	O	oral	amod	40	SENT_114	[p3l1482t2344r1545b2370],
39	dehydration	NN	O	dehydration	nn	40	SENT_114	[p3l1565t2344r1764b2379],
40	salt	NN	O	salt	conj_and	36	SENT_114	[p3l1784t2344r1845b2370],
41	.	.	O	.	_	0	SENT_114	[p3l1784t2344r1845b2370],

1	There	EX	O	there	expl	2	SENT_115	[p3l1866t2344r1962b2370],
2	was	VBD	O	be	_	0	SENT_115	[p3l1981t2353r2037b2370],
3	no	DT	O	no	det	5	SENT_115	[p3l2058t2353r2097b2370],
4	signiﬁcant	NN	O	signiﬁcant	nn	5	SENT_115	[p3l2118t2344r2287b2379],
5	difference	NN	O	difference	nsubj	2	SENT_115	[p3l1277t2392r1443b2418],
6	between	IN	O	between	_	0	SENT_115	[p3l1454t2392r1589b2418],
7	the	DT	O	the	det	11	SENT_115	[p3l1601t2392r1650b2418],
8	doxycycline	NN	O	doxycycline	nn	11	SENT_115	[p3l1662t2392r1853b2427],
9	and	CC	O	and	_	0	SENT_115	[p3l1865t2392r1924b2418],
10	placebo	NN	O	placebo	nn	11	SENT_115	[p3l1936t2392r2061b2427],
11	groups	NNS	O	group	prep_between	5	SENT_115	[p3l2073t2401r2192b2427],
12	.	.	O	.	_	0	SENT_115	[p3l2073t2401r2192b2427],

1	Thirty-three	CD	NUMBER	thirty-three	number	2	SENT_116	[p3l1314t2440r1515b2475],
2	(	CD	NUMBER	(	nsubj	15	SENT_116	[p3l1534t2438r1580b2472],
3	17	CD	NUMBER	17	num	4	SENT_116	[p3l1534t2438r1580b2472],
4	doxycycline	NN	O	doxycycline	dep	2	SENT_116	[p3l1598t2440r1790b2475],
5	and	CC	O	and	_	0	SENT_116	[p3l1808t2440r1867b2466],
6	16	CD	NUMBER	16	num	10	SENT_116	[p3l1887t2440r1921b2465],
7	placebo	NN	O	placebo	nn	10	SENT_116	[p3l1939t2440r2075b2475],
8	)	NN	O	)	nn	10	SENT_116	[p3l1939t2440r2075b2475],
9	microﬁlaremic	JJ	O	microﬁlaremic	amod	10	SENT_116	[p3l2093t2440r2285b2466, p3l1277t2488r1334b2513],
10	patients	NNS	O	patient	conj_and	2	SENT_116	[p3l1354t2488r1483b2522],
11	and	CC	O	and	_	0	SENT_116	[p3l1503t2487r1561b2513],
12	eighteen	CD	NUMBER	eighteen	num	14	SENT_116	[p3l1580t2487r1719b2522],
13	lymphedema	NN	O	lymphedema	nn	14	SENT_116	[p3l1738t2487r1948b2522],
14	patients	NNS	O	patient	conj_and	2	SENT_116	[p3l1966t2488r2096b2522],
15	(	VBP	O	(	_	0	SENT_116	[p3l2116t2487r2143b2519],
16	8	CD	NUMBER	8	num	17	SENT_116	[p3l2116t2487r2143b2519],
17	doxycycline	NN	O	doxycycline	nsubj	23	SENT_116	[p3l2162t2487r2285b2522, p3l1277t2534r1354b2560],
18	and	CC	O	and	_	0	SENT_116	[p3l1365t2534r1424b2560],
19	10	CD	NUMBER	10	num	21	SENT_116	[p3l1438t2534r1471b2559],
20	placebo	NN	O	placebo	nn	21	SENT_116	[p3l1484t2534r1620b2569],
21	)	NN	O	)	nsubj	23	SENT_116	[p3l1484t2534r1620b2569],
22	were	VBD	O	be	cop	23	SENT_116	[p3l1631t2543r1708b2560],
23	present	JJ	DATE	present	ccomp	15	SENT_116	[p3l1720t2539r1841b2569],
24	at	IN	O	at	_	0	SENT_116	[p3l1852t2539r1881b2560],
25	all	DT	O	all	det	26	SENT_116	[p3l1893t2534r1929b2560],
26	time	NN	O	time	prep_at	23	SENT_116	[p3l1941t2535r2012b2560],
27	points	NNS	O	point	nsubj	28	SENT_116	[p3l2024t2535r2125b2569],
28	(	VBP	O	(	rcmod	26	SENT_116	[p3l2138t2534r2238b2566],
29	Table	NNP	O	Table	nsubj	31	SENT_116	[p3l2138t2534r2238b2566],
30	1	CD	NUMBER	1	num	31	SENT_116	[p3l2252t2535r2286b2566],
31	)	CD	NUMBER	)	xcomp	28	SENT_116	[p3l2252t2535r2286b2566],
32	,	,	O	,	_	0	SENT_116	[p3l2252t2535r2286b2566],
33	and	CC	O	and	_	0	SENT_116	[p3l1277t2581r1336b2607],
34	the	DT	O	the	det	35	SENT_116	[p3l1362t2581r1411b2607],
35	analyses	NNS	O	analysis	nsubjpass	37	SENT_116	[p3l1436t2581r1566b2616],
36	are	VBP	O	be	auxpass	37	SENT_116	[p3l1591t2590r1641b2607],
37	based	VBN	O	base	conj_and	15	SENT_116	[p3l1665t2581r1756b2607],
38	on	IN	O	on	_	0	SENT_116	[p3l1781t2590r1821b2607],
39	these	DT	O	these	det	40	SENT_116	[p3l1847t2581r1929b2607],
40	patients	NNS	O	patient	prep_on	37	SENT_116	[p3l1954t2582r2091b2616],
41	.	.	O	.	_	0	SENT_116	[p3l1954t2582r2091b2616],

1	In	IN	O	in	_	0	SENT_117	[p3l2117t2582r2150b2606],
2	all	PDT	O	all	predet	4	SENT_117	[p3l2175t2581r2211b2607],
3	the	DT	O	the	det	4	SENT_117	[p3l2237t2581r2286b2607],
4	analyses	NNS	O	analysis	prep_in	14	SENT_117	[p3l1277t2628r1415b2663],
5	,	,	O	,	_	0	SENT_117	[p3l1277t2628r1415b2663],
6	only	RB	O	only	advmod	7	SENT_117	[p3l1437t2628r1506b2663],
7	participants	NNS	O	participant	nsubjpass	14	SENT_117	[p3l1527t2629r1723b2663],
8	present	JJ	DATE	present	amod	7	SENT_117	[p3l1745t2633r1866b2663],
9	at	IN	O	at	_	0	SENT_117	[p3l1888t2633r1917b2654],
10	all	DT	O	all	det	12	SENT_117	[p3l1938t2628r1974b2654],
11	time	NN	O	time	nn	12	SENT_117	[p3l1996t2629r2067b2654],
12	points	NNS	O	point	prep_at	8	SENT_117	[p3l2089t2629r2189b2663],
13	were	VBD	O	be	auxpass	14	SENT_117	[p3l2210t2637r2286b2654],
14	included	VBN	O	include	_	0	SENT_117	[p3l1277t2675r1426b2701],
15	.	.	O	.	_	0	SENT_117	[p3l1277t2675r1426b2701],

1	Nonetheless	RB	O	nonetheless	advmod	9	SENT_118	[p3l1448t2675r1653b2706],
2	,	,	O	,	_	0	SENT_118	[p3l1448t2675r1653b2706],
3	the	DT	O	the	det	5	SENT_118	[p3l1677t2675r1726b2701],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_118	[p3l1749t2675r1917b2710],
5	differences	NNS	O	difference	nsubjpass	9	SENT_118	[p3l1939t2675r2119b2701],
6	observed	VBN	O	observe	partmod	5	SENT_118	[p3l2141t2675r2286b2701],
7	were	VBD	O	be	auxpass	9	SENT_118	[p3l1276t2732r1352b2749],
8	not	RB	O	not	neg	9	SENT_118	[p3l1365t2728r1418b2749],
9	affected	VBN	O	affect	_	0	SENT_118	[p3l1430t2723r1560b2749],
10	when	WRB	O	when	advmod	35	SENT_118	[p3l1571t2723r1657b2749],
11	all	DT	O	all	det	12	SENT_118	[p3l1669t2723r1705b2749],
12	patients	NNS	O	patient	nsubj	35	SENT_118	[p3l1717t2724r1847b2758],
13	(	IN	O	(	_	0	SENT_118	[p3l1860t2723r2025b2758],
14	including	VBG	O	include	prepc_(	12	SENT_118	[p3l1860t2723r2025b2758],
15	the	DT	O	the	det	16	SENT_118	[p3l2037t2723r2086b2749],
16	dropouts	NNS	O	dropout	dobj	14	SENT_118	[p3l2098t2723r2245b2758],
17	at	IN	O	at	_	0	SENT_118	[p3l2258t2728r2287b2749],
18	the	DT	O	the	det	21	SENT_118	[p3l1278t2770r1327b2796],
19	follow-up	JJ	O	follow-up	amod	21	SENT_118	[p3l1339t2770r1494b2805],
20	time	NN	O	time	nn	21	SENT_118	[p3l1508t2771r1578b2796],
21	points	NNS	O	point	prep_at	14	SENT_118	[p3l1591t2771r1692b2805],
22	as	IN	O	as	mark	31	SENT_118	[p3l1705t2779r1734b2796],
23	shown	VBN	O	show	csubjpass	31	SENT_118	[p3l1746t2770r1848b2796],
24	in	IN	O	in	_	0	SENT_118	[p3l1861t2771r1891b2795],
25	Figure	NNP	O	Figure	nn	26	SENT_118	[p3l1902t2771r2007b2805],
26	1A	NN	O	1a	prep_in	23	SENT_118	[p3l2022t2770r2063b2795],
27	and	CC	O	and	_	0	SENT_118	[p3l2075t2770r2134b2796],
28	1B	NN	O	1b	nn	29	SENT_118	[p3l2149t2770r2198b2802],
29	)	NN	O	)	prep_in	23	SENT_118	[p3l2149t2770r2198b2802],
30	were	VBD	O	be	auxpass	31	SENT_118	[p3l2210t2779r2286b2796],
31	included	VBN	O	include	advcl	14	SENT_118	[p3l1277t2817r1418b2843],
32	in	IN	O	in	_	0	SENT_118	[p3l1434t2818r1464b2842],
33	the	DT	O	the	det	34	SENT_118	[p3l1480t2817r1529b2843],
34	analyses	NNS	O	analysis	prep_in	31	SENT_118	[p3l1545t2817r1674b2852],
35	(	VBP	O	(	advcl	9	SENT_118	[p3l1691t2817r1903b2852],
36	unpublished	JJ	O	unpublished	amod	38	SENT_118	[p3l1691t2817r1903b2852],
37	data	NNS	O	datum	nn	38	SENT_118	[p3l1918t2817r2006b2849],
38	)	NN	O	)	dobj	35	SENT_118	[p3l1918t2817r2006b2849],
39	.	.	O	.	_	0	SENT_118	[p3l1918t2817r2006b2849],

1	Primary	JJ	O	primary	amod	3	SENT_119	[p3l1278t2894r1407b2932],
2	Outcome	NNP	O	Outcome	nn	3	SENT_119	[p3l1423t2894r1582b2924],
3	Analysis	NN	O	analysis	nsubj	9	SENT_119	[p3l1599t2893r1736b2932],
4	in	IN	O	in	_	0	SENT_119	[p3l1754t2894r1781b2923],
5	Microfilaremic	JJ	O	microfilaremic	amod	6	SENT_119	[p3l1800t2893r2042b2924],
6	Patients	NNS	O	patient	prep_in	3	SENT_119	[p3l2061t2894r2196b2924],
7	Table	NNP	O	Table	dep	6	SENT_119	[p3l1314t2946r1405b2972],
8	1	CD	NUMBER	1	num	7	SENT_119	[p3l1435t2946r1446b2971],
9	shows	VBZ	O	show	conj_and	9	SENT_119	[p3l1477t2946r1570b2972],
10	the	DT	O	the	det	11	SENT_119	[p3l1599t2946r1649b2972],
11	changes	NNS	O	change	dobj	9	SENT_119	[p3l1676t2946r1804b2981],
12	in	IN	O	in	_	0	SENT_119	[p3l1833t2947r1863b2971],
13	Wolbachia	JJ	LOCATION	wolbachia	amod	14	SENT_119	[p3l1893t2946r2042b2972],
14	level	NN	O	level	prep_in	11	SENT_119	[p3l2069t2946r2150b2977],
15	,	,	O	,	_	0	SENT_119	[p3l2069t2946r2150b2977],
16	microﬁlaremia	NN	O	microﬁlaremia	conj_and	14	SENT_119	[p3l2178t2947r2286b2972, p3l1276t2993r1429b3024],
17	,	,	O	,	_	0	SENT_119	[p3l2178t2947r2286b2972, p3l1276t2993r1429b3024],
18	and	CC	O	and	_	0	SENT_119	[p3l1450t2993r1509b3019],
19	antigenemia	NN	O	antigenemia	prep_in	11	SENT_119	[p3l1529t2994r1731b3028],
20	from	IN	O	from	_	0	SENT_119	[p3l1751t2993r1830b3019],
21	baseline	NN	O	baseline	prep_from	9	SENT_119	[p3l1850t2993r1981b3019],
22	and	CC	O	and	_	0	SENT_119	[p3l2002t2993r2061b3019],
23	at	IN	O	at	_	0	SENT_119	[p3l2082t2999r2111b3019],
24	follow-up	NN	O	follow-up	prep_at	9	SENT_119	[p3l2131t2993r2286b3028],

1	A	DT	O	a	det	2	SENT_120	[p4l188t226r218b256],
2	Patients	NNS	O	patient	dep	7	SENT_120	[p4l494t241r588b260],
3	of	IN	O	of	_	0	SENT_120	[p4l597t240r620b260],
4	ages	NNS	O	age	prep_of	2	SENT_120	[p4l627t246r684b266],
5	18	CD	NUMBER	18	dep	7	SENT_120	[p4l695t240r721b260],
6	—	CD	NUMBER	—	number	7	SENT_120	[p4l730t252r745b254],
7	50	CD	NUMBER	50	dep	10	SENT_120	[p4l753t241r781b260],
8	with	IN	O	with	_	0	SENT_120	[p4l470t273r516b293],
9	microﬁlaraemia	NN	O	microﬁlaraemia	prep_with	7	SENT_120	[p4l527t272r705b293],
10	>	JJR	O	>	_	0	SENT_120	[p4l715t273r758b293],
11	50	CD	NUMBER	50	num	13	SENT_120	[p4l715t273r758b293],
12	mfl	NN	O	mfl	nn	13	SENT_120	[p4l768t272r804b293],
13	ml	NN	O	ml	nsubj	14	SENT_120	[p4l491t305r516b324],
14	assessed	VBN	O	assess	rcmod	10	SENT_120	[p4l526t305r636b325],
15	for	IN	O	for	_	0	SENT_120	[p4l645t305r677b325],
16	eligibility	NN	O	eligibility	prep_for	14	SENT_120	[p4l685t305r785b330],

1	Received	VBN	O	receive	_	0	SENT_121	[p4l229t661r337b681],
2	doxycycline	NN	O	doxycycline	nn	3	SENT_121	[p4l347t661r484b686],
3	(	NN	O	(	dobj	1	SENT_121	[p4l494t661r545b686],
4	200	CD	NUMBER	200	num	5	SENT_121	[p4l494t661r545b686],
5	mg	NN	O	mg	nsubj	17	SENT_121	[p4l229t698r263b718],
6	/	:	O	/	punct	13	SENT_121	[p4l272t693r280b713],
7	day	NN	DURATION	day	dep	13	SENT_121	[p4l288t693r338b718],
8	)	CD	NUMBER	)	num	7	SENT_121	[p4l288t693r338b718],
9	for	IN	O	for	_	0	SENT_121	[p4l346t693r378b713],
10	six	CD	DURATION	six	num	11	SENT_121	[p4l386t693r418b713],
11	weeks	NNS	NUMBER	week	prep_for	7	SENT_121	[p4l426t693r501b713],
12	(	CD	NUMBER	(	num	13	SENT_121	[p4l229t725r305b750],
13	n	NN	O	n	dep	5	SENT_121	[p4l229t725r305b750],
14	=	JJ	O	=	amod	5	SENT_121	[p4l229t725r305b750],
15	39	CD	NUMBER	39	number	16	SENT_121	[p4l229t725r305b750],
16	)	CD	NUMBER	)	dep	14	SENT_121	[p4l229t725r305b750],
17	Completed	VBN	O	complete	rcmod	3	SENT_121	[p4l229t757r355b782],
18	treatment	NN	O	treatment	nn	20	SENT_121	[p4l365t758r478b777],
19	(	NN	O	(	nn	20	SENT_121	[p4l487t757r562b782],
20	n	NN	O	n	nsubj	23	SENT_121	[p4l487t757r562b782],
21	=	JJ	O	=	amod	23	SENT_121	[p4l487t757r562b782],
22	39	CD	NUMBER	39	num	23	SENT_121	[p4l487t757r562b782],
23	)	NN	O	)	xcomp	17	SENT_121	[p4l487t757r562b782],

1	Lost	VBN	O	lose	_	0	SENT_122	[p4l229t926r278b946],
2	to	TO	O	to	_	0	SENT_122	[p4l286t927r307b946],
3	4	CD	DURATION	4	num	4	SENT_122	[p4l316t926r330b945],
4	month	NN	NUMBER	month	prep_to	1	SENT_122	[p4l340t926r411b946],
5	follow	VB	O	follow	ccomp	1	SENT_122	[p4l420t925r489b946],
6	up	RP	O	up	prt	5	SENT_122	[p4l498t931r525b951],
7	(	CD	NUMBER	(	num	8	SENT_122	[p4l229t957r290b983],
8	n	NN	O	n	dobj	5	SENT_122	[p4l229t957r290b983],
9	=	JJ	O	=	amod	8	SENT_122	[p4l229t957r290b983],
10	2	CD	NUMBER	2	number	11	SENT_122	[p4l229t957r290b983],
11	)	CD	NUMBER	)	dep	9	SENT_122	[p4l229t957r290b983],
12	Analyzed	VBN	O	analyze	partmod	8	SENT_122	[p4l228t990r336b1015],
13	(	NN	O	(	nn	14	SENT_122	[p4l347t990r422b1015],
14	n	NN	O	n	dobj	12	SENT_122	[p4l347t990r422b1015],
15	=	JJ	O	=	amod	14	SENT_122	[p4l347t990r422b1015],
16	37	CD	NUMBER	37	number	17	SENT_122	[p4l347t990r422b1015],
17	)	CD	NUMBER	)	dep	15	SENT_122	[p4l347t990r422b1015],

1	Received	VBN	O	receive	_	0	SENT_123	[p4l219t1146r327b1166],
2	400	CD	NUMBER	400	num	4	SENT_123	[p4l337t1146r381b1166],
3	mg	NN	O	mg	nn	4	SENT_123	[p4l391t1151r425b1172],
4	albendazole	NN	O	albendazole	dep	10	SENT_123	[p4l218t1179r361b1198],
5	and	CC	O	and	_	0	SENT_123	[p4l371t1179r413b1198],
6	150	CD	NUMBER	150	conj_and	4	SENT_123	[p4l425t1179r466b1198],
7	—	NN	O	—	dep	10	SENT_123	[p4l475t1190r490b1192],
8	200	CD	NUMBER	200	num	7	SENT_123	[p4l498t1179r542b1198],
9	pg/kg	NN	O	pg/kg	nn	10	SENT_123	[p4l219t1211r282b1236],
10	ivermectin	NN	O	ivermectin	dep	15	SENT_123	[p4l292t1211r411b1231],
11	(	CD	NUMBER	(	num	12	SENT_123	[p4l422t1211r497b1236],
12	n	NN	O	n	dep	10	SENT_123	[p4l422t1211r497b1236],
13	=	JJ	O	=	amod	15	SENT_123	[p4l422t1211r497b1236],
14	37	CD	NUMBER	37	number	15	SENT_123	[p4l422t1211r497b1236],
15	)	CD	NUMBER	)	dep	1	SENT_123	[p4l422t1211r497b1236],
16	Completed	VBN	O	complete	partmod	15	SENT_123	[p4l219t1242r345b1268],
17	treatment	NN	O	treatment	nn	19	SENT_123	[p4l355t1243r468b1263],
18	(	NN	O	(	nn	19	SENT_123	[p4l477t1242r552b1268],
19	n	NN	O	n	dobj	16	SENT_123	[p4l477t1242r552b1268],
20	=	JJ	O	=	amod	19	SENT_123	[p4l477t1242r552b1268],
21	37	CD	NUMBER	37	number	22	SENT_123	[p4l477t1242r552b1268],
22	)	CD	NUMBER	)	dep	20	SENT_123	[p4l477t1242r552b1268],

1	Patients	NNS	O	patient	dep	6	SENT_124	[p4l219t1367r314b1387],
2	present	JJ	DATE	present	amod	1	SENT_124	[p4l324t1368r411b1392],
3	at	IN	O	at	_	0	SENT_124	[p4l420t1368r441b1387],
4	12	CD	DURATION	12	num	5	SENT_124	[p4l452t1367r478b1387],
5	months	NNS	NUMBER	month	prep_at	2	SENT_124	[p4l219t1400r304b1419],
6	follow	VBP	O	follow	_	0	SENT_124	[p4l313t1399r381b1419],
7	up	RP	O	up	prt	6	SENT_124	[p4l390t1405r418b1424],
8	for	IN	O	for	_	0	SENT_124	[p4l426t1399r458b1419],
9	reexamination	NN	O	reexamination	nn	11	SENT_124	[p4l466t1405r497b1419, p4l218t1432r360b1451],
10	(	NN	O	(	nn	11	SENT_124	[p4l371t1431r447b1457],
11	n	NN	O	n	prep_for	6	SENT_124	[p4l371t1431r447b1457],
12	=	JJ	O	=	amod	11	SENT_124	[p4l371t1431r447b1457],
13	22	CD	NUMBER	22	num	14	SENT_124	[p4l371t1431r447b1457],
14	)	NN	O	)	nsubj	6	SENT_124	[p4l371t1431r447b1457],

1	Patients	NNS	O	patient	dep	6	SENT_125	[p4l229t1588r324b1608],
2	present	JJ	DATE	present	amod	1	SENT_125	[p4l334t1589r422b1613],
3	at	IN	O	at	_	0	SENT_125	[p4l430t1589r452b1608],
4	24	CD	DURATION	24	num	5	SENT_125	[p4l460t1588r488b1608],
5	months	NNS	NUMBER	month	prep_at	2	SENT_125	[p4l229t1620r314b1640],
6	follow	VBP	O	follow	_	0	SENT_125	[p4l323t1620r391b1640],
7	up	RP	O	up	prt	6	SENT_125	[p4l400t1625r428b1645],
8	for	IN	O	for	_	0	SENT_125	[p4l436t1620r468b1640],
9	reexamination	NN	O	reexamination	nn	11	SENT_125	[p4l476t1625r507b1640, p4l228t1652r370b1672],
10	(	NN	O	(	nn	11	SENT_125	[p4l381t1652r457b1677],
11	n	NN	O	n	prep_for	6	SENT_125	[p4l381t1652r457b1677],
12	=	JJ	O	=	amod	11	SENT_125	[p4l381t1652r457b1677],
13	26	CD	NUMBER	26	num	14	SENT_125	[p4l381t1652r457b1677],
14	)	NN	O	)	nsubj	6	SENT_125	[p4l381t1652r457b1677],

1	(	NN	O	(	nn	2	SENT_126	[p4l592t337r683b362],
2	n	NN	O	n	_	0	SENT_126	[p4l592t337r683b362],
3	=	JJ	O	=	dep	2	SENT_126	[p4l592t337r683b362],
4	263	CD	NUMBER	263	num	5	SENT_126	[p4l592t337r683b362],
5	)	NN	O	)	dep	2	SENT_126	[p4l592t337r683b362],

1	Randomized	VBN	O	randomize	_	0	SENT_127	[p4l516t481r663b501],
2	(	NN	O	(	nn	3	SENT_127	[p4l674t480r694b506],
3	n	NN	O	n	nsubj	6	SENT_127	[p4l674t480r694b506],
4	=	JJ	O	=	amod	6	SENT_127	[p4l705t486r718b495],
5	76	CD	NUMBER	76	num	6	SENT_127	[p4l728t480r765b506],
6	)	NN	O	)	xcomp	1	SENT_127	[p4l728t480r765b506],

1	Excluded	VBN	O	exclude	_	0	SENT_128	[p4l953t401r1059b421],
2	for	IN	O	for	_	0	SENT_128	[p4l1069t400r1100b421],
3	not	RB	O	not	neg	4	SENT_128	[p4l1109t401r1145b421],
4	meeting	VBG	O	meet	prepc_for	1	SENT_128	[p4l952t433r1044b458],
5	inclusion	NN	O	inclusion	nn	6	SENT_128	[p4l1055t433r1156b453],
6	criteria	NNS	O	criterion	nn	11	SENT_128	[p4l952t465r1030b485],
7	(	CD	NUMBER	(	num	8	SENT_128	[p4l1040t465r1130b490],
8	n	NN	O	n	dep	6	SENT_128	[p4l1040t465r1130b490],
9	=	JJ	O	=	amod	11	SENT_128	[p4l1040t465r1130b490],
10	187	CD	NUMBER	187	tmod	9	SENT_128	[p4l1040t465r1130b490],
11	)	NN	O	)	dobj	4	SENT_128	[p4l1040t465r1130b490],

1	Received	VBN	O	receive	_	0	SENT_129	[p4l680t665r788b685],
2	placebo	NN	O	placebo	dobj	1	SENT_129	[p4l799t665r890b690],
3	for	IN	O	for	_	0	SENT_129	[p4l899t665r930b685],
4	six	CD	DURATION	six	num	5	SENT_129	[p4l938t665r970b685],
5	weeks	NNS	NUMBER	week	prep_for	2	SENT_129	[p4l978t665r1053b685],
6	(	CD	NUMBER	(	num	7	SENT_129	[p4l679t697r700b722],
7	n	NN	O	n	dep	5	SENT_129	[p4l679t697r700b722],
8	=	JJ	O	=	amod	2	SENT_129	[p4l710t703r723b711],
9	37	CD	NUMBER	37	number	10	SENT_129	[p4l733t697r770b722],
10	)	CD	NUMBER	)	dep	8	SENT_129	[p4l733t697r770b722],
11	Completed	VBN	O	complete	partmod	2	SENT_129	[p4l679t729r806b754],
12	treatment	NN	O	treatment	nn	14	SENT_129	[p4l815t730r928b749],
13	(	NN	O	(	nn	14	SENT_129	[p4l937t729r958b755],
14	n	NN	O	n	dobj	11	SENT_129	[p4l937t729r958b755],
15	=	JJ	O	=	amod	14	SENT_129	[p4l968t735r981b744],
16	37	CD	NUMBER	37	number	17	SENT_129	[p4l991t729r1028b755],
17	)	CD	NUMBER	)	dep	15	SENT_129	[p4l991t729r1028b755],

1	Lost	VBN	O	lose	_	0	SENT_130	[p4l740t926r789b946],
2	to	TO	O	to	_	0	SENT_130	[p4l796t926r818b946],
3	4	CD	DURATION	4	num	4	SENT_130	[p4l826t926r840b945],
4	month	NN	NUMBER	month	prep_to	1	SENT_130	[p4l850t926r922b946],
5	follow	VB	O	follow	ccomp	1	SENT_130	[p4l931t925r999b946],
6	up	RP	O	up	prt	5	SENT_130	[p4l1008t931r1036b951],
7	(	CD	NUMBER	(	num	8	SENT_130	[p4l739t957r800b983],
8	n	NN	O	n	dobj	5	SENT_130	[p4l739t957r800b983],
9	=	JJ	O	=	amod	8	SENT_130	[p4l739t957r800b983],
10	8	CD	NUMBER	8	number	11	SENT_130	[p4l739t957r800b983],
11	)	CD	NUMBER	)	dep	9	SENT_130	[p4l739t957r800b983],
12	Analyzed	VBN	O	analyze	partmod	8	SENT_130	[p4l738t990r846b1015],
13	(	NN	O	(	nn	14	SENT_130	[p4l857t990r933b1015],
14	n	NN	O	n	dobj	12	SENT_130	[p4l857t990r933b1015],
15	=	JJ	O	=	advmod	12	SENT_130	[p4l857t990r933b1015],
16	29	CD	NUMBER	29	num	17	SENT_130	[p4l857t990r933b1015],
17	)	NN	O	)	dep	15	SENT_130	[p4l857t990r933b1015],

1	Received	VBN	O	receive	_	0	SENT_131	[p4l730t1148r838b1168],
2	400	CD	NUMBER	400	num	4	SENT_131	[p4l847t1148r891b1168],
3	mg	NN	O	mg	nn	4	SENT_131	[p4l901t1153r935b1173],
4	albendazole	NN	O	albendazole	dep	10	SENT_131	[p4l729t1180r872b1200],
5	and	CC	O	and	_	0	SENT_131	[p4l881t1180r924b1200],
6	150	CD	NUMBER	150	conj_and	4	SENT_131	[p4l936t1180r977b1200],
7	—	NN	O	—	dep	10	SENT_131	[p4l985t1191r1001b1194],
8	200	CD	NUMBER	200	num	7	SENT_131	[p4l1009t1180r1052b1200],
9	ug/kg	JJ	O	ug/kg	amod	10	SENT_131	[p4l730t1212r792b1238],
10	ivermectin	NN	O	ivermectin	dep	15	SENT_131	[p4l803t1213r921b1232],
11	(	NN	O	(	nn	12	SENT_131	[p4l932t1212r1008b1238],
12	n	NN	O	n	dep	10	SENT_131	[p4l932t1212r1008b1238],
13	=	JJ	O	=	amod	15	SENT_131	[p4l932t1212r1008b1238],
14	29	CD	NUMBER	29	number	15	SENT_131	[p4l932t1212r1008b1238],
15	)	CD	NUMBER	)	dep	1	SENT_131	[p4l932t1212r1008b1238],
16	Completed	VBN	O	complete	partmod	15	SENT_131	[p4l729t1244r856b1269],
17	treatment	NN	O	treatment	nn	19	SENT_131	[p4l865t1245r978b1264],
18	(	NN	O	(	nn	19	SENT_131	[p4l987t1244r1063b1270],
19	n	NN	O	n	dobj	16	SENT_131	[p4l987t1244r1063b1270],
20	=	JJ	O	=	amod	19	SENT_131	[p4l987t1244r1063b1270],
21	29	CD	NUMBER	29	num	22	SENT_131	[p4l987t1244r1063b1270],
22	)	NN	O	)	dep	20	SENT_131	[p4l987t1244r1063b1270],

1	Patients	NNS	O	patient	dep	6	SENT_132	[p4l730t1367r824b1387],
2	present	JJ	DATE	present	amod	1	SENT_132	[p4l834t1368r922b1392],
3	at	IN	O	at	_	0	SENT_132	[p4l930t1368r952b1387],
4	12	CD	DURATION	12	num	5	SENT_132	[p4l962t1367r988b1387],
5	months	NNS	NUMBER	month	prep_at	2	SENT_132	[p4l730t1400r815b1419],
6	follow	VBP	O	follow	_	0	SENT_132	[p4l823t1399r892b1419],
7	up	RP	O	up	prt	6	SENT_132	[p4l901t1405r928b1424],
8	for	IN	O	for	_	0	SENT_132	[p4l937t1399r968b1419],
9	reexamination	NN	O	reexamination	nn	11	SENT_132	[p4l977t1405r1007b1419, p4l729t1432r871b1451],
10	(	NN	O	(	nn	11	SENT_132	[p4l881t1431r957b1457],
11	n	NN	O	n	prep_for	6	SENT_132	[p4l881t1431r957b1457],
12	=	JJ	O	=	amod	11	SENT_132	[p4l881t1431r957b1457],
13	22	CD	NUMBER	22	num	14	SENT_132	[p4l881t1431r957b1457],
14	)	NN	O	)	nsubj	6	SENT_132	[p4l881t1431r957b1457],

1	Patients	NNS	O	patient	dep	6	SENT_133	[p4l727t1588r822b1608],
2	present	JJ	DATE	present	amod	1	SENT_133	[p4l832t1589r920b1613],
3	at	IN	O	at	_	0	SENT_133	[p4l928t1589r950b1608],
4	24	CD	DURATION	24	num	5	SENT_133	[p4l958t1588r986b1608],
5	months	NNS	NUMBER	month	prep_at	2	SENT_133	[p4l727t1620r812b1640],
6	follow	VBP	O	follow	_	0	SENT_133	[p4l821t1620r889b1640],
7	up	RP	O	up	prt	6	SENT_133	[p4l898t1625r926b1645],
8	for	IN	O	for	_	0	SENT_133	[p4l934t1620r966b1640],
9	reexamination	NN	O	reexamination	nn	11	SENT_133	[p4l974t1625r1005b1640, p4l726t1652r868b1672],
10	(	NN	O	(	nn	11	SENT_133	[p4l879t1652r955b1677],
11	n	NN	O	n	prep_for	6	SENT_133	[p4l879t1652r955b1677],
12	=	JJ	O	=	amod	11	SENT_133	[p4l879t1652r955b1677],
13	23	CD	NUMBER	23	num	14	SENT_133	[p4l879t1652r955b1677],
14	)	NN	O	)	nsubj	6	SENT_133	[p4l879t1652r955b1677],

1	B	NN	O	b	nn	3	SENT_134	[p4l191t1797r217b1827],
2	Lymphoedema	NN	O	lymphoedema	nn	3	SENT_134	[p4l467t1817r630b1840],
3	patients	NNS	O	patient	_	0	SENT_134	[p4l647t1817r733b1840],
4	of	IN	O	of	_	0	SENT_134	[p4l742t1816r763b1835],
5	ages	NNS	O	age	prep_of	3	SENT_134	[p4l489t1851r542b1870],
6	18	CD	NUMBER	18	number	7	SENT_134	[p4l552t1847r577b1865],
7	—	CD	NUMBER	—	num	8	SENT_134	[p4l585t1857r599b1860],
8	50	CD	NUMBER	50	dep	5	SENT_134	[p4l607t1847r633b1865],
9	recruited	VBN	O	recruit	partmod	5	SENT_134	[p4l643t1847r737b1865],

1	(	NN	O	(	nn	2	SENT_135	[p4l578t1877r650b1900],
2	n	NN	O	n	_	0	SENT_135	[p4l578t1877r650b1900],
3	=	JJ	O	=	dep	2	SENT_135	[p4l578t1877r650b1900],
4	26	CD	NUMBER	26	num	5	SENT_135	[p4l578t1877r650b1900],
5	)	NN	O	)	dep	2	SENT_135	[p4l578t1877r650b1900],

1	Received	VBN	O	receive	_	0	SENT_136	[p4l231t2211r333b2229],
2	doxycycline	NN	O	doxycycline	nn	3	SENT_136	[p4l342t2211r470b2234],
3	(	NN	O	(	dep	7	SENT_136	[p4l480t2210r528b2234],
4	200	CD	NUMBER	200	num	5	SENT_136	[p4l480t2210r528b2234],
5	mg	NN	O	mg	dep	3	SENT_136	[p4l231t2246r263b2264],
6	I	PRP	O	I	dep	7	SENT_136	[p4l272t2241r278b2260],
7	day	NN	DURATION	day	dep	13	SENT_136	[p4l286t2241r333b2265],
8	)	CD	NUMBER	)	num	7	SENT_136	[p4l286t2241r333b2265],
9	for	IN	O	for	_	0	SENT_136	[p4l341t2241r371b2260],
10	six	CD	DURATION	six	num	11	SENT_136	[p4l378t2241r408b2260],
11	weeks	NNS	NUMBER	week	prep_for	7	SENT_136	[p4l415t2241r486b2260],
12	(	CD	NUMBER	(	num	13	SENT_136	[p4l231t2271r288b2295],
13	n	NN	O	n	dep	16	SENT_136	[p4l231t2271r288b2295],
14	=	JJ	O	=	amod	16	SENT_136	[p4l231t2271r288b2295],
15	9	CD	NUMBER	9	tmod	14	SENT_136	[p4l231t2271r288b2295],
16	)	NN	O	)	dep	1	SENT_136	[p4l231t2271r288b2295],
17	Completed	VBN	O	complete	partmod	16	SENT_136	[p4l231t2301r349b2324],
18	treatment	NN	O	treatment	nn	20	SENT_136	[p4l358t2302r464b2320],
19	(	NN	O	(	nn	20	SENT_136	[p4l472t2301r530b2325],
20	n	NN	O	n	dobj	17	SENT_136	[p4l472t2301r530b2325],
21	=	JJ	O	=	amod	20	SENT_136	[p4l472t2301r530b2325],
22	9	CD	NUMBER	9	num	23	SENT_136	[p4l472t2301r530b2325],
23	)	NN	O	)	dep	21	SENT_136	[p4l472t2301r530b2325],

1	Lost	VBN	O	lose	_	0	SENT_137	[p4l231t2459r277b2478],
2	to	TO	O	to	_	0	SENT_137	[p4l284t2460r305b2478],
3	4	CD	DURATION	4	num	4	SENT_137	[p4l313t2459r325b2477],
4	month	NN	NUMBER	month	prep_to	1	SENT_137	[p4l335t2459r402b2478],
5	follow	VB	O	follow	ccomp	1	SENT_137	[p4l410t2459r474b2478],
6	up	RP	O	up	prt	5	SENT_137	[p4l483t2464r509b2482],
7	(	CD	NUMBER	(	num	8	SENT_137	[p4l231t2489r288b2513],
8	n	NN	O	n	dobj	5	SENT_137	[p4l231t2489r288b2513],
9	=	JJ	O	=	amod	10	SENT_137	[p4l231t2489r288b2513],
10	o	NN	O	o	nsubj	15	SENT_137	[p4l231t2489r288b2513],
11	)	CD	NUMBER	)	num	10	SENT_137	[p4l231t2489r288b2513],
12	Analyzed	VBN	O	analyze	partmod	10	SENT_137	[p4l230t2519r331b2543],
13	(	NN	O	(	nn	14	SENT_137	[p4l341t2519r398b2543],
14	n	NN	O	n	dobj	12	SENT_137	[p4l341t2519r398b2543],
15	=	JJ	O	=	rcmod	8	SENT_137	[p4l341t2519r398b2543],
16	9	CD	NUMBER	9	num	17	SENT_137	[p4l341t2519r398b2543],
17	)	NN	O	)	dobj	15	SENT_137	[p4l341t2519r398b2543],

1	Randomized	VBN	O	randomize	_	0	SENT_138	[p4l500t2042r638b2060],
2	(	NN	O	(	nn	3	SENT_138	[p4l648t2042r667b2065],
3	n	NN	O	n	nsubj	6	SENT_138	[p4l648t2042r667b2065],
4	=	JJ	O	=	amod	6	SENT_138	[p4l677t2047r689b2055],
5	19	CD	NUMBER	19	num	6	SENT_138	[p4l700t2042r733b2065],
6	)	NN	O	)	xcomp	1	SENT_138	[p4l700t2042r733b2065],

1	Excluded	VBN	O	exclude	_	0	SENT_139	[p4l909t1967r1010b1985],
2	for	IN	O	for	_	0	SENT_139	[p4l1018t1967r1048b1985],
3	not	RB	O	not	neg	4	SENT_139	[p4l1056t1967r1090b1985],
4	meeting	VBG	O	meet	prepc_for	1	SENT_139	[p4l909t1997r995b2021],
5	inclusion	NN	O	inclusion	nn	6	SENT_139	[p4l1005t1997r1100b2016],
6	criteria	NNS	O	criterion	nn	11	SENT_139	[p4l908t2027r981b2046],
7	(	CD	NUMBER	(	num	8	SENT_139	[p4l991t2027r1048b2051],
8	n	NN	O	n	dep	6	SENT_139	[p4l991t2027r1048b2051],
9	=	JJ	O	=	amod	11	SENT_139	[p4l991t2027r1048b2051],
10	7	CD	NUMBER	7	tmod	9	SENT_139	[p4l991t2027r1048b2051],
11	)	NN	O	)	dobj	4	SENT_139	[p4l991t2027r1048b2051],

1	Received	VBN	O	receive	_	0	SENT_140	[p4l654t2215r755b2233],
2	placebo	NN	O	placebo	dobj	1	SENT_140	[p4l765t2215r851b2238],
3	for	IN	O	for	_	0	SENT_140	[p4l859t2214r889b2233],
4	six	CD	DURATION	six	num	5	SENT_140	[p4l896t2215r926b2233],
5	weeks	NNS	NUMBER	week	prep_for	2	SENT_140	[p4l933t2215r1003b2233],
6	(	CD	NUMBER	(	num	7	SENT_140	[p4l653t2244r673b2268],
7	n	NN	O	n	dep	5	SENT_140	[p4l653t2244r673b2268],
8	=	JJ	O	=	amod	2	SENT_140	[p4l682t2250r694b2258],
9	10	CD	NUMBER	10	number	10	SENT_140	[p4l705t2244r738b2268],
10	)	CD	NUMBER	)	dep	8	SENT_140	[p4l705t2244r738b2268],
11	Completed	VBN	O	complete	partmod	2	SENT_140	[p4l653t2275r772b2298],
12	treatment	NN	O	treatment	nn	14	SENT_140	[p4l781t2276r886b2294],
13	(	NN	O	(	nn	14	SENT_140	[p4l895t2275r914b2299],
14	n	NN	O	n	dobj	11	SENT_140	[p4l895t2275r914b2299],
15	=	JJ	O	=	amod	14	SENT_140	[p4l924t2280r936b2288],
16	10	CD	NUMBER	10	num	17	SENT_140	[p4l947t2275r980b2299],
17	)	NN	O	)	dep	15	SENT_140	[p4l947t2275r980b2299],

1	Lost	VBN	O	lose	_	0	SENT_141	[p4l710t2459r756b2478],
2	to	TO	O	to	_	0	SENT_141	[p4l763t2460r783b2478],
3	4	CD	DURATION	4	num	4	SENT_141	[p4l791t2459r804b2477],
4	month	NN	NUMBER	month	prep_to	1	SENT_141	[p4l813t2459r880b2478],
5	follow	VB	O	follow	ccomp	1	SENT_141	[p4l889t2459r953b2478],
6	up	RP	O	up	prt	5	SENT_141	[p4l962t2464r987b2482],
7	(	CD	NUMBER	(	num	8	SENT_141	[p4l709t2489r766b2513],
8	n	NN	O	n	dobj	5	SENT_141	[p4l709t2489r766b2513],
9	=	JJ	O	=	amod	10	SENT_141	[p4l709t2489r766b2513],
10	o	NN	O	o	nsubj	15	SENT_141	[p4l709t2489r766b2513],
11	)	CD	NUMBER	)	num	10	SENT_141	[p4l709t2489r766b2513],
12	Analyzed	VBN	O	analyze	partmod	10	SENT_141	[p4l708t2519r810b2543],
13	(	NN	O	(	nn	14	SENT_141	[p4l820t2519r891b2543],
14	n	NN	O	n	dobj	12	SENT_141	[p4l820t2519r891b2543],
15	=	JJ	O	=	rcmod	8	SENT_141	[p4l820t2519r891b2543],
16	10	CD	NUMBER	10	num	17	SENT_141	[p4l820t2519r891b2543],
17	)	NN	O	)	dobj	15	SENT_141	[p4l820t2519r891b2543],

1	l	NN	O	l	tmod	2	SENT_142	[p4l384t2558r403b2644],
2	Received	VBD	O	receive	_	0	SENT_142	[p4l222t2666r323b2684],
3	400	CD	NUMBER	400	num	5	SENT_142	[p4l332t2666r373b2684],
4	mg	NN	O	mg	nn	5	SENT_142	[p4l382t2670r415b2689],
5	albendazole	NN	O	albendazole	nsubj	14	SENT_142	[p4l221t2696r355b2715],
6	and	CC	O	and	_	0	SENT_142	[p4l364t2696r404b2715],
7	150	CD	NUMBER	150	num	11	SENT_142	[p4l415t2696r454b2715],
8	—	NN	O	—	npadvmod	10	SENT_142	[p4l461t2707r476b2709],
9	200	CD	NUMBER	200	num	8	SENT_142	[p4l484t2696r524b2715],
10	ug/kg	JJ	O	ug/kg	amod	11	SENT_142	[p4l221t2726r281b2750],
11	ivermectin	NN	O	ivermectin	conj_and	5	SENT_142	[p4l290t2726r402b2745],
12	(	NN	O	(	nn	13	SENT_142	[p4l412t2726r469b2750],
13	n	NN	O	n	dep	11	SENT_142	[p4l412t2726r469b2750],
14	=	JJ	O	=	ccomp	2	SENT_142	[p4l412t2726r469b2750],
15	9	CD	NUMBER	9	num	16	SENT_142	[p4l412t2726r469b2750],
16	)	NN	O	)	dobj	14	SENT_142	[p4l412t2726r469b2750],
17	Completed	VBN	O	complete	partmod	16	SENT_142	[p4l221t2756r340b2779],
18	treatment	NN	O	treatment	nn	20	SENT_142	[p4l349t2757r455b2775],
19	(	NN	O	(	nn	20	SENT_142	[p4l463t2756r520b2780],
20	n	NN	O	n	nsubj	21	SENT_142	[p4l463t2756r520b2780],
21	=	JJ	O	=	xcomp	17	SENT_142	[p4l463t2756r520b2780],
22	9	CD	NUMBER	9	num	23	SENT_142	[p4l463t2756r520b2780],
23	)	NN	O	)	nsubj	2	SENT_142	[p4l463t2756r520b2780],

1	l	NN	O	l	tmod	2	SENT_143	[p4l863t2558r881b2644],
2	Received	VBD	O	receive	_	0	SENT_143	[p4l701t2667r802b2686],
3	400	CD	NUMBER	400	num	5	SENT_143	[p4l811t2667r852b2686],
4	mg	NN	O	mg	nn	5	SENT_143	[p4l861t2672r893b2691],
5	albendazole	NN	O	albendazole	nsubj	29	SENT_143	[p4l700t2698r834b2716],
6	and	CC	O	and	_	0	SENT_143	[p4l843t2698r882b2716],
7	150	CD	NUMBER	150	num	8	SENT_143	[p4l894t2697r932b2716],
8	—	NN	O	—	nsubj	29	SENT_143	[p4l940t2708r954b2710],
9	200	CD	NUMBER	200	num	11	SENT_143	[p4l962t2697r1003b2716],
10	pg/kg	NN	O	pg/kg	nn	11	SENT_143	[p4l699t2728r759b2752],
11	ivermectin	NN	O	ivermectin	nsubj	14	SENT_143	[p4l769t2728r880b2747],
12	(	CD	NUMBER	(	num	13	SENT_143	[p4l890t2728r961b2752],
13	n	NN	O	n	dep	11	SENT_143	[p4l890t2728r961b2752],
14	=	JJ	O	=	rcmod	8	SENT_143	[p4l890t2728r961b2752],
15	10	CD	NUMBER	10	number	16	SENT_143	[p4l890t2728r961b2752],
16	)	CD	NUMBER	)	dobj	14	SENT_143	[p4l890t2728r961b2752],
17	Completed	VBN	O	complete	partmod	16	SENT_143	[p4l700t2758r819b2781],
18	treatment	NN	O	treatment	nn	20	SENT_143	[p4l827t2758r933b2776],
19	(	NN	O	(	nn	20	SENT_143	[p4l942t2757r1013b2781],
20	n	NN	O	n	dobj	17	SENT_143	[p4l942t2757r1013b2781],
21	=	JJ	O	=	amod	20	SENT_143	[p4l942t2757r1013b2781],
22	10	CD	NUMBER	10	tmod	21	SENT_143	[p4l942t2757r1013b2781],
23	)	CD	NUMBER	)	num	24	SENT_143	[p4l942t2757r1013b2781],
24	Patients	NNS	O	patient	npadvmod	25	SENT_143	[p4l222t2873r310b2892],
25	present	JJ	DATE	present	amod	20	SENT_143	[p4l320t2874r402b2896],
26	at	IN	O	at	_	0	SENT_143	[p4l410t2874r430b2892],
27	12	CD	DURATION	12	num	28	SENT_143	[p4l440t2873r464b2891],
28	months	NNS	NUMBER	month	prep_at	17	SENT_143	[p4l222t2903r302b2922],
29	follow	VBP	O	follow	ccomp	2	SENT_143	[p4l310t2903r374b2922],
30	up	RP	O	up	prt	29	SENT_143	[p4l382t2908r408b2927],
31	for	IN	O	for	_	0	SENT_143	[p4l416t2903r445b2922],
32	reexamination	NN	O	reexamination	nn	34	SENT_143	[p4l453t2908r482b2922, p4l221t2933r354b2952],
33	(	NN	O	(	nn	34	SENT_143	[p4l364t2933r421b2957],
34	n	NN	O	n	prep_for	29	SENT_143	[p4l364t2933r421b2957],
35	=	JJ	O	=	amod	34	SENT_143	[p4l364t2933r421b2957],
36	8	CD	NUMBER	8	num	37	SENT_143	[p4l364t2933r421b2957],
37	)	NN	O	)	nsubj	2	SENT_143	[p4l364t2933r421b2957],

1	Patients	NNS	O	patient	dep	6	SENT_144	[p4l701t2873r789b2892],
2	present	JJ	DATE	present	amod	1	SENT_144	[p4l798t2874r881b2896],
3	at	IN	O	at	_	0	SENT_144	[p4l889t2874r909b2892],
4	12	CD	DURATION	12	num	5	SENT_144	[p4l918t2873r943b2891],
5	months	NNS	NUMBER	month	prep_at	2	SENT_144	[p4l700t2903r780b2922],
6	follow	VBP	O	follow	_	0	SENT_144	[p4l788t2903r852b2922],
7	up	RP	O	up	prt	6	SENT_144	[p4l861t2908r887b2927],
8	for	IN	O	for	_	0	SENT_144	[p4l894t2903r924b2922],
9	reexamination	NN	O	reexamination	nn	11	SENT_144	[p4l932t2908r961b2922, p4l700t2933r833b2952],
10	(	NN	O	(	nn	11	SENT_144	[p4l842t2933r914b2957],
11	n	NN	O	n	prep_for	6	SENT_144	[p4l842t2933r914b2957],
12	=	JJ	O	=	amod	11	SENT_144	[p4l842t2933r914b2957],
13	10	CD	NUMBER	10	num	14	SENT_144	[p4l842t2933r914b2957],
14	)	NN	O	)	nsubj	6	SENT_144	[p4l842t2933r914b2957],

1	S	NN	O	s	nn	2	SENT_145	[p4l188t3077r261b3136],
2	PLoS	NN	O	plo	nsubj	3	SENT_145	[p4l288t3093r352b3116],
3	Pathogens	VBD	O	pathogen	_	0	SENT_145	[p4l367t3092r511b3123],
4	|	CD	NUMBER	|	num	5	SENT_145	[p4l526t3091r528b3124],
5	www	NN	O	www	dobj	3	SENT_145	[p4l543t3092r882b3123],
6	.	.	O	.	_	0	SENT_145	[p4l543t3092r882b3123],

1	p	NN	O	p	_	0	SENT_146	[p4l543t3092r882b3123],
2	|	CD	NUMBER	|	num	3	SENT_146	[p4l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	dep	1	SENT_146	[p4l543t3092r882b3123],

1	Figure	NNP	O	Figure	_	0	SENT_147	[p4l1277t203r1370b234],
2	1	CD	NUMBER	1	dep	1	SENT_147	[p4l1384t205r1407b227],
3	.	.	O	.	_	0	SENT_147	[p4l1384t205r1407b227],

1	Flowchart	NN	O	flowchart	_	0	SENT_148	[p4l1422t203r1556b227],
2	of	IN	O	of	_	0	SENT_148	[p4l1569t203r1597b227],
3	Patient	NN	O	patient	nn	9	SENT_148	[p4l1609t204r1704b227],
4	Participation	NN	O	participation	nn	9	SENT_148	[p4l1718t204r1889b234],
5	(	NN	O	(	nn	9	SENT_148	[p4l1277t248r1312b275],
6	A	NN	O	a	nn	9	SENT_148	[p4l1277t248r1312b275],
7	)	CD	NUMBER	)	num	9	SENT_148	[p4l1277t248r1312b275],
8	Trial	NN	O	trial	nn	9	SENT_148	[p4l1330t247r1386b271],
9	profile	NN	O	profile	prep_of	1	SENT_148	[p4l1406t247r1492b278],
10	of	IN	O	of	_	0	SENT_148	[p4l1510t247r1538b271],
11	microfilaremic	JJ	O	microfilaremic	amod	12	SENT_148	[p4l1555t247r1748b271],
12	patients	NNS	O	patient	prep_of	9	SENT_148	[p4l1767t248r1884b278],
13	.	.	O	.	_	0	SENT_148	[p4l1767t248r1884b278],

1	Of	IN	O	of	_	0	SENT_149	[p4l1901t247r1934b271],
2	the	DT	O	the	det	4	SENT_149	[p4l1949t247r1993b271],
3	76	CD	NUMBER	76	num	4	SENT_149	[p4l2012t249r2043b271],
4	patients	NNS	O	patient	prep_of	16	SENT_149	[p4l2062t248r2178b278],
5	,	,	O	,	_	0	SENT_149	[p4l2062t248r2178b278],
6	33	CD	NUMBER	33	number	7	SENT_149	[p4l2196t249r2226b271],
7	(	CD	NUMBER	(	nsubj	16	SENT_149	[p4l2246t248r2286b275],
8	17	CD	NUMBER	17	num	9	SENT_149	[p4l2246t248r2286b275],
9	doxycycline	NN	O	doxycycline	dep	7	SENT_149	[p4l1276t282r1437b313],
10	and	CC	O	and	_	0	SENT_149	[p4l1450t282r1500b306],
11	16	CD	NUMBER	16	num	12	SENT_149	[p4l1516t284r1546b306],
12	placebo	NN	O	placebo	conj_and	7	SENT_149	[p4l1560t282r1676b313],
13	)	CD	NUMBER	)	num	14	SENT_149	[p4l1560t282r1676b313],
14	patients	NNS	O	patient	dep	12	SENT_149	[p4l1691t283r1800b313],
15	were	VBD	O	be	cop	16	SENT_149	[p4l1813t289r1880b306],
16	present	JJ	DATE	present	_	0	SENT_149	[p4l1894t286r1996b313],
17	at	IN	O	at	_	0	SENT_149	[p4l2009t286r2034b306],
18	all	DT	O	all	det	20	SENT_149	[p4l2047t282r2075b306],
19	time	NN	O	time	nn	20	SENT_149	[p4l2088t283r2150b306],
20	points	NNS	O	point	prep_at	16	SENT_149	[p4l2164t283r2255b313],
21	.	.	O	.	_	0	SENT_149	[p4l2164t283r2255b313],

1	(	NN	O	(	nn	2	SENT_150	[p4l1277t318r1310b345],
2	B	NN	O	b	_	0	SENT_150	[p4l1277t318r1310b345],
3	)	CD	NUMBER	)	num	5	SENT_150	[p4l1277t318r1310b345],
4	Trial	NN	O	trial	nn	5	SENT_150	[p4l1325t317r1381b341],
5	profile	NN	O	profile	dep	2	SENT_150	[p4l1399t317r1486b348],
6	of	IN	O	of	_	0	SENT_150	[p4l1502t317r1530b341],
7	lymphedema	NN	O	lymphedema	nn	8	SENT_150	[p4l1544t317r1723b348],
8	patients	NNS	O	patient	prep_of	5	SENT_150	[p4l1741t318r1858b348],
9	.	.	O	.	_	0	SENT_150	[p4l1741t318r1858b348],

1	Of	IN	O	of	_	0	SENT_151	[p4l1873t317r1906b341],
2	the	DT	O	the	det	4	SENT_151	[p4l1919t317r1963b341],
3	19	CD	NUMBER	19	num	4	SENT_151	[p4l1981t319r2011b341],
4	patients	NNS	O	patient	prep_of	16	SENT_151	[p4l2027t318r2144b348],
5	,	,	O	,	_	0	SENT_151	[p4l2027t318r2144b348],
6	18	CD	NUMBER	18	number	7	SENT_151	[p4l2162t319r2191b341],
7	(	CD	NUMBER	(	nsubj	16	SENT_151	[p4l2208t317r2287b348],
8	eight	CD	NUMBER	eight	num	9	SENT_151	[p4l2208t317r2287b348],
9	doxycycline	NN	O	doxycycline	dep	7	SENT_151	[p4l1276t353r1437b384],
10	and	CC	O	and	_	0	SENT_151	[p4l1450t353r1500b377],
11	ten	CD	NUMBER	ten	num	12	SENT_151	[p4l1513t357r1556b377],
12	placebo	NN	O	placebo	conj_and	7	SENT_151	[p4l1572t353r1688b384],
13	)	CD	NUMBER	)	num	14	SENT_151	[p4l1572t353r1688b384],
14	patients	NNS	O	patient	dep	12	SENT_151	[p4l1703t354r1812b384],
15	were	VBD	O	be	cop	16	SENT_151	[p4l1825t360r1892b377],
16	present	JJ	DATE	present	_	0	SENT_151	[p4l1906t357r2009b384],
17	at	IN	O	at	_	0	SENT_151	[p4l2021t357r2046b377],
18	all	DT	O	all	det	20	SENT_151	[p4l2059t353r2087b377],
19	time	NN	O	time	nn	20	SENT_151	[p4l2100t354r2162b377],
20	points	NNS	O	point	prep_at	16	SENT_151	[p4l2176t354r2267b384],
21	.	.	O	.	_	0	SENT_151	[p4l2176t354r2267b384],

1	DOI	NNP	O	DOI	_	0	SENT_152	[p4l1277t389r1334b412],
2	:	:	O	:	_	0	SENT_152	[p4l1277t389r1334b412],
3	10.1371	CD	NUMBER	10.1371	dep	1	SENT_152	[p4l1349t388r1830b419],
4	/	:	O	/	punct	6	SENT_152	[p4l1349t388r1830b419],
5	journa	NN	O	journa	nn	6	SENT_152	[p4l1349t388r1830b419],
6	|	NN	O	|	dep	3	SENT_152	[p4l1349t388r1830b419],
7	.	.	O	.	_	0	SENT_152	[p4l1349t388r1830b419],

1	ppat	NN	O	ppat	_	0	SENT_153	[p4l1349t388r1830b419],
2	.0	CD	NUMBER	.0	num	3	SENT_153	[p4l1349t388r1830b419],
3	O20092	NN	O	o20092	dep	1	SENT_153	[p4l1349t388r1830b419],
4	.	.	O	.	_	0	SENT_153	[p4l1349t388r1830b419],

1	gOO1	NN	O	goo1	_	0	SENT_154	[p4l1349t388r1830b419],

1	time	NN	O	time	nn	2	SENT_155	[p4l1278t489r1349b514],
2	points	NNS	O	point	_	0	SENT_155	[p4l1361t489r1469b523],
3	.	.	O	.	_	0	SENT_155	[p4l1361t489r1469b523],

1	In	IN	O	in	_	0	SENT_156	[p4l1481t489r1514b513],
2	all	PDT	O	all	predet	4	SENT_156	[p4l1526t488r1563b514],
3	the	DT	O	the	det	4	SENT_156	[p4l1576t488r1625b514],
4	analyses	NNS	O	analysis	prep_in	13	SENT_156	[p4l1637t488r1775b523],
5	,	,	O	,	_	0	SENT_156	[p4l1637t488r1775b523],
6	only	RB	O	only	advmod	7	SENT_156	[p4l1787t488r1856b523],
7	participants	NNS	O	participant	nsubj	13	SENT_156	[p4l1868t489r2064b523],
8	present	JJ	DATE	present	amod	7	SENT_156	[p4l2076t494r2198b523],
9	at	IN	O	at	_	0	SENT_156	[p4l2209t493r2238b514],
10	all	DT	O	all	det	12	SENT_156	[p4l2250t488r2286b514],
11	time	NN	O	time	nn	12	SENT_156	[p4l1278t535r1349b560],
12	points	NNS	O	point	prep_at	8	SENT_156	[p4l1366t535r1467b569],
13	(	VBP	O	(	_	0	SENT_156	[p4l1486t532r1532b566],
14	17	CD	NUMBER	17	num	15	SENT_156	[p4l1486t532r1532b566],
15	doxycycline	NN	O	doxycycline	nsubjpass	21	SENT_156	[p4l1550t534r1741b569],
16	and	CC	O	and	_	0	SENT_156	[p4l1759t534r1818b560],
17	16	CD	NUMBER	16	num	19	SENT_156	[p4l1838t534r1872b559],
18	placebo	NN	O	placebo	nn	19	SENT_156	[p4l1889t534r2026b569],
19	)	NN	O	)	nsubjpass	21	SENT_156	[p4l1889t534r2026b569],
20	were	VBD	O	be	auxpass	21	SENT_156	[p4l2043t543r2119b560],
21	included	VBN	O	include	ccomp	13	SENT_156	[p4l2137t534r2285b560],
22	.	.	O	.	_	0	SENT_156	[p4l2137t534r2285b560],

1	Following	VBG	O	follow	_	0	SENT_157	[p4l1276t580r1437b615],
2	doxycycline	NN	O	doxycycline	nn	3	SENT_157	[p4l1449t580r1641b615],
3	treatment	NN	O	treatment	prep_following	10	SENT_157	[p4l1655t585r1824b611],
4	,	,	O	,	_	0	SENT_157	[p4l1655t585r1824b611],
5	Wolbachia	JJ	O	wolbachia	amod	6	SENT_157	[p4l1841t580r1989b606],
6	levels	NNS	O	level	nsubjpass	10	SENT_157	[p4l2002t580r2088b606],
7	in	IN	O	in	_	0	SENT_157	[p4l2103t581r2133b605],
8	MF	NN	O	mf	prep_in	6	SENT_157	[p4l2147t581r2198b605],
9	were	VBD	O	be	auxpass	10	SENT_157	[p4l2210t589r2286b606],
10	reduced	VBN	O	reduce	_	0	SENT_157	[p4l1277t625r1408b651],
11	by	IN	O	by	_	0	SENT_157	[p4l1425t625r1461b660],
12	95	CD	PERCENT	95	number	13	SENT_157	[p4l1478t625r1546b654],
13	%	NN	PERCENT	%	amod	15	SENT_157	[p4l1478t625r1546b654],
14	(	CD	NUMBER	(	num	15	SENT_157	[p4l1568t627r1595b660],
15	[	NN	O	[	agent	10	SENT_157	[p4l1568t627r1595b660],
16	2	CD	NUMBER	2	number	17	SENT_157	[p4l1568t627r1595b660],
17	<	JJR	O	<	amod	15	SENT_157	[p4l1613t627r1638b649],
18	0.0001	CD	NUMBER	0.0001	num	19	SENT_157	[p4l1657t625r1771b657],
19	)	NN	O	)	dep	15	SENT_157	[p4l1657t625r1771b657],
20	in	IN	O	in	_	0	SENT_157	[p4l1789t626r1819b650],
21	the	DT	O	the	det	23	SENT_157	[p4l1837t625r1886b651],
22	doxycycline	NN	O	doxycycline	nn	23	SENT_157	[p4l1903t625r2094b660],
23	group	NN	O	group	prep_in	10	SENT_157	[p4l2111t634r2216b660],
24	,	,	O	,	_	0	SENT_157	[p4l2111t634r2216b660],
25	but	CC	O	but	_	0	SENT_157	[p4l2233t625r2287b651],
26	there	EX	O	there	expl	27	SENT_157	[p4l1278t671r1361b697],
27	was	VBD	O	be	conj_but	10	SENT_157	[p4l1380t680r1436b697],
28	no	DT	O	no	det	30	SENT_157	[p4l1457t680r1496b697],
29	signiﬁcant	JJ	O	signiﬁcant	amod	30	SENT_157	[p4l1516t671r1685b706],
30	change	NN	O	change	nn	40	SENT_157	[p4l1704t671r1818b706],
31	in	IN	O	in	_	0	SENT_157	[p4l1838t672r1869b696],
32	the	DT	O	the	det	34	SENT_157	[p4l1889t671r1939b697],
33	placebo	NN	O	placebo	nn	34	SENT_157	[p4l1959t671r2084b706],
34	group	NN	O	group	prep_in	30	SENT_157	[p4l2104t680r2201b706],
35	(	CD	NUMBER	(	number	36	SENT_157	[p4l2222t672r2248b706],
36	[	CD	NUMBER	[	dep	30	SENT_157	[p4l2222t672r2248b706],
37	9	CD	NUMBER	9	dep	36	SENT_157	[p4l2222t672r2248b706],
38	=	JJ	O	=	amod	40	SENT_157	[p4l2265t682r2289b691],
39	0.2588	CD	NUMBER	0.2588	tmod	38	SENT_157	[p4l1277t717r1399b749],
40	)	NN	O	)	nsubj	27	SENT_157	[p4l1277t717r1399b749],
41	.	.	O	.	_	0	SENT_157	[p4l1277t717r1399b749],

1	Microﬁlaremia	NNP	O	Microﬁlaremia	nsubj	2	SENT_158	[p4l1314t762r1557b788],
2	was	VBD	O	be	_	0	SENT_158	[p4l1574t771r1630b788],
3	only	RB	O	only	advmod	4	SENT_158	[p4l1648t762r1717b797],
4	slightly	RB	O	slightly	advmod	2	SENT_158	[p4l1735t762r1857b797],
5	,	,	O	,	_	0	SENT_158	[p4l1735t762r1857b797],
6	though	IN	O	though	dep	10	SENT_158	[p4l1878t762r1991b797],
7	not	RB	O	not	dep	10	SENT_158	[p4l2010t767r2064b788],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	10	SENT_158	[p4l2082t762r2286b797],
9	,	,	O	,	_	0	SENT_158	[p4l2082t762r2286b797],
10	reduced	VBD	O	reduce	advcl	2	SENT_158	[p4l1277t808r1408b834],
11	4	CD	DURATION	4	num	12	SENT_158	[p4l1435t809r1452b833],
12	mo	NN	DURATION	mo	dobj	10	SENT_158	[p4l1478t817r1528b834],
13	after	IN	O	after	_	0	SENT_158	[p4l1555t808r1632b834],
14	doxycycline	NN	O	doxycycline	nn	15	SENT_158	[p4l1658t808r1849b843],
15	treatment	NN	O	treatment	prep_after	10	SENT_158	[p4l1877t813r2038b834],
16	compared	VBN	O	compare	_	0	SENT_158	[p4l2064t808r2228b843],
17	to	TO	O	to	prepc_compared_to	10	SENT_158	[p4l2256t814r2286b834],
18	pretreatment	NN	O	pretreatment	nn	19	SENT_158	[p4l1277t859r1495b889],
19	levels	NNS	O	level	pobj	10	SENT_158	[p4l1517t854r1603b880],
20	in	IN	O	in	_	0	SENT_158	[p4l1626t855r1656b879],
21	the	DT	O	the	det	25	SENT_158	[p4l1679t854r1728b880],
22	doxycycline	NN	O	doxycycline	nn	25	SENT_158	[p4l1750t854r1941b889],
23	group	NN	O	group	nn	25	SENT_158	[p4l1964t863r2060b889],
24	(	CD	NUMBER	(	num	25	SENT_158	[p4l2083t856r2110b889],
25	[	NN	O	[	prep_in	19	SENT_158	[p4l2083t856r2110b889],
26	2	CD	NUMBER	2	number	27	SENT_158	[p4l2083t856r2110b889],
27	=	JJ	O	=	amod	25	SENT_158	[p4l2128t865r2153b874],
28	0.2741	CD	NUMBER	0.2741	number	29	SENT_158	[p4l2172t852r2286b886],
29	)	CD	NUMBER	)	num	25	SENT_158	[p4l2172t852r2286b886],
30	whereas	IN	O	whereas	mark	35	SENT_158	[p4l1276t899r1406b925],
31	microﬁlaria	NN	O	microﬁlaria	nn	32	SENT_158	[p4l1432t899r1624b925],
32	levels	NNS	O	level	nsubj	35	SENT_158	[p4l1650t899r1736b925],
33	had	VBD	O	have	aux	35	SENT_158	[p4l1762t899r1821b925],
34	actually	RB	O	actually	advmod	35	SENT_158	[p4l1848t899r1972b934],
35	increased	VBN	O	increase	dep	25	SENT_158	[p4l1999t899r2153b925],
36	in	IN	O	in	_	0	SENT_158	[p4l2179t900r2210b924],
37	the	DT	O	the	det	41	SENT_158	[p4l2237t899r2286b925],
38	placebo	NN	O	placebo	nn	41	SENT_158	[p4l1277t945r1402b980],
39	group	NN	O	group	nn	41	SENT_158	[p4l1423t954r1519b980],
40	(	CD	NUMBER	(	num	41	SENT_158	[p4l1541t947r1568b980],
41	[	NN	O	[	prep_in	35	SENT_158	[p4l1541t947r1568b980],
42	7	CD	NUMBER	7	num	45	SENT_158	[p4l1541t947r1568b980],
43	=	JJ	O	=	amod	45	SENT_158	[p4l1585t956r1610b965],
44	0.0017	CD	NUMBER	0.0017	tmod	43	SENT_158	[p4l1628t943r1749b977],
45	)	NN	O	)	nsubj	10	SENT_158	[p4l1628t943r1749b977],
46	.	.	O	.	_	0	SENT_158	[p4l1628t943r1749b977],

1	Both	DT	O	both	preconj	5	SENT_159	[p4l1770t945r1848b971],
2	doxycycline	NN	O	doxycycline	nn	5	SENT_159	[p4l1868t945r2060b980],
3	and	CC	O	and	_	0	SENT_159	[p4l2081t945r2140b971],
4	placebo	NN	O	placebo	conj_and	2	SENT_159	[p4l2161t945r2286b980],
5	patients	NNS	O	patient	nsubjpass	7	SENT_159	[p4l1277t992r1406b1026],
6	were	VBD	O	be	auxpass	7	SENT_159	[p4l1425t1000r1501b1017],
7	given	VBN	O	give	_	0	SENT_159	[p4l1519t992r1605b1026],
8	albendazole	NN	O	albendazole	dobj	7	SENT_159	[p4l1624t991r1816b1017],
9	and	CC	O	and	_	0	SENT_159	[p4l1835t991r1894b1017],
10	ivermectin	NN	O	ivermectin	dobj	7	SENT_159	[p4l1913t992r2087b1017],
11	after	IN	O	after	_	0	SENT_159	[p4l2106t991r2183b1017],
12	the	DT	DURATION	the	det	15	SENT_159	[p4l2202t991r2251b1017],
13	4	CD	DURATION	4	num	15	SENT_159	[p4l2269t992r2287b1016],
14	mo	NN	DURATION	mo	nn	15	SENT_159	[p4l1277t1045r1326b1062],
15	re-examination	NN	O	re-examination	prep_after	7	SENT_159	[p4l1347t1037r1598b1062],
16	to	TO	O	to	_	0	SENT_159	[p4l1619t1042r1649b1062],
17	clear	JJ	O	clear	amod	18	SENT_159	[p4l1669t1036r1748b1062],
18	microﬁlaremia	NN	O	microﬁlaremia	prep_to	7	SENT_159	[p4l1767t1036r2016b1062],
19	.	.	O	.	_	0	SENT_159	[p4l1767t1036r2016b1062],

1	At	IN	O	at	_	0	SENT_160	[p4l2035t1036r2074b1062],
2	12	CD	DURATION	12	num	5	SENT_160	[p4l2096t1036r2128b1063],
3	mo	NN	DURATION	mo	nn	5	SENT_160	[p4l2149t1045r2198b1062],
4	post	NN	O	post	nn	5	SENT_160	[p4l2219t1042r2287b1071],
5	therapy	NN	O	therapy	prep_at	10	SENT_160	[p4l1278t1082r1409b1117],
6	,	,	O	,	_	0	SENT_160	[p4l1278t1082r1409b1117],
7	microﬁlaremia	NN	O	microﬁlaremia	nsubj	10	SENT_160	[p4l1429t1082r1671b1108],
8	was	VBD	O	be	cop	10	SENT_160	[p4l1689t1091r1745b1108],
9	virtually	RB	O	virtually	advmod	10	SENT_160	[p4l1764t1082r1899b1117],
10	absent	JJ	O	absent	_	0	SENT_160	[p4l1918t1082r2022b1108],
11	in	IN	O	in	_	0	SENT_160	[p4l2042t1083r2073b1107],
12	the	DT	O	the	det	14	SENT_160	[p4l2093t1082r2142b1108],
13	doxycycline	NN	O	doxycycline	nn	14	SENT_160	[p4l2162t1082r2285b1117, p4l1277t1128r1354b1154],
14	group	NN	O	group	prep_in	10	SENT_160	[p4l1367t1137r1464b1163],
15	except	IN	O	except	dep	10	SENT_160	[p4l1478t1133r1585b1163],
16	in	IN	O	in	_	0	SENT_160	[p4l1599t1129r1629b1153],
17	one	CD	NUMBER	one	prep_in	10	SENT_160	[p4l1644t1137r1702b1154],
18	of	IN	O	of	_	0	SENT_160	[p4l1716t1128r1751b1154],
19	the	DT	O	the	det	21	SENT_160	[p4l1763t1128r1812b1154],
20	17	CD	NUMBER	17	num	21	SENT_160	[p4l1829t1126r1862b1153],
21	(	NN	O	(	prep_of	17	SENT_160	[p4l1877t1128r1952b1160],
22	6	CD	PERCENT	6	number	23	SENT_160	[p4l1877t1128r1952b1160],
23	%	NN	PERCENT	%	amod	21	SENT_160	[p4l1877t1128r1952b1160],
24	)	CD	NUMBER	)	num	25	SENT_160	[p4l1877t1128r1952b1160],
25	patients	NNS	O	patient	tmod	21	SENT_160	[p4l1966t1129r2104b1163],
26	,	,	O	,	_	0	SENT_160	[p4l1966t1129r2104b1163],
27	who	WP	O	who	nsubj	28	SENT_160	[p4l2118t1128r2184b1154],
28	had	VBD	O	have	rcmod	25	SENT_160	[p4l2198t1128r2257b1154],
29	a	DT	O	a	det	33	SENT_160	[p4l2271t1137r2287b1154],
30	very	RB	O	very	advmod	31	SENT_160	[p4l1276t1183r1344b1209],
31	low	JJ	O	low	amod	33	SENT_160	[p4l1357t1174r1412b1200],
32	MF	NN	O	mf	nn	33	SENT_160	[p4l1426t1175r1476b1199],
33	count	NN	O	count	dobj	28	SENT_160	[p4l1490t1179r1590b1200],
34	.	.	O	.	_	0	SENT_160	[p4l1490t1179r1590b1200],

1	At	IN	O	at	_	0	SENT_161	[p4l1604t1175r1643b1200],
2	24-mo	JJ	DURATION	24-mo	amod	3	SENT_161	[p4l1657t1174r1758b1201],
3	follow-up	NN	O	follow-up	prep_at	13	SENT_161	[p4l1772t1174r1935b1209],
4	,	,	O	,	_	0	SENT_161	[p4l1772t1174r1935b1209],
5	18	CD	PERCENT	18	num	6	SENT_161	[p4l1953t1174r2019b1203],
6	%	NN	PERCENT	%	nsubj	13	SENT_161	[p4l1953t1174r2019b1203],
7	of	IN	O	of	_	0	SENT_161	[p4l2037t1174r2072b1200],
8	doxycyclinetreated	JJ	O	doxycyclinetreated	amod	9	SENT_161	[p4l2082t1174r2285b1209, p4l1278t1219r1393b1245],
9	patients	NNS	O	patient	prep_of	6	SENT_161	[p4l1411t1220r1541b1254],
10	that	WDT	O	that	nsubjpass	12	SENT_161	[p4l1560t1219r1623b1245],
11	were	VBD	O	be	auxpass	12	SENT_161	[p4l1641t1228r1717b1245],
12	re-examined	VBN	O	re-examine	rcmod	9	SENT_161	[p4l1736t1219r1941b1245],
13	had	VBD	O	have	_	0	SENT_161	[p4l1959t1219r2018b1245],
14	microﬁlaremia	NN	O	microﬁlaremia	dobj	13	SENT_161	[p4l2036t1219r2285b1245],
15	.	.	O	.	_	0	SENT_161	[p4l2036t1219r2285b1245],

1	In	IN	O	in	_	0	SENT_162	[p4l1276t1266r1309b1290],
2	contrast	NN	O	contrast	prep_in	10	SENT_162	[p4l1325t1270r1466b1296],
3	,	,	O	,	_	0	SENT_162	[p4l1325t1270r1466b1296],
4	50	CD	PERCENT	50	num	5	SENT_162	[p4l1484t1265r1551b1294],
5	%	NN	PERCENT	%	nsubj	10	SENT_162	[p4l1484t1265r1551b1294],
6	of	IN	O	of	_	0	SENT_162	[p4l1572t1265r1606b1291],
7	placebo	NN	O	placebo	nn	8	SENT_162	[p4l1619t1265r1744b1300],
8	patients	NNS	O	patient	prep_of	5	SENT_162	[p4l1761t1266r1890b1300],
9	became	VBD	O	become	cop	10	SENT_162	[p4l1906t1265r2029b1291],
10	microﬁlaremic	JJ	O	microﬁlaremic	_	0	SENT_162	[p4l2046t1265r2285b1291],
11	at	IN	O	at	_	0	SENT_162	[p4l1277t1316r1306b1337],
12	12	CD	DURATION	12	num	13	SENT_162	[p4l1325t1311r1358b1338],
13	mo	NN	DURATION	mo	prep_at	10	SENT_162	[p4l1376t1320r1434b1342],
14	,	,	O	,	_	0	SENT_162	[p4l1376t1320r1434b1342],
15	and	CC	O	and	_	0	SENT_162	[p4l1452t1311r1511b1337],
16	the	DT	O	the	det	17	SENT_162	[p4l1529t1311r1578b1337],
17	number	NN	O	number	nsubj	18	SENT_162	[p4l1595t1311r1724b1337],
18	increased	VBN	O	increase	conj_and	10	SENT_162	[p4l1740t1311r1894b1337],
19	to	TO	O	to	_	0	SENT_162	[p4l1912t1316r1942b1337],
20	63	CD	PERCENT	63	num	21	SENT_162	[p4l1961t1311r2028b1340],
21	%	NN	PERCENT	%	prep_to	18	SENT_162	[p4l1961t1311r2028b1340],
22	at	IN	O	at	_	0	SENT_162	[p4l2050t1317r2079b1337],
23	24	CD	NUMBER	24	num	24	SENT_162	[p4l2096t1311r2132b1338],
24	mo.	NN	O	mo.	prep_at	21	SENT_162	[p4l2149t1320r2206b1337],
25	.	.	O	.	_	0	SENT_162	[p4l2149t1320r2206b1337],

1	The	DT	O	the	det	2	SENT_163	[p4l2224t1311r2286b1337],
2	reduction	NN	O	reduction	nsubj	20	SENT_163	[p4l1277t1356r1436b1382],
3	of	IN	O	of	_	0	SENT_163	[p4l1462t1356r1496b1382],
4	MF	NN	O	mf	prep_of	2	SENT_163	[p4l1518t1357r1569b1381],
5	in	IN	O	in	_	0	SENT_163	[p4l1595t1357r1625b1381],
6	the	DT	O	the	det	8	SENT_163	[p4l1652t1356r1701b1382],
7	doxycycline	NN	O	doxycycline	nn	8	SENT_163	[p4l1726t1356r1918b1391],
8	group	NN	O	group	prep_in	4	SENT_163	[p4l1943t1365r2039b1391],
9	compared	VBN	O	compare	_	0	SENT_163	[p4l2065t1356r2229b1391],
10	to	TO	O	to	prepc_compared_to	8	SENT_163	[p4l2256t1362r2286b1382],
11	placebo	NN	O	placebo	nn	12	SENT_163	[p4l1277t1402r1402b1437],
12	group	NN	O	group	pobj	8	SENT_163	[p4l1414t1411r1511b1437],
13	was	VBD	O	be	cop	20	SENT_163	[p4l1522t1411r1578b1428],
14	signiﬁcant	JJ	O	signiﬁcant	amod	20	SENT_163	[p4l1590t1402r1759b1437],
15	at	IN	O	at	_	0	SENT_163	[p4l1770t1407r1799b1428],
16	the	DT	DURATION	the	det	18	SENT_163	[p4l1812t1402r1861b1428],
17	12	CD	DURATION	12	num	18	SENT_163	[p4l1876t1402r1909b1429],
18	mo	NN	DURATION	mo	prep_at	14	SENT_163	[p4l1922t1411r1971b1428],
19	(	CD	NUMBER	(	num	18	SENT_163	[p4l1984t1404r2044b1437],
20	[	NN	O	[	_	0	SENT_163	[p4l1984t1404r2044b1437],
21	2	CD	NUMBER	2	dep	20	SENT_163	[p4l1984t1404r2044b1437],
22	:	:	O	:	_	0	SENT_163	[p4l1984t1404r2044b1437],
23	0.0029	CD	NUMBER	0.0029	num	24	SENT_163	[p4l2053t1402r2167b1434],
24	)	NN	O	)	conj_and	20	SENT_163	[p4l2053t1402r2167b1434],
25	and	CC	O	and	_	0	SENT_163	[p4l2179t1402r2238b1428],
26	24	CD	DURATION	24	num	27	SENT_163	[p4l2251t1402r2287b1429],
27	mo	NN	DURATION	mo	conj_and	20	SENT_163	[p4l1277t1457r1326b1474],
28	(	CD	NUMBER	(	num	29	SENT_163	[p4l1342t1450r1369b1483],
29	[	NN	O	[	npadvmod	34	SENT_163	[p4l1342t1450r1369b1483],
30	2	CD	NUMBER	2	number	31	SENT_163	[p4l1342t1450r1369b1483],
31	=	JJ	O	=	amod	29	SENT_163	[p4l1380t1459r1405b1468],
32	0.0211	CD	NUMBER	0.0211	number	33	SENT_163	[p4l1417t1448r1531b1480],
33	)	CD	NUMBER	)	num	29	SENT_163	[p4l1417t1448r1531b1480],
34	follow-up	JJ	O	follow-up	amod	36	SENT_163	[p4l1546t1448r1700b1483],
35	time	NN	O	time	nn	36	SENT_163	[p4l1717t1449r1788b1474],
36	points	NNS	O	point	dep	27	SENT_163	[p4l1803t1449r1911b1483],
37	.	.	O	.	_	0	SENT_163	[p4l1803t1449r1911b1483],

1	It	PRP	O	it	nsubjpass	4	SENT_164	[p4l1926t1449r1951b1474],
2	must	MD	O	must	aux	4	SENT_164	[p4l1966t1454r2044b1474],
3	be	VB	O	be	auxpass	4	SENT_164	[p4l2057t1448r2094b1474],
4	mentioned	VBN	O	mention	_	0	SENT_164	[p4l2110t1448r2286b1474],
5	that	IN	O	that	complm	8	SENT_164	[p4l1278t1493r1341b1519],
6	all	DT	O	all	det	7	SENT_164	[p4l1352t1493r1388b1519],
7	patients	NNS	O	patient	nsubj	8	SENT_164	[p4l1401t1494r1530b1528],
8	continued	VBD	O	continue	ccomp	4	SENT_164	[p4l1542t1493r1708b1519],
9	to	TO	O	to	aux	10	SENT_164	[p4l1721t1498r1751b1519],
10	live	VB	O	live	xcomp	8	SENT_164	[p4l1763t1493r1818b1519],
11	in	IN	O	in	_	0	SENT_164	[p4l1831t1494r1861b1518],
12	the	DT	O	the	det	14	SENT_164	[p4l1874t1493r1923b1519],
13	endemic	JJ	O	endemic	amod	14	SENT_164	[p4l1935t1493r2072b1519],
14	area	NN	O	area	prep_in	10	SENT_164	[p4l2085t1502r2161b1523],
15	;	:	O	;	_	0	SENT_164	[p4l2085t1502r2161b1523],
16	given	VBN	O	give	prep	35	SENT_164	[p4l2173t1494r2259b1528],
17	a	DT	O	a	det	20	SENT_164	[p4l2271t1502r2287b1519],
18	5-y	JJ	O	5-y	amod	20	SENT_164	[p4l1278t1539r1324b1574],
19	average	JJ	O	average	amod	20	SENT_164	[p4l1336t1548r1458b1574],
20	life-span	NN	O	life-span	dep	16	SENT_164	[p4l1470t1539r1610b1574],
21	of	IN	O	of	_	0	SENT_164	[p4l1622t1539r1657b1565],
22	adult	JJ	O	adult	amod	23	SENT_164	[p4l1666t1539r1748b1565],
23	worms	NNS	O	worm	prep_of	20	SENT_164	[p4l1759t1548r1865b1565],
24	and	CC	O	and	_	0	SENT_164	[p4l1878t1539r1937b1565],
25	constant	JJ	O	constant	amod	27	SENT_164	[p4l1949t1544r2088b1565],
26	worm	NN	O	worm	nn	27	SENT_164	[p4l2099t1548r2192b1565],
27	loads	NNS	O	load	conj_and	20	SENT_164	[p4l2204t1539r2286b1565],
28	without	IN	O	without	_	0	SENT_164	[p4l1276t1585r1402b1611],
29	treatment	NN	O	treatment	nn	30	SENT_164	[p4l1418t1590r1579b1611],
30	interference	NN	O	interference	prep_without	27	SENT_164	[p4l1594t1585r1803b1616],
31	,	,	O	,	_	0	SENT_164	[p4l1594t1585r1803b1616],
32	new	JJ	O	new	amod	33	SENT_164	[p4l1820t1594r1883b1611],
33	infections	NNS	O	infection	nsubjpass	35	SENT_164	[p4l1899t1585r2059b1611],
34	are	VBP	O	be	auxpass	35	SENT_164	[p4l2075t1594r2125b1611],
35	expected	VBN	O	expect	parataxis	4	SENT_164	[p4l2140t1585r2286b1620],
36	to	TO	O	to	aux	37	SENT_164	[p4l1278t1635r1308b1656],
37	occur	VB	O	occur	xcomp	35	SENT_164	[p4l1323t1639r1415b1656],
38	at	IN	O	at	_	0	SENT_164	[p4l1429t1635r1458b1656],
39	a	DT	O	a	det	40	SENT_164	[p4l1473t1639r1489b1656],
40	rate	NN	O	rate	prep_at	37	SENT_164	[p4l1504t1636r1567b1656],
41	of	IN	O	of	_	0	SENT_164	[p4l1582t1630r1617b1656],
42	about	RB	O	about	quantmod	43	SENT_164	[p4l1629t1630r1721b1656],
43	20	CD	PERCENT	20	num	44	SENT_164	[p4l1736t1630r1804b1659],
44	%	NN	PERCENT	%	prep_of	40	SENT_164	[p4l1736t1630r1804b1659],
45	per	IN	O	per	_	0	SENT_164	[p4l1824t1639r1878b1665],
46	year	NN	DURATION	year	prep_per	44	SENT_164	[p4l1891t1639r1967b1665],
47	.	.	O	.	_	0	SENT_164	[p4l1891t1639r1967b1665],

1	Measurement	NN	O	measurement	nsubjpass	31	SENT_165	[p4l1277t1707r1514b1736],
2	of	IN	O	of	_	0	SENT_165	[p4l1530t1705r1565b1736],
3	Adult	NN	O	adult	nn	5	SENT_165	[p4l1579t1705r1672b1736],
4	Worm	NN	O	worm	nn	5	SENT_165	[p4l1687t1707r1790b1736],
5	Vitality	NN	O	vitality	prep_of	1	SENT_165	[p4l1807t1705r1926b1744],
6	in	IN	O	in	_	0	SENT_165	[p4l1942t1706r1970b1735],
7	Microﬁlaremic	JJ	O	microﬁlaremic	amod	8	SENT_165	[p4l1988t1705r2231b1736],
8	Patients	NNS	O	patient	prep_in	5	SENT_165	[p4l1278t1755r1413b1785],
9	Circulating	VBG	O	circulate	partmod	8	SENT_165	[p4l1314t1805r1498b1840],
10	ﬁlarial	JJ	O	ﬁlarial	amod	15	SENT_165	[p4l1522t1805r1626b1831],
11	antigen	NN	O	antigen	nn	15	SENT_165	[p4l1651t1806r1772b1840],
12	(	CD	NUMBER	(	num	15	SENT_165	[p4l1798t1805r1890b1837],
13	CFA	NNP	O	CFA	nn	15	SENT_165	[p4l1798t1805r1890b1837],
14	)	NN	O	)	nn	15	SENT_165	[p4l1798t1805r1890b1837],
15	levels	NNS	O	level	dep	9	SENT_165	[p4l1915t1805r2001b1831],
16	in	IN	O	in	dep	15	SENT_165	[p4l2026t1806r2057b1830],
17	plasma	NN	O	plasma	pobj	16	SENT_165	[p4l2082t1805r2202b1840],
18	,	,	O	,	_	0	SENT_165	[p4l2082t1805r2202b1840],
19	and	CC	O	and	_	0	SENT_165	[p4l2227t1805r2286b1831],
20	presence	NN	O	presence	nsubjpass	31	SENT_165	[p4l1277t1860r1421b1886],
21	or	CC	O	or	_	0	SENT_165	[p4l1439t1860r1474b1877],
22	absence	NN	O	absence	conj_or	20	SENT_165	[p4l1491t1851r1618b1877],
23	of	IN	O	of	_	0	SENT_165	[p4l1636t1851r1671b1877],
24	worm	NN	O	worm	nn	25	SENT_165	[p4l1685t1860r1778b1877],
25	nests	NNS	O	nest	prep_of	20	SENT_165	[p4l1796t1856r1874b1877],
26	in	IN	O	in	_	0	SENT_165	[p4l1893t1852r1923b1876],
27	ultrasound	NN	O	ultrasound	nn	28	SENT_165	[p4l1941t1851r2118b1877],
28	examinations	NNS	O	examination	prep_in	25	SENT_165	[p4l2136t1852r2286b1877, p4l1278t1897r1368b1927],
29	,	,	O	,	_	0	SENT_165	[p4l2136t1852r2286b1877, p4l1278t1897r1368b1927],
30	were	VBD	O	be	auxpass	31	SENT_165	[p4l1398t1905r1477b1922],
31	used	VBN	O	use	_	0	SENT_165	[p4l1506t1896r1582b1922],
32	to	TO	O	to	aux	33	SENT_165	[p4l1613t1901r1644b1922],
33	assess	VB	O	assess	xcomp	31	SENT_165	[p4l1674t1905r1768b1922],
34	macroﬁlaricidal	JJ	O	macroﬁlaricidal	amod	35	SENT_165	[p4l1799t1896r2071b1922],
35	activity	NN	O	activity	dobj	33	SENT_165	[p4l2101t1897r2225b1931],
36	of	IN	O	of	_	0	SENT_165	[p4l2254t1896r2289b1922],
37	doxycycline	NN	O	doxycycline	prep_of	35	SENT_165	[p4l1277t1942r1476b1977],
38	.	.	O	.	_	0	SENT_165	[p4l1277t1942r1476b1977],

1	CFA	NNP	O	CFA	nsubj	4	SENT_166	[p4l1500t1942r1571b1968],
2	did	VBD	O	do	aux	4	SENT_166	[p4l1594t1942r1645b1968],
3	not	RB	O	not	neg	4	SENT_166	[p4l1669t1947r1723b1968],
4	differ	VB	O	differ	conj_and	4	SENT_166	[p4l1746t1942r1837b1968],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	4	SENT_166	[p4l1859t1942r2055b1977],
6	between	IN	O	between	_	0	SENT_166	[p4l2078t1942r2213b1968],
7	the	DT	O	the	det	9	SENT_166	[p4l2237t1942r2286b1968],
8	two	CD	NUMBER	two	num	9	SENT_166	[p4l1278t1993r1333b2014],
9	groups	NNS	O	group	prep_between	4	SENT_166	[p4l1350t1997r1460b2023],
10	before	IN	O	before	_	0	SENT_166	[p4l1476t1988r1581b2014],
11	and	CC	O	and	_	0	SENT_166	[p4l1597t1988r1656b2014],
12	at	IN	O	at	_	0	SENT_166	[p4l1673t1993r1702b2014],
13	12	CD	DURATION	12	num	14	SENT_166	[p4l1720t1988r1753b2015],
14	mo	NN	DURATION	mo	prep_before	4	SENT_166	[p4l1770t1997r1819b2014],
15	after	IN	O	after	_	0	SENT_166	[p4l1836t1988r1913b2014],
16	treatment	NN	O	treatment	prep_after	14	SENT_166	[p4l1929t1993r2090b2014],
17	(	CD	NUMBER	(	num	16	SENT_166	[p4l2107t1989r2133b2023],
18	[	CD	NUMBER	[	number	19	SENT_166	[p4l2107t1989r2133b2023],
19	9	CD	NUMBER	9	dep	14	SENT_166	[p4l2107t1989r2133b2023],
20	=	JJ	O	=	amod	21	SENT_166	[p4l2145t1999r2170b2008],
21	0.5718	CD	NUMBER	0.5718	dep	19	SENT_166	[p4l2184t1986r2286b2014],
22	and	CC	O	and	_	0	SENT_166	[p4l1277t2033r1336b2059],
23	[	CD	NUMBER	[	number	24	SENT_166	[p4l1345t2036r1364b2068],
24	9	CD	NUMBER	9	conj_and	19	SENT_166	[p4l1345t2036r1364b2068],
25	=	JJ	O	=	amod	26	SENT_166	[p4l1373t2044r1398b2053],
26	0.1748	CD	NUMBER	0.1748	dep	24	SENT_166	[p4l1408t2031r1519b2064],
27	,	,	O	,	_	0	SENT_166	[p4l1408t2031r1519b2064],
28	respectively	RB	O	respectively	advmod	14	SENT_166	[p4l1533t2033r1743b2068],
29	)	CD	NUMBER	)	dep	14	SENT_166	[p4l1533t2033r1743b2068],
30	.	.	O	.	_	0	SENT_166	[p4l1533t2033r1743b2068],

1	However	RB	O	however	advmod	6	SENT_167	[p4l1756t2034r1909b2064],
2	,	,	O	,	_	0	SENT_167	[p4l1756t2034r1909b2064],
3	the	DT	O	the	det	4	SENT_167	[p4l1923t2033r1972b2059],
4	difference	NN	O	difference	nsubj	6	SENT_167	[p4l1985t2033r2151b2059],
5	became	VBD	O	become	cop	6	SENT_167	[p4l2163t2033r2286b2059],
6	signiﬁcant	NN	O	signiﬁcant	_	0	SENT_167	[p4l1277t2079r1445b2114],
7	at	IN	O	at	_	0	SENT_167	[p4l1463t2084r1492b2105],
8	24	CD	DURATION	24	num	11	SENT_167	[p4l1510t2079r1546b2106],
9	mo	NN	DURATION	mo	nn	11	SENT_167	[p4l1563t2088r1612b2105],
10	post	NN	O	post	nn	11	SENT_167	[p4l1631t2084r1699b2114],
11	therapy	NN	O	therapy	prep_at	6	SENT_167	[p4l1717t2079r1840b2114],
12	(	NN	O	(	nn	14	SENT_167	[p4l1859t2080r1885b2114],
13	1	CD	NUMBER	1	num	14	SENT_167	[p4l1859t2080r1885b2114],
14	)	NN	O	)	dep	11	SENT_167	[p4l1859t2080r1885b2114],
15	=	JJ	O	=	amod	17	SENT_167	[p4l1899t2090r1924b2099],
16	0.0382	CD	NUMBER	0.0382	tmod	15	SENT_167	[p4l1939t2079r2061b2111],
17	)	NN	O	)	dep	14	SENT_167	[p4l1939t2079r2061b2111],
18	,	,	O	,	_	0	SENT_167	[p4l1939t2079r2061b2111],
19	with	IN	O	with	_	0	SENT_167	[p4l2078t2079r2148b2105],
20	median	JJ	O	median	amod	22	SENT_167	[p4l2166t2079r2286b2105],
21	CFA	NN	O	cfa	nn	22	SENT_167	[p4l1277t2125r1348b2151],
22	levels	NNS	O	level	nsubj	30	SENT_167	[p4l1374t2125r1460b2151],
23	in	IN	O	in	_	0	SENT_167	[p4l1488t2126r1518b2150],
24	the	DT	O	the	det	26	SENT_167	[p4l1546t2125r1595b2151],
25	doxycycline	NN	O	doxycycline	nn	26	SENT_167	[p4l1622t2125r1813b2160],
26	group	NN	O	group	prep_in	22	SENT_167	[p4l1840t2134r1937b2160],
27	being	VBG	O	be	cop	30	SENT_167	[p4l1963t2125r2054b2160],
28	only	RB	O	only	quantmod	29	SENT_167	[p4l2080t2125r2148b2160],
29	6	CD	PERCENT	6	num	30	SENT_167	[p4l2176t2125r2224b2154],
30	%	NN	PERCENT	%	prepc_with	6	SENT_167	[p4l2176t2125r2224b2154],
31	of	IN	O	of	_	0	SENT_167	[p4l2255t2125r2290b2151],
32	pretreatment	NN	O	pretreatment	nn	34	SENT_167	[p4l1277t2176r1495b2206],
33	(	CD	NUMBER	(	num	34	SENT_167	[p4l1510t2171r1610b2203],
34	Table	NNP	O	Table	prep_of	30	SENT_167	[p4l1510t2171r1610b2203],
35	1	CD	NUMBER	1	number	36	SENT_167	[p4l1627t2171r1660b2203],
36	)	CD	NUMBER	)	num	34	SENT_167	[p4l1627t2171r1660b2203],
37	.	.	O	.	_	0	SENT_167	[p4l1627t2171r1660b2203],

1	Before	IN	O	before	_	0	SENT_168	[p4l1674t2171r1782b2197],
2	doxycycline	NN	O	doxycycline	nn	3	SENT_168	[p4l1796t2171r1987b2206],
3	treatment	NN	O	treatment	prep_before	16	SENT_168	[p4l2002t2176r2171b2202],
4	,	,	O	,	_	0	SENT_168	[p4l2002t2176r2171b2202],
5	all	PDT	O	all	predet	6	SENT_168	[p4l2186t2171r2222b2197],
6	the	DT	O	the	nsubj	16	SENT_168	[p4l2237t2171r2286b2197],
7	33	CD	NUMBER	33	num	8	SENT_168	[p4l1277t2216r1313b2241],
8	(	NN	O	(	dep	6	SENT_168	[p4l1328t2214r1374b2248],
9	17	CD	NUMBER	17	num	10	SENT_168	[p4l1328t2214r1374b2248],
10	doxycycline	NN	O	doxycycline	dep	6	SENT_168	[p4l1388t2216r1580b2251],
11	and	CC	O	and	_	0	SENT_168	[p4l1594t2216r1653b2242],
12	16	CD	NUMBER	16	num	15	SENT_168	[p4l1670t2216r1704b2241],
13	placebo	NN	O	placebo	nn	15	SENT_168	[p4l1717t2216r1854b2251],
14	)	CD	NUMBER	)	num	15	SENT_168	[p4l1717t2216r1854b2251],
15	patients	NNS	O	patient	dep	6	SENT_168	[p4l1869t2217r1998b2251],
16	had	VBD	O	have	_	0	SENT_168	[p4l2012t2216r2071b2242],
17	antigenemia	NN	O	antigenemia	nn	18	SENT_168	[p4l2085t2217r2287b2251],
18	levels	NNS	O	level	dobj	16	SENT_168	[p4l1276t2262r1363b2288],
19	higher	JJR	O	higher	advmod	16	SENT_168	[p4l1378t2262r1484b2297],
20	than	IN	O	than	_	0	SENT_168	[p4l1499t2262r1570b2288],
21	32,000	CD	NUMBER	32,000	num	22	SENT_168	[p4l1585t2262r1687b2293],
22	units	NNS	O	unit	prep_than	16	SENT_168	[p4l1703t2263r1782b2288],
23	(	CD	NUMBER	(	dep	22	SENT_168	[p4l1799t2262r1925b2297],
24	highest	JJS	O	highest	dep	23	SENT_168	[p4l1799t2262r1925b2297],
25	titer	NN	O	titer	dep	23	SENT_168	[p4l1941t2263r2010b2288],
26	ranking	JJ	O	ranking	amod	25	SENT_168	[p4l2025t2262r2150b2297],
27	according	VBG	O	accord	_	0	SENT_168	[p4l2165t2262r2286b2288, p4l1277t2309r1327b2343],
28	to	TO	O	to	prepc_according_to	16	SENT_168	[p4l1342t2313r1371b2334],
29	the	DT	O	the	det	30	SENT_168	[p4l1388t2308r1437b2334],
30	manufacturer	NN	O	manufacturer	pobj	16	SENT_168	[p4l1452t2308r1684b2339],
31	,	,	O	,	_	0	SENT_168	[p4l1452t2308r1684b2339],
32	TropBio	NNP	O	TropBio	appos	30	SENT_168	[p4l1699t2309r1856b2343],
33	)	CD	NUMBER	)	num	32	SENT_168	[p4l1699t2309r1856b2343],
34	.	.	O	.	_	0	SENT_168	[p4l1699t2309r1856b2343],

1	However	RB	O	however	advmod	16	SENT_169	[p4l1871t2309r2023b2339],
2	,	,	O	,	_	0	SENT_169	[p4l1871t2309r2023b2339],
3	5/17	CD	PERCENT	5/17	nsubj	16	SENT_169	[p4l2039t2306r2102b2334],
4	(	CD	PERCENT	(	num	6	SENT_169	[p4l2118t2308r2212b2340],
5	29	CD	PERCENT	29	num	6	SENT_169	[p4l2118t2308r2212b2340],
6	%	NN	PERCENT	%	dep	3	SENT_169	[p4l2118t2308r2212b2340],
7	)	CD	NUMBER	)	number	11	SENT_169	[p4l2118t2308r2212b2340],
8	and	CC	O	and	_	0	SENT_169	[p4l2227t2308r2286b2334],
9	11/17	CD	PERCENT	11/17	num	12	SENT_169	[p4l1279t2352r1360b2380],
10	(	CD	PERCENT	(	number	11	SENT_169	[p4l1381t2354r1475b2386],
11	65	CD	PERCENT	65	num	12	SENT_169	[p4l1381t2354r1475b2386],
12	%	NN	PERCENT	%	dep	3	SENT_169	[p4l1381t2354r1475b2386],
13	)	CD	NUMBER	)	num	15	SENT_169	[p4l1381t2354r1475b2386],
14	doxycycline-treated	JJ	O	doxycycline-treated	amod	15	SENT_169	[p4l1495t2354r1818b2389],
15	patients	NNS	O	patient	dep	12	SENT_169	[p4l1838t2355r1967b2389],
16	had	VBD	O	have	_	0	SENT_169	[p4l1987t2354r2046b2380],
17	antigen	NN	O	antigen	nn	18	SENT_169	[p4l2066t2355r2187b2389],
18	units	NNS	O	unit	dep	19	SENT_169	[p4l2206t2355r2286b2380],
19	lower	JJR	O	lower	dobj	16	SENT_169	[p4l1276t2399r1367b2425],
20	than	IN	O	than	_	0	SENT_169	[p4l1386t2399r1457b2425],
21	the	DT	O	the	det	23	SENT_169	[p4l1478t2399r1527b2425],
22	32,000	CD	NUMBER	32,000	num	23	SENT_169	[p4l1547t2399r1649b2430],
23	units	NNS	O	unit	prep_than	16	SENT_169	[p4l1669t2400r1749b2425],
24	at	IN	O	at	_	0	SENT_169	[p4l1769t2405r1798b2425],
25	12	CD	NUMBER	12	prep_at	23	SENT_169	[p4l1820t2399r1853b2426],
26	and	CC	O	and	_	0	SENT_169	[p4l1873t2399r1932b2425],
27	24	CD	DURATION	24	num	28	SENT_169	[p4l1953t2399r1989b2426],
28	mo	NN	DURATION	mo	prep_than	16	SENT_169	[p4l2008t2408r2066b2430],
29	,	,	O	,	_	0	SENT_169	[p4l2008t2408r2066b2430],
30	respectively	RB	O	respectively	advmod	28	SENT_169	[p4l2086t2399r2286b2434],
31	,	,	O	,	_	0	SENT_169	[p4l2086t2399r2286b2434],
32	after	IN	O	after	dep	16	SENT_169	[p4l1277t2445r1354b2471],
33	treatment	NN	O	treatment	pobj	32	SENT_169	[p4l1371t2450r1540b2476],
34	,	,	O	,	_	0	SENT_169	[p4l1371t2450r1540b2476],
35	whereas	IN	O	whereas	mark	51	SENT_169	[p4l1557t2445r1686b2471],
36	only	RB	O	only	quantmod	38	SENT_169	[p4l1704t2445r1773b2480],
37	3/16	CD	PERCENT	3/16	number	38	SENT_169	[p4l1790t2445r1854b2471],
38	(	CD	PERCENT	(	nsubj	51	SENT_169	[p4l1873t2445r1967b2477],
39	19	CD	PERCENT	19	num	40	SENT_169	[p4l1873t2445r1967b2477],
40	%	NN	PERCENT	%	dep	38	SENT_169	[p4l1873t2445r1967b2477],
41	)	CD	NUMBER	)	number	45	SENT_169	[p4l1873t2445r1967b2477],
42	and	CC	O	and	_	0	SENT_169	[p4l1985t2445r2044b2471],
43	4/16	CD	PERCENT	4/16	num	46	SENT_169	[p4l2061t2445r2125b2471],
44	(	CD	PERCENT	(	number	45	SENT_169	[p4l2143t2445r2237b2477],
45	25	CD	PERCENT	25	num	46	SENT_169	[p4l2143t2445r2237b2477],
46	%	NN	PERCENT	%	dep	38	SENT_169	[p4l2143t2445r2237b2477],
47	)	CD	NUMBER	)	dep	46	SENT_169	[p4l2143t2445r2237b2477],
48	of	IN	O	of	_	0	SENT_169	[p4l2255t2445r2290b2471],
49	placebo	NN	O	placebo	nn	50	SENT_169	[p4l1277t2491r1402b2526],
50	patients	NNS	O	patient	prep_of	38	SENT_169	[p4l1415t2492r1544b2526],
51	had	VBD	O	have	advcl	16	SENT_169	[p4l1555t2491r1614b2517],
52	antigens	NNS	O	antigen	dep	53	SENT_169	[p4l1626t2492r1761b2526],
53	lower	JJR	O	lower	dobj	51	SENT_169	[p4l1773t2491r1863b2517],
54	than	IN	O	than	_	0	SENT_169	[p4l1874t2491r1946b2517],
55	32,000	CD	NUMBER	32,000	num	56	SENT_169	[p4l1958t2491r2060b2522],
56	units	NNS	O	unit	prep_than	51	SENT_169	[p4l2072t2492r2151b2517],
57	at	IN	O	at	_	0	SENT_169	[p4l2164t2496r2193b2517],
58	these	DT	O	these	det	60	SENT_169	[p4l2205t2491r2286b2517],
59	time	NN	O	time	nn	60	SENT_169	[p4l1278t2537r1349b2562],
60	points	NNS	O	point	prep_at	51	SENT_169	[p4l1362t2537r1471b2571],
61	.	.	O	.	_	0	SENT_169	[p4l1362t2537r1471b2571],

1	Ultrasonography	NN	O	ultrasonography	nsubj	33	SENT_170	[p4l1485t2536r1762b2571],
2	to	TO	O	to	aux	3	SENT_170	[p4l1776t2542r1806b2562],
3	detect	VB	O	detect	infmod	1	SENT_170	[p4l1820t2536r1920b2562],
4	the	DT	O	the	det	9	SENT_170	[p4l1934t2536r1983b2562],
5	ﬁlarial	JJ	O	ﬁlarial	amod	9	SENT_170	[p4l1996t2536r2101b2562],
6	dance	NN	O	dance	nn	9	SENT_170	[p4l2114t2536r2209b2562],
7	sign	NN	O	sign	nn	9	SENT_170	[p4l2223t2537r2286b2571],
8	(	CD	NUMBER	(	num	9	SENT_170	[p4l1278t2582r1365b2614],
9	FDS	NN	O	fd	dobj	3	SENT_170	[p4l1278t2582r1365b2614],
10	)	RB	O	)	advmod	3	SENT_170	[p4l1278t2582r1365b2614],
11	as	IN	O	as	mark	20	SENT_170	[p4l1391t2591r1420b2608],
12	a	DT	DURATION	a	det	14	SENT_170	[p4l1445t2591r1461b2608],
13	second	JJ	DURATION	second	amod	14	SENT_170	[p4l1485t2582r1597b2608],
14	parameter	NN	O	parameter	nsubjpass	20	SENT_170	[p4l1622t2587r1793b2617],
15	of	IN	O	of	_	0	SENT_170	[p4l1816t2582r1851b2608],
16	adult	JJ	O	adult	amod	18	SENT_170	[p4l1873t2582r1955b2608],
17	worm	NN	O	worm	nn	18	SENT_170	[p4l1979t2591r2072b2608],
18	vitality	NN	O	vitality	prep_of	14	SENT_170	[p4l2095t2582r2207b2617],
19	was	VBD	O	be	auxpass	20	SENT_170	[p4l2230t2591r2286b2608],
20	performed	VBN	O	perform	advcl	3	SENT_170	[p4l1277t2628r1452b2663],
21	only	RB	O	only	advmod	20	SENT_170	[p4l1469t2628r1538b2663],
22	in	IN	O	in	_	0	SENT_170	[p4l1556t2629r1586b2653],
23	male	JJ	O	male	amod	24	SENT_170	[p4l1605t2628r1680b2654],
24	patients	NNS	O	patient	prep_in	20	SENT_170	[p4l1699t2629r1828b2663],
25	since	IN	O	since	mark	29	SENT_170	[p4l1846t2629r1926b2654],
26	our	PRP$	O	we	poss	28	SENT_170	[p4l1944t2637r2001b2654],
27	earlier	JJR	O	earlier	amod	28	SENT_170	[p4l2018t2628r2125b2654],
28	data	NNS	O	datum	nsubj	29	SENT_170	[p4l2141t2628r2210b2654],
29	[	VBP	O	[	advcl	20	SENT_170	[p4l2230t2628r2285b2660],
30	46	CD	NUMBER	46	num	31	SENT_170	[p4l2230t2628r2285b2660],
31	]	CD	NUMBER	]	dobj	29	SENT_170	[p4l2230t2628r2285b2660],
32	had	VBD	O	have	aux	33	SENT_170	[p4l1276t2673r1335b2699],
33	shown	VBN	O	show	_	0	SENT_170	[p4l1360t2673r1462b2699],
34	that	IN	O	that	complm	38	SENT_170	[p4l1488t2673r1551b2699],
35	the	DT	O	the	det	36	SENT_170	[p4l1577t2673r1626b2699],
36	FDS	NN	O	fd	nsubjpass	38	SENT_170	[p4l1650t2673r1716b2699],
37	is	VBZ	O	be	auxpass	38	SENT_170	[p4l1743t2674r1765b2699],
38	detected	VBN	O	detect	ccomp	33	SENT_170	[p4l1790t2673r1929b2699],
39	less	RBR	O	less	advmod	40	SENT_170	[p4l1954t2673r2008b2699],
40	frequently	RB	O	frequently	advmod	38	SENT_170	[p4l2033t2673r2202b2708],
41	and	CC	O	and	_	0	SENT_170	[p4l2227t2673r2286b2699],
42	probably	RB	O	probably	advmod	43	SENT_170	[p4l1277t2719r1422b2754],
43	less	RBR	O	less	advmod	38	SENT_170	[p4l1441t2719r1495b2745],
44	reliably	RB	O	reliably	advmod	38	SENT_170	[p4l1515t2719r1635b2754],
45	in	IN	O	in	_	0	SENT_170	[p4l1655t2720r1685b2744],
46	women	NNS	O	woman	prep_in	38	SENT_170	[p4l1704t2728r1829b2745],
47	.	.	O	.	_	0	SENT_170	[p4l1704t2728r1829b2745],

1	FDS	NN	O	fd	nsubj	8	SENT_171	[p4l1848t2719r1914b2745],
2	in	IN	O	in	_	0	SENT_171	[p4l1935t2720r1965b2744],
3	the	DT	O	the	det	5	SENT_171	[p4l1986t2719r2035b2745],
4	scrotal	JJ	O	scrotal	amod	5	SENT_171	[p4l2054t2719r2162b2745],
5	region	NN	O	region	prep_in	1	SENT_171	[p4l2182t2720r2286b2754],
6	before	IN	O	before	_	0	SENT_171	[p4l1276t2765r1381b2791],
7	treatment	NN	O	treatment	prep_before	5	SENT_171	[p4l1409t2770r1571b2791],
8	showed	VBD	O	show	_	0	SENT_171	[p4l1597t2765r1716b2791],
9	that	IN	O	that	complm	20	SENT_171	[p4l1744t2765r1807b2791],
10	nine	CD	TIME	nine	nsubj	20	SENT_171	[p4l1834t2766r1905b2791],
11	of	IN	TIME	of	_	0	SENT_171	[p4l1932t2765r1966b2791],
12	13	CD	TIME	13	num	14	SENT_171	[p4l1993t2765r2026b2790],
13	male	JJ	O	male	amod	14	SENT_171	[p4l2053t2765r2129b2791],
14	patients	NNS	O	patient	prep_of	10	SENT_171	[p4l2157t2766r2286b2800],
15	examined	VBN	O	examine	partmod	14	SENT_171	[p4l1277t2810r1435b2836],
16	in	IN	O	in	_	0	SENT_171	[p4l1453t2811r1483b2835],
17	the	DT	O	the	det	19	SENT_171	[p4l1502t2810r1551b2836],
18	doxycycline	NN	O	doxycycline	nn	19	SENT_171	[p4l1569t2810r1761b2845],
19	group	NN	O	group	prep_in	15	SENT_171	[p4l1778t2819r1874b2845],
20	had	VBD	O	have	ccomp	8	SENT_171	[p4l1892t2810r1951b2836],
21	between	IN	O	between	_	0	SENT_171	[p4l1969t2810r2103b2836],
22	1-4	CD	NUMBER	1-4	num	24	SENT_171	[p4l2124t2810r2177b2835],
23	worm	NN	O	worm	nn	24	SENT_171	[p4l2194t2819r2286b2836],
24	nests	NNS	O	nest	prep_between	20	SENT_171	[p4l1277t2861r1364b2887],
25	,	,	O	,	_	0	SENT_171	[p4l1277t2861r1364b2887],
26	whereas	IN	O	whereas	mark	36	SENT_171	[p4l1380t2856r1509b2882],
27	ten	CD	TIME	ten	nsubj	36	SENT_171	[p4l1527t2861r1577b2882],
28	of	IN	TIME	of	_	0	SENT_171	[p4l1594t2856r1628b2882],
29	11	CD	TIME	11	num	31	SENT_171	[p4l1644t2856r1675b2881],
30	male	JJ	O	male	amod	31	SENT_171	[p4l1694t2856r1770b2882],
31	patients	NNS	O	patient	prep_of	27	SENT_171	[p4l1787t2857r1916b2891],
32	in	IN	O	in	_	0	SENT_171	[p4l1934t2857r1964b2881],
33	the	DT	O	the	det	35	SENT_171	[p4l1982t2856r2031b2882],
34	placebo	NN	O	placebo	nn	35	SENT_171	[p4l2047t2856r2173b2891],
35	group	NN	O	group	prep_in	31	SENT_171	[p4l2190t2865r2286b2891],
36	had	VBD	O	have	advcl	8	SENT_171	[p4l1276t2902r1335b2928],
37	worm	NN	O	worm	nn	38	SENT_171	[p4l1352t2911r1445b2928],
38	nests	NNS	O	nest	dobj	36	SENT_171	[p4l1463t2907r1541b2928],
39	ranging	VBG	O	range	partmod	38	SENT_171	[p4l1560t2903r1685b2937],
40	from	IN	O	from	_	0	SENT_171	[p4l1701t2902r1781b2928],
41	1-5	CD	NUMBER	1-5	num	43	SENT_171	[p4l1801t2902r1854b2927],
42	worm	NN	O	worm	nn	43	SENT_171	[p4l1871t2911r1964b2928],
43	nests	NNS	O	nest	prep_from	39	SENT_171	[p4l1982t2907r2068b2928],
44	.	.	O	.	_	0	SENT_171	[p4l1982t2907r2068b2928],

1	Considering	VBG	O	consider	_	0	SENT_172	[p4l2087t2902r2287b2937],
2	only	RB	O	only	advmod	5	SENT_172	[p4l1277t2948r1346b2983],
3	those	DT	O	those	det	5	SENT_172	[p4l1370t2948r1454b2974],
4	male	JJ	O	male	amod	5	SENT_172	[p4l1478t2948r1553b2974],
5	patients	NNS	O	patient	pobj	1	SENT_172	[p4l1577t2949r1706b2983],
6	who	WP	O	who	nsubj	7	SENT_172	[p4l1730t2948r1795b2974],
7	had	VBD	O	have	rcmod	5	SENT_172	[p4l1819t2948r1878b2974],
8	detectable	JJ	O	detectable	amod	9	SENT_172	[p4l1901t2948r2068b2974],
9	FDS	NN	O	fd	dobj	7	SENT_172	[p4l2091t2948r2157b2974],
10	before	IN	O	before	_	0	SENT_172	[p4l2181t2948r2286b2974],
11	treatment	NN	O	treatment	prep_before	9	SENT_172	[p4l1278t2998r1439b3019],
12	(	CD	NUMBER	(	num	11	SENT_172	[p4l1454t2994r1536b3025],
13	nine	CD	NUMBER	nine	num	14	SENT_172	[p4l1454t2994r1536b3025],
14	doxycycline	NN	O	doxycycline	dep	11	SENT_172	[p4l1551t2993r1742b3028],
15	and	CC	O	and	_	0	SENT_172	[p4l1757t2993r1816b3019],
16	ten	CD	NUMBER	ten	num	18	SENT_172	[p4l1832t2999r1882b3019],
17	placebo	NN	O	placebo	nn	18	SENT_172	[p4l1897t2993r2042b3028],
18	)	NN	O	)	prep_before	9	SENT_172	[p4l1897t2993r2042b3028],
19	,	,	O	,	_	0	SENT_172	[p4l1897t2993r2042b3028],
20	67	CD	PERCENT	67	num	21	SENT_172	[p4l2058t2991r2126b3022],
21	%	NN	PERCENT	%	appos	18	SENT_172	[p4l2058t2991r2126b3022],
22	(	CD	NUMBER	(	number	23	SENT_172	[p4l2146t2993r2212b3025],
23	6/9	CD	NUMBER	6/9	num	24	SENT_172	[p4l2146t2993r2212b3025],
24	)	NN	O	)	dep	21	SENT_172	[p4l2146t2993r2212b3025],
25	and	CC	O	and	cc	9	SENT_172	[p4l2227t2993r2286b3019],

1	Oo	NN	O	oo	_	0	SENT_173	[p5l231t217r249b245],

1	P	NN	O	p	_	0	SENT_174	[p5l1037t250r1185b276],
2	=	JJ	O	=	amod	1	SENT_174	[p5l1037t250r1185b276],
3	0.2168	CD	NUMBER	0.2168	tmod	2	SENT_174	[p5l1037t250r1185b276],

1	N	NN	O	n	_	0	SENT_175	[p5l230t405r249b432],

1	P	NN	O	p	_	0	SENT_176	[p5l877t453r1026b479],
2	=	JJ	O	=	amod	1	SENT_176	[p5l877t453r1026b479],
3	0.0404	CD	NUMBER	0.0404	tmod	2	SENT_176	[p5l877t453r1026b479],

1	Mean	NN	O	mean	nn	2	SENT_177	[p5l188t728r209b795],
2	category	NN	O	category	_	0	SENT_177	[p5l189t602r214b717],
3	of	IN	O	of	_	0	SENT_177	[p5l188t566r209b593],
4	lymphatic	JJ	O	lymphatic	amod	8	SENT_177	[p5l188t427r214b556],
5	vessel	NN	O	vessel	nn	8	SENT_177	[p5l188t337r209b418],
6	dilation	NN	O	dilation	nn	8	SENT_177	[p5l188t228r209b326],
7	A	NN	O	a	nn	8	SENT_177	[p5l232t592r244b620],
8	O	NN	O	o	prep_of	2	SENT_177	[p5l231t778r249b807],

1	Doxy	NNP	O	Doxy	nn	6	SENT_178	[p5l299t830r390b865],
2	Placebo	NNP	O	Placebo	nn	6	SENT_178	[p5l424t830r567b858],
3	Doxy	NNP	O	Doxy	nn	6	SENT_178	[p5l601t830r691b865],
4	Placebo	NNP	O	Placebo	nn	6	SENT_178	[p5l724t830r868b858],
5	Doxy	NNP	O	Doxy	nn	6	SENT_178	[p5l902t830r993b865],
6	Placebo	NNP	O	Placebo	_	0	SENT_178	[p5l1026t830r1170b858],
7	Before	IN	O	before	dep	6	SENT_178	[p5l250t887r364b913],
8	treatment	NN	O	treatment	pobj	7	SENT_178	[p5l378t888r547b913],
9	24	CD	DURATION	24	num	10	SENT_178	[p5l918t890r958b917],
10	months	NNS	NUMBER	month	tmod	8	SENT_178	[p5l969t890r1097b918],

1	Figure	NN	O	figure	_	0	SENT_179	[p5l190t952r282b983],
2	2	CD	NUMBER	2	dep	1	SENT_179	[p5l299t954r324b976],
3	.	.	O	.	_	0	SENT_179	[p5l299t954r324b976],

1	The	DT	O	the	det	2	SENT_180	[p5l339t952r390b976],
2	Effect	NN	O	effect	dep	22	SENT_180	[p5l408t952r483b976],
3	of	IN	O	of	_	0	SENT_180	[p5l500t952r528b976],
4	Doxycycline	NNP	O	Doxycycline	nn	5	SENT_180	[p5l544t952r706b983],
5	Treatment	NN	O	treatment	prep_of	2	SENT_180	[p5l722t953r866b976],
6	on	IN	O	on	_	0	SENT_180	[p5l882t959r916b976],
7	the	DT	O	the	det	11	SENT_180	[p5l933t952r978b976],
8	Supratesticular	JJ	O	supratesticular	amod	11	SENT_180	[p5l995t952r1200b983],
9	Lymphatic	JJ	O	lymphatic	amod	11	SENT_180	[p5l190t994r332b1025],
10	Vessel	NN	O	vessel	nn	11	SENT_180	[p5l344t994r427b1018],
11	Dilation	NN	O	dilation	prep_on	5	SENT_180	[p5l443t994r547b1018],
12	at	IN	O	at	_	0	SENT_180	[p5l561t998r586b1018],
13	Various	JJ	O	various	amod	19	SENT_180	[p5l598t995r699b1018],
14	Time	NNP	O	Time	nn	19	SENT_180	[p5l711t995r779b1018],
15	Points	NNP	O	Points	nn	19	SENT_180	[p5l793t995r875b1018],
16	The	NNP	O	The	nn	19	SENT_180	[p5l187t1039r238b1063],
17	supratesticular	JJ	O	supratesticular	amod	19	SENT_180	[p5l254t1039r456b1070],
18	lymphatic	JJ	O	lymphatic	amod	19	SENT_180	[p5l471t1039r606b1070],
19	vessel	NN	O	vessel	prep_at	11	SENT_180	[p5l620t1039r700b1063],
20	dilation	NN	O	dilation	dep	22	SENT_180	[p5l717t1039r819b1063],
21	(	CD	NUMBER	(	num	20	SENT_180	[p5l836t1040r920b1067],
22	mean	NN	O	mean	dep	29	SENT_180	[p5l836t1040r920b1067],
23	of	IN	O	of	_	0	SENT_180	[p5l936t1039r964b1063],
24	category	NN	O	category	prep_of	22	SENT_180	[p5l978t1043r1098b1070],
25	:	:	O	:	_	0	SENT_180	[p5l1115t1042r1135b1062],
26	SD	NN	O	sd	nn	27	SENT_180	[p5l1154t1040r1198b1067],
27	)	NN	O	)	nsubjpass	29	SENT_180	[p5l1154t1040r1198b1067],
28	was	VBD	O	be	auxpass	29	SENT_180	[p5l188t1081r240b1098],
29	determined	VBN	O	determine	_	0	SENT_180	[p5l254t1074r413b1098],
30	before	IN	O	before	_	0	SENT_180	[p5l430t1074r517b1098],
31	treatment	NN	O	treatment	prep_before	29	SENT_180	[p5l531t1078r675b1102],
32	,	,	O	,	_	0	SENT_180	[p5l531t1078r675b1102],
33	and	CC	O	and	dep	34	SENT_180	[p5l689t1074r739b1098],
34	12	CD	NUMBER	12	dep	31	SENT_180	[p5l757t1076r785b1098],
35	and	CC	O	and	_	0	SENT_180	[p5l800t1074r850b1098],
36	24	CD	DURATION	24	num	37	SENT_180	[p5l865t1076r897b1098],
37	mo	NN	DURATION	mo	dep	31	SENT_180	[p5l912t1081r955b1098],
38	thereafter	RB	O	thereafter	dep	34	SENT_180	[p5l968t1074r1111b1102],
39	,	,	O	,	_	0	SENT_180	[p5l968t1074r1111b1102],
40	using	VBG	O	use	dep	31	SENT_180	[p5l1126t1075r1198b1105],
41	USG	NNP	O	USG	dobj	40	SENT_180	[p5l190t1111r253b1134],
42	.	.	O	.	_	0	SENT_180	[p5l190t1111r253b1134],

1	The	DT	O	the	det	2	SENT_181	[p5l264t1110r315b1134],
2	mean	NN	O	mean	_	0	SENT_181	[p5l329t1117r403b1134],
3	supratesticular	JJ	O	supratesticular	amod	6	SENT_181	[p5l417t1110r619b1141],
4	lymphatic	JJ	O	lymphatic	amod	6	SENT_181	[p5l633t1110r767b1141],
5	vessel	NN	O	vessel	nn	6	SENT_181	[p5l779t1110r859b1134],
6	dilation	NN	O	dilation	nsubj	13	SENT_181	[p5l873t1110r975b1134],
7	of	IN	O	of	_	0	SENT_181	[p5l989t1110r1017b1134],
8	doxycyclinetreated	JJ	O	doxycyclinetreated	amod	10	SENT_181	[p5l1028t1110r1199b1141, p5l188t1145r286b1169],
9	(	NN	O	(	nn	10	SENT_181	[p5l298t1146r384b1176],
10	Doxy	NN	O	doxy	prep_of	6	SENT_181	[p5l298t1146r384b1176],
11	)	CD	NUMBER	)	num	12	SENT_181	[p5l298t1146r384b1176],
12	patients	NNS	O	patient	dep	10	SENT_181	[p5l395t1146r504b1176],
13	improved	VBD	O	improve	rcmod	2	SENT_181	[p5l515t1145r646b1176],
14	significantly	RB	O	significantly	advmod	13	SENT_181	[p5l657t1145r821b1176],
15	compared	VBN	O	compare	_	0	SENT_181	[p5l830t1145r968b1176],
16	to	TO	O	to	prepc_compared_to	13	SENT_181	[p5l978t1149r1006b1169],
17	pretreatment	NN	O	pretreatment	nn	19	SENT_181	[p5l1017t1149r1199b1176],
18	(	NN	O	(	nn	19	SENT_181	[p5l190t1181r213b1208],
19	n	NN	O	n	pobj	13	SENT_181	[p5l190t1181r213b1208],
20	:	:	O	:	_	0	SENT_181	[p5l225t1192r247b1200],
21	9	CD	NUMBER	9	dep	2	SENT_181	[p5l259t1182r281b1208],
22	,	,	O	,	_	0	SENT_181	[p5l259t1182r281b1208],
23	p	NN	O	p	appos	21	SENT_181	[p5l294t1187r311b1211],
24	:	:	O	:	_	0	SENT_181	[p5l323t1192r345b1200],
25	0.0404	CD	NUMBER	0.0404	num	26	SENT_181	[p5l356t1181r454b1208],
26	)	NN	O	)	dep	2	SENT_181	[p5l356t1181r454b1208],
27	at	IN	O	at	_	0	SENT_181	[p5l470t1184r495b1204],
28	24	CD	DURATION	24	num	29	SENT_181	[p5l509t1182r541b1204],
29	mo	NN	DURATION	mo	prep_at	26	SENT_181	[p5l556t1187r606b1208],
30	,	,	O	,	_	0	SENT_181	[p5l556t1187r606b1208],
31	in	IN	O	in	_	0	SENT_181	[p5l621t1181r643b1204],
32	contrast	NN	O	contrast	prep_in	26	SENT_181	[p5l658t1184r770b1204],
33	to	TO	O	to	_	0	SENT_181	[p5l783t1184r811b1204],
34	the	DT	O	the	det	38	SENT_181	[p5l825t1180r869b1204],
35	placebo	NN	O	placebo	nn	38	SENT_181	[p5l885t1180r993b1211],
36	group	NN	O	group	nn	38	SENT_181	[p5l1007t1187r1090b1211],
37	(	CD	NUMBER	(	num	38	SENT_181	[p5l1105t1181r1129b1208],
38	n	NN	O	n	prep_to	32	SENT_181	[p5l1105t1181r1129b1208],
39	:	:	O	:	_	0	SENT_181	[p5l1141t1192r1163b1200],
40	8	CD	NUMBER	8	number	41	SENT_181	[p5l1175t1181r1198b1208],
41	)	CD	NUMBER	)	num	42	SENT_181	[p5l1175t1181r1198b1208],
42	(	NN	O	(	npadvmod	43	SENT_181	[p5l190t1215r283b1246],
43	paired	JJ	O	paired	amod	44	SENT_181	[p5l190t1215r283b1246],
44	t	NN	O	t	dep	2	SENT_181	[p5l298t1216r384b1243],
45	—	CD	NUMBER	—	num	47	SENT_181	[p5l298t1216r384b1243],
46	test	NN	O	test	nn	47	SENT_181	[p5l298t1216r384b1243],
47	)	NN	O	)	dep	44	SENT_181	[p5l298t1216r384b1243],
48	.	.	O	.	_	0	SENT_181	[p5l298t1216r384b1243],

1	DOI	NNP	O	DOI	_	0	SENT_182	[p5l190t1252r246b1275],
2	:	:	O	:	_	0	SENT_182	[p5l190t1252r246b1275],
3	10.1371	CD	NUMBER	10.1371	dep	1	SENT_182	[p5l262t1251r747b1282],
4	/	:	O	/	punct	6	SENT_182	[p5l262t1251r747b1282],
5	journa	NN	O	journa	nn	6	SENT_182	[p5l262t1251r747b1282],
6	|	NN	O	|	dep	3	SENT_182	[p5l262t1251r747b1282],
7	.	.	O	.	_	0	SENT_182	[p5l262t1251r747b1282],

1	ppat	NN	O	ppat	_	0	SENT_183	[p5l262t1251r747b1282],
2	.0020092	CD	NUMBER	.0020092	dep	1	SENT_183	[p5l262t1251r747b1282],
3	.	.	O	.	_	0	SENT_183	[p5l262t1251r747b1282],

1	g002	NN	O	g002	_	0	SENT_184	[p5l262t1251r747b1282],

1	12	CD	DURATION	12	num	2	SENT_185	[p5l653t890r689b917],
2	months	NNS	DURATION	month	_	0	SENT_185	[p5l702t890r829b918],

1	89	CD	PERCENT	89	num	2	SENT_186	[p5l190t1350r258b1379],
2	%	NN	PERCENT	%	nn	5	SENT_186	[p5l190t1350r258b1379],
3	(	CD	NUMBER	(	number	4	SENT_186	[p5l278t1350r344b1382],
4	8/9	CD	NUMBER	8/9	num	2	SENT_186	[p5l278t1350r344b1382],
5	)	NN	O	)	nsubj	11	SENT_186	[p5l278t1350r344b1382],
6	of	IN	O	of	_	0	SENT_186	[p5l360t1350r395b1376],
7	male	JJ	O	male	amod	9	SENT_186	[p5l407t1350r483b1376],
8	doxycycline-treated	JJ	O	doxycycline-treated	amod	9	SENT_186	[p5l498t1350r821b1385],
9	patients	NNS	O	patient	prep_of	5	SENT_186	[p5l837t1351r966b1385],
10	became	VBD	O	become	cop	11	SENT_186	[p5l981t1350r1104b1376],
11	FDSnegative	NN	O	fdsnegative	_	0	SENT_186	[p5l1119t1350r1198b1376, p5l190t1399r324b1433],
12	at	IN	O	at	_	0	SENT_186	[p5l345t1404r374b1424],
13	12	CD	NUMBER	12	prep_at	11	SENT_186	[p5l397t1398r430b1425],
14	and	CC	O	and	_	0	SENT_186	[p5l451t1398r510b1424],
15	24	CD	DURATION	24	num	16	SENT_186	[p5l531t1398r567b1425],
16	mo	NN	DURATION	mo	conj_and	13	SENT_186	[p5l587t1407r637b1424],
17	after	IN	O	after	_	0	SENT_186	[p5l658t1398r735b1424],
18	treatment	NN	O	treatment	prep_after	11	SENT_186	[p5l755t1403r924b1429],
19	,	,	O	,	_	0	SENT_186	[p5l755t1403r924b1429],
20	respectively	RB	O	respectively	advmod	11	SENT_186	[p5l946t1398r1145b1433],
21	.	.	O	.	_	0	SENT_186	[p5l946t1398r1145b1433],

1	In	IN	O	in	_	0	SENT_187	[p5l1166t1399r1199b1423],
2	contrast	NN	O	contrast	prep_in	9	SENT_187	[p5l189t1452r330b1478],
3	,	,	O	,	_	0	SENT_187	[p5l189t1452r330b1478],
4	all	DT	O	all	det	8	SENT_187	[p5l343t1447r379b1473],
5	ten	CD	NUMBER	ten	num	8	SENT_187	[p5l393t1452r443b1473],
6	male	JJ	O	male	amod	8	SENT_187	[p5l455t1447r531b1473],
7	placebo	NN	O	placebo	nn	8	SENT_187	[p5l543t1447r669b1482],
8	patients	NNS	O	patient	nsubj	9	SENT_187	[p5l682t1448r811b1482],
9	remained	VBD	O	remain	_	0	SENT_187	[p5l824t1447r979b1473],
10	FDS-positive	JJ	O	fds-positive	amod	19	SENT_187	[p5l990t1447r1199b1482],
11	at	IN	O	at	_	0	SENT_187	[p5l189t1500r218b1521],
12	12	CD	DURATION	12	num	13	SENT_187	[p5l239t1495r272b1522],
13	mo	NN	DURATION	mo	prep_at	10	SENT_187	[p5l291t1504r340b1521],
14	and	CC	O	and	_	0	SENT_187	[p5l359t1495r418b1521],
15	20	CD	PERCENT	20	num	16	SENT_187	[p5l437t1495r505b1524],
16	%	NN	PERCENT	%	conj_and	13	SENT_187	[p5l437t1495r505b1524],
17	(	CD	NUMBER	(	number	18	SENT_187	[p5l528t1495r614b1527],
18	2/10	CD	NUMBER	2/10	num	16	SENT_187	[p5l528t1495r614b1527],
19	)	NN	O	)	nsubj	21	SENT_187	[p5l528t1495r614b1527],
20	were	VBD	O	be	cop	21	SENT_187	[p5l632t1504r708b1521],
21	FDS-negative	JJ	O	fds-negative	ccomp	9	SENT_187	[p5l726t1495r943b1530],
22	at	IN	O	at	_	0	SENT_187	[p5l961t1500r990b1521],
23	24	CD	DURATION	24	num	26	SENT_187	[p5l1009t1495r1045b1522],
24	mo	NN	DURATION	mo	nn	26	SENT_187	[p5l1063t1504r1112b1521],
25	post	NN	O	post	nn	26	SENT_187	[p5l1131t1500r1199b1530],
26	therapy	NN	O	therapy	prep_at	21	SENT_187	[p5l190t1543r321b1578],
27	.	.	O	.	_	0	SENT_187	[p5l190t1543r321b1578],

1	There	EX	O	there	expl	2	SENT_188	[p5l342t1543r439b1569],
2	was	VBD	O	be	_	0	SENT_188	[p5l459t1552r515b1569],
3	no	DT	O	no	det	4	SENT_188	[p5l536t1552r576b1569],
4	difference	NN	O	difference	nn	16	SENT_188	[p5l597t1543r763b1569],
5	between	IN	O	between	_	0	SENT_188	[p5l784t1543r918b1569],
6	the	DT	O	the	det	8	SENT_188	[p5l940t1543r989b1569],
7	two	CD	NUMBER	two	num	8	SENT_188	[p5l1011t1548r1067b1569],
8	groups	NNS	O	group	prep_between	4	SENT_188	[p5l1088t1552r1198b1578],
9	before	IN	O	before	_	0	SENT_188	[p5l189t1592r294b1618],
10	treatment	NN	O	treatment	nn	12	SENT_188	[p5l306t1597r468b1618],
11	(	CD	NUMBER	(	num	12	SENT_188	[p5l480t1590r670b1627],
12	[	NN	O	[	prep_before	8	SENT_188	[p5l480t1590r670b1627],
13	7	CD	NUMBER	7	num	12	SENT_188	[p5l480t1590r670b1627],
14	=	JJ	O	=	amod	16	SENT_188	[p5l480t1590r670b1627],
15	0.3271	CD	NUMBER	0.3271	tmod	14	SENT_188	[p5l480t1590r670b1627],
16	)	NN	O	)	nsubj	2	SENT_188	[p5l480t1590r670b1627],
17	;	:	O	;	_	0	SENT_188	[p5l480t1590r670b1627],
18	however	RB	O	however	advmod	23	SENT_188	[p5l681t1592r825b1623],
19	,	,	O	,	_	0	SENT_188	[p5l681t1592r825b1623],
20	the	DT	O	the	det	21	SENT_188	[p5l838t1592r887b1618],
21	difference	NN	O	difference	nsubj	23	SENT_188	[p5l899t1592r1065b1618],
22	became	VBD	O	become	cop	23	SENT_188	[p5l1076t1592r1199b1618],
23	signiﬁcant	NN	O	signiﬁcant	parataxis	2	SENT_188	[p5l189t1640r358b1675],
24	at	IN	O	at	_	0	SENT_188	[p5l372t1645r401b1666],
25	12	CD	NUMBER	12	prep_at	23	SENT_188	[p5l418t1640r451b1667],
26	and	CC	O	and	_	0	SENT_188	[p5l466t1640r525b1666],
27	24	CD	DURATION	24	num	28	SENT_188	[p5l541t1640r577b1667],
28	mo	NN	DURATION	mo	conj_and	25	SENT_188	[p5l591t1649r641b1666],
29	after	IN	O	after	_	0	SENT_188	[p5l656t1640r733b1666],
30	doxycycline	NN	O	doxycycline	nn	31	SENT_188	[p5l746t1640r937b1675],
31	treatment	NN	O	treatment	prep_after	23	SENT_188	[p5l953t1645r1115b1666],
32	(	CD	NUMBER	(	num	33	SENT_188	[p5l1130t1641r1156b1675],
33	[	NN	O	[	dep	31	SENT_188	[p5l1130t1641r1156b1675],
34	7	CD	NUMBER	7	number	35	SENT_188	[p5l1130t1641r1156b1675],
35	<	JJR	O	<	amod	33	SENT_188	[p5l1172t1642r1197b1664],
36	0.001	CD	NUMBER	0.001	dep	31	SENT_188	[p5l189t1688r281b1719],
37	,	,	O	,	_	0	SENT_188	[p5l189t1688r281b1719],
38	Table	NNP	O	Table	appos	31	SENT_188	[p5l296t1688r387b1714],
39	1	CD	NUMBER	1	number	40	SENT_188	[p5l405t1689r438b1720],
40	)	CD	NUMBER	)	dep	38	SENT_188	[p5l405t1689r438b1720],
41	.	.	O	.	_	0	SENT_188	[p5l405t1689r438b1720],

1	Secondary	JJ	O	secondary	amod	3	SENT_189	[p5l189t1766r369b1805],
2	Outcome	NNP	O	Outcome	nn	3	SENT_189	[p5l385t1767r544b1797],
3	Variables	NNP	O	Variables	_	0	SENT_189	[p5l560t1766r715b1797],
4	in	IN	O	in	_	0	SENT_189	[p5l732t1767r760b1796],
5	Microfilaremic	NNP	O	Microfilaremic	nn	7	SENT_189	[p5l779t1766r1021b1797],
6	Patients	NNPS	O	Patients	nn	7	SENT_189	[p5l1040t1767r1174b1797],
7	Dilation	NNP	O	Dilation	prep_in	3	SENT_189	[p5l226t1821r357b1847],
8	of	IN	O	of	_	0	SENT_189	[p5l375t1821r409b1847],
9	supratesticular	JJ	O	supratesticular	amod	11	SENT_189	[p5l424t1821r667b1856],
10	lymphatic	JJ	O	lymphatic	amod	11	SENT_189	[p5l683t1821r845b1856],
11	vessels	NNS	O	vessel	prep_of	3	SENT_189	[p5l861t1821r981b1847],
12	.	.	O	.	_	0	SENT_189	[p5l861t1821r981b1847],

1	Before	IN	O	before	_	0	SENT_190	[p5l1000t1821r1108b1847],
2	doxycycline	NN	O	doxycycline	nn	3	SENT_190	[p5l1127t1821r1198b1847, p5l188t1870r319b1905],
3	treatment	NN	O	treatment	prep_before	9	SENT_190	[p5l341t1875r509b1901],
4	,	,	O	,	_	0	SENT_190	[p5l341t1875r509b1901],
5	ultrasonography	NN	O	ultrasonography	nsubj	9	SENT_190	[p5l531t1870r800b1905],
6	(	CD	NUMBER	(	num	8	SENT_190	[p5l822t1870r917b1902],
7	USG	NNP	O	USG	nn	8	SENT_190	[p5l822t1870r917b1902],
8	)	NN	O	)	dep	5	SENT_190	[p5l822t1870r917b1902],
9	showed	VBD	O	show	_	0	SENT_190	[p5l938t1870r1057b1896],
10	that	IN	O	that	complm	21	SENT_190	[p5l1079t1870r1142b1896],
11	17	CD	NUMBER	17	num	13	SENT_190	[p5l1165t1868r1198b1895],
12	male	JJ	O	male	amod	13	SENT_190	[p5l189t1918r265b1944],
13	patients	NNS	O	patient	nsubj	21	SENT_190	[p5l286t1919r415b1953],
14	(	IN	O	(	_	0	SENT_190	[p5l437t1919r518b1950],
15	nine	CD	NUMBER	nine	num	16	SENT_190	[p5l437t1919r518b1950],
16	doxycycline	NN	O	doxycycline	prep_(	13	SENT_190	[p5l539t1918r730b1953],
17	and	CC	O	and	_	0	SENT_190	[p5l750t1918r809b1944],
18	eight	CD	NUMBER	eight	num	20	SENT_190	[p5l829t1918r910b1953],
19	placebo-treated	JJ	O	placebo-treated	amod	20	SENT_190	[p5l930t1918r1198b1953],
20	)	NN	O	)	conj_and	16	SENT_190	[p5l930t1918r1198b1953],
21	had	VBD	O	have	ccomp	9	SENT_190	[p5l189t1966r248b1992],
22	supratesticular	JJ	O	supratesticular	amod	23	SENT_190	[p5l268t1966r512b2001],
23	lymphatic	JJ	O	lymphatic	amod	25	SENT_190	[p5l531t1966r691b2001],
24	vessel	NN	O	vessel	nn	25	SENT_190	[p5l712t1966r802b1992],
25	dilation	NN	O	dilation	dobj	21	SENT_190	[p5l823t1966r957b1992],
26	.	.	O	.	_	0	SENT_190	[p5l823t1966r957b1992],

1	Figure	NN	O	figure	nsubj	6	SENT_191	[p5l978t1967r1082b2001],
2	2	CD	NUMBER	2	num	1	SENT_191	[p5l1103t1966r1119b1993],
3	and	CC	O	and	_	0	SENT_191	[p5l1140t1966r1199b1992],
4	Table	NNP	O	Table	conj_and	1	SENT_191	[p5l189t2015r279b2041],
5	2	CD	NUMBER	2	num	4	SENT_191	[p5l293t2015r309b2042],
6	illustrate	VB	O	illustrate	_	0	SENT_191	[p5l323t2015r466b2041],
7	changes	NNS	O	change	dobj	6	SENT_191	[p5l479t2015r614b2050],
8	,	,	O	,	_	0	SENT_191	[p5l479t2015r614b2050],
9	after	IN	O	after	_	0	SENT_191	[p5l628t2015r705b2041],
10	doxycycline	NN	O	doxycycline	nn	11	SENT_191	[p5l717t2015r908b2050],
11	treatment	NN	O	treatment	prep_after	7	SENT_191	[p5l922t2020r1091b2046],
12	,	,	O	,	_	0	SENT_191	[p5l922t2020r1091b2046],
13	in	IN	O	in	_	0	SENT_191	[p5l1105t2016r1136b2040],
14	the	DT	O	the	det	15	SENT_191	[p5l1150t2015r1199b2041],
15	dilation	NN	O	dilation	prep_in	7	SENT_191	[p5l189t2063r316b2089],
16	of	IN	O	of	_	0	SENT_191	[p5l335t2063r370b2089],
17	lymph	NN	O	lymph	nn	18	SENT_191	[p5l385t2063r486b2098],
18	vessels	NNS	O	vessel	prep_of	15	SENT_191	[p5l505t2063r609b2089],
19	that	WDT	O	that	nsubj	22	SENT_191	[p5l630t2063r693b2089],
20	had	VBD	O	have	aux	22	SENT_191	[p5l711t2063r770b2089],
21	not	RB	O	not	neg	22	SENT_191	[p5l790t2068r844b2089],
22	contained	VBN	O	contain	rcmod	15	SENT_191	[p5l863t2063r1025b2089],
23	worms	NNS	O	worm	dobj	22	SENT_191	[p5l1044t2072r1150b2089],
24	at	IN	O	at	_	0	SENT_191	[p5l1170t2068r1199b2089],
25	study	NN	O	study	nn	26	SENT_191	[p5l189t2111r274b2146],
26	onset	NN	O	onset	prep_at	22	SENT_191	[p5l292t2116r386b2137],
27	.	.	O	.	_	0	SENT_191	[p5l292t2116r386b2137],

1	Dilated	VBN	O	dilate	_	0	SENT_192	[p5l404t2111r522b2137],
2	lymphatic	JJ	O	lymphatic	amod	3	SENT_192	[p5l540t2111r701b2146],
3	vessels	NNS	O	vessel	dobj	1	SENT_192	[p5l719t2111r823b2137],
4	containing	VBG	O	contain	xcomp	1	SENT_192	[p5l841t2112r1017b2146],
5	no	DT	O	no	det	6	SENT_192	[p5l1035t2120r1074b2137],
6	worms	NNS	O	worm	dobj	4	SENT_192	[p5l1092t2120r1198b2137],
7	were	VBD	O	be	auxpass	8	SENT_192	[p5l188t2169r265b2186],
8	reduced	VBN	O	reduce	auxpass	1	SENT_192	[p5l288t2160r419b2186],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_192	[p5l442t2160r639b2195],
10	at	IN	O	at	_	0	SENT_192	[p5l662t2166r691b2186],
11	24	CD	DURATION	24	num	12	SENT_192	[p5l714t2160r750b2187],
12	mo	NN	DURATION	mo	prep_at	8	SENT_192	[p5l773t2169r822b2186],
13	after	IN	O	after	_	0	SENT_192	[p5l847t2160r923b2186],
14	treatment	NN	O	treatment	nn	16	SENT_192	[p5l946t2165r1107b2186],
15	(	CD	NUMBER	(	num	16	SENT_192	[p5l1131t2161r1158b2195],
16	[	NN	O	[	prep_after	8	SENT_192	[p5l1131t2161r1158b2195],
17	7	CD	NUMBER	7	number	18	SENT_192	[p5l1131t2161r1158b2195],
18	=	JJ	O	=	amod	16	SENT_192	[p5l1177t2171r1202b2180],
19	0.0404	CD	NUMBER	0.0404	num	20	SENT_192	[p5l189t2208r303b2240],
20	)	NN	O	)	nsubjpass	1	SENT_192	[p5l189t2208r303b2240],
21	in	IN	O	in	_	0	SENT_192	[p5l316t2209r346b2233],
22	the	DT	O	the	det	24	SENT_192	[p5l359t2208r408b2234],
23	doxycycline	NN	O	doxycycline	nn	24	SENT_192	[p5l419t2208r610b2243],
24	group	NN	O	group	prep_in	20	SENT_192	[p5l622t2217r718b2243],
25	but	CC	O	but	_	0	SENT_192	[p5l730t2208r784b2234],
26	not	RB	O	not	neg	20	SENT_192	[p5l796t2213r849b2234],
27	in	IN	O	in	_	0	SENT_192	[p5l861t2209r891b2233],
28	the	DT	O	the	det	32	SENT_192	[p5l904t2208r953b2234],
29	placebo	NN	O	placebo	nn	32	SENT_192	[p5l965t2208r1090b2243],
30	group	NN	O	group	nn	32	SENT_192	[p5l1102t2217r1198b2243],
31	(	CD	NUMBER	(	num	32	SENT_192	[p5l190t2257r217b2291],
32	[	NN	O	[	prep_in	20	SENT_192	[p5l190t2257r217b2291],
33	7	CD	NUMBER	7	number	34	SENT_192	[p5l190t2257r217b2291],
34	=	JJ	O	=	amod	32	SENT_192	[p5l229t2267r254b2276],
35	0.2168	CD	NUMBER	0.2168	num	36	SENT_192	[p5l267t2256r389b2288],
36	)	NN	O	)	dep	20	SENT_192	[p5l267t2256r389b2288],
37	.	.	O	.	_	0	SENT_192	[p5l267t2256r389b2288],

1	Of	IN	O	of	_	0	SENT_193	[p5l407t2256r451b2282],
2	the	DT	O	the	det	5	SENT_193	[p5l464t2256r513b2282],
3	nine	CD	NUMBER	nine	num	5	SENT_193	[p5l530t2257r601b2282],
4	doxycycline-treated	JJ	O	doxycycline-treated	amod	5	SENT_193	[p5l617t2256r940b2291],
5	patients	NNS	O	patient	prep_of	13	SENT_193	[p5l957t2257r1094b2291],
6	,	,	O	,	_	0	SENT_193	[p5l957t2257r1094b2291],
7	seven	CD	NUMBER	seven	num	8	SENT_193	[p5l1111t2265r1199b2282],
8	(	NN	O	(	appos	5	SENT_193	[p5l190t2303r284b2337],
9	78	CD	PERCENT	78	number	10	SENT_193	[p5l190t2303r284b2337],
10	%	NN	PERCENT	%	amod	8	SENT_193	[p5l190t2303r284b2337],
11	)	CD	NUMBER	)	num	12	SENT_193	[p5l190t2303r284b2337],
12	patients	NNS	O	patient	dep	8	SENT_193	[p5l297t2306r427b2340],
13	showed	VBD	O	show	_	0	SENT_193	[p5l440t2305r559b2331],
14	a	DT	O	a	det	15	SENT_193	[p5l571t2314r587b2331],
15	reduction	NN	O	reduction	dobj	13	SENT_193	[p5l600t2305r759b2331],
16	of	IN	O	of	_	0	SENT_193	[p5l771t2305r806b2331],
17	the	DT	O	the	det	19	SENT_193	[p5l816t2305r865b2331],
18	lymphatic	JJ	O	lymphatic	amod	19	SENT_193	[p5l878t2305r1038b2340],
19	vessels	NNS	O	vessel	prep_of	15	SENT_193	[p5l1051t2305r1155b2331],
20	in	IN	O	in	_	0	SENT_193	[p5l1168t2306r1199b2330],
21	comparison	NN	O	comparison	prep_in	19	SENT_193	[p5l189t2354r382b2388],
22	to	TO	O	to	_	0	SENT_193	[p5l399t2358r429b2379],
23	1/8	CD	PERCENT	1/8	number	24	SENT_193	[p5l449t2353r491b2379],
24	(	CD	PERCENT	(	prep_to	13	SENT_193	[p5l509t2353r603b2385],
25	13	CD	PERCENT	13	num	26	SENT_193	[p5l509t2353r603b2385],
26	%	NN	PERCENT	%	npadvmod	13	SENT_193	[p5l509t2353r603b2385],
27	)	CD	NUMBER	)	num	28	SENT_193	[p5l509t2353r603b2385],
28	patients	NNS	O	patient	dep	26	SENT_193	[p5l620t2354r750b2388],
29	in	IN	O	in	_	0	SENT_193	[p5l767t2354r797b2378],
30	the	DT	O	the	det	34	SENT_193	[p5l815t2353r864b2379],
31	placebo	NN	O	placebo	nn	34	SENT_193	[p5l881t2353r1006b2388],
32	group	NN	O	group	nn	34	SENT_193	[p5l1023t2362r1119b2388],
33	(	CD	NUMBER	(	num	34	SENT_193	[p5l1138t2354r1164b2388],
34	[	NN	O	[	prep_in	13	SENT_193	[p5l1138t2354r1164b2388],
35	7	CD	NUMBER	7	number	36	SENT_193	[p5l1138t2354r1164b2388],
36	=	JJ	O	=	amod	34	SENT_193	[p5l1177t2364r1202b2373],
37	0.0319	CD	NUMBER	0.0319	nsubj	13	SENT_193	[p5l189t2401r300b2432],
38	,	,	O	,	_	0	SENT_193	[p5l189t2401r300b2432],
39	Table	NNP	O	Table	appos	37	SENT_193	[p5l326t2401r417b2427],
40	2	CD	NUMBER	2	number	41	SENT_193	[p5l443t2401r478b2433],
41	)	CD	NUMBER	)	dep	39	SENT_193	[p5l443t2401r478b2433],
42	.	.	O	.	_	0	SENT_193	[p5l443t2401r478b2433],

1	In	IN	O	in	_	0	SENT_194	[p5l504t2402r537b2426],
2	addition	NN	O	addition	prep_in	16	SENT_194	[p5l564t2401r709b2432],
3	,	,	O	,	_	0	SENT_194	[p5l564t2401r709b2432],
4	lymphatic	JJ	O	lymphatic	amod	5	SENT_194	[p5l735t2401r895b2436],
5	vessels	NNS	O	vessel	nsubjpass	16	SENT_194	[p5l921t2401r1025b2427],
6	that	WDT	O	that	nsubj	8	SENT_194	[p5l1052t2401r1115b2427],
7	had	VBD	O	have	aux	8	SENT_194	[p5l1140t2401r1199b2427],
8	contained	VBN	O	contain	rcmod	5	SENT_194	[p5l1277t206r1439b232],
9	adult	JJ	O	adult	amod	10	SENT_194	[p5l1457t206r1539b232],
10	worms	NNS	O	worm	dobj	8	SENT_194	[p5l1556t215r1662b232],
11	at	IN	O	at	_	0	SENT_194	[p5l1681t211r1710b232],
12	study	NN	O	study	nn	13	SENT_194	[p5l1727t206r1812b241],
13	onset	NN	O	onset	prep_at	8	SENT_194	[p5l1830t211r1916b232],
14	were	VBD	O	be	auxpass	16	SENT_194	[p5l1933t215r2009b232],
15	also	RB	O	also	advmod	16	SENT_194	[p5l2027t206r2087b232],
16	reduced	VBN	O	reduce	_	0	SENT_194	[p5l2106t206r2237b232],
17	to	TO	O	to	aux	18	SENT_194	[p5l2256t212r2286b232],
18	normal	JJ	O	normal	xcomp	16	SENT_194	[p5l1277t252r1394b278],
19	in	IN	O	in	_	0	SENT_194	[p5l1410t253r1440b277],
20	the	DT	O	the	det	22	SENT_194	[p5l1456t252r1505b278],
21	doxycycline	NN	O	doxycycline	nn	22	SENT_194	[p5l1520t252r1711b287],
22	group	NN	O	group	prep_in	18	SENT_194	[p5l1726t261r1823b287],
23	at	IN	O	at	_	0	SENT_194	[p5l1839t257r1868b278],
24	24	CD	NUMBER	24	num	25	SENT_194	[p5l1883t252r1919b279],
25	mo.	NN	O	mo.	prep_at	16	SENT_194	[p5l1934t261r1992b278],
26	.	.	O	.	_	0	SENT_194	[p5l1934t261r1992b278],

1	Incidence	NN	O	incidence	_	0	SENT_195	[p5l1313t298r1474b324],
2	of	IN	O	of	_	0	SENT_195	[p5l1501t298r1536b324],
3	hydrocele	NN	O	hydrocele	prep_of	1	SENT_195	[p5l1560t298r1721b333],
4	during	IN	O	during	_	0	SENT_195	[p5l1749t298r1859b333],
5	the	DT	O	the	det	8	SENT_195	[p5l1887t298r1937b324],
6	24-mo	JJ	DURATION	24-mo	amod	8	SENT_195	[p5l1965t298r2065b325],
7	observation	NN	O	observation	nn	8	SENT_195	[p5l2092t298r2287b324],
8	period	NN	O	period	prep_during	1	SENT_195	[p5l1275t344r1391b379],
9	.	.	O	.	_	0	SENT_195	[p5l1275t344r1391b379],

1	In	IN	O	in	_	0	SENT_196	[p5l1413t345r1446b369],
2	support	NN	O	support	prep_in	20	SENT_196	[p5l1468t349r1595b379],
3	of	IN	O	of	_	0	SENT_196	[p5l1616t344r1651b370],
4	the	DT	O	the	det	5	SENT_196	[p5l1670t344r1719b370],
5	hypothesis	NN	O	hypothesis	prep_of	2	SENT_196	[p5l1740t344r1912b379],
6	that	IN	O	that	complm	9	SENT_196	[p5l1934t344r1997b370],
7	doxycycline	NN	O	doxycycline	nsubj	9	SENT_196	[p5l2018t344r2209b379],
8	can	MD	O	can	aux	9	SENT_196	[p5l2231t353r2286b370],
9	ameliorate	VB	O	ameliorate	dep	5	SENT_196	[p5l1277t390r1451b416],
10	lymphatic	JJ	O	lymphatic	amod	12	SENT_196	[p5l1468t390r1628b425],
11	vessel	NN	O	vessel	nn	12	SENT_196	[p5l1646t390r1736b416],
12	alteration	NN	O	alteration	dobj	9	SENT_196	[p5l1754t390r1921b421],
13	,	,	O	,	_	0	SENT_196	[p5l1754t390r1921b421],
14	more	JJR	O	more	amod	15	SENT_196	[p5l1939t399r2023b416],
15	patients	NNS	O	patient	nsubj	20	SENT_196	[p5l2041t391r2170b425],
16	in	IN	O	in	_	0	SENT_196	[p5l2188t391r2219b415],
17	the	DT	O	the	det	19	SENT_196	[p5l2237t390r2286b416],
18	placebo	NN	O	placebo	nn	19	SENT_196	[p5l1277t436r1402b471],
19	group	NN	O	group	prep_in	15	SENT_196	[p5l1416t445r1513b471],
20	developed	VBD	O	develop	_	0	SENT_196	[p5l1527t436r1693b471],
21	a	DT	O	a	det	22	SENT_196	[p5l1707t445r1723b462],
22	hydrocele	NN	O	hydrocele	dobj	20	SENT_196	[p5l1736t436r1895b471],
23	during	IN	O	during	_	0	SENT_196	[p5l1909t436r2018b471],
24	the	DT	O	the	det	26	SENT_196	[p5l2032t436r2081b462],
25	observation	NN	O	observation	nn	26	SENT_196	[p5l2095t436r2286b462],
26	period	NN	O	period	prep_during	20	SENT_196	[p5l1277t482r1384b517],
27	compared	VBN	O	compare	_	0	SENT_196	[p5l1396t482r1560b517],
28	to	TO	O	to	prepc_compared_to	20	SENT_196	[p5l1573t487r1603b508],
29	the	DT	O	the	det	31	SENT_196	[p5l1617t482r1666b508],
30	doxycycline	NN	O	doxycycline	nn	31	SENT_196	[p5l1678t482r1870b517],
31	group	NN	O	group	pobj	20	SENT_196	[p5l1882t491r1986b517],
32	.	.	O	.	_	0	SENT_196	[p5l1882t491r1986b517],

1	Thus	RB	O	thus	advmod	9	SENT_197	[p5l1999t482r2086b513],
2	,	,	O	,	_	0	SENT_197	[p5l1999t482r2086b513],
3	one	CD	NUMBER	one	num	4	SENT_197	[p5l2099t491r2158b508],
4	patient	NN	O	patient	nsubj	9	SENT_197	[p5l2170t483r2287b517],
5	in	IN	O	in	_	0	SENT_197	[p5l1277t529r1308b553],
6	the	DT	O	the	det	8	SENT_197	[p5l1323t528r1372b554],
7	doxycycline-treated	JJ	O	doxycycline-treated	amod	8	SENT_197	[p5l1387t528r1710b563],
8	group	NN	O	group	prep_in	4	SENT_197	[p5l1725t537r1821b563],
9	developed	VBD	O	develop	_	0	SENT_197	[p5l1836t528r2002b563],
10	a	DT	O	a	det	12	SENT_197	[p5l2017t537r2033b554],
11	clinical	JJ	O	clinical	amod	12	SENT_197	[p5l2048t528r2164b554],
12	hydrocele	NN	O	hydrocele	dobj	9	SENT_197	[p5l2178t528r2286b563, p5l1277t574r1338b600],
13	whereas	IN	O	whereas	mark	20	SENT_197	[p5l1355t574r1484b600],
14	in	IN	O	in	_	0	SENT_197	[p5l1502t575r1532b599],
15	another	DT	O	another	det	16	SENT_197	[p5l1550t574r1678b600],
16	patient	NN	O	patient	prep_in	20	SENT_197	[p5l1694t575r1818b609],
17	,	,	O	,	_	0	SENT_197	[p5l1694t575r1818b609],
18	the	DT	O	the	det	19	SENT_197	[p5l1837t574r1886b600],
19	hydrocele	NN	O	hydrocele	nsubj	20	SENT_197	[p5l1902t574r2062b609],
20	disappeared	VBD	O	disappear	advcl	9	SENT_197	[p5l2079t574r2285b609],
21	.	.	O	.	_	0	SENT_197	[p5l2079t574r2285b609],

1	In	IN	O	in	_	0	SENT_198	[p5l1276t621r1309b645],
2	contrast	NN	O	contrast	prep_in	11	SENT_198	[p5l1338t625r1480b651],
3	,	,	O	,	_	0	SENT_198	[p5l1338t625r1480b651],
4	in	IN	O	in	_	0	SENT_198	[p5l1510t621r1540b645],
5	the	DT	O	the	det	7	SENT_198	[p5l1569t620r1619b646],
6	placebo-treated	JJ	O	placebo-treated	amod	7	SENT_198	[p5l1647t620r1908b655],
7	group	NN	O	group	prep_in	11	SENT_198	[p5l1936t629r2042b655],
8	,	,	O	,	_	0	SENT_198	[p5l1936t629r2042b655],
9	ﬁve	NN	O	ﬁve	nn	10	SENT_198	[p5l2070t620r2126b646],
10	patients	NNS	O	patient	nsubj	11	SENT_198	[p5l2155t621r2286b655],
11	developed	VBD	O	develop	_	0	SENT_198	[p5l1277t666r1443b701],
12	hydrocele	NN	O	hydrocele	nsubj	15	SENT_198	[p5l1461t666r1620b701],
13	(	CD	NUMBER	(	number	14	SENT_198	[p5l1640t666r1735b698],
14	three	CD	NUMBER	three	npadvmod	15	SENT_198	[p5l1640t666r1735b698],
15	subclinical	JJ	O	subclinical	xcomp	11	SENT_198	[p5l1753t666r1934b697],
16	,	,	O	,	_	0	SENT_198	[p5l1753t666r1934b697],
17	as	IN	O	as	mark	18	SENT_198	[p5l1954t675r1983b692],
18	assessed	VBN	O	assess	advcl	11	SENT_198	[p5l2002t666r2131b692],
19	by	IN	O	by	_	0	SENT_198	[p5l2149t666r2186b701],
20	USG	NNP	ORGANIZATION	USG	prep_by	18	SENT_198	[p5l2204t666r2286b697],
21	,	,	O	,	_	0	SENT_198	[p5l2204t666r2286b697],
22	and	CC	O	and	_	0	SENT_198	[p5l1277t712r1336b738],
23	two	CD	NUMBER	two	num	25	SENT_198	[p5l1354t717r1410b738],
24	clinical	JJ	O	clinical	amod	25	SENT_198	[p5l1428t712r1563b744],
25	)	NN	O	)	conj_and	20	SENT_198	[p5l1428t712r1563b744],
26	.	.	O	.	_	0	SENT_198	[p5l1428t712r1563b744],

1	This	DT	O	this	det	2	SENT_199	[p5l1581t712r1650b738],
2	increase	NN	O	increase	nsubj	10	SENT_199	[p5l1669t713r1801b738],
3	of	IN	O	of	_	0	SENT_199	[p5l1819t712r1854b738],
4	hydrocele	NN	O	hydrocele	prep_of	2	SENT_199	[p5l1867t712r2026b747],
5	in	IN	O	in	_	0	SENT_199	[p5l2045t713r2075b737],
6	the	DT	O	the	det	8	SENT_199	[p5l2094t712r2143b738],
7	placebo	NN	O	placebo	nn	8	SENT_199	[p5l2161t712r2286b747],
8	group	NN	O	group	prep_in	4	SENT_199	[p5l1276t767r1373b793],
9	was	VBD	O	be	cop	10	SENT_199	[p5l1392t767r1448b784],
10	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_199	[p5l1469t758r1637b793],
11	when	WRB	O	when	advmod	12	SENT_199	[p5l1656t758r1742b784],
12	compared	VBN	O	compare	advcl	10	SENT_199	[p5l1762t758r1926b793],
13	to	TO	O	to	_	0	SENT_199	[p5l1947t764r1977b784],
14	the	DT	O	the	det	18	SENT_199	[p5l1999t758r2048b784],
15	pretreatment	NN	O	pretreatment	nn	18	SENT_199	[p5l2068t763r2287b793],
16	status	NN	O	status	nn	18	SENT_199	[p5l1277t809r1368b830],
17	(	CD	NUMBER	(	num	18	SENT_199	[p5l1381t804r1550b839],
18	hydrocele	NN	O	hydrocele	prep_to	12	SENT_199	[p5l1381t804r1550b839],
19	positive/negative	JJ	O	positive/negative	amod	18	SENT_199	[p5l1562t804r1834b839],
20	at	IN	O	at	_	0	SENT_199	[p5l1846t809r1875b830],
21	pretreatment	NN	O	pretreatment	prep_at	19	SENT_199	[p5l1887t809r2112b839],
22	:	:	O	:	_	0	SENT_199	[p5l1887t809r2112b839],
23	1/10	CD	NUMBER	1/10	dep	18	SENT_199	[p5l2128t804r2198b834],
24	;	:	O	;	_	0	SENT_199	[p5l2128t804r2198b834],
25	at	IN	O	at	_	0	SENT_199	[p5l2210t809r2239b830],
26	24	CD	DURATION	24	num	27	SENT_199	[p5l2251t804r2287b831],
27	mo	NN	DURATION	mo	prep_at	23	SENT_199	[p5l1277t859r1335b876],
28	:	:	O	:	_	0	SENT_199	[p5l1277t859r1335b876],
29	6/5	CD	NUMBER	6/5	dep	18	SENT_199	[p5l1351t850r1403b881],
30	,	,	O	,	_	0	SENT_199	[p5l1351t850r1403b881],
31	p	NN	O	p	appos	29	SENT_199	[p5l1415t853r1435b885],
32	=	JJ	O	=	amod	31	SENT_199	[p5l1447t861r1471b870],
33	0.0221	CD	NUMBER	0.0221	tmod	32	SENT_199	[p5l1484t850r1594b881],
34	,	,	O	,	_	0	SENT_199	[p5l1484t850r1594b881],
35	chi-square	JJ	O	chi-square	amod	37	SENT_199	[p5l1610t850r1779b885],
36	test	NN	O	test	nn	37	SENT_199	[p5l1796t851r1870b882],
37	)	NN	O	)	appos	18	SENT_199	[p5l1796t851r1870b882],
38	.	.	O	.	_	0	SENT_199	[p5l1796t851r1870b882],

1	Lymphangiogenic	JJ	O	lymphangiogenic	amod	2	SENT_200	[p5l1313t896r1605b931],
2	factors	NNS	O	factor	_	0	SENT_200	[p5l1621t896r1741b922],
3	.	.	O	.	_	0	SENT_200	[p5l1621t896r1741b922],

1	Mean	NN	O	mean	nn	3	SENT_201	[p5l1759t897r1847b922],
2	plasma	NN	O	plasma	nn	3	SENT_201	[p5l1864t896r1977b931],
3	concentrations	NNS	O	concentration	_	0	SENT_201	[p5l1993t897r2238b922],
4	of	IN	O	of	_	0	SENT_201	[p5l2255t896r2290b922],
5	VEGF-C	NN	O	vegf-c	nn	8	SENT_201	[p5l1275t942r1409b968],
6	and	CC	O	and	_	0	SENT_201	[p5l1425t942r1484b968],
7	soluble	JJ	O	soluble	nn	8	SENT_201	[p5l1499t942r1613b968],
8	VEGFR-3	NN	O	vegfr-3	prep_of	3	SENT_201	[p5l1627t942r1780b968],
9	(	CD	NUMBER	(	num	11	SENT_201	[p5l1797t942r1984b974],
10	sVEGFR-3	NN	O	svegfr-3	nn	11	SENT_201	[p5l1797t942r1984b974],
11	)	NN	O	)	nsubj	14	SENT_201	[p5l1797t942r1984b974],
12	were	VBD	O	be	cop	14	SENT_201	[p5l1999t951r2075b968],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_201	[p5l2090t942r2287b977],
14	elevated	JJ	O	elevated	rcmod	8	SENT_201	[p5l1277t988r1410b1014],
15	in	IN	O	in	_	0	SENT_201	[p5l1423t989r1454b1013],
16	microﬁlaremic	JJ	O	microﬁlaremic	amod	17	SENT_201	[p5l1467t988r1707b1014],
17	patients	NNS	O	patient	prep_in	14	SENT_201	[p5l1721t989r1851b1023],
18	(	IN	O	(	_	0	SENT_201	[p5l1865t990r1892b1023],
19	p	NN	O	p	prep_(	14	SENT_201	[p5l1865t990r1892b1023],
20	<	VBG	O	<	partmod	19	SENT_201	[p5l1906t990r1931b1012],
21	0.0001	CD	NUMBER	0.0001	dobj	20	SENT_201	[p5l1947t988r2057b1019],
22	,	,	O	,	_	0	SENT_201	[p5l1947t988r2057b1019],
23	Figure	NNP	O	Figure	dobj	20	SENT_201	[p5l2071t989r2175b1023],
24	3	CD	NUMBER	3	num	23	SENT_201	[p5l2189t988r2213b1019],
25	,	,	O	,	_	0	SENT_201	[p5l2189t988r2213b1019],
26	and	CC	O	and	_	0	SENT_201	[p5l2228t988r2286b1014],
27	[	NN	O	[	dobj	20	SENT_201	[p5l1273t1037r1293b1069],
28	7	CD	NUMBER	7	num	27	SENT_201	[p5l1273t1037r1293b1069],
29	=	JJ	O	=	amod	3	SENT_201	[p5l1314t1045r1338b1054],
30	0.0006	CD	NUMBER	0.0006	tmod	29	SENT_201	[p5l1361t1034r1471b1065],
31	,	,	O	,	_	0	SENT_201	[p5l1361t1034r1471b1065],
32	Figure	NNP	O	Figure	appos	3	SENT_201	[p5l1496t1035r1601b1069],
33	4	CD	NUMBER	4	num	32	SENT_201	[p5l1625t1035r1650b1065],
34	,	,	O	,	_	0	SENT_201	[p5l1625t1035r1650b1065],
35	respectively	RB	O	respectively	advmod	36	SENT_201	[p5l1676t1034r1878b1069],
36	)	CD	NUMBER	)	dep	3	SENT_201	[p5l1676t1034r1878b1069],
37	compared	VBN	O	compare	_	0	SENT_201	[p5l1903t1034r2067b1069],
38	to	TO	O	to	prepc_compared_to	36	SENT_201	[p5l2093t1040r2123b1060],
39	endemic	JJ	O	endemic	amod	40	SENT_201	[p5l2148t1034r2285b1060],
40	controls	NNS	O	control	pobj	36	SENT_201	[p5l1277t1080r1417b1111],
41	,	,	O	,	_	0	SENT_201	[p5l1277t1080r1417b1111],
42	i.e.	FW	O	i.e.	dep	36	SENT_201	[p5l1440t1081r1491b1111],
43	,	,	O	,	_	0	SENT_201	[p5l1440t1081r1491b1111],
44	residents	NNS	O	resident	dep	36	SENT_201	[p5l1514t1080r1659b1106],
45	of	IN	O	of	_	0	SENT_201	[p5l1681t1080r1715b1106],
46	the	DT	O	the	det	49	SENT_201	[p5l1734t1080r1783b1106],
47	same	JJ	O	same	amod	49	SENT_201	[p5l1805t1089r1885b1106],
48	endemic	JJ	O	endemic	amod	49	SENT_201	[p5l1906t1080r2043b1106],
49	area	NN	O	area	prep_of	44	SENT_201	[p5l2066t1089r2135b1106],
50	with	IN	O	with	_	0	SENT_201	[p5l2155t1080r2224b1106],
51	no	DT	O	no	det	52	SENT_201	[p5l2246t1089r2286b1106],
52	evidence	NN	O	evidence	prep_with	49	SENT_201	[p5l1277t1126r1419b1152],
53	of	IN	O	of	_	0	SENT_201	[p5l1431t1126r1466b1152],
54	infection	NN	O	infection	prep_of	52	SENT_201	[p5l1475t1126r1622b1152],
55	despite	IN	O	despite	_	0	SENT_201	[p5l1634t1126r1750b1161],
56	exposure	NN	O	exposure	prep_despite	49	SENT_201	[p5l1762t1135r1910b1161],
57	to	TO	O	to	_	0	SENT_201	[p5l1924t1131r1954b1152],
58	infective	JJ	O	infective	amod	59	SENT_201	[p5l1967t1126r2106b1152],
59	larvae	NNS	O	larva	prep_to	49	SENT_201	[p5l2118t1126r2214b1152],
60	(	VBP	O	(	rcmod	59	SENT_201	[p5l2228t1127r2286b1158],
61	see	VB	O	see	xcomp	60	SENT_201	[p5l2228t1127r2286b1158],
62	also	RB	O	also	advmod	61	SENT_201	[p5l1277t1172r1337b1198],
63	Materials	NNPS	O	Materials	dobj	61	SENT_201	[p5l1361t1172r1510b1198],
64	and	CC	O	and	_	0	SENT_201	[p5l1535t1172r1594b1198],
65	Methods	NNS	O	method	conj_and	63	SENT_201	[p5l1617t1172r1775b1204],
66	)	CD	NUMBER	)	num	65	SENT_201	[p5l1617t1172r1775b1204],
67	.	.	O	.	_	0	SENT_201	[p5l1617t1172r1775b1204],

1	Following	VBG	O	follow	_	0	SENT_202	[p5l1799t1172r1959b1207],
2	doxycycline	NN	O	doxycycline	nn	3	SENT_202	[p5l1982t1172r2173b1207],
3	treatment	NN	O	treatment	prep_following	5	SENT_202	[p5l2198t1177r2286b1198, p5l1277t1223r1368b1249],
4	,	,	O	,	_	0	SENT_202	[p5l2198t1177r2286b1198, p5l1277t1223r1368b1249],
5	mean	VB	O	mean	_	0	SENT_202	[p5l1382t1227r1470b1244],
6	values	NNS	O	value	nsubjpass	15	SENT_202	[p5l1483t1218r1581b1244],
7	of	IN	O	of	_	0	SENT_202	[p5l1595t1218r1629b1244],
8	VEGF-C	NN	O	vegf-c	prep_of	6	SENT_202	[p5l1639t1218r1772b1244],
9	in	IN	O	in	_	0	SENT_202	[p5l1787t1219r1817b1243],
10	the	DT	O	the	det	12	SENT_202	[p5l1832t1218r1881b1244],
11	doxycycline	NN	O	doxycycline	nn	12	SENT_202	[p5l1895t1218r2086b1253],
12	group	NN	O	group	prep_in	8	SENT_202	[p5l2100t1227r2197b1253],
13	were	VBD	O	be	auxpass	15	SENT_202	[p5l2210t1227r2286b1244],
14	signiﬁcantly	RB	O	signiﬁcantly	advmod	15	SENT_202	[p5l1277t1264r1473b1299],
15	reduced	VBN	O	reduce	ccomp	5	SENT_202	[p5l1486t1264r1617b1290],
16	(	NN	O	(	nn	17	SENT_202	[p5l1631t1265r1657b1299],
17	[	NN	O	[	dobj	15	SENT_202	[p5l1631t1265r1657b1299],
18	7	CD	NUMBER	7	num	17	SENT_202	[p5l1631t1265r1657b1299],
19	=	JJ	O	=	advmod	15	SENT_202	[p5l1667t1275r1691b1284],
20	0.0198	CD	NUMBER	0.0198	dep	19	SENT_202	[p5l1701t1264r1812b1295],
21	,	,	O	,	_	0	SENT_202	[p5l1701t1264r1812b1295],
22	Figure	NNP	O	Figure	dep	19	SENT_202	[p5l1825t1265r1929b1299],
23	5	CD	NUMBER	5	num	22	SENT_202	[p5l1943t1264r1978b1296],
24	)	CD	NUMBER	)	dep	22	SENT_202	[p5l1943t1264r1978b1296],
25	,	,	O	,	_	0	SENT_202	[p5l1943t1264r1978b1296],
26	whereas	IN	O	whereas	mark	28	SENT_202	[p5l1991t1264r2121b1290],
27	there	EX	O	there	expl	28	SENT_202	[p5l2135t1264r2218b1290],
28	was	VBD	O	be	dep	19	SENT_202	[p5l2230t1273r2286b1290],
29	no	DT	O	no	det	31	SENT_202	[p5l1277t1319r1317b1336],
30	signiﬁcant	JJ	O	signiﬁcant	amod	31	SENT_202	[p5l1333t1310r1502b1345],
31	reduction	NN	O	reduction	nsubj	28	SENT_202	[p5l1518t1310r1677b1336],
32	in	IN	O	in	_	0	SENT_202	[p5l1693t1311r1724b1335],
33	the	DT	O	the	det	35	SENT_202	[p5l1741t1310r1790b1336],
34	placebo	NN	O	placebo	nn	35	SENT_202	[p5l1806t1310r1931b1345],
35	group	NN	O	group	prep_in	31	SENT_202	[p5l1948t1319r2052b1345],
36	.	.	O	.	_	0	SENT_202	[p5l1948t1319r2052b1345],

1	Mean	NN	O	mean	nn	3	SENT_203	[p5l2069t1311r2158b1336],
2	plasma	NN	O	plasma	nn	3	SENT_203	[p5l2174t1310r2287b1345],
3	values	NNS	O	value	nsubjpass	13	SENT_203	[p5l1276t1356r1374b1382],
4	of	IN	O	of	_	0	SENT_203	[p5l1400t1356r1435b1382],
5	SVEGFR-3	NN	O	svegfr-3	prep_of	3	SENT_203	[p5l1458t1356r1623b1382],
6	in	IN	O	in	_	0	SENT_203	[p5l1650t1357r1680b1381],
7	the	DT	O	the	det	9	SENT_203	[p5l1708t1356r1757b1382],
8	doxycycline	NN	O	doxycycline	nn	9	SENT_203	[p5l1783t1356r1974b1391],
9	group	NN	O	group	prep_in	5	SENT_203	[p5l2000t1365r2097b1391],
10	were	VBD	O	be	auxpass	13	SENT_203	[p5l2123t1365r2199b1382],
11	also	RB	O	also	advmod	13	SENT_203	[p5l2226t1356r2286b1382],
12	signiﬁcantly	RB	O	signiﬁcantly	advmod	13	SENT_203	[p5l1277t1402r1473b1437],
13	reduced	VBN	O	reduce	dep	29	SENT_203	[p5l1488t1402r1619b1428],
14	12	CD	DURATION	12	num	15	SENT_203	[p5l1637t1402r1670b1429],
15	mo	NN	DURATION	mo	dobj	13	SENT_203	[p5l1685t1411r1735b1428],
16	after	IN	O	after	_	0	SENT_203	[p5l1751t1402r1827b1428],
17	doxycycline	NN	O	doxycycline	nn	18	SENT_203	[p5l1841t1402r2032b1437],
18	treatment	NN	O	treatment	prep_after	15	SENT_203	[p5l2048t1407r2210b1428],
19	to	TO	O	to	_	0	SENT_203	[p5l2225t1407r2255b1428],
20	a	DT	O	a	det	22	SENT_203	[p5l2271t1411r2287b1428],
21	level	NN	O	level	nn	22	SENT_203	[p5l1276t1448r1349b1474],
22	close	NN	O	close	prep_to	13	SENT_203	[p5l1363t1448r1441b1474],
23	to	TO	O	to	_	0	SENT_203	[p5l1456t1453r1486b1474],
24	that	DT	O	that	prep_to	13	SENT_203	[p5l1502t1448r1565b1474],
25	of	IN	O	of	_	0	SENT_203	[p5l1578t1448r1613b1474],
26	the	DT	O	the	det	28	SENT_203	[p5l1624t1448r1673b1474],
27	endemic	JJ	O	endemic	amod	28	SENT_203	[p5l1687t1448r1824b1474],
28	normals	NNS	O	normal	prep_of	24	SENT_203	[p5l1839t1448r1970b1474],
29	(	VBP	O	(	_	0	SENT_203	[p5l1985t1449r2011b1483],
30	[	NN	O	[	dobj	29	SENT_203	[p5l1985t1449r2011b1483],
31	7	CD	NUMBER	7	num	37	SENT_203	[p5l1985t1449r2011b1483],
32	=	JJ	O	=	amod	37	SENT_203	[p5l2021t1459r2046b1468],
33	0.0125	CD	NUMBER	0.0125	tmod	32	SENT_203	[p5l2057t1448r2168b1479],
34	,	,	O	,	_	0	SENT_203	[p5l2057t1448r2168b1479],
35	Figure	NNP	O	Figure	appos	33	SENT_203	[p5l2182t1449r2286b1483],
36	6	CD	NUMBER	6	num	35	SENT_203	[p5l1277t1494r1312b1526],
37	)	NN	O	)	nsubj	29	SENT_203	[p5l1277t1494r1312b1526],
38	.	.	O	.	_	0	SENT_203	[p5l1277t1494r1312b1526],

1	In	IN	O	in	_	0	SENT_204	[p5l1328t1495r1361b1519],
2	contrast	NN	O	contrast	prep_in	9	SENT_204	[p5l1376t1499r1517b1525],
3	,	,	O	,	_	0	SENT_204	[p5l1376t1499r1517b1525],
4	mean	NN	O	mean	nn	5	SENT_204	[p5l1533t1503r1621b1520],
5	levels	NNS	O	level	nsubj	9	SENT_204	[p5l1636t1494r1722b1520],
6	remained	VBD	O	remain	cop	9	SENT_204	[p5l1738t1494r1893b1520],
7	almost	RB	O	almost	advmod	9	SENT_204	[p5l1908t1494r2015b1520],
8	the	DT	O	the	det	9	SENT_204	[p5l2030t1494r2080b1520],
9	same	JJ	O	same	_	0	SENT_204	[p5l2095t1503r2175b1520],
10	in	IN	O	in	_	0	SENT_204	[p5l2191t1495r2221b1519],
11	the	DT	O	the	det	13	SENT_204	[p5l2237t1494r2286b1520],
12	placebo	NN	O	placebo	nn	13	SENT_204	[p5l1277t1540r1402b1575],
13	patients	NNS	O	patient	prep_in	9	SENT_204	[p5l1417t1541r1554b1575],
14	.	.	O	.	_	0	SENT_204	[p5l1417t1541r1554b1575],

1	Samples	NNS	O	sample	nsubj	9	SENT_205	[p5l1569t1540r1701b1575],
2	from	IN	O	from	_	0	SENT_205	[p5l1716t1540r1795b1566],
3	24	CD	DURATION	24	num	6	SENT_205	[p5l1810t1540r1846b1567],
4	mo	NN	DURATION	mo	nn	6	SENT_205	[p5l1859t1549r1909b1566],
5	post	NN	O	post	nn	6	SENT_205	[p5l1923t1545r1991b1575],
6	therapy	NN	O	therapy	prep_from	1	SENT_205	[p5l2006t1540r2129b1575],
7	were	VBD	O	be	cop	9	SENT_205	[p5l2142t1549r2218b1566],
8	not	RB	O	not	neg	9	SENT_205	[p5l2233t1545r2287b1566],
9	sufﬁcient	JJ	O	sufﬁcient	_	0	SENT_205	[p5l1277t1586r1427b1612],
10	in	IN	O	in	_	0	SENT_205	[p5l1453t1587r1484b1611],
11	volume	NN	O	volume	prep_in	9	SENT_205	[p5l1509t1586r1627b1612],
12	for	IN	O	for	_	0	SENT_205	[p5l1653t1586r1702b1612],
13	VEGF-C	NN	O	vegf-c	nn	16	SENT_205	[p5l1725t1586r1859b1612],
14	and	CC	O	and	_	0	SENT_205	[p5l1886t1586r1945b1612],
15	sVEGFR-3	NN	O	svegfr-3	nn	16	SENT_205	[p5l1971t1586r2137b1612],
16	analysis	NN	O	analysis	prep_for	11	SENT_205	[p5l2163t1586r2286b1621],
17	because	IN	O	because	mark	20	SENT_205	[p5l1276t1632r1403b1658],
18	most	JJS	O	most	amod	19	SENT_205	[p5l1420t1637r1498b1658],
19	patients	NNS	O	patient	nsubj	20	SENT_205	[p5l1515t1633r1644b1667],
20	refused	VBD	O	refuse	advcl	9	SENT_205	[p5l1663t1632r1782b1658],
21	to	TO	O	to	aux	22	SENT_205	[p5l1800t1638r1830b1658],
22	donate	VB	O	donate	xcomp	20	SENT_205	[p5l1848t1632r1959b1658],
23	the	DT	O	the	det	26	SENT_205	[p5l1978t1632r2027b1658],
24	usual	JJ	O	usual	amod	26	SENT_205	[p5l2044t1632r2127b1658],
25	10	CD	NUMBER	10	tmod	24	SENT_205	[p5l2147t1632r2180b1657],
26	ml	NN	O	ml	dobj	22	SENT_205	[p5l2198t1632r2238b1657],
27	of	IN	O	of	_	0	SENT_205	[p5l2255t1632r2290b1658],
28	venous	JJ	O	venous	amod	29	SENT_205	[p5l1276t1687r1388b1704],
29	blood	NN	O	blood	prep_of	26	SENT_205	[p5l1403t1678r1503b1704],
30	.	.	O	.	_	0	SENT_205	[p5l1403t1678r1503b1704],

1	Associations	NNS	O	association	_	0	SENT_206	[p5l1313t1724r1517b1750],
2	between	IN	O	between	_	0	SENT_206	[p5l1533t1724r1669b1750],
3	plasma	NN	O	plasma	nn	4	SENT_206	[p5l1684t1724r1799b1759],
4	levels	NNS	O	level	prep_between	1	SENT_206	[p5l1815t1724r1905b1750],
5	of	IN	O	of	_	0	SENT_206	[p5l1922t1724r1956b1750],
6	growth	NN	O	growth	nn	7	SENT_206	[p5l1969t1724r2084b1759],
7	factors	NNS	O	factor	prep_of	1	SENT_206	[p5l2100t1724r2211b1750],
8	and	CC	O	and	_	0	SENT_206	[p5l2227t1724r2287b1750],
9	parasitological	JJ	O	parasitological	amod	10	SENT_206	[p5l1275t1770r1515b1805],
10	parameters	NNS	O	parameter	prep_of	1	SENT_206	[p5l1531t1774r1725b1805],
11	.	.	O	.	_	0	SENT_206	[p5l1531t1774r1725b1805],

1	Using	VBG	O	use	partmod	6	SENT_207	[p5l1744t1771r1838b1805],
2	pretreatment	NN	O	pretreatment	nn	3	SENT_207	[p5l1855t1775r2074b1805],
3	samples	NNS	O	sample	dobj	1	SENT_207	[p5l2092t1770r2226b1805],
4	,	,	O	,	_	0	SENT_207	[p5l2092t1770r2226b1805],
5	we	PRP	O	we	nsubj	6	SENT_207	[p5l2244t1779r2286b1796],
6	found	VBD	O	find	_	0	SENT_207	[p5l1276t1816r1373b1842],
7	a	DT	O	a	det	9	SENT_207	[p5l1387t1825r1403b1842],
8	positive	JJ	O	positive	amod	9	SENT_207	[p5l1416t1817r1542b1851],
9	correlation	NN	O	correlation	nn	23	SENT_207	[p5l1556t1816r1739b1842],
10	between	IN	O	between	_	0	SENT_207	[p5l1752t1816r1887b1842],
11	VEGF-C	NN	O	vegf-c	nn	15	SENT_207	[p5l1899t1816r2033b1842],
12	and	CC	O	and	_	0	SENT_207	[p5l2048t1816r2107b1842],
13	SVEGFR-3	NN	O	svegfr-3	nn	15	SENT_207	[p5l2121t1816r2286b1842],
14	(	NN	O	(	nn	15	SENT_207	[p5l1278t1863r1301b1894],
15	r	NN	O	r	prep_between	9	SENT_207	[p5l1278t1863r1301b1894],
16	=	JJ	O	=	amod	9	SENT_207	[p5l1316t1873r1341b1882],
17	0.430	CD	NUMBER	0.430	tmod	16	SENT_207	[p5l1359t1862r1450b1893],
18	,	,	O	,	_	0	SENT_207	[p5l1359t1862r1450b1893],
19	[	CD	NUMBER	[	num	20	SENT_207	[p5l1468t1865r1487b1897],
20	7	CD	NUMBER	7	appos	9	SENT_207	[p5l1468t1865r1487b1897],
21	=	JJ	O	=	amod	23	SENT_207	[p5l1504t1873r1529b1882],
22	0.0014	CD	NUMBER	0.0014	tmod	21	SENT_207	[p5l1547t1862r1668b1894],
23	)	NN	O	)	dobj	6	SENT_207	[p5l1547t1862r1668b1894],
24	.	.	O	.	_	0	SENT_207	[p5l1547t1862r1668b1894],

1	No	DT	O	no	det	2	SENT_208	[p5l1689t1863r1736b1888],
2	correlation	NN	O	correlation	nsubjpass	4	SENT_208	[p5l1757t1862r1939b1888],
3	was	VBD	O	be	auxpass	4	SENT_208	[p5l1959t1871r2015b1888],
4	found	VBN	O	find	_	0	SENT_208	[p5l2035t1862r2132b1888],
5	between	IN	O	between	_	0	SENT_208	[p5l2152t1862r2286b1888],
6	VEGF-C	NN	O	vegf-c	prep_between	4	SENT_208	[p5l1275t1908r1409b1934],
7	and	CC	O	and	_	0	SENT_208	[p5l1423t1908r1482b1934],
8	lymphatic	JJ	O	lymphatic	amod	9	SENT_208	[p5l1494t1908r1655b1943],
9	dilation	NN	O	dilation	prep_between	4	SENT_208	[p5l1669t1908r1803b1939],
10	,	,	O	,	_	0	SENT_208	[p5l1669t1908r1803b1939],
11	but	CC	O	but	_	0	SENT_208	[p5l1816t1908r1870b1934],
12	a	DT	O	a	det	14	SENT_208	[p5l1883t1917r1899b1934],
13	strong	JJ	O	strong	amod	14	SENT_208	[p5l1911t1913r2014b1943],
14	trend	NN	O	trend	dep	26	SENT_208	[p5l2027t1908r2114b1934],
15	(	NN	O	(	nn	16	SENT_208	[p5l2128t1909r2184b1940],
16	r	NN	O	r	dep	14	SENT_208	[p5l2128t1909r2184b1940],
17	:	:	O	:	_	0	SENT_208	[p5l2128t1909r2184b1940],
18	0.390	CD	NUMBER	0.390	dep	14	SENT_208	[p5l2194t1908r2286b1939],
19	,	,	O	,	_	0	SENT_208	[p5l2194t1908r2286b1939],
20	[	CD	NUMBER	[	number	21	SENT_208	[p5l1273t1957r1293b1989],
21	7	CD	NUMBER	7	dep	22	SENT_208	[p5l1273t1957r1293b1989],
22	=	JJ	O	=	dep	18	SENT_208	[p5l1309t1965r1334b1974],
23	0.0514	CD	NUMBER	0.0514	num	24	SENT_208	[p5l1352t1954r1466b1986],
24	)	NN	O	)	nsubjpass	26	SENT_208	[p5l1352t1954r1466b1986],
25	was	VBD	O	be	auxpass	26	SENT_208	[p5l1486t1963r1541b1980],
26	noticed	VBN	O	notice	conj_but	4	SENT_208	[p5l1563t1954r1684b1980],
27	between	IN	O	between	_	0	SENT_208	[p5l1704t1954r1839b1980],
28	SVEGFR-3	NN	O	svegfr-3	nn	32	SENT_208	[p5l1859t1954r2025b1980],
29	and	CC	O	and	_	0	SENT_208	[p5l2046t1954r2105b1980],
30	lymphatic	JJ	O	lymphatic	conj_and	28	SENT_208	[p5l2125t1954r2285b1989],
31	vessel	NN	O	vessel	nn	32	SENT_208	[p5l1276t2000r1367b2026],
32	dilation	NN	O	dilation	prep_between	26	SENT_208	[p5l1381t2000r1515b2026],
33	.	.	O	.	_	0	SENT_208	[p5l1381t2000r1515b2026],

1	There	EX	O	there	expl	2	SENT_209	[p5l1530t2000r1627b2026],
2	was	VBD	O	be	_	0	SENT_209	[p5l1641t2009r1696b2026],
3	also	RB	O	also	advmod	2	SENT_209	[p5l1712t2000r1772b2026],
4	a	DT	O	a	det	6	SENT_209	[p5l1787t2009r1803b2026],
5	positive	JJ	O	positive	amod	6	SENT_209	[p5l1818t2001r1943b2035],
6	association	NN	O	association	nsubj	2	SENT_209	[p5l1958t2001r2137b2026],
7	between	IN	O	between	_	0	SENT_209	[p5l2152t2000r2286b2026],
8	levels	NNS	O	level	prep_between	6	SENT_209	[p5l1276t2046r1363b2072],
9	of	IN	O	of	_	0	SENT_209	[p5l1376t2046r1411b2072],
10	VEGF-C	NN	O	vegf-c	nn	14	SENT_209	[p5l1420t2046r1553b2072],
11	and	CC	O	and	_	0	SENT_209	[p5l1568t2046r1627b2072],
12	antigenemia	NN	O	antigenemia	conj_and	10	SENT_209	[p5l1640t2047r1842b2081],
13	(	NN	O	(	nn	14	SENT_209	[p5l1856t2047r1879b2078],
14	r	NN	O	r	prep_of	8	SENT_209	[p5l1856t2047r1879b2078],
15	=	JJ	O	=	amod	14	SENT_209	[p5l1888t2057r1912b2066],
16	0.434	CD	NUMBER	0.434	tmod	15	SENT_209	[p5l1923t2046r2014b2077],
17	,	,	O	,	_	0	SENT_209	[p5l1923t2046r2014b2077],
18	[	CD	NUMBER	[	number	19	SENT_209	[p5l2025t2049r2045b2081],
19	7	CD	NUMBER	7	num	20	SENT_209	[p5l2025t2049r2045b2081],
20	<	JJR	O	<	conj_and	8	SENT_209	[p5l2059t2048r2084b2070],
21	0.0001	CD	NUMBER	0.0001	num	22	SENT_209	[p5l2100t2046r2213b2078],
22	)	NN	O	)	dep	20	SENT_209	[p5l2100t2046r2213b2078],
23	and	CC	O	and	_	0	SENT_209	[p5l2228t2046r2286b2072],
24	between	IN	O	between	amod	25	SENT_209	[p5l1276t2092r1411b2118],
25	levels	NNS	O	level	conj_and	8	SENT_209	[p5l1427t2092r1513b2118],
26	of	IN	O	of	_	0	SENT_209	[p5l1530t2092r1565b2118],
27	SVEGFR-3	NN	O	svegfr-3	nn	31	SENT_209	[p5l1578t2092r1743b2118],
28	and	CC	O	and	_	0	SENT_209	[p5l1760t2092r1819b2118],
29	antigenemia	NN	O	antigenemia	nn	31	SENT_209	[p5l1836t2093r2037b2127],
30	(	NN	O	(	nn	31	SENT_209	[p5l2054t2093r2078b2124],
31	r	NN	O	r	prep_of	25	SENT_209	[p5l2054t2093r2078b2124],
32	=	JJ	O	=	amod	25	SENT_209	[p5l2089t2103r2114b2112],
33	0.367	CD	NUMBER	0.367	tmod	32	SENT_209	[p5l2127t2090r2219b2123],
34	,	,	O	,	_	0	SENT_209	[p5l2127t2090r2219b2123],
35	p	NN	O	p	appos	25	SENT_209	[p5l2232t2095r2252b2127],
36	=	JJ	O	=	amod	38	SENT_209	[p5l2265t2103r2289b2112],
37	0.0065	CD	NUMBER	0.0065	tmod	36	SENT_209	[p5l1277t2138r1399b2170],
38	)	NN	O	)	dep	35	SENT_209	[p5l1277t2138r1399b2170],
39	,	,	O	,	_	0	SENT_209	[p5l1277t2138r1399b2170],
40	but	CC	O	but	_	0	SENT_209	[p5l1426t2138r1480b2164],
41	no	DT	O	no	det	42	SENT_209	[p5l1508t2147r1547b2164],
42	associations	NNS	O	association	nsubjpass	64	SENT_209	[p5l1576t2139r1768b2164],
43	between	IN	O	between	_	0	SENT_209	[p5l1796t2138r1931b2164],
44	microﬁlaremia	NN	O	microﬁlaremia	prep_between	42	SENT_209	[p5l1958t2138r2200b2164],
45	and	CC	O	and	_	0	SENT_209	[p5l2227t2138r2286b2164],
46	levels	NNS	O	level	conj_and	42	SENT_209	[p5l1276t2184r1363b2210],
47	of	IN	O	of	_	0	SENT_209	[p5l1376t2184r1410b2210],
48	VEGF-C	NN	O	vegf-c	nn	50	SENT_209	[p5l1418t2184r1552b2210],
49	(	CD	NUMBER	(	num	50	SENT_209	[p5l1566t2185r1626b2219],
50	[	NN	O	[	prep_of	46	SENT_209	[p5l1566t2185r1626b2219],
51	7	CD	NUMBER	7	num	50	SENT_209	[p5l1566t2185r1626b2219],
52	:	:	O	:	_	0	SENT_209	[p5l1566t2185r1626b2219],
53	0.8864	CD	NUMBER	0.8864	num	54	SENT_209	[p5l1636t2184r1750b2216],
54	)	NN	O	)	dep	46	SENT_209	[p5l1636t2184r1750b2216],
55	and	CC	O	and	_	0	SENT_209	[p5l1763t2184r1822b2210],
56	SVEGFR-3	NN	O	svegfr-3	nn	58	SENT_209	[p5l1835t2184r2000b2210],
57	(	CD	NUMBER	(	num	58	SENT_209	[p5l2014t2185r2040b2219],
58	[	NN	O	[	dep	46	SENT_209	[p5l2014t2185r2040b2219],
59	7	CD	NUMBER	7	num	62	SENT_209	[p5l2014t2185r2040b2219],
60	=	JJ	O	=	amod	62	SENT_209	[p5l2049t2195r2074b2204],
61	0.7720	CD	NUMBER	0.7720	tmod	60	SENT_209	[p5l2084t2182r2198b2216],
62	)	NN	O	)	dep	58	SENT_209	[p5l2084t2182r2198b2216],
63	were	VBD	O	be	auxpass	64	SENT_209	[p5l2210t2193r2286b2210],
64	found	VBN	O	find	conj_but	2	SENT_209	[p5l1276t2230r1380b2256],
65	.	.	O	.	_	0	SENT_209	[p5l1276t2230r1380b2256],

1	Primary	JJ	O	primary	amod	3	SENT_210	[p5l1278t2305r1407b2343],
2	Outcome	NNP	O	Outcome	nn	3	SENT_210	[p5l1423t2305r1582b2335],
3	Analysis	NN	O	analysis	_	0	SENT_210	[p5l1599t2304r1736b2343],
4	in	IN	O	in	_	0	SENT_210	[p5l1754t2305r1781b2334],
5	Lymphedema	NNP	O	Lymphedema	nn	7	SENT_210	[p5l1801t2304r2035b2343],
6	Patients	NNPS	O	Patients	nn	7	SENT_210	[p5l2055t2305r2190b2335],
7	CFA	NNP	O	CFA	prep_in	3	SENT_210	[p5l1314t2355r1388b2381],
8	and	CC	O	and	_	0	SENT_210	[p5l1416t2355r1477b2381],
9	antiﬁlarial	JJ	O	antiﬁlarial	amod	11	SENT_210	[p5l1505t2355r1684b2381],
10	antibody	NN	O	antibody	nn	11	SENT_210	[p5l1712t2355r1861b2390],
11	titers	NNS	O	titer	prep_in	3	SENT_210	[p5l1890t2355r1979b2381],
12	of	IN	O	of	_	0	SENT_210	[p5l2007t2355r2043b2381],
13	lymphedema	NN	O	lymphedema	nn	14	SENT_210	[p5l2068t2355r2286b2390],
14	patients	NNS	O	patient	prep_of	3	SENT_210	[p5l1275t2401r1415b2436],
15	.	.	O	.	_	0	SENT_210	[p5l1275t2401r1415b2436],

1	Twenty-six	CD	NUMBER	twenty-six	num	3	SENT_211	[p5l1441t2402r1618b2436],
2	lymphedema	NN	O	lymphedema	nn	3	SENT_211	[p5l1644t2401r1853b2436],
3	patients	NNS	O	patient	nsubjpass	5	SENT_211	[p5l1879t2402r2008b2436],
4	were	VBD	O	be	auxpass	5	SENT_211	[p5l2034t2410r2110b2427],
5	recruited	VBN	O	recruit	_	0	SENT_211	[p5l2136t2401r2286b2427],

1	Table	NNP	O	Table	_	0	SENT_212	[p5l188t2510r279b2537],
2	2	CD	NUMBER	2	dep	1	SENT_212	[p5l294t2512r322b2537],
3	.	.	O	.	_	0	SENT_212	[p5l294t2512r322b2537],

1	State	NN	O	state	_	0	SENT_213	[p5l337t2511r414b2537],
2	of	IN	O	of	_	0	SENT_213	[p5l429t2510r461b2537],
3	Lymphatic	JJ	O	lymphatic	amod	5	SENT_213	[p5l474t2510r634b2545],
4	Vessel	NN	O	vessel	nn	5	SENT_213	[p5l648t2510r742b2537],
5	Dilation	NN	O	dilation	prep_of	1	SENT_213	[p5l759t2510r876b2537],
6	of	IN	O	of	_	0	SENT_213	[p5l893t2510r924b2537],
7	Patients	NNS	O	patient	prep_of	1	SENT_213	[p5l938t2511r1059b2537],
8	before	IN	O	before	dep	1	SENT_213	[p5l1075t2510r1174b2537],
9	and	CC	O	and	cc	10	SENT_213	[p5l1189t2510r1245b2537],
10	24	CD	DURATION	24	num	11	SENT_213	[p5l1261t2512r1297b2537],
11	Months	NNS	DURATION	month	pobj	8	SENT_213	[p5l1312t2510r1428b2537],
12	after	IN	O	after	dep	1	SENT_213	[p5l1443t2510r1514b2537],
13	Doxycycline	NNP	O	Doxycycline	nn	14	SENT_213	[p5l1529t2510r1712b2545],
14	Treatment	NN	O	treatment	pobj	12	SENT_213	[p5l1726t2512r1888b2537],

1	Treatment	NN	O	treatment	nn	2	SENT_214	[p5l188t2607r342b2630],
2	Number	NN	O	number	dep	16	SENT_214	[p5l435t2606r553b2630],
3	of	IN	O	of	_	0	SENT_214	[p5l565t2606r595b2630],
4	Patients	NNS	O	patient	nn	5	SENT_214	[p5l608t2606r726b2630],
5	Number	NN	O	number	prep_of	2	SENT_214	[p5l819t2606r937b2630],
6	of	IN	O	of	_	0	SENT_214	[p5l949t2606r979b2630],
7	Patients	NNS	O	patient	nn	8	SENT_214	[p5l991t2606r1110b2630],
8	Number	NN	O	number	prep_of	5	SENT_214	[p5l1285t2606r1403b2630],
9	of	IN	O	of	_	0	SENT_214	[p5l1416t2606r1446b2630],
10	Patients	NNS	O	patient	nn	11	SENT_214	[p5l1458t2606r1577b2630],
11	Number	NN	O	number	prep_of	8	SENT_214	[p5l1690t2606r1808b2630],
12	of	IN	O	of	_	0	SENT_214	[p5l1820t2606r1850b2630],
13	Patients	NNS	O	patient	prep_of	11	SENT_214	[p5l1863t2606r1981b2630],
14	p-Value	JJ	O	p-value	dep	16	SENT_214	[p5l2160t2604r2286b2637],
15	“	NNP	O	“	nn	16	SENT_214	[p5l2160t2604r2286b2637],
16	Group	NNP	O	Group	dep	19	SENT_214	[p5l189t2648r280b2678],
17	Present	JJ	DATE	present	dep	16	SENT_214	[p5l435t2648r545b2671],
18	before	IN	O	before	dep	19	SENT_214	[p5l558t2647r653b2671],
19	with	IN	O	with	_	0	SENT_214	[p5l817t2647r880b2671],
20	Improved	VBN	O	improve	dep	31	SENT_214	[p5l895t2647r1035b2678],
21	Condition	NN	O	condition	dobj	20	SENT_214	[p5l1049t2647r1192b2671],
22	with	IN	O	with	_	0	SENT_214	[p5l1284t2647r1347b2671],
23	Same	JJ	O	same	amod	24	SENT_214	[p5l1361t2648r1441b2671],
24	Condition	NN	O	condition	prep_with	21	SENT_214	[p5l1454t2647r1597b2671],
25	with	IN	O	with	_	0	SENT_214	[p5l1688t2647r1752b2671],
26	Worsened	JJ	O	worsened	amod	27	SENT_214	[p5l1765t2647r1912b2671],
27	Condition	NN	O	condition	prep_with	20	SENT_214	[p5l1926t2647r2069b2671],
28	and	CC	O	and	_	0	SENT_214	[p5l433t2689r487b2713],
29	at	IN	O	at	dep	31	SENT_214	[p5l501t2693r529b2713],
30	24	CD	DURATION	24	pobj	29	SENT_214	[p5l542t2691r577b2713],
31	months	NNS	NUMBER	month	pobj	19	SENT_214	[p5l591t2689r701b2713],

1	Doxycycline	NNP	O	Doxycycline	dep	10	SENT_215	[p5l190t2778r332b2805],
2	9 7/9	CD	PERCENT	9 7/9	num	1	SENT_215	[p5l818t2779r855b2800],[p5l434t2780r447b2799],
3	78	CD	PERCENT	78	num	4	SENT_215	[p5l867t2780r917b2799],
4	%	NN	PERCENT	%	dep	1	SENT_215	[p5l867t2780r917b2799],
5	1/9	CD	PERCENT	1/9	number	6	SENT_215	[p5l1286t2779r1322b2800],
6	11	CD	PERCENT	11	num	7	SENT_215	[p5l1336t2780r1384b2799],
7	%	NN	PERCENT	%	dep	4	SENT_215	[p5l1336t2780r1384b2799],
8	1/9	CD	PERCENT	1/9	dep	10	SENT_215	[p5l1691t2779r1727b2800],
9	11	CD	PERCENT	11	num	10	SENT_215	[p5l1740t2780r1789b2799],
10	%	NN	PERCENT	%	dep	15	SENT_215	[p5l1740t2780r1789b2799],
11	0.0319	CD	NUMBER	0.0319	num	12	SENT_215	[p5l2161t2780r2240b2799],
12	Placebo	NNP	O	Placebo	dep	10	SENT_215	[p5l190t2815r283b2836],
13	8 1/8	CD	PERCENT	8 1/8	num	12	SENT_215	[p5l819t2816r855b2837],[p5l433t2817r446b2836],
14	13	CD	PERCENT	13	num	15	SENT_215	[p5l869t2817r917b2836],
15	%	NN	PERCENT	%	_	0	SENT_215	[p5l869t2817r917b2836],
16	4/8	CD	PERCENT	4/8	number	17	SENT_215	[p5l1283t2816r1322b2837],
17	50	CD	PERCENT	50	num	18	SENT_215	[p5l1334t2817r1384b2836],
18	%	NN	PERCENT	%	dep	15	SENT_215	[p5l1334t2817r1384b2836],
19	3/8	CD	PERCENT	3/8	number	20	SENT_215	[p5l1689t2816r1727b2837],
20	37	CD	PERCENT	37	dep	21	SENT_215	[p5l1739t2817r1789b2836],
21	%	NN	PERCENT	%	dep	18	SENT_215	[p5l1739t2817r1789b2836],

1	Dilation	NN	O	dilation	nsubjpass	8	SENT_216	[p5l189t2921r274b2940],
2	of	IN	O	of	_	0	SENT_216	[p5l285t2920r308b2940],
3	the	DT	O	the	det	6	SENT_216	[p5l317t2921r353b2940],
4	supratesticular	JJ	O	supratesticular	amod	6	SENT_216	[p5l364t2921r528b2945],
5	lymphatic	JJ	O	lymphatic	amod	6	SENT_216	[p5l539t2921r648b2946],
6	vessels	NNS	O	vessel	prep_of	1	SENT_216	[p5l658t2921r735b2940],
7	was	VBD	O	be	auxpass	8	SENT_216	[p5l745t2927r787b2940],
8	determined	VBN	O	determine	_	0	SENT_216	[p5l798t2921r927b2940],
9	by	IN	O	by	_	0	SENT_216	[p5l940t2921r966b2946],
10	measuring	VBG	O	measure	agent	8	SENT_216	[p5l977t2921r1092b2946],
11	largest	JJS	O	largest	nsubj	13	SENT_216	[p5l1105t2921r1178b2946],
12	diameter	NN	O	diameter	dep	13	SENT_216	[p5l1189t2921r1289b2940],
13	using	VBG	O	use	xcomp	10	SENT_216	[p5l1300t2921r1358b2946],
14	the	DT	O	the	det	16	SENT_216	[p5l1369t2921r1405b2940],
15	two-dimensional	JJ	O	two-dimensional	amod	16	SENT_216	[p5l1415t2921r1603b2940],
16	b-mode	NN	O	b-mode	dobj	13	SENT_216	[p5l1616t2921r1708b2940],
17	.	.	O	.	_	0	SENT_216	[p5l1616t2921r1708b2940],

1	aChanges	NNS	O	achange	nsubj	8	SENT_217	[p5l188t2952r294b2979],
2	in	IN	O	in	_	0	SENT_217	[p5l305t2954r323b2973],
3	the	DT	O	the	det	4	SENT_217	[p5l334t2954r370b2973],
4	state	NN	O	state	prep_in	1	SENT_217	[p5l381t2957r434b2973],
5	of	IN	O	of	_	0	SENT_217	[p5l445t2953r468b2973],
6	lymphatic	JJ	O	lymphatic	amod	7	SENT_217	[p5l478t2954r586b2979],
7	vessels	NNS	O	vessel	prep_of	4	SENT_217	[p5l597t2954r673b2973],
8	shows	VBZ	O	show	_	0	SENT_217	[p5l685t2954r753b2973],
9	significant	JJ	O	significant	amod	10	SENT_217	[p5l765t2953r879b2979],
10	difference	NN	O	difference	dobj	8	SENT_217	[p5l889t2953r1000b2973],
11	between	IN	O	between	_	0	SENT_217	[p5l1012t2954r1108b2973],
12	doxycycline	NN	O	doxycycline	nn	15	SENT_217	[p5l1119t2954r1250b2979],
13	and	CC	O	and	_	0	SENT_217	[p5l1261t2954r1301b2973],
14	placebo	NN	O	placebo	nn	15	SENT_217	[p5l1314t2954r1401b2978],
15	patients	NNS	O	patient	prep_between	10	SENT_217	[p5l1413t2954r1507b2978],
16	;	:	O	;	_	0	SENT_217	[p5l1413t2954r1507b2978],
17	p	NN	O	p	dep	10	SENT_217	[p5l1517t2960r1531b2978],
18	:	:	O	:	_	0	SENT_217	[p5l1540t2963r1557b2970],
19	0.0319	CD	NUMBER	0.0319	dep	17	SENT_217	[p5l1566t2955r1639b2973],
20	at	IN	O	at	_	0	SENT_217	[p5l1649t2957r1670b2973],
21	24	CD	DURATION	24	num	22	SENT_217	[p5l1680t2955r1706b2973],
22	mo	NN	DURATION	mo	prep_at	19	SENT_217	[p5l1717t2960r1752b2973],
23	after	IN	O	after	_	0	SENT_217	[p5l1763t2953r1814b2973],
24	treatment	NN	O	treatment	nsubj	25	SENT_217	[p5l1823t2957r1935b2973],
25	using	VBG	O	use	dep	30	SENT_217	[p5l1946t2954r2004b2979],
26	the	DT	O	the	det	28	SENT_217	[p5l2016t2954r2052b2973],
27	Fisher	NNP	PERSON	Fisher	nn	28	SENT_217	[p5l2063t2954r2134b2973],
28	’	NN	O	’	dobj	25	SENT_217	[p5l2063t2954r2134b2973],
29	exact	JJ	O	exact	amod	30	SENT_217	[p5l2144t2957r2202b2973],
30	test	NN	O	test	prep_after	22	SENT_217	[p5l2212t2957r2259b2973],
31	.	.	O	.	_	0	SENT_217	[p5l2212t2957r2259b2973],

1	DOI	NNP	O	DOI	_	0	SENT_218	[p5l189t2987r235b3006],
2	:	:	O	:	_	0	SENT_218	[p5l189t2987r235b3006],
3	10.1371	CD	NUMBER	10.1371	dep	1	SENT_218	[p5l248t2987r636b3012],
4	/	:	O	/	punct	5	SENT_218	[p5l248t2987r636b3012],
5	journal	NN	O	journal	dep	3	SENT_218	[p5l248t2987r636b3012],
6	.	.	O	.	_	0	SENT_218	[p5l248t2987r636b3012],

1	ppat	NN	O	ppat	_	0	SENT_219	[p5l248t2987r636b3012],
2	.0	CD	NUMBER	.0	num	3	SENT_219	[p5l248t2987r636b3012],
3	O20092	NN	O	o20092	dep	1	SENT_219	[p5l248t2987r636b3012],
4	.	.	O	.	_	0	SENT_219	[p5l248t2987r636b3012],

1	t002	NN	O	t002	_	0	SENT_220	[p5l248t2987r636b3012],

1	zcO	NN	O	zco	nn	2	SENT_221	[p5l188t3077r261b3136],
2	PLoS	NN	O	plo	nsubj	3	SENT_221	[p5l288t3093r352b3116],
3	Pathogens	VBD	O	pathogen	_	0	SENT_221	[p5l367t3092r511b3123],
4	|	CD	NUMBER	|	num	5	SENT_221	[p5l526t3091r528b3124],
5	www	NN	O	www	dobj	3	SENT_221	[p5l543t3092r882b3123],
6	.	.	O	.	_	0	SENT_221	[p5l543t3092r882b3123],

1	p	NN	O	p	_	0	SENT_222	[p5l543t3092r882b3123],
2	|	CD	NUMBER	|	num	3	SENT_222	[p5l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	dep	1	SENT_222	[p5l543t3092r882b3123],

1	P	NN	O	p	_	0	SENT_223	[p6l648t217r811b247],
2	<	VBG	O	<	dep	1	SENT_223	[p6l648t217r811b247],
3	0.0001	CD	NUMBER	0.0001	num	4	SENT_223	[p6l648t217r811b247],
4	p	NN	O	p	npadvmod	5	SENT_223	[p6l927t226r1095b256],
5	=	JJ	O	=	amod	6	SENT_223	[p6l927t226r1095b256],
6	o_ooo2	NN	O	o_ooo2	dobj	2	SENT_223	[p6l927t226r1095b256],

1	-	:	O	-	_	0	SENT_224	[p6l235t231r254b257],
2	I5	NN	O	i5	_	0	SENT_224	[p6l235t231r254b257],

1	W	NN	O	w	_	0	SENT_225	[p6l236t353r253b380],

1	N	NN	O	n	_	0	SENT_226	[p6l235t475r253b502],
2	VEGF	NN	O	vegf	dep	1	SENT_226	[p6l188t606r213b731],
3	.	.	O	.	_	0	SENT_226	[p6l188t606r213b731],

1	—	NN	O	—	_	0	SENT_227	[p6l188t606r213b731],
2	.	.	O	.	_	0	SENT_227	[p6l188t606r213b731],

1	C	NN	O	c	nn	3	SENT_228	[p6l188t606r213b731],
2	plasma	NN	O	plasma	nn	3	SENT_228	[p6l188t480r219b592],
3	levels	NNS	O	level	nsubj	4	SENT_228	[p6l188t373r213b466],
4	(	VBP	O	(	_	0	SENT_228	[p6l188t251r220b359],
5	ng/ml	NN	O	ng/ml	nn	8	SENT_228	[p6l188t251r220b359],
6	)	CD	NUMBER	)	num	8	SENT_228	[p6l188t251r220b359],
7	Q	NNP	O	Q	nn	8	SENT_228	[p6l236t720r253b747],
8	A	NNP	O	A	dobj	4	SENT_228	[p6l237t598r249b625],
9	Endemic	JJ	O	endemic	amod	11	SENT_228	[p6l273t748r423b775],
10	normals	NNS	O	normal	nn	11	SENT_228	[p6l437t748r576b775],
11	Mf-positives	NNS	O	mf-positive	dep	8	SENT_228	[p6l622t747r832b781],

1	Lymphoedema	NN	PERSON	lymphoedema	_	0	SENT_229	[p6l902t748r1158b782],

1	Figure	NNP	O	Figure	_	0	SENT_230	[p6l190t816r282b847],
2	3	CD	NUMBER	3	dep	1	SENT_230	[p6l303t818r328b840],
3	.	.	O	.	_	0	SENT_230	[p6l303t818r328b840],

1	Pretreatment	NN	O	pretreatment	nn	3	SENT_231	[p6l351t817r531b840],
2	Plasma	NN	O	plasma	nn	3	SENT_231	[p6l554t816r648b840],
3	Levels	NNS	O	level	_	0	SENT_231	[p6l671t816r753b840],
4	of	IN	O	of	_	0	SENT_231	[p6l774t816r803b840],
5	VEGF	NN	O	vegf	prep_of	3	SENT_231	[p6l821t817r922b840],
6	.	.	O	.	_	0	SENT_231	[p6l821t817r922b840],

1	—	NN	O	—	_	0	SENT_232	[p6l821t817r922b840],
2	.	.	O	.	_	0	SENT_232	[p6l821t817r922b840],

1	C	NN	O	c	nsubj	5	SENT_233	[p6l821t817r922b840],
2	in	IN	O	in	_	0	SENT_233	[p6l944t817r966b840],
3	Fi	NNP	O	Fi	prep_in	1	SENT_233	[p6l990t816r1198b840],
4	|	CD	NUMBER	|	num	3	SENT_233	[p6l990t816r1198b840],
5	aria	NN	O	aria	_	0	SENT_233	[p6l990t816r1198b840],
6	|	NN	O	|	dobj	5	SENT_233	[p6l990t816r1198b840],
7	.	.	O	.	_	0	SENT_233	[p6l990t816r1198b840],

1	—	NN	O	—	_	0	SENT_234	[p6l990t816r1198b840],
2	.	.	O	.	_	0	SENT_234	[p6l990t816r1198b840],

1	|	NN	O	|	nsubj	2	SENT_235	[p6l990t816r1198b840],
2	nfected	VBD	O	nfect	_	0	SENT_235	[p6l990t816r1198b840],
3	Patients	NNS	O	patient	nsubj	9	SENT_235	[p6l190t859r298b882],
4	and	CC	O	and	_	0	SENT_235	[p6l311t858r361b882],
5	Endemic	JJ	O	endemic	amod	8	SENT_235	[p6l376t858r492b882],
6	Controls	NNP	O	Controls	nn	8	SENT_235	[p6l505t858r620b882],
7	Plasma	NN	O	plasma	nn	8	SENT_235	[p6l190t903r284b927],
8	concentrations	NNS	O	concentration	nsubj	9	SENT_235	[p6l297t904r502b927],
9	(	VBP	O	(	ccomp	2	SENT_235	[p6l516t904r600b931],
10	mean	NN	O	mean	dobj	9	SENT_235	[p6l516t904r600b931],
11	:	:	O	:	_	0	SENT_235	[p6l617t906r637b926],
12	SD	NN	O	sd	nn	13	SENT_235	[p6l653t904r697b931],
13	)	NN	O	)	dep	10	SENT_235	[p6l653t904r697b931],
14	of	IN	O	of	_	0	SENT_235	[p6l712t903r740b927],
15	VEGF	NN	O	vegf	prep_of	13	SENT_235	[p6l750t904r850b927],
16	.	.	O	.	_	0	SENT_235	[p6l750t904r850b927],

1	—	NN	O	—	_	0	SENT_236	[p6l750t904r850b927],
2	.	.	O	.	_	0	SENT_236	[p6l750t904r850b927],

1	C	NN	O	c	nsubjpass	3	SENT_237	[p6l750t904r850b927],
2	were	VBD	O	be	auxpass	3	SENT_237	[p6l863t910r930b927],
3	measured	VBN	O	measure	_	0	SENT_237	[p6l944t903r1085b931],
4	,	,	O	,	_	0	SENT_237	[p6l944t903r1085b931],
5	using	VBG	O	use	xcomp	3	SENT_237	[p6l1099t904r1171b934],
6	a	DT	O	a	det	8	SENT_237	[p6l1185t910r1198b927],
7	commercial	JJ	O	commercial	amod	8	SENT_237	[p6l189t938r351b962],
8	kit	NN	O	kit	dobj	5	SENT_237	[p6l378t938r417b966],
9	,	,	O	,	_	0	SENT_237	[p6l378t938r417b966],
10	from	IN	O	from	_	0	SENT_237	[p6l442t938r507b962],
11	plasma	NN	O	plasma	prep_from	3	SENT_237	[p6l534t938r632b969],
12	of	IN	O	of	_	0	SENT_237	[p6l658t938r686b962],
13	Iymphedema	NN	LOCATION	iymphedema	nn	14	SENT_237	[p6l710t938r893b969],
14	patients	NNS	O	patient	prep_of	11	SENT_237	[p6l920t939r1032b969],
15	(	CD	NUMBER	(	num	16	SENT_237	[p6l1058t939r1083b966],
16	n	NN	O	n	dep	14	SENT_237	[p6l1058t939r1083b966],
17	:	:	O	:	_	0	SENT_237	[p6l1106t950r1128b958],
18	26	CD	NUMBER	26	num	19	SENT_237	[p6l1150t939r1199b966],
19	)	NN	O	)	dep	16	SENT_237	[p6l1150t939r1199b966],
20	,	,	O	,	_	0	SENT_237	[p6l1150t939r1199b966],
21	microﬁlaremic	JJ	O	microﬁlaremic	amod	22	SENT_237	[p6l190t973r383b997],
22	patients	NNS	O	patient	appos	19	SENT_237	[p6l402t974r512b1004],
23	(	IN	O	(	_	0	SENT_237	[p6l531t974r554b1001],
24	n	NN	O	n	prep_(	22	SENT_237	[p6l531t974r554b1001],
25	:	:	O	:	_	0	SENT_237	[p6l570t985r592b993],
26	76	CD	NUMBER	76	num	27	SENT_237	[p6l608t974r655b1001],
27	)	NN	O	)	dep	16	SENT_237	[p6l608t974r655b1001],
28	,	,	O	,	_	0	SENT_237	[p6l608t974r655b1001],
29	and	CC	O	and	_	0	SENT_237	[p6l673t973r723b997],
30	endemic	JJ	O	endemic	amod	31	SENT_237	[p6l742t973r860b997],
31	controls	NNS	O	control	nsubj	32	SENT_237	[p6l878t973r988b997],
32	(	VBP	O	(	conj_and	3	SENT_237	[p6l1007t974r1030b1001],
33	n	NN	O	n	dobj	32	SENT_237	[p6l1007t974r1030b1001],
34	:	:	O	:	_	0	SENT_237	[p6l1046t985r1068b993],
35	23	CD	NUMBER	23	dep	33	SENT_237	[p6l1084t975r1122b1001],
36	,	,	O	,	_	0	SENT_237	[p6l1084t975r1122b1001],
37	who	WP	O	who	nsubj	40	SENT_237	[p6l1140t973r1199b997],
38	did	VBD	O	do	aux	40	SENT_237	[p6l189t1009r230b1033],
39	not	RB	O	not	neg	40	SENT_237	[p6l253t1013r297b1033],
40	have	VB	O	have	rcmod	35	SENT_237	[p6l319t1009r382b1033],
41	filarial	JJ	O	filarial	amod	43	SENT_237	[p6l401t1009r481b1033],
42	infection	NN	O	infection	nn	43	SENT_237	[p6l503t1009r639b1037],
43	)	NN	O	)	dobj	40	SENT_237	[p6l503t1009r639b1037],
44	.	.	O	.	_	0	SENT_237	[p6l503t1009r639b1037],

1	Mean	NN	O	mean	nn	3	SENT_238	[p6l660t1010r733b1033],
2	plasma	NN	O	plasma	nn	3	SENT_238	[p6l755t1009r851b1040],
3	levels	NNS	O	level	_	0	SENT_238	[p6l873t1009r947b1033],
4	of	IN	O	of	_	0	SENT_238	[p6l967t1009r995b1033],
5	VEGF	NN	O	vegf	prep_of	3	SENT_238	[p6l1012t1010r1112b1033],
6	.	.	O	.	_	0	SENT_238	[p6l1012t1010r1112b1033],

1	—	NN	O	—	_	0	SENT_239	[p6l1012t1010r1112b1033],
2	.	.	O	.	_	0	SENT_239	[p6l1012t1010r1112b1033],

1	C	NN	O	c	nsubj	4	SENT_240	[p6l1012t1010r1112b1033],
2	were	VBD	O	be	cop	4	SENT_240	[p6l1132t1016r1199b1033],
3	signiﬁcantly	RB	O	signiﬁcantly	advmod	4	SENT_240	[p6l189t1044r353b1075],
4	elevated	JJ	O	elevated	dep	25	SENT_240	[p6l366t1044r481b1068],
5	in	IN	O	in	_	0	SENT_240	[p6l496t1045r518b1068],
6	the	DT	O	the	det	9	SENT_240	[p6l532t1044r576b1068],
7	microfilaremic	JJ	O	microfilaremic	amod	9	SENT_240	[p6l591t1044r785b1068],
8	(	NN	O	(	nn	9	SENT_240	[p6l799t1045r823b1075],
9	p	NN	O	p	dep	10	SENT_240	[p6l799t1045r823b1075],
10	<	JJR	O	<	prep_in	4	SENT_240	[p6l838t1048r860b1067],
11	0.0001	CD	NUMBER	0.0001	num	12	SENT_240	[p6l875t1045r973b1072],
12	)	NN	O	)	dep	10	SENT_240	[p6l875t1045r973b1072],
13	and	CC	O	and	_	0	SENT_240	[p6l987t1044r1037b1068],
14	Iymphedema	NN	O	iymphedema	nn	15	SENT_240	[p6l1053t1044r1200b1075, p6l190t1086r229b1103],
15	patients	NNS	O	patient	conj_and	12	SENT_240	[p6l245t1080r354b1110],
16	(	CD	NUMBER	(	num	17	SENT_240	[p6l369t1080r392b1110],
17	p	NN	O	p	dep	12	SENT_240	[p6l369t1080r392b1110],
18	:	:	O	:	_	0	SENT_240	[p6l404t1091r426b1099],
19	0.0002	CD	NUMBER	0.0002	num	20	SENT_240	[p6l437t1080r535b1107],
20	)	CD	NUMBER	)	dep	12	SENT_240	[p6l437t1080r535b1107],
21	compared	VBN	O	compare	_	0	SENT_240	[p6l549t1079r687b1110],
22	to	TO	O	to	prepc_compared_to	20	SENT_240	[p6l701t1083r729b1103],
23	endemic	JJ	O	endemic	amod	24	SENT_240	[p6l743t1079r861b1103],
24	controls	NNS	O	control	pobj	20	SENT_240	[p6l874t1079r984b1103],
25	(	VBP	O	(	_	0	SENT_240	[p6l999t1079r1116b1107],
26	Student	NN	O	student	nn	27	SENT_240	[p6l999t1079r1116b1107],
27	t	NN	O	t	dobj	25	SENT_240	[p6l1130t1083r1200b1103],
28	—	CD	NUMBER	—	num	29	SENT_240	[p6l1130t1083r1200b1103],
29	test	NN	O	test	nsubj	25	SENT_240	[p6l1130t1083r1200b1103],
30	with	IN	O	with	_	0	SENT_240	[p6l188t1114r247b1138],
31	Bonferroni/Dunn	NN	O	bonferroni/dunn	nn	33	SENT_240	[p6l270t1114r500b1139],
32	correction	NN	O	correction	nn	33	SENT_240	[p6l521t1115r676b1142],
33	)	NN	O	)	prep_with	29	SENT_240	[p6l521t1115r676b1142],
34	.	.	O	.	_	0	SENT_240	[p6l521t1115r676b1142],

1	There	EX	O	there	expl	2	SENT_241	[p6l696t1114r774b1138],
2	was	VBD	O	be	_	0	SENT_241	[p6l794t1121r845b1138],
3	no	DT	O	no	det	4	SENT_241	[p6l867t1121r900b1138],
4	difference	NN	O	difference	nsubj	2	SENT_241	[p6l921t1114r1058b1138],
5	between	IN	O	between	_	0	SENT_241	[p6l1080t1114r1198b1138],
6	microﬁlaremic	JJ	O	microﬁlaremic	amod	9	SENT_241	[p6l190t1150r383b1174],
7	and	CC	O	and	_	0	SENT_241	[p6l397t1150r446b1174],
8	Iymphedema	NN	LOCATION	iymphedema	amod	9	SENT_241	[p6l462t1150r641b1181],
9	patients	NNS	O	patient	prep_between	4	SENT_241	[p6l656t1151r765b1181],
10	(	CD	NUMBER	(	num	11	SENT_241	[p6l779t1151r803b1181],
11	p	NN	O	p	dep	9	SENT_241	[p6l779t1151r803b1181],
12	:	:	O	:	_	0	SENT_241	[p6l814t1162r836b1170],
13	0.8033	CD	NUMBER	0.8033	num	14	SENT_241	[p6l846t1151r952b1178],
14	)	NN	O	)	dep	9	SENT_241	[p6l846t1151r952b1178],
15	.	.	O	.	_	0	SENT_241	[p6l846t1151r952b1178],

1	DOI	NNP	O	DOI	_	0	SENT_242	[p6l190t1186r246b1209],
2	:	:	O	:	_	0	SENT_242	[p6l190t1186r246b1209],
3	10.1371	CD	NUMBER	10.1371	dep	1	SENT_242	[p6l262t1185r746b1216],
4	/	:	O	/	punct	6	SENT_242	[p6l262t1185r746b1216],
5	journa	NN	O	journa	nn	6	SENT_242	[p6l262t1185r746b1216],
6	|	NN	O	|	dep	3	SENT_242	[p6l262t1185r746b1216],
7	.	.	O	.	_	0	SENT_242	[p6l262t1185r746b1216],

1	ppat	NN	O	ppat	_	0	SENT_243	[p6l262t1185r746b1216],
2	.0020092	CD	NUMBER	.0020092	dep	1	SENT_243	[p6l262t1185r746b1216],
3	.	.	O	.	_	0	SENT_243	[p6l262t1185r746b1216],

1	g003	NN	O	g003	_	0	SENT_244	[p6l262t1185r746b1216],

1	(	CD	NUMBER	(	num	4	SENT_245	[p6l190t1285r304b1319],
2	Figure	NNP	O	Figure	nn	4	SENT_245	[p6l190t1285r304b1319],
3	1B	NN	O	1b	nn	4	SENT_245	[p6l329t1285r387b1316],
4	)	NN	O	)	nsubj	8	SENT_245	[p6l329t1285r387b1316],
5	,	,	O	,	_	0	SENT_245	[p6l329t1285r387b1316],
6	and	CC	O	and	_	0	SENT_245	[p6l410t1284r469b1310],
7	19	CD	NUMBER	19	conj_and	4	SENT_245	[p6l494t1284r527b1309],
8	met	VBD	O	meet	_	0	SENT_245	[p6l550t1289r611b1310],
9	the	DT	O	the	det	11	SENT_245	[p6l634t1284r683b1310],
10	inclusion	NN	O	inclusion	nn	11	SENT_245	[p6l706t1284r855b1310],
11	criteria	NNS	O	criterion	dobj	8	SENT_245	[p6l877t1285r1004b1310],
12	.	.	O	.	_	0	SENT_245	[p6l877t1285r1004b1310],

1	Of	IN	O	of	_	0	SENT_246	[p6l1027t1284r1071b1310],
2	the	DT	O	the	det	4	SENT_246	[p6l1091t1284r1140b1310],
3	19	CD	NUMBER	19	num	4	SENT_246	[p6l1165t1284r1198b1309],
4	patients	NNS	O	patient	prep_of	14	SENT_246	[p6l189t1331r327b1365],
5	,	,	O	,	_	0	SENT_246	[p6l189t1331r327b1365],
6	one	CD	NUMBER	one	num	7	SENT_246	[p6l341t1339r400b1356],
7	patient	NN	O	patient	nsubj	14	SENT_246	[p6l413t1331r529b1365],
8	was	VBD	O	be	cop	14	SENT_246	[p6l542t1339r597b1356],
9	absent	JJ	O	absent	acomp	14	SENT_246	[p6l611t1330r715b1356],
10	at	IN	O	at	_	0	SENT_246	[p6l729t1335r758b1356],
11	12	CD	DURATION	12	num	12	SENT_246	[p6l773t1330r806b1357],
12	mo	NN	DURATION	mo	prep_at	14	SENT_246	[p6l820t1339r878b1361],
13	,	,	O	,	_	0	SENT_246	[p6l820t1339r878b1361],
14	leaving	VBG	O	leave	_	0	SENT_246	[p6l892t1330r1007b1365],
15	18	CD	NUMBER	18	num	16	SENT_246	[p6l1022t1330r1056b1355],
16	patients	NNS	O	patient	dobj	14	SENT_246	[p6l1069t1331r1198b1365],
17	who	WP	O	who	nsubj	19	SENT_246	[p6l188t1376r254b1402],
18	were	VBD	O	be	cop	19	SENT_246	[p6l270t1385r346b1402],
19	present	JJ	DATE	present	rcmod	16	SENT_246	[p6l362t1382r484b1411],
20	before	IN	O	before	_	0	SENT_246	[p6l499t1376r604b1402],
21	and	CC	O	and	cc	22	SENT_246	[p6l620t1376r679b1402],
22	12	CD	DURATION	12	num	23	SENT_246	[p6l698t1376r731b1403],
23	mo	NN	DURATION	mo	prep_before	19	SENT_246	[p6l748t1385r797b1402],
24	after	IN	O	after	_	0	SENT_246	[p6l814t1376r891b1402],
25	treatment	NN	O	treatment	prep_after	19	SENT_246	[p6l907t1381r1075b1402],
26	.	.	O	.	_	0	SENT_246	[p6l907t1381r1075b1402],

1	Of	IN	O	of	_	0	SENT_247	[p6l1092t1376r1136b1402],
2	the	DT	O	the	det	4	SENT_247	[p6l1150t1376r1199b1402],
3	18	CD	NUMBER	18	num	4	SENT_247	[p6l192t1423r225b1448],
4	patients	NNS	O	patient	prep_of	7	SENT_247	[p6l252t1424r389b1458],
5	,	,	O	,	_	0	SENT_247	[p6l252t1424r389b1458],
6	eight	CD	NUMBER	eight	nsubj	7	SENT_247	[p6l416t1423r496b1458],
7	received	VBD	O	receive	dep	11	SENT_247	[p6l522t1423r657b1449],
8	doxycycline	NN	O	doxycycline	dobj	7	SENT_247	[p6l684t1423r875b1458],
9	and	CC	O	and	_	0	SENT_247	[p6l901t1423r960b1449],
10	ten	CD	NUMBER	ten	dobj	7	SENT_247	[p6l987t1428r1037b1449],
11	received	VBD	O	receive	_	0	SENT_247	[p6l1064t1423r1199b1449],
12	placebo	NN	O	placebo	dobj	11	SENT_247	[p6l189t1469r315b1504],
13	(	CD	NUMBER	(	num	16	SENT_247	[p6l340t1470r454b1504],
14	Figure	NNP	O	Figure	nn	16	SENT_247	[p6l340t1470r454b1504],
15	1B	NN	O	1b	nn	16	SENT_247	[p6l480t1470r537b1501],
16	)	NN	O	)	nsubj	11	SENT_247	[p6l480t1470r537b1501],
17	.	.	O	.	_	0	SENT_247	[p6l480t1470r537b1501],

1	All	DT	O	all	det	3	SENT_248	[p6l561t1469r607b1494],
2	lymphedema	NN	O	lymphedema	nn	3	SENT_248	[p6l630t1469r840b1504],
3	patients	NNS	O	patient	nsubj	5	SENT_248	[p6l863t1470r992b1504],
4	were	VBD	O	be	cop	5	SENT_248	[p6l1016t1478r1092b1495],
5	CFApositive	JJ	O	cfapositive	_	0	SENT_248	[p6l1116t1469r1198b1495, p6l189t1516r315b1550],
6	except	IN	O	except	mark	37	SENT_248	[p6l342t1521r449b1550],
7	two	CD	NUMBER	two	number	8	SENT_248	[p6l476t1520r532b1541],
8	(	CD	NUMBER	(	nsubj	37	SENT_248	[p6l561t1516r629b1547],
9	one	CD	NUMBER	one	num	10	SENT_248	[p6l561t1516r629b1547],
10	doxycycline	NN	O	doxycycline	dep	8	SENT_248	[p6l657t1515r860b1550],
11	-	:	O	-	_	0	SENT_248	[p6l657t1515r860b1550],
12	and	CC	O	and	_	0	SENT_248	[p6l888t1515r947b1541],
13	one	CD	NUMBER	one	num	16	SENT_248	[p6l974t1524r1033b1541],
14	placebotreated	JJ	O	placebotreated	amod	16	SENT_248	[p6l1060t1515r1198b1550, p6l190t1561r316b1593],
15	)	NN	O	)	nn	16	SENT_248	[p6l1060t1515r1198b1550, p6l190t1561r316b1593],
16	patients	NNS	O	patient	nsubj	37	SENT_248	[p6l330t1562r459b1596],
17	who	WP	O	who	nsubj	18	SENT_248	[p6l472t1561r538b1587],
18	had	VBD	O	have	rcmod	16	SENT_248	[p6l551t1561r610b1587],
19	CFA	NNP	MISC	CFA	nn	20	SENT_248	[p6l623t1561r694b1587],
20	levels	NNS	O	level	dobj	18	SENT_248	[p6l706t1561r793b1587],
21	below	IN	O	below	_	0	SENT_248	[p6l806t1561r900b1587],
22	the	DT	O	the	det	26	SENT_248	[p6l914t1561r963b1587],
23	cut-off	JJ	O	cut-off	amod	26	SENT_248	[p6l977t1561r1089b1587],
24	of	IN	O	of	_	0	SENT_248	[p6l1099t1561r1133b1587],
25	128	CD	NUMBER	128	prep_of	23	SENT_248	[p6l1146t1561r1199b1588],
26	units/ml	NN	O	units/ml	prep_below	18	SENT_248	[p6l189t1607r328b1638],
27	;	:	O	;	_	0	SENT_248	[p6l189t1607r328b1638],
28	these	DT	O	these	det	30	SENT_248	[p6l354t1607r436b1633],
29	two	CD	NUMBER	two	num	30	SENT_248	[p6l462t1612r518b1633],
30	patients	NNS	O	patient	nsubj	32	SENT_248	[p6l544t1608r673b1642],
31	however	RB	O	however	advmod	32	SENT_248	[p6l698t1607r835b1633],
32	had	VBD	O	have	dep	26	SENT_248	[p6l859t1607r918b1633],
33	positive	JJ	O	positive	amod	36	SENT_248	[p6l943t1608r1069b1642],
34	ﬁlarial	JJ	O	ﬁlarial	amod	36	SENT_248	[p6l1094t1607r1199b1633],
35	antibody	NN	O	antibody	nn	36	SENT_248	[p6l189t1653r333b1688],
36	titers	NNS	O	titer	dobj	32	SENT_248	[p6l348t1654r430b1679],
37	(	VBP	O	(	advcl	5	SENT_248	[p6l447t1653r494b1685],
38	all	DT	O	all	det	39	SENT_248	[p6l447t1653r494b1685],
39	subclasses	NNS	O	subclass	nsubjpass	41	SENT_248	[p6l509t1653r669b1679],
40	are	VBP	O	be	auxpass	41	SENT_248	[p6l685t1662r734b1679],
41	measured	VBN	O	measure	ccomp	37	SENT_248	[p6l750t1653r906b1679],
42	in	IN	O	in	_	0	SENT_248	[p6l922t1654r952b1678],
43	this	DT	O	this	det	45	SENT_248	[p6l968t1653r1024b1679],
44	test	NN	O	test	nn	45	SENT_248	[p6l1041t1654r1115b1685],
45	)	NN	O	)	prep_in	41	SENT_248	[p6l1041t1654r1115b1685],
46	.	.	O	.	_	0	SENT_248	[p6l1041t1654r1115b1685],

1	One	CD	NUMBER	one	num	3	SENT_249	[p6l1131t1653r1199b1679],
2	placebo	NN	O	placebo	nn	3	SENT_249	[p6l189t1700r315b1735],
3	patient	NN	O	patient	nsubj	5	SENT_249	[p6l343t1701r459b1735],
4	was	VBD	O	be	cop	5	SENT_249	[p6l486t1709r541b1726],
5	microﬁlaremic	JJ	O	microﬁlaremic	_	0	SENT_249	[p6l570t1700r818b1726],
6	.	.	O	.	_	0	SENT_249	[p6l570t1700r818b1726],

1	All	DT	O	all	det	3	SENT_250	[p6l845t1700r891b1725],
2	18	CD	NUMBER	18	num	3	SENT_250	[p6l922t1700r955b1725],
3	patients	NNS	O	patient	nsubj	4	SENT_250	[p6l983t1701r1112b1735],
4	had	VBD	O	have	dep	8	SENT_250	[p6l1140t1700r1199b1726],
5	ﬁlarial	JJ	O	ﬁlarial	amod	7	SENT_250	[p6l189t1746r293b1772],
6	antibody	NN	O	antibody	nn	7	SENT_250	[p6l309t1746r452b1781],
7	titers	NNS	O	titer	dobj	4	SENT_250	[p6l468t1747r550b1772],
8	(	VBP	O	(	_	0	SENT_250	[p6l566t1746r765b1778],
9	1:40	CD	TIME	1:40	num	10	SENT_250	[p6l566t1746r765b1778],
10	—	CD	NUMBER	—	dobj	8	SENT_250	[p6l566t1746r765b1778],
11	1:640	CD	NUMBER	1:640	num	12	SENT_250	[p6l566t1746r765b1778],
12	)	NN	O	)	nsubj	8	SENT_250	[p6l566t1746r765b1778],
13	.	.	O	.	_	0	SENT_250	[p6l566t1746r765b1778],

1	There	EX	O	there	expl	2	SENT_251	[p6l226t1792r323b1818],
2	were	VBD	O	be	dep	34	SENT_251	[p6l341t1801r417b1818],
3	reductions	NNS	O	reduction	nsubj	2	SENT_251	[p6l437t1792r610b1818],
4	in	IN	O	in	_	0	SENT_251	[p6l630t1793r660b1817],
5	the	DT	O	the	det	7	SENT_251	[p6l681t1792r730b1818],
6	antigenemia	NN	O	antigenemia	nn	7	SENT_251	[p6l749t1793r951b1827],
7	levels	NNS	O	level	prep_in	3	SENT_251	[p6l969t1792r1055b1818],
8	in	IN	O	in	_	0	SENT_251	[p6l1075t1793r1106b1817],
9	both	DT	O	both	preconj	13	SENT_251	[p6l1124t1792r1199b1818],
10	doxycycline	NN	O	doxycycline	nn	13	SENT_251	[p6l189t1838r380b1873],
11	and	CC	O	and	_	0	SENT_251	[p6l393t1838r452b1864],
12	placebo	NN	O	placebo	conj_and	10	SENT_251	[p6l465t1838r590b1873],
13	patients	NNS	O	patient	prep_in	7	SENT_251	[p6l604t1839r733b1873],
14	with	IN	O	with	_	0	SENT_251	[p6l746t1838r815b1864],
15	Iymphedema	NN	PERSON	iymphedema	prep_with	2	SENT_251	[p6l828t1838r1038b1873],
16	at	IN	O	at	_	0	SENT_251	[p6l1050t1844r1079b1864],
17	12	CD	DURATION	12	num	18	SENT_251	[p6l1094t1838r1127b1865],
18	mo	NN	DURATION	mo	prep_at	15	SENT_251	[p6l1140t1847r1198b1869],
19	,	,	O	,	_	0	SENT_251	[p6l1140t1847r1198b1869],
20	but	CC	O	but	_	0	SENT_251	[p6l189t1885r243b1911],
21	no	DT	O	no	det	23	SENT_251	[p6l255t1894r294b1911],
22	signiﬁcant	NN	O	signiﬁcant	nn	23	SENT_251	[p6l307t1885r476b1920],
23	difference	NN	O	difference	nsubjpass	28	SENT_251	[p6l488t1885r654b1911],
24	in	IN	O	in	_	0	SENT_251	[p6l667t1886r697b1910],
25	the	DT	O	the	det	26	SENT_251	[p6l710t1885r760b1911],
26	reduction	NN	O	reduction	prep_in	23	SENT_251	[p6l773t1885r932b1911],
27	was	VBD	O	be	auxpass	28	SENT_251	[p6l943t1894r999b1911],
28	obtained	VBN	O	obtain	dep	34	SENT_251	[p6l1012t1885r1155b1911],
29	in	IN	O	in	_	0	SENT_251	[p6l1168t1886r1199b1910],
30	any	DT	O	any	prep_in	28	SENT_251	[p6l189t1940r245b1966],
31	of	IN	O	of	_	0	SENT_251	[p6l260t1931r295b1957],
32	the	DT	O	the	det	33	SENT_251	[p6l308t1931r357b1957],
33	groups	NNS	O	group	prep_of	30	SENT_251	[p6l373t1940r483b1966],
34	(	VBP	O	(	_	0	SENT_251	[p6l501t1931r601b1963],
35	Table	NNP	O	Table	dobj	34	SENT_251	[p6l501t1931r601b1963],
36	3	CD	NUMBER	3	num	37	SENT_251	[p6l617t1931r645b1963],
37	)	NN	O	)	nsubj	34	SENT_251	[p6l617t1931r645b1963],
38	at	IN	O	at	_	0	SENT_251	[p6l661t1936r690b1957],
39	this	DT	O	this	det	41	SENT_251	[p6l706t1931r762b1957],
40	time	NN	O	time	nn	41	SENT_251	[p6l779t1932r850b1957],
41	point	NN	O	point	prep_at	37	SENT_251	[p6l867t1932r961b1966],
42	.	.	O	.	_	0	SENT_251	[p6l867t1932r961b1966],

1	The	DT	O	the	det	3	SENT_252	[p6l977t1931r1040b1957],
2	antibody	NN	O	antibody	nn	3	SENT_252	[p6l1056t1931r1199b1966],
3	levels	NNS	O	level	nsubjpass	6	SENT_252	[p6l189t1977r275b2003],
4	were	VBD	O	be	auxpass	6	SENT_252	[p6l294t1986r370b2003],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_252	[p6l390t1977r586b2012],
6	reduced	VBN	O	reduce	_	0	SENT_252	[p6l606t1977r737b2003],
7	in	IN	O	in	_	0	SENT_252	[p6l757t1978r787b2002],
8	the	DT	O	the	det	10	SENT_252	[p6l807t1977r856b2003],
9	doxycycline-treated	JJ	O	doxycycline-treated	amod	10	SENT_252	[p6l876t1977r1198b2012],
10	group	NN	O	group	prep_in	6	SENT_252	[p6l189t2032r285b2058],
11	compared	VBN	O	compare	_	0	SENT_252	[p6l300t2023r464b2058],
12	to	TO	O	to	prepc_compared_to	10	SENT_252	[p6l479t2028r509b2049],
13	pretreatment	NN	O	pretreatment	nn	15	SENT_252	[p6l524t2028r742b2058],
14	(	CD	NUMBER	(	num	15	SENT_252	[p6l757t2025r784b2058],
15	[	NN	O	[	pobj	10	SENT_252	[p6l757t2025r784b2058],
16	7	CD	NUMBER	7	num	15	SENT_252	[p6l757t2025r784b2058],
17	=	JJ	O	=	amod	10	SENT_252	[p6l794t2034r819b2043],
18	0.0431	CD	NUMBER	0.0431	tmod	17	SENT_252	[p6l831t2023r941b2054],
19	,	,	O	,	_	0	SENT_252	[p6l831t2023r941b2054],
20	Wilcoxon	NNP	PERSON	Wilcoxon	nn	23	SENT_252	[p6l955t2023r1111b2049],
21	rank	NN	O	rank	nn	23	SENT_252	[p6l1126t2023r1199b2049],
22	test	NN	O	test	nn	23	SENT_252	[p6l190t2070r264b2101],
23	)	NN	O	)	appos	10	SENT_252	[p6l190t2070r264b2101],
24	,	,	O	,	_	0	SENT_252	[p6l190t2070r264b2101],
25	whereas	IN	O	whereas	mark	27	SENT_252	[p6l290t2069r420b2095],
26	there	EX	O	there	expl	27	SENT_252	[p6l447t2069r531b2095],
27	was	VBD	O	be	dep	23	SENT_252	[p6l556t2078r612b2095],
28	no	DT	O	no	det	30	SENT_252	[p6l639t2078r678b2095],
29	signiﬁcant	NN	O	signiﬁcant	nn	30	SENT_252	[p6l705t2069r874b2104],
30	difference	NN	O	difference	nsubj	27	SENT_252	[p6l899t2069r1065b2095],
31	in	IN	O	in	_	0	SENT_252	[p6l1092t2070r1122b2094],
32	the	DT	O	the	det	34	SENT_252	[p6l1150t2069r1199b2095],
33	placebo-treated	JJ	O	placebo-treated	amod	34	SENT_252	[p6l189t2115r447b2150],
34	group	NN	O	group	prep_in	30	SENT_252	[p6l461t2124r558b2150],
35	(	CD	NUMBER	(	num	36	SENT_252	[p6l574t2117r601b2150],
36	[	NN	O	[	dep	34	SENT_252	[p6l574t2117r601b2150],
37	2	CD	NUMBER	2	dep	34	SENT_252	[p6l574t2117r601b2150],
38	=	JJ	O	=	amod	37	SENT_252	[p6l612t2126r637b2135],
39	0.0935	CD	NUMBER	0.0935	tmod	38	SENT_252	[p6l650t2115r760b2146],
40	,	,	O	,	_	0	SENT_252	[p6l650t2115r760b2146],
41	Wilcoxon	NNP	PERSON	Wilcoxon	nn	44	SENT_252	[p6l775t2115r931b2141],
42	rank	NN	O	rank	nn	44	SENT_252	[p6l947t2115r1020b2141],
43	test	NN	O	test	nn	44	SENT_252	[p6l1036t2116r1110b2147],
44	)	NN	O	)	appos	34	SENT_252	[p6l1036t2116r1110b2147],
45	.	.	O	.	_	0	SENT_252	[p6l1036t2116r1110b2147],

1	Stages	NNS	O	stage	_	0	SENT_253	[p6l227t2162r328b2197],
2	of	IN	O	of	_	0	SENT_253	[p6l345t2162r380b2188],
3	Iymphedema	NN	LOCATION	iymphedema	prep_of	1	SENT_253	[p6l393t2162r612b2197],
4	.	.	O	.	_	0	SENT_253	[p6l393t2162r612b2197],

1	Table	NNP	O	Table	nsubj	3	SENT_254	[p6l631t2162r722b2188],
2	3	CD	NUMBER	3	num	1	SENT_254	[p6l741t2162r757b2187],
3	shows	VBZ	O	show	_	0	SENT_254	[p6l775t2162r868b2188],
4	the	DT	O	the	det	5	SENT_254	[p6l887t2162r936b2188],
5	changes	NNS	O	change	dobj	3	SENT_254	[p6l954t2162r1081b2197],
6	in	IN	O	in	_	0	SENT_254	[p6l1100t2163r1131b2187],
7	the	DT	O	the	det	9	SENT_254	[p6l1150t2162r1199b2188],
8	Iymphedema	NNP	O	Iymphedema	nn	9	SENT_254	[p6l189t2208r399b2243],
9	stage	NN	O	stage	prep_in	5	SENT_254	[p6l425t2208r734b2243],
10	—	CD	NUMBER	—	num	9	SENT_254	[p6l425t2208r734b2243],
11	determined	VBN	O	determine	partmod	9	SENT_254	[p6l425t2208r734b2243],
12	according	VBG	O	accord	_	0	SENT_254	[p6l761t2208r923b2243],
13	to	TO	O	to	prepc_according_to	11	SENT_254	[p6l950t2214r980b2234],
14	the	DT	O	the	det	16	SENT_254	[p6l1009t2208r1058b2234],
15	staging	NN	O	staging	nn	16	SENT_254	[p6l1085t2209r1200b2243],
16	scheme	NN	O	scheme	pobj	11	SENT_254	[p6l189t2254r308b2280],
17	by	IN	O	by	_	0	SENT_254	[p6l328t2254r364b2289],
18	Dreyer	NNP	PERSON	Dreyer	dep	21	SENT_254	[p6l384t2255r496b2289],
19	et	FW	O	et	nn	21	SENT_254	[p6l516t2260r545b2280],
20	al.	FW	O	al.	nn	21	SENT_254	[p6l565t2254r598b2280],
21	[	FW	O	[	agent	11	SENT_254	[p6l622t2252r752b2286],
22	47	CD	NUMBER	47	num	23	SENT_254	[p6l622t2252r752b2286],
23	]	NN	O	]	dep	5	SENT_254	[p6l622t2252r752b2286],
24	.	.	O	.	_	0	SENT_254	[p6l622t2252r752b2286],

1	—	NN	O	—	_	0	SENT_255	[p6l622t2252r752b2286],
2	.	.	O	.	_	0	SENT_255	[p6l622t2252r752b2286],

1	of	IN	O	of	_	0	SENT_256	[p6l622t2252r752b2286],
2	the	DT	O	the	det	4	SENT_256	[p6l770t2254r819b2280],
3	affected	VBN	O	affect	amod	4	SENT_256	[p6l840t2254r970b2280],
4	legs	NNS	O	leg	pobj	1	SENT_256	[p6l990t2254r1049b2289],
5	and	CC	O	and	_	0	SENT_256	[p6l1069t2254r1128b2280],
6	the	DT	O	the	det	7	SENT_256	[p6l1150t2254r1199b2280],
7	circumference	NN	O	circumference	conj_and	4	SENT_256	[p6l189t2300r425b2326],
8	of	IN	O	of	_	0	SENT_256	[p6l442t2300r476b2326],
9	the	DT	O	the	det	11	SENT_256	[p6l490t2300r539b2326],
10	affected	VBN	O	affect	amod	11	SENT_256	[p6l556t2300r686b2326],
11	legs	NNS	O	leg	prep_of	7	SENT_256	[p6l702t2300r761b2335],
12	from	IN	O	from	_	0	SENT_256	[p6l777t2300r857b2326],
13	baseline	NN	O	baseline	prep_from	11	SENT_256	[p6l872t2300r1004b2326],
14	and	CC	O	and	_	0	SENT_256	[p6l1021t2300r1079b2326],
15	12	CD	DURATION	12	num	16	SENT_256	[p6l1099t2300r1132b2327],
16	mo	NN	DURATION	mo	conj_and	11	SENT_256	[p6l1149t2309r1198b2326],
17	after	IN	O	after	_	0	SENT_256	[p6l189t2347r266b2373],
18	treatment	NN	O	treatment	prep_after	16	SENT_256	[p6l290t2352r458b2373],
19	.	.	O	.	_	0	SENT_256	[p6l290t2352r458b2373],

1	The	DT	O	the	det	3	SENT_257	[p6l482t2347r545b2373],
2	affected	VBN	O	affect	amod	3	SENT_257	[p6l569t2347r699b2373],
3	legs	NNS	O	leg	nsubj	9	SENT_257	[p6l722t2347r781b2382],
4	of	IN	O	of	_	0	SENT_257	[p6l805t2347r840b2373],
5	all	PDT	O	all	predet	8	SENT_257	[p6l860t2347r897b2373],
6	the	DT	O	the	det	8	SENT_257	[p6l921t2347r971b2373],
7	doXycyclinetreated	JJ	O	doxycyclinetreated	amod	8	SENT_257	[p6l995t2347r1198b2382, p6l190t2393r305b2419],
8	patients	NNS	O	patient	prep_of	3	SENT_257	[p6l321t2394r450b2428],
9	reverted	VBD	O	revert	_	0	SENT_257	[p6l466t2393r602b2419],
10	to	TO	O	to	_	0	SENT_257	[p6l618t2398r648b2419],
11	a	DT	O	a	det	14	SENT_257	[p6l664t2402r680b2419],
12	lower	JJR	O	lower	amod	14	SENT_257	[p6l695t2393r785b2419],
13	lymphedema	NN	O	lymphedema	nn	14	SENT_257	[p6l799t2393r1008b2428],
14	stage	NN	O	stage	prep_to	9	SENT_257	[p6l1023t2398r1103b2428],
15	at	IN	O	at	_	0	SENT_257	[p6l1119t2398r1148b2419],
16	12	CD	DURATION	12	num	19	SENT_257	[p6l1165t2393r1198b2420],
17	mo	NN	DURATION	mo	nn	19	SENT_257	[p6l189t2448r239b2465],
18	post	NN	O	post	nn	19	SENT_257	[p6l262t2444r330b2474],
19	therapy	NN	O	therapy	prep_at	14	SENT_257	[p6l352t2439r483b2474],
20	,	,	O	,	_	0	SENT_257	[p6l352t2439r483b2474],
21	whereas	IN	O	whereas	mark	28	SENT_257	[p6l506t2439r635b2465],
22	all	PDT	O	all	predet	25	SENT_257	[p6l658t2439r694b2465],
23	the	DT	O	the	det	25	SENT_257	[p6l718t2439r767b2465],
24	placebo-treated	JJ	O	placebo-treated	amod	25	SENT_257	[p6l789t2439r1046b2474],
25	patients	NNS	O	patient	nsubj	30	SENT_257	[p6l1069t2440r1198b2474],
26	stayed	VBD	O	stay	cop	28	SENT_257	[p6l189t2485r289b2520],
27	the	DT	O	the	det	28	SENT_257	[p6l310t2485r359b2511],
28	same	JJ	O	same	advcl	9	SENT_257	[p6l380t2494r459b2511],
29	or	CC	O	or	_	0	SENT_257	[p6l479t2494r515b2511],
30	changed	VBN	O	change	conj_or	28	SENT_257	[p6l534t2485r669b2520],
31	to	TO	O	to	_	0	SENT_257	[p6l690t2491r720b2511],
32	a	DT	O	a	det	34	SENT_257	[p6l741t2494r757b2511],
33	higher	JJR	O	higher	amod	34	SENT_257	[p6l776t2485r882b2520],
34	stage	NN	O	stage	prep_to	30	SENT_257	[p6l901t2490r980b2520],
35	at	IN	O	at	_	0	SENT_257	[p6l1001t2491r1030b2511],
36	this	DT	O	this	det	38	SENT_257	[p6l1050t2485r1106b2511],
37	time	NN	O	time	nn	38	SENT_257	[p6l1128t2486r1199b2511],
38	point	NN	O	point	prep_at	34	SENT_257	[p6l189t2532r284b2566],
39	.	.	O	.	_	0	SENT_257	[p6l189t2532r284b2566],

1	There	EX	O	there	expl	2	SENT_258	[p6l296t2531r393b2557],
2	was	VBD	O	be	conj_negcc	2	SENT_258	[p6l404t2540r460b2557],
3	a	DT	O	a	det	6	SENT_258	[p6l472t2540r488b2557],
4	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_258	[p6l499t2531r668b2566],
5	reduction	NN	O	reduction	nn	6	SENT_258	[p6l680t2531r839b2557],
6	(	NN	O	(	nsubj	2	SENT_258	[p6l852t2532r911b2566],
7	1	CD	NUMBER	1	num	8	SENT_258	[p6l852t2532r911b2566],
8	)	NN	O	)	dep	6	SENT_258	[p6l852t2532r911b2566],
9	:	:	O	:	_	0	SENT_258	[p6l852t2532r911b2566],
10	0.0051	CD	NUMBER	0.0051	dep	6	SENT_258	[p6l920t2531r1031b2562],
11	,	,	O	,	_	0	SENT_258	[p6l920t2531r1031b2562],
12	Wilcoxon	NNP	PERSON	Wilcoxon	nn	15	SENT_258	[p6l1043t2531r1199b2557],
13	rank	NN	O	rank	nn	15	SENT_258	[p6l190t2578r263b2604],
14	test	NN	O	test	nn	15	SENT_258	[p6l275t2579r341b2610],
15	)	NN	O	)	appos	10	SENT_258	[p6l275t2579r341b2610],
16	in	IN	O	in	_	0	SENT_258	[p6l354t2579r384b2603],
17	the	DT	O	the	det	19	SENT_258	[p6l397t2578r446b2604],
18	Iymphedema	NNP	O	Iymphedema	nn	19	SENT_258	[p6l458t2578r668b2613],
19	stage	NN	O	stage	prep_in	15	SENT_258	[p6l679t2583r759b2613],
20	of	IN	O	of	_	0	SENT_258	[p6l771t2578r805b2604],
21	the	DT	O	the	det	23	SENT_258	[p6l815t2578r864b2604],
22	doxycycline-treated	JJ	O	doxycycline-treated	amod	23	SENT_258	[p6l876t2578r1198b2613],
23	patients	NNS	O	patient	prep_of	19	SENT_258	[p6l189t2625r319b2659],
24	at	IN	O	at	_	0	SENT_258	[p6l338t2629r367b2650],
25	12	CD	DURATION	12	num	28	SENT_258	[p6l388t2624r421b2651],
26	mo	NN	DURATION	mo	nn	28	SENT_258	[p6l441t2633r490b2650],
27	post	NN	O	post	nn	28	SENT_258	[p6l510t2629r578b2659],
28	therapy	NN	O	therapy	prep_at	2	SENT_258	[p6l597t2624r721b2659],
29	compared	VBN	O	compare	_	0	SENT_258	[p6l739t2624r903b2659],
30	to	TO	O	to	prepc_compared_to	28	SENT_258	[p6l923t2629r953b2650],
31	pretreatment	NN	O	pretreatment	pobj	28	SENT_258	[p6l972t2629r1198b2659],
32	,	,	O	,	_	0	SENT_258	[p6l972t2629r1198b2659],
33	but	CC	O	but	_	0	SENT_258	[p6l189t2670r243b2696],
34	not	RB	O	not	_	0	SENT_258	[p6l262t2676r316b2696],
35	in	IN	O	in	_	0	SENT_258	[p6l336t2671r366b2695],
36	the	DT	O	the	det	38	SENT_258	[p6l387t2670r436b2696],
37	placebo	NN	O	placebo	nn	38	SENT_258	[p6l456t2670r581b2705],
38	group	NN	O	group	prep_in	2	SENT_258	[p6l601t2671r717b2705],
39	)	CD	NUMBER	)	dep	38	SENT_258	[p6l601t2671r717b2705],
40	.	.	O	.	_	0	SENT_258	[p6l601t2671r717b2705],

1	The	DT	O	the	det	2	SENT_259	[p6l737t2670r799b2696],
2	reduction	NN	O	reduction	nsubj	36	SENT_259	[p6l820t2670r979b2696],
3	in	IN	O	in	_	0	SENT_259	[p6l999t2671r1029b2695],
4	the	DT	O	the	det	5	SENT_259	[p6l1050t2670r1099b2696],
5	stage	NN	O	stage	prep_in	2	SENT_259	[p6l1119t2675r1199b2705],
6	manifested	VBN	O	manifest	partmod	5	SENT_259	[p6l189t2716r368b2742],
7	as	IN	O	as	_	0	SENT_259	[p6l381t2725r410b2742],
8	better	JJR	O	better	amod	11	SENT_259	[p6l423t2716r522b2742],
9	skin	NN	O	skin	nn	11	SENT_259	[p6l533t2716r598b2742],
10	integrity	NN	O	integrity	nn	11	SENT_259	[p6l611t2717r750b2751],
11	(	NN	O	(	prep_as	6	SENT_259	[p6l763t2716r863b2748],
12	fewer	JJR	O	fewer	dep	6	SENT_259	[p6l763t2716r863b2748],
13	“	CD	NUMBER	“	num	14	SENT_259	[p6l875t2715r1026b2748],
14	knobs	NNS	O	knob	tmod	24	SENT_259	[p6l875t2715r1026b2748],
15	”	CD	NUMBER	”	num	16	SENT_259	[p6l875t2715r1026b2748],
16	)	NN	O	)	dep	14	SENT_259	[p6l875t2715r1026b2748],
17	,	,	O	,	_	0	SENT_259	[p6l875t2715r1026b2748],
18	reduction	NN	O	reduction	nsubj	24	SENT_259	[p6l1040t2716r1199b2742],
19	of	IN	O	of	_	0	SENT_259	[p6l189t2762r224b2788],
20	deep	JJ	O	deep	amod	23	SENT_259	[p6l234t2762r311b2797],
21	and	CC	O	and	_	0	SENT_259	[p6l325t2762r384b2788],
22	shallow	JJ	O	shallow	conj_and	20	SENT_259	[p6l398t2762r517b2788],
23	skin	NN	O	skin	prep_of	18	SENT_259	[p6l531t2762r595b2788],
24	folds	VBZ	O	fold	ccomp	12	SENT_259	[p6l608t2762r694b2793],
25	,	,	O	,	_	0	SENT_259	[p6l608t2762r694b2793],
26	and	CC	O	and	_	0	SENT_259	[p6l708t2762r767b2788],
27	fewer	JJR	O	fewer	conj_and	12	SENT_259	[p6l781t2762r871b2788],
28	entry	NN	O	entry	nn	29	SENT_259	[p6l883t2767r968b2797],
29	lesions	NNS	O	lesion	nsubj	34	SENT_259	[p6l981t2762r1090b2788],
30	of	IN	O	of	_	0	SENT_259	[p6l1104t2762r1138b2788],
31	the	DT	O	the	det	33	SENT_259	[p6l1150t2762r1199b2788],
32	affected	JJ	O	affected	amod	33	SENT_259	[p6l189t2808r319b2834],
33	legs	NNS	O	leg	prep_of	29	SENT_259	[p6l339t2808r397b2843],
34	(	VBP	O	(	ccomp	27	SENT_259	[p6l419t2809r483b2840],
35	not	RB	O	not	neg	34	SENT_259	[p6l419t2809r483b2840],
36	shown	VBN	O	show	_	0	SENT_259	[p6l503t2808r623b2840],
37	)	NN	O	)	dobj	36	SENT_259	[p6l503t2808r623b2840],
38	.	.	O	.	_	0	SENT_259	[p6l503t2808r623b2840],

1	No	DT	O	no	det	2	SENT_260	[p6l643t2809r690b2834],
2	change	NN	O	change	nsubjpass	23	SENT_260	[p6l711t2808r824b2843],
3	in	IN	O	in	_	0	SENT_260	[p6l845t2809r875b2833],
4	the	DT	O	the	det	6	SENT_260	[p6l896t2808r945b2834],
5	mean	NN	O	mean	nn	6	SENT_260	[p6l966t2817r1053b2834],
6	circumference	NN	O	circumference	prep_in	2	SENT_260	[p6l1073t2809r1198b2834, p6l189t2855r310b2881],
7	of	IN	O	of	_	0	SENT_260	[p6l325t2855r360b2881],
8	the	DT	O	the	det	10	SENT_260	[p6l373t2855r422b2881],
9	affected	VBN	O	affect	amod	10	SENT_260	[p6l437t2855r567b2881],
10	legs	NNS	O	leg	prep_of	6	SENT_260	[p6l582t2855r641b2890],
11	in	IN	O	in	_	0	SENT_260	[p6l657t2856r687b2880],
12	both	DT	O	both	preconj	16	SENT_260	[p6l702t2855r776b2881],
13	doxycycline	NN	O	doxycycline	nn	16	SENT_260	[p6l791t2855r983b2890],
14	and	CC	O	and	_	0	SENT_260	[p6l999t2855r1058b2881],
15	placebo	NN	O	placebo	nn	16	SENT_260	[p6l1073t2855r1198b2890],
16	groups	NNS	O	group	prep_in	10	SENT_260	[p6l189t2910r299b2936],
17	at	IN	O	at	_	0	SENT_260	[p6l315t2906r344b2927],
18	12	CD	DURATION	12	num	21	SENT_260	[p6l362t2901r394b2928],
19	mo	NN	DURATION	mo	nn	21	SENT_260	[p6l410t2910r460b2927],
20	post	NN	O	post	nn	21	SENT_260	[p6l476t2906r544b2936],
21	therapy	NN	O	therapy	prep_at	10	SENT_260	[p6l559t2901r683b2936],
22	was	VBD	O	be	auxpass	23	SENT_260	[p6l697t2910r753b2927],
23	observed	VBN	O	observe	_	0	SENT_260	[p6l768t2901r920b2927],
24	.	.	O	.	_	0	SENT_260	[p6l768t2901r920b2927],

1	Lymphangiogenic	JJ	O	lymphangiogenic	amod	2	SENT_261	[p6l226t2947r518b2982],
2	factors	NNS	O	factor	_	0	SENT_261	[p6l538t2947r648b2973],
3	of	IN	O	of	_	0	SENT_261	[p6l669t2947r703b2973],
4	Iymphedema	NN	O	iymphedema	nn	5	SENT_261	[p6l720t2947r930b2982],
5	patients	NNS	O	patient	prep_of	2	SENT_261	[p6l949t2947r1089b2982],
6	.	.	O	.	_	0	SENT_261	[p6l949t2947r1089b2982],

1	Mean	NN	O	mean	nn	3	SENT_262	[p6l1111t2948r1199b2973],
2	plasma	NN	O	plasma	nn	3	SENT_262	[p6l189t2993r302b3028],
3	concentrations	NNS	O	concentration	_	0	SENT_262	[p6l318t2994r563b3019],
4	of	IN	O	of	_	0	SENT_262	[p6l580t2993r615b3019],
5	VEGF	NN	O	vegf	prep_of	3	SENT_262	[p6l627t2993r760b3019],
6	.	.	O	.	_	0	SENT_262	[p6l627t2993r760b3019],

1	—	NN	O	—	_	0	SENT_263	[p6l627t2993r760b3019],
2	.	.	O	.	_	0	SENT_263	[p6l627t2993r760b3019],

1	C	NN	O	c	_	0	SENT_264	[p6l627t2993r760b3019],
2	and	CC	O	and	_	0	SENT_264	[p6l778t2993r837b3019],
3	sVEGFR	NN	O	svegfr	conj_and	1	SENT_264	[p6l854t2993r1019b3019],
4	—	CD	NUMBER	—	number	5	SENT_264	[p6l854t2993r1019b3019],
5	3	CD	NUMBER	3	num	7	SENT_264	[p6l854t2993r1019b3019],
6	(	NN	O	(	nn	7	SENT_264	[p6l1037t2994r1165b3028],
7	Figures	NNS	O	figure	dep	1	SENT_264	[p6l1037t2994r1165b3028],
8	3	CD	NUMBER	3	dep	7	SENT_264	[p6l1183t2993r1199b3018],

1	PLoS	NN	O	plo	nsubj	2	SENT_265	[p6l288t3093r352b3116],
2	Pathogens	VBD	O	pathogen	_	0	SENT_265	[p6l367t3092r511b3123],
3	|	CD	NUMBER	|	num	4	SENT_265	[p6l526t3091r528b3124],
4	www	NN	O	www	dobj	2	SENT_265	[p6l543t3092r882b3123],
5	.	.	O	.	_	0	SENT_265	[p6l543t3092r882b3123],

1	p	NN	O	p	_	0	SENT_266	[p6l543t3092r882b3123],
2	|	CD	NUMBER	|	num	3	SENT_266	[p6l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	dep	1	SENT_266	[p6l543t3092r882b3123],

1	P	NN	O	p	_	0	SENT_267	[p6l1942t218r2119b249],
2	=	JJ	O	=	amod	1	SENT_267	[p6l1942t218r2119b249],
3	0.0024	CD	NUMBER	0.0024	tmod	2	SENT_267	[p6l1942t218r2119b249],

1	P	NN	O	p	_	0	SENT_268	[p6l2020t336r2195b367],
2	=	JJ	O	=	amod	1	SENT_268	[p6l2020t336r2195b367],
3	0.0012	CD	NUMBER	0.0012	tmod	2	SENT_268	[p6l2020t336r2195b367],

1	P	NN	O	p	_	0	SENT_269	[p6l1727t699r1903b730],
2	=	JJ	O	=	amod	1	SENT_269	[p6l1727t699r1903b730],
3	0.0006	CD	NUMBER	0.0006	tmod	2	SENT_269	[p6l1727t699r1903b730],

1	sVEGFR	NN	O	svegfr	_	0	SENT_270	[p6l1275t726r1301b894],
2	—	CD	NUMBER	—	number	3	SENT_270	[p6l1275t726r1301b894],
3	3	CD	NUMBER	3	num	5	SENT_270	[p6l1275t726r1301b894],
4	plasma	NN	O	plasma	nn	5	SENT_270	[p6l1275t594r1307b711],
5	levels	NNS	O	level	nsubj	6	SENT_270	[p6l1275t483r1301b579],
6	(	VBP	O	(	rcmod	1	SENT_270	[p6l1275t356r1308b468],
7	ng/ml	NN	O	ng/ml	nn	10	SENT_270	[p6l1275t356r1308b468],
8	)	CD	NUMBER	)	num	10	SENT_270	[p6l1275t356r1308b468],
9	co	NN	O	co	nn	10	SENT_270	[p6l1327t631r1345b659],
10	o	NN	O	o	dobj	6	SENT_270	[p6l1347t631r1365b659],
11	Endemic	JJ	O	endemic	amod	13	SENT_270	[p6l1388t908r1540b935],
12	normals	NNS	O	normal	nn	13	SENT_270	[p6l1553t908r1691b935],
13	Mf-positives	NNS	O	mf-positive	dep	10	SENT_270	[p6l1718t907r1938b943],

1	Lymphoedema	NN	PERSON	lymphoedema	_	0	SENT_271	[p6l1990t908r2245b943],

1	Figure	NNP	O	Figure	_	0	SENT_272	[p6l1277t977r1370b1008],
2	4	CD	NUMBER	4	dep	1	SENT_272	[p6l1388t979r1413b1001],
3	.	.	O	.	_	0	SENT_272	[p6l1388t979r1413b1001],

1	Pretreatment	NN	O	pretreatment	nn	3	SENT_273	[p6l1433t978r1614b1001],
2	Plasma	NN	O	plasma	nn	3	SENT_273	[p6l1634t977r1727b1001],
3	Levels	NNS	O	level	nsubjpass	31	SENT_273	[p6l1748t977r1830b1001],
4	of	IN	O	of	_	0	SENT_273	[p6l1849t977r1877b1001],
5	sVEGFR	NN	O	svegfr	prep_of	3	SENT_273	[p6l1894t978r2021b1001],
6	—	CD	NUMBER	—	number	7	SENT_273	[p6l1894t978r2021b1001],
7	3	CD	NUMBER	3	dep	5	SENT_273	[p6l1894t978r2021b1001],
8	in	IN	O	in	_	0	SENT_273	[p6l2042t978r2063b1001],
9	Fi	NNP	O	Fi	nn	11	SENT_273	[p6l2085t977r2286b1001],
10	|	CD	NUMBER	|	num	11	SENT_273	[p6l2085t977r2286b1001],
11	aria	NN	O	aria	prep_in	7	SENT_273	[p6l2085t977r2286b1001],
12	—	CD	NUMBER	—	num	13	SENT_273	[p6l2085t977r2286b1001],
13	|	NN	O	|	nsubj	14	SENT_273	[p6l2085t977r2286b1001],
14	nfected	VBD	O	nfect	rcmod	7	SENT_273	[p6l2085t977r2286b1001],
15	Patients	NNS	O	patient	nsubj	21	SENT_273	[p6l1277t1019r1385b1042],
16	and	CC	O	and	_	0	SENT_273	[p6l1398t1018r1448b1042],
17	Endemic	JJ	O	endemic	amod	20	SENT_273	[p6l1463t1018r1580b1042],
18	Controls	NNP	O	Controls	nn	20	SENT_273	[p6l1593t1018r1707b1042],
19	Plasma	NN	O	plasma	nn	20	SENT_273	[p6l1277t1063r1371b1087],
20	concentrations	NNS	O	concentration	conj_and	15	SENT_273	[p6l1383t1064r1587b1087],
21	(	VBP	O	(	ccomp	14	SENT_273	[p6l1600t1064r1683b1091],
22	mean	NN	O	mean	dobj	21	SENT_273	[p6l1600t1064r1683b1091],
23	:	:	O	:	_	0	SENT_273	[p6l1698t1066r1718b1086],
24	SD	NN	O	sd	nn	25	SENT_273	[p6l1732t1064r1776b1091],
25	)	NN	O	)	dep	7	SENT_273	[p6l1732t1064r1776b1091],
26	of	IN	O	of	_	0	SENT_273	[p6l1788t1063r1816b1087],
27	sVEGFR	NN	O	svegfr	prep_of	25	SENT_273	[p6l1825t1064r1953b1087],
28	—	CD	NUMBER	—	number	29	SENT_273	[p6l1825t1064r1953b1087],
29	3	CD	NUMBER	3	num	27	SENT_273	[p6l1825t1064r1953b1087],
30	were	VBD	O	be	auxpass	31	SENT_273	[p6l1964t1070r2031b1087],
31	measured	VBN	O	measure	_	0	SENT_273	[p6l2043t1063r2176b1087],
32	using	VBG	O	use	xcomp	31	SENT_273	[p6l2189t1064r2260b1094],
33	a	DT	O	a	det	35	SENT_273	[p6l2273t1070r2286b1087],
34	commercial	JJ	O	commercial	amod	35	SENT_273	[p6l1276t1099r1434b1123],
35	kit	NN	O	kit	dobj	32	SENT_273	[p6l1453t1099r1484b1123],
36	from	IN	O	from	_	0	SENT_273	[p6l1500t1099r1563b1123],
37	plasma	NN	O	plasma	prep_from	35	SENT_273	[p6l1582t1099r1677b1130],
38	of	IN	O	of	_	0	SENT_273	[p6l1694t1099r1722b1123],
39	Iymphedema	NN	LOCATION	iymphedema	nn	40	SENT_273	[p6l1738t1099r1917b1130],
40	patients	NNS	O	patient	prep_of	37	SENT_273	[p6l1935t1100r2044b1130],
41	(	CD	NUMBER	(	num	42	SENT_273	[p6l2062t1100r2085b1127],
42	n	NN	O	n	dep	32	SENT_273	[p6l2062t1100r2085b1127],
43	:	:	O	:	_	0	SENT_273	[p6l2100t1111r2122b1119],
44	26	CD	NUMBER	26	num	45	SENT_273	[p6l2136t1100r2183b1127],
45	)	NN	O	)	dep	42	SENT_273	[p6l2136t1100r2183b1127],
46	,	,	O	,	_	0	SENT_273	[p6l2136t1100r2183b1127],
47	microfilaremic	JJ	O	microfilaremic	amod	48	SENT_273	[p6l2201t1100r2287b1123, p6l1275t1134r1392b1158],
48	patients	NNS	O	patient	appos	45	SENT_273	[p6l1407t1135r1517b1165],
49	(	IN	O	(	_	0	SENT_273	[p6l1532t1135r1556b1162],
50	n	NN	O	n	prep_(	48	SENT_273	[p6l1532t1135r1556b1162],
51	:	:	O	:	_	0	SENT_273	[p6l1568t1146r1590b1154],
52	76	CD	NUMBER	76	num	53	SENT_273	[p6l1603t1135r1650b1162],
53	)	NN	O	)	dep	42	SENT_273	[p6l1603t1135r1650b1162],
54	,	,	O	,	_	0	SENT_273	[p6l1603t1135r1650b1162],
55	and	CC	O	and	_	0	SENT_273	[p6l1664t1134r1714b1158],
56	endemic	JJ	O	endemic	amod	57	SENT_273	[p6l1730t1134r1848b1158],
57	controls	NNS	O	control	nsubj	58	SENT_273	[p6l1862t1134r1972b1158],
58	(	VBP	O	(	conj_and	31	SENT_273	[p6l1987t1135r2011b1162],
59	n	NN	O	n	dobj	58	SENT_273	[p6l1987t1135r2011b1162],
60	:	:	O	:	_	0	SENT_273	[p6l2023t1146r2045b1154],
61	23	CD	NUMBER	23	dep	59	SENT_273	[p6l2057t1136r2096b1162],
62	,	,	O	,	_	0	SENT_273	[p6l2057t1136r2096b1162],
63	who	WP	O	who	nsubj	66	SENT_273	[p6l2110t1134r2169b1158],
64	did	VBD	O	do	aux	66	SENT_273	[p6l2184t1134r2226b1158],
65	not	RB	O	not	neg	66	SENT_273	[p6l2242t1138r2287b1158],
66	have	VB	O	have	rcmod	61	SENT_273	[p6l1277t1169r1341b1193],
67	filarial	JJ	O	filarial	amod	69	SENT_273	[p6l1351t1169r1431b1193],
68	infection	NN	O	infection	nn	69	SENT_273	[p6l1443t1169r1579b1197],
69	)	NN	O	)	dobj	66	SENT_273	[p6l1443t1169r1579b1197],
70	.	.	O	.	_	0	SENT_273	[p6l1443t1169r1579b1197],

1	Mean	NN	O	mean	nn	3	SENT_274	[p6l1591t1170r1664b1193],
2	plasma	NN	O	plasma	nn	3	SENT_274	[p6l1677t1169r1772b1200],
3	levels	NNS	O	level	nsubj	10	SENT_274	[p6l1785t1169r1859b1193],
4	of	IN	O	of	_	0	SENT_274	[p6l1870t1169r1898b1193],
5	sVEGFR	NN	O	svegfr	prep_of	3	SENT_274	[p6l1907t1170r2034b1193],
6	—	CD	NUMBER	—	number	7	SENT_274	[p6l1907t1170r2034b1193],
7	3	CD	NUMBER	3	num	5	SENT_274	[p6l1907t1170r2034b1193],
8	were	VBD	O	be	cop	10	SENT_274	[p6l2045t1176r2112b1193],
9	significantly	RB	O	significantly	advmod	10	SENT_274	[p6l2123t1169r2287b1200],
10	elevated	JJ	O	elevated	dep	31	SENT_274	[p6l1276t1205r1392b1229],
11	in	IN	O	in	_	0	SENT_274	[p6l1406t1206r1428b1229],
12	the	DT	O	the	det	15	SENT_274	[p6l1441t1205r1485b1229],
13	microfilaremic	JJ	O	microfilaremic	amod	15	SENT_274	[p6l1499t1205r1692b1229],
14	(	NN	O	(	nn	15	SENT_274	[p6l1706t1206r1730b1236],
15	p	NN	O	p	prep_in	10	SENT_274	[p6l1706t1206r1730b1236],
16	:	:	O	:	_	0	SENT_274	[p6l1740t1217r1762b1225],
17	0.0006	CD	NUMBER	0.0006	num	18	SENT_274	[p6l1771t1206r1869b1233],
18	)	NN	O	)	dep	15	SENT_274	[p6l1771t1206r1869b1233],
19	and	CC	O	and	_	0	SENT_274	[p6l1882t1205r1932b1229],
20	Iymphedema	NN	O	iymphedema	nn	21	SENT_274	[p6l1947t1205r2126b1236],
21	patients	NNS	O	patient	conj_and	18	SENT_274	[p6l2140t1206r2249b1236],
22	(	CD	NUMBER	(	num	23	SENT_274	[p6l2263t1206r2286b1236],
23	p	NN	O	p	dep	18	SENT_274	[p6l2263t1206r2286b1236],
24	:	:	O	:	_	0	SENT_274	[p6l1273t1252r1295b1260],
25	0.0012	CD	NUMBER	0.0012	number	26	SENT_274	[p6l1304t1241r1402b1268],
26	)	CD	NUMBER	)	dep	18	SENT_274	[p6l1304t1241r1402b1268],
27	compared	VBN	O	compare	_	0	SENT_274	[p6l1413t1240r1552b1271],
28	to	TO	O	to	prepc_compared_to	26	SENT_274	[p6l1563t1244r1591b1264],
29	endemic	JJ	O	endemic	amod	30	SENT_274	[p6l1602t1240r1720b1264],
30	controls	NNS	O	control	pobj	26	SENT_274	[p6l1731t1240r1841b1264],
31	(	VBP	O	(	_	0	SENT_274	[p6l1853t1240r1969b1268],
32	Student	NN	O	student	nn	33	SENT_274	[p6l1853t1240r1969b1268],
33	t	NN	O	t	dobj	31	SENT_274	[p6l1981t1244r2050b1264],
34	—	CD	NUMBER	—	num	35	SENT_274	[p6l1981t1244r2050b1264],
35	test	NN	O	test	nsubj	31	SENT_274	[p6l1981t1244r2050b1264],
36	with	IN	O	with	_	0	SENT_274	[p6l2060t1240r2119b1264],
37	Bonferronil	NNP	PERSON	Bonferronil	nn	40	SENT_274	[p6l2132t1240r2288b1265],
38	Dunn	NNP	PERSON	Dunn	nn	40	SENT_274	[p6l1277t1276r1350b1299],
39	correction	NN	O	correction	nn	40	SENT_274	[p6l1367t1276r1523b1303],
40	)	NN	O	)	prep_with	35	SENT_274	[p6l1367t1276r1523b1303],
41	.	.	O	.	_	0	SENT_274	[p6l1367t1276r1523b1303],

1	sVEGFR	NN	O	svegfr	nsubj	7	SENT_275	[p6l1539t1276r1667b1299],
2	—	CD	NUMBER	—	num	3	SENT_275	[p6l1539t1276r1667b1299],
3	3	CD	NUMBER	3	dep	1	SENT_275	[p6l1539t1276r1667b1299],
4	was	VBD	O	be	cop	7	SENT_275	[p6l1683t1282r1735b1299],
5	also	RB	O	also	advmod	7	SENT_275	[p6l1752t1275r1804b1299],
6	significantly	RB	O	significantly	advmod	7	SENT_275	[p6l1821t1275r1985b1306],
7	elevated	JJ	O	elevated	_	0	SENT_275	[p6l2001t1275r2116b1299],
8	in	IN	O	in	_	0	SENT_275	[p6l2135t1276r2156b1299],
9	Iymphedema	NN	LOCATION	iymphedema	nn	10	SENT_275	[p6l2175t1275r2287b1306, p6l1276t1310r1352b1334],
10	patients	NNS	O	patient	prep_in	7	SENT_275	[p6l1367t1311r1476b1341],
11	(	CD	NUMBER	(	num	12	SENT_275	[p6l1490t1311r1514b1341],
12	p	NN	O	p	dep	10	SENT_275	[p6l1490t1311r1514b1341],
13	:	:	O	:	_	0	SENT_275	[p6l1525t1322r1547b1330],
14	0.0024	CD	NUMBER	0.0024	number	15	SENT_275	[p6l1557t1311r1655b1338],
15	)	CD	NUMBER	)	dep	10	SENT_275	[p6l1557t1311r1655b1338],
16	compared	VBN	O	compare	_	0	SENT_275	[p6l1669t1310r1808b1341],
17	to	TO	O	to	prepc_compared_to	15	SENT_275	[p6l1821t1314r1848b1334],
18	microfilaremic	JJ	O	microfilaremic	amod	19	SENT_275	[p6l1863t1310r2057b1334],
19	patients	NNS	O	patient	pobj	15	SENT_275	[p6l2071t1311r2187b1341],
20	.	.	O	.	_	0	SENT_275	[p6l2071t1311r2187b1341],

1	DOI	NNP	O	DOI	_	0	SENT_276	[p6l1277t1347r1334b1370],
2	:	:	O	:	_	0	SENT_276	[p6l1277t1347r1334b1370],
3	10.1371	CD	NUMBER	10.1371	dep	1	SENT_276	[p6l1349t1346r1835b1377],
4	/	:	O	/	punct	6	SENT_276	[p6l1349t1346r1835b1377],
5	journa	NN	O	journa	nn	6	SENT_276	[p6l1349t1346r1835b1377],
6	|	NN	O	|	dep	3	SENT_276	[p6l1349t1346r1835b1377],
7	.	.	O	.	_	0	SENT_276	[p6l1349t1346r1835b1377],

1	ppat	NN	O	ppat	_	0	SENT_277	[p6l1349t1346r1835b1377],
2	.0020092	CD	NUMBER	.0020092	dep	1	SENT_277	[p6l1349t1346r1835b1377],
3	.	.	O	.	_	0	SENT_277	[p6l1349t1346r1835b1377],

1	g004	NN	O	g004	_	0	SENT_278	[p6l1349t1346r1835b1377],

1	and	CC	O	and	cc	2	SENT_279	[p6l1277t1445r1336b1471],
2	4	CD	NUMBER	4	num	3	SENT_279	[p6l1351t1446r1379b1477],
3	)	NN	O	)	nsubj	6	SENT_279	[p6l1351t1446r1379b1477],
4	were	VBD	O	be	cop	6	SENT_279	[p6l1393t1454r1470b1471],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_279	[p6l1485t1445r1681b1480],
6	elevated	JJ	O	elevated	dep	10	SENT_279	[p6l1696t1445r1829b1471],
7	in	IN	O	in	_	0	SENT_279	[p6l1845t1446r1875b1470],
8	Iymphedema	NN	LOCATION	iymphedema	nn	9	SENT_279	[p6l1890t1445r2100b1480],
9	patients	NNS	O	patient	prep_in	6	SENT_279	[p6l2115t1446r2244b1480],
10	(	VBP	O	(	_	0	SENT_279	[p6l2261t1446r2287b1480],
11	[	NN	O	[	dobj	10	SENT_279	[p6l2261t1446r2287b1480],
12	2	CD	NUMBER	2	num	11	SENT_279	[p6l2261t1446r2287b1480],
13	=	JJ	O	=	amod	11	SENT_279	[p6l1273t1502r1298b1511],
14	0.0002	CD	NUMBER	0.0002	tmod	13	SENT_279	[p6l1311t1491r1421b1522],
15	,	,	O	,	_	0	SENT_279	[p6l1311t1491r1421b1522],
16	and	CC	O	and	_	0	SENT_279	[p6l1438t1491r1497b1517],
17	p	NN	O	p	conj_and	11	SENT_279	[p6l1508t1494r1528b1526],
18	=	JJ	O	=	amod	19	SENT_279	[p6l1540t1502r1564b1511],
19	0.0012	CD	NUMBER	0.0012	dep	17	SENT_279	[p6l1577t1491r1688b1522],
20	,	,	O	,	_	0	SENT_279	[p6l1577t1491r1688b1522],
21	respectively	RB	O	respectively	advmod	17	SENT_279	[p6l1704t1491r1906b1526],
22	)	CD	NUMBER	)	nsubj	10	SENT_279	[p6l1704t1491r1906b1526],
23	compared	VBN	O	compare	_	0	SENT_279	[p6l1922t1491r2086b1526],
24	to	TO	O	to	prepc_compared_to	22	SENT_279	[p6l2102t1496r2132b1517],
25	endemic	JJ	O	endemic	amod	26	SENT_279	[p6l2148t1491r2285b1517],
26	controls	NNS	O	control	pobj	22	SENT_279	[p6l1277t1538r1417b1564],
27	.	.	O	.	_	0	SENT_279	[p6l1277t1538r1417b1564],

1	Interestingly	RB	O	interestingly	advmod	12	SENT_280	[p6l1436t1538r1651b1573],
2	,	,	O	,	_	0	SENT_280	[p6l1436t1538r1651b1573],
3	the	DT	O	the	det	5	SENT_280	[p6l1671t1538r1720b1564],
4	plasma	NN	O	plasma	nn	5	SENT_280	[p6l1739t1538r1852b1573],
5	levels	NNS	O	level	nsubj	12	SENT_280	[p6l1870t1538r1957b1564],
6	of	IN	O	of	_	0	SENT_280	[p6l1976t1538r2011b1564],
7	sVEGFR	NN	O	svegfr	prep_of	5	SENT_280	[p6l2026t1538r2192b1564],
8	—	CD	NUMBER	—	number	9	SENT_280	[p6l2026t1538r2192b1564],
9	3	CD	NUMBER	3	num	7	SENT_280	[p6l2026t1538r2192b1564],
10	were	VBD	O	be	cop	12	SENT_280	[p6l2210t1547r2286b1564],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_280	[p6l1277t1584r1473b1619],
12	higher	JJR	O	higher	_	0	SENT_280	[p6l1491t1584r1597b1619],
13	in	IN	O	in	_	0	SENT_280	[p6l1614t1585r1645b1609],
14	lymphedema	NN	O	lymphedema	nn	15	SENT_280	[p6l1663t1584r1872b1619],
15	patients	NNS	O	patient	prep_in	12	SENT_280	[p6l1890t1585r2020b1619],
16	than	IN	O	than	_	0	SENT_280	[p6l2040t1584r2111b1610],
17	in	IN	O	in	_	0	SENT_280	[p6l2130t1585r2160b1609],
18	microﬁlaremic	JJ	O	microﬁlaremic	amod	19	SENT_280	[p6l2179t1585r2286b1610, p6l1276t1631r1419b1657],
19	patients	NNS	O	patient	prep_in	24	SENT_280	[p6l1433t1632r1563b1666],
20	without	IN	O	without	_	0	SENT_280	[p6l1575t1631r1701b1657],
21	lymphedema	NN	O	lymphedema	prep_without	19	SENT_280	[p6l1714t1631r1923b1666],
22	(	CD	NUMBER	(	num	21	SENT_280	[p6l1937t1632r1963b1666],
23	[	CD	NUMBER	[	number	24	SENT_280	[p6l1937t1632r1963b1666],
24	9	CD	NUMBER	9	prep_than	12	SENT_280	[p6l1937t1632r1963b1666],
25	=	JJ	O	=	amod	24	SENT_280	[p6l1973t1642r1998b1651],
26	0.0024	CD	NUMBER	0.0024	tmod	25	SENT_280	[p6l2008t1631r2119b1662],
27	,	,	O	,	_	0	SENT_280	[p6l2008t1631r2119b1662],
28	Figure	NNP	O	Figure	appos	24	SENT_280	[p6l2132t1632r2237b1666],
29	4	CD	NUMBER	4	number	30	SENT_280	[p6l2250t1632r2285b1663],
30	)	CD	NUMBER	)	dep	28	SENT_280	[p6l2250t1632r2285b1663],
31	.	.	O	.	_	0	SENT_280	[p6l2250t1632r2285b1663],

1	Twelve	CD	DURATION	twelve	num	2	SENT_281	[p6l1276t1677r1389b1703],
2	months	NNS	DURATION	month	nsubj	7	SENT_281	[p6l1402t1677r1523b1703],
3	following	VBG	O	follow	_	0	SENT_281	[p6l1536t1677r1688b1712],
4	doxycycline	NN	O	doxycycline	nn	5	SENT_281	[p6l1700t1677r1891b1712],
5	treatment	NN	O	treatment	prep_following	2	SENT_281	[p6l1906t1682r2074b1708],
6	,	,	O	,	_	0	SENT_281	[p6l1906t1682r2074b1708],
7	mean	VB	O	mean	_	0	SENT_281	[p6l2088t1686r2176b1703],
8	values	NNS	O	value	dobj	7	SENT_281	[p6l2188t1677r2286b1703],
9	of	IN	O	of	_	0	SENT_281	[p6l1277t1724r1311b1750],
10	VEGF	NN	O	vegf	prep_of	8	SENT_281	[p6l1329t1724r1462b1750],
11	.	.	O	.	_	0	SENT_281	[p6l1329t1724r1462b1750],

1	—	NN	O	—	_	0	SENT_282	[p6l1329t1724r1462b1750],
2	.	.	O	.	_	0	SENT_282	[p6l1329t1724r1462b1750],

1	C	NN	O	c	nsubjpass	12	SENT_283	[p6l1329t1724r1462b1750],
2	and	CC	O	and	_	0	SENT_283	[p6l1485t1724r1544b1750],
3	sVEGFR	NN	O	svegfr	nsubjpass	12	SENT_283	[p6l1566t1724r1731b1750],
4	—	CD	NUMBER	—	number	5	SENT_283	[p6l1566t1724r1731b1750],
5	3	CD	NUMBER	3	npadvmod	1	SENT_283	[p6l1566t1724r1731b1750],
6	in	IN	O	in	_	0	SENT_283	[p6l1754t1725r1785b1749],
7	the	DT	O	the	det	9	SENT_283	[p6l1808t1724r1857b1750],
8	doxycycline	NN	O	doxycycline	nn	9	SENT_283	[p6l1879t1724r2070b1759],
9	group	NN	O	group	prep_in	1	SENT_283	[p6l2092t1733r2188b1759],
10	were	VBD	O	be	auxpass	12	SENT_283	[p6l2210t1733r2286b1750],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_283	[p6l1277t1770r1473b1805],
12	reduced	VBN	O	reduce	_	0	SENT_283	[p6l1492t1770r1623b1796],
13	(	NN	O	(	nn	14	SENT_283	[p6l1643t1772r1670b1805],
14	[	NN	O	[	dobj	12	SENT_283	[p6l1643t1772r1670b1805],
15	7	CD	NUMBER	7	num	14	SENT_283	[p6l1643t1772r1670b1805],
16	=	JJ	O	=	advmod	12	SENT_283	[p6l1685t1781r1710b1790],
17	0.0499	CD	NUMBER	0.0499	dep	16	SENT_283	[p6l1726t1770r1837b1801],
18	,	,	O	,	_	0	SENT_283	[p6l1726t1770r1837b1801],
19	Figure	NNP	O	Figure	appos	17	SENT_283	[p6l1856t1771r1961b1805],
20	7	CD	NUMBER	7	num	19	SENT_283	[p6l1981t1768r2004b1801],
21	,	,	O	,	_	0	SENT_283	[p6l1981t1768r2004b1801],
22	and	CC	O	and	_	0	SENT_283	[p6l2024t1770r2083b1796],
23	[	CD	NUMBER	[	number	24	SENT_283	[p6l2099t1773r2118b1805],
24	9	CD	NUMBER	9	dep	16	SENT_283	[p6l2099t1773r2118b1805],
25	=	JJ	O	=	amod	26	SENT_283	[p6l2134t1781r2159b1790],
26	0.0251	CD	NUMBER	0.0251	dep	24	SENT_283	[p6l2175t1770r2286b1801],
27	,	,	O	,	_	0	SENT_283	[p6l2175t1770r2286b1801],
28	Figure	NNP	O	Figure	dobj	12	SENT_283	[p6l1276t1818r1381b1852],
29	8	CD	NUMBER	8	num	28	SENT_283	[p6l1406t1817r1430b1848],
30	,	,	O	,	_	0	SENT_283	[p6l1406t1817r1430b1848],
31	respectively	RB	O	respectively	advmod	32	SENT_283	[p6l1455t1817r1666b1852],
32	)	CD	NUMBER	)	rcmod	28	SENT_283	[p6l1455t1817r1666b1852],
33	,	,	O	,	_	0	SENT_283	[p6l1455t1817r1666b1852],
34	whereas	IN	O	whereas	mark	36	SENT_283	[p6l1690t1817r1820b1843],
35	there	EX	O	there	expl	36	SENT_283	[p6l1846t1817r1929b1843],
36	were	VBD	O	be	dep	28	SENT_283	[p6l1953t1826r2029b1843],
37	no	DT	O	no	det	39	SENT_283	[p6l2054t1826r2093b1843],
38	signiﬁcant	JJ	O	signiﬁcant	amod	39	SENT_283	[p6l2118t1817r2287b1852],
39	alterations	NNS	O	alteration	nsubj	36	SENT_283	[p6l1277t1863r1450b1889],
40	in	IN	O	in	_	0	SENT_283	[p6l1475t1864r1505b1888],
41	the	DT	O	the	det	43	SENT_283	[p6l1530t1863r1579b1889],
42	placebo	NN	O	placebo	nn	43	SENT_283	[p6l1604t1863r1729b1898],
43	group	NN	O	group	prep_in	39	SENT_283	[p6l1753t1872r1858b1898],
44	.	.	O	.	_	0	SENT_283	[p6l1753t1872r1858b1898],

1	Since	IN	O	since	_	0	SENT_284	[p6l1883t1863r1969b1889],
2	the	DT	O	the	det	5	SENT_284	[p6l1995t1863r2044b1889],
3	pretreatment	NN	O	pretreatment	nn	5	SENT_284	[p6l2068t1868r2287b1898],
4	standard	JJ	O	standard	amod	5	SENT_284	[p6l1277t1910r1419b1936],
5	deviation	NN	O	deviation	prep_since	29	SENT_284	[p6l1432t1910r1584b1936],
6	of	IN	O	of	_	0	SENT_284	[p6l1598t1910r1633b1936],
7	the	DT	O	the	det	9	SENT_284	[p6l1644t1910r1693b1936],
8	sVEGFR	NN	O	svegfr	nn	9	SENT_284	[p6l1707t1910r1872b1936],
9	—	NN	O	—	prep_of	5	SENT_284	[p6l1707t1910r1872b1936],
10	3	CD	NUMBER	3	num	11	SENT_284	[p6l1707t1910r1872b1936],
11	levels	NNS	O	level	nsubj	18	SENT_284	[p6l1886t1910r1972b1936],
12	in	IN	O	in	_	0	SENT_284	[p6l1987t1911r2017b1935],
13	the	DT	O	the	det	15	SENT_284	[p6l2032t1910r2081b1936],
14	doxycycline	NN	O	doxycycline	nn	15	SENT_284	[p6l2095t1910r2286b1945],
15	group	NN	O	group	prep_in	11	SENT_284	[p6l1276t1965r1373b1991],
16	was	VBD	O	be	cop	18	SENT_284	[p6l1390t1965r1445b1982],
17	rather	RB	O	rather	advmod	18	SENT_284	[p6l1464t1956r1565b1982],
18	large	JJ	O	large	rcmod	9	SENT_284	[p6l1580t1956r1668b1991],
19	,	,	O	,	_	0	SENT_284	[p6l1580t1956r1668b1991],
20	due	JJ	O	due	_	0	SENT_284	[p6l1686t1956r1744b1982],
21	to	TO	O	to	_	0	SENT_284	[p6l1762t1961r1792b1982],
22	one	CD	NUMBER	one	prep_due_to	9	SENT_284	[p6l1810t1965r1869b1982],
23	very	RB	O	very	advmod	24	SENT_284	[p6l1886t1965r1953b1991],
24	high	JJ	O	high	amod	25	SENT_284	[p6l1970t1956r2040b1991],
25	value	NN	O	value	dep	9	SENT_284	[p6l2057t1956r2148b1987],
26	,	,	O	,	_	0	SENT_284	[p6l2057t1956r2148b1987],
27	we	PRP	O	we	nsubj	29	SENT_284	[p6l2166t1965r2208b1982],
28	also	RB	O	also	advmod	29	SENT_284	[p6l2226t1956r2286b1982],
29	applied	VBD	O	apply	_	0	SENT_284	[p6l1277t2003r1398b2038],
30	the	DT	O	the	det	32	SENT_284	[p6l1424t2003r1473b2029],
31	Wilcoxon	NNP	PERSON	Wilcoxon	nn	32	SENT_284	[p6l1498t2003r1654b2029],
32	test	NN	O	test	dobj	29	SENT_284	[p6l1680t2008r1736b2029],
33	in	IN	O	in	_	0	SENT_284	[p6l1761t2004r1791b2028],
34	this	DT	O	this	det	35	SENT_284	[p6l1818t2003r1874b2029],
35	case	NN	O	case	prep_in	29	SENT_284	[p6l1899t2012r1973b2034],
36	;	:	O	;	_	0	SENT_284	[p6l1899t2012r1973b2034],
37	there	EX	O	there	expl	38	SENT_284	[p6l1999t2003r2083b2029],
38	was	VBD	O	be	parataxis	29	SENT_284	[p6l2107t2012r2163b2029],
39	still	RB	O	still	advmod	38	SENT_284	[p6l2189t2003r2245b2029],
40	a	DT	O	a	det	42	SENT_284	[p6l2271t2012r2287b2029],
41	signiﬁcant	NN	O	signiﬁcant	nn	42	SENT_284	[p6l1277t2050r1445b2085],
42	difference	NN	O	difference	nsubj	38	SENT_284	[p6l1457t2050r1623b2076],
43	(	CD	NUMBER	(	num	44	SENT_284	[p6l1636t2052r1696b2085],
44	p	NN	O	p	dep	42	SENT_284	[p6l1636t2052r1696b2085],
45	:	:	O	:	_	0	SENT_284	[p6l1636t2052r1696b2085],
46	0.0284	CD	NUMBER	0.0284	num	47	SENT_284	[p6l1706t2050r1820b2082],
47	)	NN	O	)	dep	42	SENT_284	[p6l1706t2050r1820b2082],
48	in	IN	O	in	_	0	SENT_284	[p6l1833t2051r1863b2075],
49	sVEGFR	NN	O	svegfr	prep_in	47	SENT_284	[p6l1875t2050r2041b2076],
50	—	CD	NUMBER	—	number	51	SENT_284	[p6l1875t2050r2041b2076],
51	3	CD	NUMBER	3	num	52	SENT_284	[p6l1875t2050r2041b2076],
52	levels	NNS	O	level	dep	47	SENT_284	[p6l2053t2050r2139b2076],
53	between	IN	O	between	_	0	SENT_284	[p6l2152t2050r2286b2076],
54	pretreatment	NN	O	pretreatment	prep_between	52	SENT_284	[p6l1277t2101r1495b2131],
55	and	CC	O	and	_	0	SENT_284	[p6l1510t2096r1569b2122],
56	12	CD	NUMBER	12	num	57	SENT_284	[p6l1587t2096r1620b2123],
57	mo.	NN	O	mo.	prep_between	52	SENT_284	[p6l1636t2105r1694b2122],
58	.	.	O	.	_	0	SENT_284	[p6l1636t2105r1694b2122],

1	Discussion	NN	O	discussion	_	0	SENT_285	[p6l1278t2170r1479b2202],

1	The	DT	DATE	the	det	3	SENT_286	[p6l1314t2248r1377b2274],
2	past	JJ	DATE	past	amod	3	SENT_286	[p6l1405t2253r1471b2283],
3	decade	NN	DATE	decade	nsubj	5	SENT_286	[p6l1499t2248r1613b2274],
4	has	VBZ	O	have	aux	5	SENT_286	[p6l1641t2248r1693b2274],
5	seen	VBN	O	see	_	0	SENT_286	[p6l1721t2257r1792b2274],
6	major	JJ	O	major	amod	7	SENT_286	[p6l1820t2248r1918b2283],
7	advances	NNS	O	advance	dobj	5	SENT_286	[p6l1945t2248r2091b2274],
8	that	WDT	O	that	nsubj	10	SENT_286	[p6l2121t2248r2185b2274],
9	have	VBP	O	have	aux	10	SENT_286	[p6l2212t2248r2286b2274],
10	changed	VBN	O	change	rcmod	7	SENT_286	[p6l1277t2295r1412b2330],
11	LF	NN	O	lf	dobj	10	SENT_286	[p6l1434t2296r1476b2320],
12	from	IN	O	from	_	0	SENT_286	[p6l1499t2295r1579b2321],
13	a	DT	O	a	det	15	SENT_286	[p6l1602t2304r1618b2321],
14	neglected	VBN	O	neglect	amod	15	SENT_286	[p6l1642t2295r1797b2330],
15	disease	NN	O	disease	prep_from	10	SENT_286	[p6l1820t2295r1933b2321],
16	into	IN	O	into	_	0	SENT_286	[p6l1957t2296r2021b2321],
17	a	DT	O	a	det	18	SENT_286	[p6l2045t2304r2061b2321],
18	disease	NN	O	disease	prep_into	5	SENT_286	[p6l2084t2295r2196b2321],
19	now	RB	DATE	now	advmod	20	SENT_286	[p6l2221t2304r2286b2321],
20	accepted	VBN	O	accept	partmod	18	SENT_286	[p6l1277t2341r1421b2376],
21	as	IN	O	as	_	0	SENT_286	[p6l1441t2350r1470b2367],
22	potentially	RB	O	potentially	advmod	23	SENT_286	[p6l1491t2341r1666b2376],
23	eradicable	JJ	O	eradicable	prep_as	20	SENT_286	[p6l1686t2341r1862b2367],
24	.	.	O	.	_	0	SENT_286	[p6l1686t2341r1862b2367],

1	The	DT	O	the	det	3	SENT_287	[p6l1883t2341r1945b2367],
2	main	JJ	O	main	amod	3	SENT_287	[p6l1965t2342r2046b2367],
3	reason	NN	O	reason	nsubj	6	SENT_287	[p6l2067t2350r2173b2367],
4	is	VBZ	O	be	cop	6	SENT_287	[p6l2194t2342r2216b2367],
5	the	DT	O	the	det	6	SENT_287	[p6l2237t2341r2286b2367],
6	identiﬁcation	NN	O	identiﬁcation	_	0	SENT_287	[p6l1277t2388r1506b2414],
7	of	IN	O	of	_	0	SENT_287	[p6l1535t2388r1571b2414],
8	ivermectin	NN	O	ivermectin	prep_of	6	SENT_287	[p6l1596t2389r1786b2419],
9	,	,	O	,	_	0	SENT_287	[p6l1596t2389r1786b2419],
10	DEC	NNP	ORGANIZATION	DEC	prep_of	6	SENT_287	[p6l1815t2388r1898b2419],
11	,	,	O	,	_	0	SENT_287	[p6l1815t2388r1898b2419],
12	and	CC	O	and	_	0	SENT_287	[p6l1928t2388r1989b2414],
13	albendazole	NN	O	albendazole	prep_of	6	SENT_287	[p6l2018t2388r2226b2419],
14	,	,	O	,	_	0	SENT_287	[p6l2018t2388r2226b2419],
15	as	IN	O	as	_	0	SENT_287	[p6l2256t2397r2286b2414],
16	effective	JJ	O	effective	amod	18	SENT_287	[p6l1277t2434r1414b2460],
17	antiﬁlarial	JJ	O	antiﬁlarial	amod	18	SENT_287	[p6l1429t2434r1598b2460],
18	agents	NNS	O	agent	prep_as	6	SENT_287	[p6l1614t2440r1723b2469],
19	.	.	O	.	_	0	SENT_287	[p6l1614t2440r1723b2469],

1	While	IN	O	while	mark	5	SENT_288	[p6l1313t2481r1408b2507],
2	DEC	NNP	ORGANIZATION	DEC	nsubjpass	5	SENT_288	[p6l1424t2481r1496b2507],
3	has	VBZ	O	have	aux	5	SENT_288	[p6l1513t2481r1564b2507],
4	been	VBN	O	be	auxpass	5	SENT_288	[p6l1580t2481r1658b2507],
5	shown	VBN	O	show	advcl	15	SENT_288	[p6l1674t2481r1775b2507],
6	to	TO	O	to	aux	7	SENT_288	[p6l1793t2486r1823b2507],
7	have	VB	O	have	xcomp	5	SENT_288	[p6l1839t2481r1912b2507],
8	some	DT	O	some	det	10	SENT_288	[p6l1928t2490r2011b2507],
9	macroﬁlaricidal	JJ	O	macroﬁlaricidal	amod	10	SENT_288	[p6l2027t2481r2286b2507],
10	effect	NN	O	effect	dobj	7	SENT_288	[p6l1277t2528r1375b2559],
11	,	,	O	,	_	0	SENT_288	[p6l1277t2528r1375b2559],
12	it	PRP	O	it	nsubjpass	15	SENT_288	[p6l1393t2529r1415b2554],
13	is	VBZ	O	be	auxpass	15	SENT_288	[p6l1432t2529r1454b2554],
14	still	RB	O	still	advmod	15	SENT_288	[p6l1472t2528r1529b2554],
15	believed	VBN	O	believe	_	0	SENT_288	[p6l1546t2528r1680b2554],
16	that	IN	O	that	complm	22	SENT_288	[p6l1698t2528r1761b2554],
17	a	DT	O	a	det	20	SENT_288	[p6l1778t2537r1794b2554],
18	more	RBR	O	more	advmod	19	SENT_288	[p6l1811t2537r1895b2554],
19	potent	JJ	O	potent	amod	20	SENT_288	[p6l1913t2533r2021b2563],
20	macroﬁlaricide	NN	O	macroﬁlaricide	nsubj	22	SENT_288	[p6l2038t2528r2286b2554],
21	will	MD	O	will	aux	22	SENT_288	[p6l1276t2574r1332b2599],
22	add	VB	O	add	ccomp	15	SENT_288	[p6l1347t2574r1405b2600],
23	to	TO	O	to	_	0	SENT_288	[p6l1420t2579r1450b2600],
24	efforts	NNS	O	effort	prep_to	22	SENT_288	[p6l1465t2574r1570b2600],
25	to	TO	O	to	aux	26	SENT_288	[p6l1586t2579r1616b2600],
26	achieve	VB	O	achieve	xcomp	22	SENT_288	[p6l1632t2574r1751b2600],
27	LF	NN	O	lf	nn	28	SENT_288	[p6l1765t2575r1807b2599],
28	elimination	NN	O	elimination	dobj	26	SENT_288	[p6l1821t2574r2018b2605],
29	,	,	O	,	_	0	SENT_288	[p6l1821t2574r2018b2605],
30	halting	VBG	O	halt	xcomp	15	SENT_288	[p6l2033t2574r2147b2609],
31	also	RB	O	also	advmod	30	SENT_288	[p6l2161t2574r2221b2600],
32	the	DT	O	the	det	33	SENT_288	[p6l2237t2574r2286b2600],
33	progression	NN	O	progression	dobj	30	SENT_288	[p6l1277t2622r1469b2656],
34	of	IN	O	of	_	0	SENT_288	[p6l1484t2621r1519b2647],
35	the	DT	O	the	det	37	SENT_288	[p6l1531t2621r1580b2647],
36	clinical	JJ	O	clinical	amod	37	SENT_288	[p6l1596t2621r1712b2647],
37	manifestations	NNS	O	manifestation	prep_of	33	SENT_288	[p6l1728t2621r1966b2647],
38	induced	VBN	O	induce	partmod	37	SENT_288	[p6l1982t2621r2113b2647],
39	largely	RB	O	largely	advmod	38	SENT_288	[p6l2128t2621r2236b2656],
40	by	IN	O	by	_	0	SENT_288	[p6l2250t2621r2287b2656],
41	the	DT	O	the	det	46	SENT_288	[p6l1278t2667r1327b2693],
42	adult	JJ	O	adult	amod	46	SENT_288	[p6l1344t2667r1426b2693],
43	worm	NN	O	worm	nn	46	SENT_288	[p6l1441t2676r1534b2693],
44	[	NN	O	[	nn	46	SENT_288	[p6l1552t2667r1617b2699],
45	48	CD	NUMBER	48	num	46	SENT_288	[p6l1552t2667r1617b2699],
46	]	NN	O	]	agent	38	SENT_288	[p6l1552t2667r1617b2699],
47	.	.	O	.	_	0	SENT_288	[p6l1552t2667r1617b2699],

1	This	DT	O	this	nsubj	5	SENT_289	[p6l1634t2667r1703b2693],
2	particularly	RB	O	particularly	advmod	5	SENT_289	[p6l1720t2667r1910b2702],
3	is	VBZ	O	be	cop	5	SENT_289	[p6l1927t2668r1949b2693],
4	the	DT	O	the	det	5	SENT_289	[p6l1967t2667r2016b2693],
5	case	NN	O	case	_	0	SENT_289	[p6l2033t2676r2098b2693],
6	for	IN	O	for	_	0	SENT_289	[p6l2114t2667r2163b2693],
7	Africa	NNP	LOCATION	Africa	prep_for	5	SENT_289	[p6l2177t2667r2286b2698],
8	,	,	O	,	_	0	SENT_289	[p6l2177t2667r2286b2698],
9	where	WRB	O	where	advmod	15	SENT_289	[p6l1276t2714r1373b2740],
10	the	DT	O	the	det	11	SENT_289	[p6l1389t2714r1438b2740],
11	use	NN	O	use	nsubjpass	15	SENT_289	[p6l1451t2723r1502b2740],
12	of	IN	O	of	_	0	SENT_289	[p6l1516t2714r1551b2740],
13	DEC	NNP	DATE	DEC	prep_of	11	SENT_289	[p6l1561t2714r1634b2740],
14	is	VBZ	O	be	auxpass	15	SENT_289	[p6l1649t2715r1671b2740],
15	discouraged	VBN	O	discourage	rcmod	7	SENT_289	[p6l1685t2714r1881b2749],
16	in	IN	O	in	_	0	SENT_289	[p6l1896t2715r1926b2739],
17	areas	NNS	O	area	prep_in	15	SENT_289	[p6l1940t2723r2021b2740],
18	co-endemic	JJ	O	co-endemic	amod	17	SENT_289	[p6l2036t2714r2224b2740],
19	for	IN	O	for	_	0	SENT_289	[p6l2239t2714r2287b2740],
20	onchocerciasis	NN	O	onchocerciasis	prep_for	18	SENT_289	[p6l1277t2760r1523b2791],
21	,	,	O	,	_	0	SENT_289	[p6l1277t2760r1523b2791],
22	due	JJ	O	due	_	0	SENT_289	[p6l1545t2760r1603b2786],
23	to	TO	O	to	_	0	SENT_289	[p6l1625t2765r1655b2786],
24	the	DT	O	the	det	27	SENT_289	[p6l1678t2760r1727b2786],
25	irreversible	JJ	O	irreversible	amod	27	SENT_289	[p6l1748t2760r1933b2786],
26	ocular	JJ	O	ocular	amod	27	SENT_289	[p6l1955t2760r2058b2786],
27	damage	NN	O	damage	prep_due_to	20	SENT_289	[p6l2078t2760r2202b2795],
28	that	WDT	O	that	dobj	30	SENT_289	[p6l2224t2760r2287b2786],
29	DEC	NNP	ORGANIZATION	DEC	nsubj	30	SENT_289	[p6l1276t2807r1349b2833],
30	induces	VBZ	O	induce	rcmod	27	SENT_289	[p6l1365t2807r1496b2838],
31	,	,	O	,	_	0	SENT_289	[p6l1365t2807r1496b2838],
32	different	JJ	O	different	dep	27	SENT_289	[p6l1512t2807r1655b2833],
33	from	IN	O	from	_	0	SENT_289	[p6l1670t2807r1749b2833],
34	ivermectin	NN	O	ivermectin	prep_from	32	SENT_289	[p6l1765t2808r1939b2833],
35	[	CD	NUMBER	[	num	34	SENT_289	[p6l1956t2807r2068b2839],
36	49,50	CD	NUMBER	49,50	num	37	SENT_289	[p6l1956t2807r2068b2839],
37	]	NN	O	]	dep	20	SENT_289	[p6l1956t2807r2068b2839],
38	.	.	O	.	_	0	SENT_289	[p6l1956t2807r2068b2839],

1	Two	CD	NUMBER	two	num	3	SENT_290	[p6l1314t2855r1382b2880],
2	major	JJ	O	major	amod	3	SENT_290	[p6l1407t2854r1503b2889],
3	advances	NNS	O	advance	nsubjpass	6	SENT_290	[p6l1525t2854r1669b2880],
4	have	VBP	O	have	aux	6	SENT_290	[p6l1693t2854r1766b2880],
5	been	VBN	O	be	auxpass	6	SENT_290	[p6l1789t2854r1866b2880],
6	observed	VBN	O	observe	_	0	SENT_290	[p6l1890t2854r2035b2880],
7	in	IN	O	in	_	0	SENT_290	[p6l2059t2855r2089b2879],
8	this	DT	O	this	det	9	SENT_290	[p6l2113t2854r2169b2880],
9	study	NN	O	study	prep_in	6	SENT_290	[p6l2193t2854r2285b2889],
10	.	.	O	.	_	0	SENT_290	[p6l2193t2854r2285b2889],

1	Firstly	RB	O	firstly	advmod	10	SENT_291	[p6l1276t2900r1385b2935],
2	,	,	O	,	_	0	SENT_291	[p6l1276t2900r1385b2935],
3	a	DT	O	a	det	4	SENT_291	[p6l1401t2909r1417b2926],
4	regimen	NN	O	regimen	advmod	10	SENT_291	[p6l1433t2901r1566b2935],
5	of	IN	O	of	_	0	SENT_291	[p6l1581t2900r1616b2926],
6	6	CD	DURATION	6	num	7	SENT_291	[p6l1628t2900r1645b2925],
7	wk	NN	DURATION	wk	prep_of	4	SENT_291	[p6l1659t2900r1703b2925],
8	of	IN	O	of	_	0	SENT_291	[p6l1718t2900r1752b2926],
9	doxycycline	NN	O	doxycycline	prep_of	4	SENT_291	[p6l1764t2900r1955b2935],
10	against	IN	O	against	dep	14	SENT_291	[p6l1971t2901r2085b2935],
11	W.	NNP	O	W.	nn	12	SENT_291	[p6l2102t2901r2137b2926],
12	bancrofti	NNS	O	bancroftus	pobj	10	SENT_291	[p6l2154t2900r2285b2935],
13	,	,	O	,	_	0	SENT_291	[p6l2154t2900r2285b2935],
14	shorter	JJR	O	shorter	_	0	SENT_291	[p6l1277t2947r1399b2973],
15	than	IN	O	than	_	0	SENT_291	[p6l1428t2947r1502b2973],
16	what	WP	O	what	dobj	18	SENT_291	[p6l1530t2947r1609b2973],
17	we	PRP	O	we	nsubj	28	SENT_291	[p6l1637t2956r1680b2973],
18	published	VBD	O	publish	prepc_than	14	SENT_291	[p6l1709t2947r1873b2982],
19	earlier	JJR	O	earlier	advmod	18	SENT_291	[p6l1902t2947r2013b2973],
20	[	CD	NUMBER	[	number	21	SENT_291	[p6l2043t2947r2111b2979],
21	42	CD	NUMBER	42	num	22	SENT_291	[p6l2043t2947r2111b2979],
22	]	NN	O	]	dobj	18	SENT_291	[p6l2043t2947r2111b2979],
23	,	,	O	,	_	0	SENT_291	[p6l2043t2947r2111b2979],
24	depleted	VBN	O	deplete	partmod	22	SENT_291	[p6l2140t2947r2286b2982],
25	Wolbachia	NNP	O	Wolbachia	nn	26	SENT_291	[p6l1279t2993r1427b3019],
26	endosymbionts	NNS	O	endosymbiont	dobj	24	SENT_291	[p6l1442t2993r1688b3028],
27	and	CC	O	and	_	0	SENT_291	[p6l1705t2993r1764b3019],
28	showed	VBD	O	show	conj_and	18	SENT_291	[p6l1780t2993r1899b3019],
29	a	DT	O	a	det	31	SENT_291	[p6l1915t3002r1931b3019],
30	strong	JJ	O	strong	amod	31	SENT_291	[p6l1946t2998r2050b3028],
31	macroﬁlariciA	NN	O	macroﬁlaricia	dobj	28	SENT_291	[p6l2065t2993r2285b3019, p7l188t235r219b243],

1	4	CD	NUMBER	4	num	3	SENT_292	[p7l234t217r252b243],
2	E	NN	O	e	nn	3	SENT_292	[p7l188t247r212b280],
3	P	NN	O	p	nsubj	4	SENT_292	[p7l993t246r1139b272],
4	=	JJ	O	=	_	0	SENT_292	[p7l993t246r1139b272],
5	0.1570	CD	NUMBER	0.1570	num	7	SENT_292	[p7l993t246r1139b272],
6	T	NN	O	t	nn	7	SENT_292	[p7l188t283r219b309],
7	”	NN	O	”	dobj	4	SENT_292	[p7l188t283r219b309],
8	.	.	O	.	_	0	SENT_292	[p7l312t286r455b309],

1	-	:	O	-	_	0	SENT_293	[p7l312t286r455b309],
2	o-c-a	NN	O	o-c-a	_	0	SENT_293	[p7l312t286r455b309],
3	-	:	O	-	_	0	SENT_293	[p7l312t286r455b309],
4	'	''	O	'	_	0	SENT_293	[p7l312t286r455b309],
5	.	.	O	.	_	0	SENT_293	[p7l312t286r455b309],

1	-	:	O	-	_	0	SENT_294	[p7l312t286r455b309],
2	o-cg	NN	O	o-cg	_	0	SENT_294	[p7l312t286r455b309],
3	:	:	O	:	_	0	SENT_294	[p7l312t286r455b309],
4	-	:	O	-	_	0	SENT_294	[p7l312t286r455b309],
5	a-a-c-a-c-a	NN	O	a-a-c-a-c-a	dep	2	SENT_294	[p7l312t286r455b309],
6	-	:	O	-	_	0	SENT_294	[p7l312t286r455b309],
7	:	:	O	:	_	0	SENT_294	[p7l312t286r455b309],
8	5	CD	NUMBER	5	dep	5	SENT_294	[p7l188t312r219b340],
9	:	:	O	:	_	0	SENT_294	[p7l312t309r322b337],
10	-	:	O	-	_	0	SENT_294	[p7l380t319r384b323],
11	:	:	O	:	_	0	SENT_294	[p7l451t314r455b337],
12	P	NN	O	p	dep	17	SENT_294	[p7l777t302r923b329],
13	=	JJ	O	=	amod	14	SENT_294	[p7l777t302r923b329],
14	0.0198	CD	NUMBER	0.0198	dep	12	SENT_294	[p7l777t302r923b329],
15	m	NN	O	m	dep	17	SENT_294	[p7l194t353r212b369],
16	3	CD	NUMBER	3	num	15	SENT_294	[p7l234t336r251b362],
17	E	NN	O	e	dep	21	SENT_294	[p7l188t372r212b417],
18	5	CD	MONEY	5	num	17	SENT_294	[p7l312t371r455b413],
19	#	#	MONEY	#	dep	20	SENT_294	[p7l312t371r455b413],
20	4ZYj	NN	O	4zyj	dep	17	SENT_294	[p7l767t374r811b393],
21	.....	CD	NUMBER	.....	dep	8	SENT_294	[p7l825t388r877b393],
22	.	.	O	.	_	0	SENT_294	[p7l825t388r877b393],

1	.	.	O	.	_	0	SENT_295	[p7l882t388r896b393],

1	.	.	O	.	_	0	SENT_296	[p7l882t388r896b393],

1	2	CD	NUMBER	2	_	0	SENT_297	[p7l188t419r212b443],
2	'	''	O	'	_	0	SENT_297	[p7l312t413r455b446],
3	3	CD	NUMBER	3	dep	1	SENT_297	[p7l312t413r455b446],
4	:	:	O	:	_	0	SENT_297	[p7l312t413r455b446],
5	-	:	O	-	_	0	SENT_297	[p7l312t413r455b446],
6	cpoa-o-a-awn-c-a-c-nu	NN	O	cpoa-o-a-awn-c-a-c-nu	dep	1	SENT_297	[p7l312t413r455b446],
7	:	:	O	:	_	0	SENT_297	[p7l312t413r455b446],
8	N	NN	O	n	dep	6	SENT_297	[p7l194t457r212b473],
9	2	CD	NUMBER	2	number	8	SENT_297	[p7l234t454r251b480],
10	_	SYM	O	_	dep	6	SENT_297	[p7l312t446r322b475],
11	-	:	O	-	_	0	SENT_297	[p7l342t442r380b484],
12	_	CD	NUMBER	_	dep	6	SENT_297	[p7l342t442r380b484],
13	`	``	O	`	_	0	SENT_297	[p7l408t446r451b451],
14	XYj	NN	O	xyj	dep	12	SENT_297	[p7l408t446r451b451],
15	_	NN	O	_	nn	16	SENT_297	[p7l778t479r782b483],
16	E	NN	O	e	dep	12	SENT_297	[p7l194t476r212b500],
17	:	:	O	:	_	0	SENT_297	[p7l312t484r318b508],
18	.	.	O	.	_	0	SENT_297	[p7l342t499r346b503],

1	:	:	O	:	_	0	SENT_298	[p7l768t483r773b507],
2	2	CD	NUMBER	2	nsubj	5	SENT_298	[p7l194t505r212b539],
3	§	SYM	O	§	dep	5	SENT_298	[p7l312t480r346b541],
4	-	:	O	-	_	0	SENT_298	[p7l312t480r346b541],
5	E.	NNP	O	E.	_	0	SENT_298	[p7l768t521r773b526, p7l188t543r219b566],
6	-	:	O	-	_	0	SENT_298	[p7l312t551r322b570],
7	'	''	O	'	_	0	SENT_298	[p7l342t537r346b541],
8	H	NN	O	h	nsubj	11	SENT_298	[p7l768t536r816b564],
9	‘	CD	NUMBER	‘	num	10	SENT_298	[p7l768t536r816b564],
10	c	NN	O	c	dep	8	SENT_298	[p7l188t580r212b612],
11	_	VBD	O	_	ccomp	5	SENT_298	[p7l188t580r212b612],
12	)	CD	NUMBER	)	number	13	SENT_298	[p7l188t580r212b612],
13	1	CD	NUMBER	1	num	15	SENT_298	[p7l236t573r247b599],
14	r	NN	O	r	nn	15	SENT_298	[p7l312t579r318b589],
15	XYj	NN	O	xyj	dobj	11	SENT_298	[p7l351t594r375b598],
16	KXYj	NN	O	kxyj	prep	11	SENT_298	[p7l408t594r455b612],
17	u.	NN	O	u.	dep	16	SENT_298	[p7l188t614r212b630],
18	‘	CD	NUMBER	‘	num	17	SENT_298	[p7l312t631r313b636],
19	.	.	O	.	_	0	SENT_298	[p7l451t627r455b631],

1	(	NN	O	(	_	0	SENT_299	[p7l188t636r212b678],
2	L3	NN	O	l3	dep	1	SENT_299	[p7l188t636r212b678],
3	'	''	O	'	_	0	SENT_299	[p7l313t636r318b641],
4	.	.	O	.	_	0	SENT_299	[p7l375t641r384b664],

1	:	:	O	:	_	0	SENT_300	[p7l375t641r384b664],
2	.....	NN	O	.....	_	0	SENT_300	[p7l384t646r427b650],
3	.	.	O	.	_	0	SENT_300	[p7l432t646r455b669],

1	.	.	O	.	_	0	SENT_301	[p7l432t646r455b669],

1	:	:	O	:	_	0	SENT_302	[p7l432t646r455b669],
2	>	JJR	O	>	_	0	SENT_302	[p7l188t680r212b701],
3	o	NN	O	o	dep	2	SENT_302	[p7l234t691r251b718],

1	Doxycycline	NNP	O	Doxycycline	nn	4	SENT_303	[p7l287t727r482b761],
2	Placebo	NNP	O	Placebo	nn	4	SENT_303	[p7l547t727r678b754],
3	Doxycycline	NNP	O	Doxycycline	nn	4	SENT_303	[p7l742t727r937b761],
4	Placebo	NNP	O	Placebo	_	0	SENT_303	[p7l1002t727r1134b754],

1	Before	IN	O	before	_	0	SENT_304	[p7l308t785r428b815],
2	treatment	NN	O	treatment	pobj	1	SENT_304	[p7l441t787r619b815],
3	12	CD	DURATION	12	num	4	SENT_304	[p7l804t788r842b817],
4	months	NNS	NUMBER	month	tmod	2	SENT_304	[p7l857t788r994b817],

1	Figure	NNP	O	Figure	_	0	SENT_305	[p7l190t851r282b882],
2	5	CD	NUMBER	5	dep	1	SENT_305	[p7l294t853r319b875],
3	.	.	O	.	_	0	SENT_305	[p7l294t853r319b875],

1	Plasma	NN	O	plasma	nn	2	SENT_306	[p7l332t851r426b875],
2	Levels	NNS	O	level	_	0	SENT_306	[p7l439t851r521b875],
3	of	IN	O	of	_	0	SENT_306	[p7l533t851r561b875],
4	VEGF	NN	O	vegf	prep_of	2	SENT_306	[p7l570t852r671b875],
5	.	.	O	.	_	0	SENT_306	[p7l570t852r671b875],

1	—	NN	O	—	_	0	SENT_307	[p7l570t852r671b875],
2	.	.	O	.	_	0	SENT_307	[p7l570t852r671b875],

1	C	NN	O	c	_	0	SENT_308	[p7l570t852r671b875],
2	of	IN	O	of	_	0	SENT_308	[p7l683t851r711b875],
3	Microfilaremic	JJ	O	microfilaremic	amod	4	SENT_308	[p7l722t851r915b875],
4	Patients	NNS	O	patient	prep_of	1	SENT_308	[p7l928t852r1035b875],
5	before	IN	O	before	advmod	4	SENT_308	[p7l1048t851r1136b875],
6	and	CC	O	and	_	0	SENT_308	[p7l1148t851r1198b875],
7	12	CD	DURATION	12	num	8	SENT_308	[p7l191t895r220b917],
8	Mo	NN	DURATION	mo	conj_and	1	SENT_308	[p7l234t894r276b917],
9	after	IN	O	after	mark	14	SENT_308	[p7l289t893r352b917],
10	Doxycycline	NNP	O	Doxycycline	nn	13	SENT_308	[p7l365t893r529b924],
11	Treatment	NNP	O	Treatment	nn	13	SENT_308	[p7l540t894r684b917],
12	Plasma	NN	O	plasma	nn	13	SENT_308	[p7l190t938r284b962],
13	concentrations	NNS	O	concentration	nsubj	14	SENT_308	[p7l302t939r507b962],
14	(	VBP	O	(	dep	8	SENT_308	[p7l526t939r610b966],
15	mean	NN	O	mean	dobj	14	SENT_308	[p7l526t939r610b966],
16	:	:	O	:	_	0	SENT_308	[p7l632t941r651b961],
17	SD	NN	O	sd	nn	18	SENT_308	[p7l672t939r717b966],
18	)	NN	O	)	dep	1	SENT_308	[p7l672t939r717b966],
19	of	IN	O	of	_	0	SENT_308	[p7l736t938r764b962],
20	VEGF	NN	O	vegf	prep_of	18	SENT_308	[p7l779t939r879b962],
21	.	.	O	.	_	0	SENT_308	[p7l779t939r879b962],

1	—	NN	O	—	_	0	SENT_309	[p7l779t939r879b962],
2	.	.	O	.	_	0	SENT_309	[p7l779t939r879b962],

1	C	NN	O	c	nsubjpass	3	SENT_310	[p7l779t939r879b962],
2	were	VBD	O	be	auxpass	3	SENT_310	[p7l897t945r964b962],
3	measured	VBN	O	measure	_	0	SENT_310	[p7l983t938r1116b962],
4	from	IN	O	from	_	0	SENT_310	[p7l1134t938r1198b962],
5	plasma	NN	O	plasma	prep_from	3	SENT_310	[p7l190t973r285b1004],
6	of	IN	O	of	_	0	SENT_310	[p7l302t973r330b997],
7	microfilaremic	JJ	O	microfilaremic	amod	8	SENT_310	[p7l345t973r539b997],
8	patients	NNS	O	patient	prep_of	5	SENT_310	[p7l556t974r665b1004],
9	before	IN	O	before	_	0	SENT_310	[p7l682t973r770b997],
10	and	CC	O	and	dep	12	SENT_310	[p7l786t973r835b997],
11	12	CD	DURATION	12	number	12	SENT_310	[p7l855t975r884b997],
12	mo	NN	DURATION	mo	dep	3	SENT_310	[p7l902t980r944b997],
13	after	IN	O	after	_	0	SENT_310	[p7l960t973r1023b997],
14	doxycycline	NN	O	doxycycline	nn	15	SENT_310	[p7l1038t973r1199b1004],
15	treatment	NN	O	treatment	prep_after	12	SENT_310	[p7l188t1013r326b1033],
16	(	CD	NUMBER	(	number	17	SENT_310	[p7l338t1010r378b1037],
17	17	CD	NUMBER	17	num	18	SENT_310	[p7l338t1010r378b1037],
18	doxycycline	NN	O	doxycycline	nsubj	24	SENT_310	[p7l391t1009r551b1040],
19	treated	VBN	O	treat	partmod	18	SENT_310	[p7l563t1009r668b1037],
20	,	,	O	,	_	0	SENT_310	[p7l563t1009r668b1037],
21	16	CD	NUMBER	16	num	22	SENT_310	[p7l683t1011r713b1033],
22	placebo	NN	O	placebo	appos	18	SENT_310	[p7l726t1009r840b1040],
23	,	,	O	,	_	0	SENT_310	[p7l726t1009r840b1040],
24	see	VB	O	see	rcmod	15	SENT_310	[p7l853t1016r897b1033],
25	Table	NNP	O	Table	dobj	24	SENT_310	[p7l908t1009r983b1033],
26	1	CD	NUMBER	1	number	27	SENT_310	[p7l997t1010r1026b1037],
27	)	CD	NUMBER	)	prep_before	3	SENT_310	[p7l997t1010r1026b1037],
28	.	.	O	.	_	0	SENT_310	[p7l997t1010r1026b1037],

1	The	DT	O	the	det	2	SENT_311	[p7l1036t1009r1087b1033],
2	VEGF	NN	O	vegf	_	0	SENT_311	[p7l1098t1010r1199b1033],
3	.	.	O	.	_	0	SENT_311	[p7l1098t1010r1199b1033],

1	—	NN	O	—	_	0	SENT_312	[p7l1098t1010r1199b1033],
2	.	.	O	.	_	0	SENT_312	[p7l1098t1010r1199b1033],

1	C	NN	O	c	nn	2	SENT_313	[p7l1098t1010r1199b1033],
2	levels	NNS	O	level	nsubj	3	SENT_313	[p7l190t1044r264b1068],
3	decreased	VBD	O	decrease	_	0	SENT_313	[p7l290t1044r429b1068],
4	significantly	RB	O	significantly	advmod	3	SENT_313	[p7l455t1044r621b1075],
5	at	IN	O	at	_	0	SENT_313	[p7l645t1048r671b1068],
6	12	CD	DURATION	12	num	8	SENT_313	[p7l698t1046r727b1068],
7	mo	NN	DURATION	mo	nn	8	SENT_313	[p7l753t1051r795b1068],
8	(	NN	O	(	prep_at	3	SENT_313	[p7l821t1044r969b1075],
9	preceding	VBG	O	precede	partmod	8	SENT_313	[p7l821t1044r969b1075],
10	supratesticular	JJ	O	supratesticular	amod	12	SENT_313	[p7l995t1044r1200b1075],
11	lymphatic	JJ	O	lymphatic	amod	12	SENT_313	[p7l190t1079r324b1110],
12	dilation	NN	O	dilation	dobj	9	SENT_313	[p7l337t1079r447b1107],
13	,	,	O	,	_	0	SENT_313	[p7l337t1079r447b1107],
14	see	VB	O	see	dep	12	SENT_313	[p7l460t1086r504b1103],
15	Table	NNP	O	Table	nsubj	17	SENT_313	[p7l516t1079r591b1103],
16	2	CD	NUMBER	2	number	17	SENT_313	[p7l605t1080r628b1107],
17	)	CD	NUMBER	)	xcomp	14	SENT_313	[p7l605t1080r628b1107],
18	in	IN	O	in	_	0	SENT_313	[p7l642t1080r664b1103],
19	the	DT	O	the	det	22	SENT_313	[p7l678t1079r723b1103],
20	doxycyc	JJ	O	doxycyc	amod	22	SENT_313	[p7l736t1079r1006b1110],
21	|	NN	O	|	nn	22	SENT_313	[p7l736t1079r1006b1110],
22	ine	NN	O	ine	prep_in	17	SENT_313	[p7l736t1079r1006b1110],
23	—	CD	NUMBER	—	num	25	SENT_313	[p7l736t1079r1006b1110],
24	treated	JJ	O	treated	amod	25	SENT_313	[p7l736t1079r1006b1110],
25	patients	NNS	O	patient	tmod	9	SENT_313	[p7l1021t1080r1131b1110],
26	(	IN	O	(	_	0	SENT_313	[p7l1145t1080r1169b1110],
27	p	NN	O	p	prep_(	25	SENT_313	[p7l1145t1080r1169b1110],
28	:	:	O	:	_	0	SENT_313	[p7l1180t1091r1202b1099],
29	0.0198	CD	NUMBER	0.0198	num	30	SENT_313	[p7l189t1116r294b1143],
30	)	NN	O	)	dep	25	SENT_313	[p7l189t1116r294b1143],
31	,	,	O	,	_	0	SENT_313	[p7l189t1116r294b1143],
32	but	CC	O	but	_	0	SENT_313	[p7l308t1115r353b1139],
33	no	DT	O	no	det	34	SENT_313	[p7l366t1122r400b1139],
34	difference	NN	O	difference	nsubj	39	SENT_313	[p7l412t1115r549b1139],
35	in	IN	O	in	_	0	SENT_313	[p7l563t1116r584b1139],
36	the	DT	O	the	det	38	SENT_313	[p7l597t1115r642b1139],
37	placebo	NN	O	placebo	nn	38	SENT_313	[p7l656t1115r764b1146],
38	group	NN	O	group	prep_in	34	SENT_313	[p7l776t1122r859b1146],
39	occurred	VBD	O	occur	conj_but	3	SENT_313	[p7l871t1115r991b1139],
40	(	CD	NUMBER	(	num	42	SENT_313	[p7l1006t1115r1099b1146],
41	paired	JJ	O	paired	amod	42	SENT_313	[p7l1006t1115r1099b1146],
42	t	NN	O	t	nsubj	45	SENT_313	[p7l1114t1116r1199b1143],
43	—	CD	NUMBER	—	num	45	SENT_313	[p7l1114t1116r1199b1143],
44	test	NN	O	test	nn	45	SENT_313	[p7l1114t1116r1199b1143],
45	)	NN	O	)	xcomp	39	SENT_313	[p7l1114t1116r1199b1143],
46	.	.	O	.	_	0	SENT_313	[p7l1114t1116r1199b1143],

1	DOI	NNP	O	DOI	_	0	SENT_314	[p7l190t1151r246b1174],
2	:	:	O	:	_	0	SENT_314	[p7l190t1151r246b1174],
3	10.1371	CD	NUMBER	10.1371	dep	1	SENT_314	[p7l262t1150r746b1181],
4	/	:	O	/	punct	6	SENT_314	[p7l262t1150r746b1181],
5	journa	NN	O	journa	nn	6	SENT_314	[p7l262t1150r746b1181],
6	|	NN	O	|	dep	3	SENT_314	[p7l262t1150r746b1181],
7	.	.	O	.	_	0	SENT_314	[p7l262t1150r746b1181],

1	ppat	NN	O	ppat	_	0	SENT_315	[p7l262t1150r746b1181],
2	.0020092	CD	NUMBER	.0020092	dep	1	SENT_315	[p7l262t1150r746b1181],
3	.	.	O	.	_	0	SENT_315	[p7l262t1150r746b1181],

1	g005	NN	O	g005	_	0	SENT_316	[p7l262t1150r746b1181],

1	dal	NN	O	dal	nn	2	SENT_317	[p7l189t1232r237b1258],
2	activity	NN	O	activity	_	0	SENT_317	[p7l249t1233r373b1267],
3	,	,	O	,	_	0	SENT_317	[p7l249t1233r373b1267],
4	as	IN	O	as	mark	5	SENT_317	[p7l386t1241r415b1258],
5	evidenced	VBN	O	evidence	dep	2	SENT_317	[p7l428t1232r591b1258],
6	by	IN	O	by	_	0	SENT_317	[p7l602t1232r639b1267],
7	reduction	NN	O	reduction	prep_by	5	SENT_317	[p7l651t1232r810b1258],
8	of	IN	O	of	_	0	SENT_317	[p7l822t1232r857b1258],
9	antigenemia	NN	O	antigenemia	prep_of	7	SENT_317	[p7l865t1233r1067b1267],
10	by	IN	O	by	_	0	SENT_317	[p7l1078t1232r1114b1267],
11	94	CD	PERCENT	94	num	12	SENT_317	[p7l1126t1232r1194b1261],
12	%	NN	PERCENT	%	prep_by	9	SENT_317	[p7l1126t1232r1194b1261],
13	and	CC	O	and	_	0	SENT_317	[p7l189t1278r248b1304],
14	the	DT	O	the	det	15	SENT_317	[p7l267t1278r317b1304],
15	absence	NN	O	absence	prep_of	7	SENT_317	[p7l335t1278r462b1304],
16	of	IN	O	of	_	0	SENT_317	[p7l480t1278r515b1304],
17	adult	JJ	O	adult	amod	18	SENT_317	[p7l530t1278r612b1304],
18	worms	NNS	O	worm	prep_of	15	SENT_317	[p7l629t1287r735b1304],
19	from	IN	O	from	_	0	SENT_317	[p7l753t1278r833b1304],
20	the	DT	O	the	det	22	SENT_317	[p7l852t1278r901b1304],
21	scrotal	JJ	O	scrotal	amod	22	SENT_317	[p7l919t1278r1027b1304],
22	region	NN	O	region	prep_from	18	SENT_317	[p7l1046t1279r1150b1313],
23	in	IN	O	in	_	0	SENT_317	[p7l1168t1279r1199b1303],
24	89	CD	PERCENT	89	num	25	SENT_317	[p7l190t1324r258b1353],
25	%	NN	PERCENT	%	prep_in	22	SENT_317	[p7l190t1324r258b1353],
26	of	IN	O	of	_	0	SENT_317	[p7l275t1324r309b1350],
27	male	NN	O	male	nn	28	SENT_317	[p7l319t1324r395b1350],
28	participants	NNS	O	participant	prep_of	25	SENT_317	[p7l408t1325r604b1359],
29	by	IN	O	by	_	0	SENT_317	[p7l617t1324r654b1359],
30	USG	NNP	O	USG	nn	32	SENT_317	[p7l666t1324r740b1350],
31	24	CD	DURATION	24	num	32	SENT_317	[p7l753t1324r790b1351],
32	mo	NN	DURATION	mo	prep_by	5	SENT_317	[p7l802t1333r852b1350],
33	after	IN	O	after	_	0	SENT_317	[p7l865t1324r942b1350],
34	treatment	NN	O	treatment	prep_after	5	SENT_317	[p7l955t1329r1123b1350],
35	.	.	O	.	_	0	SENT_317	[p7l955t1329r1123b1350],

1	The	DT	O	the	det	6	SENT_318	[p7l1136t1324r1199b1350],
2	second	JJ	ORDINAL	second	amod	6	SENT_318	[p7l189t1370r301b1396],
3	and	CC	O	and	_	0	SENT_318	[p7l316t1370r375b1396],
4	fully	RB	O	fully	advmod	5	SENT_318	[p7l389t1370r460b1405],
5	novel	JJ	O	novel	conj_and	2	SENT_318	[p7l475t1370r561b1396],
6	advance	NN	O	advance	nsubj	9	SENT_318	[p7l577t1370r707b1396],
7	is	VBZ	O	be	cop	9	SENT_318	[p7l722t1371r744b1396],
8	the	DT	O	the	det	9	SENT_318	[p7l760t1370r809b1396],
9	reduction	NN	O	reduction	_	0	SENT_318	[p7l825t1370r984b1396],
10	of	IN	O	of	_	0	SENT_318	[p7l999t1370r1033b1396],
11	lymphangiogenetic	JJ	O	lymphangiogenetic	amod	12	SENT_318	[p7l1044t1370r1198b1405, p7l189t1417r356b1451],
12	factors	NNS	O	factor	prep_of	9	SENT_318	[p7l368t1416r478b1442],
13	following	VBG	O	follow	_	0	SENT_318	[p7l490t1416r642b1451],
14	doxycycline	NN	O	doxycycline	prep_following	12	SENT_318	[p7l653t1416r852b1451],
15	,	,	O	,	_	0	SENT_318	[p7l653t1416r852b1451],
16	and	CC	O	and	_	0	SENT_318	[p7l864t1416r923b1442],
17	the	DT	O	the	det	18	SENT_318	[p7l936t1416r985b1442],
18	reduction	NN	O	reduction	conj_and	9	SENT_318	[p7l997t1416r1156b1442],
19	of	IN	O	of	_	0	SENT_318	[p7l1168t1416r1202b1442],
20	lymphatic	JJ	O	lymphatic	amod	22	SENT_318	[p7l189t1461r349b1496],
21	vessel	NN	O	vessel	nn	22	SENT_318	[p7l365t1461r455b1487],
22	dilation	NN	O	dilation	prep_of	18	SENT_318	[p7l470t1461r597b1487],
23	and	CC	O	and	_	0	SENT_318	[p7l612t1461r671b1487],
24	improvement	NN	O	improvement	conj_and	18	SENT_318	[p7l687t1462r908b1496],
25	of	IN	O	of	_	0	SENT_318	[p7l923t1461r957b1487],
26	lymphedema	NN	O	lymphedema	prep_of	24	SENT_318	[p7l969t1461r1185b1496],
27	.	.	O	.	_	0	SENT_318	[p7l969t1461r1185b1496],

1	Wolbachia	JJ	O	wolbachia	amod	2	SENT_319	[p7l191t1535r367b1566],
2	Load	NN	O	load	nsubjpass	24	SENT_319	[p7l385t1535r464b1566],
3	We	PRP	O	we	nsubj	4	SENT_319	[p7l226t1587r278b1612],
4	recorded	VBD	O	record	rcmod	2	SENT_319	[p7l307t1586r457b1612],
5	a	DT	O	a	det	8	SENT_319	[p7l486t1595r502b1612],
6	95	CD	PERCENT	95	number	7	SENT_319	[p7l531t1586r600b1615],
7	%	NN	PERCENT	%	amod	8	SENT_319	[p7l531t1586r600b1615],
8	reduction	NN	O	reduction	dobj	4	SENT_319	[p7l633t1586r797b1612],
9	of	IN	O	of	_	0	SENT_319	[p7l825t1586r861b1612],
10	Wolbachia	JJ	O	wolbachia	amod	11	SENT_319	[p7l888t1586r1041b1612],
11	load	NN	O	load	prep_of	8	SENT_319	[p7l1069t1586r1139b1612],
12	in	IN	O	in	_	0	SENT_319	[p7l1168t1587r1199b1611],
13	doxycycline-treated	JJ	O	doxycycline-treated	amod	14	SENT_319	[p7l189t1632r512b1667],
14	patients	NNS	O	patient	prep_in	11	SENT_319	[p7l530t1633r660b1667],
15	4	CD	DURATION	4	num	16	SENT_319	[p7l678t1633r696b1657],
16	mo	NN	DURATION	mo	dep	11	SENT_319	[p7l714t1641r763b1658],
17	after	IN	O	after	_	0	SENT_319	[p7l782t1632r859b1658],
18	treatment	NN	O	treatment	prep_after	16	SENT_319	[p7l877t1637r1045b1663],
19	,	,	O	,	_	0	SENT_319	[p7l877t1637r1045b1663],
20	and	CC	O	and	_	0	SENT_319	[p7l1064t1632r1123b1658],
21	this	DT	O	this	det	22	SENT_319	[p7l1142t1632r1198b1658],
22	reduction	NN	O	reduction	conj_and	11	SENT_319	[p7l190t1678r349b1704],
23	was	VBD	O	be	auxpass	24	SENT_319	[p7l373t1687r429b1704],
24	sustained	VBN	O	sustain	_	0	SENT_319	[p7l454t1678r605b1704],
25	throughout	IN	O	throughout	_	0	SENT_319	[p7l631t1678r817b1713],
26	the	DT	O	the	det	29	SENT_319	[p7l842t1678r891b1704],
27	24	CD	NUMBER	24	number	28	SENT_319	[p7l917t1678r1018b1705],
28	—	CD	NUMBER	—	num	29	SENT_319	[p7l917t1678r1018b1705],
29	mo	NN	DURATION	mo	prep_throughout	24	SENT_319	[p7l917t1678r1018b1705],
30	follow-up	JJ	O	follow-up	amod	31	SENT_319	[p7l1043t1678r1198b1713],
31	period	NN	O	period	tmod	29	SENT_319	[p7l189t1724r307b1759],
32	.	.	O	.	_	0	SENT_319	[p7l189t1724r307b1759],

1	The	DT	O	the	det	2	SENT_320	[p7l335t1724r398b1750],
2	fact	NN	O	fact	nsubj	25	SENT_320	[p7l427t1724r488b1750],
3	that	IN	O	that	complm	5	SENT_320	[p7l517t1724r581b1750],
4	there	EX	O	there	expl	5	SENT_320	[p7l610t1724r694b1750],
5	was	VBD	O	be	dep	2	SENT_320	[p7l722t1733r779b1750],
6	an	DT	O	a	det	7	SENT_320	[p7l808t1733r846b1750],
7	apparent	JJ	O	apparent	nsubj	5	SENT_320	[p7l874t1729r1033b1759],
8	,	,	O	,	_	0	SENT_320	[p7l874t1729r1033b1759],
9	but	CC	O	but	_	0	SENT_320	[p7l1062t1724r1116b1750],
10	not	RB	O	not	_	0	SENT_320	[p7l1145t1729r1199b1750],
11	signiﬁcant	NN	O	signiﬁcant	nsubj	5	SENT_320	[p7l189t1769r365b1804],
12	,	,	O	,	_	0	SENT_320	[p7l189t1769r365b1804],
13	increase	NN	O	increase	appos	11	SENT_320	[p7l385t1770r517b1795],
14	in	IN	O	in	_	0	SENT_320	[p7l536t1770r567b1794],
15	Wolbachia	NNP	LOCATION	Wolbachia	nn	16	SENT_320	[p7l588t1769r736b1795],
16	loads	NNS	O	load	prep_in	13	SENT_320	[p7l753t1769r836b1795],
17	in	IN	O	in	_	0	SENT_320	[p7l855t1770r885b1794],
18	three	CD	NUMBER	three	num	21	SENT_320	[p7l905t1769r988b1795],
19	MF-positive	JJ	MISC	mf-positive	amod	21	SENT_320	[p7l1007t1770r1199b1804],
20	doxycycline	NN	O	doxycycline	nn	21	SENT_320	[p7l189t1815r381b1850],
21	patients	NNS	O	patient	prep_in	5	SENT_320	[p7l409t1816r539b1850],
22	at	IN	O	at	_	0	SENT_320	[p7l568t1820r597b1841],
23	24	CD	DURATION	24	num	24	SENT_320	[p7l625t1815r661b1842],
24	mo	NN	DURATION	mo	prep_at	21	SENT_320	[p7l688t1824r738b1841],
25	is	VBZ	O	be	_	0	SENT_320	[p7l766t1816r789b1841],
26	probably	RB	O	probably	advmod	25	SENT_320	[p7l817t1815r962b1850],
27	due	JJ	O	due	acomp	25	SENT_320	[p7l990t1815r1048b1841],
28	to	TO	O	to	_	0	SENT_320	[p7l1077t1821r1107b1841],
29	new	JJ	O	new	amod	30	SENT_320	[p7l1136t1824r1199b1841],
30	infections	NNS	O	infection	prep_to	27	SENT_320	[p7l190t1861r358b1892],
31	,	,	O	,	_	0	SENT_320	[p7l190t1861r358b1892],
32	which	WDT	O	which	nsubj	34	SENT_320	[p7l378t1861r473b1887],
33	is	VBZ	O	be	cop	34	SENT_320	[p7l493t1862r515b1887],
34	likely	JJ	O	likely	rcmod	30	SENT_320	[p7l534t1861r620b1896],
35	to	TO	O	to	aux	36	SENT_320	[p7l640t1866r670b1887],
36	occur	VB	O	occur	xcomp	34	SENT_320	[p7l690t1870r782b1887],
37	in	IN	O	in	_	0	SENT_320	[p7l801t1862r831b1886],
38	this	DT	O	this	det	39	SENT_320	[p7l852t1861r908b1887],
39	area	NN	O	area	prep_in	36	SENT_320	[p7l928t1870r997b1887],
40	of	IN	O	of	_	0	SENT_320	[p7l1016t1861r1050b1887],
41	ongoing	JJ	O	ongoing	amod	42	SENT_320	[p7l1066t1862r1200b1896],
42	transmission	NN	O	transmission	prep_of	39	SENT_320	[p7l190t1908r404b1938],
43	,	,	O	,	_	0	SENT_320	[p7l190t1908r404b1938],
44	theoretically	RB	O	theoretically	advmod	36	SENT_320	[p7l418t1907r622b1942],
45	at	IN	O	at	_	0	SENT_320	[p7l634t1912r663b1933],
46	a	DT	O	a	det	48	SENT_320	[p7l676t1916r692b1933],
47	yearly	JJ	SET	yearly	amod	48	SENT_320	[p7l703t1907r800b1942],
48	rate	NN	O	rate	prep_at	36	SENT_320	[p7l813t1913r876b1933],
49	of	IN	O	of	_	0	SENT_320	[p7l889t1907r923b1933],
50	20	CD	PERCENT	20	num	51	SENT_320	[p7l933t1907r1001b1936],
51	%	NN	PERCENT	%	prep_of	48	SENT_320	[p7l933t1907r1001b1936],
52	of	IN	O	of	_	0	SENT_320	[p7l1018t1907r1053b1933],
53	the	DT	O	the	det	56	SENT_320	[p7l1063t1907r1112b1933],
54	total	JJ	O	total	amod	56	SENT_320	[p7l1126t1907r1199b1933],
55	worm	NN	O	worm	nn	56	SENT_320	[p7l188t1962r281b1979],
56	load	NN	O	load	prep_of	51	SENT_320	[p7l294t1953r370b1984],
57	,	,	O	,	_	0	SENT_320	[p7l294t1953r370b1984],
58	given	VBN	O	give	prep	36	SENT_320	[p7l384t1954r469b1988],
59	that	IN	O	that	complm	65	SENT_320	[p7l484t1953r546b1979],
60	the	DT	O	the	det	64	SENT_320	[p7l560t1953r609b1979],
61	average	JJ	O	average	amod	64	SENT_320	[p7l623t1962r745b1988],
62	worm	NN	O	worm	nn	64	SENT_320	[p7l757t1962r850b1979],
63	life	NN	O	life	nn	64	SENT_320	[p7l863t1953r913b1979],
64	span	NN	O	span	nsubj	65	SENT_320	[p7l926t1962r1000b1988],
65	is	VBZ	O	be	pcomp	58	SENT_320	[p7l1014t1954r1036b1979],
66	about	IN	O	about	_	0	SENT_320	[p7l1049t1953r1142b1979],
67	5	CD	NUMBER	5	num	68	SENT_320	[p7l1155t1953r1171b1978],
68	y	NN	O	y	prep_about	65	SENT_320	[p7l1183t1962r1199b1988],
69	and	CC	O	and	_	0	SENT_320	[p7l189t1998r248b2024],
70	that	IN	O	that	complm	72	SENT_320	[p7l269t1998r332b2024],
71	there	EX	O	there	expl	72	SENT_320	[p7l352t1998r435b2024],
72	is	VBZ	O	be	pcomp	58	SENT_320	[p7l456t1999r477b2024],
73	a	DT	O	a	det	78	SENT_320	[p7l498t2007r514b2024],
74	rather	RB	O	rather	advmod	75	SENT_320	[p7l533t1998r634b2024],
75	stable	JJ	O	stable	amod	78	SENT_320	[p7l653t1998r745b2024],
76	adult	JJ	O	adult	amod	78	SENT_320	[p7l765t1998r847b2024],
77	worm	NN	O	worm	nn	78	SENT_320	[p7l866t2007r959b2024],
78	load	NN	O	load	nsubj	72	SENT_320	[p7l978t1998r1047b2024],
79	in	IN	O	in	_	0	SENT_320	[p7l1067t1999r1097b2023],
80	adult	JJ	O	adult	amod	81	SENT_320	[p7l1117t1998r1199b2024],
81	patients	NNS	O	patient	prep_in	78	SENT_320	[p7l189t2045r327b2079],
82	.	.	O	.	_	0	SENT_320	[p7l189t2045r327b2079],

1	New	NNP	O	New	nn	2	SENT_321	[p7l349t2045r419b2070],
2	infections	NNS	O	infection	nsubj	15	SENT_321	[p7l441t2044r601b2070],
3	with	IN	O	with	_	0	SENT_321	[p7l623t2044r692b2070],
4	concurrent	JJ	O	concurrent	amod	5	SENT_321	[p7l714t2050r897b2070],
5	rise	NN	O	rise	prep_with	2	SENT_321	[p7l919t2045r975b2070],
6	in	IN	O	in	_	0	SENT_321	[p7l997t2045r1027b2069],
7	Wolbachia	JJ	LOCATION	wolbachia	amod	8	SENT_321	[p7l1052t2044r1200b2070],
8	levels	NNS	O	level	prep_in	5	SENT_321	[p7l189t2090r275b2116],
9	following	VBG	O	follow	_	0	SENT_321	[p7l301t2090r453b2125],
10	doxycycline	NN	O	doxycycline	nn	11	SENT_321	[p7l477t2090r668b2125],
11	treatment	NN	O	treatment	prep_following	8	SENT_321	[p7l695t2095r856b2116],
12	have	VBP	O	have	aux	15	SENT_321	[p7l880t2090r954b2116],
13	already	RB	O	already	advmod	15	SENT_321	[p7l979t2090r1097b2125],
14	been	VBN	O	be	cop	15	SENT_321	[p7l1121t2090r1199b2116],
15	documented	VBN	O	document	_	0	SENT_321	[p7l189t2136r393b2162],
16	for	IN	O	for	_	0	SENT_321	[p7l418t2136r467b2162],
17	doxycycline	NN	O	doxycycline	nn	18	SENT_321	[p7l491t2136r682b2171],
18	treatment	NN	O	treatment	prep_for	15	SENT_321	[p7l709t2141r870b2162],
19	of	IN	O	of	_	0	SENT_321	[p7l895t2136r930b2162],
20	onchocerciasis	NN	O	onchocerciasis	prep_of	18	SENT_321	[p7l952t2136r1198b2167],
21	,	,	O	,	_	0	SENT_321	[p7l952t2136r1198b2167],
22	where	WRB	O	where	advmod	34	SENT_321	[p7l188t2182r286b2208],
23	old	JJ	O	old	amod	25	SENT_321	[p7l304t2182r362b2213],
24	,	,	O	,	_	0	SENT_321	[p7l304t2182r362b2213],
25	doxycycline-treated	JJ	O	doxycycline-treated	dep	34	SENT_321	[p7l380t2182r703b2217],
26	and	CC	O	and	_	0	SENT_321	[p7l721t2182r780b2208],
27	thus	RB	O	thus	advmod	28	SENT_321	[p7l798t2182r864b2208],
28	Wolbachia	JJ	PERSON	wolbachia	conj_and	25	SENT_321	[p7l885t2182r1033b2208],
29	depleted	VBN	O	deplete	partmod	28	SENT_321	[p7l1050t2182r1198b2217],
30	,	,	O	,	_	0	SENT_321	[p7l1050t2182r1198b2217],
31	female	JJ	O	female	amod	32	SENT_321	[p7l189t2227r296b2253],
32	worms	NNS	O	worm	nsubjpass	34	SENT_321	[p7l309t2236r416b2253],
33	were	VBD	O	be	auxpass	34	SENT_321	[p7l429t2236r505b2253],
34	located	VBN	O	locate	rcmod	20	SENT_321	[p7l519t2227r636b2253],
35	in	IN	O	in	_	0	SENT_321	[p7l650t2228r681b2252],
36	onchocercomas	NNS	O	onchocercoma	prep_in	34	SENT_321	[p7l694t2227r949b2253],
37	next	IN	O	next	_	0	SENT_321	[p7l963t2233r1034b2253],
38	to	TO	O	to	_	0	SENT_321	[p7l1048t2233r1078b2253],
39	young	JJ	O	young	amod	42	SENT_321	[p7l1091t2236r1198b2262],
40	,	,	O	,	_	0	SENT_321	[p7l1091t2236r1198b2262],
41	nulliparous	JJ	O	nulliparous	amod	42	SENT_321	[p7l190t2273r375b2308],
42	worms	NNS	O	worm	prep_next_to	15	SENT_321	[p7l390t2282r497b2299],
43	that	WDT	O	that	nsubj	45	SENT_321	[p7l514t2273r577b2299],
44	were	VBD	O	be	cop	45	SENT_321	[p7l592t2282r668b2299],
45	full	JJ	O	full	rcmod	42	SENT_321	[p7l684t2273r736b2299],
46	with	IN	O	with	_	0	SENT_321	[p7l752t2273r821b2299],
47	Wolbachia	JJ	O	wolbachia	amod	50	SENT_321	[p7l840t2273r988b2299],
48	[	NN	O	[	nn	50	SENT_321	[p7l1005t2273r1070b2305],
49	51	CD	NUMBER	51	num	50	SENT_321	[p7l1005t2273r1070b2305],
50	]	NN	O	]	prep_with	45	SENT_321	[p7l1005t2273r1070b2305],
51	.	.	O	.	_	0	SENT_321	[p7l1005t2273r1070b2305],

1	Due	JJ	O	due	_	0	SENT_322	[p7l1086t2274r1151b2299],
2	to	TO	O	to	_	0	SENT_322	[p7l1168t2278r1198b2299],
3	the	DT	O	the	det	4	SENT_322	[p7l190t2319r239b2345],
4	unavailability	NN	O	unavailability	prep_due_to	20	SENT_322	[p7l259t2319r479b2354],
5	of	IN	O	of	_	0	SENT_322	[p7l499t2319r534b2345],
6	adult	JJ	O	adult	amod	7	SENT_322	[p7l550t2319r632b2345],
7	worms	NNS	O	worm	prep_of	4	SENT_322	[p7l651t2328r757b2345],
8	for	IN	O	for	_	0	SENT_322	[p7l777t2319r825b2345],
9	histological	JJ	O	histological	amod	12	SENT_322	[p7l844t2319r1030b2354],
10	and	CC	O	and	_	0	SENT_322	[p7l1050t2319r1109b2345],
11	PCR	NN	O	pcr	amod	12	SENT_322	[p7l1128t2319r1200b2345],
12	analysis	NN	O	analysis	prep_for	7	SENT_322	[p7l189t2365r312b2400],
13	in	IN	O	in	_	0	SENT_322	[p7l329t2366r360b2390],
14	LF	NN	O	lf	prep_in	12	SENT_322	[p7l375t2366r425b2396],
15	,	,	O	,	_	0	SENT_322	[p7l375t2366r425b2396],
16	we	PRP	O	we	nsubj	20	SENT_322	[p7l441t2374r483b2391],
17	could	MD	O	could	aux	20	SENT_322	[p7l499t2365r588b2391],
18	not	RB	O	not	neg	20	SENT_322	[p7l605t2371r659b2391],
19	formally	RB	O	formally	advmod	20	SENT_322	[p7l674t2365r811b2400],
20	conﬁrm	VB	O	conﬁrm	_	0	SENT_322	[p7l827t2365r955b2391],
21	these	DT	O	these	det	22	SENT_322	[p7l972t2365r1053b2391],
22	ﬁndings	NNS	O	ﬁndings	dobj	20	SENT_322	[p7l1069t2365r1198b2400],
23	for	IN	O	for	_	0	SENT_322	[p7l189t2410r239b2436],
24	LF	NN	O	lf	prep_for	20	SENT_322	[p7l266t2411r316b2436],
25	.	.	O	.	_	0	SENT_322	[p7l266t2411r316b2436],

1	Doxycycline	NN	O	doxycycline	nn	2	SENT_323	[p7l345t2410r550b2445],
2	treatment	NN	O	treatment	nsubj	4	SENT_323	[p7l579t2415r746b2436],
3	also	RB	O	also	advmod	4	SENT_323	[p7l774t2410r836b2436],
4	resulted	VBD	O	result	_	0	SENT_323	[p7l866t2410r1000b2436],
5	in	IN	O	in	_	0	SENT_323	[p7l1030t2411r1060b2435],
6	almost	RB	O	almost	advmod	7	SENT_323	[p7l1090t2410r1199b2436],
7	complete	JJ	O	complete	amod	8	SENT_323	[p7l189t2456r339b2491],
8	elimination	NN	O	elimination	prep_in	4	SENT_323	[p7l355t2456r544b2482],
9	of	IN	O	of	_	0	SENT_323	[p7l560t2456r595b2482],
10	microﬁlaremia	NN	O	microﬁlaremia	prep_of	8	SENT_323	[p7l608t2456r850b2482],
11	which	WDT	O	which	nsubjpass	13	SENT_323	[p7l865t2456r960b2482],
12	was	VBD	O	be	auxpass	13	SENT_323	[p7l975t2465r1031b2482],
13	sustained	VBN	O	sustain	rcmod	10	SENT_323	[p7l1047t2456r1199b2482],
14	throughout	IN	O	throughout	_	0	SENT_323	[p7l190t2502r375b2537],
15	the	DT	O	the	det	17	SENT_323	[p7l398t2502r447b2528],
16	24-mo	JJ	DURATION	24-mo	amod	17	SENT_323	[p7l470t2502r570b2529],
17	period	NN	O	period	prep_throughout	13	SENT_323	[p7l593t2502r708b2537],
18	.	.	O	.	_	0	SENT_323	[p7l593t2502r708b2537],

1	This	DT	O	this	nsubj	10	SENT_324	[p7l730t2502r800b2528],
2	is	VBZ	O	be	cop	10	SENT_324	[p7l822t2503r844b2528],
3	consistent	JJ	O	consistent	amod	10	SENT_324	[p7l866t2503r1031b2528],
4	with	IN	O	with	_	0	SENT_324	[p7l1051t2502r1121b2528],
5	our	PRP$	O	we	poss	7	SENT_324	[p7l1143t2511r1200b2528],
6	previous	JJ	O	previous	amod	7	SENT_324	[p7l189t2549r328b2583],
7	study	NN	O	study	prep_with	3	SENT_324	[p7l341t2548r426b2583],
8	[	CD	NUMBER	[	number	9	SENT_324	[p7l441t2549r505b2580],
9	44	CD	NUMBER	44	num	7	SENT_324	[p7l441t2549r505b2580],
10	]	NN	O	]	_	0	SENT_324	[p7l441t2549r505b2580],
11	.	.	O	.	_	0	SENT_324	[p7l441t2549r505b2580],

1	The	DT	O	the	det	2	SENT_325	[p7l519t2548r581b2574],
2	loss	NN	O	loss	nsubj	10	SENT_325	[p7l594t2548r651b2574],
3	of	IN	O	of	_	0	SENT_325	[p7l664t2548r699b2574],
4	microﬁlaremia	NN	O	microﬁlaremia	prep_of	2	SENT_325	[p7l709t2548r951b2574],
5	in	IN	O	in	_	0	SENT_325	[p7l964t2549r994b2573],
6	doxycycline	NN	O	doxycycline	nn	7	SENT_325	[p7l1007t2548r1198b2583],
7	patients	NNS	O	patient	prep_in	4	SENT_325	[p7l189t2595r319b2629],
8	is	VBZ	O	be	cop	10	SENT_325	[p7l332t2595r354b2620],
9	most	RBS	O	most	advmod	10	SENT_325	[p7l368t2599r445b2620],
10	likely	JJ	O	likely	_	0	SENT_325	[p7l457t2594r543b2629],
11	due	JJ	O	due	_	0	SENT_325	[p7l555t2594r613b2620],
12	to	TO	O	to	_	0	SENT_325	[p7l627t2599r657b2620],
13	the	DT	O	the	det	14	SENT_325	[p7l672t2594r721b2620],
14	effect	NN	O	effect	prep_due_to	10	SENT_325	[p7l734t2594r824b2620],
15	of	IN	O	of	_	0	SENT_325	[p7l837t2594r871b2620],
16	Wolbachia	JJ	O	wolbachia	amod	17	SENT_325	[p7l883t2594r1031b2620],
17	depletion	NN	O	depletion	prep_of	14	SENT_325	[p7l1043t2594r1199b2629],
18	on	IN	O	on	_	0	SENT_325	[p7l189t2648r230b2665],
19	embryogenesis	NN	O	embryogenesis	prep_on	17	SENT_325	[p7l246t2639r486b2674],
20	and	CC	O	and	_	0	SENT_325	[p7l503t2639r562b2665],
21	loss	NN	O	loss	prep_on	17	SENT_325	[p7l579t2639r635b2665],
22	of	IN	O	of	_	0	SENT_325	[p7l653t2639r687b2665],
23	microﬁlariae	NN	O	microﬁlariae	prep_of	19	SENT_325	[p7l701t2639r910b2665],
24	from	IN	O	from	_	0	SENT_325	[p7l927t2639r1006b2665],
25	host	NN	O	host	nn	26	SENT_325	[p7l1022t2639r1090b2665],
26	blood	NN	O	blood	prep_from	10	SENT_325	[p7l1106t2639r1199b2665],
27	through	IN	O	through	_	0	SENT_325	[p7l190t2685r320b2720],
28	natural	JJ	O	natural	amod	29	SENT_325	[p7l348t2685r465b2711],
29	attrition	NN	O	attrition	prep_through	10	SENT_325	[p7l494t2686r639b2716],
30	,	,	O	,	_	0	SENT_325	[p7l494t2686r639b2716],
31	as	IN	O	as	mark	32	SENT_325	[p7l668t2694r697b2711],
32	recorded	VBN	O	record	advcl	10	SENT_325	[p7l725t2685r873b2711],
33	in	IN	O	in	_	0	SENT_325	[p7l901t2686r931b2710],
34	onchocerciasis	NN	O	onchocerciasis	prep_in	32	SENT_325	[p7l959t2685r1199b2711],
35	[	CD	NUMBER	[	number	36	SENT_325	[p7l191t2731r294b2763],
36	52,53	CD	NUMBER	52,53	num	37	SENT_325	[p7l191t2731r294b2763],
37	]	NN	O	]	dep	34	SENT_325	[p7l191t2731r294b2763],
38	and	CC	O	and	_	0	SENT_325	[p7l311t2731r370b2757],
39	lymphatic	JJ	O	lymphatic	amod	41	SENT_325	[p7l385t2731r545b2766],
40	ﬁlariasis	NN	O	ﬁlariasis	nn	41	SENT_325	[p7l561t2731r694b2757],
41	[	NN	O	[	conj_and	34	SENT_325	[p7l711t2731r823b2763],
42	42,44	CD	NUMBER	42,44	num	43	SENT_325	[p7l711t2731r823b2763],
43	]	NN	O	]	dep	41	SENT_325	[p7l711t2731r823b2763],
44	.	.	O	.	_	0	SENT_325	[p7l711t2731r823b2763],

1	Antigenemia	NNP	O	Antigenemia	_	0	SENT_326	[p7l189t2806r409b2844],
2	Even	RB	O	even	advmod	8	SENT_326	[p7l226t2857r304b2882],
3	though	IN	O	though	dep	8	SENT_326	[p7l320t2856r433b2891],
4	antigenemia	NN	O	antigenemia	nn	5	SENT_326	[p7l449t2857r650b2891],
5	levels	NNS	O	level	nsubjpass	8	SENT_326	[p7l664t2856r750b2882],
6	were	VBD	O	be	auxpass	8	SENT_326	[p7l765t2865r841b2882],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_326	[p7l856t2856r1053b2891],
8	reduced	VBN	O	reduce	dep	1	SENT_326	[p7l1068t2856r1199b2882],
9	by	IN	O	by	_	0	SENT_326	[p7l189t2902r225b2937],
10	94	CD	PERCENT	94	num	11	SENT_326	[p7l237t2902r305b2931],
11	%	NN	PERCENT	%	agent	8	SENT_326	[p7l237t2902r305b2931],
12	in	IN	O	in	_	0	SENT_326	[p7l321t2903r352b2927],
13	doxycycline-treated	JJ	O	doxycycline-treated	amod	14	SENT_326	[p7l364t2902r686b2937],
14	microﬁlaremic	JJ	O	microﬁlaremic	amod	38	SENT_326	[p7l698t2902r938b2928],
15	as	IN	O	as	mark	27	SENT_326	[p7l951t2911r980b2928],
16	compared	VBN	O	compare	_	0	SENT_326	[p7l992t2902r1155b2937],
17	to	TO	O	to	prepc_compared_to	27	SENT_326	[p7l1168t2907r1198b2928],
18	48	CD	PERCENT	48	num	19	SENT_326	[p7l189t2947r258b2976],
19	%	NN	PERCENT	%	pobj	27	SENT_326	[p7l189t2947r258b2976],
20	in	IN	O	in	_	0	SENT_326	[p7l278t2948r308b2972],
21	placebo	NN	O	placebo	nn	22	SENT_326	[p7l324t2947r449b2982],
22	patients	NNS	O	patient	prep_in	19	SENT_326	[p7l466t2948r603b2982],
23	,	,	O	,	_	0	SENT_326	[p7l466t2948r603b2982],
24	antigen	NN	O	antigen	nn	25	SENT_326	[p7l620t2948r741b2982],
25	units	NNS	O	unit	nsubj	27	SENT_326	[p7l756t2948r835b2973],
26	remained	VBD	O	remain	cop	27	SENT_326	[p7l851t2947r1006b2973],
27	elevated	JJ	O	elevated	ccomp	14	SENT_326	[p7l1022t2947r1155b2973],
28	at	IN	O	at	_	0	SENT_326	[p7l1170t2952r1199b2973],
29	24	CD	DURATION	24	num	30	SENT_326	[p7l190t2993r226b3020],
30	mo	NN	DURATION	mo	prep_at	27	SENT_326	[p7l249t3002r298b3019],
31	in	IN	O	in	_	0	SENT_326	[p7l323t2994r353b3018],
32	some	DT	O	some	det	34	SENT_326	[p7l376t3002r459b3019],
33	doxycycline	NN	O	doxycycline	nn	34	SENT_326	[p7l483t2993r674b3028],
34	patients	NNS	O	patient	prep_in	30	SENT_326	[p7l698t2994r835b3028],
35	,	,	O	,	_	0	SENT_326	[p7l698t2994r835b3028],
36	though	IN	O	though	advmod	27	SENT_326	[p7l860t2993r974b3028],
37	USG	NNP	O	USG	nn	38	SENT_326	[p7l997t2993r1071b3019],
38	results	NNS	O	result	prep_in	11	SENT_326	[p7l1095t2993r1198b3019],

1	d	NN	O	d	nn	3	SENT_327	[p7l188t3077r261b3136],
2	Xj	NNP	O	Xj	nn	3	SENT_327	[p7l188t3077r261b3136],
3	PLoS	NNP	O	PLoS	nsubj	4	SENT_327	[p7l288t3093r352b3116],
4	Pathogens	VBD	O	pathogen	_	0	SENT_327	[p7l367t3092r511b3123],
5	|	CD	NUMBER	|	num	6	SENT_327	[p7l526t3091r528b3124],
6	www	NN	O	www	dobj	4	SENT_327	[p7l543t3092r882b3123],
7	.	.	O	.	_	0	SENT_327	[p7l543t3092r882b3123],

1	p	NN	O	p	_	0	SENT_328	[p7l543t3092r882b3123],
2	|	CD	NUMBER	|	num	3	SENT_328	[p7l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	dep	1	SENT_328	[p7l543t3092r882b3123],

1	17.5	CD	NUMBER	17.5	num	2	SENT_329	[p7l1326t220r1394b248],
2	P	NN	O	p	_	0	SENT_329	[p7l2106t226r2244b249],
3	=	JJ	O	=	amod	2	SENT_329	[p7l2106t226r2244b249],
4	0.8139	CD	NUMBER	0.8139	tmod	3	SENT_329	[p7l2106t226r2244b249],

1	P	NN	O	p	_	0	SENT_330	[p7l1877t470r2028b495],
2	=	JJ	O	=	amod	1	SENT_330	[p7l1877t470r2028b495],
3	0.0125	CD	NUMBER	0.0125	tmod	2	SENT_330	[p7l1877t470r2028b495],

1	sVEGFR-3	NN	O	svegfr-3	nn	3	SENT_331	[p7l1275t587r1301b757],
2	plasma	NN	O	plasma	nn	3	SENT_331	[p7l1275t456r1308b572],
3	levels	NNS	O	level	nsubj	4	SENT_331	[p7l1275t344r1301b440],
4	(	VBP	O	(	_	0	SENT_331	[p7l1275t217r1308b329],
5	nglml	NN	O	nglml	nn	6	SENT_331	[p7l1275t217r1308b329],
6	)	NN	O	)	dobj	4	SENT_331	[p7l1275t217r1308b329],

1	Doxycycline	NNP	O	Doxycycline	nn	4	SENT_332	[p7l1413t766r1632b802],
2	Placebo	NNP	O	Placebo	nn	4	SENT_332	[p7l1664t766r1807b794],
3	Doxycycline	NNP	O	Doxycycline	nn	4	SENT_332	[p7l1842t766r2060b802],
4	Placebo	NNP	O	Placebo	_	0	SENT_332	[p7l2092t766r2235b794],
5	Before	IN	O	before	dep	4	SENT_332	[p7l1436t820r1564b851],
6	treatment	NN	O	treatment	pobj	5	SENT_332	[p7l1579t821r1769b851],
7	12	CD	DURATION	12	num	8	SENT_332	[p7l1878t825r1919b856],
8	months	NNS	NUMBER	month	tmod	6	SENT_332	[p7l1936t825r2082b856],

1	Figure	NNP	O	Figure	_	0	SENT_333	[p7l1277t890r1370b921],
2	6	CD	NUMBER	6	dep	1	SENT_333	[p7l1385t892r1410b914],
3	.	.	O	.	_	0	SENT_333	[p7l1385t892r1410b914],

1	Plasma	NN	O	plasma	nn	2	SENT_334	[p7l1427t890r1521b914],
2	Levels	NNS	O	level	nsubj	17	SENT_334	[p7l1538t890r1620b914],
3	of	IN	O	of	_	0	SENT_334	[p7l1636t890r1664b914],
4	sVEGFR-3	NN	O	svegfr-3	prep_of	2	SENT_334	[p7l1678t891r1805b914],
5	of	IN	O	of	_	0	SENT_334	[p7l1822t890r1850b914],
6	Microfilaremic	JJ	O	microfilaremic	amod	7	SENT_334	[p7l1864t890r2057b914],
7	Patients	NNS	O	patient	prep_of	4	SENT_334	[p7l2074t891r2182b914],
8	before	IN	O	before	advmod	7	SENT_334	[p7l2199t890r2287b914],
9	and	CC	O	and	_	0	SENT_334	[p7l1276t932r1326b956],
10	12	CD	DURATION	12	num	11	SENT_334	[p7l1343t934r1371b956],
11	Mo	NN	DURATION	mo	conj_and	4	SENT_334	[p7l1386t933r1428b956],
12	after	IN	O	after	_	0	SENT_334	[p7l1441t932r1503b956],
13	Doxycycline	NNP	O	Doxycycline	nn	16	SENT_334	[p7l1517t932r1680b963],
14	Treatment	NNP	O	Treatment	nn	16	SENT_334	[p7l1692t933r1836b956],
15	Plasma	NN	O	plasma	nn	16	SENT_334	[p7l1277t977r1371b1001],
16	concentrations	NNS	O	concentration	prep_after	11	SENT_334	[p7l1387t978r1591b1001],
17	(	VBP	O	(	_	0	SENT_334	[p7l1607t978r1691b1005],
18	mean	NN	O	mean	dobj	17	SENT_334	[p7l1607t978r1691b1005],
19	:	:	O	:	_	0	SENT_334	[p7l1709t980r1729b1000],
20	SD	NN	O	sd	nn	21	SENT_334	[p7l1747t978r1792b1005],
21	)	NN	O	)	nsubjpass	25	SENT_334	[p7l1747t978r1792b1005],
22	of	IN	O	of	_	0	SENT_334	[p7l1807t977r1836b1001],
23	sVEGFR-3	NN	O	svegfr-3	prep_of	21	SENT_334	[p7l1848t978r1976b1001],
24	were	VBD	O	be	auxpass	25	SENT_334	[p7l1991t984r2058b1001],
25	measured	VBN	O	measure	parataxis	17	SENT_334	[p7l2073t977r2207b1001],
26	from	IN	O	from	_	0	SENT_334	[p7l2221t977r2285b1001],
27	plasma	NN	O	plasma	prep_from	25	SENT_334	[p7l1277t1012r1373b1043],
28	of	IN	O	of	_	0	SENT_334	[p7l1389t1012r1417b1036],
29	microfilaremic	JJ	O	microfilaremic	amod	30	SENT_334	[p7l1432t1012r1626b1036],
30	patients	NNS	O	patient	prep_of	27	SENT_334	[p7l1643t1013r1752b1043],
31	before	IN	O	before	_	0	SENT_334	[p7l1769t1012r1857b1036],
32	and	CC	O	and	dep	34	SENT_334	[p7l1873t1012r1923b1036],
33	12	CD	DURATION	12	number	34	SENT_334	[p7l1943t1014r1971b1036],
34	mo	NN	DURATION	mo	dep	25	SENT_334	[p7l1989t1019r2032b1036],
35	after	IN	O	after	_	0	SENT_334	[p7l2048t1012r2111b1036],
36	doxycycline	NN	O	doxycycline	nn	37	SENT_334	[p7l2126t1012r2287b1043],
37	treatment	NN	O	treatment	prep_after	34	SENT_334	[p7l1275t1051r1413b1071],
38	(	CD	NUMBER	(	number	39	SENT_334	[p7l1425t1048r1464b1075],
39	17	CD	NUMBER	17	num	40	SENT_334	[p7l1425t1048r1464b1075],
40	doxycycline	NN	O	doxycycline	nsubj	46	SENT_334	[p7l1476t1047r1637b1078],
41	treated	VBN	O	treat	partmod	40	SENT_334	[p7l1647t1047r1752b1075],
42	,	,	O	,	_	0	SENT_334	[p7l1647t1047r1752b1075],
43	16	CD	NUMBER	16	num	44	SENT_334	[p7l1766t1049r1795b1071],
44	placebo	NN	O	placebo	appos	40	SENT_334	[p7l1807t1047r1922b1078],
45	,	,	O	,	_	0	SENT_334	[p7l1807t1047r1922b1078],
46	see	VB	O	see	rcmod	37	SENT_334	[p7l1933t1054r1977b1071],
47	Table	NNP	O	Table	dobj	46	SENT_334	[p7l1987t1047r2062b1071],
48	1	CD	NUMBER	1	number	49	SENT_334	[p7l2075t1048r2104b1075],
49	)	CD	NUMBER	)	prep_before	25	SENT_334	[p7l2075t1048r2104b1075],
50	.	.	O	.	_	0	SENT_334	[p7l2075t1048r2104b1075],

1	The	DT	O	the	det	3	SENT_335	[p7l2113t1047r2164b1071],
2	sVEGFR3	NN	O	svegfr3	nn	3	SENT_335	[p7l2175t1048r2287b1071, p7l1276t1084r1290b1106],
3	levels	NNS	O	level	nsubj	4	SENT_335	[p7l1313t1082r1387b1106],
4	decreased	VBD	O	decrease	_	0	SENT_335	[p7l1408t1082r1547b1106],
5	significantly	RB	O	significantly	advmod	4	SENT_335	[p7l1569t1082r1733b1113],
6	at	IN	O	at	_	0	SENT_335	[p7l1753t1086r1778b1106],
7	12	CD	DURATION	12	num	9	SENT_335	[p7l1801t1084r1830b1106],
8	mo	NN	DURATION	mo	nn	9	SENT_335	[p7l1852t1089r1895b1106],
9	(	NN	O	(	prep_at	4	SENT_335	[p7l1917t1082r2063b1113],
10	preceding	VBG	O	precede	partmod	9	SENT_335	[p7l1917t1082r2063b1113],
11	supratesticular	JJ	O	supratesticular	amod	13	SENT_335	[p7l2085t1082r2287b1113],
12	lymphatic	JJ	O	lymphatic	amod	13	SENT_335	[p7l1277t1118r1412b1149],
13	dilation	NN	O	dilation	dobj	10	SENT_335	[p7l1425t1118r1534b1146],
14	,	,	O	,	_	0	SENT_335	[p7l1425t1118r1534b1146],
15	see	VB	O	see	ccomp	4	SENT_335	[p7l1548t1125r1592b1142],
16	Table	NNP	O	Table	nsubj	18	SENT_335	[p7l1604t1118r1679b1142],
17	2	CD	NUMBER	2	number	18	SENT_335	[p7l1692t1119r1715b1146],
18	)	CD	NUMBER	)	xcomp	15	SENT_335	[p7l1692t1119r1715b1146],
19	in	IN	O	in	_	0	SENT_335	[p7l1730t1119r1752b1142],
20	the	DT	O	the	det	23	SENT_335	[p7l1766t1118r1810b1142],
21	doxycyc	JJ	O	doxycyc	amod	23	SENT_335	[p7l1823t1118r2094b1149],
22	|	NN	O	|	nn	23	SENT_335	[p7l1823t1118r2094b1149],
23	ine	NN	O	ine	prep_in	18	SENT_335	[p7l1823t1118r2094b1149],
24	—	CD	NUMBER	—	num	26	SENT_335	[p7l1823t1118r2094b1149],
25	treated	JJ	O	treated	amod	26	SENT_335	[p7l1823t1118r2094b1149],
26	patients	NNS	O	patient	dep	23	SENT_335	[p7l2109t1119r2218b1149],
27	(	IN	O	(	_	0	SENT_335	[p7l2232t1119r2256b1149],
28	p	NN	O	p	prep_(	26	SENT_335	[p7l2232t1119r2256b1149],
29	:	:	O	:	_	0	SENT_335	[p7l2267t1130r2289b1138],
30	0.0125	CD	NUMBER	0.0125	num	31	SENT_335	[p7l1276t1154r1374b1181],
31	)	NN	O	)	dep	26	SENT_335	[p7l1276t1154r1374b1181],
32	to	TO	O	to	_	0	SENT_335	[p7l1384t1157r1412b1177],
33	a	DT	O	a	det	35	SENT_335	[p7l1423t1160r1436b1177],
34	level	NN	O	level	nn	35	SENT_335	[p7l1448t1153r1508b1177],
35	close	NN	O	close	prep_to	31	SENT_335	[p7l1519t1153r1588b1177],
36	to	TO	O	to	_	0	SENT_335	[p7l1597t1157r1625b1177],
37	that	DT	O	that	prep_to	31	SENT_335	[p7l1635t1153r1690b1177],
38	of	IN	O	of	_	0	SENT_335	[p7l1700t1153r1728b1177],
39	endemic	JJ	O	endemic	amod	40	SENT_335	[p7l1736t1153r1855b1177],
40	controls	NNS	O	control	prep_of	37	SENT_335	[p7l1865t1153r1974b1177],
41	whereas	IN	O	whereas	mark	43	SENT_335	[p7l1985t1153r2098b1177],
42	there	EX	O	there	expl	43	SENT_335	[p7l2108t1153r2180b1177],
43	was	VBD	O	be	advcl	15	SENT_335	[p7l2190t1160r2241b1177],
44	no	DT	O	no	det	45	SENT_335	[p7l2253t1160r2286b1177],
45	difference	NN	O	difference	nsubj	43	SENT_335	[p7l1276t1189r1413b1213],
46	in	IN	O	in	_	0	SENT_335	[p7l1427t1190r1449b1213],
47	the	DT	O	the	det	52	SENT_335	[p7l1462t1189r1507b1213],
48	placebo	NN	O	placebo	nn	52	SENT_335	[p7l1521t1189r1629b1220],
49	group	NN	O	group	nn	52	SENT_335	[p7l1642t1196r1725b1220],
50	(	CD	NUMBER	(	num	52	SENT_335	[p7l1739t1189r1833b1220],
51	paired	JJ	O	paired	amod	52	SENT_335	[p7l1739t1189r1833b1220],
52	t	NN	O	t	prep_in	45	SENT_335	[p7l1847t1190r1933b1217],
53	—	CD	NUMBER	—	num	55	SENT_335	[p7l1847t1190r1933b1217],
54	test	NN	O	test	nn	55	SENT_335	[p7l1847t1190r1933b1217],
55	)	NN	O	)	dep	52	SENT_335	[p7l1847t1190r1933b1217],
56	.	.	O	.	_	0	SENT_335	[p7l1847t1190r1933b1217],

1	DOI	NNP	O	DOI	_	0	SENT_336	[p7l1277t1225r1334b1248],
2	:	:	O	:	_	0	SENT_336	[p7l1277t1225r1334b1248],
3	10.1371	CD	NUMBER	10.1371	dep	1	SENT_336	[p7l1349t1224r1835b1255],
4	/	:	O	/	punct	6	SENT_336	[p7l1349t1224r1835b1255],
5	journa	NN	O	journa	nn	6	SENT_336	[p7l1349t1224r1835b1255],
6	|	NN	O	|	dep	3	SENT_336	[p7l1349t1224r1835b1255],
7	.	.	O	.	_	0	SENT_336	[p7l1349t1224r1835b1255],

1	ppat	NN	O	ppat	_	0	SENT_337	[p7l1349t1224r1835b1255],
2	.0020092	CD	NUMBER	.0020092	dep	1	SENT_337	[p7l1349t1224r1835b1255],
3	.	.	O	.	_	0	SENT_337	[p7l1349t1224r1835b1255],

1	g006	NN	O	g006	_	0	SENT_338	[p7l1349t1224r1835b1255],

1	showed	VBD	O	show	_	0	SENT_339	[p7l1277t1306r1397b1332],
2	the	DT	O	the	det	3	SENT_339	[p7l1426t1306r1475b1332],
3	absence	NN	O	absence	dobj	1	SENT_339	[p7l1504t1306r1631b1332],
4	of	IN	O	of	_	0	SENT_339	[p7l1660t1306r1694b1332],
5	worm	NN	O	worm	nn	6	SENT_339	[p7l1718t1315r1812b1332],
6	nests	NNS	O	nest	prep_of	3	SENT_339	[p7l1840t1311r1927b1332],
7	.	.	O	.	_	0	SENT_339	[p7l1840t1311r1927b1332],

1	Before	IN	O	before	_	0	SENT_340	[p7l1956t1306r2064b1332],
2	doxycycline	NN	O	doxycycline	nn	3	SENT_340	[p7l2093t1306r2286b1341],
3	treatment	NN	O	treatment	prep_before	21	SENT_340	[p7l1278t1358r1446b1384],
4	,	,	O	,	_	0	SENT_340	[p7l1278t1358r1446b1384],
5	all	DT	O	all	det	7	SENT_340	[p7l1468t1353r1504b1379],
6	33	CD	NUMBER	33	num	7	SENT_340	[p7l1525t1353r1561b1378],
7	(	NN	O	(	nsubj	21	SENT_340	[p7l1583t1351r1629b1385],
8	17	CD	NUMBER	17	num	9	SENT_340	[p7l1583t1351r1629b1385],
9	doxycycline	NN	O	doxycycline	nsubj	15	SENT_340	[p7l1650t1353r1841b1388],
10	and	CC	O	and	_	0	SENT_340	[p7l1862t1353r1921b1379],
11	16	CD	NUMBER	16	num	14	SENT_340	[p7l1944t1353r1978b1378],
12	placebo	NN	O	placebo	nn	14	SENT_340	[p7l1999t1353r2135b1388],
13	)	CD	NUMBER	)	num	14	SENT_340	[p7l1999t1353r2135b1388],
14	patients	NNS	O	patient	conj_and	9	SENT_340	[p7l2157t1354r2286b1388],
15	had	VBD	O	have	rcmod	7	SENT_340	[p7l1276t1400r1335b1426],
16	antigenemia	NN	O	antigenemia	nn	17	SENT_340	[p7l1353t1401r1554b1435],
17	levels	NNS	O	level	dobj	15	SENT_340	[p7l1571t1400r1657b1426],
18	above	IN	O	above	_	0	SENT_340	[p7l1675t1400r1768b1426],
19	32,000	CD	NUMBER	32,000	num	20	SENT_340	[p7l1786t1400r1888b1431],
20	units	NNS	O	unit	prep_above	17	SENT_340	[p7l1905t1401r1985b1426],
21	(	VBP	O	(	_	0	SENT_340	[p7l2003t1400r2064b1432],
22	the	DT	O	the	det	24	SENT_340	[p7l2003t1400r2064b1432],
23	highest	JJS	O	highest	amod	24	SENT_340	[p7l2080t1400r2197b1435],
24	level	NN	O	level	nsubj	29	SENT_340	[p7l2214t1400r2286b1426],
25	that	WDT	O	that	nsubj	28	SENT_340	[p7l1278t1447r1341b1473],
26	can	MD	O	can	aux	28	SENT_340	[p7l1358t1456r1413b1473],
27	be	VB	O	be	cop	28	SENT_340	[p7l1430t1447r1467b1473],
28	semiquantitatively	JJ	O	semiquantitatively	rcmod	24	SENT_340	[p7l1484t1447r1785b1482],
29	determined	VBN	O	determine	ccomp	21	SENT_340	[p7l1802t1447r1991b1473],
30	according	VBG	O	accord	_	0	SENT_340	[p7l2009t1447r2171b1482],
31	to	TO	O	to	prepc_according_to	29	SENT_340	[p7l2188t1453r2218b1473],
32	the	DT	O	the	det	33	SENT_340	[p7l2237t1447r2286b1473],
33	manufacturer	NN	O	manufacturer	pobj	29	SENT_340	[p7l1277t1494r1509b1525],
34	,	,	O	,	_	0	SENT_340	[p7l1277t1494r1509b1525],
35	TropBio	NNP	O	TropBio	appos	33	SENT_340	[p7l1526t1495r1683b1529],
36	)	CD	NUMBER	)	num	35	SENT_340	[p7l1526t1495r1683b1529],
37	.	.	O	.	_	0	SENT_340	[p7l1526t1495r1683b1529],

1	However	RB	O	however	advmod	15	SENT_341	[p7l1700t1495r1852b1525],
2	,	,	O	,	_	0	SENT_341	[p7l1700t1495r1852b1525],
3	at	IN	O	at	_	0	SENT_341	[p7l1870t1499r1899b1520],
4	24	CD	DURATION	24	num	5	SENT_341	[p7l1916t1494r1952b1521],
5	mo	NN	DURATION	mo	prep_at	15	SENT_341	[p7l1968t1503r2026b1525],
6	,	,	O	,	_	0	SENT_341	[p7l1968t1503r2026b1525],
7	11/17	CD	PERCENT	11/17	number	8	SENT_341	[p7l2046t1491r2127b1520],
8	(	CD	PERCENT	(	appos	5	SENT_341	[p7l2144t1494r2238b1526],
9	65	CD	PERCENT	65	num	10	SENT_341	[p7l2144t1494r2238b1526],
10	%	NN	PERCENT	%	dep	8	SENT_341	[p7l2144t1494r2238b1526],
11	)	CD	NUMBER	)	nsubj	15	SENT_341	[p7l2144t1494r2238b1526],
12	of	IN	O	of	_	0	SENT_341	[p7l2255t1494r2290b1520],
13	doxycycline-treated	JJ	O	doxycycline-treated	amod	14	SENT_341	[p7l1277t1540r1599b1575],
14	patients	NNS	O	patient	prep_of	11	SENT_341	[p7l1615t1541r1745b1575],
15	had	VBD	O	have	_	0	SENT_341	[p7l1760t1540r1819b1566],
16	antigen	NN	O	antigen	nn	17	SENT_341	[p7l1834t1541r1955b1575],
17	units	NNS	O	unit	dobj	15	SENT_341	[p7l1970t1541r2050b1566],
18	below	IN	O	below	_	0	SENT_341	[p7l2065t1540r2159b1566],
19	32,000	CD	NUMBER	32,000	prep_below	15	SENT_341	[p7l2175t1540r2286b1571],
20	,	,	O	,	_	0	SENT_341	[p7l2175t1540r2286b1571],
21	compared	VBN	O	compare	_	0	SENT_341	[p7l1277t1587r1441b1622],
22	to	TO	O	to	prepc_compared_to	15	SENT_341	[p7l1456t1592r1486b1613],
23	only	RB	O	only	quantmod	25	SENT_341	[p7l1502t1587r1570b1622],
24	4/16	CD	PERCENT	4/16	number	25	SENT_341	[p7l1585t1587r1649b1613],
25	(	CD	PERCENT	(	pobj	15	SENT_341	[p7l1665t1587r1759b1619],
26	25	CD	PERCENT	25	num	27	SENT_341	[p7l1665t1587r1759b1619],
27	%	NN	PERCENT	%	dep	25	SENT_341	[p7l1665t1587r1759b1619],
28	)	CD	NUMBER	)	dep	25	SENT_341	[p7l1665t1587r1759b1619],
29	of	IN	O	of	_	0	SENT_341	[p7l1774t1587r1809b1613],
30	placebo	NN	O	placebo	nn	31	SENT_341	[p7l1820t1587r1945b1622],
31	patients	NNS	O	patient	prep_of	28	SENT_341	[p7l1961t1588r2098b1622],
32	.	.	O	.	_	0	SENT_341	[p7l1961t1588r2098b1622],

1	Given	VBN	O	give	dep	17	SENT_342	[p7l2114t1587r2208b1613],
2	that	IN	O	that	complm	4	SENT_342	[p7l2224t1587r2287b1613],
3	USG	NNP	O	USG	nsubj	4	SENT_342	[p7l1276t1634r1351b1660],
4	demonstrated	VBD	O	demonstrate	pcomp	1	SENT_342	[p7l1369t1634r1595b1660],
5	absence	NN	O	absence	dobj	4	SENT_342	[p7l1614t1634r1740b1660],
6	of	IN	O	of	_	0	SENT_342	[p7l1759t1634r1794b1660],
7	worm	NN	O	worm	nn	8	SENT_342	[p7l1808t1643r1901b1660],
8	nests	NNS	O	nest	prep_of	5	SENT_342	[p7l1919t1639r1998b1660],
9	in	IN	O	in	_	0	SENT_342	[p7l2017t1635r2047b1659],
10	most	JJS	O	most	amod	12	SENT_342	[p7l2066t1640r2144b1660],
11	doxycycline-treated	JJ	O	doxycycline-treated	amod	12	SENT_342	[p7l2162t1634r2285b1669, p7l1277t1681r1485b1707],
12	patients	NNS	O	patient	prep_in	8	SENT_342	[p7l1506t1682r1635b1716],
13	analyzed	VBN	O	analyze	partmod	8	SENT_342	[p7l1657t1681r1804b1716],
14	,	,	O	,	_	0	SENT_342	[p7l1657t1681r1804b1716],
15	our	PRP$	O	we	poss	16	SENT_342	[p7l1825t1690r1882b1707],
16	data	NNS	O	datum	nsubj	17	SENT_342	[p7l1901t1681r1971b1707],
17	suggest	VBP	O	suggest	_	0	SENT_342	[p7l1991t1686r2107b1716],
18	that	IN	O	that	complm	21	SENT_342	[p7l2128t1681r2191b1707],
19	antigenemia	NN	O	antigenemia	nsubjpass	21	SENT_342	[p7l2211t1682r2286b1707, p7l1277t1729r1414b1763],
20	is	VBZ	O	be	auxpass	21	SENT_342	[p7l1430t1729r1452b1754],
21	cleared	VBN	O	clear	ccomp	17	SENT_342	[p7l1469t1728r1586b1754],
22	from	IN	O	from	_	0	SENT_342	[p7l1602t1728r1682b1754],
23	the	DT	O	the	det	24	SENT_342	[p7l1699t1728r1748b1754],
24	blood	NN	O	blood	prep_from	21	SENT_342	[p7l1765t1728r1857b1754],
25	slowly	RB	O	slowly	advmod	24	SENT_342	[p7l1874t1728r1978b1763],
26	,	,	O	,	_	0	SENT_342	[p7l1874t1728r1978b1763],
27	but	CC	O	but	_	0	SENT_342	[p7l1995t1728r2049b1754],
28	progressively	RB	O	progressively	conj_but	25	SENT_342	[p7l2066t1728r2286b1763],
29	,	,	O	,	_	0	SENT_342	[p7l2066t1728r2286b1763],
30	after	IN	O	after	_	0	SENT_342	[p7l1277t1775r1354b1801],
31	the	DT	O	the	det	32	SENT_342	[p7l1365t1775r1414b1801],
32	death	NN	O	death	prep_after	21	SENT_342	[p7l1426t1775r1516b1801],
33	of	IN	O	of	_	0	SENT_342	[p7l1527t1775r1562b1801],
34	the	DT	O	the	det	36	SENT_342	[p7l1571t1775r1620b1801],
35	adult	JJ	O	adult	amod	36	SENT_342	[p7l1632t1775r1714b1801],
36	worms	NNS	O	worm	prep_of	32	SENT_342	[p7l1725t1784r1839b1806],
37	,	,	O	,	_	0	SENT_342	[p7l1725t1784r1839b1806],
38	as	IN	O	as	mark	42	SENT_342	[p7l1851t1784r1880b1801],
39	suggested	VBN	O	suggest	csubj	42	SENT_342	[p7l1892t1775r2047b1810],
40	by	IN	O	by	_	0	SENT_342	[p7l2058t1775r2095b1810],
41	others	NNS	O	other	prep_by	39	SENT_342	[p7l2106t1775r2207b1801],
42	[	VBP	O	[	advcl	21	SENT_342	[p7l2221t1775r2285b1807],
43	54	CD	NUMBER	54	num	44	SENT_342	[p7l2221t1775r2285b1807],
44	]	CD	NUMBER	]	dobj	42	SENT_342	[p7l2221t1775r2285b1807],
45	.	.	O	.	_	0	SENT_342	[p7l2221t1775r2285b1807],

1	The	DT	O	the	det	3	SENT_343	[p7l1276t1822r1338b1848],
2	lower	JJR	O	lower	amod	3	SENT_343	[p7l1356t1822r1447b1848],
3	proportion	NN	O	proportion	nsubj	16	SENT_343	[p7l1463t1823r1646b1857],
4	of	IN	O	of	_	0	SENT_343	[p7l1664t1822r1699b1848],
5	patients	NNS	O	patient	prep_of	3	SENT_343	[p7l1714t1823r1843b1857],
6	with	IN	O	with	_	0	SENT_343	[p7l1861t1822r1930b1848],
7	high	JJ	O	high	amod	8	SENT_343	[p7l1948t1822r2019b1857],
8	antigenemia	NN	O	antigenemia	prep_with	5	SENT_343	[p7l2037t1823r2238b1857],
9	in	IN	O	in	_	0	SENT_343	[p7l2256t1823r2286b1847],
10	the	DT	O	the	det	12	SENT_343	[p7l1278t1868r1327b1894],
11	doxycycline	NN	O	doxycycline	nn	12	SENT_343	[p7l1349t1868r1540b1903],
12	group	NN	O	group	prep_in	8	SENT_343	[p7l1563t1877r1659b1903],
13	underscores	VBZ	O	underscore	_	0	SENT_343	[p7l1682t1868r1879b1894],
14	this	DT	O	this	dobj	13	SENT_343	[p7l1903t1868r1959b1894],
15	and	CC	O	and	_	0	SENT_343	[p7l1982t1868r2040b1894],
16	shows	VBZ	O	show	conj_and	13	SENT_343	[p7l2063t1868r2156b1894],
17	that	IN	O	that	complm	20	SENT_343	[p7l2180t1868r2243b1894],
18	it	PRP	O	it	nsubj	20	SENT_343	[p7l2265t1869r2287b1894],
19	probably	RB	O	probably	advmod	20	SENT_343	[p7l1277t1915r1422b1950],
20	takes	VBZ	O	take	ccomp	16	SENT_343	[p7l1446t1915r1526b1941],
21	more	JJR	DURATION	more	mwe	22	SENT_343	[p7l1550t1924r1634b1941],
22	than	IN	DURATION	than	quantmod	23	SENT_343	[p7l1659t1915r1731b1941],
23	24	CD	DURATION	24	num	24	SENT_343	[p7l1756t1915r1792b1942],
24	mo	NN	DURATION	mo	dobj	20	SENT_343	[p7l1815t1924r1865b1941],
25	for	IN	O	for	_	0	SENT_343	[p7l1889t1915r1938b1941],
26	the	DT	O	the	det	27	SENT_343	[p7l1962t1915r2011b1941],
27	antigens	NNS	O	antigen	prep_for	24	SENT_343	[p7l2035t1916r2170b1950],
28	to	TO	O	to	aux	30	SENT_343	[p7l2195t1920r2225b1941],
29	be	VB	O	be	auxpass	30	SENT_343	[p7l2249t1915r2286b1941],
30	cleared	VBN	O	clear	xcomp	20	SENT_343	[p7l1277t1962r1394b1988],
31	from	IN	O	from	_	0	SENT_343	[p7l1409t1962r1488b1988],
32	the	DT	O	the	det	33	SENT_343	[p7l1504t1962r1554b1988],
33	blood	NN	O	blood	prep_from	30	SENT_343	[p7l1568t1962r1661b1988],
34	after	IN	O	after	_	0	SENT_343	[p7l1676t1962r1753b1988],
35	the	DT	O	the	det	36	SENT_343	[p7l1768t1962r1817b1988],
36	death	NN	O	death	prep_after	30	SENT_343	[p7l1832t1962r1922b1988],
37	of	IN	O	of	_	0	SENT_343	[p7l1938t1962r1972b1988],
38	the	DT	O	the	det	40	SENT_343	[p7l1985t1962r2034b1988],
39	adult	JJ	O	adult	amod	40	SENT_343	[p7l2050t1962r2132b1988],
40	worms	NNS	O	worm	prep_of	36	SENT_343	[p7l2146t1971r2260b1988],
41	.	.	O	.	_	0	SENT_343	[p7l2146t1971r2260b1988],

1	We	PRP	O	we	nsubj	4	SENT_344	[p7l1313t2011r1365b2036],
2	can	MD	O	can	aux	4	SENT_344	[p7l1390t2015r1502b2036],
3	not	RB	O	not	neg	4	SENT_344	[p7l1390t2015r1502b2036],
4	exclude	VB	O	exclude	_	0	SENT_344	[p7l1526t2010r1650b2036],
5	that	IN	O	that	complm	18	SENT_344	[p7l1676t2010r1739b2036],
6	the	DT	O	the	det	8	SENT_344	[p7l1765t2010r1814b2036],
7	partial	JJ	O	partial	amod	8	SENT_344	[p7l1839t2010r1946b2045],
8	reduction	NN	O	reduction	nsubj	18	SENT_344	[p7l1971t2010r2130b2036],
9	in	IN	O	in	_	0	SENT_344	[p7l2156t2011r2186b2035],
10	antigenemia	NN	O	antigenemia	prep_in	8	SENT_344	[p7l2211t2011r2286b2036, p7l1277t2057r1414b2091],
11	observed	VBN	O	observe	partmod	10	SENT_344	[p7l1431t2056r1576b2082],
12	in	IN	O	in	_	0	SENT_344	[p7l1595t2057r1626b2081],
13	the	DT	O	the	det	15	SENT_344	[p7l1645t2056r1694b2082],
14	placebo	NN	O	placebo	nn	15	SENT_344	[p7l1713t2056r1838b2091],
15	patients	NNS	O	patient	prep_in	11	SENT_344	[p7l1858t2057r1987b2091],
16	could	MD	O	could	aux	18	SENT_344	[p7l2006t2056r2095b2082],
17	be	VB	O	be	cop	18	SENT_344	[p7l2114t2056r2151b2082],
18	due	JJ	O	due	ccomp	4	SENT_344	[p7l2169t2056r2236b2087],
19	,	,	O	,	_	0	SENT_344	[p7l2169t2056r2236b2087],
20	to	TO	O	to	_	0	SENT_344	[p7l2256t2062r2286b2082],
21	some	DT	O	some	det	22	SENT_344	[p7l1277t2112r1359b2129],
22	extent	NN	O	extent	prep_to	18	SENT_344	[p7l1373t2108r1482b2134],
23	,	,	O	,	_	0	SENT_344	[p7l1373t2108r1482b2134],
24	to	TO	O	to	_	0	SENT_344	[p7l1497t2108r1527b2129],
25	a	DT	O	a	det	28	SENT_344	[p7l1542t2112r1558b2129],
26	partial	JJ	O	partial	amod	28	SENT_344	[p7l1571t2103r1677b2138],
27	macroﬁlaricidal	JJ	O	macroﬁlaricidal	amod	28	SENT_344	[p7l1691t2103r1950b2129],
28	effect	NN	O	effect	prep_to	18	SENT_344	[p7l1963t2103r2054b2129],
29	of	IN	O	of	_	0	SENT_344	[p7l2067t2103r2102b2129],
30	ivermectin	NN	O	ivermectin	prep_of	28	SENT_344	[p7l2112t2104r2286b2129],
31	plus	CC	O	plus	prep	30	SENT_344	[p7l1277t2150r1342b2185],
32	albendazole	NN	O	albendazole	nn	33	SENT_344	[p7l1355t2150r1547b2176],
33	treatment	NN	O	treatment	dep	31	SENT_344	[p7l1560t2155r1729b2176],
34	.	.	O	.	_	0	SENT_344	[p7l1560t2155r1729b2176],

1	USG	NNP	O	USG	nsubj	2	SENT_345	[p7l1742t2150r1816b2176],
2	results	VBZ	O	result	_	0	SENT_345	[p7l1829t2150r1933b2176],
3	did	VBD	O	do	aux	4	SENT_345	[p7l1945t2150r1997b2176],
4	show	VB	O	show	ccomp	2	SENT_345	[p7l2009t2150r2089b2176],
5	20	CD	PERCENT	20	number	6	SENT_345	[p7l2102t2150r2169b2179],
6	%	NN	PERCENT	%	amod	7	SENT_345	[p7l2102t2150r2169b2179],
7	loss	NN	O	loss	dobj	4	SENT_345	[p7l2186t2150r2242b2176],
8	of	IN	O	of	_	0	SENT_345	[p7l2255t2150r2290b2176],
9	worm	NN	O	worm	nn	10	SENT_345	[p7l1276t2206r1369b2223],
10	nests	NNS	O	nest	prep_of	7	SENT_345	[p7l1385t2203r1463b2223],
11	at	IN	O	at	_	0	SENT_345	[p7l1480t2203r1509b2223],
12	24	CD	DURATION	24	num	13	SENT_345	[p7l1525t2197r1561b2224],
13	mo	NN	DURATION	mo	prep_at	4	SENT_345	[p7l1577t2206r1635b2227],
14	;	:	O	;	_	0	SENT_345	[p7l1577t2206r1635b2227],
15	however	RB	O	however	advmod	21	SENT_345	[p7l1651t2197r1795b2228],
16	,	,	O	,	_	0	SENT_345	[p7l1651t2197r1795b2228],
17	this	DT	O	this	det	18	SENT_345	[p7l1812t2197r1868b2223],
18	reduction	NN	O	reduction	nsubj	21	SENT_345	[p7l1885t2197r2044b2223],
19	did	VBD	O	do	aux	21	SENT_345	[p7l2060t2197r2112b2223],
20	not	RB	O	not	neg	21	SENT_345	[p7l2128t2203r2182b2223],
21	reach	VB	O	reach	parataxis	2	SENT_345	[p7l2198t2197r2286b2223],
22	statistical	JJ	O	statistical	amod	23	SENT_345	[p7l1277t2244r1429b2270],
23	signiﬁcance	NN	O	signiﬁcance	dobj	21	SENT_345	[p7l1445t2244r1643b2279],
24	.	.	O	.	_	0	SENT_345	[p7l1445t2244r1643b2279],

1	The	DT	O	the	det	2	SENT_346	[p7l1659t2244r1722b2270],
2	lack	NN	O	lack	nsubj	7	SENT_346	[p7l1737t2244r1801b2270],
3	of	IN	O	of	_	0	SENT_346	[p7l1817t2244r1851b2270],
4	signiﬁcance	NN	O	signiﬁcance	prep_of	2	SENT_346	[p7l1864t2244r2054b2279],
5	could	MD	O	could	aux	7	SENT_346	[p7l2070t2244r2159b2270],
6	be	VB	O	be	cop	7	SENT_346	[p7l2175t2244r2212b2270],
7	due	JJ	O	due	_	0	SENT_346	[p7l2228t2244r2286b2270],
8	to	TO	O	to	_	0	SENT_346	[p7l1278t2297r1308b2317],
9	the	DT	O	the	det	12	SENT_346	[p7l1332t2291r1381b2317],
10	rather	RB	O	rather	advmod	11	SENT_346	[p7l1404t2291r1505b2317],
11	small	JJ	O	small	amod	12	SENT_346	[p7l1527t2291r1609b2317],
12	number	NN	O	number	prep_to	7	SENT_346	[p7l1633t2291r1761b2317],
13	of	IN	O	of	_	0	SENT_346	[p7l1783t2291r1818b2317],
14	placebo	NN	O	placebo	nn	15	SENT_346	[p7l1837t2291r1962b2326],
15	patients	NNS	O	patient	prep_of	12	SENT_346	[p7l1986t2292r2115b2326],
16	(	CD	NUMBER	(	num	17	SENT_346	[p7l2139t2292r2167b2323],
17	n	NN	O	n	dep	15	SENT_346	[p7l2139t2292r2167b2323],
18	=	JJ	O	=	amod	20	SENT_346	[p7l2186t2302r2211b2311],
19	16	CD	NUMBER	16	tmod	18	SENT_346	[p7l2233t2291r2286b2323],
20	)	NN	O	)	dep	17	SENT_346	[p7l2233t2291r2286b2323],
21	;	:	O	;	_	0	SENT_346	[p7l2233t2291r2286b2323],
22	however	RB	O	however	advmod	44	SENT_346	[p7l1276t2337r1420b2368],
23	,	,	O	,	_	0	SENT_346	[p7l1276t2337r1420b2368],
24	even	RB	O	even	advmod	31	SENT_346	[p7l1439t2346r1513b2363],
25	if	IN	O	if	dep	31	SENT_346	[p7l1531t2337r1556b2362],
26	a	DT	O	a	det	28	SENT_346	[p7l1571t2346r1587b2363],
27	signiﬁcant	NN	O	signiﬁcant	nn	28	SENT_346	[p7l1604t2337r1773b2372],
28	difference	NN	O	difference	nsubjpass	31	SENT_346	[p7l1791t2337r1957b2363],
29	had	VBD	O	have	aux	31	SENT_346	[p7l1975t2337r2034b2363],
30	been	VBN	O	be	auxpass	31	SENT_346	[p7l2051t2337r2129b2363],
31	detected	VBN	O	detect	dep	44	SENT_346	[p7l2147t2337r2286b2363],
32	with	IN	O	with	_	0	SENT_346	[p7l1276t2384r1346b2410],
33	higher	JJR	O	higher	amod	34	SENT_346	[p7l1361t2384r1467b2419],
34	numbers	NNS	O	number	prep_with	31	SENT_346	[p7l1482t2384r1631b2415],
35	,	,	O	,	_	0	SENT_346	[p7l1482t2384r1631b2415],
36	the	DT	O	the	det	37	SENT_346	[p7l1649t2384r1698b2410],
37	extent	NN	O	extent	nsubj	44	SENT_346	[p7l1714t2389r1816b2410],
38	of	IN	O	of	_	0	SENT_346	[p7l1831t2384r1866b2410],
39	the	DT	O	the	det	40	SENT_346	[p7l1879t2384r1928b2410],
40	reduction	NN	O	reduction	prep_of	37	SENT_346	[p7l1945t2384r2104b2410],
41	would	MD	O	would	aux	44	SENT_346	[p7l2119t2384r2217b2410],
42	not	RB	O	not	neg	44	SENT_346	[p7l2233t2389r2287b2410],
43	have	VB	O	have	aux	44	SENT_346	[p7l1276t2431r1349b2457],
44	increased	VBN	O	increase	parataxis	7	SENT_346	[p7l1377t2431r1538b2457],
45	.	.	O	.	_	0	SENT_346	[p7l1377t2431r1538b2457],

1	Thus	RB	O	thus	advmod	6	SENT_347	[p7l1565t2431r1653b2462],
2	,	,	O	,	_	0	SENT_347	[p7l1565t2431r1653b2462],
3	our	PRP$	O	we	poss	4	SENT_347	[p7l1680t2440r1737b2457],
4	ﬁndings	NNS	O	ﬁndings	nsubj	6	SENT_347	[p7l1762t2431r1891b2466],
5	rather	RB	O	rather	advmod	6	SENT_347	[p7l1919t2431r2020b2457],
6	support	VBP	O	support	_	0	SENT_347	[p7l2045t2437r2173b2466],
7	other	JJ	O	other	amod	8	SENT_347	[p7l2199t2431r2287b2457],
8	reports	NNS	O	report	dobj	6	SENT_347	[p7l1277t2483r1394b2513],
9	that	IN	O	that	complm	13	SENT_347	[p7l1415t2478r1478b2504],
10	ivermectin	NN	O	ivermectin	nsubj	13	SENT_347	[p7l1497t2479r1672b2504],
11	plus	CC	O	plus	prep	10	SENT_347	[p7l1691t2478r1756b2513],
12	albendazole	NN	O	albendazole	dep	11	SENT_347	[p7l1776t2478r1968b2504],
13	has	VBZ	O	have	ccomp	6	SENT_347	[p7l1987t2478r2039b2504],
14	no	DT	O	no	det	22	SENT_347	[p7l2059t2487r2098b2504],
15	signiﬁcant	JJ	O	signiﬁcant	amod	22	SENT_347	[p7l2118t2478r2287b2513],
16	macroﬁlaricidal	NN	O	macroﬁlaricidal	nn	22	SENT_347	[p7l1277t2525r1537b2551],
17	effect	NN	O	effect	nn	22	SENT_347	[p7l1564t2525r1655b2551],
18	[	CD	NUMBER	[	num	22	SENT_347	[p7l1685t2523r1808b2557],
19	55	CD	NUMBER	55	num	22	SENT_347	[p7l1685t2523r1808b2557],
20	—	NN	O	—	nn	22	SENT_347	[p7l1685t2523r1808b2557],
21	57	CD	NUMBER	57	num	22	SENT_347	[p7l1685t2523r1808b2557],
22	]	NN	O	]	dobj	13	SENT_347	[p7l1685t2523r1808b2557],
23	.	.	O	.	_	0	SENT_347	[p7l1685t2523r1808b2557],

1	Another	DT	O	another	det	2	SENT_348	[p7l1835t2525r1974b2551],
2	explanation	NN	O	explanation	nsubj	19	SENT_348	[p7l2000t2525r2195b2560],
3	that	WDT	O	that	nsubj	5	SENT_348	[p7l2224t2525r2287b2551],
4	probably	RB	O	probably	advmod	5	SENT_348	[p7l1277t2572r1422b2607],
5	accounts	VBZ	O	account	rcmod	2	SENT_348	[p7l1436t2578r1578b2598],
6	for	IN	O	for	_	0	SENT_348	[p7l1593t2572r1642b2598],
7	more	JJR	O	more	prep_for	5	SENT_348	[p7l1655t2581r1739b2598],
8	of	IN	O	of	_	0	SENT_348	[p7l1754t2572r1789b2598],
9	the	DT	O	the	det	10	SENT_348	[p7l1801t2572r1850b2598],
10	reduction	NN	O	reduction	prep_of	7	SENT_348	[p7l1866t2572r2025b2598],
11	of	IN	O	of	_	0	SENT_348	[p7l2039t2572r2074b2598],
12	antigenemia	NN	O	antigenemia	prep_of	10	SENT_348	[p7l2085t2573r2287b2607],
13	in	IN	O	in	_	0	SENT_348	[p7l1277t2620r1308b2644],
14	the	DT	O	the	det	16	SENT_348	[p7l1324t2619r1373b2645],
15	placebo	NN	O	placebo	nn	16	SENT_348	[p7l1390t2619r1515b2654],
16	group	NN	O	group	prep_in	12	SENT_348	[p7l1531t2628r1628b2654],
17	is	VBZ	O	be	cop	19	SENT_348	[p7l1645t2620r1666b2645],
18	the	DT	O	the	det	19	SENT_348	[p7l1684t2619r1733b2645],
19	depletion	NN	O	depletion	_	0	SENT_348	[p7l1749t2619r1904b2654],
20	of	IN	O	of	_	0	SENT_348	[p7l1920t2619r1955b2645],
21	microﬁlaremia	NN	O	microﬁlaremia	prep_of	19	SENT_348	[p7l1968t2619r2210b2645],
22	as	IN	O	as	mark	29	SENT_348	[p7l2225t2628r2254b2645],
23	a	DT	O	a	det	24	SENT_348	[p7l2271t2628r2287b2645],
24	result	NN	O	result	nsubj	29	SENT_348	[p7l1277t2665r1368b2691],
25	of	IN	O	of	_	0	SENT_348	[p7l1383t2665r1418b2691],
26	the	DT	O	the	det	28	SENT_348	[p7l1431t2665r1480b2691],
27	antiﬁlarial	JJ	O	antiﬁlarial	amod	28	SENT_348	[p7l1496t2665r1665b2691],
28	treatment	NN	O	treatment	prep_of	24	SENT_348	[p7l1681t2670r1842b2691],
29	offered	VBD	O	offer	advcl	19	SENT_348	[p7l1858t2665r1976b2691],
30	to	TO	O	to	_	0	SENT_348	[p7l1992t2670r2022b2691],
31	all	PDT	O	all	predet	33	SENT_348	[p7l2039t2665r2075b2691],
32	the	DT	O	the	det	33	SENT_348	[p7l2091t2665r2140b2691],
33	patients	NNS	O	patient	prep_to	29	SENT_348	[p7l2157t2666r2286b2700],
34	at	IN	O	at	_	0	SENT_348	[p7l1277t2717r1306b2738],
35	the	DT	O	the	det	38	SENT_348	[p7l1326t2712r1375b2738],
36	4-mo	JJ	DURATION	4-mo	amod	38	SENT_348	[p7l1395t2713r1477b2738],
37	time	NN	O	time	nn	38	SENT_348	[p7l1499t2713r1569b2738],
38	point	NN	O	point	prep_at	29	SENT_348	[p7l1590t2713r1684b2747],
39	.	.	O	.	_	0	SENT_348	[p7l1590t2713r1684b2747],

1	In	IN	O	in	_	0	SENT_349	[p7l1704t2713r1738b2737],
2	this	DT	O	this	det	3	SENT_349	[p7l1759t2712r1815b2738],
3	study	NN	O	study	prep_in	6	SENT_349	[p7l1835t2712r1927b2747],
4	,	,	O	,	_	0	SENT_349	[p7l1835t2712r1927b2747],
5	we	PRP	O	we	nsubj	6	SENT_349	[p7l1947t2721r1989b2738],
6	found	VBD	O	find	_	0	SENT_349	[p7l2009t2712r2105b2738],
7	a	DT	O	a	det	9	SENT_349	[p7l2125t2721r2141b2738],
8	positive	JJ	O	positive	amod	9	SENT_349	[p7l2161t2713r2286b2747],
9	correlation	NN	O	correlation	dobj	6	SENT_349	[p7l1277t2759r1459b2785],
10	between	IN	O	between	_	0	SENT_349	[p7l1484t2759r1618b2785],
11	microﬁlaremia	NN	O	microﬁlaremia	nn	15	SENT_349	[p7l1644t2759r1885b2785],
12	and	CC	O	and	_	0	SENT_349	[p7l1910t2759r1969b2785],
13	antigenemia	NN	O	antigenemia	nn	15	SENT_349	[p7l1994t2760r2196b2794],
14	(	NN	O	(	nn	15	SENT_349	[p7l2221t2760r2245b2791],
15	r	NN	O	r	prep_between	9	SENT_349	[p7l2221t2760r2245b2791],
16	=	JJ	O	=	amod	15	SENT_349	[p7l2265t2770r2289b2779],
17	0.754	CD	NUMBER	0.754	tmod	16	SENT_349	[p7l1277t2804r1368b2837],
18	,	,	O	,	_	0	SENT_349	[p7l1277t2804r1368b2837],
19	p	NN	O	p	dep	20	SENT_349	[p7l1380t2809r1400b2841],
20	<	JJR	O	<	appos	9	SENT_349	[p7l1417t2808r1442b2830],
21	0.0001	CD	NUMBER	0.0001	num	22	SENT_349	[p7l1460t2806r1581b2838],
22	)	NN	O	)	dep	20	SENT_349	[p7l1460t2806r1581b2838],
23	.	.	O	.	_	0	SENT_349	[p7l1460t2806r1581b2838],

1	This	DT	O	this	nsubj	9	SENT_350	[p7l1597t2806r1666b2832],
2	is	VBZ	O	be	cop	9	SENT_350	[p7l1683t2807r1704b2832],
3	consistent	JJ	O	consistent	amod	9	SENT_350	[p7l1720t2807r1885b2832],
4	with	IN	O	with	_	0	SENT_350	[p7l1899t2806r1969b2832],
5	another	DT	O	another	det	6	SENT_350	[p7l1984t2806r2113b2832],
6	study	NN	O	study	prep_with	3	SENT_350	[p7l2127t2806r2213b2841],
7	[	CD	NUMBER	[	number	8	SENT_350	[p7l2229t2806r2285b2838],
8	58	CD	NUMBER	58	num	6	SENT_350	[p7l2229t2806r2285b2838],
9	]	NN	O	]	_	0	SENT_350	[p7l2229t2806r2285b2838],
10	in	IN	O	in	_	0	SENT_350	[p7l1277t2854r1308b2878],
11	which	WDT	O	which	rel	21	SENT_350	[p7l1324t2853r1420b2879],
12	a	DT	O	a	det	14	SENT_350	[p7l1438t2862r1454b2879],
13	positive	JJ	O	positive	amod	14	SENT_350	[p7l1471t2854r1597b2888],
14	correlation	NN	O	correlation	nsubjpass	21	SENT_350	[p7l1615t2853r1798b2879],
15	between	IN	O	between	_	0	SENT_350	[p7l1815t2853r1950b2879],
16	microﬁlaremia	NN	O	microﬁlaremia	prep_between	14	SENT_350	[p7l1968t2853r2210b2879],
17	and	CC	O	and	_	0	SENT_350	[p7l2227t2853r2286b2879],
18	antigenemia	NN	O	antigenemia	conj_and	16	SENT_350	[p7l1277t2901r1478b2935],
19	was	VBD	O	be	auxpass	21	SENT_350	[p7l1496t2909r1552b2926],
20	also	RB	O	also	advmod	21	SENT_350	[p7l1572t2900r1632b2926],
21	reported	VBN	O	report	ccomp	9	SENT_350	[p7l1652t2900r1803b2935],
22	,	,	O	,	_	0	SENT_350	[p7l1652t2900r1803b2935],
23	implying	VBG	O	imply	xcomp	21	SENT_350	[p7l1824t2900r1967b2935],
24	that	IN	O	that	complm	38	SENT_350	[p7l1986t2900r2049b2926],
25	as	IN	O	as	mark	31	SENT_350	[p7l2068t2909r2097b2926],
26	MF	NN	O	mf	nsubjpass	31	SENT_350	[p7l2116t2901r2167b2925],
27	in	IN	O	in	_	0	SENT_350	[p7l2187t2901r2217b2925],
28	the	DT	O	the	det	29	SENT_350	[p7l2237t2900r2286b2926],
29	blood	NN	O	blood	prep_in	26	SENT_350	[p7l1276t2946r1369b2972],
30	are	VBP	O	be	auxpass	31	SENT_350	[p7l1384t2955r1434b2972],
31	depleted	VBN	O	deplete	advcl	38	SENT_350	[p7l1449t2946r1598b2981],
32	,	,	O	,	_	0	SENT_350	[p7l1449t2946r1598b2981],
33	the	DT	O	the	det	34	SENT_350	[p7l1615t2946r1664b2972],
34	level	NN	O	level	nsubj	38	SENT_350	[p7l1679t2946r1751b2972],
35	of	IN	O	of	_	0	SENT_350	[p7l1767t2946r1801b2972],
36	antigenemia	NN	O	antigenemia	prep_of	34	SENT_350	[p7l1813t2947r2015b2981],
37	also	RB	O	also	advmod	38	SENT_350	[p7l2030t2946r2090b2972],
38	goes	VBZ	O	go	ccomp	23	SENT_350	[p7l2106t2955r2175b2981],
39	down	RB	O	down	advmod	38	SENT_350	[p7l2190t2946r2286b2977],
40	,	,	O	,	_	0	SENT_350	[p7l2190t2946r2286b2977],
41	hence	RB	O	hence	advmod	9	SENT_350	[p7l1276t2993r1372b3019],
42	the	DT	O	the	det	43	SENT_350	[p7l1387t2993r1436b3019],
43	reduction	NN	O	reduction	dep	9	SENT_350	[p7l1451t2993r1610b3019],
44	seen	VBN	O	see	partmod	43	SENT_350	[p7l1624t3002r1694b3019],
45	at	IN	O	at	_	0	SENT_350	[p7l1708t2998r1737b3019],
46	12	CD	NUMBER	12	prep_at	44	SENT_350	[p7l1754t2993r1787b3020],
47	and	CC	O	and	_	0	SENT_350	[p7l1802t2993r1860b3019],
48	24	CD	DURATION	24	num	49	SENT_350	[p7l1876t2993r1912b3020],
49	mo	NN	DURATION	mo	prep_at	44	SENT_350	[p7l1925t3002r1975b3019],
50	after	IN	O	after	_	0	SENT_350	[p7l1990t2993r2067b3019],
51	treatment	NN	O	treatment	prep_after	44	SENT_350	[p7l2081t2998r2242b3019],
52	in	IN	O	in	prep	44	SENT_350	[p7l2256t2994r2286b3018],

1	Table	NNP	O	Table	_	0	SENT_351	[p8l188t247r279b274],
2	3	CD	NUMBER	3	dep	1	SENT_351	[p8l294t249r322b274],
3	.	.	O	.	_	0	SENT_351	[p8l294t249r322b274],

1	Primary	JJ	O	primary	amod	2	SENT_352	[p8l338t248r454b282],
2	Variables	NNS	O	variable	nsubj	3	SENT_352	[p8l467t247r606b274],
3	Measured	VBN	O	measure	conj_and	3	SENT_352	[p8l622t247r771b274],
4	before	IN	O	before	_	0	SENT_352	[p8l789t247r887b274],
5	and	CC	O	and	_	0	SENT_352	[p8l902t247r958b274],
6	after	IN	O	after	_	0	SENT_352	[p8l974t247r1045b274],
7	Treatment	NN	O	treatment	prep_before	3	SENT_352	[p8l1057t249r1219b274],
8	in	IN	O	in	_	0	SENT_352	[p8l1235t248r1259b274],
9	Lymphedema	NNP	O	Lymphedema	nn	10	SENT_352	[p8l1277t247r1487b282],
10	Patients	NNS	O	patient	prep_in	3	SENT_352	[p8l1505t248r1626b274],

1	Treatment	NNP	O	Treatment	nn	2	SENT_353	[p8l188t345r342b368],
2	Group	NNP	O	Group	_	0	SENT_353	[p8l355t345r446b375],

1	Time	NNP	O	Time	nn	2	SENT_354	[p8l1263t344r1335b368],
2	Point	NNP	O	Point	_	0	SENT_354	[p8l1349t344r1425b368],
3	after	IN	O	after	_	0	SENT_354	[p8l1438t344r1508b368],
4	Treatment	NN	O	treatment	prep_after	2	SENT_354	[p8l1519t345r1674b368],

1	Before	IN	O	before	_	0	SENT_355	[p8l1265t403r1360b427],
2	Treatment	NN	O	treatment	nn	5	SENT_355	[p8l1372t404r1527b427],
3	12	CD	DURATION	12	num	5	SENT_355	[p8l1748t405r1780b427],
4	mo	NN	DURATION	mo	nn	5	SENT_355	[p8l1795t410r1840b427],
5	p-Value	NN	O	p-value	pobj	1	SENT_355	[p8l2173t403r2287b434],

1	Doxycycline	NNP	O	Doxycycline	dep	136	SENT_356	[p8l189t492r343b519],
2	(	CD	NUMBER	(	dep	136	SENT_356	[p8l355t493r376b517],
3	n	NN	O	n	dep	136	SENT_356	[p8l355t493r376b517],
4	=	JJ	O	=	dep	136	SENT_356	[p8l389t502r408b509],
5	8	CD	NUMBER	8	dep	136	SENT_356	[p8l420t493r440b517],
6	)	CD	NUMBER	)	dep	136	SENT_356	[p8l420t493r440b517],
7	Median	JJ	O	median	dep	136	SENT_356	[p8l544t492r631b513],
8	of	IN	O	of	dep	136	SENT_356	[p8l644t492r669b513],
9	antigenemia	NN	O	antigenemia	dep	136	SENT_356	[p8l678t493r829b519],
10	(	CD	PERCENT	(	dep	136	SENT_356	[p8l842t493r877b517],
11	%	NN	PERCENT	%	dep	136	SENT_356	[p8l842t493r877b517],
12	)	CD	NUMBER	)	dep	136	SENT_356	[p8l842t493r877b517],
13	(	CD	NUMBER	(	dep	136	SENT_356	[p8l890t492r1020b517],
14	10th	JJ	ORDINAL	10th	dep	136	SENT_356	[p8l890t492r1020b517],
15	—	NN	O	—	dep	136	SENT_356	[p8l890t492r1020b517],
16	90th	JJ	ORDINAL	90th	dep	136	SENT_356	[p8l890t492r1020b517],
17	percentile	NN	O	percentile	dep	136	SENT_356	[p8l1034t492r1160b519],
18	)	NN	O	)	dep	136	SENT_356	[p8l1034t492r1160b519],
19	721	CD	NUMBER	721	dep	136	SENT_356	[p8l1264t494r1301b513],
20	(	NN	O	(	dep	136	SENT_356	[p8l1318t493r1399b517],
21	100	CD	PERCENT	100	dep	136	SENT_356	[p8l1318t493r1399b517],
22	%	NN	PERCENT	%	dep	136	SENT_356	[p8l1318t493r1399b517],
23	)	CD	NUMBER	)	dep	136	SENT_356	[p8l1318t493r1399b517],
24	(	NN	O	(	dep	136	SENT_356	[p8l1412t493r1549b517],
25	200	CD	NUMBER	200	dep	136	SENT_356	[p8l1412t493r1549b517],
26	—	CD	NUMBER	—	dep	136	SENT_356	[p8l1412t493r1549b517],
27	2,061	CD	NUMBER	2,061	dep	136	SENT_356	[p8l1412t493r1549b517],
28	)	NN	O	)	dep	136	SENT_356	[p8l1412t493r1549b517],
29	257	CD	NUMBER	257	dep	136	SENT_356	[p8l1746t494r1788b513],
30	(	NN	O	(	dep	136	SENT_356	[p8l1801t493r1866b517],
31	36	CD	PERCENT	36	dep	136	SENT_356	[p8l1801t493r1866b517],
32	%	NN	PERCENT	%	dep	136	SENT_356	[p8l1801t493r1866b517],
33	)	CD	NUMBER	)	dep	136	SENT_356	[p8l1801t493r1866b517],
34	(	CD	NUMBER	(	dep	136	SENT_356	[p8l1880t493r1996b517],
35	180-532	CD	NUMBER	180-532	dep	136	SENT_356	[p8l1880t493r1996b517],
36	)	NN	O	)	dep	136	SENT_356	[p8l1880t493r1996b517],
37	0.14413	CD	NUMBER	0.14413	dep	136	SENT_356	[p8l2174t490r2263b513],
38	Mean	NN	O	mean	dep	136	SENT_356	[p8l544t530r608b550],
39	(	NN	O	(	dep	136	SENT_356	[p8l622t530r705b556],
40	range	NN	O	range	dep	136	SENT_356	[p8l622t530r705b556],
41	)	CD	NUMBER	)	dep	136	SENT_356	[p8l622t530r705b556],
42	stage	NN	O	stage	dep	136	SENT_356	[p8l718t533r781b556],
43	of	IN	O	of	dep	136	SENT_356	[p8l793t529r818b550],
44	affected	VBN	O	affect	dep	136	SENT_356	[p8l827t529r923b550],
45	legs	NNS	O	leg	dep	136	SENT_356	[p8l937t529r983b556],
46	3.3	CD	NUMBER	3.3	dep	136	SENT_356	[p8l1264t531r1297b550],
47	(	CD	NUMBER	(	dep	136	SENT_356	[p8l1310t530r1367b554],
48	3-5	CD	NUMBER	3-5	dep	136	SENT_356	[p8l1310t530r1367b554],
49	)	NN	O	)	dep	136	SENT_356	[p8l1310t530r1367b554],
50	2.3	CD	NUMBER	2.3	dep	136	SENT_356	[p8l1746t531r1779b550],
51	(	CD	NUMBER	(	dep	136	SENT_356	[p8l1792t530r1849b554],
52	2-4	CD	NUMBER	2-4	dep	136	SENT_356	[p8l1792t530r1849b554],
53	)	NN	O	)	dep	136	SENT_356	[p8l1792t530r1849b554],
54	00051	CD	NUMBER	00051	dep	136	SENT_356	[p8l2174t523r2266b550],
55	”	CD	NUMBER	”	dep	136	SENT_356	[p8l2174t523r2266b550],
56	Mean	NN	O	mean	dep	136	SENT_356	[p8l544t567r608b587],
57	size	NN	O	size	dep	136	SENT_356	[p8l621t567r664b587],
58	of	IN	O	of	dep	136	SENT_356	[p8l676t566r701b587],
59	affected	VBN	O	affect	dep	136	SENT_356	[p8l710t566r806b587],
60	legs	NNS	O	leg	dep	136	SENT_356	[p8l820t566r866b593],
61	(	CD	NUMBER	(	dep	136	SENT_356	[p8l878t567r929b591],
62	cm	NN	O	cm	dep	136	SENT_356	[p8l878t567r929b591],
63	)	NN	O	)	dep	136	SENT_356	[p8l878t567r929b591],
64	181	CD	NUMBER	181	dep	136	SENT_356	[p8l1266t568r1302b587],
65	178	CD	NUMBER	178	dep	136	SENT_356	[p8l1748t568r1789b587],
66	0.5754	CD	NUMBER	0.5754	dep	136	SENT_356	[p8l2174t560r2266b587],
67	”	CD	NUMBER	”	dep	136	SENT_356	[p8l2174t560r2266b587],
68	Placebo	NN	O	placebo	dep	136	SENT_356	[p8l189t604r289b625],
69	(	NN	O	(	dep	136	SENT_356	[p8l302t605r322b629],
70	n	NN	O	n	dep	136	SENT_356	[p8l302t605r322b629],
71	=	JJ	O	=	dep	136	SENT_356	[p8l335t614r354b621],
72	10	CD	NUMBER	10	dep	136	SENT_356	[p8l369t605r401b629],
73	)	CD	NUMBER	)	dep	136	SENT_356	[p8l369t605r401b629],
74	Median	JJ	O	median	dep	136	SENT_356	[p8l544t604r631b625],
75	of	IN	O	of	dep	136	SENT_356	[p8l644t604r669b625],
76	antigenemia	NN	O	antigenemia	dep	136	SENT_356	[p8l678t605r829b631],
77	(	CD	PERCENT	(	dep	136	SENT_356	[p8l842t605r877b629],
78	%	NN	PERCENT	%	dep	136	SENT_356	[p8l842t605r877b629],
79	)	CD	NUMBER	)	dep	136	SENT_356	[p8l842t605r877b629],
80	(	CD	NUMBER	(	dep	136	SENT_356	[p8l890t604r1020b629],
81	10th	JJ	ORDINAL	10th	dep	136	SENT_356	[p8l890t604r1020b629],
82	—	NN	O	—	dep	136	SENT_356	[p8l890t604r1020b629],
83	90th	JJ	ORDINAL	90th	dep	136	SENT_356	[p8l890t604r1020b629],
84	percentile	NN	O	percentile	dep	136	SENT_356	[p8l1034t604r1160b631],
85	)	CD	NUMBER	)	dep	136	SENT_356	[p8l1034t604r1160b631],
86	10,807	CD	NUMBER	10,807	dep	136	SENT_356	[p8l1266t606r1341b629],
87	(	NN	O	(	dep	136	SENT_356	[p8l1354t605r1434b629],
88	100	CD	PERCENT	100	dep	136	SENT_356	[p8l1354t605r1434b629],
89	%	NN	PERCENT	%	dep	136	SENT_356	[p8l1354t605r1434b629],
90	)	CD	NUMBER	)	dep	136	SENT_356	[p8l1354t605r1434b629],
91	(	NN	O	(	dep	136	SENT_356	[p8l1448t605r1464b629],
92	1	CD	NUMBER	1	dep	136	SENT_356	[p8l1448t605r1464b629],
93	271-676 634	CD	NUMBER	271-676 634	dep	136	SENT_356	[p8l1593t605r1643b629],[p8l1480t606r1582b625],
94	)	NN	O	)	dep	136	SENT_356	[p8l1593t605r1643b629],
95	1,145	CD	PERCENT	1,145	dep	136	SENT_356	[p8l1748t606r1809b629],
96	(	CD	PERCENT	(	dep	136	SENT_356	[p8l1822t605r1887b629],
97	11	CD	PERCENT	11	dep	136	SENT_356	[p8l1822t605r1887b629],
98	%	NN	PERCENT	%	dep	136	SENT_356	[p8l1822t605r1887b629],
99	)	CD	NUMBER	)	dep	136	SENT_356	[p8l1822t605r1887b629],
100	(	NN	O	(	dep	136	SENT_356	[p8l1901t605r2009b629],
101	193	CD	NUMBER	193	dep	136	SENT_356	[p8l1901t605r2009b629],
102	—	NN	O	—	dep	136	SENT_356	[p8l1901t605r2009b629],
103	337	CD	NUMBER	337	dep	136	SENT_356	[p8l1901t605r2009b629],
104	374	CD	NUMBER	374	dep	136	SENT_356	[p8l2022t605r2071b629],
105	)	NN	O	)	dep	136	SENT_356	[p8l2022t605r2071b629],
106	0.11593	CD	NUMBER	0.11593	dep	136	SENT_356	[p8l2174t602r2263b625],
107	Mean	NN	O	mean	dep	136	SENT_356	[p8l544t642r608b662],
108	(	NN	O	(	dep	136	SENT_356	[p8l622t642r705b668],
109	range	NN	O	range	dep	136	SENT_356	[p8l622t642r705b668],
110	)	CD	NUMBER	)	dep	136	SENT_356	[p8l622t642r705b668],
111	stage	NN	O	stage	dep	136	SENT_356	[p8l718t645r781b668],
112	of	IN	O	of	dep	136	SENT_356	[p8l793t641r818b662],
113	affected	VBN	O	affect	dep	136	SENT_356	[p8l827t641r923b662],
114	legs	NNS	O	leg	dep	136	SENT_356	[p8l937t641r983b668],
115	2.5	CD	NUMBER	2.5	dep	136	SENT_356	[p8l1264t643r1297b662],
116	(	CD	NUMBER	(	dep	136	SENT_356	[p8l1310t642r1367b666],
117	2-3	CD	NUMBER	2-3	dep	136	SENT_356	[p8l1310t642r1367b666],
118	)	NN	O	)	dep	136	SENT_356	[p8l1310t642r1367b666],
119	2.8	CD	NUMBER	2.8	dep	136	SENT_356	[p8l1746t643r1780b662],
120	(	CD	NUMBER	(	dep	136	SENT_356	[p8l1792t642r1849b666],
121	3-4	CD	NUMBER	3-4	dep	136	SENT_356	[p8l1792t642r1849b666],
122	)	NN	O	)	dep	136	SENT_356	[p8l1792t642r1849b666],
123	0.1088	CD	NUMBER	0.1088	dep	136	SENT_356	[p8l2174t635r2266b662],
124	”	CD	NUMBER	”	dep	136	SENT_356	[p8l2174t635r2266b662],
125	Mean	NN	O	mean	dep	136	SENT_356	[p8l544t679r608b699],
126	circumference	NN	O	circumference	dep	136	SENT_356	[p8l621t678r792b699],
127	of	IN	O	of	dep	136	SENT_356	[p8l804t678r829b699],
128	affected	VBN	O	affect	dep	136	SENT_356	[p8l838t678r934b699],
129	legs	NNS	O	leg	dep	136	SENT_356	[p8l948t678r994b705],
130	(	CD	NUMBER	(	dep	136	SENT_356	[p8l1006t679r1057b703],
131	cm	NN	O	cm	dep	136	SENT_356	[p8l1006t679r1057b703],
132	)	NN	O	)	dep	136	SENT_356	[p8l1006t679r1057b703],
133	178	CD	NUMBER	178	dep	136	SENT_356	[p8l1266t680r1306b699],
134	175	CD	NUMBER	175	dep	136	SENT_356	[p8l1748t680r1788b699],
135	0.2076	CD	NUMBER	0.2076	dep	136	SENT_356	[p8l2174t672r2266b699],
136	”	NN	O	”	_	0	SENT_356	[p8l2174t672r2266b699],

1	aChanges	NNS	O	achange	nsubjpass	12	SENT_357	[p8l188t782r294b809],
2	in	IN	O	in	_	0	SENT_357	[p8l305t784r323b803],
3	median	NN	O	median	prep_in	1	SENT_357	[p8l336t784r417b803],
4	of	IN	O	of	_	0	SENT_357	[p8l429t783r451b803],
5	antigenemia	NN	O	antigenemia	nn	6	SENT_357	[p8l460t784r599b809],
6	values	NNS	O	value	prep_of	3	SENT_357	[p8l610t784r680b803],
7	before	IN	O	before	_	0	SENT_357	[p8l691t783r763b803],
8	and	CC	O	and	_	0	SENT_357	[p8l773t784r814b803],
9	after	IN	O	after	_	0	SENT_357	[p8l825t783r876b803],
10	treatment	NN	O	treatment	prep_after	6	SENT_357	[p8l886t787r997b803],
11	were	VBD	O	be	auxpass	12	SENT_357	[p8l1008t790r1062b803],
12	compared	VBN	O	compare	_	0	SENT_357	[p8l1072t784r1185b808],
13	by	IN	O	by	_	0	SENT_357	[p8l1197t784r1223b809],
14	Wilcoxon	NNP	PERSON	Wilcoxon	nn	16	SENT_357	[p8l1233t784r1335b803],
15	rank	NN	O	rank	nn	16	SENT_357	[p8l1347t784r1395b803],
16	test	NN	O	test	agent	12	SENT_357	[p8l1404t787r1450b803],
17	.	.	O	.	_	0	SENT_357	[p8l1404t787r1450b803],

1	bChanges	NNS	O	bchange	nsubjpass	19	SENT_358	[p8l189t811r296b842],
2	in	IN	O	in	_	0	SENT_358	[p8l307t817r325b836],
3	the	DT	O	the	det	5	SENT_358	[p8l336t817r372b836],
4	mean	JJ	O	mean	amod	5	SENT_358	[p8l384t823r444b836],
5	stage	NN	O	stage	prep_in	1	SENT_358	[p8l456t820r515b842],
6	of	IN	O	of	_	0	SENT_358	[p8l526t816r549b836],
7	affected	VBN	O	affect	amod	8	SENT_358	[p8l557t816r646b836],
8	legs	NNS	O	leg	prep_of	5	SENT_358	[p8l659t817r701b842],
9	and	CC	O	and	_	0	SENT_358	[p8l712t817r753b836],
10	circumference	NN	O	circumference	prep_of	5	SENT_358	[p8l764t816r923b836],
11	of	IN	O	of	_	0	SENT_358	[p8l933t816r956b836],
12	affected	VBN	O	affect	amod	13	SENT_358	[p8l965t816r1054b836],
13	legs	NNS	O	leg	prep_of	8	SENT_358	[p8l1067t817r1109b842],
14	before	IN	O	before	_	0	SENT_358	[p8l1121t816r1192b836],
15	and	CC	O	and	_	0	SENT_358	[p8l1203t817r1243b836],
16	after	IN	O	after	_	0	SENT_358	[p8l1255t816r1306b836],
17	treatment	NN	O	treatment	prep_after	13	SENT_358	[p8l1315t820r1427b836],
18	were	VBD	O	be	auxpass	19	SENT_358	[p8l1437t823r1491b836],
19	compared	VBN	O	compare	_	0	SENT_358	[p8l1502t817r1614b841],
20	by	IN	O	by	_	0	SENT_358	[p8l1627t817r1653b842],
21	paired	JJ	O	paired	amod	22	SENT_358	[p8l1664t817r1732b841],
22	t-test	NN	O	t-test	agent	19	SENT_358	[p8l1745t820r1806b836],
23	.	.	O	.	_	0	SENT_358	[p8l1745t820r1806b836],

1	DOI	NNP	O	DOI	_	0	SENT_359	[p8l189t851r235b870],
2	:	:	O	:	_	0	SENT_359	[p8l189t851r235b870],
3	10.1371	CD	NUMBER	10.1371	dep	1	SENT_359	[p8l248t851r636b876],
4	/	:	O	/	punct	5	SENT_359	[p8l248t851r636b876],
5	journal	NN	O	journal	dep	3	SENT_359	[p8l248t851r636b876],
6	.	.	O	.	_	0	SENT_359	[p8l248t851r636b876],

1	ppat	NN	O	ppat	_	0	SENT_360	[p8l248t851r636b876],
2	.0	CD	NUMBER	.0	num	3	SENT_360	[p8l248t851r636b876],
3	O20092	NN	O	o20092	dep	1	SENT_360	[p8l248t851r636b876],
4	.	.	O	.	_	0	SENT_360	[p8l248t851r636b876],

1	t003	NN	O	t003	_	0	SENT_361	[p8l248t851r636b876],

1	the	DT	O	the	det	2	SENT_362	[p8l190t945r239b971],
2	placebo	NN	O	placebo	_	0	SENT_362	[p8l262t945r387b980],
3	group	NN	O	group	dep	2	SENT_362	[p8l410t954r514b980],
4	.	.	O	.	_	0	SENT_362	[p8l410t954r514b980],

1	A	DT	O	a	det	4	SENT_363	[p8l536t945r562b970],
2	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_363	[p8l583t945r752b980],
3	macroﬁlaricidal	JJ	O	macroﬁlaricidal	amod	4	SENT_363	[p8l774t945r1033b971],
4	effect	NN	O	effect	nsubj	12	SENT_363	[p8l1055t945r1146b971],
5	of	IN	O	of	_	0	SENT_363	[p8l1168t945r1202b971],
6	ivermectin	NN	O	ivermectin	prep_of	4	SENT_363	[p8l190t992r364b1017],
7	and	CC	O	and	_	0	SENT_363	[p8l381t991r440b1017],
8	albendazole	NN	O	albendazole	prep_of	4	SENT_363	[p8l458t991r650b1017],
9	in	IN	O	in	_	0	SENT_363	[p8l668t992r698b1016],
10	placebo	NN	O	placebo	nn	11	SENT_363	[p8l716t991r841b1026],
11	patients	NNS	O	patient	prep_in	6	SENT_363	[p8l859t992r989b1026],
12	is	VBZ	O	be	_	0	SENT_363	[p8l1007t992r1037b1022],
13	,	,	O	,	_	0	SENT_363	[p8l1007t992r1037b1022],
14	however	RB	O	however	advmod	12	SENT_363	[p8l1054t991r1198b1022],
15	,	,	O	,	_	0	SENT_363	[p8l1054t991r1198b1022],
16	not	RB	O	not	dep	42	SENT_363	[p8l190t1041r243b1062],
17	supported	VBN	O	support	csubj	42	SENT_363	[p8l271t1036r438b1071],
18	by	IN	O	by	_	0	SENT_363	[p8l465t1036r502b1071],
19	the	DT	O	the	det	21	SENT_363	[p8l530t1036r579b1062],
20	USG	NNP	O	USG	nn	21	SENT_363	[p8l607t1036r681b1062],
21	results	NNS	O	result	prep_by	17	SENT_363	[p8l709t1036r821b1067],
22	,	,	O	,	_	0	SENT_363	[p8l709t1036r821b1067],
23	which	WDT	O	which	nsubj	24	SENT_363	[p8l849t1036r944b1062],
24	demonstrated	VBD	O	demonstrate	rcmod	21	SENT_363	[p8l972t1036r1199b1062],
25	mostly	RB	O	mostly	advmod	26	SENT_363	[p8l189t1082r295b1117],
26	stable	JJ	O	stable	amod	28	SENT_363	[p8l318t1082r410b1108],
27	worm	NN	O	worm	nn	28	SENT_363	[p8l433t1091r526b1108],
28	nests	NNS	O	nest	nsubj	32	SENT_363	[p8l549t1087r627b1108],
29	in	IN	O	in	_	0	SENT_363	[p8l651t1083r682b1107],
30	placebo	NN	O	placebo	nn	31	SENT_363	[p8l705t1082r830b1117],
31	patients	NNS	O	patient	prep_in	28	SENT_363	[p8l855t1083r984b1117],
32	(	VBP	O	(	ccomp	24	SENT_363	[p8l1008t1082r1200b1117],
33	conﬁrming	VBG	O	conﬁrming	xcomp	32	SENT_363	[p8l1008t1082r1200b1117],
34	earlier	JJR	O	earlier	amod	35	SENT_363	[p8l189t1128r296b1154],
35	results	NNS	O	result	dobj	33	SENT_363	[p8l309t1128r413b1154],
36	by	IN	O	by	_	0	SENT_363	[p8l427t1128r464b1163],
37	Dreyer	NNP	PERSON	Dreyer	prep_by	33	SENT_363	[p8l477t1129r589b1163],
38	et	FW	O	et	nn	39	SENT_363	[p8l602t1133r631b1154],
39	al.	FW	O	al.	tmod	33	SENT_363	[p8l645t1128r679b1154],
40	and	CC	O	and	_	0	SENT_363	[p8l693t1128r752b1154],
41	others	NNS	O	other	conj_and	39	SENT_363	[p8l766t1128r878b1160],
42	)	VBP	O	)	ccomp	12	SENT_363	[p8l766t1128r878b1160],
43	[	CD	NUMBER	[	number	44	SENT_363	[p8l895t1126r1007b1160],
44	47,48	CD	NUMBER	47,48	num	45	SENT_363	[p8l895t1126r1007b1160],
45	]	NN	O	]	dobj	42	SENT_363	[p8l895t1126r1007b1160],
46	,	,	O	,	_	0	SENT_363	[p8l895t1126r1007b1160],
47	in	IN	O	in	_	0	SENT_363	[p8l1022t1129r1052b1153],
48	contrast	NN	O	contrast	prep_in	45	SENT_363	[p8l1066t1133r1199b1154],
49	to	TO	O	to	_	0	SENT_363	[p8l190t1179r220b1200],
50	most	JJS	O	most	prep_to	42	SENT_363	[p8l236t1179r314b1200],
51	of	IN	O	of	_	0	SENT_363	[p8l328t1174r363b1200],
52	the	DT	O	the	det	54	SENT_363	[p8l376t1174r425b1200],
53	doxycycline-treated	JJ	O	doxycycline-treated	amod	54	SENT_363	[p8l440t1174r763b1209],
54	patients	NNS	O	patient	prep_of	50	SENT_363	[p8l778t1175r916b1209],
55	.	.	O	.	_	0	SENT_363	[p8l778t1175r916b1209],

1	VEGF	NN	O	vegf	nn	2	SENT_364	[p8l188t1250r276b1278],
2	Levels	NNS	O	level	dep	17	SENT_364	[p8l295t1248r398b1279],
3	Apart	RB	O	apart	_	0	SENT_364	[p8l225t1300r321b1334],
4	from	IN	O	from	_	0	SENT_364	[p8l336t1299r416b1325],
5	the	DT	O	the	det	7	SENT_364	[p8l433t1299r482b1325],
6	macroﬁlaricidal	JJ	O	macroﬁlaricidal	amod	7	SENT_364	[p8l498t1299r757b1325],
7	effect	NN	O	effect	prep_apart_from	2	SENT_364	[p8l774t1299r864b1325],
8	by	IN	O	by	dep	2	SENT_364	[p8l880t1299r916b1334],
9	doxycycline	NN	O	doxycycline	pobj	8	SENT_364	[p8l932t1299r1131b1334],
10	,	,	O	,	_	0	SENT_364	[p8l932t1299r1131b1334],
11	the	DT	O	the	det	13	SENT_364	[p8l1150t1299r1199b1325],
12	second	JJ	ORDINAL	second	amod	13	SENT_364	[p8l189t1344r301b1370],
13	observation	NN	O	observation	nsubj	17	SENT_364	[p8l325t1344r516b1370],
14	in	IN	O	in	_	0	SENT_364	[p8l541t1345r571b1369],
15	this	DT	O	this	det	16	SENT_364	[p8l596t1344r652b1370],
16	study	NN	O	study	prep_in	13	SENT_364	[p8l677t1344r762b1379],
17	is	VBZ	O	be	_	0	SENT_364	[p8l786t1345r808b1370],
18	that	IN	O	that	complm	32	SENT_364	[p8l834t1344r896b1370],
19	plasma	NN	O	plasma	nn	20	SENT_364	[p8l921t1344r1033b1379],
20	levels	NNS	O	level	nsubj	32	SENT_364	[p8l1057t1344r1143b1370],
21	of	IN	O	of	_	0	SENT_364	[p8l1168t1344r1202b1370],
22	VEGF-C	NN	O	vegf-c	prep_of	20	SENT_364	[p8l188t1390r321b1416],
23	and	CC	O	and	_	0	SENT_364	[p8l337t1390r396b1416],
24	its	PRP$	O	its	poss	26	SENT_364	[p8l410t1391r445b1416],
25	soluble	JJ	O	soluble	amod	26	SENT_364	[p8l460t1390r573b1416],
26	receptor	NN	O	receptor	prep_of	20	SENT_364	[p8l588t1396r735b1425],
27	,	,	O	,	_	0	SENT_364	[p8l588t1396r735b1425],
28	SVEGFR-3	NN	O	svegfr-3	appos	20	SENT_364	[p8l750t1390r924b1421],
29	,	,	O	,	_	0	SENT_364	[p8l750t1390r924b1421],
30	are	VBP	O	be	cop	32	SENT_364	[p8l939t1399r988b1416],
31	signiﬁcantly	RB	O	signiﬁcantly	advmod	32	SENT_364	[p8l1003t1390r1199b1425],
32	elevated	JJ	O	elevated	ccomp	17	SENT_364	[p8l189t1436r322b1462],
33	in	IN	O	in	_	0	SENT_364	[p8l334t1437r365b1461],
34	patients	NNS	O	patient	prep_in	32	SENT_364	[p8l376t1437r505b1471],
35	infected	VBN	O	infect	partmod	34	SENT_364	[p8l518t1436r649b1462],
36	with	IN	O	with	_	0	SENT_364	[p8l660t1436r730b1462],
37	ﬁlarial	JJ	O	ﬁlarial	amod	38	SENT_364	[p8l741t1436r845b1462],
38	worms	NNS	O	worm	prep_with	35	SENT_364	[p8l856t1445r971b1467],
39	,	,	O	,	_	0	SENT_364	[p8l856t1445r971b1467],
40	and	CC	O	and	_	0	SENT_364	[p8l983t1436r1042b1462],
41	there	EX	O	there	expl	42	SENT_364	[p8l1054t1436r1138b1462],
42	is	VBZ	O	be	conj_and	17	SENT_364	[p8l1150t1437r1172b1462],
43	a	DT	O	a	det	44	SENT_364	[p8l1184t1445r1200b1462],
44	correlation	NN	O	correlation	nsubj	42	SENT_364	[p8l189t1482r378b1508],
45	between	IN	O	between	_	0	SENT_364	[p8l407t1482r546b1508],
46	sVEGFR-3	NN	O	svegfr-3	nn	49	SENT_364	[p8l574t1482r744b1508],
47	and	CC	O	and	_	0	SENT_364	[p8l774t1482r834b1508],
48	lymphatic	JJ	O	lymphatic	conj_and	46	SENT_364	[p8l863t1482r1029b1517],
49	dilation	NN	O	dilation	prep_between	44	SENT_364	[p8l1058t1482r1198b1508],
50	.	.	O	.	_	0	SENT_364	[p8l1058t1482r1198b1508],

1	Targeting	NN	O	targeting	nsubj	35	SENT_365	[p8l189t1529r349b1563],
2	the	DT	O	the	det	4	SENT_365	[p8l362t1528r411b1554],
3	ﬁlarial	JJ	O	ﬁlarial	amod	4	SENT_365	[p8l423t1528r528b1554],
4	worms	NNS	O	worm	nsubj	7	SENT_365	[p8l540t1537r646b1554],
5	by	IN	O	by	_	0	SENT_365	[p8l659t1528r696b1563],
6	doxycycline	NN	O	doxycycline	prep_by	4	SENT_365	[p8l708t1528r899b1563],
7	reduces	VBZ	O	reduce	rcmod	1	SENT_365	[p8l913t1528r1036b1554],
8	the	DT	O	the	det	9	SENT_365	[p8l1050t1528r1099b1554],
9	levels	NNS	O	level	dobj	7	SENT_365	[p8l1112t1528r1198b1554],
10	of	IN	O	of	_	0	SENT_365	[p8l189t1574r224b1600],
11	VEGF-C/sVEGFR	NN	O	vegf-c/svegfr	prep_of	9	SENT_365	[p8l242t1574r561b1605],
12	-3	CD	NUMBER	-3	num	11	SENT_365	[p8l242t1574r561b1605],
13	,	,	O	,	_	0	SENT_365	[p8l242t1574r561b1605],
14	with	IN	O	with	_	0	SENT_365	[p8l583t1574r653b1600],
15	amelioration	NN	O	amelioration	prep_with	7	SENT_365	[p8l676t1574r886b1600],
16	of	IN	O	of	_	0	SENT_365	[p8l909t1574r944b1600],
17	dilated	JJ	O	dilated	amod	20	SENT_365	[p8l962t1574r1074b1600],
18	supratesticular	JJ	O	supratesticular	amod	20	SENT_365	[p8l1097t1583r1198b1609, p8l190t1619r341b1645],
19	lymphatic	JJ	O	lymphatic	amod	20	SENT_365	[p8l363t1619r523b1654],
20	vessels	NNS	O	vessel	prep_of	15	SENT_365	[p8l547t1619r651b1645],
21	and	CC	O	and	_	0	SENT_365	[p8l675t1619r733b1645],
22	improvement	NN	O	improvement	prep_with	7	SENT_365	[p8l757t1620r978b1654],
23	in	IN	O	in	_	0	SENT_365	[p8l1001t1620r1031b1644],
24	the	DT	O	the	det	25	SENT_365	[p8l1056t1619r1105b1645],
25	conditions	NNS	O	condition	prep_in	22	SENT_365	[p8l1128t1628r1198b1645, p8l189t1665r300b1691],
26	of	IN	O	of	_	0	SENT_365	[p8l312t1665r347b1691],
27	lymphedema	NN	O	lymphedema	nn	28	SENT_365	[p8l355t1665r564b1700],
28	patients	NNS	O	patient	prep_of	25	SENT_365	[p8l575t1666r705b1700],
29	(	RB	O	(	dep	30	SENT_365	[p8l718t1665r818b1697],
30	Table	NNP	O	Table	dep	1	SENT_365	[p8l718t1665r818b1697],
31	2	CD	NUMBER	2	num	30	SENT_365	[p8l830t1665r854b1696],
32	,	,	O	,	_	0	SENT_365	[p8l830t1665r854b1696],
33	Figure	NNP	O	Figure	dep	35	SENT_365	[p8l866t1666r970b1700],
34	2	CD	NUMBER	2	num	35	SENT_365	[p8l982t1665r1017b1697],
35	)	CD	NUMBER	)	_	0	SENT_365	[p8l982t1665r1017b1697],
36	.	.	O	.	_	0	SENT_365	[p8l982t1665r1017b1697],

1	Given	VBN	O	give	dep	22	SENT_366	[p8l1030t1665r1124b1691],
2	that	IN	O	that	complm	6	SENT_366	[p8l1136t1665r1199b1691],
3	the	DT	O	the	det	4	SENT_366	[p8l190t1711r239b1737],
4	SVEGFR-3	NN	O	svegfr-3	nsubjpass	6	SENT_366	[p8l258t1711r423b1737],
5	are	VBP	O	be	auxpass	6	SENT_366	[p8l442t1720r492b1737],
6	secreted	VBN	O	secrete	pcomp	1	SENT_366	[p8l510t1711r645b1737],
7	into	IN	O	into	_	0	SENT_366	[p8l664t1712r728b1737],
8	the	DT	O	the	det	9	SENT_366	[p8l748t1711r797b1737],
9	plasma	NN	O	plasma	prep_into	6	SENT_366	[p8l816t1711r929b1746],
10	following	VBG	O	follow	_	0	SENT_366	[p8l946t1711r1098b1746],
11	overstimulation	NN	O	overstimulation	prep_following	9	SENT_366	[p8l1116t1720r1198b1737, p8l189t1757r375b1783],
12	of	IN	O	of	_	0	SENT_366	[p8l396t1757r431b1783],
13	the	DT	O	the	det	15	SENT_366	[p8l450t1757r499b1783],
14	lymphangiogenesis	NN	O	lymphangiogenesis	nn	15	SENT_366	[p8l521t1757r830b1792],
15	system	NN	O	system	prep_of	11	SENT_366	[p8l852t1762r958b1792],
16	[	CD	NUMBER	[	number	17	SENT_366	[p8l982t1757r1094b1789],
17	59,60	CD	NUMBER	59,60	num	18	SENT_366	[p8l982t1757r1094b1789],
18	]	NN	O	]	dep	15	SENT_366	[p8l982t1757r1094b1789],
19	,	,	O	,	_	0	SENT_366	[p8l982t1757r1094b1789],
20	these	DT	O	these	det	21	SENT_366	[p8l1117t1757r1199b1783],
21	data	NNS	O	datum	nsubj	22	SENT_366	[p8l189t1802r258b1828],
22	indicate	VBP	O	indicate	_	0	SENT_366	[p8l286t1802r417b1828],
23	that	IN	O	that	complm	34	SENT_366	[p8l446t1802r509b1828],
24	the	DT	O	the	det	25	SENT_366	[p8l538t1802r587b1828],
25	stimulation	NN	O	stimulation	nsubjpass	34	SENT_366	[p8l615t1802r801b1828],
26	of	IN	O	of	_	0	SENT_366	[p8l829t1802r864b1828],
27	lymphangiogenesis	NN	O	lymphangiogenesis	prep_of	25	SENT_366	[p8l888t1802r1198b1837],
28	followed	VBN	O	follow	partmod	27	SENT_366	[p8l189t1848r328b1874],
29	by	IN	O	by	_	0	SENT_366	[p8l346t1848r383b1883],
30	lymphatic	JJ	O	lymphatic	amod	31	SENT_366	[p8l402t1848r562b1883],
31	dilation	NN	O	dilation	agent	28	SENT_366	[p8l582t1848r709b1874],
32	may	MD	O	may	aux	34	SENT_366	[p8l728t1857r794b1883],
33	be	VB	O	be	auxpass	34	SENT_366	[p8l812t1848r849b1874],
34	reduced	VBN	O	reduce	ccomp	22	SENT_366	[p8l869t1848r1000b1874],
35	by	IN	O	by	_	0	SENT_366	[p8l1019t1848r1055b1883],
36	doxycycline	NN	O	doxycycline	agent	34	SENT_366	[p8l1074t1848r1198b1883, p8l189t1894r274b1925],
37	,	,	O	,	_	0	SENT_366	[p8l1074t1848r1198b1883, p8l189t1894r274b1925],
38	and	CC	O	and	_	0	SENT_366	[p8l299t1894r358b1920],
39	the	DT	O	the	det	42	SENT_366	[p8l383t1894r432b1920],
40	VEGF-C/VEGFR	NN	O	vegf-c/vegfr	nn	42	SENT_366	[p8l455t1894r752b1920],
41	-3	CD	NUMBER	-3	num	42	SENT_366	[p8l455t1894r752b1920],
42	system	NN	O	system	nsubj	44	SENT_366	[p8l777t1899r883b1929],
43	may	MD	O	may	aux	44	SENT_366	[p8l907t1903r973b1929],
44	constitute	VB	O	constitute	conj_and	22	SENT_366	[p8l996t1895r1159b1920],
45	a	DT	O	a	det	47	SENT_366	[p8l1184t1903r1200b1920],
46	major	JJ	O	major	amod	47	SENT_366	[p8l189t1940r285b1975],
47	mediator	NN	O	mediator	dobj	44	SENT_366	[p8l299t1940r449b1966],
48	of	IN	O	of	_	0	SENT_366	[p8l462t1940r497b1966],
49	pathological	JJ	O	pathological	amod	51	SENT_366	[p8l509t1940r709b1975],
50	lymphatic	JJ	O	lymphatic	amod	51	SENT_366	[p8l724t1940r885b1975],
51	dilation	NN	O	dilation	prep_of	47	SENT_366	[p8l900t1940r1034b1966],
52	.	.	O	.	_	0	SENT_366	[p8l900t1940r1034b1966],

1	This	DT	DATE	this	nsubj	4	SENT_367	[p8l1050t1940r1119b1966],
2	may	MD	DATE	may	aux	4	SENT_367	[p8l1134t1949r1199b1975],
3	be	VB	O	be	cop	4	SENT_367	[p8l189t1986r226b2012],
4	similar	JJ	O	similar	_	0	SENT_367	[p8l253t1986r364b2012],
5	to	TO	O	to	_	0	SENT_367	[p8l391t1992r421b2012],
6	what	WP	O	what	dobj	26	SENT_367	[p8l448t1986r525b2012],
7	pertains	NNS	O	pertain	nsubj	26	SENT_367	[p8l552t1987r684b2021],
8	in	IN	O	in	_	0	SENT_367	[p8l711t1987r742b2011],
9	animal	NN	O	animal	nn	10	SENT_367	[p8l769t1986r878b2012],
10	models	NNS	O	model	prep_in	7	SENT_367	[p8l906t1986r1019b2012],
11	in	IN	O	in	_	0	SENT_367	[p8l1047t1987r1077b2011],
12	which	WDT	O	which	rel	24	SENT_367	[p8l1103t1986r1199b2012],
13	inhibition	NN	O	inhibition	nsubj	24	SENT_367	[p8l190t2031r353b2057],
14	of	IN	O	of	_	0	SENT_367	[p8l374t2031r409b2057],
15	the	DT	O	the	det	16	SENT_367	[p8l427t2031r476b2057],
16	binding	NN	O	binding	prep_of	13	SENT_367	[p8l497t2031r624b2066],
17	of	IN	O	of	_	0	SENT_367	[p8l644t2031r679b2057],
18	VEGF-C	NN	O	vegf-c	prep_of	16	SENT_367	[p8l696t2031r829b2057],
19	to	TO	O	to	_	0	SENT_367	[p8l852t2037r882b2057],
20	membrane-bound	JJ	O	membrane-bound	amod	21	SENT_367	[p8l904t2031r1199b2057],
21	VEGFR-3	NN	O	vegfr-3	prep_to	18	SENT_367	[p8l188t2077r341b2103],
22	by	IN	O	by	_	0	SENT_367	[p8l360t2077r397b2112],
23	sVEGFR-3	NN	O	svegfr-3	prep_by	21	SENT_367	[p8l416t2077r582b2103],
24	led	VBD	O	lead	rcmod	10	SENT_367	[p8l602t2077r650b2103],
25	to	TO	O	to	aux	26	SENT_367	[p8l670t2082r700b2103],
26	complete	VB	O	complete	prepc_to	4	SENT_367	[p8l721t2077r871b2112],
27	destruction	NN	O	destruction	dobj	26	SENT_367	[p8l891t2077r1078b2103],
28	of	IN	O	of	_	0	SENT_367	[p8l1098t2077r1132b2103],
29	the	DT	O	the	det	31	SENT_367	[p8l1150t2077r1199b2103],
30	lymphatic	JJ	O	lymphatic	amod	31	SENT_367	[p8l189t2123r349b2158],
31	network	NN	O	network	prep_of	27	SENT_367	[p8l370t2123r503b2149],
32	and	CC	O	and	_	0	SENT_367	[p8l523t2123r582b2149],
33	a	DT	O	a	det	35	SENT_367	[p8l602t2132r618b2149],
34	lymphedema-like	JJ	O	lymphedema-like	amod	35	SENT_367	[p8l637t2123r918b2158],
35	phenotype	NN	O	phenotype	conj_and	27	SENT_367	[p8l938t2123r1111b2158],
36	[	CD	NUMBER	[	number	37	SENT_367	[p8l1134t2123r1198b2155],
37	36	CD	NUMBER	36	num	38	SENT_367	[p8l1134t2123r1198b2155],
38	]	NN	O	]	dep	35	SENT_367	[p8l1134t2123r1198b2155],
39	.	.	O	.	_	0	SENT_367	[p8l1134t2123r1198b2155],

1	Recent	JJ	O	recent	amod	2	SENT_368	[p8l189t2170r301b2195],
2	studies	NNS	O	study	nsubj	10	SENT_368	[p8l328t2169r438b2195],
3	in	IN	O	in	_	0	SENT_368	[p8l466t2170r496b2194],
4	solid	JJ	O	solid	amod	5	SENT_368	[p8l522t2169r598b2195],
5	tumor	NN	O	tumor	prep_in	2	SENT_368	[p8l626t2174r727b2195],
6	murine	JJ	O	murine	amod	7	SENT_368	[p8l753t2170r870b2195],
7	models	NNS	O	model	dep	5	SENT_368	[p8l897t2169r1011b2195],
8	have	VBP	O	have	aux	10	SENT_368	[p8l1038t2169r1111b2195],
9	also	RB	O	also	advmod	10	SENT_368	[p8l1138t2169r1198b2195],
10	correlated	VBN	O	correlate	_	0	SENT_368	[p8l189t2215r357b2241],
11	increased	VBN	O	increase	amod	13	SENT_368	[p8l376t2215r530b2241],
12	tumor-derived	JJ	O	tumor-derived	amod	13	SENT_368	[p8l550t2215r786b2241],
13	VEGF-C	NN	O	vegf-c	dobj	10	SENT_368	[p8l804t2215r937b2241],
14	with	IN	O	with	_	0	SENT_368	[p8l956t2215r1026b2241],
15	lymphangiogenesis	NN	O	lymphangiogenesis	prep_with	13	SENT_368	[p8l1044t2215r1198b2250, p8l189t2261r354b2295],
16	and	CC	O	and	_	0	SENT_368	[p8l375t2260r434b2286],
17	lymph	NN	O	lymph	nn	18	SENT_368	[p8l454t2260r555b2295],
18	metastasis	NN	O	metastasis	dobj	10	SENT_368	[p8l576t2261r739b2286],
19	[	CD	NUMBER	[	number	20	SENT_368	[p8l762t2260r827b2292],
20	61	CD	NUMBER	61	num	21	SENT_368	[p8l762t2260r827b2292],
21	]	NN	O	]	dep	18	SENT_368	[p8l762t2260r827b2292],
22	,	,	O	,	_	0	SENT_368	[p8l762t2260r827b2292],
23	supporting	VBG	O	support	partmod	10	SENT_368	[p8l848t2261r1028b2295],
24	a	DT	O	a	det	25	SENT_368	[p8l1048t2269r1064b2286],
25	role	NN	O	role	dobj	23	SENT_368	[p8l1085t2260r1147b2286],
26	of	IN	O	of	_	0	SENT_368	[p8l1168t2260r1202b2286],
27	VEGF-C	NN	O	vegf-c	prep_of	25	SENT_368	[p8l188t2306r324b2332],
28	in	IN	O	in	_	0	SENT_368	[p8l354t2307r385b2331],
29	tumor	NN	O	tumor	nn	30	SENT_368	[p8l414t2311r517b2332],
30	progression	NN	O	progression	prep_in	23	SENT_368	[p8l545t2307r741b2341],
31	by	IN	O	by	_	0	SENT_368	[p8l769t2306r806b2341],
32	acting	VBG	O	act	agent	23	SENT_368	[p8l835t2307r937b2341],
33	on	IN	O	on	_	0	SENT_368	[p8l964t2315r1005b2332],
34	lymphatic	JJ	O	lymphatic	amod	35	SENT_368	[p8l1034t2306r1198b2341],
35	endothelium	NN	O	endothelium	prep_on	32	SENT_368	[p8l189t2352r405b2378],
36	.	.	O	.	_	0	SENT_368	[p8l189t2352r405b2378],

1	It	PRP	O	it	nsubjpass	5	SENT_369	[p8l424t2353r449b2378],
2	has	VBZ	O	have	aux	5	SENT_369	[p8l466t2352r518b2378],
3	also	RB	O	also	advmod	5	SENT_369	[p8l537t2352r597b2378],
4	been	VBN	O	be	auxpass	5	SENT_369	[p8l616t2352r693b2378],
5	shown	VBN	O	show	_	0	SENT_369	[p8l712t2352r814b2378],
6	that	IN	O	that	complm	13	SENT_369	[p8l834t2352r896b2378],
7	VEGFR-3	NN	O	vegfr-3	nsubjpass	13	SENT_369	[p8l913t2352r1066b2378],
8	and	CC	O	and	_	0	SENT_369	[p8l1085t2352r1144b2378],
9	its	PRP$	O	its	poss	11	SENT_369	[p8l1163t2353r1198b2378],
10	ligand	NN	O	ligand	nn	11	SENT_369	[p8l189t2398r289b2433],
11	VEGF-C	NN	O	vegf-c	conj_and	7	SENT_369	[p8l306t2398r440b2424],
12	are	VBP	O	be	auxpass	13	SENT_369	[p8l459t2407r509b2424],
13	up-regulated	VBN	O	up-regulate	ccomp	5	SENT_369	[p8l527t2398r737b2433],
14	in	IN	O	in	_	0	SENT_369	[p8l756t2399r786b2423],
15	several	JJ	O	several	amod	16	SENT_369	[p8l805t2398r915b2424],
16	diseases	NNS	O	disease	prep_in	13	SENT_369	[p8l934t2398r1060b2424],
17	such	JJ	O	such	_	0	SENT_369	[p8l1079t2398r1151b2424],
18	as	IN	O	as	_	0	SENT_369	[p8l1169t2407r1198b2424],
19	AIDS-linked	JJ	O	aids-linked	amod	20	SENT_369	[p8l188t2444r390b2470],
20	Kaposi	NN	PERSON	kaposus	poss	25	SENT_369	[p8l409t2444r542b2479],
21	’s	POS	O	’s	_	0	SENT_369	[p8l409t2444r542b2479],
22	sarcoma	NN	O	sarcoma	nn	25	SENT_369	[p8l562t2453r697b2470],
23	[	CD	NUMBER	[	number	24	SENT_369	[p8l718t2444r774b2476],
24	62	CD	NUMBER	62	num	25	SENT_369	[p8l718t2444r774b2476],
25	]	NN	O	]	prep_such_as	16	SENT_369	[p8l718t2444r774b2476],
26	and	CC	O	and	_	0	SENT_369	[p8l795t2444r854b2470],
27	tumor	NN	O	tumor	nn	28	SENT_369	[p8l874t2449r975b2470],
28	lymphangiogenesis	NN	O	lymphangiogenesis	conj_and	25	SENT_369	[p8l993t2444r1198b2479, p8l189t2490r303b2524],
29	in	IN	O	in	_	0	SENT_369	[p8l319t2490r349b2514],
30	breast	NN	O	breast	nn	31	SENT_369	[p8l364t2489r463b2515],
31	cancer	NN	O	cancer	prep_in	28	SENT_369	[p8l477t2498r585b2515],
32	[	CD	NUMBER	[	number	33	SENT_369	[p8l601t2489r666b2521],
33	63	CD	NUMBER	63	num	34	SENT_369	[p8l601t2489r666b2521],
34	]	NN	O	]	dep	28	SENT_369	[p8l601t2489r666b2521],
35	.	.	O	.	_	0	SENT_369	[p8l601t2489r666b2521],

1	The	DT	O	the	det	4	SENT_370	[p8l226t2535r288b2561],
2	mean	NN	O	mean	nn	4	SENT_370	[p8l305t2544r393b2561],
3	plasma	NN	O	plasma	nn	4	SENT_370	[p8l410t2535r523b2570],
4	level	NN	O	level	nsubj	38	SENT_370	[p8l538t2535r611b2561],
5	of	IN	O	of	_	0	SENT_370	[p8l628t2535r663b2561],
6	VEGF-C	NN	O	vegf-c	prep_of	4	SENT_370	[p8l674t2535r808b2561],
7	given	VBN	O	give	partmod	6	SENT_370	[p8l825t2536r910b2570],
8	by	IN	O	by	_	0	SENT_370	[p8l927t2535r963b2570],
9	the	DT	O	the	det	10	SENT_370	[p8l980t2535r1030b2561],
10	manufacturer	NN	O	manufacturer	agent	7	SENT_370	[p8l1047t2535r1198b2561, p8l190t2586r272b2607],
11	of	IN	O	of	_	0	SENT_370	[p8l292t2581r327b2607],
12	Quantikine	NN	O	quantikine	nn	13	SENT_370	[p8l345t2581r530b2616],
13	immunoassay	NN	O	immunoassay	prep_of	10	SENT_370	[p8l551t2582r770b2616],
14	enzyme-linked	JJ	O	enzyme-linked	amod	16	SENT_370	[p8l791t2581r1028b2616],
15	immunosorbent	JJ	O	immunosorbent	amod	16	SENT_370	[p8l1049t2582r1198b2607, p8l189t2627r320b2653],
16	assay	NN	O	assay	dep	23	SENT_370	[p8l348t2636r433b2662],
17	(	CD	NUMBER	(	num	18	SENT_370	[p8l462t2627r593b2659],
18	ELISA	NN	ORGANIZATION	elisa	dep	16	SENT_370	[p8l462t2627r593b2659],
19	)	CD	NUMBER	)	num	20	SENT_370	[p8l462t2627r593b2659],
20	kits	NNS	O	kit	dep	23	SENT_370	[p8l621t2627r681b2653],
21	(	CD	NUMBER	(	num	23	SENT_370	[p8l711t2627r800b2659],
22	R&D	NNP	O	R&D	nn	23	SENT_370	[p8l711t2627r800b2659],
23	Systems	NNPS	O	Systems	dep	7	SENT_370	[p8l830t2627r973b2662],
24	,	,	O	,	_	0	SENT_370	[p8l830t2627r973b2662],
25	Wiesbaden	NNP	LOCATION	Wiesbaden	appos	23	SENT_370	[p8l1001t2627r1198b2658],
26	,	,	O	,	_	0	SENT_370	[p8l1001t2627r1198b2658],
27	Germany	NNP	LOCATION	Germany	appos	23	SENT_370	[p8l189t2673r349b2708],
28	)	CD	NUMBER	)	num	27	SENT_370	[p8l189t2673r349b2708],
29	in	IN	O	in	_	0	SENT_370	[p8l364t2674r395b2698],
30	a	DT	O	a	det	31	SENT_370	[p8l410t2682r426b2699],
31	cohort	NN	O	cohort	prep_in	7	SENT_370	[p8l440t2673r548b2699],
32	of	IN	O	of	_	0	SENT_370	[p8l562t2673r596b2699],
33	healthy	JJ	O	healthy	amod	35	SENT_370	[p8l607t2673r726b2708],
34	European	JJ	MISC	european	amod	35	SENT_370	[p8l739t2674r899b2708],
35	individuals	NNS	O	individual	prep_of	31	SENT_370	[p8l914t2673r1091b2699],
36	is	VBZ	O	be	cop	38	SENT_370	[p8l1106t2674r1128b2699],
37	225	CD	NUMBER	225	num	38	SENT_370	[p8l1144t2673r1199b2700],
38	(	NN	O	(	_	0	SENT_370	[p8l190t2718r373b2750],
39	185	CD	NUMBER	185	num	40	SENT_370	[p8l190t2718r373b2750],
40	—	NN	O	—	dep	38	SENT_370	[p8l190t2718r373b2750],
41	1,231	CD	NUMBER	1,231	number	42	SENT_370	[p8l190t2718r373b2750],
42	)	CD	NUMBER	)	num	43	SENT_370	[p8l190t2718r373b2750],
43	pg/ml	NN	O	pg/ml	dep	40	SENT_370	[p8l398t2718r495b2753],
44	.	.	O	.	_	0	SENT_370	[p8l398t2718r495b2753],

1	The	DT	O	the	det	2	SENT_371	[p8l520t2718r582b2744],
2	levels	NNS	O	level	nsubj	12	SENT_371	[p8l607t2718r693b2744],
3	of	IN	O	of	_	0	SENT_371	[p8l718t2718r753b2744],
4	endemic	JJ	O	endemic	amod	5	SENT_371	[p8l774t2718r911b2744],
5	normals	NNS	O	normal	prep_of	2	SENT_371	[p8l938t2718r1068b2744],
6	in	IN	O	in	_	0	SENT_371	[p8l1094t2719r1124b2743],
7	the	DT	O	the	det	9	SENT_371	[p8l1150t2718r1199b2744],
8	present	JJ	DATE	present	amod	9	SENT_371	[p8l189t2770r311b2799],
9	study	NN	O	study	prep_in	5	SENT_371	[p8l325t2764r410b2799],
10	was	VBD	O	be	cop	12	SENT_371	[p8l423t2773r478b2790],
11	somewhat	RB	O	somewhat	advmod	12	SENT_371	[p8l493t2764r654b2790],
12	higher	JJR	O	higher	_	0	SENT_371	[p8l667t2764r780b2799],
13	,	,	O	,	_	0	SENT_371	[p8l667t2764r780b2799],
14	with	IN	O	with	_	0	SENT_371	[p8l794t2764r864b2790],
15	a	DT	O	a	det	16	SENT_371	[p8l878t2773r894b2790],
16	mean	NN	O	mean	prep_with	12	SENT_371	[p8l907t2773r995b2790],
17	of	IN	O	of	_	0	SENT_371	[p8l1009t2764r1044b2790],
18	1,851	CD	NUMBER	1,851	num	21	SENT_371	[p8l1057t2764r1135b2795],
19	pgl	NN	O	pgl	nn	21	SENT_371	[p8l1152t2764r1200b2799],
20	ml	NN	O	ml	nn	21	SENT_371	[p8l189t2810r229b2835],
21	(	NN	O	(	prep_of	16	SENT_371	[p8l253t2811r353b2845],
22	range	NN	O	range	dep	21	SENT_371	[p8l253t2811r353b2845],
23	634	CD	NUMBER	634	num	22	SENT_371	[p8l377t2810r557b2842],
24	—	CD	NUMBER	—	number	25	SENT_371	[p8l377t2810r557b2842],
25	2,805	CD	NUMBER	2,805	num	26	SENT_371	[p8l377t2810r557b2842],
26	)	NN	O	)	dep	22	SENT_371	[p8l377t2810r557b2842],
27	;	:	O	;	_	0	SENT_371	[p8l377t2810r557b2842],
28	it	PRP	O	it	nsubj	31	SENT_371	[p8l581t2811r603b2836],
29	is	VBZ	O	be	cop	31	SENT_371	[p8l626t2811r647b2836],
30	not	RB	O	not	neg	31	SENT_371	[p8l671t2815r725b2836],
31	clear	JJ	O	clear	parataxis	12	SENT_371	[p8l747t2810r826b2836],
32	whether	IN	O	whether	complm	34	SENT_371	[p8l847t2810r980b2836],
33	this	DT	O	this	nsubj	34	SENT_371	[p8l1003t2810r1059b2836],
34	reﬂects	VBZ	O	reﬂects	ccomp	31	SENT_371	[p8l1082t2810r1198b2836],
35	genetic	JJ	O	genetic	amod	36	SENT_371	[p8l189t2857r305b2891],
36	differences	NNS	O	difference	dobj	34	SENT_371	[p8l320t2856r499b2882],
37	between	IN	O	between	_	0	SENT_371	[p8l513t2856r648b2882],
38	people	NNS	O	people	prep_between	36	SENT_371	[p8l662t2856r772b2891],
39	of	IN	O	of	_	0	SENT_371	[p8l786t2856r821b2882],
40	European	JJ	MISC	european	amod	41	SENT_371	[p8l830t2857r990b2891],
41	descent	NN	O	descent	prep_of	38	SENT_371	[p8l1004t2856r1126b2882],
42	and	CC	O	and	_	0	SENT_371	[p8l1140t2856r1199b2882],
43	Africans	NNS	MISC	african	conj_and	41	SENT_371	[p8l188t2902r333b2933],
44	,	,	O	,	_	0	SENT_371	[p8l188t2902r333b2933],
45	or	CC	O	or	_	0	SENT_371	[p8l346t2911r382b2928],
46	a	DT	O	a	det	48	SENT_371	[p8l393t2911r409b2928],
47	possible	JJ	O	possible	amod	48	SENT_371	[p8l421t2902r551b2937],
48	exposure	NN	O	exposure	dobj	34	SENT_371	[p8l563t2911r711b2937],
49	of	IN	O	of	_	0	SENT_371	[p8l724t2902r758b2928],
50	these	DT	O	these	det	51	SENT_371	[p8l768t2902r850b2928],
51	persons	NNS	O	person	prep_of	48	SENT_371	[p8l863t2911r987b2937],
52	to	TO	O	to	_	0	SENT_371	[p8l1001t2908r1031b2928],
53	stimuli	NNS	O	stimulus	prep_to	34	SENT_371	[p8l1044t2902r1155b2928],
54	of	IN	O	of	_	0	SENT_371	[p8l1168t2902r1202b2928],
55	the	DT	O	the	det	57	SENT_371	[p8l190t2947r239b2973],
56	lymphangiogenetic	JJ	O	lymphangiogenetic	amod	57	SENT_371	[p8l252t2947r563b2982],
57	system	NN	O	system	prep_of	53	SENT_371	[p8l577t2953r684b2982],
58	other	JJ	O	other	dep	57	SENT_371	[p8l697t2947r785b2973],
59	than	IN	O	than	_	0	SENT_371	[p8l798t2947r870b2973],
60	lymphatic	JJ	O	lymphatic	amod	61	SENT_371	[p8l883t2947r1043b2982],
61	ﬁlariasis	NN	O	ﬁlariasis	prep_than	57	SENT_371	[p8l1057t2947r1198b2973],
62	.	.	O	.	_	0	SENT_371	[p8l1057t2947r1198b2973],

1	However	RB	O	however	_	0	SENT_372	[p8l189t2994r347b3024],
2	,	,	O	,	_	0	SENT_372	[p8l189t2994r347b3024],
3	the	DT	O	the	det	4	SENT_372	[p8l377t2993r427b3019],
4	levels	NNS	O	level	dep	5	SENT_372	[p8l456t2993r546b3019],
5	of	IN	O	of	dep	1	SENT_372	[p8l574t2993r610b3019],
6	VEGF-C	NN	O	vegf-c	pobj	5	SENT_372	[p8l633t2993r771b3019],
7	in	IN	O	in	_	0	SENT_372	[p8l800t2994r831b3018],
8	microﬁlaremic	JJ	O	microﬁlaremic	prep_in	6	SENT_372	[p8l860t2993r1109b3019],
9	and	CC	O	and	advmod	8	SENT_372	[p8l1138t2993r1199b3019],

1	PLoS	NN	O	plo	nsubj	2	SENT_373	[p8l288t3093r352b3116],
2	Pathogens	VBD	O	pathogen	_	0	SENT_373	[p8l367t3092r511b3123],
3	|	CD	NUMBER	|	num	4	SENT_373	[p8l526t3091r528b3124],
4	www	NN	O	www	dobj	2	SENT_373	[p8l543t3092r882b3123],
5	.	.	O	.	_	0	SENT_373	[p8l543t3092r882b3123],

1	p	NN	O	p	nsubjpass	8	SENT_374	[p8l543t3092r882b3123],
2	|	CD	NUMBER	|	num	5	SENT_374	[p8l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	nn	5	SENT_374	[p8l543t3092r882b3123],
4	lymphedema	NN	O	lymphedema	nn	5	SENT_374	[p8l1277t945r1486b980],
5	patients	NNS	O	patient	dep	1	SENT_374	[p8l1501t946r1630b980],
6	were	VBD	O	be	auxpass	8	SENT_374	[p8l1645t954r1721b971],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_374	[p8l1736t945r1932b980],
8	increased	VBN	O	increase	_	0	SENT_374	[p8l1947t945r2101b971],
9	over	IN	O	over	_	0	SENT_374	[p8l2116t954r2187b971],
10	those	DT	O	those	prep_over	8	SENT_374	[p8l2202t945r2286b971],
11	of	IN	O	of	_	0	SENT_374	[p8l1277t990r1311b1016],
12	endemic	JJ	O	endemic	amod	13	SENT_374	[p8l1320t990r1457b1016],
13	normals	NNS	O	normal	prep_of	10	SENT_374	[p8l1471t990r1601b1016],
14	before	IN	O	before	_	0	SENT_374	[p8l1613t990r1718b1016],
15	treatment	NN	O	treatment	prep_before	8	SENT_374	[p8l1732t995r1900b1016],
16	.	.	O	.	_	0	SENT_374	[p8l1732t995r1900b1016],

1	This	DT	O	this	det	2	SENT_375	[p8l1913t990r1982b1016],
2	ﬁnding	NN	O	ﬁnding	nsubj	36	SENT_375	[p8l1994t990r2118b1025],
3	,	,	O	,	_	0	SENT_375	[p8l1994t990r2118b1025],
4	and	CC	O	and	_	0	SENT_375	[p8l2131t990r2190b1016],
5	more	RBR	O	more	advmod	6	SENT_375	[p8l2202t999r2286b1016],
6	so	IN	O	so	advmod	9	SENT_375	[p8l1277t1045r1309b1062],
7	the	DT	O	the	det	8	SENT_375	[p8l1338t1036r1388b1062],
8	yet	RB	O	yet	dep	9	SENT_375	[p8l1415t1041r1464b1071],
9	signiﬁcantly	JJ	O	signiﬁcantly	amod	11	SENT_375	[p8l1491t1036r1692b1071],
10	elevated	JJ	O	elevated	amod	11	SENT_375	[p8l1719t1036r1856b1062],
11	levels	NNS	O	level	conj_and	2	SENT_375	[p8l1883t1036r1972b1062],
12	of	IN	O	of	_	0	SENT_375	[p8l1999t1036r2035b1062],
13	SVEGFR-3	NN	O	svegfr-3	prep_of	11	SENT_375	[p8l2059t1036r2227b1062],
14	in	IN	O	in	_	0	SENT_375	[p8l2256t1037r2286b1061],
15	lymphedema	NN	O	lymphedema	nn	16	SENT_375	[p8l1277t1082r1494b1117],
16	patients	NNS	O	patient	prep_in	13	SENT_375	[p8l1522t1083r1657b1117],
17	in	IN	O	in	_	0	SENT_375	[p8l1686t1083r1717b1107],
18	comparison	NN	O	comparison	prep_in	16	SENT_375	[p8l1746t1083r1946b1117],
19	to	TO	O	to	_	0	SENT_375	[p8l1975t1087r2006b1108],
20	microﬁlaremic	JJ	O	microﬁlaremic	amod	21	SENT_375	[p8l2035t1082r2285b1108],
21	patients	NNS	O	patient	prep_to	18	SENT_375	[p8l1277t1129r1406b1163],
22	(	IN	O	(	_	0	SENT_375	[p8l1425t1130r1495b1163],
23	e.g.	FW	O	e.g.	prep_(	21	SENT_375	[p8l1425t1130r1495b1163],
24	,	,	O	,	_	0	SENT_375	[p8l1425t1130r1495b1163],
25	those	DT	O	those	conj_but	25	SENT_375	[p8l1514t1128r1599b1154],
26	with	IN	O	with	_	0	SENT_375	[p8l1616t1128r1685b1154],
27	ﬁlarial	JJ	O	ﬁlarial	amod	28	SENT_375	[p8l1703t1128r1807b1154],
28	infection	NN	O	infection	prep_with	25	SENT_375	[p8l1826t1128r1972b1154],
29	but	CC	O	but	_	0	SENT_375	[p8l1990t1128r2043b1154],
30	without	IN	O	without	_	0	SENT_375	[p8l2060t1128r2186b1154],
31	overt	JJ	O	overt	amod	34	SENT_375	[p8l2203t1134r2287b1154],
32	lymphatic	JJ	O	lymphatic	amod	34	SENT_375	[p8l1277t1174r1437b1209],
33	pathology	NN	O	pathology	nn	34	SENT_375	[p8l1451t1174r1631b1209],
34	)	NN	O	)	prep_without	25	SENT_375	[p8l1451t1174r1631b1209],
35	,	,	O	,	_	0	SENT_375	[p8l1451t1174r1631b1209],
36	raises	VBZ	O	raise	_	0	SENT_375	[p8l1644t1175r1733b1200],
37	the	DT	O	the	det	38	SENT_375	[p8l1746t1174r1795b1200],
38	question	NN	O	question	dobj	36	SENT_375	[p8l1808t1175r1948b1209],
39	about	IN	O	about	_	0	SENT_375	[p8l1961t1174r2053b1200],
40	the	DT	O	the	det	42	SENT_375	[p8l2066t1174r2115b1200],
41	biological	JJ	O	biological	amod	42	SENT_375	[p8l2127t1174r2286b1209],
42	signiﬁcance	NN	O	signiﬁcance	prep_about	38	SENT_375	[p8l1277t1219r1475b1254],
43	.	.	O	.	_	0	SENT_375	[p8l1277t1219r1475b1254],

1	Despite	IN	O	despite	_	0	SENT_376	[p8l1488t1220r1610b1254],
2	a	DT	O	a	det	4	SENT_376	[p8l1623t1228r1639b1245],
3	vast	JJ	O	vast	amod	4	SENT_376	[p8l1650t1224r1711b1245],
4	literature	NN	O	literature	prep_despite	23	SENT_376	[p8l1723t1219r1876b1245],
5	on	IN	O	on	_	0	SENT_376	[p8l1889t1228r1929b1245],
6	VEGF-C	NN	O	vegf-c	nn	9	SENT_376	[p8l1940t1219r2074b1245],
7	or	CC	O	or	_	0	SENT_376	[p8l2087t1228r2122b1245],
8	sVEGFR3	NN	O	svegfr3	nn	9	SENT_376	[p8l2133t1219r2286b1245],
9	expression	NN	O	expression	prep_on	4	SENT_376	[p8l1277t1266r1451b1300],
10	in	IN	O	in	_	0	SENT_376	[p8l1463t1266r1493b1290],
11	tissue	NN	O	tissue	nn	14	SENT_376	[p8l1507t1266r1595b1291],
12	(	CD	NUMBER	(	num	14	SENT_376	[p8l1608t1266r1815b1300],
13	quantitative	JJ	O	quantitative	amod	14	SENT_376	[p8l1608t1266r1815b1300],
14	PCR	NN	O	pcr	prep_in	9	SENT_376	[p8l1827t1265r1899b1291],
15	and	CC	O	and	_	0	SENT_376	[p8l1910t1265r1969b1291],
16	immunohistology	NN	O	immunohistology	nn	17	SENT_376	[p8l1981t1265r2285b1300],
17	)	NN	O	)	prep_in	9	SENT_376	[p8l1981t1265r2285b1300],
18	,	,	O	,	_	0	SENT_376	[p8l1981t1265r2285b1300],
19	few	JJ	O	few	amod	20	SENT_376	[p8l1277t1311r1331b1337],
20	data	NNS	O	datum	nsubj	23	SENT_376	[p8l1345t1311r1414b1337],
21	on	IN	O	on	_	0	SENT_376	[p8l1428t1320r1469b1337],
22	plasma	NN	O	plasma	prep_on	20	SENT_376	[p8l1484t1311r1596b1346],
23	exist	VBP	O	exist	_	0	SENT_376	[p8l1610t1312r1684b1337],
24	for	IN	O	for	_	0	SENT_376	[p8l1698t1311r1747b1337],
25	these	DT	O	these	det	27	SENT_376	[p8l1761t1311r1843b1337],
26	two	CD	NUMBER	two	num	27	SENT_376	[p8l1859t1316r1914b1337],
27	factors	NNS	O	factor	prep_for	23	SENT_376	[p8l1929t1311r2047b1342],
28	,	,	O	,	_	0	SENT_376	[p8l1929t1311r2047b1342],
29	which	WDT	O	which	nsubj	34	SENT_376	[p8l2062t1311r2157b1337],
30	are	VBP	O	be	cop	34	SENT_376	[p8l2172t1320r2221b1337],
31	the	DT	O	the	det	34	SENT_376	[p8l2237t1311r2286b1337],
32	major	JJ	O	major	amod	34	SENT_376	[p8l1277t1358r1373b1392],
33	axis	NN	O	axis	nn	34	SENT_376	[p8l1399t1358r1459b1383],
34	speciﬁc	NN	O	speciﬁc	rcmod	27	SENT_376	[p8l1486t1357r1606b1392],
35	for	IN	O	for	_	0	SENT_376	[p8l1634t1357r1683b1383],
36	lymphangiogenesis	NN	O	lymphangiogenesis	prep_for	34	SENT_376	[p8l1708t1357r2027b1392],
37	.	.	O	.	_	0	SENT_376	[p8l1708t1357r2027b1392],

1	What	WDT	O	what	nsubjpass	4	SENT_377	[p8l2054t1357r2141b1383],
2	can	MD	O	can	aux	4	SENT_377	[p8l2167t1366r2222b1383],
3	be	VB	O	be	auxpass	4	SENT_377	[p8l2249t1357r2286b1383],
4	concluded	VBN	O	conclude	csubj	11	SENT_377	[p8l1277t1403r1445b1429],
5	from	IN	O	from	_	0	SENT_377	[p8l1470t1403r1550b1429],
6	the	DT	O	the	det	8	SENT_377	[p8l1576t1403r1625b1429],
7	available	JJ	O	available	amod	8	SENT_377	[p8l1651t1403r1792b1429],
8	data	NNS	O	datum	prep_from	4	SENT_377	[p8l1817t1403r1886b1429],
9	are	VBP	O	be	cop	11	SENT_377	[p8l1911t1412r1961b1429],
10	the	DT	O	the	det	11	SENT_377	[p8l1987t1403r2037b1429],
11	following	NN	O	following	_	0	SENT_377	[p8l2062t1403r2221b1438],
12	:	:	O	:	_	0	SENT_377	[p8l2062t1403r2221b1438],
13	(	CD	NUMBER	(	num	17	SENT_377	[p8l2248t1403r2286b1435],
14	1	CD	NUMBER	1	num	17	SENT_377	[p8l2248t1403r2286b1435],
15	)	NN	O	)	nn	17	SENT_377	[p8l2248t1403r2286b1435],
16	serum	NN	O	serum	nn	17	SENT_377	[p8l1277t1458r1376b1475],
17	levels	NNS	O	level	nsubj	23	SENT_377	[p8l1386t1449r1472b1475],
18	of	IN	O	of	_	0	SENT_377	[p8l1483t1449r1518b1475],
19	VEGF-C	NN	O	vegf-c	prep_of	17	SENT_377	[p8l1524t1449r1657b1475],
20	are	VBP	O	be	cop	23	SENT_377	[p8l1669t1458r1718b1475],
21	usually	RB	O	usually	advmod	23	SENT_377	[p8l1729t1449r1840b1484],
22	10-fold	RB	O	10-fold	advmod	23	SENT_377	[p8l1853t1449r1965b1475],
23	higher	JJR	O	higher	dep	11	SENT_377	[p8l1975t1449r2081b1484],
24	than	IN	O	than	_	0	SENT_377	[p8l2092t1449r2163b1475],
25	plasma	NN	O	plasma	nn	26	SENT_377	[p8l2174t1449r2287b1484],
26	levels	NNS	O	level	prep_than	23	SENT_377	[p8l1277t1494r1371b1525],
27	,	,	O	,	_	0	SENT_377	[p8l1277t1494r1371b1525],
28	because	IN	O	because	mark	29	SENT_377	[p8l1389t1494r1515b1520],
29	of	IN	O	of	advcl	23	SENT_377	[p8l1533t1494r1568b1520],
30	release	NN	O	release	pobj	29	SENT_377	[p8l1583t1494r1693b1520],
31	from	IN	O	from	_	0	SENT_377	[p8l1711t1494r1790b1520],
32	platelets	NNS	O	platelet	prep_from	30	SENT_377	[p8l1808t1494r1943b1529],
33	during	IN	O	during	_	0	SENT_377	[p8l1961t1494r2070b1529],
34	coagulation	NN	O	coagulation	prep_during	32	SENT_377	[p8l2087t1494r2286b1529],
35	;	:	O	;	_	0	SENT_377	[p8l2087t1494r2286b1529],
36	this	DT	O	this	nsubj	38	SENT_377	[p8l1278t1540r1334b1566],
37	also	RB	O	also	advmod	38	SENT_377	[p8l1348t1540r1408b1566],
38	means	VBZ	O	mean	dep	11	SENT_377	[p8l1423t1549r1524b1566],
39	that	IN	O	that	complm	47	SENT_377	[p8l1539t1540r1602b1566],
40	plasma	NN	O	plasma	nn	41	SENT_377	[p8l1615t1540r1728b1575],
41	levels	NNS	O	level	nsubj	47	SENT_377	[p8l1741t1540r1827b1566],
42	would	MD	O	would	aux	47	SENT_377	[p8l1841t1540r1939b1566],
43	be	VB	O	be	cop	47	SENT_377	[p8l1952t1540r1989b1566],
44	the	DT	O	the	det	47	SENT_377	[p8l2004t1540r2053b1566],
45	more	RBR	O	more	advmod	46	SENT_377	[p8l2067t1549r2151b1566],
46	reliable	JJ	O	reliable	amod	47	SENT_377	[p8l2165t1540r2286b1566],
47	marker	NN	O	marker	ccomp	38	SENT_377	[p8l1277t1586r1395b1612],
48	since	IN	O	since	mark	50	SENT_377	[p8l1408t1587r1488b1612],
49	there	EX	O	there	expl	50	SENT_377	[p8l1503t1586r1586b1612],
50	is	VBZ	O	be	advcl	47	SENT_377	[p8l1601t1587r1623b1612],
51	no	DT	O	no	det	55	SENT_377	[p8l1637t1595r1677b1612],
52	(	NN	O	(	nn	55	SENT_377	[p8l1692t1586r1872b1618],
53	dominant	JJ	O	dominant	amod	55	SENT_377	[p8l1692t1586r1872b1618],
54	)	NN	O	)	nn	55	SENT_377	[p8l1692t1586r1872b1618],
55	interference	NN	O	interference	nsubj	50	SENT_377	[p8l1887t1586r2088b1612],
56	by	IN	O	by	_	0	SENT_377	[p8l2101t1586r2138b1621],
57	plateletderived	JJ	O	plateletderived	amod	58	SENT_377	[p8l2152t1586r2285b1621, p8l1277t1632r1398b1658],
58	VEGF-C	NN	O	vegf-c	prep_by	50	SENT_377	[p8l1408t1632r1542b1658],
59	[	CD	NUMBER	[	number	60	SENT_377	[p8l1556t1632r1621b1664],
60	64	CD	NUMBER	64	num	61	SENT_377	[p8l1556t1632r1621b1664],
61	]	NN	O	]	dep	50	SENT_377	[p8l1556t1632r1621b1664],
62	;	:	O	;	_	0	SENT_377	[p8l1556t1632r1621b1664],
63	and	CC	O	and	_	0	SENT_377	[p8l1633t1632r1692b1658],
64	(	NN	O	(	nsubj	83	SENT_377	[p8l1705t1632r1743b1664],
65	2	CD	NUMBER	2	number	66	SENT_377	[p8l1705t1632r1743b1664],
66	)	CD	NUMBER	)	num	67	SENT_377	[p8l1705t1632r1743b1664],
67	measurement	NN	O	measurement	nsubj	75	SENT_377	[p8l1755t1637r1976b1658],
68	of	IN	O	of	_	0	SENT_377	[p8l1987t1632r2021b1658],
69	plasma	NN	O	plasma	nn	71	SENT_377	[p8l2029t1632r2142b1667],
70	VEGF-C	NN	O	vegf-c	nn	71	SENT_377	[p8l2152t1632r2286b1658],
71	levels	NNS	O	level	prep_of	67	SENT_377	[p8l1277t1677r1363b1703],
72	in	IN	O	in	_	0	SENT_377	[p8l1389t1678r1419b1702],
73	cancer	NN	O	cancer	nn	74	SENT_377	[p8l1444t1686r1553b1703],
74	patients	NNS	O	patient	prep_in	71	SENT_377	[p8l1577t1678r1707b1712],
75	revealed	VBD	O	reveal	rcmod	64	SENT_377	[p8l1733t1677r1868b1703],
76	3-fold	RB	O	3-fold	advmod	77	SENT_377	[p8l1894t1677r1989b1703],
77	higher	JJR	O	higher	amod	78	SENT_377	[p8l2014t1677r2120b1712],
78	levels	NNS	O	level	dobj	75	SENT_377	[p8l2144t1677r2230b1703],
79	in	IN	O	in	_	0	SENT_377	[p8l2256t1678r2286b1702],
80	comparison	NN	O	comparison	prep_in	75	SENT_377	[p8l1277t1724r1469b1758],
81	to	TO	O	to	_	0	SENT_377	[p8l1484t1729r1514b1749],
82	controls	NNS	O	control	prep_to	75	SENT_377	[p8l1528t1723r1660b1749],
83	[	VBP	O	[	dep	11	SENT_377	[p8l1676t1723r1741b1755],
84	65	CD	NUMBER	65	num	85	SENT_377	[p8l1676t1723r1741b1755],
85	]	CD	NUMBER	]	dobj	83	SENT_377	[p8l1676t1723r1741b1755],
86	.	.	O	.	_	0	SENT_377	[p8l1676t1723r1741b1755],

1	In	IN	O	in	_	0	SENT_378	[p8l1755t1724r1788b1748],
2	this	DT	O	this	det	3	SENT_378	[p8l1803t1723r1859b1749],
3	regard	NN	O	regard	prep_in	7	SENT_378	[p8l1873t1723r1987b1758],
4	,	,	O	,	_	0	SENT_378	[p8l1873t1723r1987b1758],
5	it	PRP	O	it	nsubjpass	7	SENT_378	[p8l2001t1724r2023b1749],
6	is	VBZ	O	be	auxpass	7	SENT_378	[p8l2037t1724r2059b1749],
7	assumed	VBN	O	assume	_	0	SENT_378	[p8l2073t1723r2209b1749],
8	that	IN	O	that	complm	27	SENT_378	[p8l2224t1723r2287b1749],
9	the	DT	O	the	det	12	SENT_378	[p8l1278t1769r1327b1795],
10	almost	RB	O	almost	advmod	11	SENT_378	[p8l1341t1769r1447b1795],
11	3-fold	JJ	O	3-fold	amod	12	SENT_378	[p8l1460t1769r1555b1795],
12	increase	NN	O	increase	nsubj	27	SENT_378	[p8l1569t1770r1702b1795],
13	of	IN	O	of	_	0	SENT_378	[p8l1715t1769r1750b1795],
14	plasma	NN	O	plasma	nn	16	SENT_378	[p8l1760t1769r1873b1804],
15	VEGF-C	NN	O	vegf-c	nn	16	SENT_378	[p8l1884t1769r2018b1795],
16	levels	NNS	O	level	prep_of	12	SENT_378	[p8l2032t1769r2118b1795],
17	in	IN	O	in	_	0	SENT_378	[p8l2132t1770r2163b1794],
18	our	PRP$	O	we	poss	20	SENT_378	[p8l2176t1778r2233b1795],
19	LF	NN	O	lf	nn	20	SENT_378	[p8l2245t1770r2287b1794],
20	patients	NNS	O	patient	prep_in	16	SENT_378	[p8l1277t1816r1406b1850],
21	over	IN	O	over	_	0	SENT_378	[p8l1422t1824r1494b1841],
22	endemic	JJ	O	endemic	amod	23	SENT_378	[p8l1508t1815r1645b1841],
23	normals	NNS	O	normal	prep_over	12	SENT_378	[p8l1663t1815r1793b1841],
24	would	MD	O	would	aux	27	SENT_378	[p8l1808t1815r1906b1841],
25	be	VB	O	be	cop	27	SENT_378	[p8l1922t1815r1958b1841],
26	biologically	RB	O	biologically	advmod	27	SENT_378	[p8l1974t1815r2161b1850],
27	signiﬁcant	JJ	O	signiﬁcant	ccomp	7	SENT_378	[p8l2177t1815r2286b1850, p8l1277t1865r1346b1886],
28	based	VBN	O	base	_	0	SENT_378	[p8l1362t1860r1453b1886],
29	on	IN	O	on	prepc_based_on	27	SENT_378	[p8l1470t1869r1511b1886],
30	the	DT	O	the	det	31	SENT_378	[p8l1529t1860r1578b1886],
31	comparison	NN	O	comparison	pobj	27	SENT_378	[p8l1596t1861r1788b1895],
32	with	IN	O	with	_	0	SENT_378	[p8l1805t1860r1874b1886],
33	cancer	NN	O	cancer	nn	34	SENT_378	[p8l1892t1869r2000b1886],
34	patients	NNS	O	patient	prep_with	31	SENT_378	[p8l2016t1861r2154b1895],
35	.	.	O	.	_	0	SENT_378	[p8l2016t1861r2154b1895],

1	Importantly	RB	O	importantly	advmod	23	SENT_379	[p8l2171t1861r2286b1895, p8l1278t1906r1377b1941],
2	,	,	O	,	_	0	SENT_379	[p8l2171t1861r2286b1895, p8l1278t1906r1377b1941],
3	in	IN	O	in	_	0	SENT_379	[p8l1393t1907r1423b1931],
4	our	PRP$	O	we	poss	5	SENT_379	[p8l1438t1915r1495b1932],
5	study	NN	O	study	prep_in	23	SENT_379	[p8l1509t1906r1602b1941],
6	,	,	O	,	_	0	SENT_379	[p8l1509t1906r1602b1941],
7	VEGF-C	NN	O	vegf-c	nn	8	SENT_379	[p8l1616t1906r1750b1932],
8	levels	NNS	O	level	nsubj	23	SENT_379	[p8l1765t1906r1852b1932],
9	decreased	VBN	O	decrease	partmod	8	SENT_379	[p8l1867t1906r2028b1932],
10	by	IN	O	by	_	0	SENT_379	[p8l2042t1906r2079b1941],
11	12	CD	DURATION	12	num	12	SENT_379	[p8l2096t1906r2129b1933],
12	mo	NN	DURATION	mo	agent	9	SENT_379	[p8l2145t1915r2195b1932],
13	after	IN	O	after	_	0	SENT_379	[p8l2211t1906r2287b1932],
14	doxycycline	NN	O	doxycycline	nn	15	SENT_379	[p8l1277t1952r1468b1987],
15	treatment	NN	O	treatment	prep_after	9	SENT_379	[p8l1489t1957r1657b1983],
16	,	,	O	,	_	0	SENT_379	[p8l1489t1957r1657b1983],
17	well	RB	O	well	advmod	9	SENT_379	[p8l1677t1952r1740b1978],
18	before	IN	O	before	_	0	SENT_379	[p8l1759t1952r1864b1978],
19	the	DT	O	the	det	22	SENT_379	[p8l1885t1952r1934b1978],
20	supratesticular	JJ	O	supratesticular	amod	22	SENT_379	[p8l1954t1952r2198b1987],
21	lymphatic	JJ	O	lymphatic	amod	22	SENT_379	[p8l2216t1952r2286b1987, p8l1277t1998r1377b2033],
22	dilation	NN	O	dilation	prep_before	9	SENT_379	[p8l1389t1998r1515b2024],
23	improved	VBN	O	improve	_	0	SENT_379	[p8l1527t1998r1691b2033],
24	.	.	O	.	_	0	SENT_379	[p8l1527t1998r1691b2033],

1	The	DT	O	the	det	2	SENT_380	[p8l1703t1998r1765b2024],
2	fact	NN	O	fact	nsubj	12	SENT_380	[p8l1776t1998r1836b2024],
3	that	IN	O	that	complm	7	SENT_380	[p8l1847t1998r1910b2024],
4	the	DT	O	the	det	6	SENT_380	[p8l1922t1998r1971b2024],
5	VEGF-C	JJ	O	vegf-c	amod	6	SENT_380	[p8l1981t1998r2115b2024],
6	reduction	NN	O	reduction	nsubj	7	SENT_380	[p8l2127t1998r2286b2024],
7	preceded	VBD	O	precede	dep	2	SENT_380	[p8l1277t2044r1427b2079],
8	the	DT	O	the	det	9	SENT_380	[p8l1443t2044r1492b2070],
9	improvement	NN	O	improvement	dobj	7	SENT_380	[p8l1508t2045r1729b2079],
10	of	IN	O	of	_	0	SENT_380	[p8l1744t2044r1778b2070],
11	pathology	NN	O	pathology	prep_of	9	SENT_380	[p8l1790t2044r1951b2079],
12	indicates	VBZ	O	indicate	_	0	SENT_380	[p8l1967t2044r2110b2070],
13	a	DT	O	a	det	16	SENT_380	[p8l2126t2053r2142b2070],
14	possible	JJ	O	possible	amod	16	SENT_380	[p8l2157t2044r2286b2079],
15	causal	JJ	O	causal	amod	16	SENT_380	[p8l1277t2090r1374b2116],
16	interaction	NN	O	interaction	dobj	12	SENT_380	[p8l1389t2091r1571b2116],
17	between	IN	O	between	_	0	SENT_380	[p8l1585t2090r1720b2116],
18	lymphangiogenic	JJ	O	lymphangiogenic	amod	19	SENT_380	[p8l1734t2090r2014b2125],
19	factors	NNS	O	factor	prep_between	16	SENT_380	[p8l2029t2090r2139b2116],
20	reduced	VBN	O	reduce	partmod	19	SENT_380	[p8l2155t2090r2286b2116],
21	by	IN	O	by	dep	20	SENT_380	[p8l1276t2135r1313b2170],
22	doxycycline	NN	O	doxycycline	nn	23	SENT_380	[p8l1334t2135r1525b2170],
23	treatment	NN	O	treatment	pobj	21	SENT_380	[p8l1548t2140r1709b2161],
24	and	CC	O	and	_	0	SENT_380	[p8l1731t2135r1790b2161],
25	lymphatic	JJ	O	lymphatic	amod	26	SENT_380	[p8l1811t2135r1972b2170],
26	pathology	NN	O	pathology	pobj	21	SENT_380	[p8l1995t2135r2163b2170],
27	,	,	O	,	_	0	SENT_380	[p8l1995t2135r2163b2170],
28	rather	RB	O	rather	_	0	SENT_380	[p8l2186t2135r2287b2161],
29	than	IN	O	than	_	0	SENT_380	[p8l1278t2181r1349b2207],
30	only	RB	O	only	advmod	32	SENT_380	[p8l1363t2181r1432b2216],
31	a	DT	O	a	det	32	SENT_380	[p8l1446t2190r1462b2207],
32	coincidence	NN	O	coincidence	conj_negcc	21	SENT_380	[p8l1476t2181r1671b2207],
33	or	CC	O	or	_	0	SENT_380	[p8l1686t2190r1721b2207],
34	an	DT	O	a	det	35	SENT_380	[p8l1735t2190r1772b2207],
35	epiphenomenon	NN	O	epiphenomenon	conj_negcc	21	SENT_380	[p8l1786t2181r2064b2216],
36	.	.	O	.	_	0	SENT_380	[p8l1786t2181r2064b2216],

1	A	DT	O	a	det	2	SENT_381	[p8l1313t2227r1338b2252],
2	report	NN	O	report	nsubj	10	SENT_381	[p8l1363t2232r1466b2262],
3	on	IN	O	on	_	0	SENT_381	[p8l1490t2236r1531b2253],
4	VEGF-C	NN	O	vegf-c	nn	5	SENT_381	[p8l1553t2227r1687b2253],
5	levels	NNS	O	level	prep_on	2	SENT_381	[p8l1712t2227r1798b2253],
6	in	IN	O	in	_	0	SENT_381	[p8l1823t2228r1853b2252],
7	cervical	JJ	O	cervical	amod	9	SENT_381	[p8l1877t2227r2001b2253],
8	cancer	NN	O	cancer	nn	9	SENT_381	[p8l2025t2236r2133b2253],
9	patients	NNS	O	patient	prep_in	5	SENT_381	[p8l2157t2228r2286b2262],
10	provides	VBZ	O	provide	_	0	SENT_381	[p8l1277t2273r1415b2308],
11	levels	NNS	O	level	dobj	10	SENT_381	[p8l1436t2273r1522b2299],
12	in	IN	O	in	_	0	SENT_381	[p8l1543t2274r1573b2298],
13	serum	NN	O	serum	prep_in	11	SENT_381	[p8l1594t2282r1701b2304],
14	,	,	O	,	_	0	SENT_381	[p8l1594t2282r1701b2304],
15	not	RB	O	not	neg	13	SENT_381	[p8l1722t2279r1776b2299],
16	plasma	NN	O	plasma	dep	13	SENT_381	[p8l1796t2273r1916b2308],
17	,	,	O	,	_	0	SENT_381	[p8l1796t2273r1916b2308],
18	and	CC	O	and	_	0	SENT_381	[p8l1937t2273r1996b2299],
19	is	VBZ	O	be	cop	23	SENT_381	[p8l2017t2274r2039b2299],
20	therefore	RB	O	therefore	advmod	23	SENT_381	[p8l2061t2273r2212b2299],
21	not	RB	O	not	neg	23	SENT_381	[p8l2233t2278r2287b2299],
22	directly	RB	O	directly	advmod	23	SENT_381	[p8l1277t2318r1400b2353],
23	comparable	JJ	O	comparable	csubj	27	SENT_381	[p8l1417t2318r1609b2353],
24	to	TO	O	to	_	0	SENT_381	[p8l1627t2324r1657b2344],
25	our	PRP$	O	we	poss	26	SENT_381	[p8l1674t2327r1731b2344],
26	data	NNS	O	datum	prep_to	23	SENT_381	[p8l1747t2318r1816b2344],
27	(	VBP	O	(	conj_and	10	SENT_381	[p8l1833t2320r1892b2350],
28	see	VB	O	see	xcomp	27	SENT_381	[p8l1833t2320r1892b2350],
29	the	DT	O	the	det	30	SENT_381	[p8l1910t2318r1959b2344],
30	constraints	NNS	O	constraint	dobj	28	SENT_381	[p8l1976t2319r2156b2344],
31	above	IN	O	above	_	0	SENT_381	[p8l2173t2318r2286b2350],
32	)	NN	O	)	prep_above	28	SENT_381	[p8l2173t2318r2286b2350],
33	;	:	O	;	_	0	SENT_381	[p8l2173t2318r2286b2350],
34	nevertheless	RB	O	nevertheless	advmod	45	SENT_381	[p8l1277t2364r1484b2395],
35	,	,	O	,	_	0	SENT_381	[p8l1277t2364r1484b2395],
36	in	IN	O	in	_	0	SENT_381	[p8l1510t2365r1540b2389],
37	that	DT	O	that	det	38	SENT_381	[p8l1566t2364r1629b2390],
38	report	NN	O	report	prep_in	45	SENT_381	[p8l1653t2369r1765b2399],
39	,	,	O	,	_	0	SENT_381	[p8l1653t2369r1765b2399],
40	after	IN	O	after	_	0	SENT_381	[p8l1790t2364r1867b2390],
41	anticancer	JJ	O	anticancer	amod	42	SENT_381	[p8l1891t2365r2064b2390],
42	therapy	NN	O	therapy	prep_after	45	SENT_381	[p8l2088t2364r2212b2399],
43	the	DT	O	the	det	44	SENT_381	[p8l2237t2364r2286b2390],
44	levels	NNS	O	level	nsubj	45	SENT_381	[p8l1277t2410r1363b2436],
45	decreased	VBD	O	decrease	parataxis	10	SENT_381	[p8l1386t2410r1546b2436],
46	to	TO	O	to	_	0	SENT_381	[p8l1570t2415r1600b2436],
47	the	DT	O	the	det	48	SENT_381	[p8l1625t2410r1674b2436],
48	level	NN	O	level	prep_to	45	SENT_381	[p8l1697t2410r1769b2436],
49	of	IN	O	of	_	0	SENT_381	[p8l1792t2410r1827b2436],
50	controls	NNS	O	control	prep_of	48	SENT_381	[p8l1846t2410r1987b2441],
51	,	,	O	,	_	0	SENT_381	[p8l1846t2410r1987b2441],
52	accompanied	VBN	O	accompany	csubj	62	SENT_381	[p8l2011t2410r2228b2445],
53	by	IN	O	by	_	0	SENT_381	[p8l2250t2410r2287b2445],
54	concomitant	JJ	O	concomitant	amod	55	SENT_381	[p8l1277t2457r1484b2482],
55	improvement	NN	O	improvement	prep_by	52	SENT_381	[p8l1500t2457r1721b2491],
56	in	IN	O	in	_	0	SENT_381	[p8l1738t2457r1769b2481],
57	the	DT	O	the	det	58	SENT_381	[p8l1786t2456r1835b2482],
58	conditions	NNS	O	condition	prep_in	55	SENT_381	[p8l1852t2456r2024b2482],
59	of	IN	O	of	_	0	SENT_381	[p8l2042t2456r2076b2482],
60	the	DT	O	the	det	61	SENT_381	[p8l2090t2456r2139b2482],
61	patients	NNS	O	patient	prep_of	58	SENT_381	[p8l2157t2457r2286b2491],
62	[	VBD	O	[	dep	45	SENT_381	[p8l1279t2502r1343b2534],
63	66	CD	NUMBER	66	num	64	SENT_381	[p8l1279t2502r1343b2534],
64	]	NN	O	]	dobj	62	SENT_381	[p8l1279t2502r1343b2534],
65	,	,	O	,	_	0	SENT_381	[p8l1279t2502r1343b2534],
66	as	IN	O	as	mark	68	SENT_381	[p8l1356t2511r1385b2528],
67	also	RB	O	also	advmod	68	SENT_381	[p8l1398t2502r1458b2528],
68	observed	VBN	O	observe	dep	64	SENT_381	[p8l1471t2502r1615b2528],
69	in	IN	O	in	_	0	SENT_381	[p8l1628t2503r1658b2527],
70	our	PRP$	O	we	poss	71	SENT_381	[p8l1670t2511r1727b2528],
71	study	NN	O	study	prep_in	68	SENT_381	[p8l1738t2502r1823b2537],
72	in	IN	O	in	_	0	SENT_381	[p8l1835t2503r1865b2527],
73	which	WDT	O	which	rel	75	SENT_381	[p8l1876t2502r1972b2528],
74	levels	NNS	O	level	nsubj	75	SENT_381	[p8l1983t2502r2070b2528],
75	decreased	VBD	O	decrease	rcmod	71	SENT_381	[p8l2082t2502r2243b2528],
76	to	TO	O	to	_	0	SENT_381	[p8l2256t2508r2286b2528],
77	those	DT	O	those	prep_to	75	SENT_381	[p8l1278t2548r1362b2574],
78	of	IN	O	of	_	0	SENT_381	[p8l1377t2548r1412b2574],
79	endemic	JJ	O	endemic	amod	80	SENT_381	[p8l1423t2548r1560b2574],
80	normals	NNS	O	normal	prep_of	77	SENT_381	[p8l1577t2548r1707b2574],
81	following	VBG	O	follow	_	0	SENT_381	[p8l1723t2548r1875b2583],
82	doxycycline	NN	O	doxycycline	nn	83	SENT_381	[p8l1889t2548r2080b2583],
83	treatment	NN	O	treatment	prep_following	80	SENT_381	[p8l2097t2553r2265b2574],
84	.	.	O	.	_	0	SENT_381	[p8l2097t2553r2265b2574],

1	Unfortunately	RB	O	unfortunately	advmod	4	SENT_382	[p8l1314t2593r1547b2628],
2	no	DT	O	no	det	3	SENT_382	[p8l1565t2602r1604b2619],
3	data	NNS	O	datum	nsubj	4	SENT_382	[p8l1623t2593r1692b2619],
4	exist	VBP	O	exist	_	0	SENT_382	[p8l1710t2594r1784b2619],
5	as	RB	O	as	advmod	6	SENT_382	[p8l1802t2602r1831b2619],
6	yet	RB	O	yet	advmod	4	SENT_382	[p8l1848t2599r1896b2628],
7	with	IN	O	with	_	0	SENT_382	[p8l1913t2593r1982b2619],
8	regard	NN	O	regard	_	0	SENT_382	[p8l2001t2593r2106b2628],
9	to	TO	O	to	_	0	SENT_382	[p8l2125t2598r2155b2619],
10	plasma	NN	O	plasma	nn	12	SENT_382	[p8l2174t2593r2287b2628],
11	SVEGFR3	NN	O	svegfr3	nn	12	SENT_382	[p8l1277t2639r1429b2665],
12	levels	NNS	O	level	prep_with_regard_to	4	SENT_382	[p8l1446t2639r1532b2665],
13	and	CC	O	and	_	0	SENT_382	[p8l1549t2639r1608b2665],
14	their	PRP$	O	they	poss	16	SENT_382	[p8l1625t2639r1703b2665],
15	biological	JJ	O	biological	amod	16	SENT_382	[p8l1717t2639r1876b2674],
16	signiﬁcance	NN	O	signiﬁcance	conj_and	4	SENT_382	[p8l1892t2639r2083b2674],
17	for	IN	O	for	_	0	SENT_382	[p8l2099t2639r2148b2665],
18	tumors	NNS	O	tumor	prep_for	16	SENT_382	[p8l2164t2645r2285b2665],
19	.	.	O	.	_	0	SENT_382	[p8l2164t2645r2285b2665],

1	However	RB	O	however	advmod	13	SENT_383	[p8l1277t2686r1429b2716],
2	,	,	O	,	_	0	SENT_383	[p8l1277t2686r1429b2716],
3	the	DT	O	the	det	7	SENT_383	[p8l1454t2685r1504b2711],
4	more	JJR	O	more	dep	6	SENT_383	[p8l1528t2694r1612b2711],
5	than	IN	O	than	dep	6	SENT_383	[p8l1637t2685r1708b2711],
6	3-fold	JJ	O	3-fold	amod	7	SENT_383	[p8l1732t2685r1827b2711],
7	elevation	NN	O	elevation	nsubjpass	13	SENT_383	[p8l1851t2685r1999b2711],
8	in	IN	O	in	_	0	SENT_383	[p8l2023t2686r2054b2710],
9	lymphedema	NN	O	lymphedema	nn	10	SENT_383	[p8l2077t2685r2287b2720],
10	patients	NNS	O	patient	prep_in	7	SENT_383	[p8l1277t2732r1406b2766],
11	is	VBZ	O	be	auxpass	13	SENT_383	[p8l1422t2732r1444b2757],
12	not	RB	O	not	neg	13	SENT_383	[p8l1460t2736r1514b2757],
13	considered	VBN	O	consider	_	0	SENT_383	[p8l1528t2731r1707b2757],
14	to	TO	O	to	aux	17	SENT_383	[p8l1723t2737r1753b2757],
15	be	VB	O	be	cop	17	SENT_383	[p8l1768t2731r1805b2757],
16	biologically	RB	O	biologically	advmod	17	SENT_383	[p8l1820t2731r2007b2766],
17	meaningless	JJ	O	meaningless	xcomp	13	SENT_383	[p8l2022t2731r2226b2766],
18	.	.	O	.	_	0	SENT_383	[p8l2022t2731r2226b2766],

1	Supratesticular	JJ	O	supratesticular	amod	3	SENT_384	[p8l1277t2805r1534b2843],
2	Lymphatic	JJ	O	lymphatic	amod	3	SENT_384	[p8l1552t2805r1729b2844],
3	Dilation	NN	O	dilation	nsubjpass	14	SENT_384	[p8l1748t2805r1878b2836],
4	The	DT	O	the	det	5	SENT_384	[p8l1314t2856r1376b2882],
5	degree	NN	O	degree	nsubj	9	SENT_384	[p8l1388t2856r1496b2891],
6	of	IN	O	of	_	0	SENT_384	[p8l1508t2856r1543b2882],
7	lymphatic	JJ	O	lymphatic	amod	8	SENT_384	[p8l1551t2856r1711b2891],
8	dilation	NN	O	dilation	prep_of	5	SENT_384	[p8l1724t2856r1850b2882],
9	caused	VBN	O	cause	rcmod	3	SENT_384	[p8l1862t2856r1970b2882],
10	by	IN	O	by	_	0	SENT_384	[p8l1982t2856r2018b2891],
11	ﬁlarial	JJ	O	ﬁlarial	amod	12	SENT_384	[p8l2030t2856r2134b2882],
12	worms	NNS	O	worm	prep_by	9	SENT_384	[p8l2145t2865r2251b2882],
13	is	VBZ	O	be	auxpass	14	SENT_384	[p8l2264t2857r2286b2882],
14	considered	VBN	O	consider	_	0	SENT_384	[p8l1277t2902r1455b2928],
15	an	DT	O	a	det	17	SENT_384	[p8l1468t2911r1506b2928],
16	indirect	JJ	O	indirect	amod	17	SENT_384	[p8l1519t2902r1647b2928],
17	measurement	NN	O	measurement	dobj	14	SENT_384	[p8l1659t2907r1880b2928],
18	of	IN	O	of	_	0	SENT_384	[p8l1893t2902r1927b2928],
19	the	DT	O	the	det	22	SENT_384	[p8l1938t2902r1987b2928],
20	altered	JJ	O	altered	amod	22	SENT_384	[p8l2000t2902r2113b2928],
21	lymphatic	JJ	O	lymphatic	amod	22	SENT_384	[p8l2125t2902r2285b2937],
22	function	NN	O	function	prep_of	17	SENT_384	[p8l1276t2947r1416b2973],
23	[	CD	NUMBER	[	number	24	SENT_384	[p8l1440t2945r1504b2979],
24	67	CD	NUMBER	67	num	25	SENT_384	[p8l1440t2945r1504b2979],
25	]	NN	O	]	dep	22	SENT_384	[p8l1440t2945r1504b2979],
26	.	.	O	.	_	0	SENT_384	[p8l1440t2945r1504b2979],

1	One	CD	NUMBER	one	num	2	SENT_385	[p8l1528t2947r1596b2973],
2	study	NN	O	study	nsubj	3	SENT_385	[p8l1618t2947r1703b2982],
3	suggests	VBZ	O	suggest	_	0	SENT_385	[p8l1725t2952r1854b2982],
4	that	IN	O	that	complm	8	SENT_385	[p8l1878t2947r1941b2973],
5	diffusible	JJ	O	diffusible	amod	7	SENT_385	[p8l1963t2947r2115b2973],
6	secretory	JJ	O	secretory	amod	7	SENT_385	[p8l2137t2952r2287b2982],
7	products	NNS	O	product	nsubj	8	SENT_385	[p8l1277t2993r1420b3028],
8	released	VBN	O	release	ccomp	3	SENT_385	[p8l1435t2993r1567b3019],
9	either	CC	O	either	preconj	8	SENT_385	[p8l1582t2993r1679b3019],
10	by	IN	O	by	_	0	SENT_385	[p8l1692t2993r1728b3028],
11	the	DT	O	the	det	13	SENT_385	[p8l1743t2993r1793b3019],
12	adult	JJ	O	adult	amod	13	SENT_385	[p8l1807t2993r1890b3019],
13	worm	NN	O	worm	prep_by	8	SENT_385	[p8l1903t3002r1996b3019],
14	or	CC	O	or	_	0	SENT_385	[p8l2010t3002r2046b3019],
15	by	IN	O	by	_	0	SENT_385	[p8l2058t2993r2095b3028],
16	the	DT	O	the	det	17	SENT_385	[p8l2110t2993r2159b3019],
17	human	JJ	O	human	conj_or	13	SENT_385	[p8l2173t2993r2286b3019],

1	P	NN	O	p	_	0	SENT_386	[p9l1000t301r1148b326],
2	=	JJ	O	=	amod	4	SENT_386	[p9l1000t301r1148b326],
3	0.7213	CD	NUMBER	0.7213	tmod	2	SENT_386	[p9l1000t301r1148b326],
4	P	NN	O	p	dep	1	SENT_386	[p9l765t333r913b359],
5	=	JJ	O	=	amod	4	SENT_386	[p9l765t333r913b359],
6	0.0499	CD	NUMBER	0.0499	tmod	5	SENT_386	[p9l765t333r913b359],

1	VEGF-C	NN	O	vegf-c	dep	4	SENT_387	[p9l188t598r214b726],
2	plasma	NN	O	plasma	nn	3	SENT_387	[p9l188t470r220b584],
3	levels	NNS	O	level	dep	1	SENT_387	[p9l188t359r214b455],
4	(	VBP	O	(	_	0	SENT_387	[p9l188t235r221b345],
5	ng/ml	JJ	O	ng/ml	amod	6	SENT_387	[p9l188t235r221b345],
6	)	NN	O	)	dobj	4	SENT_387	[p9l188t235r221b345],
7	N	NN	O	n	nn	12	SENT_387	[p9l239t495r257b522],
8	o	NN	O	o	nn	12	SENT_387	[p9l269t495r287b523],
9	Doxycycline	NNP	O	Doxycycline	nn	12	SENT_387	[p9l308t755r526b790],
10	Placebo	NNP	O	Placebo	nn	12	SENT_387	[p9l565t755r705b782],
11	Doxycycline	NNP	O	Doxycycline	nn	12	SENT_387	[p9l745t755r962b790],
12	Placebo	NNP	O	Placebo	nsubj	4	SENT_387	[p9l1001t755r1143b782],

1	Before	IN	O	before	_	0	SENT_388	[p9l362t810r479b839],
2	treatment	NN	O	treatment	pobj	1	SENT_388	[p9l492t812r660b839],
3	12	CD	DURATION	12	num	4	SENT_388	[p9l808t813r845b840],
4	months	NNS	NUMBER	month	tmod	2	SENT_388	[p9l858t813r985b841],

1	Figure	NN	O	figure	_	0	SENT_389	[p9l190t875r282b906],
2	7	CD	NUMBER	7	dep	1	SENT_389	[p9l295t877r319b899],
3	.	.	O	.	_	0	SENT_389	[p9l295t877r319b899],

1	Plasma	NN	O	plasma	nn	2	SENT_390	[p9l333t875r427b899],
2	Levels	NNS	O	level	nsubj	17	SENT_390	[p9l441t875r523b899],
3	of	IN	O	of	_	0	SENT_390	[p9l535t875r563b899],
4	VEGF-C	NN	O	vegf-c	prep_of	2	SENT_390	[p9l573t876r673b899],
5	of	IN	O	of	_	0	SENT_390	[p9l686t875r714b899],
6	Lymphedema	NNP	O	Lymphedema	nn	7	SENT_390	[p9l725t875r913b906],
7	Patients	NNPS	O	Patients	prep_of	4	SENT_390	[p9l927t876r1035b899],
8	before	IN	O	before	advmod	7	SENT_390	[p9l1048t875r1136b899],
9	and	CC	O	and	_	0	SENT_390	[p9l1148t875r1198b899],
10	12	CD	DURATION	12	num	11	SENT_390	[p9l191t919r220b941],
11	Mo	NN	DURATION	mo	conj_and	4	SENT_390	[p9l234t918r276b941],
12	after	IN	O	after	_	0	SENT_390	[p9l289t917r352b941],
13	Doxycycline	NNP	O	Doxycycline	nn	16	SENT_390	[p9l365t917r529b948],
14	Treatment	NNP	O	Treatment	nn	16	SENT_390	[p9l540t918r684b941],
15	Plasma	NN	O	plasma	nn	16	SENT_390	[p9l190t962r284b986],
16	concentrations	NNS	O	concentration	prep_after	11	SENT_390	[p9l302t963r507b986],
17	(	VBP	O	(	_	0	SENT_390	[p9l526t963r610b990],
18	mean	NN	O	mean	dobj	17	SENT_390	[p9l526t963r610b990],
19	:	:	O	:	_	0	SENT_390	[p9l632t965r651b985],
20	SD	NN	O	sd	nn	21	SENT_390	[p9l672t963r717b990],
21	)	NN	O	)	nsubjpass	25	SENT_390	[p9l672t963r717b990],
22	of	IN	O	of	_	0	SENT_390	[p9l736t962r764b986],
23	VEGF-C	NN	O	vegf-c	prep_of	21	SENT_390	[p9l779t963r879b986],
24	were	VBD	O	be	auxpass	25	SENT_390	[p9l897t969r964b986],
25	measured	VBN	O	measure	parataxis	17	SENT_390	[p9l983t962r1116b986],
26	from	IN	O	from	_	0	SENT_390	[p9l1134t962r1198b986],
27	plasma	NN	O	plasma	prep_from	25	SENT_390	[p9l190t997r285b1028],
28	of	IN	O	of	_	0	SENT_390	[p9l303t997r331b1021],
29	lymphedema	NN	O	lymphedema	nn	30	SENT_390	[p9l348t997r527b1028],
30	patients	NNS	O	patient	prep_of	27	SENT_390	[p9l546t998r656b1028],
31	before	IN	O	before	_	0	SENT_390	[p9l674t997r762b1021],
32	and	CC	O	and	cc	33	SENT_390	[p9l780t997r829b1021],
33	12	CD	DURATION	12	num	34	SENT_390	[p9l851t999r879b1021],
34	mo	NN	DURATION	mo	prep_before	25	SENT_390	[p9l898t1004r941b1021],
35	after	IN	O	after	_	0	SENT_390	[p9l959t997r1022b1021],
36	doxycycline	NN	O	doxycycline	nn	37	SENT_390	[p9l1038t997r1199b1028],
37	treatment	NN	O	treatment	prep_after	25	SENT_390	[p9l188t1037r332b1057],
38	.	.	O	.	_	0	SENT_390	[p9l188t1037r332b1057],

1	The	DT	O	the	det	3	SENT_391	[p9l348t1033r399b1057],
2	VEGF-C	NN	O	vegf-c	nn	3	SENT_391	[p9l415t1034r515b1057],
3	levels	NNS	O	level	nsubj	4	SENT_391	[p9l534t1033r608b1057],
4	decreased	VBD	O	decrease	_	0	SENT_391	[p9l625t1033r763b1057],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	4	SENT_391	[p9l782t1033r946b1064],
6	at	IN	O	at	_	0	SENT_391	[p9l962t1037r987b1057],
7	12	CD	DURATION	12	num	8	SENT_391	[p9l1007t1035r1035b1057],
8	mo	NN	DURATION	mo	prep_at	4	SENT_391	[p9l1054t1040r1097b1057],
9	in	IN	O	in	_	0	SENT_391	[p9l1115t1034r1137b1057],
10	the	DT	O	the	det	13	SENT_391	[p9l1154t1033r1199b1057],
11	doxycyc	JJ	O	doxycyc	amod	13	SENT_391	[p9l189t1068r459b1099],
12	|	NN	O	|	nn	13	SENT_391	[p9l189t1068r459b1099],
13	ine	NN	O	ine	prep_in	8	SENT_391	[p9l189t1068r459b1099],
14	—	CD	NUMBER	—	num	16	SENT_391	[p9l189t1068r459b1099],
15	treated	JJ	O	treated	amod	16	SENT_391	[p9l189t1068r459b1099],
16	patients	NNS	O	patient	tmod	4	SENT_391	[p9l479t1069r589b1099],
17	(	IN	O	(	_	0	SENT_391	[p9l608t1069r632b1099],
18	p	NN	O	p	prep_(	16	SENT_391	[p9l608t1069r632b1099],
19	:	:	O	:	_	0	SENT_391	[p9l648t1080r670b1088],
20	0.0499	CD	NUMBER	0.0499	num	21	SENT_391	[p9l686t1069r791b1096],
21	)	NN	O	)	dep	16	SENT_391	[p9l686t1069r791b1096],
22	,	,	O	,	_	0	SENT_391	[p9l686t1069r791b1096],
23	in	IN	O	in	_	0	SENT_391	[p9l811t1069r833b1092],
24	contrast	NN	O	contrast	prep_in	4	SENT_391	[p9l852t1072r964b1092],
25	to	TO	O	to	_	0	SENT_391	[p9l981t1072r1009b1092],
26	the	DT	O	the	det	31	SENT_391	[p9l1027t1068r1072b1092],
27	placebo	NN	O	placebo	nn	31	SENT_391	[p9l1091t1068r1199b1099],
28	group	NN	O	group	nn	31	SENT_391	[p9l189t1110r271b1134],
29	(	CD	NUMBER	(	num	31	SENT_391	[p9l286t1103r379b1134],
30	paired	JJ	O	paired	amod	31	SENT_391	[p9l286t1103r379b1134],
31	t	NN	O	t	prep_to	4	SENT_391	[p9l394t1104r480b1131],
32	—	CD	NUMBER	—	num	34	SENT_391	[p9l394t1104r480b1131],
33	test	NN	O	test	nn	34	SENT_391	[p9l394t1104r480b1131],
34	)	NN	O	)	dep	31	SENT_391	[p9l394t1104r480b1131],
35	.	.	O	.	_	0	SENT_391	[p9l394t1104r480b1131],

1	DOI	NNP	O	DOI	_	0	SENT_392	[p9l190t1139r246b1162],
2	:	:	O	:	_	0	SENT_392	[p9l190t1139r246b1162],
3	10.1371	CD	NUMBER	10.1371	dep	1	SENT_392	[p9l262t1138r747b1169],
4	/	:	O	/	punct	6	SENT_392	[p9l262t1138r747b1169],
5	journa	NN	O	journa	nn	6	SENT_392	[p9l262t1138r747b1169],
6	|	NN	O	|	dep	3	SENT_392	[p9l262t1138r747b1169],
7	.	.	O	.	_	0	SENT_392	[p9l262t1138r747b1169],

1	ppat	NN	O	ppat	_	0	SENT_393	[p9l262t1138r747b1169],
2	.0020092	CD	NUMBER	.0020092	dep	1	SENT_393	[p9l262t1138r747b1169],
3	.	.	O	.	_	0	SENT_393	[p9l262t1138r747b1169],

1	g007	NN	O	g007	_	0	SENT_394	[p9l262t1138r747b1169],

1	host	NN	O	host	nsubj	8	SENT_395	[p9l189t1238r257b1264],
2	in	IN	O	in	_	0	SENT_395	[p9l284t1239r315b1263],
3	response	NN	O	response	prep_in	1	SENT_395	[p9l343t1247r486b1273],
4	to	TO	O	to	_	0	SENT_395	[p9l514t1243r544b1264],
5	the	DT	O	the	det	6	SENT_395	[p9l574t1238r623b1264],
6	parasite	NN	O	parasite	prep_to	3	SENT_395	[p9l651t1239r779b1273],
7	may	MD	O	may	aux	8	SENT_395	[p9l808t1247r873b1273],
8	induce	VB	O	induce	_	0	SENT_395	[p9l901t1238r1010b1264],
9	lymphatic	JJ	O	lymphatic	amod	10	SENT_395	[p9l1037t1238r1198b1273],
10	dilation	NN	O	dilation	dobj	8	SENT_395	[p9l189t1284r316b1310],
11	[	CD	NUMBER	[	num	13	SENT_395	[p9l331t1284r395b1316],
12	68	CD	NUMBER	68	num	13	SENT_395	[p9l331t1284r395b1316],
13	]	NN	O	]	dep	10	SENT_395	[p9l331t1284r395b1316],
14	.	.	O	.	_	0	SENT_395	[p9l331t1284r395b1316],

1	Here	RB	O	here	advmod	5	SENT_396	[p9l409t1285r497b1315],
2	,	,	O	,	_	0	SENT_396	[p9l409t1285r497b1315],
3	we	PRP	O	we	nsubj	5	SENT_396	[p9l510t1293r552b1310],
4	have	VBP	O	have	aux	5	SENT_396	[p9l564t1284r638b1310],
5	provided	VBN	O	provide	_	0	SENT_396	[p9l651t1284r797b1319],
6	circumstantial	JJ	O	circumstantial	amod	7	SENT_396	[p9l810t1284r1044b1310],
7	evidence	NN	O	evidence	dobj	5	SENT_396	[p9l1057t1284r1198b1310],
8	for	IN	O	for	_	0	SENT_396	[p9l189t1330r237b1356],
9	both	DT	O	both	prep_for	5	SENT_396	[p9l251t1330r333b1361],
10	,	,	O	,	_	0	SENT_396	[p9l251t1330r333b1361],
11	in	IN	O	in	_	0	SENT_396	[p9l349t1331r379b1355],
12	a	DT	O	a	det	13	SENT_396	[p9l395t1339r411b1356],
13	series	NN	O	series	prep_in	5	SENT_396	[p9l425t1331r514b1356],
14	of	IN	O	of	_	0	SENT_396	[p9l529t1330r564b1356],
15	events	NNS	O	event	prep_of	13	SENT_396	[p9l575t1335r684b1356],
16	:	:	O	:	_	0	SENT_396	[p9l575t1335r684b1356],
17	the	DT	O	the	det	19	SENT_396	[p9l701t1330r750b1356],
18	lymphatic	JJ	O	lymphatic	amod	19	SENT_396	[p9l765t1330r925b1365],
19	dilation	NN	O	dilation	nsubjpass	23	SENT_396	[p9l941t1330r1067b1356],
20	may	MD	O	may	aux	23	SENT_396	[p9l1082t1339r1148b1365],
21	be	VB	O	be	auxpass	23	SENT_396	[p9l1162t1330r1199b1356],
22	partly	RB	O	partly	advmod	23	SENT_396	[p9l189t1377r285b1412],
23	caused	VBN	O	cause	parataxis	5	SENT_396	[p9l303t1377r411b1403],
24	by	IN	O	by	_	0	SENT_396	[p9l430t1377r466b1412],
25	overexpression	NN	O	overexpression	agent	23	SENT_396	[p9l485t1378r731b1412],
26	of	IN	O	of	_	0	SENT_396	[p9l750t1377r785b1403],
27	VEGF-C/sVEGFR	NN	O	vegf-c/svegfr	prep_of	25	SENT_396	[p9l799t1377r1110b1403],
28	-3	CD	NUMBER	-3	num	27	SENT_396	[p9l799t1377r1110b1403],
29	produced	VBN	O	produce	partmod	27	SENT_396	[p9l1130t1386r1198b1412, p9l189t1424r286b1450],
30	by	IN	O	by	_	0	SENT_396	[p9l301t1424r337b1459],
31	the	DT	O	the	det	33	SENT_396	[p9l353t1424r402b1450],
32	endothelial	JJ	O	endothelial	amod	33	SENT_396	[p9l416t1424r600b1450],
33	cells	NNS	O	cell	agent	29	SENT_396	[p9l615t1424r683b1450],
34	of	IN	O	of	_	0	SENT_396	[p9l698t1424r732b1450],
35	the	DT	O	the	det	37	SENT_396	[p9l745t1424r794b1450],
36	lymphatic	JJ	O	lymphatic	amod	37	SENT_396	[p9l808t1424r969b1459],
37	vessels	NNS	O	vessel	prep_of	33	SENT_396	[p9l983t1424r1088b1450],
38	of	IN	O	of	_	0	SENT_396	[p9l1103t1424r1137b1450],
39	the	DT	O	the	det	40	SENT_396	[p9l1150t1424r1199b1450],
40	host	NN	O	host	prep_of	37	SENT_396	[p9l189t1470r257b1496],
41	in	IN	O	in	_	0	SENT_396	[p9l279t1471r309b1495],
42	response	NN	O	response	prep_in	40	SENT_396	[p9l332t1479r475b1505],
43	to	TO	O	to	_	0	SENT_396	[p9l498t1475r528b1496],
44	products	NNS	O	product	prep_to	29	SENT_396	[p9l552t1470r695b1505],
45	of	IN	O	of	_	0	SENT_396	[p9l718t1470r753b1496],
46	the	DT	O	the	det	48	SENT_396	[p9l772t1470r821b1496],
47	adult	JJ	O	adult	amod	48	SENT_396	[p9l844t1470r927b1496],
48	worm	NN	O	worm	prep_of	44	SENT_396	[p9l948t1479r1041b1496],
49	that	WDT	O	that	nsubjpass	51	SENT_396	[p9l1064t1470r1127b1496],
50	are	VBP	O	be	auxpass	51	SENT_396	[p9l1149t1479r1199b1496],
51	reduced	VBN	O	reduce	rcmod	48	SENT_396	[p9l190t1517r321b1543],
52	by	IN	O	by	_	0	SENT_396	[p9l332t1517r369b1552],
53	doxycycline	NN	O	doxycycline	agent	51	SENT_396	[p9l381t1517r580b1552],
54	.	.	O	.	_	0	SENT_396	[p9l381t1517r580b1552],

1	Importantly	RB	O	importantly	advmod	24	SENT_397	[p9l592t1517r797b1552],
2	,	,	O	,	_	0	SENT_397	[p9l592t1517r797b1552],
3	the	DT	O	the	det	4	SENT_397	[p9l811t1517r860b1543],
4	reduction	NN	O	reduction	nsubjpass	24	SENT_397	[p9l873t1517r1032b1543],
5	of	IN	O	of	_	0	SENT_397	[p9l1044t1517r1079b1543],
6	dilated	JJ	O	dilated	amod	7	SENT_397	[p9l1087t1517r1199b1543],
7	vessels	NNS	O	vessel	prep_of	4	SENT_397	[p9l188t1563r293b1589],
8	was	VBD	O	be	auxpass	24	SENT_397	[p9l304t1572r360b1589],
9	not	RB	O	not	neg	24	SENT_397	[p9l372t1568r426b1589],
10	mechanical	JJ	O	mechanical	acomp	24	SENT_397	[p9l438t1563r622b1589],
11	as	IN	O	as	_	0	SENT_397	[p9l634t1572r663b1589],
12	a	DT	O	a	det	13	SENT_397	[p9l675t1572r691b1589],
13	result	NN	O	result	prep_as	10	SENT_397	[p9l703t1563r793b1589],
14	of	IN	O	of	_	0	SENT_397	[p9l805t1563r840b1589],
15	the	DT	O	the	det	16	SENT_397	[p9l849t1563r898b1589],
16	death	NN	O	death	prep_of	13	SENT_397	[p9l910t1563r1000b1589],
17	of	IN	O	of	_	0	SENT_397	[p9l1012t1563r1046b1589],
18	the	DT	O	the	det	20	SENT_397	[p9l1056t1563r1105b1589],
19	adult	JJ	O	adult	amod	20	SENT_397	[p9l1117t1563r1199b1589],
20	worms	NNS	O	worm	prep_of	16	SENT_397	[p9l188t1619r303b1641],
21	,	,	O	,	_	0	SENT_397	[p9l188t1619r303b1641],
22	since	IN	O	since	advmod	24	SENT_397	[p9l322t1611r402b1636],
23	the	DT	O	the	dep	22	SENT_397	[p9l422t1610r471b1636],
24	dilated	VBN	O	dilate	_	0	SENT_397	[p9l490t1610r601b1636],
25	vessels	NNS	O	vessel	dobj	24	SENT_397	[p9l619t1610r724b1636],
26	that	WDT	O	that	nsubjpass	28	SENT_397	[p9l743t1610r806b1636],
27	were	VBD	O	be	auxpass	28	SENT_397	[p9l824t1619r900b1636],
28	analyzed	VBN	O	analyze	rcmod	25	SENT_397	[p9l919t1610r1057b1645],
29	for	IN	O	for	mark	34	SENT_397	[p9l1076t1610r1124b1636],
30	this	DT	O	this	det	31	SENT_397	[p9l1142t1610r1198b1636],
31	purpose	NN	O	purpose	nsubj	34	SENT_397	[p9l189t1665r321b1691],
32	did	VBD	O	do	aux	34	SENT_397	[p9l337t1656r388b1682],
33	not	RB	O	not	neg	34	SENT_397	[p9l404t1661r457b1682],
34	contain	VB	O	contain	advcl	28	SENT_397	[p9l472t1657r595b1682],
35	worm	NN	O	worm	nn	36	SENT_397	[p9l609t1665r702b1682],
36	nests	NNS	O	nest	dobj	34	SENT_397	[p9l718t1661r804b1682],
37	.	.	O	.	_	0	SENT_397	[p9l718t1661r804b1682],

1	The	DT	O	the	det	2	SENT_398	[p9l226t1703r288b1729],
2	mechanism	NN	O	mechanism	nsubjpass	24	SENT_398	[p9l304t1703r488b1729],
3	of	IN	O	of	_	0	SENT_398	[p9l503t1703r538b1729],
4	action	NN	O	action	prep_of	2	SENT_398	[p9l550t1704r650b1729],
5	of	IN	O	of	_	0	SENT_398	[p9l665t1703r700b1729],
6	doxycycline	NN	O	doxycycline	prep_of	4	SENT_398	[p9l712t1703r903b1738],
7	on	IN	O	on	_	0	SENT_398	[p9l918t1712r959b1729],
8	the	DT	O	the	det	9	SENT_398	[p9l975t1703r1024b1729],
9	reduction	NN	O	reduction	prep_on	6	SENT_398	[p9l1040t1703r1199b1729],
10	of	IN	O	of	_	0	SENT_398	[p9l189t1750r224b1776],
11	VEGF-C/SVEGFR	NN	O	vegf-c/svegfr	prep_of	9	SENT_398	[p9l242t1750r553b1776],
12	-3	CD	NUMBER	-3	num	11	SENT_398	[p9l242t1750r553b1776],
13	and	CC	O	and	_	0	SENT_398	[p9l577t1750r636b1776],
14	its	PRP$	O	its	poss	16	SENT_398	[p9l660t1751r695b1776],
15	ameliorating	VBG	O	ameliorate	amod	16	SENT_398	[p9l720t1750r929b1785],
16	effect	NN	O	effect	conj_and	4	SENT_398	[p9l951t1750r1042b1776],
17	on	IN	O	on	_	0	SENT_398	[p9l1065t1759r1105b1776],
18	lymphatic	JJ	O	lymphatic	amod	19	SENT_398	[p9l1128t1750r1198b1785, p9l189t1796r289b1831],
19	vessel	NN	O	vessel	prep_on	16	SENT_398	[p9l307t1796r397b1822],
20	is	VBZ	O	be	auxpass	24	SENT_398	[p9l415t1797r437b1822],
21	not	RB	O	not	neg	24	SENT_398	[p9l455t1802r509b1822],
22	yet	RB	O	yet	advmod	24	SENT_398	[p9l525t1801r572b1831],
23	fully	RB	O	fully	advmod	24	SENT_398	[p9l589t1796r660b1831],
24	clariﬁed	VBN	O	clariﬁed	_	0	SENT_398	[p9l677t1796r817b1822],
25	.	.	O	.	_	0	SENT_398	[p9l677t1796r817b1822],

1	However	RB	O	however	advmod	6	SENT_399	[p9l835t1797r987b1827],
2	,	,	O	,	_	0	SENT_399	[p9l835t1797r987b1827],
3	this	DT	DATE	this	nsubjpass	6	SENT_399	[p9l1006t1796r1062b1822],
4	may	MD	DATE	may	aux	6	SENT_399	[p9l1080t1805r1145b1831],
5	be	VB	O	be	auxpass	6	SENT_399	[p9l1162t1796r1199b1822],
6	associated	VBN	O	associate	_	0	SENT_399	[p9l189t1843r354b1869],
7	with	IN	O	with	_	0	SENT_399	[p9l378t1843r448b1869],
8	depletion	NN	O	depletion	prep_with	6	SENT_399	[p9l472t1843r628b1878],
9	of	IN	O	of	_	0	SENT_399	[p9l653t1843r688b1869],
10	Wolbachia	NNP	LOCATION	Wolbachia	prep_of	8	SENT_399	[p9l712t1843r860b1869],
11	from	IN	O	from	_	0	SENT_399	[p9l883t1843r963b1869],
12	adult	JJ	O	adult	amod	14	SENT_399	[p9l988t1843r1070b1869],
13	ﬁlarial	JJ	O	ﬁlarial	amod	14	SENT_399	[p9l1094t1843r1199b1869],
14	worms	NNS	O	worm	prep_from	6	SENT_399	[p9l188t1898r295b1915],
15	in	IN	O	in	_	0	SENT_399	[p9l317t1890r347b1914],
16	the	DT	O	the	det	18	SENT_399	[p9l369t1889r419b1915],
17	lymphatic	JJ	O	lymphatic	amod	18	SENT_399	[p9l440t1889r600b1924],
18	vessels	NNS	O	vessel	prep_in	14	SENT_399	[p9l622t1889r734b1915],
19	.	.	O	.	_	0	SENT_399	[p9l622t1889r734b1915],

1	There	EX	O	there	expl	2	SENT_400	[p9l756t1889r852b1915],
2	are	VBP	O	be	_	0	SENT_400	[p9l874t1898r924b1915],
3	now	RB	DATE	now	advmod	2	SENT_400	[p9l945t1898r1011b1915],
4	valid	JJ	O	valid	amod	5	SENT_400	[p9l1032t1889r1109b1915],
5	data	NNS	O	datum	nsubj	2	SENT_400	[p9l1130t1889r1199b1915],
6	from	IN	O	from	_	0	SENT_400	[p9l189t1935r268b1961],
7	human	JJ	O	human	amod	8	SENT_400	[p9l287t1935r400b1961],
8	studies	NNS	O	study	prep_from	5	SENT_400	[p9l420t1935r531b1961],
9	that	WDT	O	that	dobj	11	SENT_400	[p9l552t1935r615b1961],
10	Wolbachia	NNP	LOCATION	Wolbachia	nsubj	11	SENT_400	[p9l637t1935r785b1961],
11	stimulate	VBP	O	stimulate	rcmod	5	SENT_400	[p9l804t1935r954b1961],
12	proinﬂammatory	JJ	O	proinﬂammatory	amod	13	SENT_400	[p9l974t1935r1198b1970, p9l190t1987r255b2017],
13	cytokines	NNS	O	cytokine	dobj	11	SENT_400	[p9l268t1982r419b2017],
14	such	JJ	O	such	_	0	SENT_400	[p9l433t1982r505b2008],
15	as	IN	O	as	_	0	SENT_400	[p9l518t1991r547b2008],
16	TNF	NN	O	tnf	prep_such_as	13	SENT_400	[p9l560t1983r640b2013],
17	,	,	O	,	_	0	SENT_400	[p9l560t1983r640b2013],
18	IL-1B	NN	O	il-1b	prep_such_as	13	SENT_400	[p9l654t1983r752b2013],
19	,	,	O	,	_	0	SENT_400	[p9l654t1983r752b2013],
20	IL-6	NN	O	il-6	prep_such_as	13	SENT_400	[p9l766t1982r840b2013],
21	,	,	O	,	_	0	SENT_400	[p9l766t1982r840b2013],
22	and	CC	O	and	_	0	SENT_400	[p9l855t1982r914b2008],
23	nitric	JJ	O	nitric	amod	24	SENT_400	[p9l928t1983r1015b2008],
24	oxide	NN	O	oxide	prep_such_as	13	SENT_400	[p9l1029t1982r1118b2008],
25	[	CD	NUMBER	[	number	26	SENT_400	[p9l1134t1982r1198b2014],
26	45	CD	NUMBER	45	num	27	SENT_400	[p9l1134t1982r1198b2014],
27	]	NN	O	]	dep	24	SENT_400	[p9l1134t1982r1198b2014],
28	,	,	O	,	_	0	SENT_400	[p9l1134t1982r1198b2014],
29	which	WDT	O	which	nsubjpass	31	SENT_400	[p9l188t2028r284b2054],
30	are	VBP	O	be	auxpass	31	SENT_400	[p9l302t2037r351b2054],
31	known	VBN	O	know	rcmod	13	SENT_400	[p9l368t2028r476b2054],
32	to	TO	O	to	aux	33	SENT_400	[p9l495t2033r525b2054],
33	up-regulate	VB	O	up-regulate	xcomp	31	SENT_400	[p9l543t2028r731b2063],
34	the	DT	O	the	det	35	SENT_400	[p9l750t2028r799b2054],
35	expression	NN	O	expression	dobj	33	SENT_400	[p9l817t2029r991b2063],
36	of	IN	O	of	_	0	SENT_400	[p9l1009t2028r1043b2054],
37	VEGF-C	NN	O	vegf-c	prep_of	35	SENT_400	[p9l1056t2028r1199b2058],
38	;	:	O	;	_	0	SENT_400	[p9l1056t2028r1199b2058],
39	importantly	RB	O	importantly	advmod	44	SENT_400	[p9l190t2075r392b2110],
40	,	,	O	,	_	0	SENT_400	[p9l190t2075r392b2110],
41	these	DT	O	these	det	42	SENT_400	[p9l413t2075r494b2101],
42	cytokines	NNS	O	cytokine	nsubjpass	44	SENT_400	[p9l514t2075r665b2110],
43	are	VBP	O	be	auxpass	44	SENT_400	[p9l686t2084r735b2101],
44	down-regulated	VBN	O	down-regulate	parataxis	2	SENT_400	[p9l755t2075r1011b2110],
45	after	IN	O	after	_	0	SENT_400	[p9l1031t2075r1108b2101],
46	doxycycline	NN	O	doxycycline	nn	47	SENT_400	[p9l1127t2075r1198b2101, p9l188t2122r321b2157],
47	treatment	NN	O	treatment	prep_after	44	SENT_400	[p9l351t2127r515b2148],
48	[	CD	NUMBER	[	number	49	SENT_400	[p9l545t2122r611b2154],
49	45	CD	NUMBER	45	num	50	SENT_400	[p9l545t2122r611b2154],
50	]	NN	O	]	dep	44	SENT_400	[p9l545t2122r611b2154],
51	.	.	O	.	_	0	SENT_400	[p9l545t2122r611b2154],

1	This	DT	O	this	nsubj	2	SENT_401	[p9l640t2122r710b2148],
2	raises	VBZ	O	raise	_	0	SENT_401	[p9l739t2123r829b2148],
3	the	DT	O	the	det	4	SENT_401	[p9l859t2122r909b2148],
4	possibility	NN	O	possibility	dobj	2	SENT_401	[p9l938t2122r1106b2157],
5	that	IN	O	that	complm	17	SENT_401	[p9l1135t2122r1199b2148],
6	proinﬂammatory	JJ	O	proinﬂammatory	amod	7	SENT_401	[p9l189t2168r470b2203],
7	cytokines	NNS	O	cytokine	nsubj	17	SENT_401	[p9l487t2168r639b2203],
8	such	JJ	O	such	_	0	SENT_401	[p9l657t2168r728b2194],
9	as	IN	O	as	_	0	SENT_401	[p9l747t2177r776b2194],
10	TNF	NN	O	tnf	prep_such_as	7	SENT_401	[p9l793t2169r866b2194],
11	and	CC	O	and	_	0	SENT_401	[p9l884t2168r942b2194],
12	IL-lB	NN	O	il-lb	conj_and	10	SENT_401	[p9l960t2168r1050b2193],
13	induced	VBN	O	induce	partmod	10	SENT_401	[p9l1069t2168r1199b2194],
14	by	IN	O	by	_	0	SENT_401	[p9l189t2215r225b2250],
15	Wolbachia	NNP	PERSON	Wolbachia	agent	13	SENT_401	[p9l239t2215r388b2241],
16	could	MD	O	could	aux	17	SENT_401	[p9l399t2215r488b2241],
17	affect	VB	O	affect	ccomp	2	SENT_401	[p9l500t2215r590b2241],
18	lymphatic	JJ	O	lymphatic	amod	19	SENT_401	[p9l602t2215r762b2250],
19	vessels	NNS	O	vessel	dobj	17	SENT_401	[p9l774t2215r878b2241],
20	via	IN	O	via	_	0	SENT_401	[p9l890t2216r936b2241],
21	VEGF-C	NN	O	vegf-c	prep_via	19	SENT_401	[p9l946t2215r1079b2241],
22	and	CC	O	and	_	0	SENT_401	[p9l1092t2215r1151b2241],
23	its	PRP$	O	its	poss	25	SENT_401	[p9l1163t2216r1198b2241],
24	receptor	NN	O	receptor	nn	25	SENT_401	[p9l190t2266r330b2296],
25	sVEGFR-3	NN	O	svegfr-3	conj_and	21	SENT_401	[p9l356t2261r529b2287],
26	.	.	O	.	_	0	SENT_401	[p9l356t2261r529b2287],

1	It	PRP	O	it	nsubj	4	SENT_402	[p9l556t2262r581b2287],
2	is	VBZ	O	be	cop	4	SENT_402	[p9l608t2262r630b2287],
3	therefore	RB	O	therefore	advmod	4	SENT_402	[p9l658t2261r809b2287],
4	conceivable	JJ	O	conceivable	_	0	SENT_402	[p9l836t2261r1026b2287],
5	that	IN	O	that	complm	28	SENT_402	[p9l1054t2261r1117b2287],
6	any	DT	O	any	det	8	SENT_402	[p9l1144t2270r1199b2296],
7	therapeutic	JJ	O	therapeutic	amod	8	SENT_402	[p9l190t2307r377b2342],
8	intervention	NN	O	intervention	nsubj	28	SENT_402	[p9l396t2308r600b2333],
9	that	WDT	O	that	nsubj	10	SENT_402	[p9l619t2307r682b2333],
10	causes	VBZ	O	cause	rcmod	8	SENT_402	[p9l700t2316r800b2333],
11	reduction	NN	O	reduction	dobj	10	SENT_402	[p9l819t2307r978b2333],
12	of	IN	O	of	_	0	SENT_402	[p9l997t2307r1031b2333],
13	VEGFCinducing	VBG	O	vegfcinduce	prepc_of	11	SENT_402	[p9l1045t2307r1198b2333, p9l190t2354r333b2389],
14	proinﬂammatory	JJ	O	proinﬂammatory	amod	15	SENT_402	[p9l346t2354r626b2389],
15	cytokines	NNS	O	cytokine	dobj	13	SENT_402	[p9l640t2354r791b2389],
16	such	JJ	O	such	_	0	SENT_402	[p9l805t2354r877b2380],
17	as	IN	O	as	_	0	SENT_402	[p9l891t2363r920b2380],
18	TNF	NN	O	tnf	prep_such_as	15	SENT_402	[p9l933t2355r1013b2385],
19	,	,	O	,	_	0	SENT_402	[p9l933t2355r1013b2385],
20	IL-1B	NN	O	il-1b	appos	18	SENT_402	[p9l1027t2355r1117b2379],
21	[	CD	NUMBER	[	num	20	SENT_402	[p9l1134t2354r1198b2386],
22	45	CD	NUMBER	45	num	23	SENT_402	[p9l1134t2354r1198b2386],
23	]	NN	O	]	nn	20	SENT_402	[p9l1134t2354r1198b2386],
24	,	,	O	,	_	0	SENT_402	[p9l1134t2354r1198b2386],
25	etc.	FW	O	etc.	dep	20	SENT_402	[p9l189t2406r243b2427],
26	would	MD	O	would	aux	28	SENT_402	[p9l256t2401r354b2427],
27	be	VB	O	be	cop	28	SENT_402	[p9l367t2401r404b2427],
28	able	JJ	O	able	ccomp	4	SENT_402	[p9l418t2401r483b2427],
29	to	TO	O	to	aux	30	SENT_402	[p9l497t2407r527b2427],
30	reduce	VB	O	reduce	xcomp	28	SENT_402	[p9l541t2401r651b2427],
31	levels	NNS	O	level	dobj	30	SENT_402	[p9l664t2401r750b2427],
32	of	IN	O	of	_	0	SENT_402	[p9l764t2401r798b2427],
33	VEGF-C/SVEGFR	NN	O	vegf-c/svegfr	prep_of	31	SENT_402	[p9l806t2401r1126b2432],
34	-3	CD	NUMBER	-3	num	33	SENT_402	[p9l806t2401r1126b2432],
35	,	,	O	,	_	0	SENT_402	[p9l806t2401r1126b2432],
36	and	CC	O	and	_	0	SENT_402	[p9l1140t2401r1199b2427],
37	hence	RB	O	hence	advmod	30	SENT_402	[p9l189t2447r284b2473],
38	lead	VB	O	lead	conj_and	30	SENT_402	[p9l300t2447r366b2473],
39	to	TO	O	to	_	0	SENT_402	[p9l383t2452r413b2473],
40	reduction	NN	O	reduction	prep_to	38	SENT_402	[p9l429t2447r588b2473],
41	of	IN	O	of	_	0	SENT_402	[p9l604t2447r639b2473],
42	dilated	JJ	O	dilated	amod	45	SENT_402	[p9l651t2447r763b2473],
43	supratesticular	JJ	O	supratesticular	amod	45	SENT_402	[p9l779t2447r1023b2482],
44	lymphatic	JJ	O	lymphatic	amod	45	SENT_402	[p9l1038t2447r1198b2482],
45	vessels	NNS	O	vessel	prep_of	40	SENT_402	[p9l188t2494r293b2520],
46	as	IN	O	as	mark	49	SENT_402	[p9l308t2503r337b2520],
47	we	PRP	O	we	nsubj	49	SENT_402	[p9l352t2503r394b2520],
48	have	VBP	O	have	aux	49	SENT_402	[p9l409t2494r482b2520],
49	shown	VBN	O	show	advcl	28	SENT_402	[p9l497t2494r599b2520],
50	here	RB	O	here	advmod	49	SENT_402	[p9l613t2494r693b2520],
51	.	.	O	.	_	0	SENT_402	[p9l613t2494r693b2520],

1	In	IN	O	in	_	0	SENT_403	[p9l226t2542r259b2566],
2	this	DT	O	this	det	3	SENT_403	[p9l275t2541r331b2567],
3	regard	NN	O	regard	prep_in	7	SENT_403	[p9l347t2541r460b2576],
4	,	,	O	,	_	0	SENT_403	[p9l347t2541r460b2576],
5	it	PRP	O	it	nsubj	7	SENT_403	[p9l477t2542r499b2567],
6	is	VBZ	O	be	cop	7	SENT_403	[p9l514t2542r536b2567],
7	remarkable	JJ	O	remarkable	_	0	SENT_403	[p9l552t2541r736b2567],
8	that	IN	O	that	complm	10	SENT_403	[p9l752t2541r815b2567],
9	there	EX	O	there	expl	10	SENT_403	[p9l831t2541r914b2567],
10	was	VBD	O	be	ccomp	7	SENT_403	[p9l929t2550r985b2567],
11	a	DT	O	a	det	13	SENT_403	[p9l1000t2550r1016b2567],
12	signiﬁcant	JJ	O	signiﬁcant	amod	13	SENT_403	[p9l1031t2541r1199b2576],
13	increase	NN	O	increase	nsubj	10	SENT_403	[p9l190t2588r323b2613],
14	in	IN	O	in	_	0	SENT_403	[p9l352t2588r382b2612],
15	the	DT	O	the	det	16	SENT_403	[p9l411t2587r460b2613],
16	prevalence	NN	O	prevalence	prep_in	13	SENT_403	[p9l489t2587r666b2622],
17	of	IN	O	of	_	0	SENT_403	[p9l694t2587r729b2613],
18	hydroceles	NNS	O	hydrocele	prep_of	16	SENT_403	[p9l752t2587r927b2622],
19	in	IN	O	in	_	0	SENT_403	[p9l956t2588r986b2612],
20	placebo	NN	O	placebo	prep_in	18	SENT_403	[p9l1014t2587r1141b2622],
21	as	IN	O	as	prep	10	SENT_403	[p9l1169t2596r1198b2613],
22	compared	VBN	O	compare	_	0	SENT_403	[p9l189t2633r353b2668],
23	to	TO	O	to	prepc_compared_to	10	SENT_403	[p9l369t2639r399b2659],
24	doxycycline	NN	O	doxycycline	nn	26	SENT_403	[p9l415t2633r606b2668],
25	treated	JJ	O	treated	amod	26	SENT_403	[p9l622t2633r737b2659],
26	patients	NNS	O	patient	pobj	10	SENT_403	[p9l753t2634r882b2668],
27	in	IN	O	in	_	0	SENT_403	[p9l898t2634r928b2658],
28	our	PRP$	O	we	poss	29	SENT_403	[p9l944t2642r1000b2659],
29	study	NN	O	study	prep_in	26	SENT_403	[p9l1014t2633r1107b2668],
30	.	.	O	.	_	0	SENT_403	[p9l1014t2633r1107b2668],

1	Lymphedema	NNP	O	Lymphedema	nsubj	2	SENT_404	[p9l191t2709r425b2748],
2	Stages	VBZ	O	stage	_	0	SENT_404	[p9l443t2710r555b2748],
3	Doxycycline	NN	O	doxycycline	nn	4	SENT_404	[p9l226t2761r424b2796],
4	treatment	NN	O	treatment	nsubj	6	SENT_404	[p9l446t2766r607b2787],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_404	[p9l628t2761r824b2796],
6	reduced	VBD	O	reduce	ccomp	2	SENT_404	[p9l845t2761r976b2787],
7	the	DT	O	the	det	8	SENT_404	[p9l997t2761r1046b2787],
8	stage	NN	O	stage	dobj	6	SENT_404	[p9l1067t2766r1147b2796],
9	of	IN	O	of	_	0	SENT_404	[p9l1168t2761r1202b2787],
10	disease	NN	O	disease	prep_of	8	SENT_404	[p9l189t2807r302b2833],
11	in	IN	O	in	_	0	SENT_404	[p9l321t2808r352b2832],
12	lymphedema	NN	O	lymphedema	nn	13	SENT_404	[p9l370t2807r580b2842],
13	patients	NNS	O	patient	prep_in	6	SENT_404	[p9l598t2808r736b2842],
14	,	,	O	,	_	0	SENT_404	[p9l598t2808r736b2842],
15	whereas	IN	O	whereas	mark	21	SENT_404	[p9l755t2807r884b2833],
16	the	DT	O	the	det	17	SENT_404	[p9l904t2807r953b2833],
17	stage	NN	O	stage	nsubjpass	21	SENT_404	[p9l972t2812r1052b2842],
18	was	VBD	O	be	auxpass	21	SENT_404	[p9l1070t2816r1126b2833],
19	not	RB	O	not	neg	21	SENT_404	[p9l1146t2812r1199b2833],
20	signiﬁcantly	RB	O	signiﬁcantly	advmod	21	SENT_404	[p9l189t2854r386b2889],
21	altered	VBN	O	alter	advcl	6	SENT_404	[p9l400t2854r513b2880],
22	in	IN	O	in	_	0	SENT_404	[p9l528t2855r559b2879],
23	placebo	NN	O	placebo	nn	24	SENT_404	[p9l574t2854r699b2889],
24	patients	NNS	O	patient	prep_in	21	SENT_404	[p9l714t2855r852b2889],
25	,	,	O	,	_	0	SENT_404	[p9l714t2855r852b2889],
26	who	WP	O	who	nsubj	30	SENT_404	[p9l867t2854r941b2885],
27	,	,	O	,	_	0	SENT_404	[p9l867t2854r941b2885],
28	rather	RB	O	rather	advmod	30	SENT_404	[p9l957t2854r1064b2885],
29	,	,	O	,	_	0	SENT_404	[p9l957t2854r1064b2885],
30	showed	VBD	O	show	rcmod	24	SENT_404	[p9l1080t2854r1199b2880],
31	a	DT	O	a	det	32	SENT_404	[p9l189t2909r205b2926],
32	trend	NN	O	trend	dobj	30	SENT_404	[p9l219t2900r307b2926],
33	towards	IN	O	towards	_	0	SENT_404	[p9l321t2900r446b2926],
34	deterioration	NN	O	deterioration	prep_towards	30	SENT_404	[p9l460t2900r687b2926],
35	.	.	O	.	_	0	SENT_404	[p9l460t2900r687b2926],

1	The	DT	O	the	det	2	SENT_405	[p9l701t2900r763b2926],
2	improvement	NN	O	improvement	nsubj	17	SENT_405	[p9l777t2901r998b2935],
3	in	IN	O	in	_	0	SENT_405	[p9l1012t2901r1042b2925],
4	the	DT	O	the	det	5	SENT_405	[p9l1056t2900r1105b2926],
5	stage	NN	O	stage	prep_in	2	SENT_405	[p9l1119t2905r1199b2935],
6	in	IN	O	in	_	0	SENT_405	[p9l190t2948r220b2972],
7	doxycycline	NN	O	doxycycline	nn	8	SENT_405	[p9l243t2947r434b2982],
8	patients	NNS	O	patient	prep_in	5	SENT_405	[p9l458t2948r587b2982],
9	manifested	VBN	O	manifest	partmod	8	SENT_405	[p9l611t2947r789b2973],
10	as	IN	O	as	_	0	SENT_405	[p9l813t2956r842b2973],
11	better	JJR	O	better	amod	13	SENT_405	[p9l865t2947r964b2973],
12	skin	NN	O	skin	nn	13	SENT_405	[p9l986t2947r1050b2973],
13	texture	NN	O	texture	prep_as	9	SENT_405	[p9l1074t2953r1198b2978],
14	,	,	O	,	_	0	SENT_405	[p9l1074t2953r1198b2978],
15	fewer	JJR	O	fewer	dep	16	SENT_405	[p9l189t2993r279b3019],
16	deep	JJ	O	deep	amod	13	SENT_405	[p9l292t2993r369b3028],
17	folds	VBZ	O	fold	_	0	SENT_405	[p9l384t2993r469b3024],
18	,	,	O	,	_	0	SENT_405	[p9l384t2993r469b3024],
19	and	CC	O	and	dep	20	SENT_405	[p9l484t2993r543b3019],
20	also	RB	O	also	dep	17	SENT_405	[p9l558t2993r618b3019],
21	fewer	JJR	O	fewer	amod	23	SENT_405	[p9l633t2993r723b3019],
22	entry	NN	O	entry	nn	23	SENT_405	[p9l736t2999r821b3028],
23	lesions	NNS	O	lesion	dobj	17	SENT_405	[p9l835t2993r944b3019],
24	of	IN	O	of	_	0	SENT_405	[p9l958t2993r993b3019],
25	the	DT	O	the	prep_of	23	SENT_405	[p9l1005t2993r1054b3019],
26	affected	VBN	O	affect	amod	25	SENT_405	[p9l1069t2993r1199b3019],

1	N	NN	O	n	nn	2	SENT_406	[p9l188t3077r261b3136],
2	PLoS	NN	O	plo	nsubj	3	SENT_406	[p9l288t3093r352b3116],
3	Pathogens	VBD	O	pathogen	_	0	SENT_406	[p9l367t3092r511b3123],
4	|	CD	NUMBER	|	num	5	SENT_406	[p9l526t3091r528b3124],
5	www	NN	O	www	dobj	3	SENT_406	[p9l543t3092r882b3123],
6	.	.	O	.	_	0	SENT_406	[p9l543t3092r882b3123],

1	p	NN	O	p	_	0	SENT_407	[p9l543t3092r882b3123],
2	|	CD	NUMBER	|	num	3	SENT_407	[p9l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	dep	1	SENT_407	[p9l543t3092r882b3123],

1	P	NN	O	p	_	0	SENT_408	[p9l2098t507r2250b533],
2	=	JJ	O	=	amod	4	SENT_408	[p9l2098t507r2250b533],
3	0.3329	CD	NUMBER	0.3329	tmod	2	SENT_408	[p9l2098t507r2250b533],
4	P	NN	O	p	dep	1	SENT_408	[p9l1872t574r2026b603],
5	=	JJ	O	=	amod	4	SENT_408	[p9l1872t574r2026b603],
6	0.0251	CD	NUMBER	0.0251	tmod	5	SENT_408	[p9l1872t574r2026b603],

1	sVEGFR-3	NN	O	svegfr-3	nn	3	SENT_409	[p9l1275t593r1302b765],
2	plasma	NN	O	plasma	nn	3	SENT_409	[p9l1275t459r1308b578],
3	levels	NNS	O	level	nsubj	4	SENT_409	[p9l1275t346r1302b444],
4	(	VBP	O	(	_	0	SENT_409	[p9l1275t217r1309b331],
5	ng/ml	JJ	O	ng/ml	amod	6	SENT_409	[p9l1275t217r1309b331],
6	)	NN	O	)	dobj	4	SENT_409	[p9l1275t217r1309b331],

1	Doxycycline	NNP	O	Doxycycline	nn	4	SENT_410	[p9l1413t774r1634b811],
2	Placebo	NNP	O	Placebo	nn	4	SENT_410	[p9l1662t774r1808b803],
3	Doxycycline	NNP	O	Doxycycline	nn	4	SENT_410	[p9l1841t774r2062b810],
4	Placebo	NNP	O	Placebo	_	0	SENT_410	[p9l2090t774r2236b803],
5	Before	IN	O	before	dep	4	SENT_410	[p9l1428t829r1544b855],
6	treatment	NN	O	treatment	pobj	5	SENT_410	[p9l1560t830r1733b855],
7	12	CD	DURATION	12	num	8	SENT_410	[p9l1926t829r1963b857],
8	months	NNS	NUMBER	month	tmod	6	SENT_410	[p9l1976t829r2107b858],

1	Figure	NNP	O	Figure	_	0	SENT_411	[p9l1277t892r1370b923],
2	8	CD	NUMBER	8	dep	1	SENT_411	[p9l1385t894r1410b916],
3	.	.	O	.	_	0	SENT_411	[p9l1385t894r1410b916],

1	Plasma	NN	O	plasma	nn	2	SENT_412	[p9l1428t892r1522b916],
2	Levels	NNS	O	level	nsubj	17	SENT_412	[p9l1540t892r1622b916],
3	of	IN	O	of	_	0	SENT_412	[p9l1638t892r1666b916],
4	sVEGFR-3	NN	O	svegfr-3	prep_of	2	SENT_412	[p9l1681t893r1808b916],
5	of	IN	O	of	_	0	SENT_412	[p9l1825t892r1853b916],
6	Lymphedema	NNP	O	Lymphedema	nn	7	SENT_412	[p9l1868t892r2056b923],
7	Patients	NNPS	O	Patients	prep_of	4	SENT_412	[p9l2074t893r2181b916],
8	before	IN	O	before	advmod	7	SENT_412	[p9l2199t892r2287b916],
9	and	CC	O	and	_	0	SENT_412	[p9l1276t933r1326b957],
10	12	CD	DURATION	12	num	11	SENT_412	[p9l1343t935r1371b957],
11	Mo	NN	DURATION	mo	conj_and	4	SENT_412	[p9l1386t934r1428b957],
12	after	IN	O	after	_	0	SENT_412	[p9l1441t933r1503b957],
13	Doxycycline	NNP	O	Doxycycline	nn	16	SENT_412	[p9l1517t933r1680b964],
14	Treatment	NNP	O	Treatment	nn	16	SENT_412	[p9l1692t934r1836b957],
15	Plasma	NN	O	plasma	nn	16	SENT_412	[p9l1277t979r1371b1003],
16	concentrations	NNS	O	concentration	prep_after	11	SENT_412	[p9l1387t980r1591b1003],
17	(	VBP	O	(	_	0	SENT_412	[p9l1607t980r1691b1007],
18	mean	NN	O	mean	dobj	17	SENT_412	[p9l1607t980r1691b1007],
19	:	:	O	:	_	0	SENT_412	[p9l1709t982r1729b1002],
20	SD	NN	O	sd	nn	21	SENT_412	[p9l1747t980r1792b1007],
21	)	NN	O	)	nsubjpass	25	SENT_412	[p9l1747t980r1792b1007],
22	of	IN	O	of	_	0	SENT_412	[p9l1807t979r1836b1003],
23	sVEGFR-3	NN	O	svegfr-3	prep_of	21	SENT_412	[p9l1848t980r1976b1003],
24	were	VBD	O	be	auxpass	25	SENT_412	[p9l1991t986r2058b1003],
25	measured	VBN	O	measure	parataxis	17	SENT_412	[p9l2073t979r2207b1003],
26	from	IN	O	from	_	0	SENT_412	[p9l2221t979r2285b1003],
27	plasma	NN	O	plasma	prep_from	25	SENT_412	[p9l1277t1014r1373b1045],
28	of	IN	O	of	_	0	SENT_412	[p9l1391t1014r1419b1038],
29	lymphedema	NN	O	lymphedema	nn	30	SENT_412	[p9l1435t1014r1614b1045],
30	patients	NNS	O	patient	prep_of	27	SENT_412	[p9l1634t1015r1743b1045],
31	before	IN	O	before	_	0	SENT_412	[p9l1762t1014r1850b1038],
32	and	CC	O	and	cc	33	SENT_412	[p9l1867t1014r1917b1038],
33	12	CD	DURATION	12	num	34	SENT_412	[p9l1938t1016r1967b1038],
34	mo	NN	DURATION	mo	prep_before	25	SENT_412	[p9l1986t1021r2028b1038],
35	after	IN	O	after	_	0	SENT_412	[p9l2046t1014r2109b1038],
36	doxycycline	NN	O	doxycycline	nn	37	SENT_412	[p9l2126t1014r2287b1045],
37	treatment	NN	O	treatment	prep_after	25	SENT_412	[p9l1275t1053r1419b1073],
38	.	.	O	.	_	0	SENT_412	[p9l1275t1053r1419b1073],

1	The	DT	O	the	det	3	SENT_413	[p9l1433t1049r1483b1073],
2	sVEGFR-3	NN	O	svegfr-3	nn	3	SENT_413	[p9l1498t1050r1625b1073],
3	levels	NNS	O	level	nsubj	4	SENT_413	[p9l1641t1049r1715b1073],
4	decreased	VBD	O	decrease	_	0	SENT_413	[p9l1730t1049r1868b1073],
5	significantly	RB	O	significantly	advmod	16	SENT_413	[p9l1883t1049r2048b1080],
6	at	IN	O	at	_	0	SENT_413	[p9l2061t1053r2086b1073],
7	12	CD	DURATION	12	num	8	SENT_413	[p9l2103t1051r2131b1073],
8	mo	NN	DURATION	mo	prep_at	5	SENT_413	[p9l2147t1056r2190b1073],
9	in	IN	O	in	_	0	SENT_413	[p9l2205t1050r2227b1073],
10	the	DT	O	the	det	13	SENT_413	[p9l2242t1049r2287b1073],
11	doxycyc	JJ	O	doxycyc	amod	13	SENT_413	[p9l1276t1084r1554b1115],
12	|	NN	O	|	nn	13	SENT_413	[p9l1276t1084r1554b1115],
13	ine	NN	O	ine	prep_in	8	SENT_413	[p9l1276t1084r1554b1115],
14	—	CD	NUMBER	—	num	16	SENT_413	[p9l1276t1084r1554b1115],
15	treated	JJ	O	treated	amod	16	SENT_413	[p9l1276t1084r1554b1115],
16	patients	NNS	O	patient	dobj	4	SENT_413	[p9l1581t1085r1692b1115],
17	(	IN	O	(	_	0	SENT_413	[p9l1719t1085r1743b1115],
18	p	NN	O	p	prep_(	16	SENT_413	[p9l1719t1085r1743b1115],
19	:	:	O	:	_	0	SENT_413	[p9l1765t1096r1787b1104],
20	0.0251	CD	NUMBER	0.0251	number	21	SENT_413	[p9l1810t1085r1910b1112],
21	)	CD	NUMBER	)	dep	16	SENT_413	[p9l1810t1085r1910b1112],
22	whereas	IN	O	whereas	mark	24	SENT_413	[p9l1935t1084r2051b1108],
23	there	EX	O	there	expl	24	SENT_413	[p9l2076t1084r2149b1108],
24	was	VBD	O	be	dep	21	SENT_413	[p9l2174t1091r2226b1108],
25	no	DT	O	no	det	26	SENT_413	[p9l2253t1091r2286b1108],
26	difference	NN	O	difference	nsubj	24	SENT_413	[p9l1276t1120r1413b1144],
27	in	IN	O	in	_	0	SENT_413	[p9l1427t1121r1449b1144],
28	the	DT	O	the	det	33	SENT_413	[p9l1462t1120r1507b1144],
29	placebo	NN	O	placebo	nn	33	SENT_413	[p9l1521t1120r1629b1151],
30	group	NN	O	group	nn	33	SENT_413	[p9l1642t1127r1725b1151],
31	(	CD	NUMBER	(	num	33	SENT_413	[p9l1739t1120r1833b1151],
32	paired	JJ	O	paired	amod	33	SENT_413	[p9l1739t1120r1833b1151],
33	t	NN	O	t	prep_in	26	SENT_413	[p9l1847t1121r1933b1148],
34	—	CD	NUMBER	—	num	36	SENT_413	[p9l1847t1121r1933b1148],
35	test	NN	O	test	nn	36	SENT_413	[p9l1847t1121r1933b1148],
36	)	NN	O	)	dep	33	SENT_413	[p9l1847t1121r1933b1148],
37	.	.	O	.	_	0	SENT_413	[p9l1847t1121r1933b1148],

1	DOI	NNP	O	DOI	_	0	SENT_414	[p9l1277t1156r1334b1179],
2	:	:	O	:	_	0	SENT_414	[p9l1277t1156r1334b1179],
3	10.1371	CD	NUMBER	10.1371	dep	1	SENT_414	[p9l1349t1155r1835b1186],
4	/	:	O	/	punct	6	SENT_414	[p9l1349t1155r1835b1186],
5	journa	NN	O	journa	nn	6	SENT_414	[p9l1349t1155r1835b1186],
6	|	NN	O	|	dep	3	SENT_414	[p9l1349t1155r1835b1186],
7	.	.	O	.	_	0	SENT_414	[p9l1349t1155r1835b1186],

1	ppat	NN	O	ppat	_	0	SENT_415	[p9l1349t1155r1835b1186],
2	.0020092	CD	NUMBER	.0020092	dep	1	SENT_415	[p9l1349t1155r1835b1186],
3	.	.	O	.	_	0	SENT_415	[p9l1349t1155r1835b1186],

1	gO08	NN	O	go08	_	0	SENT_416	[p9l1349t1155r1835b1186],

1	legs	NNS	O	leg	_	0	SENT_417	[p9l1277t1268r1335b1303],
2	(	CD	NUMBER	(	num	4	SENT_417	[p9l1349t1268r1562b1303],
3	unpublished	JJ	O	unpublished	amod	4	SENT_417	[p9l1349t1268r1562b1303],
4	data	NNS	O	datum	dep	1	SENT_417	[p9l1575t1268r1662b1300],
5	)	NN	O	)	dep	4	SENT_417	[p9l1575t1268r1662b1300],
6	.	.	O	.	_	0	SENT_417	[p9l1575t1268r1662b1300],

1	This	DT	O	this	nsubj	2	SENT_418	[p9l1676t1268r1745b1294],
2	suggests	VBZ	O	suggest	_	0	SENT_418	[p9l1758t1273r1887b1303],
3	that	IN	O	that	complm	7	SENT_418	[p9l1902t1268r1965b1294],
4	doxycycline	NN	O	doxycycline	nsubjpass	7	SENT_418	[p9l1977t1268r2168b1303],
5	can	MD	O	can	aux	7	SENT_418	[p9l2181t1277r2237b1294],
6	be	VB	O	be	auxpass	7	SENT_418	[p9l2249t1268r2286b1294],
7	used	VBN	O	use	ccomp	2	SENT_418	[p9l1276t1314r1349b1340],
8	to	TO	O	to	aux	9	SENT_418	[p9l1368t1319r1398b1340],
9	improve	VB	O	improve	xcomp	7	SENT_418	[p9l1417t1315r1551b1349],
10	the	DT	O	the	det	12	SENT_418	[p9l1570t1314r1619b1340],
11	clinical	JJ	O	clinical	amod	12	SENT_418	[p9l1637t1314r1753b1340],
12	manifestations	NNS	O	manifestation	nsubj	15	SENT_418	[p9l1772t1314r2010b1340],
13	of	IN	O	of	_	0	SENT_418	[p9l2029t1314r2063b1340],
14	lymphedema	NN	O	lymphedema	prep_of	12	SENT_418	[p9l2077t1314r2287b1349],
15	due	JJ	O	due	xcomp	9	SENT_418	[p9l1277t1361r1335b1387],
16	to	TO	O	to	_	0	SENT_418	[p9l1356t1366r1386b1387],
17	ﬁlariasis	NN	O	ﬁlariasis	prep_to	15	SENT_418	[p9l1407t1361r1548b1387],
18	.	.	O	.	_	0	SENT_418	[p9l1407t1361r1548b1387],

1	A	DT	O	a	det	2	SENT_419	[p9l1568t1361r1593b1386],
2	reduction	NN	O	reduction	nsubjpass	28	SENT_419	[p9l1614t1361r1773b1387],
3	of	IN	O	of	_	0	SENT_419	[p9l1793t1361r1828b1387],
4	the	DT	O	the	det	5	SENT_419	[p9l1846t1361r1895b1387],
5	number	NN	O	number	prep_of	2	SENT_419	[p9l1916t1361r2044b1387],
6	of	IN	O	of	_	0	SENT_419	[p9l2063t1361r2098b1387],
7	adenolymphangitis	NN	O	adenolymphangitis	nn	9	SENT_419	[p9l2115t1361r2285b1396, p9l1277t1407r1426b1442],
8	(	CD	NUMBER	(	num	9	SENT_419	[p9l1444t1408r1540b1439],
9	ADL	NNP	ORGANIZATION	ADL	prep_of	5	SENT_419	[p9l1444t1408r1540b1439],
10	)	CD	NUMBER	)	num	11	SENT_419	[p9l1444t1408r1540b1439],
11	attacks	NNS	O	attack	dep	9	SENT_419	[p9l1557t1407r1668b1433],
12	that	WDT	O	that	nsubjpass	14	SENT_419	[p9l1686t1407r1749b1433],
13	was	VBD	O	be	auxpass	14	SENT_419	[p9l1765t1416r1820b1433],
14	noted	VBN	O	note	rcmod	5	SENT_419	[p9l1838t1407r1931b1433],
15	in	IN	O	in	prep	14	SENT_419	[p9l1948t1408r1979b1432],
16	both	CC	O	both	dep	14	SENT_419	[p9l1995t1407r2077b1438],
17	,	,	O	,	_	0	SENT_419	[p9l1995t1407r2077b1438],
18	doxycycline	NN	O	doxycycline	nn	21	SENT_419	[p9l2095t1407r2286b1442],
19	and	CC	O	and	_	0	SENT_419	[p9l1277t1454r1336b1480],
20	placebo	NN	O	placebo	conj_and	18	SENT_419	[p9l1352t1454r1477b1489],
21	patients	NNS	O	patient	nsubj	25	SENT_419	[p9l1494t1455r1623b1489],
22	(	CD	NUMBER	(	num	25	SENT_419	[p9l1640t1454r1853b1489],
23	unpublished	JJ	O	unpublished	amod	25	SENT_419	[p9l1640t1454r1853b1489],
24	data	NNS	O	datum	nn	25	SENT_419	[p9l1869t1454r1948b1486],
25	)	NN	O	)	conj	14	SENT_419	[p9l1869t1454r1948b1486],
26	could	MD	O	could	aux	28	SENT_419	[p9l1964t1454r2053b1480],
27	be	VB	O	be	auxpass	28	SENT_419	[p9l2069t1454r2106b1480],
28	attributed	VBN	O	attribute	conj_and	28	SENT_419	[p9l2122t1454r2286b1480],
29	to	TO	O	to	_	0	SENT_419	[p9l1278t1507r1308b1527],
30	the	DT	O	the	det	33	SENT_419	[p9l1322t1501r1371b1527],
31	foot-care	JJ	O	foot-care	amod	33	SENT_419	[p9l1383t1501r1531b1527],
32	hygiene	NN	O	hygiene	nn	33	SENT_419	[p9l1543t1501r1669b1536],
33	training	NN	O	training	prep_to	28	SENT_419	[p9l1682t1502r1813b1536],
34	given	VBN	O	give	prep	33	SENT_419	[p9l1824t1502r1909b1536],
35	to	TO	O	to	pcomp	34	SENT_419	[p9l1923t1507r1953b1527],
36	all	PDT	O	all	predet	39	SENT_419	[p9l1966t1501r2002b1527],
37	the	DT	O	the	det	39	SENT_419	[p9l2016t1501r2065b1527],
38	lymphedema	NN	O	lymphedema	nn	39	SENT_419	[p9l2077t1501r2287b1536],
39	patients	NNS	O	patient	pobj	35	SENT_419	[p9l1277t1548r1415b1582],
40	,	,	O	,	_	0	SENT_419	[p9l1277t1548r1415b1582],
41	and	CC	O	and	_	0	SENT_419	[p9l1428t1547r1487b1573],
42	with	IN	O	with	_	0	SENT_419	[p9l1498t1547r1568b1573],
43	an	DT	O	a	det	44	SENT_419	[p9l1581t1556r1618b1573],
44	attempt	NN	O	attempt	prep_with	28	SENT_419	[p9l1631t1552r1759b1582],
45	by	IN	O	by	_	0	SENT_419	[p9l1770t1547r1807b1582],
46	patients	NNS	O	patient	prep_by	44	SENT_419	[p9l1819t1548r1948b1582],
47	to	TO	O	to	aux	48	SENT_419	[p9l1962t1552r1992b1573],
48	demonstrate	VB	O	demonstrate	infmod	46	SENT_419	[p9l2005t1547r2210b1573],
49	best	JJS	O	best	dobj	48	SENT_419	[p9l2222t1547r2287b1573],
50	compliance	NN	O	compliance	dep	49	SENT_419	[p9l1277t1594r1472b1629],
51	.	.	O	.	_	0	SENT_419	[p9l1277t1594r1472b1629],

1	This	DT	O	this	nsubj	3	SENT_420	[p9l1486t1594r1555b1620],
2	is	VBZ	O	be	cop	3	SENT_420	[p9l1569t1595r1591b1620],
3	consistent	JJ	O	consistent	_	0	SENT_420	[p9l1605t1595r1769b1620],
4	with	IN	O	with	mark	7	SENT_420	[p9l1781t1594r1851b1620],
5	other	JJ	O	other	amod	6	SENT_420	[p9l1864t1594r1953b1620],
6	reports	NNS	O	report	nsubj	7	SENT_420	[p9l1965t1599r2082b1629],
7	[	VBP	O	[	advcl	3	SENT_420	[p9l2098t1591r2286b1626],
8	8	CD	NUMBER	8	dobj	7	SENT_420	[p9l2098t1591r2286b1626],
9	,	,	O	,	_	0	SENT_420	[p9l2098t1591r2286b1626],
10	l0	CD	NUMBER	l0	num	12	SENT_420	[p9l2098t1591r2286b1626],
11	,69,70	CD	NUMBER	,69,70	num	12	SENT_420	[p9l2098t1591r2286b1626],
12	]	NN	O	]	appos	8	SENT_420	[p9l2098t1591r2286b1626],
13	,	,	O	,	_	0	SENT_420	[p9l2098t1591r2286b1626],
14	which	WDT	O	which	nsubj	16	SENT_420	[p9l1276t1640r1371b1666],
15	also	RB	O	also	advmod	16	SENT_420	[p9l1389t1640r1449b1666],
16	showed	VBD	O	show	rcmod	8	SENT_420	[p9l1468t1640r1587b1666],
17	a	DT	O	a	det	19	SENT_420	[p9l1605t1649r1621b1666],
18	signiﬁcant	JJ	O	signiﬁcant	amod	19	SENT_420	[p9l1638t1640r1806b1675],
19	reduction	NN	O	reduction	nsubj	22	SENT_420	[p9l1824t1640r1983b1666],
20	of	IN	O	of	_	0	SENT_420	[p9l2001t1640r2036b1666],
21	attacks	NNS	O	attack	prep_of	19	SENT_420	[p9l2050t1640r2160b1666],
22	due	JJ	O	due	xcomp	16	SENT_420	[p9l2179t1640r2237b1666],
23	to	TO	O	to	_	0	SENT_420	[p9l2256t1646r2286b1666],
24	foot-care	JJ	O	foot-care	amod	25	SENT_420	[p9l1277t1687r1426b1713],
25	hygiene	NN	O	hygiene	prep_to	22	SENT_420	[p9l1453t1687r1587b1722],
26	.	.	O	.	_	0	SENT_420	[p9l1453t1687r1587b1722],

1	However	RB	O	however	advmod	10	SENT_421	[p9l1615t1688r1769b1718],
2	,	,	O	,	_	0	SENT_421	[p9l1615t1688r1769b1718],
3	a	DT	O	a	det	4	SENT_421	[p9l1798t1696r1814b1713],
4	combination	NN	O	combination	nsubj	10	SENT_421	[p9l1841t1687r2050b1713],
5	of	IN	O	of	_	0	SENT_421	[p9l2078t1687r2113b1713],
6	foot-care	JJ	O	foot-care	amod	7	SENT_421	[p9l2137t1687r2286b1713],
7	hygiene	NN	O	hygiene	prep_of	4	SENT_421	[p9l1276t1734r1401b1769],
8	and	CC	O	and	_	0	SENT_421	[p9l1421t1734r1480b1760],
9	DEC	NNP	ORGANIZATION	DEC	prep_of	4	SENT_421	[p9l1499t1734r1571b1760],
10	gave	VBD	O	give	_	0	SENT_421	[p9l1591t1743r1661b1769],
11	no	DT	O	no	det	13	SENT_421	[p9l1681t1743r1720b1760],
12	additional	JJ	O	additional	amod	13	SENT_421	[p9l1740t1734r1906b1760],
13	beneﬁts	NNS	O	beneﬁts	nsubj	21	SENT_421	[p9l1925t1734r2052b1760],
14	regarding	VBG	O	regard	_	0	SENT_421	[p9l2072t1734r2230b1769],
15	an	DT	O	a	det	16	SENT_421	[p9l2249t1743r2286b1760],
16	improvement	NN	O	improvement	prep_regarding	13	SENT_421	[p9l1277t1781r1504b1815],
17	of	IN	O	of	_	0	SENT_421	[p9l1532t1780r1567b1806],
18	the	DT	O	the	det	20	SENT_421	[p9l1594t1780r1644b1806],
19	lymphedema	NN	O	lymphedema	nn	20	SENT_421	[p9l1672t1780r1887b1815],
20	stages	NNS	O	stage	prep_of	16	SENT_421	[p9l1915t1785r2011b1815],
21	[	VBP	O	[	ccomp	10	SENT_421	[p9l2042t1778r2187b1812],
22	8,69,70	CD	NUMBER	8,69,70	number	23	SENT_421	[p9l2042t1778r2187b1812],
23	]	CD	NUMBER	]	dobj	21	SENT_421	[p9l2042t1778r2187b1812],
24	.	.	O	.	_	0	SENT_421	[p9l2042t1778r2187b1812],

1	This	DT	O	this	nsubj	2	SENT_422	[p9l2216t1780r2286b1806],
2	conﬁrms	VBZ	O	conﬁrms	_	0	SENT_422	[p9l1277t1827r1418b1853],
3	that	IN	O	that	complm	10	SENT_422	[p9l1438t1827r1501b1853],
4	local	JJ	O	local	amod	6	SENT_422	[p9l1520t1827r1595b1853],
5	limb	NN	O	limb	nn	6	SENT_422	[p9l1613t1827r1685b1853],
6	care	NN	O	care	nsubj	10	SENT_422	[p9l1704t1836r1772b1853],
7	is	VBZ	O	be	cop	10	SENT_422	[p9l1791t1828r1813b1853],
8	an	DT	O	a	det	10	SENT_422	[p9l1832t1836r1870b1853],
9	important	JJ	O	important	amod	10	SENT_422	[p9l1889t1828r2055b1862],
10	intervention	NN	O	intervention	ccomp	2	SENT_422	[p9l2074t1828r2286b1858],
11	,	,	O	,	_	0	SENT_422	[p9l2074t1828r2286b1858],
12	whereas	IN	O	whereas	mark	17	SENT_422	[p9l1276t1874r1406b1900],
13	addition	NN	O	addition	nsubj	17	SENT_422	[p9l1421t1874r1558b1900],
14	of	IN	O	of	_	0	SENT_422	[p9l1574t1874r1608b1900],
15	doxycycline	NN	O	doxycycline	prep_of	13	SENT_422	[p9l1620t1874r1811b1909],
16	further	JJ	O	further	amod	15	SENT_422	[p9l1826t1874r1944b1900],
17	reduces	VBZ	O	reduce	advcl	10	SENT_422	[p9l1959t1874r2082b1900],
18	the	DT	O	the	det	19	SENT_422	[p9l2098t1874r2148b1900],
19	severity	NN	O	severity	dobj	17	SENT_422	[p9l2163t1875r2287b1909],
20	of	IN	O	of	_	0	SENT_422	[p9l1277t1920r1311b1946],
21	lymphedema	NN	O	lymphedema	prep_of	19	SENT_422	[p9l1330t1920r1546b1955],
22	.	.	O	.	_	0	SENT_422	[p9l1330t1920r1546b1955],

1	Neither	DT	O	neither	det	2	SENT_423	[p9l1569t1920r1695b1946],
2	doxycycline	NN	O	doxycycline	nsubj	6	SENT_423	[p9l1716t1920r1907b1955],
3	nor	CC	O	nor	_	0	SENT_423	[p9l1930t1929r1987b1946],
4	placebo	NN	O	placebo	nn	5	SENT_423	[p9l2008t1920r2133b1955],
5	patients	NNS	O	patient	conj_nor	2	SENT_423	[p9l2157t1921r2286b1955],
6	showed	VBD	O	show	_	0	SENT_423	[p9l1277t1967r1396b1993],
7	a	DT	O	a	det	9	SENT_423	[p9l1414t1976r1430b1993],
8	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_423	[p9l1448t1967r1617b2002],
9	reduction	NN	O	reduction	dobj	6	SENT_423	[p9l1636t1967r1794b1993],
10	of	IN	O	of	_	0	SENT_423	[p9l1813t1967r1848b1993],
11	the	DT	O	the	det	12	SENT_423	[p9l1864t1967r1913b1993],
12	circumference	NN	O	circumference	prep_of	9	SENT_423	[p9l1932t1967r2168b1993],
13	of	IN	O	of	_	0	SENT_423	[p9l2186t1967r2221b1993],
14	the	DT	O	the	det	16	SENT_423	[p9l2237t1967r2286b1993],
15	affected	VBN	O	affect	amod	16	SENT_423	[p9l1277t2013r1407b2039],
16	legs	NNS	O	leg	prep_of	12	SENT_423	[p9l1424t2013r1490b2048],
17	.	.	O	.	_	0	SENT_423	[p9l1424t2013r1490b2048],

1	This	DT	DATE	this	nsubj	4	SENT_424	[p9l1508t2013r1577b2039],
2	may	MD	DATE	may	aux	4	SENT_424	[p9l1595t2022r1660b2048],
3	be	VB	O	be	cop	4	SENT_424	[p9l1676t2013r1713b2039],
4	due	JJ	O	due	_	0	SENT_424	[p9l1731t2013r1789b2039],
5	to	TO	O	to	_	0	SENT_424	[p9l1808t2018r1837b2039],
6	the	DT	O	the	det	7	SENT_424	[p9l1856t2013r1905b2039],
7	fact	NN	O	fact	prep_to	4	SENT_424	[p9l1922t2013r1982b2039],
8	that	IN	O	that	complm	16	SENT_424	[p9l2000t2013r2063b2039],
9	that	IN	O	that	dep	16	SENT_424	[p9l2081t2013r2144b2039],
10	circumference	NN	O	circumference	nn	11	SENT_424	[p9l2161t2014r2286b2039, p9l1277t2060r1397b2086],
11	determination	NN	O	determination	nsubj	16	SENT_424	[p9l1416t2060r1652b2086],
12	is	VBZ	O	be	cop	16	SENT_424	[p9l1671t2061r1693b2086],
13	not	RB	O	not	neg	16	SENT_424	[p9l1712t2065r1766b2086],
14	a	DT	O	a	det	16	SENT_424	[p9l1784t2069r1800b2086],
15	reliable	JJ	O	reliable	amod	16	SENT_424	[p9l1819t2060r1939b2086],
16	parameter	NN	O	parameter	ccomp	4	SENT_424	[p9l1958t2065r2129b2095],
17	to	TO	O	to	aux	18	SENT_424	[p9l2147t2065r2177b2086],
18	assess	VB	O	assess	infmod	16	SENT_424	[p9l2197t2069r2286b2086],
19	improvement	NN	O	improvement	dobj	18	SENT_424	[p9l1277t2107r1498b2141],
20	of	IN	O	of	_	0	SENT_424	[p9l1514t2106r1549b2132],
21	the	DT	O	the	det	22	SENT_424	[p9l1562t2106r1611b2132],
22	disease	NN	O	disease	prep_of	19	SENT_424	[p9l1628t2106r1748b2137],
23	,	,	O	,	_	0	SENT_424	[p9l1628t2106r1748b2137],
24	as	IN	O	as	mark	30	SENT_424	[p9l1766t2115r1795b2132],
25	suggested	VBN	O	suggest	csubj	30	SENT_424	[p9l1811t2106r1967b2141],
26	by	IN	O	by	_	0	SENT_424	[p9l1982t2106r2019b2141],
27	Dreyer	NNP	PERSON	Dreyer	prep_by	25	SENT_424	[p9l2034t2107r2147b2141],
28	and	CC	O	and	_	0	SENT_424	[p9l2162t2106r2221b2132],
29	coworkers	NNS	O	coworker	prep_by	25	SENT_424	[p9l2238t2115r2286b2132, p9l1276t2153r1404b2179],
30	[	VBP	O	[	advcl	16	SENT_424	[p9l1426t2151r1491b2185],
31	47	CD	NUMBER	47	num	32	SENT_424	[p9l1426t2151r1491b2185],
32	]	CD	NUMBER	]	dobj	30	SENT_424	[p9l1426t2151r1491b2185],
33	,	,	O	,	_	0	SENT_424	[p9l1426t2151r1491b2185],
34	since	IN	O	since	mark	36	SENT_424	[p9l1511t2154r1592b2179],
35	it	PRP	O	it	nsubj	36	SENT_424	[p9l1612t2154r1634b2179],
36	shows	VBZ	O	show	advcl	4	SENT_424	[p9l1653t2153r1746b2179],
37	considerable	JJ	O	considerable	amod	38	SENT_424	[p9l1766t2153r1973b2179],
38	variability	NN	O	variability	dobj	36	SENT_424	[p9l1993t2153r2157b2188],
39	due	JJ	O	due	_	0	SENT_424	[p9l2177t2153r2235b2179],
40	to	TO	O	to	_	0	SENT_424	[p9l2256t2159r2286b2179],
41	transient	JJ	O	transient	amod	42	SENT_424	[p9l1278t2201r1423b2226],
42	effects	NNS	O	effect	prep_due_to	36	SENT_424	[p9l1436t2200r1540b2226],
43	such	JJ	O	such	_	0	SENT_424	[p9l1553t2200r1624b2226],
44	as	IN	O	as	_	0	SENT_424	[p9l1638t2209r1667b2226],
45	keeping	VBG	O	keep	prepc_such_as	42	SENT_424	[p9l1679t2200r1809b2235],
46	the	DT	O	the	det	47	SENT_424	[p9l1822t2200r1871b2226],
47	leg	NN	O	leg	dobj	45	SENT_424	[p9l1884t2200r1930b2235],
48	elevated	JJ	O	elevated	amod	47	SENT_424	[p9l1942t2200r2075b2226],
49	in	IN	O	in	_	0	SENT_424	[p9l2089t2201r2119b2225],
50	the	DT	DURATION	the	det	51	SENT_424	[p9l2133t2200r2182b2226],
51	hours	NNS	DURATION	hour	prep_in	47	SENT_424	[p9l2195t2200r2286b2226],
52	before	IN	O	before	_	0	SENT_424	[p9l1276t2246r1381b2272],
53	measurement	NN	O	measurement	prep_before	51	SENT_424	[p9l1396t2251r1625b2277],
54	,	,	O	,	_	0	SENT_424	[p9l1396t2251r1625b2277],
55	or	CC	O	or	_	0	SENT_424	[p9l1640t2255r1675b2272],
56	the	DT	O	the	det	60	SENT_424	[p9l1690t2246r1739b2272],
57	female	JJ	O	female	amod	60	SENT_424	[p9l1753t2246r1861b2272],
58	monthly	JJ	SET	monthly	amod	60	SENT_424	[p9l1876t2246r2011b2281],
59	hormonal	JJ	O	hormonal	amod	60	SENT_424	[p9l2024t2246r2184b2272],
60	cycle	NN	O	cycle	dobj	45	SENT_424	[p9l2199t2246r2285b2281],
61	,	,	O	,	_	0	SENT_424	[p9l2199t2246r2285b2281],
62	etc.	FW	O	etc.	nn	63	SENT_424	[p9l1277t2298r1331b2319],
63	[	FW	O	[	appos	60	SENT_424	[p9l1349t2291r1413b2325],
64	47	CD	NUMBER	47	num	65	SENT_424	[p9l1349t2291r1413b2325],
65	]	NN	O	]	dep	63	SENT_424	[p9l1349t2291r1413b2325],
66	.	.	O	.	_	0	SENT_424	[p9l1349t2291r1413b2325],

1	Clinical	JJ	O	clinical	amod	2	SENT_425	[p9l1314t2340r1438b2366],
2	manifestations	NNS	O	manifestation	nsubj	8	SENT_425	[p9l1453t2340r1692b2366],
3	of	IN	O	of	_	0	SENT_425	[p9l1707t2340r1742b2366],
4	lymphedema	NN	O	lymphedema	prep_of	2	SENT_425	[p9l1752t2340r1962b2375],
5	do	VBP	O	do	aux	8	SENT_425	[p9l1976t2340r2015b2366],
6	not	RB	O	not	neg	8	SENT_425	[p9l2031t2345r2085b2366],
7	only	RB	O	only	advmod	8	SENT_425	[p9l2099t2340r2168b2375],
8	hasten	VB	O	hasten	_	0	SENT_425	[p9l2181t2340r2286b2366],
9	the	DT	O	the	det	10	SENT_425	[p9l1278t2387r1327b2413],
10	progression	NN	O	progression	dobj	8	SENT_425	[p9l1340t2388r1532b2422],
11	of	IN	O	of	_	0	SENT_425	[p9l1545t2387r1579b2413],
12	lymphedema	NN	O	lymphedema	prep_of	10	SENT_425	[p9l1589t2387r1798b2422],
13	to	TO	O	to	_	0	SENT_425	[p9l1812t2393r1842b2413],
14	elephantiasis	NN	O	elephantiasis	prep_to	8	SENT_425	[p9l1855t2387r2065b2422],
15	[	CD	NUMBER	[	number	16	SENT_425	[p9l2081t2384r2145b2419],
16	71	CD	NUMBER	71	num	17	SENT_425	[p9l2081t2384r2145b2419],
17	]	NN	O	]	dep	14	SENT_425	[p9l2081t2384r2145b2419],
18	,	,	O	,	_	0	SENT_425	[p9l2081t2384r2145b2419],
19	but	CC	O	but	_	0	SENT_425	[p9l2159t2387r2212b2413],
20	also	RB	O	also	advmod	8	SENT_425	[p9l2226t2387r2286b2413],
21	reduce	VB	O	reduce	conj_but	8	SENT_425	[p9l1277t2433r1387b2459],
22	the	DT	O	the	det	23	SENT_425	[p9l1401t2433r1450b2459],
23	workforce	NN	O	workforce	dobj	21	SENT_425	[p9l1462t2433r1627b2459],
24	and	CC	O	and	_	0	SENT_425	[p9l1640t2433r1699b2459],
25	economic	JJ	O	economic	amod	26	SENT_425	[p9l1712t2434r1869b2459],
26	resources	NNS	O	resource	nsubj	33	SENT_425	[p9l1884t2442r2036b2459],
27	of	IN	O	of	_	0	SENT_425	[p9l2049t2433r2084b2459],
28	the	DT	O	the	det	30	SENT_425	[p9l2094t2433r2143b2459],
29	affected	VBN	O	affect	amod	30	SENT_425	[p9l2157t2433r2286b2459],
30	individuals	NNS	O	individual	prep_of	26	SENT_425	[p9l1277t2480r1454b2506],
31	and	CC	O	and	_	0	SENT_425	[p9l1470t2480r1529b2506],
32	communities	NNS	O	community	conj_and	30	SENT_425	[p9l1545t2481r1755b2506],
33	[	VBP	O	[	conj_and	8	SENT_425	[p9l1773t2477r1876b2512],
34	72,73	CD	NUMBER	72,73	number	35	SENT_425	[p9l1773t2477r1876b2512],
35	]	CD	NUMBER	]	dobj	33	SENT_425	[p9l1773t2477r1876b2512],
36	in	IN	O	in	_	0	SENT_425	[p9l1893t2481r1924b2505],
37	many	JJ	O	many	amod	39	SENT_425	[p9l1940t2489r2027b2515],
38	endemic	JJ	O	endemic	amod	39	SENT_425	[p9l2042t2480r2179b2506],
39	areas	NNS	O	area	prep_in	35	SENT_425	[p9l2196t2489r2285b2506],
40	.	.	O	.	_	0	SENT_425	[p9l2196t2489r2285b2506],

1	Therefore	RB	O	therefore	advmod	7	SENT_426	[p9l1276t2526r1449b2557],
2	,	,	O	,	_	0	SENT_426	[p9l1276t2526r1449b2557],
3	better	JJR	O	better	amod	5	SENT_426	[p9l1464t2526r1563b2552],
4	treatment	NN	O	treatment	nn	5	SENT_426	[p9l1578t2531r1739b2552],
5	options	NNS	O	option	nsubj	7	SENT_426	[p9l1754t2527r1876b2561],
6	are	VBP	O	be	cop	7	SENT_426	[p9l1892t2535r1941b2552],
7	mandatory	JJ	O	mandatory	_	0	SENT_426	[p9l1956t2526r2141b2561],
8	.	.	O	.	_	0	SENT_426	[p9l1956t2526r2141b2561],

1	The	DT	O	the	det	3	SENT_427	[p9l1314t2573r1376b2599],
2	current	JJ	DATE	current	amod	3	SENT_427	[p9l1389t2579r1511b2599],
3	treatment	NN	O	treatment	nsubj	15	SENT_427	[p9l1524t2578r1685b2599],
4	of	IN	O	of	_	0	SENT_427	[p9l1698t2573r1732b2599],
5	lymphedema	NN	O	lymphedema	prep_of	3	SENT_427	[p9l1741t2573r1958b2608],
6	,	,	O	,	_	0	SENT_427	[p9l1741t2573r1958b2608],
7	which	WDT	O	which	nsubj	9	SENT_427	[p9l1971t2573r2066b2599],
8	mainly	RB	O	mainly	advmod	9	SENT_427	[p9l2079t2573r2188b2608],
9	relies	VBZ	O	rely	rcmod	3	SENT_427	[p9l2201t2573r2286b2599],
10	on	IN	O	on	_	0	SENT_427	[p9l1277t2629r1317b2646],
11	foot	NN	O	foot	nn	12	SENT_427	[p9l1339t2620r1405b2646],
12	hygiene	NN	O	hygiene	prep_on	9	SENT_427	[p9l1425t2620r1559b2655],
13	,	,	O	,	_	0	SENT_427	[p9l1425t2620r1559b2655],
14	is	VBZ	O	be	cop	15	SENT_427	[p9l1581t2621r1603b2646],
15	suboptimal	JJ	O	suboptimal	_	0	SENT_427	[p9l1625t2620r1807b2655],
16	and	CC	O	and	_	0	SENT_427	[p9l1829t2620r1888b2646],
17	still	RB	O	still	advmod	18	SENT_427	[p9l1910t2620r1967b2646],
18	empirical	JJ	O	empirical	conj_and	15	SENT_427	[p9l1988t2620r2150b2655],
19	.	.	O	.	_	0	SENT_427	[p9l1988t2620r2150b2655],

1	This	DT	O	this	nsubj	2	SENT_428	[p9l2173t2620r2242b2646],
2	is	VBZ	O	be	_	0	SENT_428	[p9l2264t2621r2286b2646],
3	because	IN	O	because	mark	7	SENT_428	[p9l1276t2667r1403b2693],
4	it	PRP	O	it	nsubj	7	SENT_428	[p9l1416t2668r1438b2693],
5	is	VBZ	O	be	cop	7	SENT_428	[p9l1451t2668r1473b2693],
6	not	RB	O	not	neg	7	SENT_428	[p9l1487t2672r1540b2693],
7	clear	JJ	O	clear	advcl	2	SENT_428	[p9l1553t2667r1632b2693],
8	at	IN	O	at	_	0	SENT_428	[p9l1644t2672r1673b2693],
9	present	JJ	DATE	present	prep_at	7	SENT_428	[p9l1686t2672r1808b2702],
10	to	TO	O	to	_	0	SENT_428	[p9l1821t2672r1851b2693],
11	which	WDT	O	which	det	12	SENT_428	[p9l1864t2667r1959b2693],
12	extent	NN	O	extent	rel	16	SENT_428	[p9l1973t2672r2075b2693],
13	ADL	NN	ORGANIZATION	adl	nn	14	SENT_428	[p9l2086t2668r2162b2692],
14	attacks	NNS	O	attack	nsubjpass	16	SENT_428	[p9l2175t2667r2286b2693],
15	are	VBP	O	be	auxpass	16	SENT_428	[p9l1277t2722r1326b2739],
16	caused	VBN	O	cause	rcmod	9	SENT_428	[p9l1354t2713r1463b2739],
17	by	IN	O	by	prep	16	SENT_428	[p9l1490t2713r1527b2748],
18	either	CC	O	either	dep	17	SENT_428	[p9l1555t2713r1652b2739],
19	ﬁlarial	JJ	O	ﬁlarial	amod	20	SENT_428	[p9l1678t2713r1783b2739],
20	worms	NNS	O	worm	conj	17	SENT_428	[p9l1810t2722r1925b2744],
21	,	,	O	,	_	0	SENT_428	[p9l1810t2722r1925b2744],
22	including	VBG	O	include	_	0	SENT_428	[p9l1954t2713r2109b2748],
23	Wolbachia	JJ	O	wolbachia	amod	24	SENT_428	[p9l2138t2713r2287b2739],
24	endosymbionts	NNS	O	endosymbiont	prep_including	20	SENT_428	[p9l1277t2760r1531b2795],
25	,	,	O	,	_	0	SENT_428	[p9l1277t2760r1531b2795],
26	by	IN	O	by	_	0	SENT_428	[p9l1546t2760r1583b2795],
27	exogenous	JJ	O	exogenous	amod	28	SENT_428	[p9l1597t2769r1769b2795],
28	bacteria	NNS	O	bacterium	prep_by	17	SENT_428	[p9l1784t2760r1923b2791],
29	,	,	O	,	_	0	SENT_428	[p9l1784t2760r1923b2791],
30	or	CC	O	or	_	0	SENT_428	[p9l1939t2769r1975b2786],
31	by	IN	O	by	_	0	SENT_428	[p9l1988t2760r2025b2795],
32	both	DT	O	both	det	35	SENT_428	[p9l2039t2760r2114b2786],
33	[	CD	NUMBER	[	number	34	SENT_428	[p9l2131t2758r2242b2792],
34	74,75	CD	NUMBER	74,75	num	35	SENT_428	[p9l2131t2758r2242b2792],
35	]	NN	O	]	prep_by	7	SENT_428	[p9l2131t2758r2242b2792],
36	.	.	O	.	_	0	SENT_428	[p9l2131t2758r2242b2792],

1	Several	JJ	O	several	amod	3	SENT_429	[p9l1314t2807r1430b2833],
2	chemotherapeutic	JJ	O	chemotherapeutic	amod	3	SENT_429	[p9l1447t2807r1744b2842],
3	agents	NNS	O	agent	nsubjpass	6	SENT_429	[p9l1762t2812r1864b2842],
4	have	VBP	O	have	aux	6	SENT_429	[p9l1880t2807r1953b2833],
5	been	VBN	O	be	auxpass	6	SENT_429	[p9l1969t2807r2047b2833],
6	tested	VBN	O	test	_	0	SENT_429	[p9l2064t2807r2167b2838],
7	,	,	O	,	_	0	SENT_429	[p9l2064t2807r2167b2838],
8	but	CC	O	but	_	0	SENT_429	[p9l2184t2807r2238b2833],
9	so	RB	O	so	advmod	10	SENT_429	[p9l2254t2816r2286b2833],
10	far	RB	O	far	advmod	18	SENT_429	[p9l1277t2853r1329b2884],
11	,	,	O	,	_	0	SENT_429	[p9l1277t2853r1329b2884],
12	only	RB	O	only	advmod	14	SENT_429	[p9l1352t2853r1421b2888],
13	5,6	CD	NUMBER	5,6	num	14	SENT_429	[p9l1444t2853r1488b2884],
14	benzo-alpha-pyrone	NN	O	benzo-alpha-pyrone	nsubj	18	SENT_429	[p9l1509t2853r1838b2888],
15	(	CD	NUMBER	(	num	17	SENT_429	[p9l1862t2854r2040b2885],
16	coumarin	NN	O	coumarin	nn	17	SENT_429	[p9l1862t2854r2040b2885],
17	)	NN	O	)	dep	14	SENT_429	[p9l1862t2854r2040b2885],
18	showed	VBD	O	show	conj_but	6	SENT_429	[p9l2062t2853r2181b2879],
19	some	DT	O	some	det	21	SENT_429	[p9l2204t2862r2286b2879],
20	encouraging	JJ	O	encouraging	amod	21	SENT_429	[p9l1277t2901r1480b2935],
21	results	NNS	O	result	nsubj	22	SENT_429	[p9l1503t2900r1607b2926],
22	[	VBP	O	[	ccomp	18	SENT_429	[p9l1632t2897r1696b2932],
23	76	CD	NUMBER	76	number	24	SENT_429	[p9l1632t2897r1696b2932],
24	]	CD	NUMBER	]	dobj	22	SENT_429	[p9l1632t2897r1696b2932],
25	.	.	O	.	_	0	SENT_429	[p9l1632t2897r1696b2932],

1	However	RB	O	however	advmod	8	SENT_430	[p9l1720t2901r1872b2931],
2	,	,	O	,	_	0	SENT_430	[p9l1720t2901r1872b2931],
3	this	DT	O	this	det	4	SENT_430	[p9l1897t2900r1953b2926],
4	drug	NN	O	drug	nsubjpass	8	SENT_430	[p9l1976t2900r2052b2935],
5	is	VBZ	O	be	auxpass	8	SENT_430	[p9l2074t2901r2096b2926],
6	no	RB	O	no	advmod	7	SENT_430	[p9l2120t2909r2159b2926],
7	longer	RB	O	longer	advmod	8	SENT_430	[p9l2182t2900r2287b2935],
8	recommended	VBN	O	recommend	_	0	SENT_430	[p9l1277t2947r1512b2973],
9	since	IN	O	since	mark	13	SENT_430	[p9l1525t2948r1605b2973],
10	it	PRP	O	it	nsubjpass	13	SENT_430	[p9l1618t2948r1640b2973],
11	has	VBZ	O	have	aux	13	SENT_430	[p9l1652t2947r1703b2973],
12	been	VBN	O	be	auxpass	13	SENT_430	[p9l1715t2947r1792b2973],
13	shown	VBN	O	show	advcl	8	SENT_430	[p9l1805t2947r1907b2973],
14	to	TO	O	to	aux	17	SENT_430	[p9l1920t2952r1950b2973],
15	be	VB	O	be	cop	17	SENT_430	[p9l1963t2947r2000b2973],
16	hepatotoxic	JJ	O	hepatotoxic	amod	17	SENT_430	[p9l2012t2947r2205b2982],
17	[	NN	O	[	xcomp	13	SENT_430	[p9l2221t2944r2285b2979],
18	77	CD	NUMBER	77	num	19	SENT_430	[p9l2221t2944r2285b2979],
19	]	NN	O	]	dep	17	SENT_430	[p9l2221t2944r2285b2979],
20	.	.	O	.	_	0	SENT_430	[p9l2221t2944r2285b2979],

1	Penicillin	NN	O	penicillin	nsubjpass	24	SENT_431	[p9l1277t2993r1439b3024],
2	,	,	O	,	_	0	SENT_431	[p9l1277t2993r1439b3024],
3	which	WDT	O	which	nsubj	4	SENT_431	[p9l1460t2993r1555b3019],
4	acts	VBZ	O	act	rcmod	1	SENT_431	[p9l1576t2998r1635b3019],
5	on	IN	O	on	prep	4	SENT_431	[p9l1656t3002r1697b3019],
6	some	DT	O	some	det	8	SENT_431	[p9l1717t3002r1800b3019],
7	exogenous	JJ	O	exogenous	amod	8	SENT_431	[p9l1820t3002r1992b3028],
8	bacteria	NNS	O	bacterium	pobj	5	SENT_431	[p9l2012t2993r2144b3019],
9	such	JJ	O	such	_	0	SENT_431	[p9l2165t2993r2236b3019],
10	as	IN	O	as	_	0	SENT_431	[p9l2257t3002r2286b3019],
11	streptococci	NNS	O	streptococcus	prep_such_as	8	SENT_431	[p10l189t207r397b241],
12	,	,	O	,	_	0	SENT_431	[p10l189t207r397b241],
13	but	CC	O	but	_	0	SENT_431	[p10l417t206r471b232],
14	not	RB	O	not	prep	4	SENT_431	[p10l490t212r544b232],
15	on	IN	O	on	dep	5	SENT_431	[p10l563t215r604b232],
16	Wolbachia	JJ	LOCATION	wolbachia	amod	17	SENT_431	[p10l626t206r774b232],
17	endosymbionts	NNS	O	endosymbiont	pobj	15	SENT_431	[p10l793t206r1047b241],
18	,	,	O	,	_	0	SENT_431	[p10l793t206r1047b241],
19	has	VBZ	O	have	aux	22	SENT_431	[p10l1067t206r1118b232],
20	also	RB	O	also	advmod	22	SENT_431	[p10l1138t206r1198b232],
21	been	VBN	O	be	auxpass	22	SENT_431	[p10l189t252r266b278],
22	tested	VBN	O	test	_	0	SENT_431	[p10l279t252r373b278],
23	and	CC	O	and	_	0	SENT_431	[p10l385t252r444b278],
24	reported	VBN	O	report	conj_and	22	SENT_431	[p10l456t252r599b287],
25	to	TO	O	to	aux	27	SENT_431	[p10l612t257r642b278],
26	be	VB	O	be	cop	27	SENT_431	[p10l653t252r690b278],
27	beneﬁcial	JJ	O	beneﬁcial	xcomp	22	SENT_431	[p10l702t252r859b278],
28	in	IN	O	in	_	0	SENT_431	[p10l871t253r901b277],
29	reducing	VBG	O	reduce	prepc_in	27	SENT_431	[p10l913t252r1058b287],
30	only	RB	O	only	advmod	32	SENT_431	[p10l1068t252r1137b287],
31	the	DT	O	the	det	32	SENT_431	[p10l1150t252r1199b278],
32	incidence	NN	O	incidence	nsubj	36	SENT_431	[p10l190t298r346b324],
33	of	IN	O	of	_	0	SENT_431	[p10l367t298r402b324],
34	ADL	NN	ORGANIZATION	adl	nn	35	SENT_431	[p10l418t298r494b323],
35	attacks	NNS	O	attack	prep_of	32	SENT_431	[p10l514t298r625b324],
36	[	VBP	O	[	ccomp	29	SENT_431	[p10l648t298r693b330],
37	8	CD	NUMBER	8	number	38	SENT_431	[p10l648t298r693b330],
38	]	CD	NUMBER	]	dobj	36	SENT_431	[p10l648t298r693b330],
39	,	,	O	,	_	0	SENT_431	[p10l648t298r693b330],
40	but	CC	O	but	_	0	SENT_431	[p10l714t298r768b324],
41	there	EX	O	there	expl	42	SENT_431	[p10l789t298r873b324],
42	was	VBD	O	be	conj_but	22	SENT_431	[p10l893t307r948b324],
43	no	DT	O	no	det	45	SENT_431	[p10l970t307r1009b324],
44	signiﬁcant	JJ	O	signiﬁcant	amod	45	SENT_431	[p10l1031t298r1199b333],
45	reduction	NN	O	reduction	nsubj	42	SENT_431	[p10l190t343r349b369],
46	in	IN	O	in	_	0	SENT_431	[p10l367t344r397b368],
47	the	DT	O	the	det	48	SENT_431	[p10l416t343r465b369],
48	lymphedema	NN	O	lymphedema	prep_in	45	SENT_431	[p10l482t343r692b378],
49	stages	NNS	O	stage	nsubj	50	SENT_431	[p10l709t349r802b378],
50	[	VBP	O	[	rcmod	48	SENT_431	[p10l822t343r867b375],
51	8	CD	NUMBER	8	number	52	SENT_431	[p10l822t343r867b375],
52	]	CD	NUMBER	]	dobj	50	SENT_431	[p10l822t343r867b375],
53	.	.	O	.	_	0	SENT_431	[p10l822t343r867b375],

1	In	IN	O	in	_	0	SENT_432	[p10l885t344r918b368],
2	contrast	NN	O	contrast	prep_in	11	SENT_432	[p10l936t348r1077b374],
3	,	,	O	,	_	0	SENT_432	[p10l936t348r1077b374],
4	in	IN	O	in	_	0	SENT_432	[p10l1095t344r1125b368],
5	our	PRP$	O	we	poss	6	SENT_432	[p10l1143t352r1200b369],
6	study	NN	O	study	prep_in	11	SENT_432	[p10l189t389r286b424],
7	,	,	O	,	_	0	SENT_432	[p10l189t389r286b424],
8	treatment	NN	O	treatment	nsubj	11	SENT_432	[p10l316t394r484b415],
9	with	IN	O	with	_	0	SENT_432	[p10l511t389r583b415],
10	doxycycline	NN	O	doxycycline	prep_with	8	SENT_432	[p10l612t389r811b424],
11	led	VBD	O	lead	_	0	SENT_432	[p10l840t389r889b415],
12	to	TO	O	to	_	0	SENT_432	[p10l919t394r950b415],
13	a	DT	O	a	det	15	SENT_432	[p10l980t398r996b415],
14	signiﬁcant	JJ	O	signiﬁcant	amod	15	SENT_432	[p10l1024t389r1199b424],
15	amelioration	NN	O	amelioration	prep_to	11	SENT_432	[p10l189t435r400b461],
16	of	IN	O	of	_	0	SENT_432	[p10l421t435r456b461],
17	lymphedema	NN	O	lymphedema	nn	18	SENT_432	[p10l474t435r683b470],
18	stages	NNS	O	stage	prep_of	15	SENT_432	[p10l704t440r806b470],
19	.	.	O	.	_	0	SENT_432	[p10l704t440r806b470],

1	This	DT	O	this	nsubj	4	SENT_433	[p10l828t435r897b461],
2	could	MD	O	could	aux	4	SENT_433	[p10l919t435r1008b461],
3	be	VB	O	be	cop	4	SENT_433	[p10l1029t435r1066b461],
4	due	JJ	O	due	_	0	SENT_433	[p10l1087t435r1146b461],
5	to	TO	O	to	_	0	SENT_433	[p10l1168t440r1198b461],
6	the	DT	O	the	det	7	SENT_433	[p10l190t480r239b506],
7	fact	NN	O	fact	prep_to	4	SENT_433	[p10l254t480r314b506],
8	that	IN	O	that	complm	19	SENT_433	[p10l329t480r392b506],
9	doxycycline	NN	O	doxycycline	nsubj	23	SENT_433	[p10l406t480r606b515],
10	,	,	O	,	_	0	SENT_433	[p10l406t480r606b515],
11	in	IN	O	in	_	0	SENT_433	[p10l622t481r652b505],
12	addition	NN	O	addition	_	0	SENT_433	[p10l667t480r804b506],
13	to	TO	O	to	_	0	SENT_433	[p10l820t486r850b506],
14	targeting	VBG	O	target	prepc_in_addition_to	9	SENT_433	[p10l866t481r1013b515],
15	exogenous	JJ	O	exogenous	amod	16	SENT_433	[p10l1027t489r1198b515],
16	bacteria	NNS	O	bacterium	dobj	14	SENT_433	[p10l189t526r328b557],
17	,	,	O	,	_	0	SENT_433	[p10l189t526r328b557],
18	also	RB	O	also	advmod	19	SENT_433	[p10l344t526r404b552],
19	targeted	VBN	O	target	ccomp	4	SENT_433	[p10l420t526r554b561],
20	Wolbachia	JJ	O	wolbachia	amod	21	SENT_433	[p10l571t526r719b552],
21	endosymbionts	NNS	O	endosymbiont	dobj	19	SENT_433	[p10l733t526r979b561],
22	and	CC	O	and	_	0	SENT_433	[p10l994t526r1053b552],
23	reduced	VBN	O	reduce	conj_and	19	SENT_433	[p10l1068t526r1199b552],
24	lymphangiogenic	JJ	O	lymphangiogenic	amod	25	SENT_433	[p10l189t572r468b607],
25	factors	NNS	O	factor	npadvmod	23	SENT_433	[p10l492t572r602b598],
26	along	IN	O	along	_	0	SENT_433	[p10l626t572r715b607],
27	with	IN	O	with	_	0	SENT_433	[p10l737t572r806b598],
28	a	DT	O	a	det	29	SENT_433	[p10l830t581r846b598],
29	reversion	NN	O	reversion	prep_along_with	23	SENT_433	[p10l869t573r1020b598],
30	of	IN	O	of	_	0	SENT_433	[p10l1043t572r1078b598],
31	lymph	NN	O	lymph	nn	33	SENT_433	[p10l1098t572r1199b607],
32	vessel	NN	O	vessel	nn	33	SENT_433	[p10l188t617r284b643],
33	dilation	NN	O	dilation	prep_of	29	SENT_433	[p10l314t617r456b643],
34	.	.	O	.	_	0	SENT_433	[p10l314t617r456b643],

1	In	IN	O	in	_	0	SENT_434	[p10l486t618r520b642],
2	order	NN	O	order	prep_in	16	SENT_434	[p10l549t617r644b643],
3	for	IN	O	for	_	0	SENT_434	[p10l672t617r723b643],
4	doxycycline	NN	O	doxycycline	prep_for	2	SENT_434	[p10l751t617r953b652],
5	to	TO	O	to	aux	6	SENT_434	[p10l984t622r1015b643],
6	exert	VB	O	exert	infmod	2	SENT_434	[p10l1045t622r1132b643],
7	its	PRP$	O	its	poss	9	SENT_434	[p10l1161t618r1198b643],
8	ameliorating	VBG	O	ameliorate	amod	9	SENT_434	[p10l189t663r398b698],
9	activity	NN	O	activity	dobj	6	SENT_434	[p10l415t664r532b698],
10	by	IN	O	by	_	0	SENT_434	[p10l549t663r586b698],
11	targeting	VBG	O	target	prepc_by	6	SENT_434	[p10l604t664r751b698],
12	Wolbachia	NNP	LOCATION	Wolbachia	dobj	11	SENT_434	[p10l770t663r924b694],
13	,	,	O	,	_	0	SENT_434	[p10l770t663r924b694],
14	it	PRP	O	it	nsubj	16	SENT_434	[p10l943t664r965b689],
15	is	VBZ	O	be	cop	16	SENT_434	[p10l982t664r1004b689],
16	mandatory	JJ	O	mandatory	_	0	SENT_434	[p10l1022t663r1199b698],
17	that	IN	O	that	complm	33	SENT_434	[p10l190t709r253b735],
18	the	DT	O	the	det	19	SENT_434	[p10l272t709r321b735],
19	targets	NNS	O	target	nsubj	33	SENT_434	[p10l340t714r456b744],
20	,	,	O	,	_	0	SENT_434	[p10l340t714r456b744],
21	i.e.	FW	O	i.e.	conj_or	19	SENT_434	[p10l475t710r527b740],
22	,	,	O	,	_	0	SENT_434	[p10l475t710r527b740],
23	adult	JJ	O	adult	amod	24	SENT_434	[p10l546t709r628b735],
24	worms	NNS	O	worm	nsubj	33	SENT_434	[p10l645t718r752b735],
25	or	CC	O	or	_	0	SENT_434	[p10l770t718r806b735],
26	at	IN	O	at	advmod	19	SENT_434	[p10l823t715r852b735],
27	least	JJS	O	least	pobj	26	SENT_434	[p10l869t709r942b735],
28	incoming	JJ	O	incoming	amod	30	SENT_434	[p10l960t710r1114b744],
29	L3/4	NN	O	l3/4	nn	30	SENT_434	[p10l1131t709r1200b735],
30	larvae	NNS	O	larva	conj_or	19	SENT_434	[p10l189t755r293b786],
31	,	,	O	,	_	0	SENT_434	[p10l189t755r293b786],
32	are	VBP	O	be	cop	33	SENT_434	[p10l308t764r357b781],
33	present	JJ	DATE	present	ccomp	16	SENT_434	[p10l371t760r492b790],
34	in	IN	O	in	_	0	SENT_434	[p10l506t756r536b780],
35	the	DT	O	the	det	36	SENT_434	[p10l550t755r599b781],
36	host	NN	O	host	poss	38	SENT_434	[p10l612t755r702b781],
37	’s	POS	O	’s	_	0	SENT_434	[p10l612t755r702b781],
38	body	NN	O	body	prep_in	33	SENT_434	[p10l715t755r801b790],
39	.	.	O	.	_	0	SENT_434	[p10l715t755r801b790],

1	Indeed	RB	O	indeed	advmod	9	SENT_435	[p10l815t755r936b786],
2	,	,	O	,	_	0	SENT_435	[p10l815t755r936b786],
3	all	DT	O	all	det	5	SENT_435	[p10l950t755r986b781],
4	our	PRP$	O	we	poss	5	SENT_435	[p10l1000t764r1057b781],
5	patients	NNS	O	patient	nsubj	9	SENT_435	[p10l1069t756r1198b790],
6	were	VBD	O	be	cop	9	SENT_435	[p10l188t809r265b826],
7	either	RB	O	either	advmod	9	SENT_435	[p10l278t800r375b826],
8	CFA-positive	JJ	O	cfa-positive	amod	9	SENT_435	[p10l388t800r599b835],
9	(	NN	O	(	_	0	SENT_435	[p10l614t800r768b835],
10	although	IN	O	although	mark	24	SENT_435	[p10l614t800r768b835],
11	most	JJS	O	most	nsubj	24	SENT_435	[p10l781t806r859b826],
12	they	PRP	O	they	nsubj	15	SENT_435	[p10l873t800r940b835],
13	did	VBD	O	do	aux	15	SENT_435	[p10l953t800r1005b826],
14	not	RB	O	not	neg	15	SENT_435	[p10l1019t805r1072b826],
15	exhibit	VB	O	exhibit	rcmod	11	SENT_435	[p10l1086t800r1199b826],
16	high	JJ	O	high	amod	17	SENT_435	[p10l189t846r259b881],
17	levels	NNS	O	level	dobj	15	SENT_435	[p10l275t846r369b877],
18	,	,	O	,	_	0	SENT_435	[p10l275t846r369b877],
19	as	RB	O	as	advmod	20	SENT_435	[p10l386t855r415b872],
20	known	VBN	O	know	amod	17	SENT_435	[p10l430t846r538b872],
21	for	IN	O	for	_	0	SENT_435	[p10l554t846r602b872],
22	lymphedema	NN	O	lymphedema	nn	23	SENT_435	[p10l616t846r826b881],
23	patients	NNS	O	patient	prep_for	11	SENT_435	[p10l842t847r982b881],
24	)	VBP	O	)	advcl	9	SENT_435	[p10l842t847r982b881],
25	[	NN	O	[	nn	27	SENT_435	[p10l1000t844r1065b878],
26	78	CD	NUMBER	78	num	27	SENT_435	[p10l1000t844r1065b878],
27	]	NN	O	]	dobj	24	SENT_435	[p10l1000t844r1065b878],
28	,	,	O	,	_	0	SENT_435	[p10l1000t844r1065b878],
29	or	CC	O	or	_	0	SENT_435	[p10l1081t855r1117b872],
30	they	PRP	O	they	nsubj	31	SENT_435	[p10l1132t846r1199b881],
31	showed	VBD	O	show	conj_or	9	SENT_435	[p10l189t892r308b918],
32	clearly	RB	O	clearly	advmod	33	SENT_435	[p10l322t892r428b927],
33	positive	JJ	O	positive	amod	36	SENT_435	[p10l442t893r567b927],
34	antiﬁlarial	JJ	O	antiﬁlarial	amod	36	SENT_435	[p10l581t892r750b918],
35	antibody	NN	O	antibody	nn	36	SENT_435	[p10l764t892r908b927],
36	titers	NNS	O	titer	dep	31	SENT_435	[p10l922t893r1004b918],
37	as	IN	O	as	_	0	SENT_435	[p10l1018t901r1047b918],
38	a	DT	O	a	det	39	SENT_435	[p10l1061t901r1077b918],
39	sign	NN	O	sign	prep_as	36	SENT_435	[p10l1090t893r1154b927],
40	of	IN	O	of	_	0	SENT_435	[p10l1168t892r1202b918],
41	recent	JJ	O	recent	amod	42	SENT_435	[p10l190t942r292b963],
42	exposure	NN	O	exposure	prep_of	39	SENT_435	[p10l308t946r455b972],
43	(	CD	NUMBER	(	num	45	SENT_435	[p10l472t938r539b969],
44	two	CD	NUMBER	two	num	45	SENT_435	[p10l472t938r539b969],
45	cases	NNS	O	case	dobj	31	SENT_435	[p10l555t938r653b969],
46	)	RB	O	)	advmod	31	SENT_435	[p10l555t938r653b969],
47	,	,	O	,	_	0	SENT_435	[p10l555t938r653b969],
48	in	IN	O	in	_	0	SENT_435	[p10l670t938r700b962],
49	accordance	NN	O	accordance	prep_in	31	SENT_435	[p10l716t937r901b963],
50	with	IN	O	with	_	0	SENT_435	[p10l916t937r986b963],
51	the	DT	O	the	det	52	SENT_435	[p10l1002t937r1051b963],
52	assumption	NN	O	assumption	prep_with	31	SENT_435	[p10l1067t946r1198b972, p10l190t984r254b1009],
53	that	IN	O	that	complm	58	SENT_435	[p10l268t983r331b1009],
54	it	PRP	O	it	nsubj	58	SENT_435	[p10l344t984r366b1009],
55	is	VBZ	O	be	cop	58	SENT_435	[p10l379t984r401b1009],
56	a	DT	O	a	det	58	SENT_435	[p10l415t992r431b1009],
57	characteristic	JJ	O	characteristic	amod	58	SENT_435	[p10l443t983r663b1009],
58	feature	NN	O	feature	ccomp	31	SENT_435	[p10l677t983r793b1009],
59	of	IN	O	of	_	0	SENT_435	[p10l806t983r841b1009],
60	lymphedema	NN	O	lymphedema	prep_of	58	SENT_435	[p10l850t983r1059b1018],
61	that	IN	O	that	complm	64	SENT_435	[p10l1073t983r1136b1009],
62	the	DT	O	the	det	63	SENT_435	[p10l1150t983r1199b1009],
63	patients	NNS	O	patient	nsubj	64	SENT_435	[p10l189t1030r319b1064],
64	have	VBP	O	have	ccomp	58	SENT_435	[p10l337t1029r410b1055],
65	a	DT	O	a	det	68	SENT_435	[p10l429t1038r445b1055],
66	strong	JJ	O	strong	amod	68	SENT_435	[p10l463t1034r567b1064],
67	immune	JJ	O	immune	amod	68	SENT_435	[p10l585t1030r718b1055],
68	reaction	NN	O	reaction	dobj	64	SENT_435	[p10l738t1030r872b1055],
69	that	WDT	O	that	nsubjpass	71	SENT_435	[p10l892t1029r955b1055],
70	is	VBZ	O	be	auxpass	71	SENT_435	[p10l973t1030r995b1055],
71	targeted	VBN	O	target	rcmod	68	SENT_435	[p10l1015t1029r1149b1064],
72	to	TO	O	to	_	0	SENT_435	[p10l1168t1034r1198b1055],
73	incoming	JJ	O	incoming	amod	74	SENT_435	[p10l190t1075r343b1109],
74	L3	NN	O	l3	prep_to	71	SENT_435	[p10l357t1074r397b1099],
75	and	CC	O	and	_	0	SENT_435	[p10l412t1074r471b1100],
76	L4	NN	O	l4	nn	77	SENT_435	[p10l486t1075r527b1099],
77	larvae	NNS	O	larva	conj_and	74	SENT_435	[p10l541t1074r645b1105],
78	,	,	O	,	_	0	SENT_435	[p10l541t1074r645b1105],
79	effectively	RB	O	effectively	advmod	80	SENT_435	[p10l661t1074r827b1109],
80	killing	VBG	O	kill	xcomp	71	SENT_435	[p10l841t1074r943b1109],
81	them	PRP	O	they	dobj	80	SENT_435	[p10l959t1074r1048b1105],
82	,	,	O	,	_	0	SENT_435	[p10l959t1074r1048b1105],
83	however	RB	O	however	advmod	64	SENT_435	[p10l1063t1074r1200b1100],
84	at	IN	O	at	_	0	SENT_435	[p10l189t1125r218b1146],
85	the	DT	O	the	det	86	SENT_435	[p10l245t1120r295b1146],
86	expense	NN	O	expense	prep_at	64	SENT_435	[p10l321t1129r451b1155],
87	of	IN	O	of	_	0	SENT_435	[p10l478t1120r512b1146],
88	strong	JJ	O	strong	amod	92	SENT_435	[p10l535t1125r639b1155],
89	inﬂammation	NN	O	inﬂammation	nn	92	SENT_435	[p10l665t1120r885b1146],
90	[	NN	O	[	nn	92	SENT_435	[p10l913t1120r978b1152],
91	21	CD	NUMBER	21	num	92	SENT_435	[p10l913t1120r978b1152],
92	]	NN	O	]	prep_of	86	SENT_435	[p10l913t1120r978b1152],
93	.	.	O	.	_	0	SENT_435	[p10l913t1120r978b1152],

1	Studies	NNS	O	study	nsubj	4	SENT_436	[p10l1006t1120r1122b1146],
2	are	VBP	O	be	cop	4	SENT_436	[p10l1149t1129r1199b1146],
3	currently	RB	DATE	currently	advmod	4	SENT_436	[p10l189t1166r339b1201],
4	ongoing	JJ	O	ongoing	_	0	SENT_436	[p10l355t1167r488b1201],
5	to	TO	O	to	aux	6	SENT_436	[p10l504t1171r534b1192],
6	compare	VB	O	compare	xcomp	4	SENT_436	[p10l551t1175r693b1201],
7	the	DT	O	the	det	8	SENT_436	[p10l710t1166r760b1192],
8	efﬁcacy	NN	O	efﬁcacy	dobj	6	SENT_436	[p10l776t1166r898b1201],
9	of	IN	O	of	_	0	SENT_436	[p10l913t1166r948b1192],
10	doxycycline	NN	O	doxycycline	prep_of	8	SENT_436	[p10l961t1166r1152b1201],
11	in	IN	O	in	_	0	SENT_436	[p10l1168t1167r1199b1191],
12	CFA-positive	JJ	O	cfa-positive	prep_in	6	SENT_436	[p10l189t1211r401b1246],
13	in	IN	O	in	_	0	SENT_436	[p10l429t1212r460b1236],
14	comparison	NN	O	comparison	prep_in	12	SENT_436	[p10l487t1212r680b1246],
15	to	TO	O	to	_	0	SENT_436	[p10l709t1216r739b1237],
16	a	DT	O	a	det	18	SENT_436	[p10l767t1220r783b1237],
17	larger	JJR	O	larger	amod	18	SENT_436	[p10l810t1211r906b1246],
18	group	NN	O	group	prep_to	6	SENT_436	[p10l932t1220r1028b1246],
19	of	IN	O	of	_	0	SENT_436	[p10l1057t1211r1091b1237],
20	CFAnegative	JJ	O	cfanegative	amod	22	SENT_436	[p10l1116t1211r1198b1237, p10l190t1258r324b1292],
21	lymphedema	NN	O	lymphedema	nn	22	SENT_436	[p10l339t1257r549b1292],
22	patients	NNS	O	patient	prep_of	18	SENT_436	[p10l564t1258r701b1292],
23	.	.	O	.	_	0	SENT_436	[p10l564t1258r701b1292],

1	Lymphedema	NN	O	lymphedema	nn	2	SENT_437	[p10l226t1303r449b1338],
2	patients	NNS	O	patient	nsubj	3	SENT_437	[p10l462t1304r591b1338],
3	have	VBP	O	have	_	0	SENT_437	[p10l605t1303r678b1329],
4	a	DT	O	a	det	6	SENT_437	[p10l693t1312r709b1329],
5	high	JJ	O	high	amod	6	SENT_437	[p10l721t1303r792b1338],
6	level	NN	O	level	dobj	3	SENT_437	[p10l805t1303r878b1329],
7	of	IN	O	of	_	0	SENT_437	[p10l892t1303r927b1329],
8	suffering	NN	O	suffering	prep_of	6	SENT_437	[p10l937t1303r1089b1338],
9	,	,	O	,	_	0	SENT_437	[p10l937t1303r1089b1338],
10	and	CC	O	and	_	0	SENT_437	[p10l1104t1303r1163b1329],
11	it	PRP	O	it	nsubjpass	15	SENT_437	[p10l1177t1304r1199b1329],
12	can	MD	O	can	aux	15	SENT_437	[p10l189t1357r244b1374],
13	be	VB	O	be	auxpass	15	SENT_437	[p10l256t1348r293b1374],
14	well	RB	O	well	advmod	15	SENT_437	[p10l304t1348r367b1374],
15	expected	VBN	O	expect	conj_and	3	SENT_437	[p10l379t1348r525b1383],
16	that	IN	O	that	complm	19	SENT_437	[p10l538t1348r601b1374],
17	they	PRP	O	they	nsubj	19	SENT_437	[p10l614t1348r681b1383],
18	would	MD	O	would	aux	19	SENT_437	[p10l692t1348r790b1374],
19	use	VB	O	use	ccomp	15	SENT_437	[p10l801t1357r853b1374],
20	doxycycline	NN	O	doxycycline	dobj	19	SENT_437	[p10l865t1348r1056b1383],
21	for	IN	O	for	_	0	SENT_437	[p10l1068t1348r1117b1374],
22	6	CD	DURATION	6	num	23	SENT_437	[p10l1128t1348r1145b1373],
23	wk	NN	DURATION	wk	prep_for	20	SENT_437	[p10l1156t1348r1199b1373],
24	without	IN	O	without	_	0	SENT_437	[p10l188t1394r314b1420],
25	the	DT	O	the	det	26	SENT_437	[p10l336t1394r385b1420],
26	need	NN	O	need	prep_without	23	SENT_437	[p10l407t1394r484b1420],
27	of	IN	O	of	_	0	SENT_437	[p10l505t1394r540b1420],
28	a	DT	O	a	det	31	SENT_437	[p10l558t1403r574b1420],
29	directly	RB	O	directly	advmod	30	SENT_437	[p10l594t1394r718b1429],
30	observed	VBN	O	observe	amod	31	SENT_437	[p10l738t1394r883b1420],
31	treatment	NN	O	treatment	prep_of	26	SENT_437	[p10l905t1399r1067b1420],
32	(	CD	NUMBER	(	num	33	SENT_437	[p10l1088t1394r1198b1426],
33	DOT	NNP	O	DOT	dep	20	SENT_437	[p10l1088t1394r1198b1426],
34	)	CD	NUMBER	)	num	33	SENT_437	[p10l1088t1394r1198b1426],
35	.	.	O	.	_	0	SENT_437	[p10l1088t1394r1198b1426],

1	This	DT	O	this	nsubj	3	SENT_438	[p10l189t1440r258b1466],
2	is	VBZ	O	be	cop	3	SENT_438	[p10l272t1441r294b1466],
3	so	RB	O	so	_	0	SENT_438	[p10l308t1449r340b1466],
4	all	PDT	O	all	dep	6	SENT_438	[p10l355t1440r391b1466],
5	the	DT	O	the	dep	6	SENT_438	[p10l406t1440r455b1466],
6	more	RBR	O	more	advmod	3	SENT_438	[p10l469t1449r553b1466],
7	since	IN	O	since	mark	14	SENT_438	[p10l568t1441r648b1466],
8	the	DT	O	the	det	11	SENT_438	[p10l663t1440r712b1466],
9	current	JJ	DATE	current	amod	11	SENT_438	[p10l726t1445r848b1466],
10	mass	NN	O	mass	nn	11	SENT_438	[p10l862t1449r937b1466],
11	treatment	NN	O	treatment	nsubj	14	SENT_438	[p10l952t1445r1113b1466],
12	does	VBZ	O	do	aux	14	SENT_438	[p10l1127t1440r1198b1466],
13	not	RB	O	not	neg	14	SENT_438	[p10l190t1490r243b1511],
14	improve	VB	O	improve	ccomp	3	SENT_438	[p10l261t1486r396b1520],
15	lymphedema	NN	O	lymphedema	dobj	14	SENT_438	[p10l414t1485r624b1520],
16	per	FW	O	per	nn	17	SENT_438	[p10l642t1494r696b1520],
17	se	FW	O	se	advmod	14	SENT_438	[p10l713t1494r751b1511],
18	.	.	O	.	_	0	SENT_438	[p10l713t1494r751b1511],

1	Hence	RB	O	hence	advmod	6	SENT_439	[p10l769t1486r881b1516],
2	,	,	O	,	_	0	SENT_439	[p10l769t1486r881b1516],
3	doxycycline	NN	O	doxycycline	nn	4	SENT_439	[p10l900t1485r1091b1520],
4	treatment	NN	O	treatment	nsubj	6	SENT_439	[p10l1111t1490r1198b1511, p10l189t1536r273b1557],
5	will	MD	O	will	aux	6	SENT_439	[p10l293t1531r349b1556],
6	have	VB	O	have	_	0	SENT_439	[p10l371t1531r444b1557],
7	a	DT	O	a	det	9	SENT_439	[p10l467t1540r483b1557],
8	good	JJ	O	good	amod	9	SENT_439	[p10l504t1531r583b1566],
9	chance	NN	O	chance	dobj	6	SENT_439	[p10l606t1531r718b1557],
10	to	TO	O	to	aux	15	SENT_439	[p10l741t1536r771b1557],
11	be	VB	O	be	cop	15	SENT_439	[p10l793t1531r830b1557],
12	the	DT	O	the	det	15	SENT_439	[p10l854t1531r903b1557],
13	ﬁrst	JJ	O	ﬁrst	amod	15	SENT_439	[p10l925t1531r988b1557],
14	chemotherapeutic	JJ	O	chemotherapeutic	amod	15	SENT_439	[p10l1010t1531r1198b1557, p10l189t1578r308b1612],
15	approach	NN	O	approach	infmod	9	SENT_439	[p10l324t1577r478b1612],
16	to	TO	O	to	aux	17	SENT_439	[p10l494t1583r524b1603],
17	address	VB	O	address	infmod	15	SENT_439	[p10l540t1577r660b1603],
18	lymphatic	JJ	O	lymphatic	amod	19	SENT_439	[p10l675t1577r836b1612],
19	pathology	NN	O	pathology	dobj	17	SENT_439	[p10l852t1577r1020b1612],
20	.	.	O	.	_	0	SENT_439	[p10l852t1577r1020b1612],

1	In	IN	O	in	dep	108	SENT_440	[p10l226t1624r260b1648],
2	conclusion	NN	O	conclusion	dep	108	SENT_440	[p10l289t1623r481b1654],
3	,	,	O	,	_	0	SENT_440	[p10l289t1623r481b1654],
4	our	PRP$	O	we	dep	108	SENT_440	[p10l511t1632r569b1649],
5	data	NNS	O	datum	dep	108	SENT_440	[p10l597t1623r669b1649],
6	are	VBP	O	be	dep	108	SENT_440	[p10l698t1632r749b1649],
7	in	IN	O	in	dep	108	SENT_440	[p10l778t1624r809b1648],
8	agreement	NN	O	agreement	dep	108	SENT_440	[p10l839t1629r1018b1658],
9	with	IN	O	with	dep	108	SENT_440	[p10l1046t1623r1118b1649],
10	the	DT	O	the	dep	108	SENT_440	[p10l1148t1623r1199b1649],
11	hypothesis	NN	O	hypothesis	dep	108	SENT_440	[p10l189t1668r360b1703],
12	that	IN	O	that	dep	108	SENT_440	[p10l389t1668r452b1694],
13	progression	NN	O	progression	dep	108	SENT_440	[p10l479t1669r671b1703],
14	of	IN	O	of	dep	108	SENT_440	[p10l698t1668r733b1694],
15	infection	NN	O	infection	dep	108	SENT_440	[p10l757t1668r903b1694],
16	to	TO	O	to	dep	108	SENT_440	[p10l932t1673r962b1694],
17	lymphedema	NN	O	lymphedema	dep	108	SENT_440	[p10l990t1668r1199b1703],
18	may	MD	O	may	dep	108	SENT_440	[p10l189t1723r255b1749],
19	be	VB	O	be	dep	108	SENT_440	[p10l275t1714r312b1740],
20	due	JJ	O	due	dep	108	SENT_440	[p10l333t1714r392b1740],
21	to	TO	O	to	dep	108	SENT_440	[p10l414t1719r444b1740],
22	overexpression	NN	O	overexpression	dep	108	SENT_440	[p10l466t1715r713b1749],
23	of	IN	O	of	dep	108	SENT_440	[p10l735t1714r769b1740],
24	lymphangiogenic	JJ	O	lymphangiogenic	dep	108	SENT_440	[p10l787t1714r1066b1749],
25	factors	NNS	O	factor	dep	108	SENT_440	[p10l1088t1714r1198b1740],
26	such	JJ	O	such	dep	108	SENT_440	[p10l189t1760r261b1786],
27	as	IN	O	as	dep	108	SENT_440	[p10l282t1769r311b1786],
28	VEGF-C	NN	O	vegf-c	dep	108	SENT_440	[p10l332t1760r465b1786],
29	and	CC	O	and	dep	108	SENT_440	[p10l488t1760r547b1786],
30	more	RBR	O	more	dep	108	SENT_440	[p10l568t1769r652b1786],
31	so	RB	O	so	dep	108	SENT_440	[p10l674t1769r714b1791],
32	,	,	O	,	_	0	SENT_440	[p10l674t1769r714b1791],
33	sVEGF-R3	NN	O	svegf-r3	dep	108	SENT_440	[p10l736t1760r910b1791],
34	,	,	O	,	_	0	SENT_440	[p10l736t1760r910b1791],
35	ﬁrst	NN	O	ﬁrst	dep	108	SENT_440	[p10l932t1760r995b1786],
36	due	JJ	O	due	dep	108	SENT_440	[p10l1016t1760r1074b1786],
37	to	TO	O	to	dep	108	SENT_440	[p10l1097t1765r1127b1786],
38	the	DT	O	the	dep	108	SENT_440	[p10l1150t1760r1199b1786],
39	presence	NN	O	presence	dep	108	SENT_440	[p10l189t1814r333b1840],
40	or	CC	O	or	dep	108	SENT_440	[p10l346t1814r381b1831],
41	the	DT	O	the	dep	108	SENT_440	[p10l394t1805r443b1831],
42	death	NN	O	death	dep	108	SENT_440	[p10l455t1805r545b1831],
43	of	IN	O	of	dep	108	SENT_440	[p10l558t1805r593b1831],
44	adult	JJ	O	adult	dep	108	SENT_440	[p10l602t1805r684b1831],
45	ﬁlarial	JJ	O	ﬁlarial	dep	108	SENT_440	[p10l696t1805r800b1831],
46	worms	NNS	O	worm	dep	108	SENT_440	[p10l812t1814r919b1831],
47	in	IN	O	in	dep	108	SENT_440	[p10l932t1806r962b1830],
48	the	DT	O	the	dep	108	SENT_440	[p10l976t1805r1025b1831],
49	lymphatic	JJ	O	lymphatic	dep	108	SENT_440	[p10l1038t1805r1198b1840],
50	vessels	NNS	O	vessel	dep	108	SENT_440	[p10l188t1851r293b1877],
51	and	CC	O	and	dep	108	SENT_440	[p10l311t1851r370b1877],
52	later	JJ	O	later	dep	108	SENT_440	[p10l388t1851r463b1877],
53	(	NN	O	(	dep	108	SENT_440	[p10l481t1852r522b1883],
54	in	IN	O	in	dep	108	SENT_440	[p10l481t1852r522b1883],
55	the	DT	O	the	dep	108	SENT_440	[p10l541t1851r590b1877],
56	CFA-negative	JJ	MISC	cfa-negative	dep	108	SENT_440	[p10l609t1851r829b1886],
57	phase	NN	O	phase	dep	108	SENT_440	[p10l848t1851r939b1886],
58	of	IN	O	of	dep	108	SENT_440	[p10l957t1851r992b1877],
59	the	DT	O	the	dep	108	SENT_440	[p10l1007t1851r1056b1877],
60	disease	NN	O	disease	dep	108	SENT_440	[p10l1075t1851r1198b1883],
61	)	NN	O	)	dep	108	SENT_440	[p10l1075t1851r1198b1883],
62	either	CC	O	either	dep	108	SENT_440	[p10l189t1897r286b1923],
63	by	IN	O	by	dep	108	SENT_440	[p10l300t1897r336b1932],
64	the	DT	O	the	dep	108	SENT_440	[p10l352t1897r401b1923],
65	incoming	JJ	O	incoming	dep	108	SENT_440	[p10l417t1898r571b1932],
66	larval	JJ	O	larval	dep	108	SENT_440	[p10l585t1897r673b1923],
67	stages	NNS	O	stage	dep	108	SENT_440	[p10l689t1903r782b1932],
68	of	IN	O	of	dep	108	SENT_440	[p10l798t1897r833b1923],
69	the	DT	O	the	dep	108	SENT_440	[p10l845t1897r894b1923],
70	parasite	NN	O	parasite	dep	108	SENT_440	[p10l910t1898r1039b1932],
71	releasing	VBG	O	release	dep	108	SENT_440	[p10l1055t1897r1200b1932],
72	Wolbachia	NNP	O	Wolbachia	dep	108	SENT_440	[p10l192t1942r347b1968],
73	upon	IN	O	upon	dep	108	SENT_440	[p10l375t1951r462b1977],
74	being	VBG	O	be	dep	108	SENT_440	[p10l490t1942r584b1977],
75	killed	VBN	O	kill	dep	108	SENT_440	[p10l612t1942r714b1973],
76	,	,	O	,	_	0	SENT_440	[p10l612t1942r714b1973],
77	or	CC	O	or	dep	108	SENT_440	[p10l744t1951r781b1968],
78	(	NN	O	(	dep	108	SENT_440	[p10l810t1942r1036b1977],
79	additionally	RB	O	additionally	dep	108	SENT_440	[p10l810t1942r1036b1977],
80	)	RB	O	)	dep	108	SENT_440	[p10l810t1942r1036b1977],
81	by	IN	O	by	dep	108	SENT_440	[p10l1065t1942r1103b1977],
82	skin	NN	O	skin	dep	108	SENT_440	[p10l1132t1942r1199b1968],
83	commensals	NNS	O	commensal	dep	108	SENT_440	[p10l189t1988r386b2014],
84	such	JJ	O	such	dep	108	SENT_440	[p10l406t1988r477b2014],
85	as	IN	O	as	dep	108	SENT_440	[p10l497t1997r526b2014],
86	streptococci	NNS	O	streptococcus	dep	108	SENT_440	[p10l547t1989r746b2023],
87	[	CD	NUMBER	[	dep	108	SENT_440	[p10l768t1986r919b2020],
88	71,79,80	CD	NUMBER	71,79,80	dep	108	SENT_440	[p10l768t1986r919b2020],
89	]	NN	O	]	dep	108	SENT_440	[p10l768t1986r919b2020],
90	that	WDT	O	that	dep	108	SENT_440	[p10l941t1988r1004b2014],
91	exacerbate	VBP	O	exacerbate	dep	108	SENT_440	[p10l1023t1988r1199b2014],
92	the	DT	O	the	dep	108	SENT_440	[p10l190t2034r239b2060],
93	condition	NN	O	condition	dep	108	SENT_440	[p10l262t2034r421b2060],
94	by	IN	O	by	dep	108	SENT_440	[p10l443t2034r480b2069],
95	stimulating	VBG	O	stimulate	dep	108	SENT_440	[p10l503t2034r687b2069],
96	more	RBR	O	more	dep	108	SENT_440	[p10l709t2043r793b2060],
97	proinﬂammatory	JJ	O	proinﬂammatory	dep	108	SENT_440	[p10l817t2034r1097b2069],
98	cytokines	NNS	O	cytokine	dep	108	SENT_440	[p10l1119t2039r1198b2069, p10l188t2079r272b2105],
99	and	CC	O	and	dep	108	SENT_440	[p10l301t2079r360b2105],
100	VEGF	NN	O	vegf	dep	108	SENT_440	[p10l387t2079r484b2105],
101	molecules	NNS	O	molecule	dep	108	SENT_440	[p10l512t2079r682b2110],
102	,	,	O	,	_	0	SENT_440	[p10l512t2079r682b2110],
103	which	WDT	O	which	dep	108	SENT_440	[p10l710t2079r806b2105],
104	are	VBP	O	be	dep	108	SENT_440	[p10l834t2088r884b2105],
105	also	RB	O	also	dep	108	SENT_440	[p10l912t2079r973b2105],
106	reduced	VBN	O	reduce	dep	108	SENT_440	[p10l1002t2079r1135b2105],
107	by	IN	O	by	dep	108	SENT_440	[p10l1162t2079r1199b2114],
108	doxycycline	NN	O	doxycycline	_	0	SENT_440	[p10l189t2125r388b2160],
109	.	.	O	.	_	0	SENT_440	[p10l189t2125r388b2160],

1	This	DT	O	this	det	2	SENT_441	[p10l403t2125r472b2151],
2	hypothesis	NN	O	hypothesis	nsubj	4	SENT_441	[p10l486t2125r658b2160],
3	is	VBZ	O	be	cop	4	SENT_441	[p10l673t2126r695b2151],
4	further	JJ	O	further	_	0	SENT_441	[p10l709t2125r827b2151],
5	supported	VBN	O	support	partmod	4	SENT_441	[p10l840t2125r1007b2160],
6	by	IN	O	by	_	0	SENT_441	[p10l1021t2125r1057b2160],
7	another	DT	O	another	det	11	SENT_441	[p10l1071t2125r1200b2151],
8	study	NN	O	study	nn	11	SENT_441	[p10l189t2171r274b2206],
9	[	CD	NUMBER	[	number	10	SENT_441	[p10l295t2171r350b2203],
10	81	CD	NUMBER	81	num	11	SENT_441	[p10l295t2171r350b2203],
11	]	NN	O	]	agent	5	SENT_441	[p10l295t2171r350b2203],
12	in	IN	O	in	_	0	SENT_441	[p10l371t2172r401b2196],
13	which	WDT	O	which	rel	20	SENT_441	[p10l419t2171r514b2197],
14	the	DT	O	the	det	15	SENT_441	[p10l534t2171r583b2197],
15	level	NN	O	level	nsubjpass	20	SENT_441	[p10l601t2171r674b2197],
16	of	IN	O	of	_	0	SENT_441	[p10l693t2171r727b2197],
17	serum	NN	O	serum	nn	18	SENT_441	[p10l742t2180r841b2197],
18	VEGF	NN	ORGANIZATION	vegf	prep_of	15	SENT_441	[p10l859t2171r955b2197],
19	was	VBD	O	be	auxpass	20	SENT_441	[p10l972t2180r1028b2197],
20	shown	VBN	O	show	rcmod	11	SENT_441	[p10l1047t2171r1149b2197],
21	to	TO	O	to	aux	35	SENT_441	[p10l1168t2176r1198b2197],
22	remain	VB	O	remain	cop	35	SENT_441	[p10l190t2217r304b2242],
23	the	DT	O	the	det	35	SENT_441	[p10l322t2216r371b2242],
24	same	JJ	O	same	amod	35	SENT_441	[p10l388t2225r468b2242],
25	in	IN	O	in	_	0	SENT_441	[p10l485t2217r516b2241],
26	patients	NNS	O	patient	prep_in	24	SENT_441	[p10l533t2217r662b2251],
27	with	IN	O	with	_	0	SENT_441	[p10l679t2216r748b2242],
28	bancroftian	JJ	O	bancroftian	amod	29	SENT_441	[p10l765t2216r956b2242],
29	ﬁlariasis	NN	O	ﬁlariasis	prep_with	26	SENT_441	[p10l973t2216r1106b2242],
30	after	IN	O	after	_	0	SENT_441	[p10l1123t2216r1200b2242],
31	DEC	NNP	ORGANIZATION	DEC	nn	32	SENT_441	[p10l189t2262r261b2288],
32	treatment	NN	O	treatment	prep_after	24	SENT_441	[p10l275t2267r437b2288],
33	[	CD	NUMBER	[	number	34	SENT_441	[p10l451t2262r516b2294],
34	81	CD	NUMBER	81	num	35	SENT_441	[p10l451t2262r516b2294],
35	]	NN	O	]	xcomp	20	SENT_441	[p10l451t2262r516b2294],
36	,	,	O	,	_	0	SENT_441	[p10l451t2262r516b2294],
37	which	WDT	O	which	nsubj	40	SENT_441	[p10l528t2262r623b2288],
38	does	VBZ	O	do	aux	40	SENT_441	[p10l636t2262r707b2288],
39	not	RB	O	not	neg	40	SENT_441	[p10l721t2267r775b2288],
40	have	VB	O	have	rcmod	35	SENT_441	[p10l786t2262r859b2288],
41	beneﬁcial	JJ	O	beneﬁcial	amod	42	SENT_441	[p10l871t2262r1029b2288],
42	effects	NNS	O	effect	dobj	40	SENT_441	[p10l1041t2262r1145b2288],
43	on	IN	O	on	_	0	SENT_441	[p10l1158t2271r1199b2288],
44	lymphedema	NN	O	lymphedema	nn	45	SENT_441	[p10l189t2308r399b2343],
45	patients	NNS	O	patient	prep_on	40	SENT_441	[p10l413t2309r542b2343],
46	apart	RB	O	apart	_	0	SENT_441	[p10l558t2313r643b2343],
47	from	IN	O	from	_	0	SENT_441	[p10l657t2308r737b2334],
48	reducing	VBG	O	reduce	prepc_apart_from	40	SENT_441	[p10l752t2308r896b2343],
49	parasite	NN	O	parasite	nn	50	SENT_441	[p10l910t2309r1039b2343],
50	loads	NNS	O	load	nsubj	51	SENT_441	[p10l1053t2308r1136b2334],
51	[	VBP	O	[	ccomp	48	SENT_441	[p10l1153t2308r1198b2340],
52	8	CD	NUMBER	8	number	53	SENT_441	[p10l1153t2308r1198b2340],
53	]	CD	NUMBER	]	dobj	51	SENT_441	[p10l1153t2308r1198b2340],
54	.	.	O	.	_	0	SENT_441	[p10l1153t2308r1198b2340],

1	This	DT	O	this	nsubj	4	SENT_442	[p10l189t2353r258b2379],
2	is	VBZ	O	be	cop	4	SENT_442	[p10l275t2354r297b2379],
3	probably	RB	O	probably	advmod	4	SENT_442	[p10l314t2353r459b2388],
4	due	JJ	O	due	_	0	SENT_442	[p10l476t2353r534b2379],
5	to	TO	O	to	_	0	SENT_442	[p10l552t2359r582b2379],
6	the	DT	O	the	det	7	SENT_442	[p10l600t2353r649b2379],
7	fact	NN	O	fact	prep_to	4	SENT_442	[p10l666t2353r726b2379],
8	that	IN	O	that	complm	11	SENT_442	[p10l743t2353r806b2379],
9	DEC	NNP	DATE	DEC	nn	10	SENT_442	[p10l822t2353r894b2379],
10	treatment	NN	O	treatment	nsubj	11	SENT_442	[p10l913t2358r1074b2379],
11	has	VBZ	O	have	dep	7	SENT_442	[p10l1090t2353r1141b2379],
12	no	DT	O	no	det	13	SENT_442	[p10l1159t2362r1198b2379],
13	effect	NN	O	effect	nn	21	SENT_442	[p10l189t2399r280b2425],
14	on	IN	O	on	_	0	SENT_442	[p10l295t2408r335b2425],
15	bacteria	NNS	O	bacterium	prep_on	13	SENT_442	[p10l350t2399r482b2425],
16	(	CD	NUMBER	(	num	15	SENT_442	[p10l498t2399r628b2431],
17	neither	CC	O	neither	dep	15	SENT_442	[p10l498t2399r628b2431],
18	Wolbachia	NNP	O	Wolbachia	conj	15	SENT_442	[p10l645t2399r793b2425],
19	nor	CC	O	nor	_	0	SENT_442	[p10l808t2408r865b2425],
20	exogenous	JJ	O	exogenous	nn	21	SENT_442	[p10l879t2408r1050b2434],
21	species	NNS	O	species	dobj	11	SENT_442	[p10l1066t2400r1198b2434],
22	)	RB	O	)	advmod	11	SENT_442	[p10l1066t2400r1198b2434],
23	,	,	O	,	_	0	SENT_442	[p10l1066t2400r1198b2434],
24	and	CC	O	and	_	0	SENT_442	[p10l189t2445r248b2471],
25	therefore	RB	O	therefore	advmod	26	SENT_442	[p10l270t2445r421b2471],
26	has	VBZ	O	have	conj_and	4	SENT_442	[p10l441t2445r493b2471],
27	no	DT	O	no	det	28	SENT_442	[p10l514t2454r553b2471],
28	effect	NN	O	effect	dobj	26	SENT_442	[p10l574t2445r665b2471],
29	on	IN	O	on	_	0	SENT_442	[p10l685t2454r726b2471],
30	proinﬂammatory	JJ	O	proinﬂammatory	amod	31	SENT_442	[p10l747t2445r1027b2480],
31	cytokines	NNS	O	cytokine	prep_on	28	SENT_442	[p10l1047t2445r1198b2480],
32	that	WDT	O	that	nsubj	33	SENT_442	[p10l190t2491r253b2517],
33	regulate	VBP	O	regulate	rcmod	28	SENT_442	[p10l276t2491r407b2526],
34	this	DT	O	this	det	36	SENT_442	[p10l431t2491r487b2517],
35	VEGF	NN	O	vegf	nn	36	SENT_442	[p10l509t2491r605b2517],
36	family	NN	O	family	dobj	33	SENT_442	[p10l627t2491r735b2526],
37	,	,	O	,	_	0	SENT_442	[p10l627t2491r735b2526],
38	although	IN	O	although	mark	42	SENT_442	[p10l759t2491r902b2526],
39	it	PRP	O	it	nsubj	42	SENT_442	[p10l925t2492r947b2517],
40	does	VBZ	O	do	aux	42	SENT_442	[p10l969t2491r1041b2517],
41	partially	RB	O	partially	advmod	42	SENT_442	[p10l1064t2491r1199b2526],
42	reduce	VB	O	reduce	advcl	4	SENT_442	[p10l190t2536r299b2562],
43	adult	JJ	O	adult	amod	45	SENT_442	[p10l315t2536r397b2562],
44	worm	NN	O	worm	nn	45	SENT_442	[p10l411t2545r504b2562],
45	levels	NNS	O	level	dobj	42	SENT_442	[p10l518t2536r613b2562],
46	.	.	O	.	_	0	SENT_442	[p10l518t2536r613b2562],

1	Although	IN	O	although	mark	7	SENT_443	[p10l225t2582r378b2617],
2	both	DT	O	both	det	6	SENT_443	[p10l399t2582r474b2608],
3	microﬁlaremic	JJ	O	microﬁlaremic	amod	6	SENT_443	[p10l495t2582r735b2608],
4	and	CC	O	and	_	0	SENT_443	[p10l758t2582r817b2608],
5	lymphedema	NN	O	lymphedema	amod	6	SENT_443	[p10l838t2582r1048b2617],
6	patients	NNS	O	patient	nsubj	7	SENT_443	[p10l1069t2583r1198b2617],
7	had	VBD	O	have	advcl	20	SENT_443	[p10l189t2628r248b2654],
8	elevated	JJ	O	elevated	amod	9	SENT_443	[p10l260t2628r393b2654],
9	VEGF-C	NN	O	vegf-c	dobj	7	SENT_443	[p10l405t2628r538b2654],
10	and	CC	O	and	_	0	SENT_443	[p10l552t2628r611b2654],
11	sVEGFR-3	NN	O	svegfr-3	nn	12	SENT_443	[p10l624t2628r789b2654],
12	levels	NNS	O	level	dobj	7	SENT_443	[p10l803t2628r897b2659],
13	,	,	O	,	_	0	SENT_443	[p10l803t2628r897b2659],
14	those	DT	O	those	nsubj	20	SENT_443	[p10l911t2628r996b2654],
15	of	IN	O	of	_	0	SENT_443	[p10l1008t2628r1043b2654],
16	sVEGFR3	NN	O	svegfr3	prep_of	14	SENT_443	[p10l1052t2628r1198b2654, p10l190t2673r206b2698],
17	were	VBD	O	be	cop	20	SENT_443	[p10l233t2682r310b2699],
18	yet	RB	O	yet	advmod	20	SENT_443	[p10l337t2678r384b2708],
19	signiﬁcantly	RB	O	signiﬁcantly	advmod	20	SENT_443	[p10l412t2673r610b2708],
20	higher	JJR	O	higher	_	0	SENT_443	[p10l637t2673r744b2708],
21	in	IN	O	in	_	0	SENT_443	[p10l771t2674r802b2698],
22	lymphedema	NN	O	lymphedema	nn	23	SENT_443	[p10l829t2673r1040b2708],
23	patients	NNS	O	patient	prep_in	20	SENT_443	[p10l1068t2674r1198b2708],
24	compared	VBN	O	compare	_	0	SENT_443	[p10l189t2719r354b2754],
25	to	TO	O	to	prepc_compared_to	20	SENT_443	[p10l383t2724r413b2745],
26	non-lymphedema	JJ	O	non-lymphedema	amod	27	SENT_443	[p10l443t2719r733b2754],
27	patients	NNS	O	patient	pobj	20	SENT_443	[p10l760t2720r891b2754],
28	that	WDT	O	that	nsubj	32	SENT_443	[p10l920t2719r984b2745],
29	are	VBP	O	be	cop	32	SENT_443	[p10l1012t2728r1062b2745],
30	microﬁlaremic	JJ	O	microﬁlaremic	amod	32	SENT_443	[p10l1090t2720r1198b2745, p10l189t2765r331b2791],
31	(	NN	O	(	nn	32	SENT_443	[p10l350t2767r377b2800],
32	[	NN	O	[	rcmod	27	SENT_443	[p10l350t2767r377b2800],
33	7	CD	NUMBER	7	num	35	SENT_443	[p10l350t2767r377b2800],
34	=	JJ	O	=	amod	35	SENT_443	[p10l390t2776r415b2785],
35	0.0024	CD	NUMBER	0.0024	attr	32	SENT_443	[p10l429t2765r540b2796],
36	,	,	O	,	_	0	SENT_443	[p10l429t2765r540b2796],
37	Figure	NNP	O	Figure	appos	27	SENT_443	[p10l557t2766r661b2800],
38	4	CD	NUMBER	4	number	39	SENT_443	[p10l678t2765r714b2797],
39	)	CD	NUMBER	)	dep	37	SENT_443	[p10l678t2765r714b2797],
40	.	.	O	.	_	0	SENT_443	[p10l678t2765r714b2797],

1	This	DT	O	this	nsubj	5	SENT_444	[p10l731t2765r800b2791],
2	could	MD	O	could	aux	5	SENT_444	[p10l817t2765r907b2791],
3	be	VB	O	be	cop	5	SENT_444	[p10l923t2765r960b2791],
4	an	DT	O	a	det	5	SENT_444	[p10l977t2774r1015b2791],
5	indication	NN	O	indication	_	0	SENT_444	[p10l1032t2765r1199b2791],
6	that	WDT	O	that	dep	13	SENT_444	[p10l190t2811r253b2837],
7	plasma	NN	O	plasma	nn	8	SENT_444	[p10l271t2811r384b2846],
8	levels	NNS	O	level	nsubj	13	SENT_444	[p10l401t2811r487b2837],
9	of	IN	O	of	_	0	SENT_444	[p10l505t2811r540b2837],
10	VEGF-C/SVEGFR	NN	O	vegf-c/svegfr	prep_of	8	SENT_444	[p10l553t2811r864b2837],
11	-3	CD	NUMBER	-3	num	10	SENT_444	[p10l553t2811r864b2837],
12	may	MD	O	may	aux	13	SENT_444	[p10l883t2820r948b2846],
13	correlate	VB	O	correlate	rcmod	5	SENT_444	[p10l966t2811r1112b2837],
14	with	IN	O	with	_	0	SENT_444	[p10l1129t2811r1199b2837],
15	disease	NN	O	disease	nn	16	SENT_444	[p10l189t2856r302b2882],
16	progression	NN	O	progression	prep_with	13	SENT_444	[p10l319t2857r511b2891],
17	in	IN	O	in	_	0	SENT_444	[p10l528t2857r559b2881],
18	LF	NN	O	lf	prep_in	13	SENT_444	[p10l575t2857r617b2881],
19	leading	VBG	O	lead	amod	18	SENT_444	[p10l634t2856r753b2891],
20	to	TO	O	to	_	0	SENT_444	[p10l770t2861r800b2882],
21	lymphatic	JJ	O	lymphatic	amod	22	SENT_444	[p10l818t2856r978b2891],
22	dilation	NN	O	dilation	prep_to	18	SENT_444	[p10l996t2856r1122b2882],
23	and	CC	O	and	_	0	SENT_444	[p10l1140t2856r1199b2882],
24	lymphedema	NN	O	lymphedema	nn	25	SENT_444	[p10l189t2902r399b2937],
25	development	NN	O	development	prep_to	18	SENT_444	[p10l412t2902r625b2937],
26	and	CC	O	and	_	0	SENT_444	[p10l639t2902r698b2928],
27	hence	RB	O	hence	advmod	31	SENT_444	[p10l712t2902r815b2933],
28	,	,	O	,	_	0	SENT_444	[p10l712t2902r815b2933],
29	might	MD	O	might	aux	31	SENT_444	[p10l830t2902r924b2937],
30	be	VB	O	be	auxpass	31	SENT_444	[p10l937t2902r974b2928],
31	developed	VBN	O	develop	rcmod	5	SENT_444	[p10l989t2902r1155b2937],
32	as	IN	O	as	_	0	SENT_444	[p10l1169t2911r1198b2928],
33	prognostic	JJ	O	prognostic	amod	34	SENT_444	[p10l189t2949r363b2983],
34	indicators	NNS	O	indicator	prep_as	31	SENT_444	[p10l384t2948r546b2974],
35	of	IN	O	of	_	0	SENT_444	[p10l566t2948r601b2974],
36	an	DT	O	a	det	38	SENT_444	[p10l617t2957r655b2974],
37	increased	VBN	O	increase	amod	38	SENT_444	[p10l675t2948r829b2974],
38	risk	NN	O	risk	prep_of	34	SENT_444	[p10l849t2948r907b2974],
39	of	IN	O	of	_	0	SENT_444	[p10l926t2948r961b2974],
40	LF	NN	O	lf	nn	41	SENT_444	[p10l976t2949r1018b2973],
41	pathology	NN	O	pathology	prep_of	38	SENT_444	[p10l1038t2948r1199b2983],
42	before	IN	O	before	mark	46	SENT_444	[p10l189t2993r294b3019],
43	it	PRP	O	it	nsubj	46	SENT_444	[p10l312t2994r334b3019],
44	actually	RB	O	actually	advmod	46	SENT_444	[p10l351t2993r476b3028],
45	becomes	VBZ	O	become	cop	46	SENT_444	[p10l493t2993r633b3019],
46	manifest	JJ	O	manifest	advcl	5	SENT_444	[p10l651t2993r798b3019],
47	.	.	O	.	_	0	SENT_444	[p10l651t2993r798b3019],

1	Importantly	RB	O	importantly	_	0	SENT_445	[p10l816t2993r1021b3028],
2	,	,	O	,	_	0	SENT_445	[p10l816t2993r1021b3028],
3	reduction	NN	O	reduction	appos	1	SENT_445	[p10l1040t2993r1199b3019],

1	@	IN	O	@	_	0	SENT_446	[p10l188t3077r261b3136],
2	Z	NN	O	z	nn	3	SENT_446	[p10l188t3077r261b3136],
3	PLoS	NN	O	plo	prep_@	4	SENT_446	[p10l288t3093r352b3116],
4	Pathogens	VBD	O	pathogen	_	0	SENT_446	[p10l367t3092r511b3123],
5	|	CD	NUMBER	|	num	6	SENT_446	[p10l526t3091r528b3124],
6	www	NN	O	www	nsubj	4	SENT_446	[p10l543t3092r882b3123],
7	.	.	O	.	_	0	SENT_446	[p10l543t3092r882b3123],

1	p	NN	O	p	nsubj	7	SENT_447	[p10l543t3092r882b3123],
2	|	SYM	O	|	dep	3	SENT_447	[p10l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	rcmod	1	SENT_447	[p10l543t3092r882b3123],
4	of	IN	O	of	_	0	SENT_447	[p10l1277t206r1311b232],
5	lymphangiogenic	JJ	O	lymphangiogenic	amod	6	SENT_447	[p10l1330t206r1610b241],
6	factors	NNS	O	factor	prep_of	1	SENT_447	[p10l1633t206r1743b232],
7	preceded	VBD	O	precede	_	0	SENT_447	[p10l1766t206r1916b241],
8	the	DT	O	the	det	9	SENT_447	[p10l1940t206r1989b232],
9	improvement	NN	O	improvement	dobj	7	SENT_447	[p10l2012t207r2233b241],
10	in	IN	O	in	_	0	SENT_447	[p10l2256t207r2286b231],
11	pathology	NN	O	pathology	prep_in	7	SENT_447	[p10l1277t252r1445b287],
12	.	.	O	.	_	0	SENT_447	[p10l1277t252r1445b287],

1	On	IN	O	on	_	0	SENT_448	[p10l1471t252r1521b278],
2	the	DT	O	the	det	4	SENT_448	[p10l1547t252r1596b278],
3	one	CD	NUMBER	one	num	4	SENT_448	[p10l1620t261r1679b278],
4	hand	NN	O	hand	prep_on	8	SENT_448	[p10l1704t252r1792b283],
5	,	,	O	,	_	0	SENT_448	[p10l1704t252r1792b283],
6	these	DT	O	these	det	7	SENT_448	[p10l1819t252r1900b278],
7	data	NNS	O	datum	nsubj	8	SENT_448	[p10l1925t252r1994b278],
8	argue	VBP	O	argue	_	0	SENT_448	[p10l2018t261r2108b287],
9	against	IN	O	against	_	0	SENT_448	[p10l2133t253r2246b287],
10	a	DT	O	a	det	12	SENT_448	[p10l2271t261r2287b278],
11	possible	JJ	O	possible	amod	12	SENT_448	[p10l1277t298r1406b333],
12	hypothesis	NN	O	hypothesis	prep_against	8	SENT_448	[p10l1417t298r1589b333],
13	that	IN	O	that	_	0	SENT_448	[p10l1602t298r1665b324],
14	elevated	JJ	O	elevated	amod	15	SENT_448	[p10l1676t298r1809b324],
15	levels	NNS	O	level	prep_that	12	SENT_448	[p10l1820t298r1906b324],
16	of	IN	O	of	_	0	SENT_448	[p10l1918t298r1953b324],
17	these	DT	O	these	det	18	SENT_448	[p10l1962t298r2043b324],
18	factors	NNS	O	factor	prep_of	15	SENT_448	[p10l2055t298r2165b324],
19	merely	RB	O	merely	advmod	15	SENT_448	[p10l2177t298r2287b333],
20	reﬂect	JJ	O	reﬂect	amod	21	SENT_448	[p10l1277t344r1380b370],
21	infection	NN	O	infection	dep	15	SENT_448	[p10l1397t344r1552b370],
22	.	.	O	.	_	0	SENT_448	[p10l1397t344r1552b370],

1	On	IN	O	on	_	0	SENT_449	[p10l1570t344r1620b370],
2	the	DT	O	the	det	3	SENT_449	[p10l1638t344r1687b370],
3	other	JJ	O	other	prep_on	7	SENT_449	[p10l1705t344r1800b375],
4	,	,	O	,	_	0	SENT_449	[p10l1705t344r1800b375],
5	they	PRP	O	they	nsubj	7	SENT_449	[p10l1819t344r1886b379],
6	do	VBP	O	do	aux	7	SENT_449	[p10l1904t344r1943b370],
7	offer	VB	O	offer	_	0	SENT_449	[p10l1961t344r2040b370],
8	a	DT	O	a	det	9	SENT_449	[p10l2057t353r2073b370],
9	potential	JJ	O	potential	dobj	7	SENT_449	[p10l2090t344r2237b379],
10	to	TO	O	to	aux	11	SENT_449	[p10l2256t350r2286b370],
11	identify	VB	O	identify	xcomp	7	SENT_449	[p10l1277t390r1402b425],
12	individuals	NNS	O	individual	dobj	11	SENT_449	[p10l1422t390r1598b416],
13	who	WP	O	who	nsubj	15	SENT_449	[p10l1617t390r1683b416],
14	are	VBP	O	be	cop	15	SENT_449	[p10l1703t399r1752b416],
15	prone	JJ	O	prone	rcmod	12	SENT_449	[p10l1771t399r1868b425],
16	to	TO	O	to	aux	17	SENT_449	[p10l1888t395r1918b416],
17	develop	VB	O	develop	xcomp	15	SENT_449	[p10l1938t390r2063b425],
18	more	RBR	O	more	advmod	19	SENT_449	[p10l2083t399r2167b416],
19	severe	JJ	O	severe	amod	20	SENT_449	[p10l2187t399r2286b416],
20	disease	NN	O	disease	dobj	17	SENT_449	[p10l1277t436r1397b462],
21	.	.	O	.	_	0	SENT_449	[p10l1277t436r1397b462],

1	For	IN	O	for	_	0	SENT_450	[p10l1417t437r1474b462],
2	this	DT	O	this	prep_for	8	SENT_450	[p10l1494t436r1558b467],
3	,	,	O	,	_	0	SENT_450	[p10l1494t436r1558b467],
4	a	DT	O	a	det	6	SENT_450	[p10l1579t445r1595b462],
5	prospective	JJ	O	prospective	amod	6	SENT_450	[p10l1614t437r1802b471],
6	study	NN	O	study	nsubjpass	8	SENT_450	[p10l1822t436r1907b471],
7	is	VBZ	O	be	auxpass	8	SENT_450	[p10l1927t437r1949b462],
8	needed	VBN	O	need	_	0	SENT_450	[p10l1969t436r2086b462],
9	that	DT	O	that	nsubj	11	SENT_450	[p10l2107t436r2170b462],
10	would	MD	O	would	aux	11	SENT_450	[p10l2188t436r2286b462],
11	screen	VB	O	screen	ccomp	8	SENT_450	[p10l1277t490r1380b507],
12	VEGF-C	NN	O	vegf-c	nn	15	SENT_450	[p10l1396t481r1530b507],
13	and	CC	O	and	_	0	SENT_450	[p10l1548t481r1607b507],
14	sVEGFR-3	NN	O	svegfr-3	nn	15	SENT_450	[p10l1624t481r1790b507],
15	levels	NNS	O	level	dobj	11	SENT_450	[p10l1807t481r1893b507],
16	in	IN	O	in	_	0	SENT_450	[p10l1911t482r1941b506],
17	children	NNS	O	child	prep_in	11	SENT_450	[p10l1959t481r2095b507],
18	and	CC	O	and	_	0	SENT_450	[p10l2112t481r2171b507],
19	young	JJ	O	young	amod	20	SENT_450	[p10l2187t490r2287b516],
20	adults	NNS	O	adult	conj_and	17	SENT_450	[p10l1277t527r1382b558],
21	,	,	O	,	_	0	SENT_450	[p10l1277t527r1382b558],
22	and	CC	O	and	_	0	SENT_450	[p10l1411t527r1471b553],
23	monitor	NN	O	monitor	nn	24	SENT_450	[p10l1499t528r1635b553],
24	development	NN	O	development	prep_in	11	SENT_450	[p10l1662t527r1878b562],
25	of	IN	O	of	_	0	SENT_450	[p10l1905t527r1940b553],
26	pathology	NN	O	pathology	prep_of	24	SENT_450	[p10l1965t527r2128b562],
27	such	JJ	O	such	_	0	SENT_450	[p10l2156t527r2228b553],
28	as	IN	O	as	_	0	SENT_450	[p10l2257t536r2286b553],
29	lymphedema	NN	O	lymphedema	prep_such_as	26	SENT_450	[p10l1276t573r1493b608],
30	.	.	O	.	_	0	SENT_450	[p10l1276t573r1493b608],

1	In	IN	O	in	_	0	SENT_451	[p10l1521t574r1554b598],
2	human	JJ	O	human	amod	3	SENT_451	[p10l1580t573r1693b599],
3	studies	NNS	O	study	prep_in	14	SENT_451	[p10l1720t573r1831b599],
4	of	IN	O	of	_	0	SENT_451	[p10l1858t573r1893b599],
5	lymphedema	NN	O	lymphedema	nn	6	SENT_451	[p10l1916t573r2126b608],
6	families	NNS	O	family	prep_of	3	SENT_451	[p10l2152t573r2286b604],
7	,	,	O	,	_	0	SENT_451	[p10l2152t573r2286b604],
8	heterozygous	JJ	O	heterozygous	amod	11	SENT_451	[p10l1276t619r1492b654],
9	inactivating	VBG	O	inactivate	amod	11	SENT_451	[p10l1521t620r1716b654],
10	missense	NN	O	missense	nn	11	SENT_451	[p10l1743t620r1885b645],
11	mutations	NNS	O	mutation	appos	6	SENT_451	[p10l1914t620r2079b645],
12	have	VBP	O	have	aux	14	SENT_451	[p10l2107t619r2180b645],
13	been	VBN	O	be	auxpass	14	SENT_451	[p10l2208t619r2286b645],
14	detected	VBN	O	detect	_	0	SENT_451	[p10l1277t665r1416b691],
15	in	IN	O	in	_	0	SENT_451	[p10l1443t666r1473b690],
16	the	DT	O	the	det	19	SENT_451	[p10l1501t665r1550b691],
17	tyrosine	NN	O	tyrosine	nn	19	SENT_451	[p10l1578t666r1708b700],
18	kinase	NN	O	kinase	nn	19	SENT_451	[p10l1734t665r2009b700],
19	—	NN	O	—	prep_in	14	SENT_451	[p10l1734t665r2009b700],
20	encoding	VBG	O	encode	partmod	19	SENT_451	[p10l1734t665r2009b700],
21	region	NN	O	region	dobj	20	SENT_451	[p10l2035t666r2140b700],
22	of	IN	O	of	_	0	SENT_451	[p10l2167t665r2201b691],
23	Flt4	NN	O	flt4	nn	25	SENT_451	[p10l2224t665r2287b691],
24	(	CD	NUMBER	(	num	25	SENT_451	[p10l1278t711r1451b743],
25	VEGFR-3	NN	O	vegfr-3	prep_of	21	SENT_451	[p10l1278t711r1451b743],
26	)	CD	NUMBER	)	num	25	SENT_451	[p10l1278t711r1451b743],
27	[	CD	NUMBER	[	number	28	SENT_451	[p10l1473t711r1537b743],
28	82	CD	NUMBER	82	num	29	SENT_451	[p10l1473t711r1537b743],
29	]	NN	O	]	nsubjpass	14	SENT_451	[p10l1473t711r1537b743],
30	,	,	O	,	_	0	SENT_451	[p10l1473t711r1537b743],
31	indicating	VBG	O	indicate	partmod	29	SENT_451	[p10l1558t711r1723b746],
32	that	IN	O	that	complm	36	SENT_451	[p10l1743t711r1806b737],
33	some	DT	O	some	det	35	SENT_451	[p10l1825t720r1908b737],
34	lymphedema	NN	O	lymphedema	nn	35	SENT_451	[p10l1927t711r2137b746],
35	patients	NNS	O	patient	nsubj	36	SENT_451	[p10l2157t712r2286b746],
36	have	VBP	O	have	ccomp	31	SENT_451	[p10l1276t757r1349b783],
37	dysfunctional	JJ	O	dysfunctional	amod	38	SENT_451	[p10l1375t757r1595b792],
38	lymphatics	NNS	O	lymphatic	nsubj	39	SENT_451	[p10l1621t757r1796b792],
39	due	JJ	O	due	xcomp	36	SENT_451	[p10l1822t757r1880b783],
40	to	TO	O	to	_	0	SENT_451	[p10l1907t763r1937b783],
41	defective	JJ	O	defective	amod	43	SENT_451	[p10l1963t757r2109b783],
42	VEGFR-3	NN	O	vegfr-3	nn	43	SENT_451	[p10l2133t757r2286b783],
43	signaling	NN	O	signaling	prep_to	39	SENT_451	[p10l1277t802r1429b837],
44	.	.	O	.	_	0	SENT_451	[p10l1277t802r1429b837],

1	This	DT	O	this	nsubjpass	5	SENT_452	[p10l1440t802r1509b828],
2	might	MD	O	might	aux	5	SENT_452	[p10l1521t802r1615b837],
3	also	RB	O	also	advmod	5	SENT_452	[p10l1627t802r1687b828],
4	be	VB	O	be	auxpass	5	SENT_452	[p10l1699t802r1736b828],
5	exploited	VBN	O	exploit	_	0	SENT_452	[p10l1747t802r1900b837],
6	for	IN	O	for	_	0	SENT_452	[p10l1911t802r1960b828],
7	the	DT	O	the	det	8	SENT_452	[p10l1971t802r2020b828],
8	development	NN	O	development	prep_for	5	SENT_452	[p10l2032t802r2244b837],
9	of	IN	O	of	_	0	SENT_452	[p10l2255t802r2290b828],
10	an	DT	O	a	det	12	SENT_452	[p10l1277t857r1315b874],
11	early	JJ	O	early	amod	12	SENT_452	[p10l1330t848r1408b883],
12	marker	NN	O	marker	prep_of	8	SENT_452	[p10l1423t848r1541b874],
13	for	IN	O	for	_	0	SENT_452	[p10l1554t848r1603b874],
14	lymphedema	NN	O	lymphedema	prep_for	12	SENT_452	[p10l1617t848r1834b883],
15	.	.	O	.	_	0	SENT_452	[p10l1617t848r1834b883],

1	Considering	VBG	O	consider	_	0	SENT_453	[p10l1314t894r1514b929],
2	the	DT	O	the	det	4	SENT_453	[p10l1534t894r1584b920],
3	possible	JJ	O	possible	amod	4	SENT_453	[p10l1604t894r1733b929],
4	effect	NN	O	effect	prep_considering	33	SENT_453	[p10l1754t894r1844b920],
5	of	IN	O	of	_	0	SENT_453	[p10l1864t894r1899b920],
6	VEGF-C/SVEGFR	NN	O	vegf-c/svegfr	prep_of	4	SENT_453	[p10l1914t894r2225b920],
7	-3	CD	NUMBER	-3	num	6	SENT_453	[p10l1914t894r2225b920],
8	on	IN	O	on	_	0	SENT_453	[p10l2246t903r2286b920],
9	lymphatic	JJ	O	lymphatic	amod	10	SENT_453	[p10l1276t940r1437b975],
10	dilation	NN	O	dilation	prep_on	6	SENT_453	[p10l1455t940r1582b966],
11	and	CC	O	and	_	0	SENT_453	[p10l1599t940r1658b966],
12	lymphedema	NN	O	lymphedema	nn	13	SENT_453	[p10l1676t940r1885b975],
13	development	NN	O	development	conj_and	10	SENT_453	[p10l1902t940r2122b975],
14	,	,	O	,	_	0	SENT_453	[p10l1902t940r2122b975],
15	a	DT	O	a	det	16	SENT_453	[p10l2140t949r2156b966],
16	combination	NN	O	combination	nsubj	33	SENT_453	[p10l2174t940r2286b966, p10l1277t987r1382b1012],
17	of	IN	O	of	_	0	SENT_453	[p10l1405t986r1440b1012],
18	classical	JJ	O	classical	amod	19	SENT_453	[p10l1460t986r1589b1012],
19	antiﬁlarial	JJ	O	antiﬁlarial	prep_of	16	SENT_453	[p10l1612t986r1781b1012],
20	plus	CC	O	plus	prep	19	SENT_453	[p10l1804t986r1869b1021],
21	antiwolbachial	JJ	O	antiwolbachial	amod	22	SENT_453	[p10l1893t986r2130b1012],
22	therapy	NN	O	therapy	dep	20	SENT_453	[p10l2155t986r2286b1021],
23	,	,	O	,	_	0	SENT_453	[p10l2155t986r2286b1021],
24	which	WDT	O	which	nsubj	26	SENT_453	[p10l1276t1032r1371b1058],
25	will	MD	O	will	aux	26	SENT_453	[p10l1386t1032r1442b1057],
26	reduce	VB	O	reduce	rcmod	16	SENT_453	[p10l1458t1032r1568b1058],
27	production	NN	O	production	dobj	26	SENT_453	[p10l1584t1032r1768b1067],
28	of	IN	O	of	_	0	SENT_453	[p10l1783t1032r1818b1058],
29	proinﬂammatory	JJ	O	proinﬂammatory	amod	30	SENT_453	[p10l1830t1032r2111b1067],
30	cytokines	NNS	O	cytokine	prep_of	27	SENT_453	[p10l2126t1032r2286b1067],
31	,	,	O	,	_	0	SENT_453	[p10l2126t1032r2286b1067],
32	may	MD	O	may	aux	33	SENT_453	[p10l1277t1087r1342b1113],
33	prove	VB	O	prove	_	0	SENT_453	[p10l1366t1087r1458b1113],
34	to	TO	O	to	aux	37	SENT_453	[p10l1483t1083r1513b1104],
35	be	VB	O	be	cop	37	SENT_453	[p10l1537t1078r1574b1104],
36	more	RBR	O	more	advmod	37	SENT_453	[p10l1599t1087r1683b1104],
37	effective	JJ	O	effective	xcomp	33	SENT_453	[p10l1707t1078r1844b1104],
38	in	IN	O	in	_	0	SENT_453	[p10l1869t1079r1899b1103],
39	treating	VBG	O	treat	prepc_in	37	SENT_453	[p10l1925t1079r2053b1113],
40	pathogenesis	NN	O	pathogenesis	dobj	39	SENT_453	[p10l2076t1078r2286b1113],
41	associated	VBN	O	associate	partmod	40	SENT_453	[p10l1277t1124r1441b1150],
42	with	IN	O	with	_	0	SENT_453	[p10l1455t1124r1525b1150],
43	LF	NN	O	lf	prep_with	41	SENT_453	[p10l1539t1125r1581b1149],
44	than	IN	O	than	_	0	SENT_453	[p10l1597t1124r1668b1150],
45	antiﬁlarial	JJ	O	antiﬁlarial	amod	46	SENT_453	[p10l1684t1124r1853b1150],
46	therapy	NN	O	therapy	prep_than	41	SENT_453	[p10l1869t1124r1992b1159],
47	alone	RB	O	alone	advmod	37	SENT_453	[p10l2007t1124r2102b1150],
48	.	.	O	.	_	0	SENT_453	[p10l2007t1124r2102b1150],

1	This	DT	O	this	det	2	SENT_454	[p10l2117t1124r2186b1150],
2	study	NN	O	study	nsubj	3	SENT_454	[p10l2201t1124r2287b1159],
3	represents	VBZ	O	represent	_	0	SENT_454	[p10l1277t1176r1446b1205],
4	a	DT	O	a	det	6	SENT_454	[p10l1471t1179r1487b1196],
5	ﬁrst	JJ	O	ﬁrst	amod	6	SENT_454	[p10l1510t1170r1573b1196],
6	observation	NN	O	observation	dobj	3	SENT_454	[p10l1597t1170r1788b1196],
7	that	IN	O	that	complm	10	SENT_454	[p10l1813t1170r1876b1196],
8	antiwolbachial	JJ	O	antiwolbachial	amod	9	SENT_454	[p10l1901t1170r2138b1196],
9	therapy	NN	O	therapy	nsubj	10	SENT_454	[p10l2163t1170r2287b1205],
10	does	VBZ	O	do	ccomp	3	SENT_454	[p10l1277t1216r1348b1242],
11	not	RB	O	not	neg	12	SENT_454	[p10l1363t1222r1417b1242],
12	only	RB	O	only	dobj	10	SENT_454	[p10l1431t1216r1499b1251],
13	have	VBP	O	have	dep	12	SENT_454	[p10l1513t1216r1586b1242],
14	macroﬁlaricidal	JJ	O	macroﬁlaricidal	amod	15	SENT_454	[p10l1600t1216r1859b1242],
15	activity	NN	O	activity	dobj	13	SENT_454	[p10l1873t1217r1991b1251],
16	but	CC	O	but	_	0	SENT_454	[p10l2004t1216r2058b1242],
17	may	MD	O	may	aux	19	SENT_454	[p10l2072t1225r2137b1251],
18	also	RB	O	also	advmod	19	SENT_454	[p10l2151t1216r2211b1242],
19	halt	VB	O	halt	conj_but	13	SENT_454	[p10l2225t1216r2287b1242],
20	progression	NN	O	progression	dobj	19	SENT_454	[p10l1277t1262r1471b1296],
21	of	IN	O	of	_	0	SENT_454	[p10l1499t1261r1534b1287],
22	manifestations	NNS	O	manifestation	prep_of	20	SENT_454	[p10l1559t1261r1801b1287],
23	associated	VBN	O	associate	partmod	22	SENT_454	[p10l1830t1261r1997b1287],
24	with	IN	O	with	_	0	SENT_454	[p10l2024t1261r2095b1287],
25	lymphatic	JJ	O	lymphatic	amod	26	SENT_454	[p10l2123t1261r2286b1296],
26	ﬁlariasis	NN	O	ﬁlariasis	prep_with	23	SENT_454	[p10l1276t1307r1418b1338],
27	,	,	O	,	_	0	SENT_454	[p10l1276t1307r1418b1338],
28	and	CC	O	and	_	0	SENT_454	[p10l1447t1307r1506b1333],
29	have	VBP	O	have	dep	12	SENT_454	[p10l1534t1307r1607b1333],
30	a	DT	O	a	det	33	SENT_454	[p10l1635t1316r1651b1333],
31	potential	JJ	O	potential	amod	33	SENT_454	[p10l1679t1307r1827b1342],
32	restorative	JJ	O	restorative	amod	33	SENT_454	[p10l1855t1308r2030b1333],
33	effect	NN	O	effect	dobj	29	SENT_454	[p10l2058t1307r2149b1333],
34	on	IN	O	on	_	0	SENT_454	[p10l2176t1316r2217b1333],
35	LF	NN	O	lf	nn	36	SENT_454	[p10l2244t1308r2286b1332],
36	patients	NNS	O	patient	prep_on	33	SENT_454	[p10l1277t1354r1414b1388],
37	.	.	O	.	_	0	SENT_454	[p10l1277t1354r1414b1388],

1	As	IN	O	as	mark	2	SENT_455	[p10l1427t1353r1466b1379],
2	discussed	VBN	O	discuss	advcl	14	SENT_455	[p10l1479t1353r1629b1379],
3	earlier	RBR	O	earlier	advmod	2	SENT_455	[p10l1642t1353r1756b1384],
4	,	,	O	,	_	0	SENT_455	[p10l1642t1353r1756b1384],
5	compliance	NN	O	compliance	nsubjpass	14	SENT_455	[p10l1770t1353r1958b1388],
6	to	TO	O	to	aux	7	SENT_455	[p10l1972t1359r2002b1379],
7	take	VB	O	take	infmod	5	SENT_455	[p10l2016t1353r2082b1379],
8	doxycycline	NN	O	doxycycline	dobj	7	SENT_455	[p10l2095t1353r2286b1388],
9	for	IN	O	for	_	0	SENT_455	[p10l1276t1399r1325b1425],
10	extended	JJ	O	extended	amod	11	SENT_455	[p10l1345t1399r1495b1425],
11	periods	NNS	O	period	prep_for	7	SENT_455	[p10l1517t1399r1638b1434],
12	is	VBZ	O	be	auxpass	14	SENT_455	[p10l1661t1400r1683b1425],
13	not	RB	O	not	neg	14	SENT_455	[p10l1705t1405r1759b1425],
14	expected	VBN	O	expect	_	0	SENT_455	[p10l1780t1399r1926b1434],
15	to	TO	O	to	aux	18	SENT_455	[p10l1949t1405r1979b1425],
16	be	VB	O	be	cop	18	SENT_455	[p10l2001t1399r2038b1425],
17	an	DT	O	a	det	18	SENT_455	[p10l2060t1408r2097b1425],
18	issue	NN	O	issue	xcomp	14	SENT_455	[p10l2120t1400r2195b1425],
19	with	IN	O	with	_	0	SENT_455	[p10l2217t1399r2286b1425],
20	individuals	NNS	O	individual	prep_with	18	SENT_455	[p10l1277t1445r1454b1471],
21	suffering	VBG	O	suffer	partmod	20	SENT_455	[p10l1469t1445r1615b1480],
22	from	IN	O	from	_	0	SENT_455	[p10l1629t1445r1709b1471],
23	lymphatic	JJ	O	lymphatic	amod	24	SENT_455	[p10l1723t1445r1884b1480],
24	pathology	NN	O	pathology	prep_from	21	SENT_455	[p10l1900t1445r2068b1480],
25	.	.	O	.	_	0	SENT_455	[p10l1900t1445r2068b1480],

1	Materials	NNPS	O	Materials	_	0	SENT_456	[p10l1277t1543r1455b1575],
2	and	CC	O	and	_	0	SENT_456	[p10l1472t1543r1543b1575],
3	Methods	NNS	O	method	conj_and	1	SENT_456	[p10l1561t1543r1729b1575],

1	This	DT	O	this	det	5	SENT_457	[p10l1313t1613r1375b1636],
2	placebo-controlled	JJ	O	placebo-controlled	amod	5	SENT_457	[p10l1387t1613r1670b1644],
3	,	,	O	,	_	0	SENT_457	[p10l1387t1613r1670b1644],
4	double-blind	JJ	O	double-blind	amod	5	SENT_457	[p10l1682t1613r1868b1636],
5	study	NN	O	study	nsubjpass	7	SENT_457	[p10l1880t1613r1956b1644],
6	was	VBD	O	be	auxpass	7	SENT_457	[p10l1967t1621r2016b1636],
7	carried	VBN	O	carry	_	0	SENT_457	[p10l2028t1613r2132b1636],
8	out	RP	O	out	prt	7	SENT_457	[p10l2144t1618r2191b1636],
9	in	IN	O	in	_	0	SENT_457	[p10l2203t1613r2230b1635],
10	the	DT	O	the	det	13	SENT_457	[p10l2243t1613r2286b1636],
11	Nzema	NNP	LOCATION	Nzema	nn	13	SENT_457	[p10l1276t1649r1375b1671],
12	East	NNP	LOCATION	East	nn	13	SENT_457	[p10l1388t1649r1446b1671],
13	District	NNP	LOCATION	District	prep_in	7	SENT_457	[p10l1460t1648r1568b1671],
14	in	IN	O	in	_	0	SENT_457	[p10l1582t1648r1609b1670],
15	the	DT	O	the	det	17	SENT_457	[p10l1624t1648r1667b1671],
16	Western	JJ	MISC	western	amod	17	SENT_457	[p10l1681t1649r1801b1671],
17	region	NN	O	region	prep_in	7	SENT_457	[p10l1816t1648r1908b1679],
18	of	IN	O	of	_	0	SENT_457	[p10l1922t1648r1953b1670],
19	Ghana	NNP	LOCATION	Ghana	prep_of	17	SENT_457	[p10l1964t1648r2064b1671],
20	.	.	O	.	_	0	SENT_457	[p10l1964t1648r2064b1671],

1	The	DT	O	the	det	2	SENT_458	[p10l2078t1648r2134b1671],
2	study	NN	O	study	nsubjpass	4	SENT_458	[p10l2148t1648r2224b1679],
3	was	VBD	O	be	auxpass	4	SENT_458	[p10l2237t1656r2286b1671],
4	approved	VBN	O	approve	_	0	SENT_458	[p10l1277t1684r1413b1715],
5	by	IN	O	by	_	0	SENT_458	[p10l1427t1684r1459b1715],
6	the	DT	O	the	det	8	SENT_458	[p10l1473t1684r1517b1707],
7	Ethical	NNP	ORGANIZATION	Ethical	nn	8	SENT_458	[p10l1531t1684r1630b1707],
8	Committee	NNP	ORGANIZATION	Committee	agent	4	SENT_458	[p10l1644t1684r1806b1707],
9	on	IN	ORGANIZATION	on	_	0	SENT_458	[p10l1819t1692r1855b1706],
10	Human	NNP	ORGANIZATION	Human	nn	11	SENT_458	[p10l1869t1685r1977b1707],
11	Research	NNP	ORGANIZATION	Research	prep_on	8	SENT_458	[p10l1991t1684r2120b1707],
12	and	CC	ORGANIZATION	and	_	0	SENT_458	[p10l2134t1684r2187b1707],
13	Ethics	NNP	ORGANIZATION	Ethics	conj_and	11	SENT_458	[p10l2200t1684r2286b1707],
14	of	IN	ORGANIZATION	of	_	0	SENT_458	[p10l1276t1719r1307b1741],
15	the	DT	ORGANIZATION	the	det	16	SENT_458	[p10l1318t1719r1362b1742],
16	School	NNP	ORGANIZATION	School	prep_of	8	SENT_458	[p10l1376t1719r1472b1742],
17	of	IN	ORGANIZATION	of	_	0	SENT_458	[p10l1486t1719r1517b1741],
18	Medical	NNP	ORGANIZATION	Medical	nn	19	SENT_458	[p10l1527t1719r1640b1742],
19	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	8	SENT_458	[p10l1653t1719r1774b1742],
20	of	IN	ORGANIZATION	of	_	0	SENT_458	[p10l1788t1719r1819b1741],
21	Kwame	NNP	ORGANIZATION	Kwame	nn	23	SENT_458	[p10l1829t1720r1934b1742],
22	Nkrumah	NNP	ORGANIZATION	Nkrumah	nn	23	SENT_458	[p10l1947t1719r2084b1741],
23	University	NNP	ORGANIZATION	University	prep_of	19	SENT_458	[p10l2098t1719r2246b1750],
24	of	IN	ORGANIZATION	of	_	0	SENT_458	[p10l2259t1719r2290b1741],
25	Science	NNP	ORGANIZATION	Science	prep_of	23	SENT_458	[p10l1277t1754r1385b1777],
26	and	CC	ORGANIZATION	and	_	0	SENT_458	[p10l1400t1754r1452b1777],
27	Technology	NNP	ORGANIZATION	Technology	prep_of	23	SENT_458	[p10l1465t1754r1635b1785],
28	(	CD	NUMBER	(	num	29	SENT_458	[p10l1650t1754r1788b1783],
29	KNUST	NNP	O	KNUST	dep	8	SENT_458	[p10l1650t1754r1788b1783],
30	)	CD	NUMBER	)	num	29	SENT_458	[p10l1650t1754r1788b1783],
31	,	,	O	,	_	0	SENT_458	[p10l1650t1754r1788b1783],
32	Kumasi	NNP	LOCATION	Kumasi	nn	34	SENT_458	[p10l1802t1754r1916b1781],
33	,	,	O	,	_	0	SENT_458	[p10l1802t1754r1916b1781],
34	Ghana	NNP	LOCATION	Ghana	appos	29	SENT_458	[p10l1931t1754r2031b1781],
35	,	,	O	,	_	0	SENT_458	[p10l1931t1754r2031b1781],
36	as	RB	O	as	_	0	SENT_458	[p10l2046t1762r2072b1777],
37	well	RB	O	well	_	0	SENT_458	[p10l2085t1754r2141b1777],
38	as	IN	O	as	_	0	SENT_458	[p10l2156t1762r2181b1777],
39	by	IN	O	by	_	0	SENT_458	[p10l2196t1754r2228b1785],
40	the	DT	O	the	det	42	SENT_458	[p10l2243t1754r2286b1777],
41	ethics	NNS	O	ethic	nn	42	SENT_458	[p10l1276t1790r1359b1813],
42	committee	NN	O	committee	agent	4	SENT_458	[p10l1377t1790r1531b1813],
43	of	IN	O	of	_	0	SENT_458	[p10l1550t1790r1581b1812],
44	the	DT	O	the	det	45	SENT_458	[p10l1597t1790r1641b1813],
45	University	NNP	ORGANIZATION	University	prep_of	42	SENT_458	[p10l1660t1790r1808b1821],
46	of	IN	ORGANIZATION	of	_	0	SENT_458	[p10l1826t1790r1857b1812],
47	Liverpool	NNP	ORGANIZATION	Liverpool	prep_of	45	SENT_458	[p10l1872t1790r2012b1821],
48	which	WDT	O	which	nsubj	49	SENT_458	[p10l2030t1790r2115b1813],
49	acted	VBD	O	act	rcmod	42	SENT_458	[p10l2133t1790r2209b1813],
50	as	IN	O	as	_	0	SENT_458	[p10l2228t1798r2254b1813],
51	a	DT	O	a	det	53	SENT_458	[p10l2273t1798r2287b1813],
52	control	NN	O	control	nn	53	SENT_458	[p10l1276t1826r1382b1849],
53	body	NN	O	body	prep_as	49	SENT_458	[p10l1404t1826r1474b1857],
54	since	IN	O	since	mark	57	SENT_458	[p10l1495t1826r1567b1849],
55	this	DT	O	this	det	56	SENT_458	[p10l1589t1826r1639b1849],
56	work	NN	O	work	nsubj	57	SENT_458	[p10l1661t1826r1732b1848],
57	formed	VBD	O	form	advcl	49	SENT_458	[p10l1753t1826r1859b1849],
58	part	NN	O	part	dobj	57	SENT_458	[p10l1881t1831r1941b1857],
59	of	IN	O	of	_	0	SENT_458	[p10l1963t1826r1994b1848],
60	a	DT	O	a	det	63	SENT_458	[p10l2013t1834r2027b1849],
61	European	JJ	MISC	european	amod	63	SENT_458	[p10l2048t1827r2189b1857],
62	study	NN	O	study	nn	63	SENT_458	[p10l2211t1826r2287b1857],
63	network	NN	O	network	prep_of	58	SENT_458	[p10l1277t1861r1395b1884],
64	funded	VBN	O	fund	partmod	63	SENT_458	[p10l1406t1861r1509b1884],
65	by	IN	O	by	_	0	SENT_458	[p10l1520t1861r1553b1892],
66	the	DT	O	the	det	68	SENT_458	[p10l1565t1861r1609b1884],
67	European	JJ	ORGANIZATION	european	amod	68	SENT_458	[p10l1621t1862r1762b1892],
68	Commission	NNP	ORGANIZATION	Commission	agent	64	SENT_458	[p10l1775t1861r1960b1884],
69	.	.	O	.	_	0	SENT_458	[p10l1775t1861r1960b1884],

1	The	DT	O	the	det	2	SENT_459	[p10l1972t1861r2028b1884],
2	study	NN	O	study	nsubj	3	SENT_459	[p10l2040t1861r2116b1892],
3	conformed	VBD	O	conform	_	0	SENT_459	[p10l2127t1861r2287b1884],
4	to	TO	O	to	_	0	SENT_459	[p10l1277t1901r1304b1919],
5	the	DT	O	the	det	6	SENT_459	[p10l1321t1896r1365b1919],
6	principles	NNS	O	principle	prep_to	3	SENT_459	[p10l1381t1896r1525b1927],
7	of	IN	O	of	_	0	SENT_459	[p10l1540t1896r1571b1918],
8	the	DT	O	the	det	10	SENT_459	[p10l1585t1896r1628b1919],
9	Helsinki	NNP	LOCATION	Helsinki	nn	10	SENT_459	[p10l1644t1896r1764b1919],
10	Declaration	NN	O	declaration	prep_of	6	SENT_459	[p10l1779t1896r1949b1919],
11	of	IN	O	of	_	0	SENT_459	[p10l1965t1896r1995b1918],
12	1975	CD	DATE	1975	num	13	SENT_459	[p10l2011t1894r2075b1918],
13	(	CD	NUMBER	(	prep_of	10	SENT_459	[p10l2091t1897r2126b1925],
14	as	IN	O	as	_	0	SENT_459	[p10l2091t1897r2126b1925],
15	revised	VBN	O	revise	amod	20	SENT_459	[p10l2143t1896r2244b1919],
16	in	IN	O	in	_	0	SENT_459	[p10l2260t1896r2286b1918],
17	1983	CD	DATE	1983	prep_in	15	SENT_459	[p10l1279t1932r1343b1954],
18	and	CC	DATE	and	_	0	SENT_459	[p10l1357t1932r1409b1955],
19	2000	CD	DATE	2000	prep_in	15	SENT_459	[p10l1423t1932r1506b1961],
20	)	NN	O	)	prep_as	3	SENT_459	[p10l1423t1932r1506b1961],
21	.	.	O	.	_	0	SENT_459	[p10l1423t1932r1506b1961],

1	The	DT	O	the	det	4	SENT_460	[p10l1519t1932r1575b1955],
2	trial	NN	O	trial	nn	4	SENT_460	[p10l1589t1932r1647b1955],
3	registration	NN	O	registration	nn	4	SENT_460	[p10l1662t1932r1830b1963],
4	number	NN	O	number	nsubj	6	SENT_460	[p10l1844t1932r1958b1955],
5	is	VBZ	O	be	cop	6	SENT_460	[p10l1971t1932r1990b1954],
6	ISRCTN	NNP	O	ISRCTN	_	0	SENT_460	[p10l2003t1932r2122b1955],
7	14757	CD	NUMBER	14757	num	6	SENT_460	[p10l2139t1930r2227b1954],
8	.	.	O	.	_	0	SENT_460	[p10l2139t1930r2227b1954],

1	Study	NNP	O	Study	_	0	SENT_461	[p10l1314t1967r1395b1998],
2	population	NN	O	population	dep	1	SENT_461	[p10l1418t1967r1585b1998],
3	.	.	O	.	_	0	SENT_461	[p10l1418t1967r1585b1998],

1	Individuals	NNS	O	individual	nsubj	2	SENT_462	[p10l1611t1967r1771b1990],
2	enrolled	VBD	O	enrol	_	0	SENT_462	[p10l1797t1967r1918b1990],
3	from	IN	O	from	_	0	SENT_462	[p10l1943t1967r2014b1989],
4	the	DT	O	the	det	6	SENT_462	[p10l2039t1967r2083b1990],
5	neighboring	VBG	O	neighbor	amod	6	SENT_462	[p10l2109t1967r2288b1998],
6	villages	NNS	O	village	prep_from	2	SENT_462	[p10l1276t2003r1380b2034],
7	of	IN	O	of	_	0	SENT_462	[p10l1398t2003r1429b2025],
8	Adjan	NNP	LOCATION	Adjan	nn	10	SENT_462	[p10l1443t2003r1537b2034],
9	,	,	O	,	_	0	SENT_462	[p10l1443t2003r1537b2034],
10	Domunli	NNP	LOCATION	Domunli	prep_of	6	SENT_462	[p10l1555t2003r1689b2030],
11	,	,	O	,	_	0	SENT_462	[p10l1555t2003r1689b2030],
12	and	CC	O	and	_	0	SENT_462	[p10l1708t2003r1761b2026],
13	Akonu	NNP	PERSON	Akonu	nsubj	20	SENT_462	[p10l1779t2003r1875b2025],
14	in	IN	O	in	_	0	SENT_462	[p10l1894t2003r1921b2025],
15	the	DT	O	the	det	17	SENT_462	[p10l1940t2003r1983b2026],
16	Western	JJ	O	western	amod	17	SENT_462	[p10l2002t2004r2121b2026],
17	Region	NN	O	region	prep_in	13	SENT_462	[p10l2140t2003r2240b2034],
18	of	IN	O	of	_	0	SENT_462	[p10l2259t2003r2290b2025],
19	Ghana	NNP	LOCATION	Ghana	prep_of	17	SENT_462	[p10l1277t2038r1370b2061],
20	took	VBD	O	take	conj_and	2	SENT_462	[p10l1385t2038r1448b2061],
21	part	NN	O	part	dobj	20	SENT_462	[p10l1463t2043r1522b2069],
22	in	IN	O	in	_	0	SENT_462	[p10l1538t2038r1564b2060],
23	the	DT	O	the	det	24	SENT_462	[p10l1579t2038r1623b2061],
24	study	NN	O	study	prep_in	20	SENT_462	[p10l1638t2038r1720b2069],
25	.	.	O	.	_	0	SENT_462	[p10l1638t2038r1720b2069],

1	No	DT	O	no	det	5	SENT_463	[p10l1735t2039r1776b2060],
2	other	JJ	O	other	amod	5	SENT_463	[p10l1791t2038r1870b2061],
3	human	JJ	O	human	amod	5	SENT_463	[p10l1883t2038r1983b2061],
4	ﬁlarial	JJ	O	ﬁlarial	amod	5	SENT_463	[p10l1997t2038r2090b2061],
5	species	NNS	O	species	nsubj	7	SENT_463	[p10l2105t2038r2205b2069],
6	were	VBD	O	be	cop	7	SENT_463	[p10l2219t2046r2286b2061],
7	endemic	JJ	O	endemic	_	0	SENT_463	[p10l1276t2074r1398b2097],
8	in	IN	O	in	_	0	SENT_463	[p10l1417t2074r1443b2096],
9	these	DT	O	these	det	10	SENT_463	[p10l1461t2074r1534b2097],
10	villages	NNS	O	village	prep_in	7	SENT_463	[p10l1550t2074r1661b2105],
11	.	.	O	.	_	0	SENT_463	[p10l1550t2074r1661b2105],

1	A	DT	O	a	det	2	SENT_464	[p10l1678t2074r1700b2096],
2	total	NN	O	total	nsubj	25	SENT_464	[p10l1718t2074r1782b2097],
3	of	IN	O	of	_	0	SENT_464	[p10l1799t2074r1830b2096],
4	76	CD	NUMBER	76	number	5	SENT_464	[p10l1845t2072r1877b2096],
5	(	CD	NUMBER	(	num	14	SENT_464	[p10l1894t2074r1936b2102],
6	55	CD	NUMBER	55	num	7	SENT_464	[p10l1894t2074r1936b2102],
7	males	NNS	O	male	nn	14	SENT_464	[p10l1953t2074r2033b2097],
8	and	CC	O	and	_	0	SENT_464	[p10l2050t2074r2102b2097],
9	21	CD	NUMBER	21	num	10	SENT_464	[p10l2120t2074r2149b2097],
10	females	NNS	O	female	npadvmod	11	SENT_464	[p10l2168t2074r2286b2103],
11	)	JJ	O	)	conj_and	7	SENT_464	[p10l2168t2074r2286b2103],
12	microﬁlaremic	JJ	O	microﬁlaremic	amod	14	SENT_464	[p10l1277t2109r1491b2132],
13	(	NN	O	(	nn	14	SENT_464	[p10l1518t2109r1620b2140],
14	Figure	NN	O	figure	prep_of	2	SENT_464	[p10l1518t2109r1620b2140],
15	1A	NN	O	1a	nn	16	SENT_464	[p10l1648t2109r1694b2138],
16	)	NN	O	)	dep	14	SENT_464	[p10l1648t2109r1694b2138],
17	and	CC	O	and	_	0	SENT_464	[p10l1719t2109r1772b2132],
18	19	CD	NUMBER	19	num	21	SENT_464	[p10l1800t2109r1829b2131],
19	(	CD	NUMBER	(	num	21	SENT_464	[p10l1855t2109r1896b2138],
20	13	CD	NUMBER	13	num	21	SENT_464	[p10l1855t2109r1896b2138],
21	females	NNS	O	female	prep_of	2	SENT_464	[p10l1921t2109r2030b2132],
22	and	CC	O	and	_	0	SENT_464	[p10l2055t2109r2108b2132],
23	six	CD	NUMBER	six	num	24	SENT_464	[p10l2133t2109r2171b2132],
24	males	NNS	O	male	conj_and	14	SENT_464	[p10l2196t2109r2286b2138],
25	)	VBP	O	)	_	0	SENT_464	[p10l2196t2109r2286b2138],
26	lymphedema	NN	O	lymphedema	nn	28	SENT_464	[p10l1277t2145r1462b2176],
27	(	CD	NUMBER	(	num	28	SENT_464	[p10l1480t2145r1581b2176],
28	Figure	NNP	O	Figure	dobj	25	SENT_464	[p10l1480t2145r1581b2176],
29	113	CD	NUMBER	113	number	30	SENT_464	[p10l1601t2145r1644b2174],
30	)	CD	NUMBER	)	num	31	SENT_464	[p10l1601t2145r1644b2174],
31	patients	NNS	O	patient	nsubjpass	33	SENT_464	[p10l1661t2145r1776b2176],
32	were	VBD	O	be	auxpass	33	SENT_464	[p10l1793t2153r1860b2168],
33	included	VBN	O	include	rcmod	28	SENT_464	[p10l1878t2145r2003b2168],
34	in	IN	O	in	_	0	SENT_464	[p10l2020t2145r2047b2167],
35	this	DT	O	this	det	36	SENT_464	[p10l2065t2145r2114b2168],
36	study	NN	O	study	prep_in	33	SENT_464	[p10l2132t2145r2214b2176],
37	.	.	O	.	_	0	SENT_464	[p10l2132t2145r2214b2176],

1	The	DT	O	the	det	3	SENT_465	[p10l2231t2145r2286b2168],
2	study	NN	O	study	nn	3	SENT_465	[p10l1277t2180r1352b2211],
3	site	NN	O	site	nsubjpass	5	SENT_465	[p10l1377t2180r1425b2203],
4	was	VBD	O	be	auxpass	5	SENT_465	[p10l1449t2188r1498b2203],
5	selected	VBN	O	select	_	0	SENT_465	[p10l1524t2180r1638b2203],
6	based	VBN	O	base	_	0	SENT_465	[p10l1663t2180r1743b2203],
7	on	IN	O	on	prepc_based_on	5	SENT_465	[p10l1768t2188r1804b2202],
8	an	DT	O	a	det	10	SENT_465	[p10l1829t2188r1862b2203],
9	established	JJ	O	established	amod	10	SENT_465	[p10l1887t2180r2046b2203],
10	occurrence	NN	O	occurrence	pobj	5	SENT_465	[p10l2071t2188r2234b2203],
11	of	IN	O	of	_	0	SENT_465	[p10l2259t2180r2289b2202],
12	lymphatic	JJ	O	lymphatic	amod	13	SENT_465	[p10l1277t2216r1420b2247],
13	ﬁlariasis	NN	O	ﬁlariasis	prep_of	10	SENT_465	[p10l1446t2216r1566b2239],
14	within	IN	O	within	_	0	SENT_465	[p10l1590t2216r1683b2239],
15	the	DT	O	the	det	17	SENT_465	[p10l1709t2216r1753b2239],
16	surrounding	JJ	O	surrounding	amod	17	SENT_465	[p10l1778t2216r1961b2247],
17	region	NN	O	region	prep_within	13	SENT_465	[p10l1986t2216r2078b2247],
18	and	CC	O	and	_	0	SENT_465	[p10l2104t2216r2157b2239],
19	clinical	JJ	O	clinical	amod	20	SENT_465	[p10l2182t2216r2286b2239],
20	observations	NNS	O	observation	nsubj	21	SENT_465	[p10l1276t2251r1458b2274],
21	(	VBP	O	(	conj_and	5	SENT_465	[p10l1473t2251r1559b2282],
22	rapid	JJ	O	rapid	amod	24	SENT_465	[p10l1473t2251r1559b2282],
23	assessment	NN	O	assessment	nn	24	SENT_465	[p10l1573t2252r1739b2279],
24	)	NN	O	)	nsubj	34	SENT_465	[p10l1573t2252r1739b2279],
25	consistent	JJ	O	consistent	amod	24	SENT_465	[p10l1752t2251r1898b2274],
26	with	IN	O	with	_	0	SENT_465	[p10l1911t2251r1973b2274],
27	symptomatic	JJ	O	symptomatic	amod	28	SENT_465	[p10l1987t2251r2171b2282],
28	disease	NN	O	disease	prep_with	25	SENT_465	[p10l2186t2251r2286b2274],
29	in	IN	O	in	_	0	SENT_465	[p10l1277t2287r1304b2309],
30	a	DT	O	a	det	31	SENT_465	[p10l1325t2295r1340b2309],
31	proportion	NN	O	proportion	prep_in	28	SENT_465	[p10l1361t2287r1523b2318],
32	of	IN	O	of	_	0	SENT_465	[p10l1545t2287r1576b2309],
33	villagers	NNS	O	villager	prep_of	31	SENT_465	[p10l1593t2287r1711b2318],
34	[	VBP	O	[	ccomp	21	SENT_465	[p10l1735t2287r1792b2315],
35	44	CD	NUMBER	44	number	36	SENT_465	[p10l1735t2287r1792b2315],
36	]	CD	NUMBER	]	dobj	34	SENT_465	[p10l1735t2287r1792b2315],
37	.	.	O	.	_	0	SENT_465	[p10l1735t2287r1792b2315],

1	Written	VBN	O	write	csubjpass	5	SENT_466	[p10l1814t2287r1926b2310],
2	informed	JJ	O	informed	amod	3	SENT_466	[p10l1948t2287r2083b2310],
3	consent	NN	O	consent	dobj	1	SENT_466	[p10l2104t2292r2216b2310],
4	was	VBD	O	be	auxpass	5	SENT_466	[p10l2237t2295r2286b2310],
5	obtained	VBN	O	obtain	_	0	SENT_466	[p10l1276t2322r1405b2345],
6	from	IN	O	from	_	0	SENT_466	[p10l1418t2322r1489b2344],
7	all	DT	O	all	det	8	SENT_466	[p10l1503t2322r1536b2344],
8	participants	NNS	O	participant	prep_from	5	SENT_466	[p10l1550t2322r1732b2353],
9	.	.	O	.	_	0	SENT_466	[p10l1550t2322r1732b2353],

1	Individuals	NNS	O	individual	nsubj	12	SENT_467	[p10l1747t2322r1906b2345],
2	eligible	JJ	O	eligible	amod	1	SENT_467	[p10l1921t2322r2025b2353],
3	for	IN	O	for	_	0	SENT_467	[p10l2039t2322r2082b2344],
4	participation	NN	O	participation	prep_for	2	SENT_467	[p10l2096t2322r2286b2353],
5	were	VBD	O	be	cop	12	SENT_467	[p10l1276t2366r1343b2381],
6	adults	NNS	O	adult	nn	12	SENT_467	[p10l1355t2358r1440b2381],
7	of	IN	O	of	_	0	SENT_467	[p10l1452t2358r1483b2380],
8	both	DT	O	both	det	9	SENT_467	[p10l1492t2358r1558b2381],
9	sexes	NNS	O	sex	prep_of	6	SENT_467	[p10l1570t2366r1641b2381],
10	aged	JJ	O	aged	amod	12	SENT_467	[p10l1654t2358r1719b2389],
11	18-50	CD	NUMBER	18-50	tmod	10	SENT_467	[p10l1734t2358r1814b2380],
12	y	NN	O	y	conj_and	12	SENT_467	[p10l1826t2366r1847b2389],
13	,	,	O	,	_	0	SENT_467	[p10l1826t2366r1847b2389],
14	with	IN	O	with	_	0	SENT_467	[p10l1859t2358r1921b2381],
15	a	DT	O	a	det	18	SENT_467	[p10l1933t2366r1947b2381],
16	minimum	JJ	O	minimum	amod	18	SENT_467	[p10l1959t2358r2100b2380],
17	body	NN	O	body	nn	18	SENT_467	[p10l2111t2358r2181b2389],
18	weight	NN	O	weight	prep_with	12	SENT_467	[p10l2192t2358r2287b2389],
19	of	IN	O	of	_	0	SENT_467	[p10l1276t2393r1307b2415],
20	more	JJR	O	more	mwe	21	SENT_467	[p10l1315t2401r1389b2416],
21	than	IN	O	than	quantmod	22	SENT_467	[p10l1400t2393r1464b2416],
22	40	CD	NUMBER	40	num	23	SENT_467	[p10l1474t2393r1505b2415],
23	kg	NN	O	kg	prep_of	18	SENT_467	[p10l1516t2393r1555b2424],
24	,	,	O	,	_	0	SENT_467	[p10l1516t2393r1555b2424],
25	in	IN	O	in	_	0	SENT_467	[p10l1566t2393r1592b2415],
26	good	JJ	O	good	amod	27	SENT_467	[p10l1602t2393r1673b2424],
27	health	NN	O	health	prep_in	12	SENT_467	[p10l1683t2393r1779b2420],
28	,	,	O	,	_	0	SENT_467	[p10l1683t2393r1779b2420],
29	and	CC	O	and	_	0	SENT_467	[p10l1790t2393r1843b2416],
30	without	IN	O	without	_	0	SENT_467	[p10l1852t2393r1964b2416],
31	any	DT	O	any	det	33	SENT_467	[p10l1974t2401r2023b2424],
32	clinical	JJ	O	clinical	amod	33	SENT_467	[p10l2033t2393r2136b2416],
33	condition	NN	O	condition	prep_without	12	SENT_467	[p10l2146t2393r2286b2416],
34	requiring	VBG	O	require	partmod	33	SENT_467	[p10l1277t2429r1414b2460],
35	chronic	JJ	O	chronic	amod	36	SENT_467	[p10l1438t2429r1548b2452],
36	medication	NN	O	medication	dobj	34	SENT_467	[p10l1574t2429r1744b2452],
37	.	.	O	.	_	0	SENT_467	[p10l1574t2429r1744b2452],

1	Hepatic	JJ	MISC	hepatic	amod	4	SENT_468	[p10l1770t2429r1883b2460],
2	and	CC	O	and	_	0	SENT_468	[p10l1909t2429r1962b2452],
3	renal	JJ	O	renal	conj_and	1	SENT_468	[p10l1987t2429r2060b2452],
4	function	NN	O	function	nsubjpass	8	SENT_468	[p10l2084t2429r2209b2452],
5	and	CC	O	and	_	0	SENT_468	[p10l2234t2429r2286b2452],
6	pregnancy	NN	O	pregnancy	conj_and	4	SENT_468	[p10l1277t2472r1427b2495],
7	were	VBD	O	be	auxpass	8	SENT_468	[p10l1446t2472r1514b2487],
8	assessed	VBN	O	assess	_	0	SENT_468	[p10l1534t2464r1649b2487],
9	by	IN	O	by	_	0	SENT_468	[p10l1669t2464r1701b2495],
10	dipstick	NN	O	dipstick	nn	11	SENT_468	[p10l1721t2464r1834b2495],
11	chemistry	NN	O	chemistry	agent	8	SENT_468	[p10l1854t2464r2001b2495],
12	.	.	O	.	_	0	SENT_468	[p10l1854t2464r2001b2495],

1	Exclusion	NN	MISC	exclusion	nn	2	SENT_469	[p10l2021t2464r2161b2487],
2	criteria	NNS	O	criterion	nsubj	3	SENT_469	[p10l2181t2464r2287b2487],
3	encompassed	VBD	O	encompass	_	0	SENT_469	[p10l1276t2499r1477b2530],
4	a	DT	O	a	det	6	SENT_469	[p10l1503t2507r1517b2522],
5	microﬁlarial	JJ	O	microﬁlarial	amod	6	SENT_469	[p10l1543t2499r1730b2522],
6	load	NN	O	load	dep	7	SENT_469	[p10l1757t2499r1820b2522],
7	<	JJR	O	<	dobj	3	SENT_469	[p10l1847t2499r1906b2521],
8	50	CD	NUMBER	50	num	10	SENT_469	[p10l1847t2499r1906b2521],
9	MF/ml	NN	O	mf/ml	nn	10	SENT_469	[p10l1933t2499r2026b2522],
10	(	NN	O	(	tmod	3	SENT_469	[p10l2053t2499r2285b2528],
11	microﬁlaremic	JJ	O	microﬁlaremic	amod	12	SENT_469	[p10l2053t2499r2285b2528],
12	patients	NNS	O	patient	nsubj	20	SENT_469	[p10l1277t2535r1409b2566],
13	)	RB	O	)	advmod	20	SENT_469	[p10l1277t2535r1409b2566],
14	,	,	O	,	_	0	SENT_469	[p10l1277t2535r1409b2566],
15	abnormal	JJ	O	abnormal	amod	16	SENT_469	[p10l1430t2535r1568b2558],
16	hepatic	JJ	O	hepatic	nsubj	20	SENT_469	[p10l1589t2535r1694b2566],
17	and	CC	O	and	_	0	SENT_469	[p10l1716t2535r1768b2558],
18	renal	JJ	O	renal	amod	19	SENT_469	[p10l1789t2535r1861b2558],
19	enzymes	NNS	O	enzyme	conj_and	16	SENT_469	[p10l1882t2543r2001b2566],
20	(	VBP	O	(	rcmod	10	SENT_469	[p10l2023t2536r2164b2566],
21	aspartate	NN	O	aspartate	dobj	20	SENT_469	[p10l2023t2536r2164b2566],
22	aminotransferase	NN	O	aminotransferase	nn	24	SENT_469	[p10l2185t2535r2286b2558, p10l1277t2570r1435b2593],
23	[	CD	NUMBER	[	num	24	SENT_469	[p10l1448t2570r1525b2598],
24	AST	NNP	O	AST	dep	21	SENT_469	[p10l1448t2570r1525b2598],
25	;	:	O	;	_	0	SENT_469	[p10l1448t2570r1525b2598],
26	0-40	CD	NUMBER	0-40	num	28	SENT_469	[p10l1537t2570r1603b2592],
27	IU/l	NN	O	iu/l	nn	28	SENT_469	[p10l1614t2570r1683b2598],
28	]	NN	O	]	dep	21	SENT_469	[p10l1614t2570r1683b2598],
29	,	,	O	,	_	0	SENT_469	[p10l1614t2570r1683b2598],
30	alanine	NN	O	alanine	nn	31	SENT_469	[p10l1695t2570r1800b2593],
31	aminotransferase	NN	O	aminotransferase	appos	28	SENT_469	[p10l1811t2570r2062b2593],
32	[	CD	NUMBER	[	num	33	SENT_469	[p10l2076t2570r2155b2598],
33	ALT	NN	O	alt	dep	31	SENT_469	[p10l2076t2570r2155b2598],
34	;	:	O	;	_	0	SENT_469	[p10l2076t2570r2155b2598],
35	0-45	CD	NUMBER	0-45	num	36	SENT_469	[p10l2166t2570r2233b2592],
36	IUI	NN	O	iuus	dep	21	SENT_469	[p10l2244t2570r2287b2593],
37	l	NN	O	l	tmod	36	SENT_469	[p10l1277t2606r1293b2634],
38	]	NN	O	]	dep	47	SENT_469	[p10l1277t2606r1293b2634],
39	and	CC	O	and	_	0	SENT_469	[p10l1306t2606r1358b2629],
40	creatinine	NN	O	creatinine	dep	47	SENT_469	[p10l1370t2606r1517b2629],
41	[	CD	NUMBER	[	number	42	SENT_469	[p10l1531t2606r1624b2634],
42	3	CD	NUMBER	3	dep	38	SENT_469	[p10l1531t2606r1624b2634],
43	—	NN	O	—	dep	42	SENT_469	[p10l1531t2606r1624b2634],
44	126	CD	NUMBER	126	num	45	SENT_469	[p10l1531t2606r1624b2634],
45	umol/1	NN	O	umol/1	dep	47	SENT_469	[p10l1636t2606r1752b2635],
46	]	CD	NUMBER	]	num	47	SENT_469	[p10l1636t2606r1752b2635],
47	)	NN	O	)	dep	21	SENT_469	[p10l1636t2606r1752b2635],
48	,	,	O	,	_	0	SENT_469	[p10l1636t2606r1752b2635],
49	pregnancy	NN	O	pregnancy	dep	21	SENT_469	[p10l1765t2614r1922b2637],
50	,	,	O	,	_	0	SENT_469	[p10l1765t2614r1922b2637],
51	lactation	NN	O	lactation	dep	21	SENT_469	[p10l1935t2606r2069b2633],
52	,	,	O	,	_	0	SENT_469	[p10l1935t2606r2069b2633],
53	intolerance	NN	O	intolerance	nn	55	SENT_469	[p10l2082t2606r2246b2629],
54	to	TO	O	to	dep	55	SENT_469	[p10l2259t2611r2286b2629],
55	doxycycline	NN	O	doxycycline	dep	21	SENT_469	[p10l1276t2641r1453b2672],
56	,	,	O	,	_	0	SENT_469	[p10l1276t2641r1453b2672],
57	alcohol	NN	O	alcohol	nn	60	SENT_469	[p10l1467t2641r1571b2664],
58	or	CC	O	or	_	0	SENT_469	[p10l1585t2649r1616b2663],
59	drug	NN	O	drug	conj_or	57	SENT_469	[p10l1629t2641r1696b2672],
60	abuse	NN	O	abuse	dep	21	SENT_469	[p10l1708t2641r1796b2668],
61	,	,	O	,	_	0	SENT_469	[p10l1708t2641r1796b2668],
62	or	CC	O	or	_	0	SENT_469	[p10l1810t2649r1841b2663],
63	antiﬁlarial	JJ	O	antiﬁlarial	amod	64	SENT_469	[p10l1853t2641r2003b2664],
64	therapy	NN	O	therapy	dep	21	SENT_469	[p10l2017t2641r2127b2672],
65	in	IN	O	in	_	0	SENT_469	[p10l2141t2641r2167b2663],
66	the	DT	O	the	det	69	SENT_469	[p10l2182t2641r2226b2664],
67	last	JJ	DATE	last	amod	69	SENT_469	[p10l2239t2641r2287b2664],
68	10	CD	DATE	10	num	69	SENT_469	[p10l1279t2677r1308b2699],
69	mo.	NN	DATE	mo.	prep_in	20	SENT_469	[p10l1323t2685r1373b2699],
70	.	.	O	.	_	0	SENT_469	[p10l1323t2685r1373b2699],

1	Randomization	NN	O	randomization	_	0	SENT_470	[p10l1313t2712r1535b2735],
2	of	IN	O	of	_	0	SENT_470	[p10l1558t2712r1588b2734],
3	patients	NNS	O	patient	prep_of	1	SENT_470	[p10l1608t2712r1724b2743],
4	and	CC	O	and	_	0	SENT_470	[p10l1747t2712r1800b2735],
5	treatment	NN	O	treatment	nn	6	SENT_470	[p10l1823t2716r1965b2735],
6	regimens	NNS	O	regimen	prep_of	1	SENT_470	[p10l1988t2712r2129b2743],
7	.	.	O	.	_	0	SENT_470	[p10l1988t2712r2129b2743],

1	Randomization	NN	O	randomization	nsubjpass	5	SENT_471	[p10l2154t2712r2286b2735, p10l1277t2748r1374b2771],
2	of	IN	O	of	_	0	SENT_471	[p10l1384t2748r1415b2770],
3	patients	NNS	O	patient	prep_of	1	SENT_471	[p10l1423t2748r1538b2779],
4	was	VBD	O	be	auxpass	5	SENT_471	[p10l1548t2756r1597b2771],
5	carried	VBN	O	carry	_	0	SENT_471	[p10l1608t2748r1711b2771],
6	out	RP	O	out	prt	5	SENT_471	[p10l1721t2753r1769b2771],
7	using	VBG	O	use	xcomp	5	SENT_471	[p10l1778t2748r1855b2779],
8	computer-generated	JJ	O	computer-generated	amod	11	SENT_471	[p10l1864t2748r2163b2779],
9	random	JJ	O	random	amod	11	SENT_471	[p10l2174t2748r2287b2771],
10	number	NN	O	number	nn	11	SENT_471	[p10l1277t2783r1391b2806],
11	software	NN	O	software	dobj	7	SENT_471	[p10l1401t2783r1522b2806],
12	(	CD	NUMBER	(	num	13	SENT_471	[p10l1534t2783r1688b2812],
13	StatView	NNP	O	StatView	dep	11	SENT_471	[p10l1534t2783r1688b2812],
14	)	CD	NUMBER	)	num	13	SENT_471	[p10l1534t2783r1688b2812],
15	.	.	O	.	_	0	SENT_471	[p10l1534t2783r1688b2812],

1	Blinding	VBG	O	blind	nsubjpass	3	SENT_472	[p10l1700t2783r1824b2814],
2	was	VBD	O	be	auxpass	3	SENT_472	[p10l1834t2791r1883b2806],
3	assured	VBN	O	assure	_	0	SENT_472	[p10l1895t2783r2002b2806],
4	by	IN	O	by	_	0	SENT_472	[p10l2013t2783r2045b2814],
5	the	DT	O	the	det	6	SENT_472	[p10l2057t2783r2101b2806],
6	exclusion	NN	O	exclusion	agent	3	SENT_472	[p10l2112t2783r2248b2806],
7	of	IN	O	of	_	0	SENT_472	[p10l2259t2783r2290b2805],
8	persons	NNS	O	person	prep_of	6	SENT_472	[p10l1277t2827r1387b2850],
9	involved	VBN	O	involve	partmod	8	SENT_472	[p10l1399t2819r1520b2842],
10	in	IN	O	in	_	0	SENT_472	[p10l1532t2819r1558b2841],
11	randomization	NN	O	randomization	nn	14	SENT_472	[p10l1570t2819r1783b2842],
12	or	CC	O	or	_	0	SENT_472	[p10l1794t2827r1826b2841],
13	tablet	JJ	O	tablet	conj_or	11	SENT_472	[p10l1836t2819r1918b2842],
14	packaging	NN	O	packaging	prep_in	9	SENT_472	[p10l1928t2819r2075b2850],
15	in	IN	O	in	_	0	SENT_472	[p10l2085t2819r2112b2841],
16	any	DT	O	any	det	20	SENT_472	[p10l2123t2827r2172b2850],
17	clinical	JJ	O	clinical	amod	20	SENT_472	[p10l2183t2819r2286b2842],
18	or	CC	O	or	_	0	SENT_472	[p10l1276t2862r1308b2876],
19	laboratory	JJ	O	laboratory	conj_or	17	SENT_472	[p10l1320t2854r1472b2885],
20	assessment	NN	O	assessment	prep_in	14	SENT_472	[p10l1485t2859r1647b2877],
21	.	.	O	.	_	0	SENT_472	[p10l1485t2859r1647b2877],

1	Participants	NNS	O	participant	nsubj	2	SENT_473	[p10l1314t2890r1497b2921],
2	received	VBD	O	receive	_	0	SENT_473	[p10l1523t2890r1648b2913],
3	2	CD	NUMBER	2	num	4	SENT_473	[p10l1675t2890r1689b2913],
4	X	NN	O	x	iobj	2	SENT_473	[p10l1715t2892r1734b2911],
5	100	CD	NUMBER	100	num	7	SENT_473	[p10l1762t2890r1810b2912],
6	mg	NN	O	mg	nn	7	SENT_473	[p10l1837t2898r1880b2921],
7	capsules	NNS	O	capsule	dobj	2	SENT_473	[p10l1905t2890r2028b2921],
8	of	IN	O	of	_	0	SENT_473	[p10l2055t2890r2086b2912],
9	doxycycline	NN	O	doxycycline	nn	11	SENT_473	[p10l2109t2890r2286b2921],
10	(	CD	NUMBER	(	num	11	SENT_473	[p10l1277t2925r1463b2956],
11	Vibramycin	NN	LOCATION	vibramycin	prep_of	7	SENT_473	[p10l1277t2925r1463b2956],
12	;	:	O	;	_	0	SENT_473	[p10l1277t2925r1463b2956],
13	Pﬁzer	NNP	O	Pﬁzer	prep_of	7	SENT_473	[p10l1474t2925r1563b2952],
14	,	,	O	,	_	0	SENT_473	[p10l1474t2925r1563b2952],
15	New	NNP	LOCATION	New	nn	16	SENT_473	[p10l1574t2926r1636b2948],
16	York	NNP	LOCATION	York	prep_of	7	SENT_473	[p10l1646t2925r1723b2952],
17	,	,	O	,	_	0	SENT_473	[p10l1646t2925r1723b2952],
18	New	NNP	LOCATION	New	nn	19	SENT_473	[p10l1734t2926r1797b2948],
19	York	NNP	LOCATION	York	conj_or	11	SENT_473	[p10l1807t2925r1883b2952],
20	,	,	O	,	_	0	SENT_473	[p10l1807t2925r1883b2952],
21	United	NNP	LOCATION	United	nn	22	SENT_473	[p10l1895t2925r1995b2948],
22	States	NNPS	LOCATION	States	conj_or	11	SENT_473	[p10l2006t2925r2099b2954],
23	)	CD	NUMBER	)	dep	22	SENT_473	[p10l2006t2925r2099b2954],
24	or	CC	O	or	_	0	SENT_473	[p10l2110t2933r2142b2947],
25	matching	VBG	O	match	amod	26	SENT_473	[p10l2153t2925r2288b2956],
26	placebo	NN	O	placebo	conj_or	11	SENT_473	[p10l1277t2961r1388b2992],
27	supplied	VBN	O	supply	partmod	26	SENT_473	[p10l1409t2961r1532b2992],
28	by	IN	O	by	_	0	SENT_473	[p10l1551t2961r1584b2992],
29	the	DT	O	the	det	30	SENT_473	[p10l1605t2961r1648b2984],
30	manufacturer	NN	O	manufacturer	agent	27	SENT_473	[p10l1669t2961r1869b2984],
31	daily	RB	SET	daily	advmod	27	SENT_473	[p10l1888t2961r1956b2992],
32	for	IN	O	for	_	0	SENT_473	[p10l1976t2961r2019b2983],
33	a	DT	O	a	det	34	SENT_473	[p10l2038t2969r2053b2983],
34	total	NN	O	total	prep_for	27	SENT_473	[p10l2073t2961r2138b2984],
35	of	IN	O	of	_	0	SENT_473	[p10l2158t2961r2189b2983],
36	6	CD	DURATION	6	num	37	SENT_473	[p10l2207t2961r2221b2983],
37	wk	NN	DURATION	wk	prep_of	34	SENT_473	[p10l2240t2961r2286b2983],
38	.	.	O	.	_	0	SENT_473	[p10l2240t2961r2286b2983],

1	Treatment	NN	O	treatment	nsubjpass	3	SENT_474	[p10l1276t2997r1431b3019],
2	was	VBD	O	be	auxpass	3	SENT_474	[p10l1441t3004r1490b3019],
3	done	VBN	O	do	_	0	SENT_474	[p10l1501t2996r1572b3019],
4	and	CC	O	and	_	0	SENT_474	[p10l1584t2996r1636b3019],
5	monitored	VBN	O	monitor	conj_and	3	SENT_474	[p10l1648t2996r1801b3019],
6	by	IN	O	by	_	0	SENT_474	[p10l1811t2996r1844b3027],
7	a	DT	O	a	det	9	SENT_474	[p10l1855t3004r1869b3019],
8	trial	NN	O	trial	nn	9	SENT_474	[p10l1880t2996r1938b3019],
9	clinician	NN	O	clinician	agent	3	SENT_474	[p10l1949t2996r2073b3019],
10	in	IN	O	in	_	0	SENT_474	[p10l2085t2996r2111b3018],
11	the	DT	O	the	det	12	SENT_474	[p10l2123t2996r2167b3019],
12	form	NN	O	form	prep_in	9	SENT_474	[p10l2177t2996r2248b3018],
13	of	IN	O	of	prep	12	SENT_474	[p10l2259t2996r2290b3018],

1	Figure	NNP	O	Figure	_	0	SENT_475	[p11l190t1064r282b1095],
2	9	CD	NUMBER	9	dep	1	SENT_475	[p11l298t1066r323b1088],
3	.	.	O	.	_	0	SENT_475	[p11l298t1066r323b1088],

1	Grading	NN	O	grading	_	0	SENT_476	[p11l340t1064r448b1095],
2	of	IN	O	of	_	0	SENT_476	[p11l466t1064r494b1088],
3	the	DT	O	the	det	7	SENT_476	[p11l508t1064r552b1088],
4	Supratesticular	JJ	O	supratesticular	amod	7	SENT_476	[p11l569t1064r774b1095],
5	Lymphatic	JJ	O	lymphatic	amod	7	SENT_476	[p11l791t1064r933b1095],
6	Vessel	NN	O	vessel	nn	7	SENT_476	[p11l949t1064r1032b1088],
7	Dilation	NN	O	dilation	prep_of	1	SENT_476	[p11l1051t1064r1155b1088],
8	of	IN	O	of	prep	7	SENT_476	[p11l1173t1064r1201b1088],

1	Fi	NNP	O	Fi	_	0	SENT_477	[p11l190t1105r398b1129],
2	|	JJ	O	|	amod	4	SENT_477	[p11l190t1105r398b1129],
3	aria	NN	O	aria	nn	4	SENT_477	[p11l190t1105r398b1129],
4	|	NN	O	|	dep	1	SENT_477	[p11l190t1105r398b1129],
5	.	.	O	.	_	0	SENT_477	[p11l190t1105r398b1129],

1	—	NN	O	—	_	0	SENT_478	[p11l190t1105r398b1129],
2	.	.	O	.	_	0	SENT_478	[p11l190t1105r398b1129],

1	|	NN	O	|	nsubj	2	SENT_479	[p11l190t1105r398b1129],
2	nfected	VBD	O	nfect	_	0	SENT_479	[p11l190t1105r398b1129],
3	Patients	NNS	O	patient	dobj	2	SENT_479	[p11l413t1106r521b1129],
4	Displayed	VBN	O	display	partmod	3	SENT_479	[p11l535t1105r667b1136],
5	by	IN	O	by	_	0	SENT_479	[p11l682t1105r714b1136],
6	USG	NNP	O	USG	agent	4	SENT_479	[p11l728t1106r783b1129],

1	Dilation	NN	O	dilation	nsubjpass	8	SENT_480	[p11l190t1150r294b1174],
2	of	IN	O	of	_	0	SENT_480	[p11l315t1150r343b1174],
3	the	DT	O	the	det	6	SENT_480	[p11l360t1150r405b1174],
4	supratesticular	JJ	O	supratesticular	amod	6	SENT_480	[p11l425t1150r627b1181],
5	lymphatic	JJ	O	lymphatic	amod	6	SENT_480	[p11l647t1150r781b1181],
6	vessels	NNS	O	vessel	prep_of	1	SENT_480	[p11l801t1150r895b1174],
7	was	VBD	O	be	auxpass	8	SENT_480	[p11l914t1157r966b1174],
8	determined	VBN	O	determine	_	0	SENT_480	[p11l987t1150r1145b1174],
9	by	IN	O	by	_	0	SENT_480	[p11l1167t1150r1200b1181],
10	measuring	VBG	O	measure	agent	8	SENT_480	[p11l190t1186r332b1216],
11	the	DT	O	the	det	13	SENT_480	[p11l349t1185r394b1209],
12	largest	JJS	O	largest	amod	13	SENT_480	[p11l412t1185r503b1216],
13	diameter	NN	O	diameter	nsubj	14	SENT_480	[p11l520t1185r643b1209],
14	detectable	JJ	O	detectable	xcomp	10	SENT_480	[p11l659t1185r805b1209],
15	in	IN	O	in	_	0	SENT_480	[p11l823t1186r844b1209],
16	the	DT	O	the	det	20	SENT_480	[p11l862t1185r907b1209],
17	two	CD	NUMBER	two	num	20	SENT_480	[p11l923t1185r1154b1209],
18	—	CD	NUMBER	—	num	20	SENT_480	[p11l923t1185r1154b1209],
19	dimensional	JJ	O	dimensional	amod	20	SENT_480	[p11l923t1185r1154b1209],
20	bmode	NN	O	bmode	prep_in	14	SENT_480	[p11l1173t1185r1199b1209, p11l190t1221r268b1245],
21	of	IN	O	of	_	0	SENT_480	[p11l293t1221r321b1245],
22	a	DT	O	a	det	25	SENT_480	[p11l344t1228r357b1245],
23	portable	JJ	O	portable	amod	25	SENT_480	[p11l384t1221r500b1252],
24	ultrasound	NN	O	ultrasound	nn	25	SENT_480	[p11l526t1221r674b1245],
25	machine	NN	O	machine	prep_of	20	SENT_480	[p11l701t1221r826b1245],
26	.	.	O	.	_	0	SENT_480	[p11l701t1221r826b1245],

1	A	DT	O	a	det	3	SENT_481	[p11l850t1222r869b1245],
2	grading	NN	O	grading	nn	3	SENT_481	[p11l893t1221r1000b1252],
3	system	NN	O	system	nsubjpass	5	SENT_481	[p11l1026t1225r1121b1252],
4	was	VBD	O	be	auxpass	5	SENT_481	[p11l1146t1228r1198b1245],
5	developed	VBN	O	develop	_	0	SENT_481	[p11l189t1256r333b1287],
6	to	TO	O	to	aux	7	SENT_481	[p11l351t1260r379b1280],
7	determine	VB	O	determine	xcomp	5	SENT_481	[p11l397t1256r539b1280],
8	the	DT	O	the	det	9	SENT_481	[p11l556t1256r601b1280],
9	degree	NN	O	degree	dobj	7	SENT_481	[p11l619t1256r714b1287],
10	of	IN	O	of	_	0	SENT_481	[p11l732t1256r760b1280],
11	lymphatic	JJ	O	lymphatic	amod	12	SENT_481	[p11l777t1256r912b1287],
12	dilation	NN	O	dilation	prep_of	9	SENT_481	[p11l929t1256r1031b1280],
13	as	IN	O	as	dep	14	SENT_481	[p11l1050t1263r1077b1280],
14	follows	VBZ	O	follow	advcl	7	SENT_481	[p11l1094t1256r1199b1280],
15	:	:	O	:	_	0	SENT_481	[p11l1094t1256r1199b1280],
16	(	CD	NUMBER	(	dep	14	SENT_481	[p11l190t1293r225b1320],
17	A	DT	O	a	det	19	SENT_481	[p11l190t1293r225b1320],
18	)	NN	O	)	nn	19	SENT_481	[p11l190t1293r225b1320],
19	category	NN	O	category	dep	16	SENT_481	[p11l237t1296r358b1323],
20	1	CD	NUMBER	1	dep	19	SENT_481	[p11l371t1294r390b1316],
21	:	:	O	:	_	0	SENT_481	[p11l371t1294r390b1316],
22	patients	NNS	O	patient	dep	16	SENT_481	[p11l403t1293r512b1323],
23	with	IN	O	with	_	0	SENT_481	[p11l523t1292r582b1316],
24	minimal	JJ	O	minimal	amod	26	SENT_481	[p11l596t1292r704b1316],
25	lymphatic	JJ	O	lymphatic	amod	26	SENT_481	[p11l718t1292r852b1323],
26	dilation	NN	O	dilation	prep_with	22	SENT_481	[p11l863t1292r965b1316],
27	of	IN	O	of	_	0	SENT_481	[p11l978t1292r1006b1316],
28	up	RB	O	up	quantmod	30	SENT_481	[p11l1017t1299r1051b1323],
29	to	TO	O	to	dep	30	SENT_481	[p11l1062t1296r1089b1316],
30	0.2	CD	NUMBER	0.2	num	31	SENT_481	[p11l1101t1294r1139b1316],
31	cm	NN	O	cm	prep_of	26	SENT_481	[p11l1152t1299r1199b1320],
32	;	:	O	;	_	0	SENT_481	[p11l1152t1299r1199b1320],
33	(	NN	O	(	nn	34	SENT_481	[p11l190t1328r222b1355],
34	B	NN	O	b	conj_and	19	SENT_481	[p11l190t1328r222b1355],
35	)	CD	NUMBER	)	num	36	SENT_481	[p11l190t1328r222b1355],
36	category	NN	O	category	dep	34	SENT_481	[p11l246t1331r366b1358],
37	2	CD	NUMBER	2	dep	36	SENT_481	[p11l388t1329r409b1351],
38	:	:	O	:	_	0	SENT_481	[p11l388t1329r409b1351],
39	patients	NNS	O	patient	conj_and	19	SENT_481	[p11l433t1328r542b1358],
40	with	IN	O	with	_	0	SENT_481	[p11l564t1327r623b1351],
41	mild	JJ	O	mild	amod	42	SENT_481	[p11l648t1327r705b1351],
42	dilation	NN	O	dilation	prep_with	39	SENT_481	[p11l729t1327r831b1351],
43	from	IN	O	from	_	0	SENT_481	[p11l853t1327r917b1351],
44	0.21-0	CD	NUMBER	0.21-0	num	45	SENT_481	[p11l941t1329r1071b1351],
45	.50	CD	NUMBER	.50	prep_from	42	SENT_481	[p11l941t1329r1071b1351],
46	cm	NN	O	cm	dep	39	SENT_481	[p11l1093t1334r1141b1355],
47	;	:	O	;	_	0	SENT_481	[p11l1093t1334r1141b1355],
48	(	CD	NUMBER	(	num	49	SENT_481	[p11l1164t1328r1198b1355],
49	C	NN	O	c	conj_and	19	SENT_481	[p11l1164t1328r1198b1355],
50	)	CD	NUMBER	)	num	51	SENT_481	[p11l1164t1328r1198b1355],
51	category	NN	O	category	dep	49	SENT_481	[p11l189t1366r309b1393],
52	3	CD	NUMBER	3	dep	51	SENT_481	[p11l323t1364r345b1386],
53	:	:	O	:	_	0	SENT_481	[p11l323t1364r345b1386],
54	patients	NNS	O	patient	conj_and	19	SENT_481	[p11l361t1363r470b1393],
55	with	IN	O	with	_	0	SENT_481	[p11l485t1362r543b1386],
56	moderate	JJ	O	moderate	amod	57	SENT_481	[p11l560t1362r693b1386],
57	dilation	NN	O	dilation	prep_with	54	SENT_481	[p11l708t1362r809b1386],
58	from	IN	O	from	_	0	SENT_481	[p11l825t1362r888b1386],
59	0.51	CD	NUMBER	0.51	num	60	SENT_481	[p11l905t1364r1017b1386],
60	—	CD	NUMBER	—	prep_from	57	SENT_481	[p11l905t1364r1017b1386],
61	1.0	CD	NUMBER	1.0	num	62	SENT_481	[p11l905t1364r1017b1386],
62	cm	NN	O	cm	dep	54	SENT_481	[p11l1032t1369r1080b1390],
63	;	:	O	;	_	0	SENT_481	[p11l1032t1369r1080b1390],
64	and	CC	O	and	_	0	SENT_481	[p11l1094t1362r1144b1386],
65	(	NN	O	(	nn	66	SENT_481	[p11l1161t1363r1198b1390],
66	D	NN	O	d	conj_and	19	SENT_481	[p11l1161t1363r1198b1390],
67	)	CD	NUMBER	)	num	68	SENT_481	[p11l1161t1363r1198b1390],
68	category	NN	O	category	dep	66	SENT_481	[p11l189t1401r309b1428],
69	4	CD	NUMBER	4	dep	66	SENT_481	[p11l320t1399r343b1421],
70	:	:	O	:	_	0	SENT_481	[p11l320t1399r343b1421],
71	patients	NNS	O	patient	dep	19	SENT_481	[p11l357t1398r466b1428],
72	with	IN	O	with	_	0	SENT_481	[p11l479t1397r538b1421],
73	severe	JJ	O	severe	amod	74	SENT_481	[p11l552t1404r639b1421],
74	dilation	NN	O	dilation	prep_with	71	SENT_481	[p11l652t1397r754b1421],
75	of	IN	O	of	_	0	SENT_481	[p11l768t1397r796b1421],
76	above	JJ	O	above	prep_of	74	SENT_481	[p11l807t1397r891b1421],
77	1.0	CD	NUMBER	1.0	num	78	SENT_481	[p11l906t1399r942b1421],
78	cm	NN	O	cm	nsubj	14	SENT_481	[p11l956t1404r1003b1421],
79	.	.	O	.	_	0	SENT_481	[p11l956t1404r1003b1421],

1	DOI	NNP	O	DOI	_	0	SENT_482	[p11l190t1434r246b1457],
2	:	:	O	:	_	0	SENT_482	[p11l190t1434r246b1457],
3	10.1371	CD	NUMBER	10.1371	dep	1	SENT_482	[p11l262t1433r747b1464],
4	/	:	O	/	punct	6	SENT_482	[p11l262t1433r747b1464],
5	journa	NN	O	journa	nn	6	SENT_482	[p11l262t1433r747b1464],
6	|	NN	O	|	dep	3	SENT_482	[p11l262t1433r747b1464],
7	.	.	O	.	_	0	SENT_482	[p11l262t1433r747b1464],

1	ppat	NN	O	ppat	_	0	SENT_483	[p11l262t1433r747b1464],
2	.0020092	CD	NUMBER	.0020092	dep	1	SENT_483	[p11l262t1433r747b1464],
3	.	.	O	.	_	0	SENT_483	[p11l262t1433r747b1464],

1	g009	NN	O	g009	_	0	SENT_484	[p11l262t1433r747b1464],

1	daily	RB	SET	daily	advmod	2	SENT_485	[p11l189t1532r257b1563],
2	observed	VBN	O	observe	_	0	SENT_485	[p11l278t1532r407b1555],
3	treatment	NN	O	treatment	nsubj	2	SENT_485	[p11l428t1537r572b1555],
4	(	CD	NUMBER	(	num	3	SENT_485	[p11l594t1532r691b1561],
5	DOT	NNP	O	DOT	dep	3	SENT_485	[p11l594t1532r691b1561],
6	)	CD	NUMBER	)	num	5	SENT_485	[p11l594t1532r691b1561],
7	.	.	O	.	_	0	SENT_485	[p11l594t1532r691b1561],

1	Four	CD	DURATION	four	num	2	SENT_486	[p11l713t1533r782b1554],
2	months	NNS	DURATION	month	npadvmod	11	SENT_486	[p11l803t1532r910b1555],
3	after	IN	O	after	_	0	SENT_486	[p11l931t1532r1000b1555],
4	the	DT	O	the	det	5	SENT_486	[p11l1021t1532r1064b1555],
5	start	NN	O	start	prep_after	11	SENT_486	[p11l1086t1537r1150b1555],
6	of	IN	O	of	_	0	SENT_486	[p11l1171t1532r1202b1554],
7	treatment	NN	O	treatment	prep_of	5	SENT_486	[p11l190t1573r339b1595],
8	,	,	O	,	_	0	SENT_486	[p11l190t1573r339b1595],
9	all	DT	O	all	det	10	SENT_486	[p11l355t1568r388b1590],
10	participants	NNS	O	participant	nsubj	11	SENT_486	[p11l403t1568r577b1599],
11	received	VBD	O	receive	_	0	SENT_486	[p11l594t1568r714b1591],
12	a	DT	O	a	det	15	SENT_486	[p11l729t1576r743b1591],
13	standard	JJ	O	standard	amod	15	SENT_486	[p11l758t1568r884b1591],
14	oral	JJ	O	oral	amod	15	SENT_486	[p11l899t1568r955b1591],
15	dose	NN	O	dose	dep	21	SENT_486	[p11l970t1568r1034b1591],
16	of	IN	O	of	_	0	SENT_486	[p11l1049t1568r1080b1590],
17	400	CD	NUMBER	400	num	18	SENT_486	[p11l1092t1568r1141b1590],
18	mg	NN	O	mg	prep_of	15	SENT_486	[p11l1157t1576r1200b1599],
19	albendazole	NN	O	albendazole	dep	21	SENT_486	[p11l189t1603r360b1626],
20	(	CD	NUMBER	(	num	19	SENT_486	[p11l372t1603r637b1632],
21	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	dep	11	SENT_486	[p11l372t1603r637b1632],
22	,	,	O	,	_	0	SENT_486	[p11l372t1603r637b1632],
23	Uxbridge	NNP	LOCATION	Uxbridge	dep	11	SENT_486	[p11l649t1603r791b1634],
24	,	,	O	,	_	0	SENT_486	[p11l649t1603r791b1634],
25	United	NNP	LOCATION	United	nn	27	SENT_486	[p11l803t1603r902b1626],
26	Kingdom	NNP	LOCATION	Kingdom	nn	27	SENT_486	[p11l914t1603r1057b1634],
27	)	NN	O	)	dep	11	SENT_486	[p11l914t1603r1057b1634],
28	and	CC	O	and	_	0	SENT_486	[p11l1068t1603r1121b1626],
29	150200	CD	NUMBER	150200	num	31	SENT_486	[p11l1135t1603r1199b1625, p11l190t1639r238b1662],
30	pg/kg	NN	O	pg/kg	nn	31	SENT_486	[p11l254t1639r328b1670],
31	ivermectin	NN	O	ivermectin	dep	11	SENT_486	[p11l343t1639r497b1662],
32	(	CD	NUMBER	(	num	33	SENT_486	[p11l513t1639r660b1667],
33	Mectizan	NN	O	mectizan	dobj	11	SENT_486	[p11l513t1639r660b1667],
34	;	:	O	;	_	0	SENT_486	[p11l513t1639r660b1667],
35	Merck	NNP	ORGANIZATION	Merck	dep	33	SENT_486	[p11l675t1639r771b1666],
36	,	,	ORGANIZATION	,	_	0	SENT_486	[p11l675t1639r771b1666],
37	Sharp	NNP	ORGANIZATION	Sharp	dep	33	SENT_486	[p11l787t1639r871b1670],
38	&	CC	ORGANIZATION	&	_	0	SENT_486	[p11l887t1639r908b1662],
39	Dohme	NNP	ORGANIZATION	Dohme	dep	33	SENT_486	[p11l922t1639r1034b1666],
40	,	,	O	,	_	0	SENT_486	[p11l922t1639r1034b1666],
41	ClermontFerrand	NNP	O	ClermontFerrand	nn	43	SENT_486	[p11l1049t1639r1199b1662, p11l189t1675r312b1702],
42	,	,	O	,	_	0	SENT_486	[p11l1049t1639r1199b1662, p11l189t1675r312b1702],
43	France	NNP	LOCATION	France	appos	35	SENT_486	[p11l325t1676r441b1704],
44	)	CD	NUMBER	)	num	43	SENT_486	[p11l325t1676r441b1704],
45	.	.	O	.	_	0	SENT_486	[p11l325t1676r441b1704],

1	USG	NNP	O	USG	_	0	SENT_487	[p11l226t1711r293b1734],
2	examinations	NNS	O	examination	dep	1	SENT_487	[p11l315t1711r517b1734],
3	.	.	O	.	_	0	SENT_487	[p11l315t1711r517b1734],

1	Male	JJ	O	male	amod	2	SENT_488	[p11l542t1711r610b1734],
2	participants	NNS	O	participant	nsubjpass	4	SENT_488	[p11l634t1711r807b1742],
3	were	VBD	O	be	auxpass	4	SENT_488	[p11l831t1719r898b1734],
4	examined	VBN	O	examine	_	0	SENT_488	[p11l922t1711r1063b1734],
5	using	VBG	O	use	xcomp	4	SENT_488	[p11l1086t1711r1163b1742],
6	a	DT	O	a	det	13	SENT_488	[p11l1185t1719r1200b1733],
7	portable	JJ	O	portable	amod	13	SENT_488	[p11l189t1746r311b1777],
8	ultrasound	NN	O	ultrasound	nn	13	SENT_488	[p11l326t1746r483b1769],
9	machine	NN	O	machine	nn	13	SENT_488	[p11l500t1746r621b1769],
10	(	CD	NUMBER	(	num	13	SENT_488	[p11l638t1746r775b1775],
11	SonoSite	NNP	ORGANIZATION	SonoSite	nn	13	SENT_488	[p11l638t1746r775b1775],
12	180	CD	NUMBER	180	num	13	SENT_488	[p11l793t1746r840b1768],
13	Plus	NN	O	plus	dobj	5	SENT_488	[p11l856t1746r921b1773],
14	;	:	O	;	_	0	SENT_488	[p11l856t1746r921b1773],
15	SonoSite	NNP	ORGANIZATION	SonoSite	nn	19	SENT_488	[p11l937t1746r1072b1773],
16	,	,	O	,	_	0	SENT_488	[p11l937t1746r1072b1773],
17	Bothell	NNP	LOCATION	Bothell	appos	19	SENT_488	[p11l1088t1746r1199b1773],
18	,	,	O	,	_	0	SENT_488	[p11l1088t1746r1199b1773],
19	Washington	NNP	LOCATION	Washington	nsubj	24	SENT_488	[p11l188t1782r368b1813],
20	,	,	O	,	_	0	SENT_488	[p11l188t1782r368b1813],
21	United	NNP	LOCATION	United	nn	23	SENT_488	[p11l385t1782r485b1805],
22	States	NNPS	LOCATION	States	nn	23	SENT_488	[p11l501t1782r595b1811],
23	)	NN	O	)	dep	19	SENT_488	[p11l501t1782r595b1811],
24	equipped	VBN	O	equip	parataxis	4	SENT_488	[p11l611t1782r748b1813],
25	with	IN	O	with	_	0	SENT_488	[p11l763t1782r825b1805],
26	a	DT	O	a	det	28	SENT_488	[p11l841t1790r855b1805],
27	7.5	CD	NUMBER	7.5	num	28	SENT_488	[p11l872t1780r911b1804],
28	MHZ	NN	O	mhz	prep_with	24	SENT_488	[p11l927t1783r1000b1804],
29	linear	JJ	O	linear	amod	30	SENT_488	[p11l1017t1782r1101b1805],
30	transducer	NN	O	transducer	dobj	24	SENT_488	[p11l1116t1787r1199b1805, p11l189t1818r272b1841],
31	as	IN	O	as	amod	30	SENT_488	[p11l282t1826r308b1841],
32	described	VBN	O	describe	partmod	30	SENT_488	[p11l319t1818r458b1841],
33	previously	RB	DATE	previously	advmod	32	SENT_488	[p11l470t1818r618b1849],
34	[	CD	NUMBER	[	number	35	SENT_488	[p11l631t1818r688b1846],
35	83	CD	NUMBER	83	num	36	SENT_488	[p11l631t1818r688b1846],
36	]	NN	O	]	dobj	32	SENT_488	[p11l631t1818r688b1846],
37	.	.	O	.	_	0	SENT_488	[p11l631t1818r688b1846],

1	Brieﬂy	NNP	O	Brieﬂy	nsubjpass	5	SENT_489	[p11l700t1818r802b1849],
2	,	,	O	,	_	0	SENT_489	[p11l700t1818r802b1849],
3	patients	NNS	O	patient	nsubjpass	5	SENT_489	[p11l814t1818r929b1849],
4	were	VBD	O	be	auxpass	5	SENT_489	[p11l939t1826r1007b1841],
5	screened	VBN	O	screen	_	0	SENT_489	[p11l1019t1818r1146b1841],
6	for	IN	O	for	_	0	SENT_489	[p11l1157t1818r1200b1840],
7	worm	NN	O	worm	nn	8	SENT_489	[p11l188t1861r271b1875],
8	nests	NNS	O	nest	prep_for	5	SENT_489	[p11l296t1858r365b1876],
9	in	IN	O	in	_	0	SENT_489	[p11l390t1853r417b1875],
10	the	DT	O	the	det	12	SENT_489	[p11l441t1853r485b1876],
11	scrotal	JJ	O	scrotal	amod	12	SENT_489	[p11l510t1853r605b1876],
12	area	NN	O	area	prep_in	8	SENT_489	[p11l630t1861r697b1876],
13	.	.	O	.	_	0	SENT_489	[p11l630t1861r697b1876],

1	Each	DT	O	each	det	4	SENT_490	[p11l722t1853r790b1876],
2	detected	VBN	O	detect	amod	4	SENT_490	[p11l814t1853r938b1876],
3	worm	NN	O	worm	nn	4	SENT_490	[p11l961t1861r1044b1875],
4	nest	NN	O	nest	nsubjpass	6	SENT_490	[p11l1069t1858r1126b1876],
5	was	VBD	O	be	auxpass	6	SENT_490	[p11l1149t1861r1199b1876],
6	documented	VBN	O	document	_	0	SENT_490	[p11l189t1889r370b1912],
7	using	VBG	O	use	xcomp	6	SENT_490	[p11l390t1889r467b1920],
8	print	NN	O	print	nn	9	SENT_490	[p11l487t1889r560b1920],
9	outs	NNS	O	out	dobj	7	SENT_490	[p11l580t1894r639b1912],
10	in	IN	O	in	dep	9	SENT_490	[p11l660t1889r687b1911],
11	b	NN	O	b	nn	12	SENT_490	[p11l707t1889r742b1916],
12	—	NN	O	—	pobj	10	SENT_490	[p11l707t1889r742b1916],
13	,	,	O	,	_	0	SENT_490	[p11l707t1889r742b1916],
14	m	NN	O	m	appos	12	SENT_490	[p11l764t1897r808b1916],
15	-	:	O	-	_	0	SENT_490	[p11l764t1897r808b1916],
16	,	,	O	,	_	0	SENT_490	[p11l764t1897r808b1916],
17	and	CC	O	and	_	0	SENT_490	[p11l829t1889r882b1912],
18	pulse-wave	JJ	O	pulse-wave	amod	20	SENT_490	[p11l902t1889r1059b1920],
19	Doppler	NN	MISC	doppler	nn	20	SENT_490	[p11l1079t1889r1200b1920],
20	modes	NNS	O	mode	conj_and	10	SENT_490	[p11l190t1925r288b1948],
21	.	.	O	.	_	0	SENT_490	[p11l190t1925r288b1948],

1	Additionally	RB	O	additionally	advmod	8	SENT_491	[p11l305t1925r492b1956],
2	,	,	O	,	_	0	SENT_491	[p11l305t1925r492b1956],
3	worms	NNS	O	worm	nsubjpass	8	SENT_491	[p11l508t1933r603b1948],
4	in	IN	O	in	_	0	SENT_491	[p11l620t1925r647b1947],
5	lymphatic	JJ	O	lymphatic	amod	6	SENT_491	[p11l664t1925r806b1956],
6	vessels	NNS	O	vessel	prep_in	3	SENT_491	[p11l823t1925r915b1948],
7	were	VBD	O	be	auxpass	8	SENT_491	[p11l931t1933r999b1948],
8	recorded	VBN	O	record	_	0	SENT_491	[p11l1017t1925r1147b1948],
9	on	IN	O	on	_	0	SENT_491	[p11l1163t1933r1199b1947],
10	DVtapes	NNS	O	dvtape	prep_on	8	SENT_491	[p11l189t1962r311b1992],
11	using	VBG	O	use	partmod	10	SENT_491	[p11l334t1961r411b1992],
12	a	DT	O	a	det	15	SENT_491	[p11l433t1969r447b1984],
13	SonyPC	NN	O	sonypc	nn	15	SENT_491	[p11l471t1961r582b1992],
14	120E	NN	O	120e	nn	15	SENT_491	[p11l609t1961r675b1984],
15	Handycam	NN	O	handycam	dobj	11	SENT_491	[p11l699t1961r854b1992],
16	(	CD	NUMBER	(	num	19	SENT_491	[p11l878t1961r963b1992],
17	Sony	NNP	ORGANIZATION	Sony	nn	19	SENT_491	[p11l878t1961r963b1992],
18	,	,	O	,	_	0	SENT_491	[p11l878t1961r963b1992],
19	Tokyo	NNP	LOCATION	Tokyo	tmod	11	SENT_491	[p11l987t1961r1084b1992],
20	,	,	O	,	_	0	SENT_491	[p11l987t1961r1084b1992],
21	japan	NN	LOCATION	japan	nn	22	SENT_491	[p11l1103t1962r1199b1992],
22	)	NN	O	)	appos	19	SENT_491	[p11l1103t1962r1199b1992],
23	connected	VBN	O	connect	partmod	22	SENT_491	[p11l189t1996r339b2019],
24	to	TO	O	to	_	0	SENT_491	[p11l356t2001r382b2019],
25	the	DT	O	the	det	27	SENT_491	[p11l400t1996r444b2019],
26	ultrasound	NN	O	ultrasound	nn	27	SENT_491	[p11l460t1996r617b2019],
27	machine	NN	O	machine	prep_to	23	SENT_491	[p11l634t1996r756b2019],
28	in	IN	O	in	mark	31	SENT_491	[p11l773t1996r799b2018],
29	order	NN	O	order	dep	31	SENT_491	[p11l815t1996r896b2019],
30	to	TO	O	to	aux	31	SENT_491	[p11l912t2001r939b2019],
31	get	VB	O	get	purpcl	23	SENT_491	[p11l956t2001r998b2027],
32	an	DT	O	a	det	34	SENT_491	[p11l1014t2004r1048b2018],
33	animated	JJ	O	animated	amod	34	SENT_491	[p11l1064t1996r1199b2019],
34	documentation	NN	O	documentation	dobj	31	SENT_491	[p11l189t2032r411b2055],
35	of	IN	O	of	_	0	SENT_491	[p11l423t2032r454b2054],
36	the	DT	O	the	det	38	SENT_491	[p11l465t2032r509b2055],
37	moving	VBG	O	move	amod	38	SENT_491	[p11l522t2032r629b2063],
38	worms	NNS	O	worm	prep_of	34	SENT_491	[p11l640t2040r742b2055],
39	.	.	O	.	_	0	SENT_491	[p11l640t2040r742b2055],

1	Dilation	NN	O	dilation	nsubjpass	12	SENT_492	[p11l755t2032r873b2055],
2	of	IN	O	of	_	0	SENT_492	[p11l886t2032r917b2054],
3	the	DT	O	the	det	6	SENT_492	[p11l927t2032r971b2055],
4	supratesticular	JJ	O	supratesticular	amod	6	SENT_492	[p11l984t2032r1200b2063],
5	lymphatic	JJ	O	lymphatic	amod	6	SENT_492	[p11l189t2068r331b2099],
6	vessels	NNS	O	vessel	prep_of	1	SENT_492	[p11l354t2068r447b2091],
7	containing	VBG	O	contain	partmod	6	SENT_492	[p11l470t2068r626b2099],
8	no	DT	O	no	det	10	SENT_492	[p11l649t2076r683b2090],
9	worm	NN	O	worm	nn	10	SENT_492	[p11l706t2076r789b2090],
10	nests	NNS	O	nest	dobj	7	SENT_492	[p11l812t2073r881b2091],
11	was	VBD	O	be	auxpass	12	SENT_492	[p11l903t2076r953b2091],
12	determined	VBN	O	determine	_	0	SENT_492	[p11l976t2068r1144b2091],
13	by	IN	O	by	_	0	SENT_492	[p11l1167t2068r1199b2099],
14	measuring	VBG	O	measure	agent	12	SENT_492	[p11l190t2103r340b2134],
15	the	DT	O	the	det	17	SENT_492	[p11l356t2103r400b2126],
16	largest	JJS	O	largest	amod	17	SENT_492	[p11l416t2103r511b2134],
17	diameter	NN	O	diameter	dobj	14	SENT_492	[p11l526t2103r657b2126],
18	using	VBG	O	use	partmod	17	SENT_492	[p11l671t2103r748b2134],
19	the	DT	O	the	det	21	SENT_492	[p11l764t2103r808b2126],
20	two-dimensional	JJ	O	two-dimensional	amod	21	SENT_492	[p11l825t2103r1065b2126],
21	b-mode	NN	O	b-mode	dobj	18	SENT_492	[p11l1081t2103r1198b2126],
22	.	.	O	.	_	0	SENT_492	[p11l1081t2103r1198b2126],

1	Since	IN	O	since	mark	3	SENT_493	[p11l189t2139r266b2162],
2	there	EX	O	there	expl	3	SENT_493	[p11l278t2139r352b2162],
3	is	VBZ	O	be	advcl	12	SENT_493	[p11l364t2139r383b2162],
4	no	DT	O	no	det	6	SENT_493	[p11l394t2147r429b2161],
5	grading	NN	O	grading	nn	6	SENT_493	[p11l440t2139r552b2170],
6	system	NN	O	system	nsubj	3	SENT_493	[p11l562t2144r656b2170],
7	for	IN	O	for	_	0	SENT_493	[p11l666t2139r710b2161],
8	lymphatic	JJ	O	lymphatic	amod	9	SENT_493	[p11l720t2139r862b2170],
9	dilation	NN	O	dilation	prep_for	6	SENT_493	[p11l873t2139r993b2166],
10	,	,	O	,	_	0	SENT_493	[p11l873t2139r993b2166],
11	we	PRP	O	we	nsubj	12	SENT_493	[p11l1003t2147r1041b2162],
12	developed	VBD	O	develop	dep	48	SENT_493	[p11l1051t2139r1199b2170],
13	a	DT	O	a	det	15	SENT_493	[p11l189t2183r203b2198],
14	grading	NN	O	grading	nn	15	SENT_493	[p11l219t2175r330b2206],
15	system	NN	O	system	dobj	12	SENT_493	[p11l346t2180r440b2206],
16	to	TO	O	to	aux	17	SENT_493	[p11l457t2180r484b2198],
17	determine	VB	O	determine	xcomp	12	SENT_493	[p11l501t2175r650b2198],
18	the	DT	O	the	det	19	SENT_493	[p11l667t2175r711b2198],
19	degree	NN	O	degree	dobj	17	SENT_493	[p11l728t2175r824b2206],
20	of	IN	O	of	_	0	SENT_493	[p11l840t2175r871b2197],
21	lymphatic	JJ	O	lymphatic	amod	22	SENT_493	[p11l885t2175r1027b2206],
22	dilation	NN	O	dilation	prep_of	19	SENT_493	[p11l1044t2175r1156b2198],
23	as	IN	O	as	dep	24	SENT_493	[p11l1173t2183r1199b2198],
24	follows	VBZ	O	follow	advcl	17	SENT_493	[p11l188t2210r296b2232],
25	:	:	O	:	_	0	SENT_493	[p11l188t2210r296b2232],
26	category	NN	O	category	nn	27	SENT_493	[p11l318t2215r441b2241],
27	o	NN	O	o	dep	24	SENT_493	[p11l462t2210r477b2232],
28	:	:	O	:	_	0	SENT_493	[p11l496t2220r518b2228],
29	no	DT	O	no	det	30	SENT_493	[p11l538t2218r573b2232],
30	dilation	NN	O	dilation	dep	27	SENT_493	[p11l595t2210r707b2233],
31	(	RB	O	(	advmod	30	SENT_493	[p11l730t2210r868b2241],
32	normally	RB	O	normally	advmod	33	SENT_493	[p11l730t2210r868b2241],
33	up	IN	O	up	dep	27	SENT_493	[p11l889t2218r926b2241],
34	to	TO	O	to	dep	27	SENT_493	[p11l948t2215r975b2233],
35	0.10	CD	NUMBER	0.10	num	37	SENT_493	[p11l997t2210r1054b2232],
36	cm	NN	O	cm	nn	37	SENT_493	[p11l1076t2218r1117b2233],
37	[	NN	O	[	pobj	34	SENT_493	[p11l1141t2210r1199b2238],
38	84	CD	NUMBER	84	num	39	SENT_493	[p11l1141t2210r1199b2238],
39	]	NN	O	]	nsubj	24	SENT_493	[p11l1141t2210r1199b2238],
40	,	,	O	,	_	0	SENT_493	[p11l1141t2210r1199b2238],
41	category	NN	O	category	appos	39	SENT_493	[p11l189t2251r312b2277],
42	1	CD	NUMBER	1	num	41	SENT_493	[p11l325t2246r334b2268],
43	:	:	O	:	_	0	SENT_493	[p11l345t2256r367b2264],
44	the	DT	O	the	det	47	SENT_493	[p11l376t2246r420b2269],
45	maximally	RB	O	maximally	advmod	46	SENT_493	[p11l432t2246r580b2277],
46	dilated	JJ	O	dilated	amod	47	SENT_493	[p11l590t2246r690b2269],
47	vessel	NN	O	vessel	dep	41	SENT_493	[p11l700t2246r780b2269],
48	has	VBZ	O	have	_	0	SENT_493	[p11l791t2246r836b2269],
49	a	DT	O	a	det	50	SENT_493	[p11l848t2254r862b2269],
50	dilation	NN	O	dilation	npadvmod	51	SENT_493	[p11l872t2246r985b2269],
51	up	IN	O	up	advmod	48	SENT_493	[p11l995t2254r1032b2277],
52	to	TO	O	to	_	0	SENT_493	[p11l1044t2251r1070b2269],
53	0.20	CD	NUMBER	0.20	num	54	SENT_493	[p11l1082t2246r1139b2269],
54	cm	NN	O	cm	prep_to	51	SENT_493	[p11l1150t2254r1198b2273],
55	,	,	O	,	_	0	SENT_493	[p11l1150t2254r1198b2273],
56	category	NN	O	category	appos	54	SENT_493	[p11l189t2287r312b2313],
57	2	CD	NUMBER	2	num	56	SENT_493	[p11l326t2282r340b2305],
58	:	:	O	:	_	0	SENT_493	[p11l351t2292r373b2300],
59	dilation	NN	O	dilation	dep	54	SENT_493	[p11l385t2282r497b2305],
60	from	IN	O	from	_	0	SENT_493	[p11l511t2282r582b2304],
61	0.21-0	CD	NUMBER	0.21-0	num	63	SENT_493	[p11l596t2282r729b2305],
62	.50	CD	NUMBER	.50	num	63	SENT_493	[p11l596t2282r729b2305],
63	cm	NN	O	cm	prep_from	59	SENT_493	[p11l743t2290r792b2309],
64	,	,	O	,	_	0	SENT_493	[p11l743t2290r792b2309],
65	category	NN	O	category	appos	63	SENT_493	[p11l806t2287r929b2313],
66	3	CD	NUMBER	3	num	65	SENT_493	[p11l944t2282r958b2304],
67	:	:	O	:	_	0	SENT_493	[p11l969t2292r991b2300],
68	dilation	NN	O	dilation	dep	54	SENT_493	[p11l1003t2282r1115b2305],
69	from	IN	O	from	_	0	SENT_493	[p11l1128t2282r1199b2304],
70	0.51	CD	NUMBER	0.51	num	71	SENT_493	[p11l189t2318r305b2340],
71	—	CD	NUMBER	—	prep_from	68	SENT_493	[p11l189t2318r305b2340],
72	1.0	CD	NUMBER	1.0	num	73	SENT_493	[p11l189t2318r305b2340],
73	cm	NN	O	cm	dep	68	SENT_493	[p11l318t2326r367b2345],
74	,	,	O	,	_	0	SENT_493	[p11l318t2326r367b2345],
75	and	CC	O	and	_	0	SENT_493	[p11l381t2318r433b2341],
76	category	NN	O	category	conj_and	54	SENT_493	[p11l446t2323r569b2349],
77	4	CD	NUMBER	4	number	78	SENT_493	[p11l582t2318r597b2340],
78	2	CD	NUMBER	2	num	79	SENT_493	[p11l607t2328r629b2336],
79	dilation	NN	O	dilation	dep	76	SENT_493	[p11l640t2318r752b2341],
80	above	IN	O	above	_	0	SENT_493	[p11l765t2318r848b2341],
81	1.0	CD	NUMBER	1.0	num	82	SENT_493	[p11l864t2318r900b2340],
82	cm	NN	O	cm	prep_above	51	SENT_493	[p11l914t2326r956b2341],
83	(	CD	NUMBER	(	num	85	SENT_493	[p11l970t2318r1071b2349],
84	Figure	NNP	O	Figure	nn	85	SENT_493	[p11l970t2318r1071b2349],
85	9A	NN	O	9a	dobj	48	SENT_493	[p11l1085t2318r1199b2347],
86	—	CD	NUMBER	—	num	88	SENT_493	[p11l1085t2318r1199b2347],
87	9D	NN	O	9d	nn	88	SENT_493	[p11l1085t2318r1199b2347],
88	)	NN	O	)	nsubj	48	SENT_493	[p11l1085t2318r1199b2347],
89	.	.	O	.	_	0	SENT_493	[p11l1085t2318r1199b2347],

1	The	DT	O	the	det	2	SENT_494	[p11l188t2353r244b2376],
2	procedure	NN	O	procedure	nsubjpass	4	SENT_494	[p11l257t2353r407b2384],
3	was	VBD	O	be	auxpass	4	SENT_494	[p11l420t2361r469b2376],
4	repeated	VBN	O	repeat	_	0	SENT_494	[p11l484t2353r611b2384],
5	12	CD	NUMBER	12	dobj	4	SENT_494	[p11l627t2353r655b2376],
6	and	CC	O	and	_	0	SENT_494	[p11l669t2353r722b2376],
7	24	CD	DURATION	24	num	8	SENT_494	[p11l736t2353r768b2376],
8	mo	NN	DURATION	mo	dobj	4	SENT_494	[p11l781t2361r825b2375],
9	after	IN	O	after	_	0	SENT_494	[p11l839t2353r907b2376],
10	treatment	NN	O	treatment	prep_after	4	SENT_494	[p11l920t2358r1070b2376],
11	.	.	O	.	_	0	SENT_494	[p11l920t2358r1070b2376],

1	Determination	NN	O	determination	_	0	SENT_495	[p11l226t2389r438b2412],
2	of	IN	O	of	_	0	SENT_495	[p11l452t2389r483b2411],
3	microﬁlarial	JJ	O	microﬁlarial	amod	4	SENT_495	[p11l495t2389r673b2412],
4	load	NN	O	load	prep_of	1	SENT_495	[p11l687t2389r756b2412],
5	.	.	O	.	_	0	SENT_495	[p11l687t2389r756b2412],

1	For	IN	O	for	_	0	SENT_496	[p11l772t2390r822b2411],
2	a	DT	O	a	det	4	SENT_496	[p11l836t2397r851b2411],
3	quick	JJ	O	quick	amod	4	SENT_496	[p11l865t2389r943b2420],
4	screening	NN	O	screening	prep_for	13	SENT_496	[p11l959t2389r1098b2420],
5	in	IN	O	in	_	0	SENT_496	[p11l1113t2389r1139b2411],
6	the	DT	O	the	det	7	SENT_496	[p11l1155t2389r1199b2412],
7	night	NN	TIME	night	prep_in	4	SENT_496	[p11l190t2425r275b2456],
8	,	,	O	,	_	0	SENT_496	[p11l190t2425r275b2456],
9	the	DT	O	the	det	11	SENT_496	[p11l302t2425r347b2448],
10	microﬁlarial	JJ	O	microﬁlarial	amod	11	SENT_496	[p11l374t2425r561b2448],
11	load	NN	O	load	nsubjpass	13	SENT_496	[p11l588t2425r651b2448],
12	was	VBD	O	be	auxpass	13	SENT_496	[p11l676t2433r727b2448],
13	determined	VBN	O	determine	_	0	SENT_496	[p11l754t2425r929b2448],
14	by	IN	O	by	_	0	SENT_496	[p11l955t2425r988b2456],
15	microscopic	JJ	O	microscopic	amod	16	SENT_496	[p11l1015t2425r1198b2456],
16	examination	NN	O	examination	agent	13	SENT_496	[p11l189t2460r377b2483],
17	of	IN	O	of	_	0	SENT_496	[p11l402t2460r434b2482],
18	ﬁnger-prick	JJ	O	ﬁnger-prick	amod	20	SENT_496	[p11l456t2460r635b2491],
19	blood	NN	O	blood	nn	20	SENT_496	[p11l660t2460r745b2483],
20	samples	NNS	O	sample	prep_of	16	SENT_496	[p11l771t2460r886b2491],
21	as	IN	O	as	_	0	SENT_496	[p11l913t2468r939b2483],
22	published	VBN	O	publish	amod	23	SENT_496	[p11l965t2460r1111b2491],
23	[	NN	O	[	prep_as	13	SENT_496	[p11l1138t2460r1198b2488],
24	44	CD	NUMBER	44	num	25	SENT_496	[p11l1138t2460r1198b2488],
25	]	NN	O	]	dep	23	SENT_496	[p11l1138t2460r1198b2488],
26	.	.	O	.	_	0	SENT_496	[p11l1138t2460r1198b2488],

1	Subsequently	RB	O	subsequently	advmod	5	SENT_497	[p11l189t2496r388b2527],
2	,	,	O	,	_	0	SENT_497	[p11l189t2496r388b2527],
3	eligible	JJ	O	eligible	amod	4	SENT_497	[p11l406t2496r509b2527],
4	patients	NNS	O	patient	nsubj	5	SENT_497	[p11l527t2496r642b2527],
5	donated	VBD	O	donate	_	0	SENT_497	[p11l659t2496r778b2519],
6	10	CD	NUMBER	10	num	7	SENT_497	[p11l798t2496r826b2518],
7	ml	NN	O	ml	dobj	5	SENT_497	[p11l845t2496r879b2518],
8	of	IN	O	of	_	0	SENT_497	[p11l897t2496r927b2518],
9	venous	JJ	O	venous	amod	10	SENT_497	[p11l941t2504r1041b2519],
10	blood	NN	O	blood	prep_of	7	SENT_497	[p11l1058t2496r1140b2519],
11	for	IN	O	for	_	0	SENT_497	[p11l1157t2496r1200b2518],
12	accurate	JJ	O	accurate	amod	13	SENT_497	[p11l189t2537r311b2555],
13	quantiﬁcation	NN	O	quantiﬁcation	prep_for	5	SENT_497	[p11l324t2532r529b2563],
14	using	VBG	O	use	partmod	13	SENT_497	[p11l542t2532r618b2563],
15	Whatman	NNP	PERSON	Whatman	nn	18	SENT_497	[p11l630t2532r770b2555],
16	Nucleopore	NNP	PERSON	Nucleopore	nn	18	SENT_497	[p11l783t2532r954b2563],
17	ﬁlter	NN	O	ﬁlter	nn	18	SENT_497	[p11l966t2532r1037b2555],
18	method	NN	O	method	dobj	14	SENT_497	[p11l1050t2532r1160b2555],
19	as	IN	O	as	mark	20	SENT_497	[p11l1173t2540r1199b2555],
20	described	VBN	O	describe	dep	18	SENT_497	[p11l189t2568r328b2591],
21	previously	RB	DATE	previously	advmod	20	SENT_497	[p11l340t2568r489b2599],
22	[	CD	NUMBER	[	num	24	SENT_497	[p11l503t2568r560b2596],
23	44	CD	NUMBER	44	num	24	SENT_497	[p11l503t2568r560b2596],
24	]	NN	O	]	dobj	20	SENT_497	[p11l503t2568r560b2596],
25	.	.	O	.	_	0	SENT_497	[p11l503t2568r560b2596],

1	The	DT	O	the	det	3	SENT_498	[p11l573t2568r628b2591],
2	same	JJ	O	same	amod	3	SENT_498	[p11l641t2576r712b2591],
3	volume	NN	O	volume	nsubjpass	7	SENT_498	[p11l723t2568r829b2591],
4	of	IN	O	of	_	0	SENT_498	[p11l841t2568r872b2590],
5	blood	NN	O	blood	prep_of	3	SENT_498	[p11l881t2568r963b2591],
6	was	VBD	O	be	auxpass	7	SENT_498	[p11l975t2576r1025b2591],
7	taken	VBN	O	take	_	0	SENT_498	[p11l1038t2568r1116b2591],
8	from	IN	O	from	_	0	SENT_498	[p11l1128t2568r1199b2590],
9	each	DT	O	each	det	10	SENT_498	[p11l189t2603r254b2626],
10	patient	NN	O	patient	prep_from	7	SENT_498	[p11l269t2603r373b2634],
11	4	CD	NUMBER	4	num	10	SENT_498	[p11l388t2603r403b2625],
12	and	CC	O	and	_	0	SENT_498	[p11l419t2603r471b2626],
13	12	CD	DURATION	12	num	14	SENT_498	[p11l490t2603r518b2626],
14	mo	NN	DURATION	mo	prep_from	7	SENT_498	[p11l535t2611r579b2625],
15	after	IN	O	after	_	0	SENT_498	[p11l595t2603r663b2626],
16	the	DT	O	the	det	17	SENT_498	[p11l679t2603r722b2626],
17	commencement	NN	O	commencement	prep_after	7	SENT_498	[p11l738t2608r970b2626],
18	of	IN	O	of	_	0	SENT_498	[p11l986t2603r1017b2625],
19	doxycycline	NN	O	doxycycline	nn	20	SENT_498	[p11l1029t2603r1199b2634],
20	treatment	NN	O	treatment	prep_of	17	SENT_498	[p11l190t2644r339b2666],
21	,	,	O	,	_	0	SENT_498	[p11l190t2644r339b2666],
22	but	CC	O	but	_	0	SENT_498	[p11l356t2639r404b2662],
23	a	DT	O	a	det	25	SENT_498	[p11l420t2647r434b2662],
24	lesser	JJR	O	lesser	amod	25	SENT_498	[p11l450t2639r529b2662],
25	volume	NN	O	volume	nsubjpass	30	SENT_498	[p11l543t2639r649b2662],
26	of	IN	O	of	_	0	SENT_498	[p11l665t2639r696b2661],
27	7	CD	NUMBER	7	num	28	SENT_498	[p11l710t2637r724b2661],
28	ml	NN	O	ml	prep_of	25	SENT_498	[p11l741t2639r775b2661],
29	was	VBD	O	be	auxpass	30	SENT_498	[p11l791t2647r840b2662],
30	taken	VBN	O	take	conj_but	7	SENT_498	[p11l858t2639r936b2662],
31	at	IN	O	at	_	0	SENT_498	[p11l952t2644r978b2662],
32	24	CD	DURATION	24	num	33	SENT_498	[p11l994t2639r1026b2662],
33	mo	NN	DURATION	mo	prep_at	30	SENT_498	[p11l1043t2647r1086b2661],
34	due	JJ	O	due	_	0	SENT_498	[p11l1103t2639r1154b2662],
35	to	TO	O	to	_	0	SENT_498	[p11l1172t2644r1198b2662],
36	complaints	NNS	O	complaint	prep_due_to	33	SENT_498	[p11l189t2675r348b2706],
37	from	IN	O	from	_	0	SENT_498	[p11l361t2675r432b2697],
38	the	DT	O	the	det	39	SENT_498	[p11l447t2675r490b2698],
39	patients	NNS	O	patient	prep_from	36	SENT_498	[p11l505t2675r627b2706],
40	.	.	O	.	_	0	SENT_498	[p11l505t2675r627b2706],

1	At	IN	O	at	_	0	SENT_499	[p11l640t2675r674b2698],
2	each	DT	O	each	det	4	SENT_499	[p11l688t2675r753b2698],
3	time	NN	O	time	nn	4	SENT_499	[p11l767t2675r831b2698],
4	point	NN	O	point	prep_at	8	SENT_499	[p11l845t2675r929b2706],
5	,	,	O	,	_	0	SENT_499	[p11l845t2675r929b2706],
6	plasma	NN	O	plasma	nsubjpass	17	SENT_499	[p11l944t2675r1044b2706],
7	was	VBD	O	be	auxpass	8	SENT_499	[p11l1056t2683r1106b2698],
8	taken	VBN	O	take	_	0	SENT_499	[p11l1121t2675r1199b2698],
9	from	IN	O	from	_	0	SENT_499	[p11l188t2710r259b2732],
10	the	DT	O	the	det	12	SENT_499	[p11l272t2710r316b2733],
11	remaining	VBG	O	remain	amod	12	SENT_499	[p11l329t2710r478b2741],
12	sample	NN	O	sample	prep_from	8	SENT_499	[p11l489t2710r596b2741],
13	,	,	O	,	_	0	SENT_499	[p11l489t2710r596b2741],
14	aliquoted	VBN	O	aliquote	conj_and	8	SENT_499	[p11l609t2710r753b2741],
15	,	,	O	,	_	0	SENT_499	[p11l609t2710r753b2741],
16	and	CC	O	and	_	0	SENT_499	[p11l765t2710r818b2733],
17	frozen	VBN	O	freeze	conj_and	8	SENT_499	[p11l830t2710r922b2733],
18	at	IN	O	at	_	0	SENT_499	[p11l934t2715r960b2733],
19	-80	CD	NUMBER	-80	num	21	SENT_499	[p11l970t2710r1023b2732],
20	°	CD	NUMBER	°	num	21	SENT_499	[p11l1035t2708r1067b2733],
21	C	NN	O	c	prep_at	17	SENT_499	[p11l1035t2708r1067b2733],
22	for	IN	O	for	_	0	SENT_499	[p11l1079t2710r1123b2732],
23	later	JJ	O	later	amod	24	SENT_499	[p11l1134t2710r1200b2733],
24	analysis	NN	O	analysis	prep_for	21	SENT_499	[p11l189t2746r298b2777],
25	of	IN	O	of	_	0	SENT_499	[p11l312t2746r343b2768],
26	antigenemia	NN	O	antigenemia	nn	29	SENT_499	[p11l353t2746r532b2777],
27	and	CC	O	and	_	0	SENT_499	[p11l545t2746r597b2769],
28	lymphangiogenic	JJ	O	lymphangiogenic	nn	29	SENT_499	[p11l611t2746r858b2777],
29	factors	NNS	O	factor	prep_of	24	SENT_499	[p11l872t2746r977b2769],
30	.	.	O	.	_	0	SENT_499	[p11l872t2746r977b2769],

1	Determination	NN	O	determination	_	0	SENT_500	[p11l226t2782r438b2805],
2	of	IN	O	of	_	0	SENT_500	[p11l448t2782r478b2804],
3	Wolbachia	JJ	O	wolbachia	amod	4	SENT_500	[p11l488t2782r626b2805],
4	levels	NNS	O	level	prep_of	1	SENT_500	[p11l635t2782r715b2805],
5	in	IN	O	in	_	0	SENT_500	[p11l725t2782r752b2804],
6	MF	NN	O	mf	prep_in	1	SENT_500	[p11l761t2783r808b2804],
7	by	IN	O	by	_	0	SENT_500	[p11l817t2782r851b2813],
8	PCR	NN	O	pcr	prep_by	1	SENT_500	[p11l860t2782r934b2805],
9	.	.	O	.	_	0	SENT_500	[p11l860t2782r934b2805],

1	Wolbachia	JJ	MISC	wolbachia	amod	2	SENT_501	[p11l948t2782r1079b2804],
2	content	NN	O	content	nsubjpass	4	SENT_501	[p11l1088t2787r1200b2805],
3	was	VBD	O	be	auxpass	4	SENT_501	[p11l188t2826r238b2841],
4	quantiﬁed	VBN	O	quantiﬁed	_	0	SENT_501	[p11l257t2818r405b2849],
5	by	IN	O	by	_	0	SENT_501	[p11l423t2818r456b2849],
6	real-time	JJ	O	real-time	amod	7	SENT_501	[p11l475t2818r606b2841],
7	PCR	NN	O	pcr	agent	4	SENT_501	[p11l625t2818r688b2841],
8	of	IN	O	of	_	0	SENT_501	[p11l706t2818r737b2840],
9	the	DT	O	the	det	15	SENT_501	[p11l753t2818r797b2841],
10	W.	NNP	O	W.	nn	15	SENT_501	[p11l819t2818r850b2841],
11	bancrofti	NN	O	bancroftus	nn	15	SENT_501	[p11l870t2818r982b2849],
12	W0lbachia	NN	O	w0lbachium	nn	15	SENT_501	[p11l1003t2818r1200b2849],
13	—	CD	NUMBER	—	num	15	SENT_501	[p11l1003t2818r1200b2849],
14	ft5Z	NN	O	ft5z	nn	15	SENT_501	[p11l1003t2818r1200b2849],
15	gene	NN	O	gene	prep_of	7	SENT_501	[p11l189t2862r262b2885],
16	,	,	O	,	_	0	SENT_501	[p11l189t2862r262b2885],
17	derived	VBN	O	derive	partmod	15	SENT_501	[p11l276t2854r384b2877],
18	from	IN	O	from	_	0	SENT_501	[p11l396t2854r466b2876],
19	500	CD	NUMBER	500	num	22	SENT_501	[p11l480t2854r622b2881],
20	—	CD	NUMBER	—	num	22	SENT_501	[p11l480t2854r622b2881],
21	1,000	CD	NUMBER	1,000	num	22	SENT_501	[p11l480t2854r622b2881],
22	microﬁlariae	NNS	O	microﬁlariae	prep_from	17	SENT_501	[p11l636t2854r821b2877],
23	using	VBG	O	use	partmod	22	SENT_501	[p11l834t2854r910b2885],
24	a	DT	O	a	det	29	SENT_501	[p11l922t2862r936b2877],
25	Rotor-Gene	JJ	O	rotor-gene	amod	29	SENT_501	[p11l949t2854r1119b2877],
26	3000	CD	NUMBER	3000	tmod	25	SENT_501	[p11l1133t2854r1199b2876],
27	(	CD	NUMBER	(	num	29	SENT_501	[p11l190t2889r311b2918],
28	Corbett	NNP	ORGANIZATION	Corbett	nn	29	SENT_501	[p11l190t2889r311b2918],
29	Research	NNP	ORGANIZATION	Research	dobj	23	SENT_501	[p11l323t2889r460b2916],
30	,	,	O	,	_	0	SENT_501	[p11l323t2889r460b2916],
31	Brussels	NNP	LOCATION	Brussels	appos	29	SENT_501	[p11l473t2889r595b2916],
32	,	,	O	,	_	0	SENT_501	[p11l473t2889r595b2916],
33	Belgium	NNP	LOCATION	Belgium	dobj	23	SENT_501	[p11l608t2889r736b2920],
34	)	CD	NUMBER	)	num	33	SENT_501	[p11l608t2889r736b2920],
35	at	IN	O	at	_	0	SENT_501	[p11l749t2894r775b2912],
36	pretreatment	NN	O	pretreatment	prep_at	33	SENT_501	[p11l788t2894r981b2920],
37	and	CC	O	and	_	0	SENT_501	[p11l994t2889r1046b2912],
38	4	CD	NUMBER	4	dobj	23	SENT_501	[p11l1059t2889r1081b2916],
39	,	,	O	,	_	0	SENT_501	[p11l1059t2889r1081b2916],
40	12	CD	NUMBER	12	num	38	SENT_501	[p11l1097t2889r1133b2916],
41	,	,	O	,	_	0	SENT_501	[p11l1097t2889r1133b2916],
42	and	CC	DURATION	and	_	0	SENT_501	[p11l1147t2889r1199b2912],
43	24	CD	DURATION	24	conj_and	29	SENT_501	[p11l190t2925r222b2948],
44	mo	NN	DURATION	mo	dep	38	SENT_501	[p11l232t2933r276b2947],
45	after	IN	O	after	_	0	SENT_501	[p11l287t2925r355b2948],
46	treatment	NN	O	treatment	prep_after	23	SENT_501	[p11l365t2930r515b2948],
47	.	.	O	.	_	0	SENT_501	[p11l365t2930r515b2948],

1	Details	NNS	O	detail	nsubjpass	6	SENT_502	[p11l526t2925r624b2948],
2	of	IN	O	of	_	0	SENT_502	[p11l635t2925r666b2947],
3	the	DT	O	the	det	4	SENT_502	[p11l674t2925r718b2948],
4	technique	NN	O	technique	prep_of	1	SENT_502	[p11l729t2925r872b2956],
5	are	VBP	O	be	auxpass	6	SENT_502	[p11l883t2933r927b2948],
6	given	VBN	O	give	_	0	SENT_502	[p11l937t2925r1013b2956],
7	in	IN	O	in	_	0	SENT_502	[p11l1024t2925r1051b2947],
8	reference	NN	O	reference	prep_in	6	SENT_502	[p11l1062t2925r1199b2948],
9	[	CD	NUMBER	[	number	10	SENT_502	[p11l191t2961r248b2989],
10	44	CD	NUMBER	44	num	11	SENT_502	[p11l191t2961r248b2989],
11	]	NN	O	]	dep	6	SENT_502	[p11l191t2961r248b2989],
12	.	.	O	.	_	0	SENT_502	[p11l191t2961r248b2989],

1	Brieﬂy	NNP	O	Brieﬂy	nsubjpass	5	SENT_503	[p11l266t2961r368b2992],
2	,	,	O	,	_	0	SENT_503	[p11l266t2961r368b2992],
3	DNA	NN	O	dna	appos	1	SENT_503	[p11l386t2961r458b2983],
4	was	VBD	O	be	auxpass	5	SENT_503	[p11l474t2969r524b2984],
5	extracted	VBN	O	extract	_	0	SENT_503	[p11l542t2961r678b2984],
6	with	IN	O	with	_	0	SENT_503	[p11l694t2961r756b2984],
7	DNeasy	JJ	O	dneasy	amod	8	SENT_503	[p11l774t2962r882b2992],
8	kit	NN	O	kit	prep_with	5	SENT_503	[p11l899t2961r937b2984],
9	(	CD	NUMBER	(	num	12	SENT_503	[p11l955t2961r1074b2992],
10	Qiagen	NNP	ORGANIZATION	Qiagen	nn	12	SENT_503	[p11l955t2961r1074b2992],
11	,	,	O	,	_	0	SENT_503	[p11l955t2961r1074b2992],
12	Hilden	NNP	PERSON	Hilden	tmod	5	SENT_503	[p11l1093t2961r1199b2988],
13	,	,	O	,	_	0	SENT_503	[p11l1093t2961r1199b2988],
14	Germany	NNP	LOCATION	Germany	appos	12	SENT_503	[p11l189t2996r332b3027],
15	)	CD	NUMBER	)	num	14	SENT_503	[p11l189t2996r332b3027],
16	following	VBG	O	follow	_	0	SENT_503	[p11l356t2996r493b3027],
17	manufacturer	NN	O	manufacturer	poss	19	SENT_503	[p11l518t2996r737b3019],
18	’s	POS	O	’s	_	0	SENT_503	[p11l518t2996r737b3019],
19	protocol	NN	O	protocol	prep_following	14	SENT_503	[p11l763t2996r888b3027],
20	with	IN	O	with	_	0	SENT_503	[p11l912t2996r974b3019],
21	Proteinase	NNP	O	Proteinase	nn	22	SENT_503	[p11l999t2996r1153b3019],
22	K	NNP	O	K	prep_with	19	SENT_503	[p11l1178t2997r1200b3018],

1	G	NN	O	g	nsubj	4	SENT_504	[p11l188t3077r261b3136],
2	\	CD	NUMBER	\	num	3	SENT_504	[p11l188t3077r261b3136],
3	PLoS	NN	O	plo	dep	1	SENT_504	[p11l288t3093r352b3116],
4	Pathogens	VBD	O	pathogen	_	0	SENT_504	[p11l367t3092r511b3123],
5	|	CD	NUMBER	|	num	6	SENT_504	[p11l526t3091r528b3124],
6	www	NN	O	www	dobj	4	SENT_504	[p11l543t3092r882b3123],
7	.	.	O	.	_	0	SENT_504	[p11l543t3092r882b3123],

1	p	NN	O	p	_	0	SENT_505	[p11l543t3092r882b3123],
2	|	CD	NUMBER	|	num	4	SENT_505	[p11l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	nn	4	SENT_505	[p11l543t3092r882b3123],
4	digestion	NN	O	digestion	dep	1	SENT_505	[p11l1276t206r1415b237],
5	.	.	O	.	_	0	SENT_505	[p11l1276t206r1415b237],

1	For	IN	O	for	_	0	SENT_506	[p11l1436t207r1486b228],
2	the	DT	O	the	det	3	SENT_506	[p11l1506t206r1550b229],
3	quantiﬁcation	NN	O	quantiﬁcation	prep_for	23	SENT_506	[p11l1570t206r1782b237],
4	,	,	O	,	_	0	SENT_506	[p11l1570t206r1782b237],
5	primers	NNS	O	primer	conj_and	3	SENT_506	[p11l1803t206r1915b237],
6	and	CC	O	and	_	0	SENT_506	[p11l1935t206r1988b229],
7	a	DT	O	a	det	10	SENT_506	[p11l2008t214r2022b229],
8	Taqman	NN	MISC	taqman	nn	10	SENT_506	[p11l2042t207r2161b237],
9	hybridization	NN	O	hybridization	nn	10	SENT_506	[p11l2181t206r2286b237, p11l1277t242r1374b265],
10	probe	NN	O	probe	prep_for	23	SENT_506	[p11l1388t242r1472b273],
11	with	IN	O	with	_	0	SENT_506	[p11l1485t242r1547b265],
12	the	DT	O	the	det	13	SENT_506	[p11l1560t242r1604b265],
13	ﬂuorescent	JJ	O	ﬂuorescent	prep_with	10	SENT_506	[p11l1617t242r1779b265],
14	dye	VB	O	dye	ccomp	13	SENT_506	[p11l1791t242r1839b273],
15	6-FAM	JJ	O	6-fam	amod	17	SENT_506	[p11l1854t242r1950b264],
16	(	NN	O	(	nn	17	SENT_506	[p11l1964t242r2286b273],
17	6-carboxyﬂuorescein	NN	O	6-carboxyﬂuorescein	dobj	14	SENT_506	[p11l1964t242r2286b273],
18	)	CD	NUMBER	)	number	19	SENT_506	[p11l1964t242r2286b273],
19	(	CD	NUMBER	(	num	13	SENT_506	[p11l1277t277r1399b308],
20	Qiagen	NNP	ORGANIZATION	Qiagen	nsubjpass	23	SENT_506	[p11l1277t277r1399b308],
21	)	CD	NUMBER	)	num	20	SENT_506	[p11l1277t277r1399b308],
22	were	VBD	O	be	auxpass	23	SENT_506	[p11l1416t285r1483b300],
23	used	VBN	O	use	_	0	SENT_506	[p11l1500t277r1565b300],
24	to	TO	O	to	aux	25	SENT_506	[p11l1582t282r1609b300],
25	amplify	VB	O	amplify	xcomp	23	SENT_506	[p11l1626t277r1735b308],
26	a	DT	O	a	det	29	SENT_506	[p11l1751t285r1766b299],
27	286-base	JJ	O	286-base	amod	29	SENT_506	[p11l1782t277r1906b300],
28	pair	NN	O	pair	nn	29	SENT_506	[p11l1923t277r1982b308],
29	fragment	NN	O	fragment	dobj	25	SENT_506	[p11l1997t277r2130b308],
30	of	IN	O	of	_	0	SENT_506	[p11l2146t277r2177b299],
31	the	DT	O	the	det	33	SENT_506	[p11l2191t277r2235b300],
32	W.	NNP	O	W.	nn	33	SENT_506	[p11l2255t277r2286b300],
33	brmcmfti	NN	O	brmcmftus	prep_of	29	SENT_506	[p11l1277t312r1388b343],
34	Wolbtzchia	NNP	O	Wolbtzchia	nn	36	SENT_506	[p11l1405t312r1608b343],
35	—	CD	NUMBER	—	num	36	SENT_506	[p11l1405t312r1608b343],
36	ftsZ	NN	O	ftsz	dep	33	SENT_506	[p11l1405t312r1608b343],
37	.	.	O	.	_	0	SENT_506	[p11l1405t312r1608b343],

1	The	DT	O	the	det	2	SENT_507	[p11l1624t312r1679b335],
2	products	NNS	O	product	nsubjpass	4	SENT_507	[p11l1695t312r1822b343],
3	were	VBD	O	be	auxpass	4	SENT_507	[p11l1837t320r1905b335],
4	quantiﬁed	VBN	O	quantiﬁed	_	0	SENT_507	[p11l1920t312r2068b343],
5	by	IN	O	by	_	0	SENT_507	[p11l2083t312r2115b343],
6	comparing	VBG	O	compare	agent	4	SENT_507	[p11l2130t312r2288b343],
7	with	IN	O	with	_	0	SENT_507	[p11l1276t348r1338b371],
8	a	DT	O	a	det	10	SENT_507	[p11l1358t356r1372b371],
9	standard	JJ	O	standard	amod	10	SENT_507	[p11l1392t348r1518b371],
10	curve	NN	O	curve	prep_with	6	SENT_507	[p11l1538t356r1616b371],
11	of	IN	O	of	_	0	SENT_507	[p11l1636t348r1667b370],
12	the	DT	O	the	det	13	SENT_507	[p11l1684t348r1728b371],
13	plasmid	NN	O	plasmid	prep_of	10	SENT_507	[p11l1748t348r1861b379],
14	containing	VBG	O	contain	partmod	13	SENT_507	[p11l1881t348r2037b379],
15	the	DT	O	the	det	17	SENT_507	[p11l2057t348r2101b371],
16	W.	NNP	O	W.	nn	17	SENT_507	[p11l2124t348r2155b370],
17	btmcmfti	NN	O	btmcmftus	dobj	14	SENT_507	[p11l2176t348r2288b379],
18	Wolba	NNP	O	Wolba	tmod	14	SENT_507	[p11l1279t383r1477b414],
19	£	CD	NUMBER	£	num	18	SENT_507	[p11l1279t383r1477b414],
20	hia	NN	O	hium	nn	23	SENT_507	[p11l1279t383r1477b414],
21	—	CD	NUMBER	—	num	23	SENT_507	[p11l1279t383r1477b414],
22	ftsZ	NN	O	ftsz	nn	23	SENT_507	[p11l1279t383r1477b414],
23	fragment	NN	O	fragment	dep	18	SENT_507	[p11l1488t383r1628b414],
24	.	.	O	.	_	0	SENT_507	[p11l1488t383r1628b414],

1	Determination	NN	O	determination	_	0	SENT_508	[p11l1313t418r1525b441],
2	of	IN	O	of	_	0	SENT_508	[p11l1540t418r1571b440],
3	circulating	VBG	O	circulate	prepc_of	1	SENT_508	[p11l1583t418r1737b449],
4	ﬁlarial	JJ	O	ﬁlarial	amod	5	SENT_508	[p11l1751t418r1845b441],
5	antigenemia	NN	O	antigenemia	dobj	3	SENT_508	[p11l1859t418r2045b449],
6	.	.	O	.	_	0	SENT_508	[p11l1859t418r2045b449],

1	For	IN	O	for	_	0	SENT_509	[p11l2061t419r2112b440],
2	determination	NN	O	determination	prep_for	18	SENT_509	[p11l2126t418r2286b441, p11l1277t454r1334b477],
3	of	IN	O	of	_	0	SENT_509	[p11l1347t454r1378b476],
4	circulating	VBG	O	circulate	prepc_of	2	SENT_509	[p11l1388t454r1544b485],
5	ﬁlarial	JJ	O	ﬁlarial	amod	7	SENT_509	[p11l1555t454r1648b477],
6	antigenemia	NN	O	antigenemia	nn	7	SENT_509	[p11l1662t454r1840b485],
7	(	NN	O	(	dobj	4	SENT_509	[p11l1854t454r1955b483],
8	ﬁlarial	JJ	O	ﬁlarial	amod	11	SENT_509	[p11l1854t454r1955b483],
9	adult	JJ	O	adult	amod	11	SENT_509	[p11l1969t454r2042b477],
10	worm	NN	O	worm	nn	11	SENT_509	[p11l2053t462r2136b476],
11	antigens	NNS	O	antigen	nsubj	12	SENT_509	[p11l2149t454r2286b485],
12	)	VBP	O	)	rcmod	7	SENT_509	[p11l2149t454r2286b485],
13	,	,	O	,	_	0	SENT_509	[p11l2149t454r2286b485],
14	W.	NNP	O	W.	nn	16	SENT_509	[p11l1279t489r1310b512],
15	btmcrofti	NN	O	btmcroftus	nn	16	SENT_509	[p11l1328t489r1439b520],
16	antigen	NN	O	antigen	nsubjpass	18	SENT_509	[p11l1455t489r1562b520],
17	was	VBD	O	be	auxpass	18	SENT_509	[p11l1578t497r1627b512],
18	measured	VBN	O	measure	_	0	SENT_509	[p11l1645t489r1783b512],
19	with	IN	O	with	_	0	SENT_509	[p11l1799t489r1861b512],
20	the	DT	O	the	det	24	SENT_509	[p11l1878t489r1921b512],
21	TropBio	NNP	O	TropBio	nn	24	SENT_509	[p11l1937t489r2060b520],
22	ELISA	NN	O	elisa	nn	24	SENT_509	[p11l2076t489r2168b512],
23	test	NN	O	test	nn	24	SENT_509	[p11l2184t494r2234b512],
24	kit	NN	O	kit	prep_with	18	SENT_509	[p11l2250t489r2287b512],
25	(	CD	NUMBER	(	tmod	18	SENT_509	[p11l1277t524r1416b555],
26	TropBio	NNP	O	TropBio	nn	30	SENT_509	[p11l1277t524r1416b555],
27	,	,	O	,	_	0	SENT_509	[p11l1277t524r1416b555],
28	Townsville	NNP	LOCATION	Townsville	appos	30	SENT_509	[p11l1435t524r1596b551],
29	,	,	O	,	_	0	SENT_509	[p11l1435t524r1596b551],
30	Australia	NNP	LOCATION	Australia	dep	25	SENT_509	[p11l1615t524r1763b552],
31	)	CD	NUMBER	)	num	30	SENT_509	[p11l1615t524r1763b552],
32	.	.	O	.	_	0	SENT_509	[p11l1615t524r1763b552],

1	The	DT	O	the	det	2	SENT_510	[p11l1782t524r1837b547],
2	manufacturer	NN	O	manufacturer	poss	4	SENT_510	[p11l1857t524r2075b547],
3	’s	POS	O	’s	_	0	SENT_510	[p11l1857t524r2075b547],
4	protocol	NN	O	protocol	nsubjpass	6	SENT_510	[p11l2095t524r2218b555],
5	was	VBD	O	be	auxpass	6	SENT_510	[p11l2237t532r2286b547],
6	followed	VBN	O	follow	_	0	SENT_510	[p11l1276t560r1399b583],
7	except	IN	O	except	_	0	SENT_510	[p11l1415t565r1510b591],
8	that	IN	O	that	complm	12	SENT_510	[p11l1526t560r1582b583],
9	the	DT	O	the	det	10	SENT_510	[p11l1598t560r1642b583],
10	samples	NNS	O	sample	nsubjpass	12	SENT_510	[p11l1659t560r1770b591],
11	were	VBD	O	be	auxpass	12	SENT_510	[p11l1786t568r1853b583],
12	diluted	VBN	O	dilute	prepc_except	6	SENT_510	[p11l1870t560r1972b583],
13	(	CD	NUMBER	(	number	14	SENT_510	[p11l1988t560r2054b588],
14	1:20	CD	TIME	1:20	num	16	SENT_510	[p11l1988t560r2054b588],
15	ratio	NN	O	ratio	nn	16	SENT_510	[p11l2071t560r2149b588],
16	)	NN	O	)	dobj	12	SENT_510	[p11l2071t560r2149b588],
17	with	IN	O	with	_	0	SENT_510	[p11l2164t560r2226b583],
18	the	DT	O	the	det	22	SENT_510	[p11l2243t560r2286b583],
19	diluent	JJ	O	diluent	amod	22	SENT_510	[p11l1276t595r1380b618],
20	[	NN	O	[	nn	22	SENT_510	[p11l1400t595r1449b623],
21	42	CD	NUMBER	42	num	22	SENT_510	[p11l1400t595r1449b623],
22	]	NN	O	]	prep_with	12	SENT_510	[p11l1400t595r1449b623],
23	before	IN	O	before	_	0	SENT_510	[p11l1469t595r1563b618],
24	pipetting	VBG	O	pipet	prepc_before	12	SENT_510	[p11l1582t595r1716b626],
25	into	IN	O	into	_	0	SENT_510	[p11l1735t595r1791b618],
26	the	DT	O	the	det	30	SENT_510	[p11l1812t595r1855b618],
27	TropBio	NNP	O	TropBio	nn	30	SENT_510	[p11l1874t595r1997b626],
28	ELISA	NN	O	elisa	nn	30	SENT_510	[p11l2016t595r2108b618],
29	test	NN	O	test	nn	30	SENT_510	[p11l2127t600r2177b618],
30	plates	NNS	O	plate	prep_into	24	SENT_510	[p11l2196t595r2286b626],
31	.	.	O	.	_	0	SENT_510	[p11l2196t595r2286b626],

1	Samples	NNS	O	sample	nsubjpass	3	SENT_511	[p11l1277t630r1394b661],
2	were	VBD	O	be	auxpass	3	SENT_511	[p11l1405t638r1472b653],
3	tested	VBN	O	test	_	0	SENT_511	[p11l1484t630r1569b653],
4	in	IN	O	in	_	0	SENT_511	[p11l1581t630r1607b652],
5	duplicate	VB	O	duplicate	conj_and	5	SENT_511	[p11l1619t630r1753b661],
6	before	IN	O	before	_	0	SENT_511	[p11l1764t630r1857b653],
7	treatment	NN	O	treatment	prep_before	5	SENT_511	[p11l1869t635r2013b653],
8	and	CC	O	and	_	0	SENT_511	[p11l2024t630r2076b653],
9	at	IN	O	at	_	0	SENT_511	[p11l2087t635r2113b653],
10	12	CD	NUMBER	12	prep_at	5	SENT_511	[p11l2127t630r2167b653],
11	-	:	O	-	_	0	SENT_511	[p11l2127t630r2167b653],
12	and	CC	O	and	_	0	SENT_511	[p11l2179t630r2232b653],
13	24mo	JJ	O	24mo	nsubj	14	SENT_511	[p11l2244t630r2286b653, p11l1277t673r1321b687],
14	follow	VBP	O	follow	conj_and	3	SENT_511	[p11l1339t665r1496b696],
15	—	CD	NUMBER	—	num	16	SENT_511	[p11l1339t665r1496b696],
16	ups	NNS	O	up	dobj	14	SENT_511	[p11l1339t665r1496b696],
17	.	.	O	.	_	0	SENT_511	[p11l1339t665r1496b696],

1	The	DT	O	the	det	3	SENT_512	[p11l1515t665r1570b688],
2	optical	JJ	O	optical	amod	3	SENT_512	[p11l1588t665r1687b696],
3	density	NN	O	density	nsubjpass	8	SENT_512	[p11l1705t665r1808b696],
4	at	IN	O	at	_	0	SENT_512	[p11l1826t670r1851b688],
5	414	CD	NUMBER	414	num	6	SENT_512	[p11l1869t665r1919b687],
6	nm	NN	O	nm	prep_at	3	SENT_512	[p11l1937t673r1982b687],
7	was	VBD	O	be	auxpass	8	SENT_512	[p11l2000t673r2049b688],
8	recorded	VBN	O	record	_	0	SENT_512	[p11l2068t665r2199b688],
9	from	IN	O	from	_	0	SENT_512	[p11l2216t665r2287b687],
10	plasma	NN	O	plasma	nn	11	SENT_512	[p11l1277t701r1377b732],
11	samples	NNS	O	sample	prep_from	8	SENT_512	[p11l1389t701r1508b732],
12	.	.	O	.	_	0	SENT_512	[p11l1389t701r1508b732],

1	Antigen	NN	O	antigen	nn	2	SENT_513	[p11l1520t701r1636b732],
2	units	NNS	O	unit	nsubjpass	4	SENT_513	[p11l1648t701r1719b724],
3	were	VBD	O	be	auxpass	4	SENT_513	[p11l1731t709r1799b724],
4	calculated	VBN	O	calculate	_	0	SENT_513	[p11l1811t701r1957b724],
5	with	IN	O	with	_	0	SENT_513	[p11l1969t701r2031b724],
6	a	DT	O	a	det	8	SENT_513	[p11l2044t709r2058b724],
7	standard	JJ	O	standard	amod	8	SENT_513	[p11l2070t701r2196b724],
8	curve	NN	O	curve	prep_with	4	SENT_513	[p11l2208t709r2286b724],
9	from	IN	O	from	_	0	SENT_513	[p11l1276t736r1347b758],
10	standards	NNS	O	standard	prep_from	4	SENT_513	[p11l1364t736r1502b759],
11	provided	VBN	O	provide	partmod	10	SENT_513	[p11l1520t736r1650b767],
12	by	IN	O	by	_	0	SENT_513	[p11l1667t736r1700b767],
13	the	DT	O	the	det	14	SENT_513	[p11l1718t736r1761b759],
14	manufacturer	NN	O	manufacturer	agent	11	SENT_513	[p11l1780t736r1985b763],
15	,	,	O	,	_	0	SENT_513	[p11l1780t736r1985b763],
16	and	CC	O	and	_	0	SENT_513	[p11l2004t736r2056b759],
17	the	DT	O	the	det	19	SENT_513	[p11l2074t736r2118b759],
18	ﬁnal	JJ	O	ﬁnal	amod	19	SENT_513	[p11l2135t736r2198b758],
19	units	NNS	O	unit	nsubj	20	SENT_513	[p11l2216t736r2286b759],
20	multiplied	VBN	O	multiply	conj_and	4	SENT_513	[p11l1277t772r1427b803],
21	by	IN	O	by	_	0	SENT_513	[p11l1440t772r1472b803],
22	the	DT	O	the	det	24	SENT_513	[p11l1486t772r1530b795],
23	dilution	NN	O	dilution	nn	24	SENT_513	[p11l1543t772r1658b795],
24	factor	NN	O	factor	prep_by	20	SENT_513	[p11l1671t772r1758b795],
25	of	IN	O	of	_	0	SENT_513	[p11l1770t772r1801b794],
26	20	CD	NUMBER	20	prep_of	24	SENT_513	[p11l1812t772r1850b795],
27	.	.	O	.	_	0	SENT_513	[p11l1812t772r1850b795],

1	Limb	NN	O	limb	nn	2	SENT_514	[p11l1313t807r1389b829],
2	measurement	NN	O	measurement	_	0	SENT_514	[p11l1399t811r1595b830],
3	of	IN	O	of	_	0	SENT_514	[p11l1605t807r1636b829],
4	lymphedema	NN	O	lymphedema	nn	5	SENT_514	[p11l1643t807r1830b838],
5	patients	NNS	O	patient	prep_of	2	SENT_514	[p11l1838t807r1962b838],
6	.	.	O	.	_	0	SENT_514	[p11l1838t807r1962b838],

1	The	DT	O	the	det	2	SENT_515	[p11l1973t807r2028b830],
2	circumference	NN	O	circumference	nsubjpass	10	SENT_515	[p11l2039t807r2248b830],
3	of	IN	O	of	_	0	SENT_515	[p11l2259t807r2290b829],
4	both	DT	O	both	det	8	SENT_515	[p11l1276t842r1342b865],
5	affected	VBN	O	affect	amod	8	SENT_515	[p11l1354t842r1469b865],
6	and	CC	O	and	_	0	SENT_515	[p11l1481t842r1533b865],
7	normal	JJ	O	normal	amod	8	SENT_515	[p11l1545t842r1648b865],
8	legs	NNS	O	leg	prep_of	2	SENT_515	[p11l1660t842r1712b873],
9	were	VBD	O	be	auxpass	10	SENT_515	[p11l1723t850r1791b865],
10	measured	VBN	O	measure	_	0	SENT_515	[p11l1803t842r1942b865],
11	with	IN	O	with	_	0	SENT_515	[p11l1952t842r2015b865],
12	measuring	VBG	O	measure	prepc_with	10	SENT_515	[p11l2027t842r2177b873],
13	tape	NN	O	tape	dobj	12	SENT_515	[p11l2188t847r2249b873],
14	at	IN	O	at	_	0	SENT_515	[p11l2261t847r2287b865],
15	ﬁve	CD	NUMBER	ﬁve	num	17	SENT_515	[p11l1276t877r1325b900],
16	different	JJ	O	different	amod	17	SENT_515	[p11l1342t877r1470b900],
17	points	NNS	O	point	prep_at	12	SENT_515	[p11l1487t877r1583b908],
18	.	.	O	.	_	0	SENT_515	[p11l1487t877r1583b908],

1	Measurements	NNS	O	measurement	nsubjpass	3	SENT_516	[p11l1601t878r1809b900],
2	were	VBD	O	be	auxpass	3	SENT_516	[p11l1825t885r1893b900],
3	taken	VBN	O	take	_	0	SENT_516	[p11l1910t877r1988b900],
4	at	IN	O	at	_	0	SENT_516	[p11l2006t882r2031b900],
5	10	CD	NUMBER	10	num	6	SENT_516	[p11l2051t877r2079b899],
6	cm	NN	O	cm	prep_at	3	SENT_516	[p11l2097t885r2138b900],
7	from	IN	O	from	_	0	SENT_516	[p11l2154t877r2225b899],
8	the	DT	O	the	det	10	SENT_516	[p11l2243t877r2286b900],
9	large	JJ	O	large	amod	10	SENT_516	[p11l1277t913r1347b944],
10	toe	NN	O	toe	prep_from	6	SENT_516	[p11l1358t918r1408b940],
11	,	,	O	,	_	0	SENT_516	[p11l1358t918r1408b940],
12	and	CC	O	and	_	0	SENT_516	[p11l1419t913r1471b936],
13	12	CD	NUMBER	12	num	14	SENT_516	[p11l1485t913r1513b936],
14	cm	NN	O	cm	prep_from	6	SENT_516	[p11l1524t921r1573b940],
15	,	,	O	,	_	0	SENT_516	[p11l1524t921r1573b940],
16	20	CD	NUMBER	20	num	17	SENT_516	[p11l1584t913r1615b936],
17	cm	NN	O	cm	prep_from	6	SENT_516	[p11l1626t921r1674b940],
18	,	,	O	,	_	0	SENT_516	[p11l1626t921r1674b940],
19	30	CD	NUMBER	30	num	20	SENT_516	[p11l1686t913r1717b935],
20	cm	NN	O	cm	conj_and	10	SENT_516	[p11l1727t921r1769b936],
21	and	CC	O	and	_	0	SENT_516	[p11l1779t913r1832b936],
22	50	CD	NUMBER	50	num	23	SENT_516	[p11l1843t913r1874b935],
23	cm	NN	O	cm	conj_and	10	SENT_516	[p11l1884t921r1926b936],
24	from	IN	O	from	_	0	SENT_516	[p11l1935t913r2006b935],
25	the	DT	O	the	det	26	SENT_516	[p11l2017t913r2061b936],
26	sole	NN	O	sole	prep_from	3	SENT_516	[p11l2072t913r2125b936],
27	of	IN	O	of	_	0	SENT_516	[p11l2136t913r2167b935],
28	the	DT	O	the	det	29	SENT_516	[p11l2174t913r2218b936],
29	foot	NN	O	foot	prep_of	26	SENT_516	[p11l2228t913r2287b936],
30	as	IN	O	as	mark	31	SENT_516	[p11l1277t956r1302b971],
31	described	VBN	O	describe	advcl	3	SENT_516	[p11l1317t948r1456b971],
32	in	IN	O	in	_	0	SENT_516	[p11l1472t948r1498b970],
33	reference	NN	O	reference	prep_in	31	SENT_516	[p11l1514t948r1650b971],
34	[	CD	NUMBER	[	number	35	SENT_516	[p11l1667t948r1724b976],
35	85	CD	NUMBER	85	num	36	SENT_516	[p11l1667t948r1724b976],
36	]	NN	O	]	dobj	31	SENT_516	[p11l1667t948r1724b976],
37	,	,	O	,	_	0	SENT_516	[p11l1667t948r1724b976],
38	and	CC	O	and	_	0	SENT_516	[p11l1740t948r1792b971],
39	the	DT	O	the	det	40	SENT_516	[p11l1807t948r1851b971],
40	average	NN	O	average	nsubj	45	SENT_516	[p11l1866t956r1975b979],
41	of	IN	O	of	_	0	SENT_516	[p11l1990t948r2020b970],
42	the	DT	O	the	det	44	SENT_516	[p11l2033t948r2076b971],
43	ﬁve	JJ	O	ﬁve	amod	44	SENT_516	[p11l2091t948r2140b971],
44	measurements	NNS	O	measurement	prep_of	40	SENT_516	[p11l2156t956r2286b971, p11l1277t988r1362b1006],
45	taken	VBN	O	take	conj_and	3	SENT_516	[p11l1381t983r1459b1006],
46	as	IN	O	as	_	0	SENT_516	[p11l1477t991r1502b1006],
47	the	DT	O	the	det	49	SENT_516	[p11l1521t983r1565b1006],
48	mean	NN	O	mean	nn	49	SENT_516	[p11l1583t991r1660b1006],
49	circumference	NN	O	circumference	prep_as	45	SENT_516	[p11l1678t983r1887b1006],
50	of	IN	O	of	_	0	SENT_516	[p11l1905t983r1936b1005],
51	the	DT	O	the	det	52	SENT_516	[p11l1951t983r1995b1006],
52	leg	NN	O	leg	prep_of	49	SENT_516	[p11l2013t983r2059b1014],
53	.	.	O	.	_	0	SENT_516	[p11l2013t983r2059b1014],

1	Measurements	NNS	O	measurement	nsubjpass	3	SENT_517	[p11l2078t984r2286b1006],
2	were	VBD	O	be	auxpass	3	SENT_517	[p11l1276t1027r1343b1042],
3	taken	VBN	O	take	_	0	SENT_517	[p11l1358t1019r1436b1042],
4	before	RB	O	before	dep	3	SENT_517	[p11l1449t1019r1542b1042],
5	and	CC	O	and	_	0	SENT_517	[p11l1555t1019r1608b1042],
6	12	CD	DURATION	12	num	7	SENT_517	[p11l1624t1019r1653b1042],
7	mo	NN	DURATION	mo	dep	3	SENT_517	[p11l1667t1027r1711b1041],
8	post	NN	O	post	nn	9	SENT_517	[p11l1725t1024r1785b1050],
9	therapy	NN	O	therapy	dep	7	SENT_517	[p11l1799t1019r1915b1050],
10	.	.	O	.	_	0	SENT_517	[p11l1799t1019r1915b1050],

1	Grading	NN	O	grading	_	0	SENT_518	[p11l1314t1054r1432b1085],
2	or	CC	O	or	_	0	SENT_518	[p11l1450t1062r1480b1076],
3	staging	NN	O	staging	conj_or	1	SENT_518	[p11l1498t1054r1602b1085],
4	of	IN	O	of	_	0	SENT_518	[p11l1620t1054r1650b1076],
5	lymphedema	NN	O	lymphedema	nn	6	SENT_518	[p11l1666t1054r1853b1085],
6	legs	NNS	O	leg	prep_of	1	SENT_518	[p11l1870t1054r1933b1085],
7	.	.	O	.	_	0	SENT_518	[p11l1870t1054r1933b1085],

1	Grading	NN	O	grading	nsubjpass	7	SENT_519	[p11l1953t1054r2072b1085],
2	or	CC	O	or	_	0	SENT_519	[p11l2090t1062r2121b1076],
3	staging	NN	O	staging	nsubjpass	7	SENT_519	[p11l2139t1054r2241b1085],
4	of	IN	O	of	_	0	SENT_519	[p11l2259t1054r2290b1076],
5	lymphedema	NN	O	lymphedema	prep_of	1	SENT_519	[p11l1277t1089r1462b1120],
6	was	VBD	O	be	auxpass	7	SENT_519	[p11l1474t1097r1524b1112],
7	performed	VBN	O	perform	_	0	SENT_519	[p11l1538t1089r1693b1120],
8	along	IN	O	along	_	0	SENT_519	[p11l1706t1089r1785b1120],
9	the	DT	O	the	det	10	SENT_519	[p11l1798t1089r1842b1112],
10	guidelines	NNS	O	guideline	prep_along	7	SENT_519	[p11l1855t1089r2001b1120],
11	of	IN	O	of	_	0	SENT_519	[p11l2014t1089r2045b1111],
12	“	CD	NUMBER	“	prep_of	10	SENT_519	[p11l2056t1088r2144b1112],
13	Basic	JJ	O	basic	amod	15	SENT_519	[p11l2056t1088r2144b1112],
14	Lymphedema	NNP	O	Lymphedema	nn	15	SENT_519	[p11l2158t1089r2286b1120, p11l1277t1125r1355b1148],
15	Management	NNP	O	Management	tmod	7	SENT_519	[p11l1367t1124r1569b1156],
16	”	CD	NUMBER	”	number	17	SENT_519	[p11l1367t1124r1569b1156],
17	[	CD	NUMBER	[	nsubj	21	SENT_519	[p11l1586t1123r1635b1153],
18	47	CD	NUMBER	47	num	19	SENT_519	[p11l1586t1123r1635b1153],
19	]	NN	O	]	dep	17	SENT_519	[p11l1586t1123r1635b1153],
20	(	CD	NUMBER	(	dep	17	SENT_519	[p11l1651t1126r1702b1154],
21	see	VBP	O	see	rcmod	15	SENT_519	[p11l1651t1126r1702b1154],
22	Figure	NNP	O	Figure	dobj	21	SENT_519	[p11l1716t1125r1808b1156],
23	10	CD	NUMBER	10	rcmod	22	SENT_519	[p11l1824t1125r1871b1154],
24	.	.	O	.	_	0	SENT_519	[p11l1824t1125r1871b1154],
25	)	SYM	O	)	dep	22	SENT_519	[p11l1824t1125r1871b1154],

1	Stage	NN	O	stage	_	0	SENT_520	[p11l1314t1160r1390b1191],
2	1	CD	NUMBER	1	num	1	SENT_520	[p11l1408t1160r1417b1182],
3	:	:	O	:	_	0	SENT_520	[p11l1432t1170r1454b1178],
4	swelling	VBG	O	swell	dep	1	SENT_520	[p11l1467t1160r1582b1191],
5	that	DT	O	that	nsubj	7	SENT_520	[p11l1597t1160r1653b1183],
6	is	VBZ	O	be	cop	7	SENT_520	[p11l1668t1160r1687b1182],
7	reversible	JJ	O	reversible	ccomp	4	SENT_520	[p11l1703t1160r1843b1183],
8	overnight	JJ	TIME	overnight	tmod	7	SENT_520	[p11l1858t1160r2004b1191],
9	,	,	O	,	_	0	SENT_520	[p11l1858t1160r2004b1191],
10	Stage	NN	O	stage	appos	8	SENT_520	[p11l2020t1160r2096b1191],
11	2	CD	NUMBER	2	num	10	SENT_520	[p11l2112t1160r2125b1183],
12	:	:	O	:	_	0	SENT_520	[p11l2138t1170r2160b1178],
13	swelling	VBG	O	swell	parataxis	4	SENT_520	[p11l2173t1160r2288b1191],
14	that	DT	O	that	nsubj	17	SENT_520	[p11l1277t1195r1333b1218],
15	is	VBZ	O	be	cop	17	SENT_520	[p11l1348t1195r1367b1218],
16	not	RB	O	not	neg	17	SENT_520	[p11l1382t1200r1429b1218],
17	reversible	JJ	O	reversible	ccomp	13	SENT_520	[p11l1444t1195r1583b1218],
18	overnight	JJ	TIME	overnight	amod	17	SENT_520	[p11l1598t1195r1744b1226],
19	,	,	O	,	_	0	SENT_520	[p11l1598t1195r1744b1226],
20	Stage	NNP	O	Stage	appos	17	SENT_520	[p11l1759t1195r1835b1226],
21	3	CD	NUMBER	3	num	20	SENT_520	[p11l1850t1195r1864b1217],
22	:	:	O	:	_	0	SENT_520	[p11l1876t1205r1898b1213],
23	shallow	JJ	O	shallow	amod	24	SENT_520	[p11l1910t1195r2015b1218],
24	skin	NN	O	skin	nsubj	25	SENT_520	[p11l2029t1195r2086b1218],
25	folds	VBZ	O	fold	rcmod	17	SENT_520	[p11l2099t1195r2168b1218],
26	(	RB	O	(	advmod	28	SENT_520	[p11l2184t1195r2286b1224],
27	ankle	NN	O	ankle	nn	28	SENT_520	[p11l2184t1195r2286b1224],
28	)	NN	O	)	dobj	25	SENT_520	[p11l2184t1195r2286b1224],
29	,	,	O	,	_	0	SENT_520	[p11l2184t1195r2286b1224],
30	Stage	NNP	O	Stage	appos	28	SENT_520	[p11l1277t1231r1353b1262],
31	4	CD	NUMBER	4	num	30	SENT_520	[p11l1367t1231r1383b1253],
32	:	:	O	:	_	0	SENT_520	[p11l1394t1241r1416b1249],
33	presence	NN	O	presence	dep	28	SENT_520	[p11l1428t1239r1555b1262],
34	of	IN	O	of	_	0	SENT_520	[p11l1570t1231r1601b1253],
35	knobs	NNS	O	knob	prep_of	33	SENT_520	[p11l1612t1231r1696b1254],
36	(	CD	NUMBER	(	num	37	SENT_520	[p11l1712t1231r1807b1262],
37	lumps	NNS	O	lump	tmod	35	SENT_520	[p11l1712t1231r1807b1262],
38	or	CC	O	or	_	0	SENT_520	[p11l1821t1239r1853b1253],
39	protrusions	NNS	O	protrusion	conj_or	37	SENT_520	[p11l1867t1231r2052b1262],
40	)	RB	O	)	advmod	37	SENT_520	[p11l1867t1231r2052b1262],
41	,	,	O	,	_	0	SENT_520	[p11l1867t1231r2052b1262],
42	Stage	NNP	O	Stage	appos	35	SENT_520	[p11l2067t1231r2143b1262],
43	5	CD	NUMBER	5	num	42	SENT_520	[p11l2158t1231r2173b1253],
44	:	:	O	:	_	0	SENT_520	[p11l2184t1241r2206b1249],
45	deep	JJ	O	deep	amod	46	SENT_520	[p11l2218t1231r2286b1262],
46	skin	NN	O	skin	nsubj	47	SENT_520	[p11l1277t1266r1333b1289],
47	folds	VBZ	O	fold	dep	42	SENT_520	[p11l1345t1266r1413b1289],
48	plus	CC	O	plus	nsubj	49	SENT_520	[p11l1426t1266r1483b1297],
49	knobs	VBZ	O	knob	ccomp	47	SENT_520	[p11l1495t1266r1587b1293],
50	,	,	O	,	_	0	SENT_520	[p11l1495t1266r1587b1293],
51	Stage	NNP	O	Stage	conj_and	42	SENT_520	[p11l1599t1266r1675b1297],
52	6	CD	NUMBER	6	num	51	SENT_520	[p11l1688t1266r1702b1288],
53	:	:	O	:	_	0	SENT_520	[p11l1711t1276r1733b1284],
54	deep	JJ	O	deep	amod	55	SENT_520	[p11l1742t1266r1810b1297],
55	skin	NN	O	skin	conj_and	42	SENT_520	[p11l1823t1266r1879b1289],
56	folds	VBZ	O	fold	rcmod	55	SENT_520	[p11l1891t1266r1959b1289],
57	plus	CC	O	plus	nsubj	58	SENT_520	[p11l1972t1266r2029b1297],
58	knobs	VBZ	O	knob	ccomp	56	SENT_520	[p11l2041t1266r2125b1289],
59	and	CC	O	and	_	0	SENT_520	[p11l2137t1266r2190b1289],
60	mossy	JJ	O	mossy	amod	61	SENT_520	[p11l2202t1274r2287b1297],
61	lesions	NNS	O	lesion	conj_and	42	SENT_520	[p11l1277t1301r1380b1328],
62	,	,	O	,	_	0	SENT_520	[p11l1277t1301r1380b1328],
63	and	CC	O	and	_	0	SENT_520	[p11l1397t1301r1449b1324],
64	Stage	NN	O	stage	conj_and	42	SENT_520	[p11l1465t1301r1542b1332],
65	7	CD	NUMBER	7	num	64	SENT_520	[p11l1559t1299r1573b1323],
66	:	:	O	:	_	0	SENT_520	[p11l1586t1311r1608b1319],
67	parameters	NNS	O	parameter	dep	64	SENT_520	[p11l1622t1306r1784b1332],
68	mentioned	VBN	O	mention	partmod	67	SENT_520	[p11l1801t1301r1958b1324],
69	above	IN	O	above	_	0	SENT_520	[p11l1974t1301r2057b1324],
70	plus	CC	O	plus	cc	71	SENT_520	[p11l2073t1301r2131b1332],
71	patient	NN	O	patient	prep_above	68	SENT_520	[p11l2148t1301r2251b1332],
72	is	VBZ	O	be	cop	73	SENT_520	[p11l2267t1301r2286b1324],
73	unable	JJ	O	unable	rcmod	71	SENT_520	[p11l1276t1337r1373b1360],
74	to	TO	O	to	aux	75	SENT_520	[p11l1387t1342r1414b1360],
75	perform	VB	O	perform	xcomp	73	SENT_520	[p11l1428t1337r1548b1368],
76	routine	JJ	O	routine	amod	78	SENT_520	[p11l1562t1337r1668b1360],
77	daily	JJ	SET	daily	amod	78	SENT_520	[p11l1682t1337r1750b1368],
78	activities	NNS	O	activity	dobj	75	SENT_520	[p11l1763t1337r1897b1360],
79	.	.	O	.	_	0	SENT_520	[p11l1763t1337r1897b1360],

1	Foot	NNP	O	Foot	_	0	SENT_521	[p11l1313t1373r1378b1394],
2	care	NN	O	care	dep	1	SENT_521	[p11l1392t1380r1451b1395],
3	and	CC	O	and	_	0	SENT_521	[p11l1465t1372r1518b1395],
4	ADL	NN	ORGANIZATION	adl	dep	1	SENT_521	[p11l1530t1372r1605b1395],
5	.	.	O	.	_	0	SENT_521	[p11l1530t1372r1605b1395],

1	Before	IN	O	before	mark	4	SENT_522	[p11l1620t1372r1716b1395],
2	the	DT	O	the	det	3	SENT_522	[p11l1731t1372r1775b1395],
3	treatment	NN	O	treatment	nsubj	4	SENT_522	[p11l1790t1377r1934b1395],
4	began	VBD	O	begin	advcl	10	SENT_522	[p11l1947t1372r2040b1403],
5	,	,	O	,	_	0	SENT_522	[p11l1947t1372r2040b1403],
6	all	DT	O	all	det	8	SENT_522	[p11l2055t1372r2087b1395],
7	lymphedema	NN	O	lymphedema	nn	8	SENT_522	[p11l2101t1372r2287b1403],
8	patients	NNS	O	patient	nsubjpass	10	SENT_522	[p11l1277t1407r1392b1438],
9	were	VBD	O	be	auxpass	10	SENT_522	[p11l1406t1415r1474b1430],
10	taught	VBN	O	teach	_	0	SENT_522	[p11l1490t1407r1581b1438],
11	about	IN	O	about	_	0	SENT_522	[p11l1596t1407r1678b1430],
12	hygienic	JJ	O	hygienic	amod	13	SENT_522	[p11l1693t1407r1812b1438],
13	care	NN	O	care	prep_about	10	SENT_522	[p11l1828t1415r1888b1430],
14	and	CC	O	and	_	0	SENT_522	[p11l1904t1407r1956b1430],
15	physical	JJ	O	physical	amod	16	SENT_522	[p11l1971t1407r2086b1438],
16	exercises	NNS	O	exercise	prep_about	10	SENT_522	[p11l2101t1407r2229b1430],
17	for	IN	O	for	_	0	SENT_522	[p11l2244t1407r2288b1429],
18	the	DT	O	the	det	20	SENT_522	[p11l1277t1442r1321b1465],
19	affected	VBN	O	affect	amod	20	SENT_522	[p11l1339t1442r1454b1465],
20	legs	NNS	O	leg	prep_for	16	SENT_522	[p11l1473t1442r1532b1473],
21	,	,	O	,	_	0	SENT_522	[p11l1473t1442r1532b1473],
22	and	CC	O	and	cc	23	SENT_522	[p11l1550t1442r1603b1465],
23	importantly	RB	O	importantly	advmod	13	SENT_522	[p11l1621t1442r1800b1473],
24	,	,	O	,	_	0	SENT_522	[p11l1621t1442r1800b1473],
25	daily	JJ	SET	daily	advmod	10	SENT_522	[p11l1819t1442r1887b1473],
26	cleansing	VBG	O	cleanse	ccomp	10	SENT_522	[p11l1904t1442r2038b1473],
27	of	IN	O	of	_	0	SENT_522	[p11l2055t1442r2086b1464],
28	affected	VBN	O	affect	amod	29	SENT_522	[p11l2101t1442r2217b1465],
29	legs	NNS	O	leg	prep_of	26	SENT_522	[p11l2234t1442r2286b1473],
30	with	IN	O	with	_	0	SENT_522	[p11l1276t1478r1338b1501],
31	soap	NN	O	soap	prep_with	29	SENT_522	[p11l1359t1486r1423b1509],
32	and	CC	O	and	_	0	SENT_522	[p11l1445t1478r1498b1501],
33	water	NN	O	water	prep_with	29	SENT_522	[p11l1518t1483r1605b1505],
34	,	,	O	,	_	0	SENT_522	[p11l1518t1483r1605b1505],
35	and	CC	O	and	_	0	SENT_522	[p11l1627t1478r1679b1501],
36	keeping	VBG	O	keep	ccomp	10	SENT_522	[p11l1701t1478r1815b1509],
37	the	DT	O	the	det	39	SENT_522	[p11l1836t1478r1880b1501],
38	affected	JJ	O	affected	amod	39	SENT_522	[p11l1902t1478r2017b1501],
39	leg	NN	O	leg	dobj	36	SENT_522	[p11l2039t1478r2079b1509],
40	dry	JJ	O	dry	amod	39	SENT_522	[p11l2100t1478r2146b1509],
41	between	IN	O	between	_	0	SENT_522	[p11l2167t1478r2286b1501],
42	washes	NNS	O	wash	prep_between	40	SENT_522	[p11l1276t1513r1380b1536],
43	.	.	O	.	_	0	SENT_522	[p11l1276t1513r1380b1536],

1	All	PDT	O	all	predet	4	SENT_523	[p11l1397t1513r1438b1535],
2	the	DT	O	the	det	4	SENT_523	[p11l1456t1513r1500b1536],
3	lymphedema	NN	O	lymphedema	nn	4	SENT_523	[p11l1518t1513r1704b1544],
4	patients	NNS	O	patient	nsubjpass	6	SENT_523	[p11l1720t1513r1835b1544],
5	were	VBD	O	be	auxpass	6	SENT_523	[p11l1852t1521r1920b1536],
6	given	VBN	O	give	_	0	SENT_523	[p11l1937t1513r2013b1544],
7	soap	NN	O	soap	dobj	6	SENT_523	[p11l2031t1521r2102b1544],
8	,	,	O	,	_	0	SENT_523	[p11l2031t1521r2102b1544],
9	towels	NNS	O	towel	appos	7	SENT_523	[p11l2121t1513r2216b1540],
10	,	,	O	,	_	0	SENT_523	[p11l2121t1513r2216b1540],
11	and	CC	O	and	_	0	SENT_523	[p11l2234t1513r2287b1536],
12	plastic	JJ	O	plastic	nsubj	13	SENT_523	[p11l1277t1548r1368b1579],
13	bowls	VBZ	O	bowl	conj_and	6	SENT_523	[p11l1384t1548r1464b1571],
14	for	IN	O	for	_	0	SENT_523	[p11l1479t1548r1522b1570],
15	washing	VBG	O	wash	prepc_for	13	SENT_523	[p11l1536t1548r1652b1579],
16	the	DT	O	the	det	17	SENT_523	[p11l1667t1548r1711b1571],
17	legs	NNS	O	leg	dobj	15	SENT_523	[p11l1726t1548r1785b1579],
18	.	.	O	.	_	0	SENT_523	[p11l1726t1548r1785b1579],

1	They	PRP	O	they	nsubjpass	3	SENT_524	[p11l1801t1548r1872b1579],
2	were	VBD	O	be	auxpass	3	SENT_524	[p11l1887t1556r1954b1571],
3	visited	VBN	O	visit	_	0	SENT_524	[p11l1969t1548r2063b1571],
4	every	DT	SET	every	det	6	SENT_524	[p11l2078t1556r2154b1579],
5	6	CD	SET	6	num	6	SENT_524	[p11l2169t1548r2184b1570],
6	mo	NN	SET	mo	dobj	3	SENT_524	[p11l2200t1556r2243b1570],
7	in	IN	O	in	_	0	SENT_524	[p11l2260t1548r2286b1570],
8	their	PRP$	O	they	poss	9	SENT_524	[p11l1277t1584r1347b1607],
9	villages	NNS	O	village	prep_in	6	SENT_524	[p11l1368t1584r1479b1615],
10	.	.	O	.	_	0	SENT_524	[p11l1368t1584r1479b1615],

1	At	IN	O	at	_	0	SENT_525	[p11l1502t1584r1536b1607],
2	each	DT	O	each	det	3	SENT_525	[p11l1559t1584r1624b1607],
3	visit	NN	O	visit	prep_at	8	SENT_525	[p11l1646t1584r1711b1611],
4	,	,	O	,	_	0	SENT_525	[p11l1646t1584r1711b1611],
5	the	DT	O	the	det	6	SENT_525	[p11l1735t1584r1779b1607],
6	patients	NNS	O	patient	nsubjpass	8	SENT_525	[p11l1803t1584r1918b1615],
7	were	VBD	O	be	auxpass	8	SENT_525	[p11l1941t1592r2008b1607],
8	asked	VBN	O	ask	_	0	SENT_525	[p11l2032t1584r2111b1607],
9	through	IN	O	through	_	0	SENT_525	[p11l2134t1584r2250b1615],
10	a	DT	O	a	det	11	SENT_525	[p11l2273t1592r2287b1607],
11	questionnaire	NN	O	questionnaire	prep_through	8	SENT_525	[p11l1276t1619r1476b1650],
12	the	DT	O	the	det	13	SENT_525	[p11l1491t1619r1534b1642],
13	number	NN	O	number	nsubj	16	SENT_525	[p11l1549t1619r1663b1642],
14	of	IN	O	of	_	0	SENT_525	[p11l1675t1619r1706b1641],
15	attacks	NNS	O	attack	prep_of	13	SENT_525	[p11l1716t1619r1814b1642],
16	experienced	VBD	O	experience	rcmod	11	SENT_525	[p11l1828t1619r2013b1650],
17	.	.	O	.	_	0	SENT_525	[p11l1828t1619r2013b1650],

1	Serology	NN	O	serology	nsubj	2	SENT_526	[p11l1314t1654r1438b1685],
2	test	NN	O	test	_	0	SENT_526	[p11l1460t1658r1519b1677],
3	.	.	O	.	_	0	SENT_526	[p11l1460t1658r1519b1677],

1	Filarial	JJ	O	filarial	amod	2	SENT_527	[p11l1543t1654r1644b1677],
2	antibodies	NNS	O	antibody	nsubjpass	4	SENT_527	[p11l1668t1654r1818b1677],
3	were	VBD	O	be	auxpass	4	SENT_527	[p11l1840t1662r1908b1677],
4	measured	VBN	O	measure	_	0	SENT_527	[p11l1932t1654r2070b1677],
5	from	IN	O	from	_	0	SENT_527	[p11l2093t1654r2163b1676],
6	all	DT	O	all	prep_from	4	SENT_527	[p11l2187t1654r2219b1677],
7	the	DT	O	the	det	9	SENT_527	[p11l2243t1654r2286b1677],
8	lymphedema	NN	O	lymphedema	nn	9	SENT_527	[p11l1277t1690r1462b1721],
9	patients	NNS	O	patient	tmod	6	SENT_527	[p11l1479t1690r1594b1721],
10	before	IN	O	before	advmod	9	SENT_527	[p11l1611t1690r1705b1713],
11	and	CC	O	and	_	0	SENT_527	[p11l1722t1690r1775b1713],
12	12	CD	DURATION	12	num	13	SENT_527	[p11l1795t1690r1824b1713],
13	mo	NN	DURATION	mo	prep_from	4	SENT_527	[p11l1842t1698r1886b1712],
14	after	IN	O	after	_	0	SENT_527	[p11l1904t1690r1972b1713],
15	treatment	NN	O	treatment	prep_after	13	SENT_527	[p11l1989t1695r2132b1713],
16	using	VBG	O	use	xcomp	4	SENT_527	[p11l2149t1690r2226b1721],
17	the	DT	O	the	det	24	SENT_527	[p11l2243t1690r2286b1713],
18	indirect	JJ	O	indirect	amod	24	SENT_527	[p11l1277t1725r1393b1748],
19	immunoﬂuorescence	NN	O	immunoﬂuorescence	nn	24	SENT_527	[p11l1418t1725r1728b1748],
20	antibody	NN	O	antibody	nn	24	SENT_527	[p11l1753t1725r1883b1756],
21	(	CD	NUMBER	(	num	24	SENT_527	[p11l1909t1725r1993b1754],
22	IIFA	NN	O	iifa	nn	24	SENT_527	[p11l1909t1725r1993b1754],
23	)	CD	NUMBER	)	num	24	SENT_527	[p11l1909t1725r1993b1754],
24	test	NN	O	test	dobj	16	SENT_527	[p11l2019t1730r2076b1748],
25	.	.	O	.	_	0	SENT_527	[p11l2019t1730r2076b1748],

1	For	IN	O	for	_	0	SENT_528	[p11l2102t1726r2153b1747],
2	antigen	NN	O	antigen	nn	3	SENT_528	[p11l2177t1725r2286b1756],
3	preparation	NN	O	preparation	prep_for	10	SENT_528	[p11l1277t1760r1457b1791],
4	,	,	O	,	_	0	SENT_528	[p11l1277t1760r1457b1791],
5	adult	JJ	O	adult	amod	8	SENT_528	[p11l1469t1760r1542b1783],
6	B.	NNP	O	B.	nn	8	SENT_528	[p11l1551t1761r1576b1782],
7	malayi	NN	O	malayus	nn	8	SENT_528	[p11l1588t1760r1672b1791],
8	males	NNS	O	male	nsubjpass	10	SENT_528	[p11l1682t1760r1762b1783],
9	were	VBD	O	be	auxpass	10	SENT_528	[p11l1772t1768r1840b1783],
10	recovered	VBN	O	recover	_	0	SENT_528	[p11l1851t1760r1994b1783],
11	6	CD	DURATION	6	num	14	SENT_528	[p11l2005t1760r2019b1782],
12	mo	NN	DURATION	mo	nn	14	SENT_528	[p11l2031t1768r2074b1782],
13	post	NN	O	post	nn	14	SENT_528	[p11l2086t1765r2146b1791],
14	infection	NN	O	infection	dobj	10	SENT_528	[p11l2157t1760r2287b1783],
15	from	IN	O	from	_	0	SENT_528	[p11l1276t1796r1347b1818],
16	Mastomys	NNPS	O	Mastomys	nn	17	SENT_528	[p11l1355t1797r1482b1827],
17	coucha	NN	O	coucha	prep_from	10	SENT_528	[p11l1491t1796r1582b1818],
18	.	.	O	.	_	0	SENT_528	[p11l1491t1796r1582b1818],

1	Parasites	NNS	O	parasite	nsubjpass	5	SENT_529	[p11l1594t1796r1720b1819],
2	were	VBD	O	be	auxpass	3	SENT_529	[p11l1729t1804r1797b1819],
3	washed	VBN	O	wash	_	0	SENT_529	[p11l1807t1796r1911b1819],
4	and	CC	O	and	_	0	SENT_529	[p11l1921t1796r1973b1819],
5	stored	VBN	O	store	conj_and	3	SENT_529	[p11l1983t1796r2073b1819],
6	at	IN	O	at	_	0	SENT_529	[p11l2083t1801r2109b1819],
7	4	CD	NUMBER	4	number	8	SENT_529	[p11l2119t1796r2134b1818],
8	°	CD	NUMBER	°	num	9	SENT_529	[p11l2143t1794r2175b1819],
9	C	NN	O	c	prep_at	3	SENT_529	[p11l2143t1794r2175b1819],
10	for	IN	O	for	_	0	SENT_529	[p11l2185t1796r2229b1818],
11	4	CD	NUMBER	4	num	12	SENT_529	[p11l2237t1796r2253b1818],
12	h.	NN	O	h.	prep_for	9	SENT_529	[p11l2262t1796r2286b1818],
13	They	PRP	O	they	nsubjpass	16	SENT_529	[p11l1276t1831r1347b1862],
14	were	VBD	O	be	auxpass	16	SENT_529	[p11l1366t1839r1434b1854],
15	then	RB	O	then	advmod	16	SENT_529	[p11l1455t1831r1519b1854],
16	placed	VBN	O	place	rcmod	12	SENT_529	[p11l1539t1831r1632b1862],
17	in	IN	O	in	_	0	SENT_529	[p11l1653t1831r1680b1853],
18	canine	JJ	O	canine	amod	19	SENT_529	[p11l1700t1831r1795b1854],
19	musculature	NN	O	musculature	prep_in	16	SENT_529	[p11l1816t1831r2001b1858],
20	,	,	O	,	_	0	SENT_529	[p11l1816t1831r2001b1858],
21	frozen	VBN	O	freeze	partmod	12	SENT_529	[p11l2021t1831r2120b1858],
22	,	,	O	,	_	0	SENT_529	[p11l2021t1831r2120b1858],
23	and	CC	O	and	_	0	SENT_529	[p11l2141t1831r2193b1854],
24	7-um	JJ	O	7-um	amod	25	SENT_529	[p11l2214t1829r2287b1860],
25	sections	NNS	O	section	nsubjpass	27	SENT_529	[p11l1277t1866r1390b1889],
26	were	VBD	O	be	auxpass	27	SENT_529	[p11l1402t1874r1470b1889],
27	prepared	VBN	O	prepare	conj_and	3	SENT_529	[p11l1482t1866r1615b1897],
28	and	CC	O	and	_	0	SENT_529	[p11l1627t1866r1680b1889],
29	transferred	VBN	O	transfer	conj_and	27	SENT_529	[p11l1692t1866r1855b1889],
30	onto	IN	O	onto	_	0	SENT_529	[p11l1867t1871r1933b1889],
31	glass	NN	O	glass	nn	32	SENT_529	[p11l1945t1866r2010b1897],
32	slides	NNS	O	slide	prep_onto	27	SENT_529	[p11l2022t1866r2106b1889],
33	.	.	O	.	_	0	SENT_529	[p11l2022t1866r2106b1889],

1	Quality	NNP	O	Quality	nsubjpass	3	SENT_530	[p11l2119t1866r2226b1897],
2	was	VBD	O	be	auxpass	3	SENT_530	[p11l2237t1874r2286b1889],
3	controlled	VBN	O	control	_	0	SENT_530	[p11l1276t1902r1426b1925],
4	by	IN	O	by	_	0	SENT_530	[p11l1437t1902r1469b1933],
5	using	VBG	O	use	agent	3	SENT_530	[p11l1480t1902r1557b1933],
6	a	DT	O	a	dobj	5	SENT_530	[p11l1567t1910r1581b1925],
7	deﬁned	VBN	O	deﬁned	partmod	6	SENT_530	[p11l1592t1902r1700b1925],
8	internal	JJ	O	internal	amod	14	SENT_530	[p11l1711t1902r1825b1925],
9	control	NN	O	control	nn	14	SENT_530	[p11l1836t1902r1941b1925],
10	serum	NN	O	serum	nn	14	SENT_530	[p11l1953t1910r2041b1925],
11	(	CD	NUMBER	(	num	14	SENT_530	[p11l2053t1902r2124b1931],
12	titer	NN	O	titer	nn	14	SENT_530	[p11l2053t1902r2124b1931],
13	1:320	CD	NUMBER	1:320	num	14	SENT_530	[p11l2137t1902r2226b1931],
14	)	NN	O	)	dobj	7	SENT_530	[p11l2137t1902r2226b1931],
15	.	.	O	.	_	0	SENT_530	[p11l2137t1902r2226b1931],

1	For	IN	O	for	_	0	SENT_531	[p11l2237t1903r2288b1924],
2	the	DT	O	the	det	4	SENT_531	[p11l1277t1937r1321b1960],
3	IIFA	NNP	O	IIFA	nn	4	SENT_531	[p11l1331t1937r1395b1959],
4	test	NN	O	test	prep_for	12	SENT_531	[p11l1406t1942r1462b1964],
5	,	,	O	,	_	0	SENT_531	[p11l1406t1942r1462b1964],
6	100	CD	NUMBER	100	number	7	SENT_531	[p11l1476t1937r1522b1959],
7	[	CD	NUMBER	[	num	8	SENT_531	[p11l1533t1937r1557b1966],
8	ll	NN	O	ll	nsubjpass	12	SENT_531	[p11l1533t1937r1557b1966],
9	of	IN	O	of	_	0	SENT_531	[p11l1568t1937r1599b1959],
10	plasma	NN	O	plasma	prep_of	8	SENT_531	[p11l1606t1937r1707b1968],
11	was	VBD	O	be	auxpass	12	SENT_531	[p11l1715t1945r1765b1960],
12	inactivated	VBN	O	inactivate	_	0	SENT_531	[p11l1776t1937r1935b1960],
13	at	IN	O	at	_	0	SENT_531	[p11l1946t1942r1971b1960],
14	56	CD	NUMBER	56	number	15	SENT_531	[p11l1982t1937r2014b1959],
15	°	CD	NUMBER	°	num	16	SENT_531	[p11l2023t1935r2055b1960],
16	C	NN	O	c	prep_at	12	SENT_531	[p11l2023t1935r2055b1960],
17	for	IN	O	for	_	0	SENT_531	[p11l2065t1937r2109b1959],
18	30	CD	DURATION	30	num	19	SENT_531	[p11l2119t1937r2150b1959],
19	min	NN	DURATION	min	prep_for	16	SENT_531	[p11l2161t1937r2223b1964],
20	,	,	O	,	_	0	SENT_531	[p11l2161t1937r2223b1964],
21	and	CC	O	and	_	0	SENT_531	[p11l2234t1937r2287b1960],
22	diluted	VBN	O	dilute	conj_and	12	SENT_531	[p11l1276t1972r1379b1995],
23	1:10	CD	TIME	1:10	dobj	22	SENT_531	[p11l1399t1972r1452b1994],
24	in	IN	O	in	_	0	SENT_531	[p11l1470t1972r1497b1994],
25	PBS	NNP	O	PBS	prep_in	22	SENT_531	[p11l1515t1972r1570b1995],
26	(	CD	NUMBER	(	num	25	SENT_531	[p11l1589t1973r1642b2003],
27	pH	NN	O	ph	nn	29	SENT_531	[p11l1589t1973r1642b2003],
28	7.2	CD	NUMBER	7.2	num	29	SENT_531	[p11l1661t1970r1716b2001],
29	)	NN	O	)	dobj	12	SENT_531	[p11l1661t1970r1716b2001],
30	.	.	O	.	_	0	SENT_531	[p11l1661t1970r1716b2001],

1	Seven-fold	JJ	O	seven-fold	amod	3	SENT_532	[p11l1734t1972r1887b1995],
2	serial	NN	O	serial	nn	3	SENT_532	[p11l1905t1972r1980b1995],
3	dilutions	NNS	O	dilution	nsubjpass	7	SENT_532	[p11l1998t1972r2125b1995],
4	to	TO	O	to	_	0	SENT_532	[p11l2143t1977r2170b1995],
5	121,280	CD	NUMBER	121,280	prep_to	3	SENT_532	[p11l2190t1972r2286b1999],
6	were	VBD	O	be	auxpass	7	SENT_532	[p11l1276t2015r1343b2030],
7	made	VBN	O	make	_	0	SENT_532	[p11l1355t2007r1432b2030],
8	from	IN	O	from	_	0	SENT_532	[p11l1443t2007r1513b2029],
9	the	DT	O	the	det	13	SENT_532	[p11l1525t2007r1569b2030],
10	initial	JJ	O	initial	amod	13	SENT_532	[p11l1581t2007r1665b2030],
11	1:10	CD	TIME	1:10	num	13	SENT_532	[p11l1680t2007r1733b2029],
12	screening	NN	O	screening	nn	13	SENT_532	[p11l1745t2007r1884b2038],
13	dilution	NN	O	dilution	prep_from	7	SENT_532	[p11l1894t2007r2016b2030],
14	.	.	O	.	_	0	SENT_532	[p11l1894t2007r2016b2030],

1	A	DT	O	a	det	4	SENT_533	[p11l2027t2007r2050b2029],
2	10	CD	NUMBER	10	num	4	SENT_533	[p11l2063t2007r2132b2036],
3	-	:	O	-	_	0	SENT_533	[p11l2063t2007r2132b2036],
4	]	CD	NUMBER	]	nsubjpass	28	SENT_533	[p11l2063t2007r2132b2036],
5	,	,	O	,	_	0	SENT_533	[p11l2063t2007r2132b2036],
6	ll	NN	O	ll	nn	7	SENT_533	[p11l2063t2007r2132b2036],
7	volume	NN	O	volume	appos	4	SENT_533	[p11l2142t2007r2248b2030],
8	of	IN	O	of	_	0	SENT_533	[p11l2259t2007r2290b2029],
9	each	DT	O	each	prep_of	7	SENT_533	[p11l1276t2043r1341b2066],
10	of	IN	O	of	_	0	SENT_533	[p11l1359t2043r1390b2065],
11	the	DT	O	the	det	13	SENT_533	[p11l1405t2043r1448b2066],
12	diluted	VBN	O	dilute	amod	13	SENT_533	[p11l1466t2043r1568b2066],
13	samples	NNS	O	sample	prep_of	9	SENT_533	[p11l1586t2043r1698b2074],
14	was	VBD	O	be	auxpass	15	SENT_533	[p11l1715t2051r1764b2066],
15	added	VBN	O	add	_	0	SENT_533	[p11l1782t2043r1869b2066],
16	to	TO	O	to	aux	17	SENT_533	[p11l1888t2048r1914b2066],
17	separate	VB	O	separate	xcomp	15	SENT_533	[p11l1933t2048r2053b2074],
18	wells	NNS	O	well	dobj	17	SENT_533	[p11l2070t2043r2138b2066],
19	on	IN	O	on	_	0	SENT_533	[p11l2156t2051r2192b2065],
20	slides	NNS	O	slide	prep_on	17	SENT_533	[p11l2210t2043r2286b2066],
21	containing	VBG	O	contain	partmod	20	SENT_533	[p11l1276t2078r1433b2109],
22	the	DT	O	the	det	25	SENT_533	[p11l1445t2078r1489b2101],
23	B.	NNP	MISC	B.	nn	25	SENT_533	[p11l1501t2079r1526b2100],
24	malayi	NN	O	malayus	nn	25	SENT_533	[p11l1540t2078r1624b2109],
25	antigens	NNS	O	antigen	dobj	21	SENT_533	[p11l1636t2078r1763b2109],
26	,	,	O	,	_	0	SENT_533	[p11l1636t2078r1763b2109],
27	and	CC	O	and	_	0	SENT_533	[p11l1777t2078r1829b2101],
28	incubated	VBN	O	incubate	conj_and	15	SENT_533	[p11l1843t2078r1986b2101],
29	at	IN	O	at	_	0	SENT_533	[p11l1999t2083r2024b2101],
30	37	CD	NUMBER	37	number	31	SENT_533	[p11l2038t2076r2069b2100],
31	°	CD	NUMBER	°	num	32	SENT_533	[p11l2081t2076r2113b2101],
32	C	NN	O	c	prep_at	28	SENT_533	[p11l2081t2076r2113b2101],
33	in	IN	O	in	_	0	SENT_533	[p11l2127t2078r2154b2100],
34	a	DT	O	a	det	36	SENT_533	[p11l2167t2086r2181b2101],
35	humid	JJ	O	humid	amod	36	SENT_533	[p11l2194t2078r2287b2101],
36	chamber	NN	O	chamber	prep_in	28	SENT_533	[p11l1276t2113r1403b2136],
37	for	IN	O	for	_	0	SENT_533	[p11l1423t2113r1466b2135],
38	45	CD	DURATION	45	num	39	SENT_533	[p11l1486t2113r1519b2135],
39	min	NN	DURATION	min	prep_for	36	SENT_533	[p11l1540t2113r1602b2135],
40	.	.	O	.	_	0	SENT_533	[p11l1540t2113r1602b2135],

1	After	IN	O	after	_	0	SENT_534	[p11l1623t2113r1700b2136],
2	the	DT	O	the	det	3	SENT_534	[p11l1721t2113r1764b2136],
3	incubation	NN	O	incubation	prep_after	9	SENT_534	[p11l1786t2113r1950b2140],
4	,	,	O	,	_	0	SENT_534	[p11l1786t2113r1950b2140],
5	the	DT	O	the	det	7	SENT_534	[p11l1972t2113r2016b2136],
6	IIFA	NNP	O	IIFA	nn	7	SENT_534	[p11l2037t2113r2101b2135],
7	slides	NNS	O	slide	nsubjpass	9	SENT_534	[p11l2121t2113r2198b2136],
8	were	VBD	O	be	auxpass	9	SENT_534	[p11l2219t2121r2286b2136],
9	washed	VBN	O	wash	_	0	SENT_534	[p11l1276t2149r1380b2172],
10	four	CD	NUMBER	four	number	11	SENT_534	[p11l1393t2149r1456b2171],
11	times	NNS	O	time	dobj	9	SENT_534	[p11l1470t2149r1545b2172],
12	for	IN	O	for	_	0	SENT_534	[p11l1559t2149r1603b2171],
13	20	CD	DURATION	20	num	14	SENT_534	[p11l1616t2149r1647b2172],
14	min	NN	DURATION	min	prep_for	11	SENT_534	[p11l1663t2149r1718b2171],
15	(	CD	NUMBER	(	number	16	SENT_534	[p11l1733t2149r1778b2178],
16	3	CD	NUMBER	3	num	17	SENT_534	[p11l1733t2149r1778b2178],
17	>	JJR	O	>	npadvmod	18	SENT_534	[p11l1733t2149r1778b2178],
18	<	JJR	O	<	amod	11	SENT_534	[p11l1733t2149r1778b2178],
19	in	IN	O	in	_	0	SENT_534	[p11l1793t2149r1820b2171],
20	0.1	CD	NUMBER	0.1	num	22	SENT_534	[p11l1834t2149r1902b2171],
21	M	NN	O	m	nn	22	SENT_534	[p11l1834t2149r1902b2171],
22	PBS	NNP	O	PBS	prep_in	18	SENT_534	[p11l1917t2149r1973b2172],
23	and	CC	O	and	_	0	SENT_534	[p11l1988t2149r2040b2172],
24	IX	CD	NUMBER	ix	conj_and	22	SENT_534	[p11l2058t2149r2091b2171],
25	in	IN	O	in	_	0	SENT_534	[p11l2105t2149r2132b2171],
26	deionized	JJ	O	deionized	amod	28	SENT_534	[p11l2146t2149r2287b2172],
27	water	NN	O	water	nn	28	SENT_534	[p11l1276t2185r1374b2213],
28	)	NN	O	)	prep_in	9	SENT_534	[p11l1276t2185r1374b2213],
29	.	.	O	.	_	0	SENT_534	[p11l1276t2185r1374b2213],

1	A	DT	O	a	det	3	SENT_535	[p11l1399t2184r1421b2206],
2	ﬂuorescein	NN	O	ﬂuorescein	nn	3	SENT_535	[p11l1445t2184r1727b2207],
3	—	NN	O	—	nsubjpass	28	SENT_535	[p11l1445t2184r1727b2207],
4	labeled	VBN	O	label	partmod	3	SENT_535	[p11l1445t2184r1727b2207],
5	anti-total	JJ	O	anti-total	amod	7	SENT_535	[p11l1752t2184r1888b2207],
6	human	JJ	O	human	amod	7	SENT_535	[p11l1914t2184r2015b2207],
7	immunoglobulin	NN	O	immunoglobulin	dobj	4	SENT_535	[p11l2041t2184r2286b2215],
8	(	CD	NUMBER	(	num	9	SENT_535	[p11l1277t2219r1451b2247],
9	Fluoline-H	NN	O	fluoline-h	dep	7	SENT_535	[p11l1277t2219r1451b2247],
10	;	:	O	;	_	0	SENT_535	[p11l1277t2219r1451b2247],
11	bioMerieux	NNP	O	bioMerieux	dep	7	SENT_535	[p11l1465t2219r1639b2246],
12	,	,	O	,	_	0	SENT_535	[p11l1465t2219r1639b2246],
13	Marcy	NNP	PERSON	Marcy	nn	14	SENT_535	[p11l1654t2220r1742b2250],
14	l’Etoile	NNP	PERSON	l’Etoile	appos	11	SENT_535	[p11l1756t2219r1863b2246],
15	,	,	O	,	_	0	SENT_535	[p11l1756t2219r1863b2246],
16	France	NNP	LOCATION	France	appos	11	SENT_535	[p11l1878t2220r1986b2248],
17	)	CD	NUMBER	)	num	16	SENT_535	[p11l1878t2220r1986b2248],
18	diluted	VBN	O	dilute	partmod	16	SENT_535	[p11l2000t2219r2102b2242],
19	1:90	CD	NUMBER	1:90	dobj	18	SENT_535	[p11l2120t2219r2173b2241],
20	in	IN	O	in	_	0	SENT_535	[p11l2189t2219r2215b2241],
21	PBS	NNP	O	PBS	prep_in	18	SENT_535	[p11l2230t2219r2286b2242],
22	was	VBD	O	be	auxpass	23	SENT_535	[p11l1276t2263r1325b2278],
23	applied	VBN	O	apply	_	0	SENT_535	[p11l1336t2255r1444b2286],
24	to	TO	O	to	_	0	SENT_535	[p11l1455t2260r1481b2278],
25	each	DT	O	each	prep_to	23	SENT_535	[p11l1492t2255r1557b2278],
26	well	RB	O	well	advmod	23	SENT_535	[p11l1567t2255r1623b2278],
27	and	CC	O	and	_	0	SENT_535	[p11l1633t2255r1686b2278],
28	incubated	VBN	O	incubate	conj_and	23	SENT_535	[p11l1697t2255r1840b2278],
29	for	IN	O	for	_	0	SENT_535	[p11l1849t2255r1893b2277],
30	45	CD	DURATION	45	num	31	SENT_535	[p11l1902t2255r1935b2277],
31	min	NN	DURATION	min	prep_for	28	SENT_535	[p11l1946t2255r2001b2277],
32	at	IN	O	at	_	0	SENT_535	[p11l2011t2260r2037b2278],
33	37	CD	NUMBER	37	number	34	SENT_535	[p11l2048t2253r2079b2277],
34	°	CD	NUMBER	°	num	35	SENT_535	[p11l2089t2253r2121b2278],
35	C	NN	O	c	prep_at	31	SENT_535	[p11l2089t2253r2121b2278],
36	in	IN	O	in	_	0	SENT_535	[p11l2132t2255r2159b2277],
37	a	DT	O	a	det	39	SENT_535	[p11l2170t2263r2184b2278],
38	humid	JJ	O	humid	amod	39	SENT_535	[p11l2194t2255r2287b2278],
39	chamber	NN	O	chamber	prep_in	28	SENT_535	[p11l1276t2290r1409b2313],
40	.	.	O	.	_	0	SENT_535	[p11l1276t2290r1409b2313],

1	The	DT	O	the	det	2	SENT_536	[p11l1423t2290r1478b2313],
2	slides	NNS	O	slide	nsubjpass	4	SENT_536	[p11l1492t2290r1569b2313],
3	were	VBD	O	be	auxpass	4	SENT_536	[p11l1582t2298r1650b2313],
4	washed	VBN	O	wash	_	0	SENT_536	[p11l1663t2290r1768b2313],
5	four	CD	NUMBER	four	number	6	SENT_536	[p11l1780t2290r1843b2312],
6	times	NNS	O	time	dobj	4	SENT_536	[p11l1856t2290r1932b2313],
7	for	IN	O	for	_	0	SENT_536	[p11l1945t2290r1989b2312],
8	20	CD	DURATION	20	num	9	SENT_536	[p11l2002t2290r2033b2313],
9	min	NN	DURATION	min	prep_for	6	SENT_536	[p11l2048t2290r2103b2312],
10	(	CD	NUMBER	(	number	11	SENT_536	[p11l2118t2290r2163b2319],
11	3	CD	NUMBER	3	num	12	SENT_536	[p11l2118t2290r2163b2319],
12	>	JJR	O	>	npadvmod	13	SENT_536	[p11l2118t2290r2163b2319],
13	<	JJR	O	<	amod	6	SENT_536	[p11l2118t2290r2163b2319],
14	in	IN	O	in	_	0	SENT_536	[p11l2178t2290r2204b2312],
15	0.1	CD	NUMBER	0.1	num	17	SENT_536	[p11l2218t2290r2286b2312],
16	M	NN	O	m	nn	17	SENT_536	[p11l2218t2290r2286b2312],
17	PBS	NNP	O	PBS	prep_in	13	SENT_536	[p11l1277t2325r1333b2348],
18	and	CC	O	and	_	0	SENT_536	[p11l1348t2325r1400b2348],
19	1X	NNP	O	1X	prep_in	13	SENT_536	[p11l1418t2325r1450b2347],
20	in	IN	O	in	_	0	SENT_536	[p11l1466t2325r1492b2347],
21	deionized	JJ	O	deionized	amod	23	SENT_536	[p11l1507t2325r1647b2348],
22	water	NN	O	water	nn	23	SENT_536	[p11l1661t2326r1757b2354],
23	)	NN	O	)	prep_in	4	SENT_536	[p11l1661t2326r1757b2354],
24	.	.	O	.	_	0	SENT_536	[p11l1661t2326r1757b2354],

1	Excess	JJ	O	excess	amod	2	SENT_537	[p11l1772t2326r1863b2348],
2	water	NN	O	water	nsubjpass	4	SENT_537	[p11l1877t2330r1958b2348],
3	was	VBD	O	be	auxpass	4	SENT_537	[p11l1970t2333r2020b2348],
4	removed	VBN	O	remove	_	0	SENT_537	[p11l2035t2325r2161b2348],
5	and	CC	O	and	_	0	SENT_537	[p11l2175t2325r2227b2348],
6	the	DT	O	the	det	7	SENT_537	[p11l2243t2325r2286b2348],
7	slides	NNS	O	slide	nsubj	8	SENT_537	[p11l1277t2361r1353b2384],
8	dried	VBD	O	dry	conj_and	4	SENT_537	[p11l1367t2361r1450b2388],
9	,	,	O	,	_	0	SENT_537	[p11l1367t2361r1450b2388],
10	covered	VBN	O	cover	dep	8	SENT_537	[p11l1463t2361r1576b2384],
11	with	IN	O	with	_	0	SENT_537	[p11l1589t2361r1651b2384],
12	glycerol	NN	O	glycerol	nn	14	SENT_537	[p11l1664t2361r1777b2392],
13	(	CD	NUMBER	(	num	14	SENT_537	[p11l1791t2361r1981b2390],
14	Euroimmun	NNP	PERSON	Euroimmun	prep_with	10	SENT_537	[p11l1791t2361r1981b2390],
15	,	,	O	,	_	0	SENT_537	[p11l1791t2361r1981b2390],
16	Luebeck	NNP	LOCATION	Luebeck	conj_and	14	SENT_537	[p11l1995t2361r2123b2388],
17	,	,	O	,	_	0	SENT_537	[p11l1995t2361r2123b2388],
18	Germany	NNP	LOCATION	Germany	nn	19	SENT_537	[p11l2137t2361r2286b2392],
19	)	NNP	O	)	prep_with	10	SENT_537	[p11l2137t2361r2286b2392],
20	,	,	O	,	_	0	SENT_537	[p11l2137t2361r2286b2392],
21	and	CC	O	and	_	0	SENT_537	[p11l1277t2396r1329b2419],
22	cover	NN	O	cover	nn	23	SENT_537	[p11l1347t2404r1426b2419],
23	slides	NNS	O	slide	conj_and	14	SENT_537	[p11l1443t2396r1527b2419],
24	.	.	O	.	_	0	SENT_537	[p11l1443t2396r1527b2419],

1	Wells	NNP	PERSON	Wells	nsubjpass	3	SENT_538	[p11l1545t2396r1621b2419],
2	were	VBD	O	be	auxpass	3	SENT_538	[p11l1639t2404r1706b2419],
3	observed	VBN	O	observe	_	0	SENT_538	[p11l1724t2396r1853b2419],
4	with	IN	O	with	_	0	SENT_538	[p11l1870t2396r1932b2419],
5	a	DT	O	a	det	7	SENT_538	[p11l1950t2404r1964b2419],
6	immunoﬂuorescence	NN	O	immunoﬂuorescence	nn	7	SENT_538	[p11l1982t2396r2286b2419],
7	microscope	NN	O	microscope	prep_with	3	SENT_538	[p11l1277t2431r1443b2462],
8	(	CD	NUMBER	(	tmod	3	SENT_538	[p11l1460t2432r1545b2460],
9	Ernst	NNP	PERSON	Ernst	nn	14	SENT_538	[p11l1460t2432r1545b2460],
10	Leitz	NNP	PERSON	Leitz	nn	14	SENT_538	[p11l1560t2431r1637b2458],
11	,	,	O	,	_	0	SENT_538	[p11l1560t2431r1637b2458],
12	Wetzlar	NNP	PERSON	Wetzlar	appos	14	SENT_538	[p11l1653t2431r1771b2458],
13	,	,	O	,	_	0	SENT_538	[p11l1653t2431r1771b2458],
14	Germany	NNP	LOCATION	Germany	dep	8	SENT_538	[p11l1787t2431r1936b2462],
15	)	CD	NUMBER	)	num	14	SENT_538	[p11l1787t2431r1936b2462],
16	.	.	O	.	_	0	SENT_538	[p11l1787t2431r1936b2462],

1	Fluorescence	NN	O	fluorescence	nsubjpass	16	SENT_539	[p11l1953t2431r2142b2454],
2	of	IN	O	of	_	0	SENT_539	[p11l2158t2431r2189b2453],
3	either	CC	O	either	advmod	7	SENT_539	[p11l2201t2431r2288b2454],
4	the	DT	O	the	det	7	SENT_539	[p11l1277t2467r1321b2490],
5	complete	JJ	O	complete	amod	7	SENT_539	[p11l1333t2467r1466b2498],
6	worm	NN	O	worm	nn	7	SENT_539	[p11l1477t2475r1559b2489],
7	section	NN	O	section	prep_of	1	SENT_539	[p11l1571t2467r1673b2490],
8	including	VBG	O	include	_	0	SENT_539	[p11l1685t2467r1822b2498],
9	mesenchym	NN	O	mesenchym	prep_including	7	SENT_539	[p11l1833t2467r2001b2498],
10	and	CC	O	and	_	0	SENT_539	[p11l2013t2467r2065b2490],
11	cuticle	NN	O	cuticle	prep_including	7	SENT_539	[p11l2077t2467r2172b2490],
12	or	CC	O	or	_	0	SENT_539	[p11l2183t2475r2215b2489],
13	only	RB	O	only	advmod	14	SENT_539	[p11l2226t2467r2287b2498],
14	mesenchym	NN	O	mesenchym	prep_including	7	SENT_539	[p11l1277t2502r1445b2533],
15	was	VBD	O	be	auxpass	16	SENT_539	[p11l1458t2510r1508b2525],
16	deﬁned	VBN	O	deﬁned	_	0	SENT_539	[p11l1521t2502r1629b2525],
17	as	IN	O	as	_	0	SENT_539	[p11l1643t2510r1668b2525],
18	positive	JJ	O	positive	prep_as	16	SENT_539	[p11l1683t2502r1801b2533],
19	.	.	O	.	_	0	SENT_539	[p11l1683t2502r1801b2533],

1	Fluorescence	NN	O	fluorescence	nsubjpass	8	SENT_540	[p11l1815t2502r2004b2525],
2	of	IN	O	of	_	0	SENT_540	[p11l2018t2502r2049b2524],
3	the	DT	O	the	det	4	SENT_540	[p11l2060t2502r2104b2525],
4	mesenchym	NN	O	mesenchym	prep_of	1	SENT_540	[p11l2118t2502r2287b2533],
5	without	IN	O	without	_	0	SENT_540	[p11l1276t2537r1387b2560],
6	cuticle	NN	O	cuticle	prep_without	4	SENT_540	[p11l1398t2537r1493b2560],
7	was	VBD	O	be	auxpass	8	SENT_540	[p11l1503t2545r1552b2560],
8	regarded	VBN	O	regard	_	0	SENT_540	[p11l1564t2537r1693b2568],
9	as	IN	O	as	_	0	SENT_540	[p11l1703t2545r1729b2560],
10	non-speciﬁc	JJ	O	non-speciﬁc	prep_as	8	SENT_540	[p11l1741t2537r1923b2568],
11	.	.	O	.	_	0	SENT_540	[p11l1741t2537r1923b2568],

1	A	DT	O	a	det	2	SENT_541	[p11l1934t2537r1956b2559],
2	titer	NN	O	titer	nsubjpass	13	SENT_541	[p11l1967t2537r2029b2560],
3	of	IN	O	of	_	0	SENT_541	[p11l2039t2537r2070b2559],
4	nore	NN	O	nore	prep_of	2	SENT_541	[p11l2078t2545r2143b2560],
5	than	IN	O	than	_	0	SENT_541	[p11l2155t2537r2219b2560],
6	1:80	CD	NUMBER	1:80	number	7	SENT_541	[p11l2233t2537r2286b2559],
7	(	CD	NUMBER	(	prep_than	4	SENT_541	[p11l1277t2572r1424b2603],
8	including	VBG	O	include	_	0	SENT_541	[p11l1277t2572r1424b2603],
9	cuticle	NN	O	cuticle	nn	11	SENT_541	[p11l1435t2572r1530b2595],
10	ﬂuorescence	NN	O	ﬂuorescence	nn	11	SENT_541	[p11l1541t2572r1733b2601],
11	)	NN	O	)	prep_including	7	SENT_541	[p11l1541t2572r1733b2601],
12	was	VBD	O	be	auxpass	13	SENT_541	[p11l1744t2580r1794b2595],
13	regarded	VBN	O	regard	_	0	SENT_541	[p11l1807t2572r1936b2603],
14	as	IN	O	as	_	0	SENT_541	[p11l1948t2580r1974b2595],
15	indicative	JJ	O	indicative	prep_as	13	SENT_541	[p11l1987t2572r2128b2595],
16	for	IN	O	for	_	0	SENT_541	[p11l2139t2572r2183b2594],
17	ﬁlarial	JJ	O	ﬁlarial	amod	18	SENT_541	[p11l2193t2572r2286b2595],
18	infection	NN	O	infection	prep_for	13	SENT_541	[p11l1277t2608r1414b2631],
19	.	.	O	.	_	0	SENT_541	[p11l1277t2608r1414b2631],

1	A	DT	O	a	det	2	SENT_542	[p11l1426t2608r1449b2630],
2	titer	NN	O	titer	nsubjpass	10	SENT_542	[p11l1462t2608r1524b2631],
3	equal	JJ	O	equal	amod	2	SENT_542	[p11l1535t2608r1612b2639],
4	to	TO	O	to	_	0	SENT_542	[p11l1626t2613r1652b2631],
5	or	CC	O	or	cc	6	SENT_542	[p11l1666t2616r1697b2630],
6	less	JJR	O	less	prep_to	3	SENT_542	[p11l1709t2608r1757b2631],
7	than	IN	O	than	_	0	SENT_542	[p11l1770t2608r1834b2631],
8	1:20	CD	TIME	1:20	prep_than	6	SENT_542	[p11l1850t2608r1903b2631],
9	was	VBD	O	be	auxpass	10	SENT_542	[p11l1916t2616r1965b2631],
10	regarded	VBN	O	regard	_	0	SENT_542	[p11l1979t2608r2108b2639],
11	as	IN	O	as	_	0	SENT_542	[p11l2120t2616r2146b2631],
12	negative	JJ	O	negative	prep_as	10	SENT_542	[p11l2160t2608r2286b2639],
13	.	.	O	.	_	0	SENT_542	[p11l2160t2608r2286b2639],

1	Positive	JJ	O	positive	amod	4	SENT_543	[p11l1277t2643r1388b2666],
2	and	CC	O	and	_	0	SENT_543	[p11l1403t2643r1455b2666],
3	negative	JJ	O	negative	conj_and	1	SENT_543	[p11l1470t2643r1589b2674],
4	controls	NNS	O	control	nsubjpass	6	SENT_543	[p11l1603t2643r1720b2666],
5	were	VBD	O	be	auxpass	6	SENT_543	[p11l1734t2651r1802b2666],
6	included	VBN	O	include	_	0	SENT_543	[p11l1817t2643r1941b2666],
7	in	IN	O	in	_	0	SENT_543	[p11l1956t2643r1983b2665],
8	the	DT	O	the	det	9	SENT_543	[p11l1998t2643r2041b2666],
9	test	NN	O	test	prep_in	6	SENT_543	[p11l2056t2648r2112b2666],
10	.	.	O	.	_	0	SENT_543	[p11l2056t2648r2112b2666],

1	This	DT	O	this	det	2	SENT_544	[p11l2126t2643r2188b2665],
2	test	NN	O	test	nsubjpass	4	SENT_544	[p11l2203t2648r2253b2666],
3	is	VBZ	O	be	auxpass	4	SENT_544	[p11l2267t2643r2286b2666],
4	validated	VBN	O	validate	_	0	SENT_544	[p11l1276t2679r1408b2702],
5	in	IN	O	in	_	0	SENT_544	[p11l1422t2679r1449b2701],
6	regular	JJ	O	regular	amod	7	SENT_544	[p11l1463t2679r1567b2710],
7	intervals	NNS	O	interval	prep_in	4	SENT_544	[p11l1580t2679r1702b2702],
8	within	IN	O	within	_	0	SENT_544	[p11l1716t2679r1808b2702],
9	a	DT	O	a	det	11	SENT_544	[p11l1822t2687r1836b2702],
10	German	JJ	MISC	german	amod	11	SENT_544	[p11l1850t2679r1966b2702],
11	network	NN	O	network	prep_within	4	SENT_544	[p11l1981t2679r2098b2702],
12	of	IN	O	of	_	0	SENT_544	[p11l2112t2679r2143b2701],
13	laboratories	NNS	O	laboratory	prep_of	11	SENT_544	[p11l2154t2679r2286b2702, p11l1277t2714r1327b2737],
14	for	IN	O	for	_	0	SENT_544	[p11l1340t2714r1383b2736],
15	quality	NN	O	quality	nn	16	SENT_544	[p11l1396t2714r1494b2745],
16	control	NN	O	control	prep_for	13	SENT_544	[p11l1507t2714r1619b2737],
17	.	.	O	.	_	0	SENT_544	[p11l1507t2714r1619b2737],

1	Determination	NN	O	determination	_	0	SENT_545	[p11l1313t2749r1525b2772],
2	of	IN	O	of	_	0	SENT_545	[p11l1540t2749r1570b2771],
3	plasma	NN	O	plasma	nn	4	SENT_545	[p11l1582t2749r1684b2780],
4	levels	NNS	O	level	prep_of	1	SENT_545	[p11l1698t2749r1778b2772],
5	of	IN	O	of	_	0	SENT_545	[p11l1793t2749r1823b2771],
6	VEGF-C	NN	O	vegf-c	prep_of	1	SENT_545	[p11l1835t2749r1953b2772],
7	and	CC	O	and	_	0	SENT_545	[p11l1969t2749r2022b2772],
8	SVEGFR-3	NN	O	svegfr-3	prep_of	1	SENT_545	[p11l2036t2749r2193b2772],
9	.	.	O	.	_	0	SENT_545	[p11l2036t2749r2193b2772],

1	In	IN	O	in	_	0	SENT_546	[p11l2209t2750r2239b2771],
2	all	DT	O	all	det	3	SENT_546	[p11l2254t2749r2286b2772],
3	patients	NNS	O	patient	prep_in	13	SENT_546	[p11l1277t2784r1399b2815],
4	,	,	O	,	_	0	SENT_546	[p11l1277t2784r1399b2815],
5	the	DT	O	the	det	7	SENT_546	[p11l1414t2784r1458b2807],
6	plasma	NN	O	plasma	nn	7	SENT_546	[p11l1472t2784r1573b2815],
7	concentrations	NNS	O	concentration	nsubjpass	13	SENT_546	[p11l1586t2784r1803b2807],
8	of	IN	O	of	_	0	SENT_546	[p11l1818t2784r1849b2806],
9	VEGF-C	NN	O	vegf-c	prep_of	7	SENT_546	[p11l1859t2784r1977b2807],
10	and	CC	O	and	_	0	SENT_546	[p11l1992t2784r2044b2807],
11	sVEGFR-3	NN	O	svegfr-3	prep_of	7	SENT_546	[p11l2059t2784r2205b2807],
12	were	VBD	O	be	auxpass	13	SENT_546	[p11l2219t2792r2286b2807],
13	measured	VBN	O	measure	_	0	SENT_546	[p11l1277t2820r1416b2843],
14	using	VBG	O	use	xcomp	13	SENT_546	[p11l1426t2820r1502b2851],
15	Quantikine	NN	O	quantikine	nn	18	SENT_546	[p11l1512t2820r1675b2850],
16	immunoassay	NN	O	immunoassay	nn	18	SENT_546	[p11l1686t2820r1881b2851],
17	ELISA	NN	O	elisa	nn	18	SENT_546	[p11l1890t2820r1982b2843],
18	kits	NNS	O	kit	dobj	14	SENT_546	[p11l1991t2820r2040b2843],
19	according	VBG	O	accord	_	0	SENT_546	[p11l2051t2820r2195b2851],
20	to	TO	O	to	prepc_according_to	14	SENT_546	[p11l2204t2825r2231b2843],
21	the	DT	O	the	det	22	SENT_546	[p11l2243t2820r2286b2843],
22	manufacturer	NN	O	manufacturer	poss	24	SENT_546	[p11l1277t2855r1499b2878],
23	’s	POS	O	’s	_	0	SENT_546	[p11l1277t2855r1499b2878],
24	instructions	NNS	O	instruction	pobj	14	SENT_546	[p11l1525t2855r1700b2878],
25	(	CD	NUMBER	(	num	27	SENT_546	[p11l1727t2855r1804b2884],
26	R&D	NNP	O	R&D	nn	27	SENT_546	[p11l1727t2855r1804b2884],
27	Systems	NNPS	O	Systems	dep	24	SENT_546	[p11l1830t2855r1961b2886],
28	)	NN	O	)	dep	27	SENT_546	[p11l1830t2855r1961b2886],
29	.	.	O	.	_	0	SENT_546	[p11l1830t2855r1961b2886],

1	After	IN	O	after	_	0	SENT_547	[p11l1986t2855r2064b2878],
2	stopping	VBG	O	stop	prepc_after	8	SENT_547	[p11l2088t2855r2217b2886],
3	the	DT	O	the	det	4	SENT_547	[p11l2242t2855r2286b2878],
4	reaction	NN	O	reaction	dobj	2	SENT_547	[p11l1277t2890r1403b2917],
5	,	,	O	,	_	0	SENT_547	[p11l1277t2890r1403b2917],
6	plates	NNS	O	plate	nsubjpass	8	SENT_547	[p11l1418t2890r1501b2921],
7	were	VBD	O	be	auxpass	8	SENT_547	[p11l1514t2898r1582b2913],
8	read	VBN	O	read	_	0	SENT_547	[p11l1597t2890r1659b2913],
9	at	IN	O	at	_	0	SENT_547	[p11l1674t2895r1699b2913],
10	450	CD	NUMBER	450	num	11	SENT_547	[p11l1713t2890r1762b2912],
11	nm	NN	O	nm	prep_at	8	SENT_547	[p11l1777t2898r1822b2912],
12	and	CC	O	and	_	0	SENT_547	[p11l1837t2890r1889b2913],
13	540	CD	NUMBER	540	num	14	SENT_547	[p11l1904t2890r1952b2912],
14	nm	NN	O	nm	conj_and	11	SENT_547	[p11l1967t2898r2012b2912],
15	with	IN	O	with	_	0	SENT_547	[p11l2025t2890r2087b2913],
16	a	DT	O	a	det	21	SENT_547	[p11l2101t2898r2116b2912],
17	microplate	JJ	O	microplate	amod	21	SENT_547	[p11l2130t2890r2286b2921],
18	reader	NN	O	reader	nn	21	SENT_547	[p11l1277t2926r1371b2949],
19	(	CD	NUMBER	(	num	21	SENT_547	[p11l1386t2926r1603b2955],
20	SPECTRAmax	NN	O	spectramax	nn	21	SENT_547	[p11l1386t2926r1603b2955],
21	340PC	NN	O	340pc	prep_with	8	SENT_547	[p11l1618t2926r1717b2953],
22	;	:	O	;	_	0	SENT_547	[p11l1618t2926r1717b2953],
23	Sunnyvale	NNP	LOCATION	Sunnyvale	nn	25	SENT_547	[p11l1732t2926r1886b2957],
24	,	,	O	,	_	0	SENT_547	[p11l1732t2926r1886b2957],
25	California	NNP	LOCATION	California	dep	21	SENT_547	[p11l1902t2926r2055b2953],
26	,	,	O	,	_	0	SENT_547	[p11l1902t2926r2055b2953],
27	United	NNP	LOCATION	United	nn	29	SENT_547	[p11l2071t2926r2170b2949],
28	States	NNPS	LOCATION	States	nn	29	SENT_547	[p11l2185t2926r2286b2955],
29	)	NN	O	)	appos	25	SENT_547	[p11l2185t2926r2286b2955],
30	.	.	O	.	_	0	SENT_547	[p11l2185t2926r2286b2955],

1	Twenty-three	CD	NUMBER	twenty-three	num	3	SENT_548	[p11l1276t2961r1470b2992],
2	endemic	JJ	O	endemic	amod	3	SENT_548	[p11l1487t2961r1608b2984],
3	normals	NNS	O	normal	_	0	SENT_548	[p11l1626t2961r1749b2988],
4	,	,	O	,	_	0	SENT_548	[p11l1626t2961r1749b2988],
5	i.e.	FW	O	i.e.	appos	3	SENT_548	[p11l1766t2961r1811b2988],
6	,	,	O	,	_	0	SENT_548	[p11l1766t2961r1811b2988],
7	residents	NNS	O	resident	appos	3	SENT_548	[p11l1828t2961r1957b2984],
8	of	IN	O	of	_	0	SENT_548	[p11l1973t2961r2004b2983],
9	the	DT	O	the	det	12	SENT_548	[p11l2017t2961r2061b2984],
10	same	JJ	O	same	amod	12	SENT_548	[p11l2077t2969r2148b2984],
11	endemic	JJ	O	endemic	amod	12	SENT_548	[p11l2164t2961r2286b2984],
12	area	NN	O	area	prep_of	7	SENT_548	[p11l1277t3004r1338b3019],
13	with	IN	O	with	dep	3	SENT_548	[p11l1362t2996r1425b3019],
14	no	DT	O	no	det	15	SENT_548	[p11l1450t3004r1485b3018],
15	evidence	NN	O	evidence	pobj	13	SENT_548	[p11l1511t2996r1638b3019],
16	of	IN	O	of	_	0	SENT_548	[p11l1664t2996r1695b3018],
17	infection	NN	O	infection	prep_of	15	SENT_548	[p11l1717t2996r1849b3019],
18	conﬁrmed	VBN	O	conﬁrmed	partmod	17	SENT_548	[p11l1874t2996r2025b3019],
19	by	IN	O	by	_	0	SENT_548	[p11l2049t2996r2082b3027],
20	the	DT	O	the	det	21	SENT_548	[p11l2107t2996r2152b3019],
21	lack	NN	O	lack	agent	18	SENT_548	[p11l2177t2996r2233b3019],
22	of	IN	O	of	prep	21	SENT_548	[p11l2258t2996r2289b3018],

1	`	``	O	`	_	0	SENT_549	[p12l188t3077r261b3136],
2	_	NN	O	_	_	0	SENT_549	[p12l188t3077r261b3136],
3	:	:	O	:	_	0	SENT_549	[p12l188t3077r261b3136],
4	PLoS	NN	O	plo	nsubj	5	SENT_549	[p12l288t3093r352b3116],
5	Pathogens	VBD	O	pathogen	dep	2	SENT_549	[p12l367t3092r511b3123],
6	|	CD	NUMBER	|	num	7	SENT_549	[p12l526t3091r528b3124],
7	www	NN	O	www	dobj	5	SENT_549	[p12l543t3092r882b3123],
8	.	.	O	.	_	0	SENT_549	[p12l543t3092r882b3123],

1	p	NN	O	p	nn	3	SENT_550	[p12l543t3092r882b3123],
2	|	CD	NUMBER	|	num	3	SENT_550	[p12l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	_	0	SENT_550	[p12l543t3092r882b3123],
4	0840	CD	DATE	0840	num	7	SENT_550	[p12l1205t3094r1270b3116],
5	September	NNP	DATE	September	nn	7	SENT_550	[p12l1685t3092r1837b3123],
6	2006	CD	DATE	2006	num	7	SENT_550	[p12l1849t3094r1914b3116],
7	|	NNP	O	|	dep	3	SENT_550	[p12l1929t3091r1931b3124],
8	Volume	NN	O	volume	dep	3	SENT_550	[p12l1945t3092r2051b3116],
9	2	CD	NUMBER	2	number	10	SENT_550	[p12l2064t3094r2078b3116],
10	|	CD	NUMBER	|	num	14	SENT_550	[p12l2093t3091r2096b3124],
11	Issue	NNP	O	Issue	nn	14	SENT_550	[p12l2112t3093r2178b3116],
12	9	CD	NUMBER	9	num	14	SENT_550	[p12l2191t3094r2206b3116],
13	|	NN	O	|	nn	14	SENT_550	[p12l2221t3091r2223b3124],
14	e92	NN	O	e92	dep	8	SENT_550	[p12l2238t3094r2286b3116],

1	Figure	NNP	O	Figure	_	0	SENT_551	[p13l190t204r282b235],
2	10	CD	NUMBER	10	dep	1	SENT_551	[p13l297t206r338b228],
3	.	.	O	.	_	0	SENT_551	[p13l297t206r338b228],

1	Lymphedema	NNP	O	Lymphedema	nsubj	2	SENT_552	[p13l352t204r540b235],
2	Stages	VBZ	O	stage	_	0	SENT_552	[p13l554t205r643b235],

1	The	DT	O	the	det	3	SENT_553	[p13l187t248r238b272],
2	lymphedema	NN	O	lymphedema	nn	3	SENT_553	[p13l252t248r431b279],
3	stages	NNS	O	stage	_	0	SENT_553	[p13l445t252r531b279],
4	according	VBG	O	accord	_	0	SENT_553	[p13l545t248r679b279],
5	to	TO	O	to	prepc_according_to	3	SENT_553	[p13l693t252r720b272],
6	the	DT	O	the	det	7	SENT_553	[p13l733t248r778b272],
7	classification	NN	O	classification	pobj	3	SENT_553	[p13l791t248r962b272],
8	by	IN	O	by	_	0	SENT_553	[p13l978t248r1010b279],
9	Dreyer	NNP	PERSON	Dreyer	dep	12	SENT_553	[p13l1024t249r1113b279],
10	et	FW	O	et	nn	12	SENT_553	[p13l1126t252r1151b272],
11	al.	FW	O	al.	nn	12	SENT_553	[p13l1164t248r1192b272],
12	[	FW	O	[	prepc_by	7	SENT_553	[p13l1207t249r1263b276],
13	47	CD	NUMBER	47	num	14	SENT_553	[p13l1207t249r1263b276],
14	]	NN	O	]	dep	7	SENT_553	[p13l1207t249r1263b276],
15	;	:	O	;	_	0	SENT_553	[p13l1207t249r1263b276],
16	patients	NNS	O	patient	nsubj	17	SENT_553	[p13l1277t249r1386b279],
17	are	VBP	O	be	parataxis	3	SENT_553	[p13l1400t255r1441b272],
18	from	IN	O	from	_	0	SENT_553	[p13l1453t248r1517b272],
19	this	DT	O	this	det	20	SENT_553	[p13l1530t248r1579b272],
20	study	NN	O	study	prep_from	17	SENT_553	[p13l1592t248r1674b279],
21	.	.	O	.	_	0	SENT_553	[p13l1592t248r1674b279],

1	(	NN	O	(	nn	2	SENT_554	[p13l190t284r225b311],
2	A	NN	O	a	nsubj	11	SENT_554	[p13l190t284r225b311],
3	)	CD	NUMBER	)	num	4	SENT_554	[p13l190t284r225b311],
4	Stage	NN	O	stage	amod	2	SENT_554	[p13l239t284r315b314],
5	2	CD	NUMBER	2	dep	4	SENT_554	[p13l328t285r349b311],
6	,	,	O	,	_	0	SENT_554	[p13l328t285r349b311],
7	swelling	VBG	O	swell	partmod	11	SENT_554	[p13l363t283r474b314],
8	that	DT	O	that	dobj	7	SENT_554	[p13l487t283r542b307],
9	is	VBZ	O	be	cop	11	SENT_554	[p13l556t284r573b307],
10	not	RB	O	not	neg	11	SENT_554	[p13l588t287r633b307],
11	reversible	JJ	O	reversible	_	0	SENT_554	[p13l646t283r778b307],
12	overnight	JJ	TIME	overnight	amod	11	SENT_554	[p13l791t283r931b314],
13	.	.	O	.	_	0	SENT_554	[p13l791t283r931b314],

1	B	NN	O	b	nn	3	SENT_555	[p13l199t320r222b347],
2	)	CD	NUMBER	)	num	3	SENT_555	[p13l199t320r222b347],
3	Stage	NN	O	stage	nsubj	8	SENT_555	[p13l236t320r313b350],
4	3	CD	NUMBER	3	dep	3	SENT_555	[p13l326t321r347b347],
5	,	,	O	,	_	0	SENT_555	[p13l326t321r347b347],
6	shallow	JJ	O	shallow	amod	7	SENT_555	[p13l361t319r464b343],
7	skin	NN	O	skin	appos	3	SENT_555	[p13l477t319r528b343],
8	folds	VBZ	O	fold	_	0	SENT_555	[p13l541t319r607b343],
9	at	IN	O	at	_	0	SENT_555	[p13l621t323r646b343],
10	the	DT	O	the	det	11	SENT_555	[p13l658t319r702b343],
11	ankle	NN	O	ankle	prep_at	8	SENT_555	[p13l716t319r794b343],
12	.	.	O	.	_	0	SENT_555	[p13l716t319r794b343],

1	(	NN	O	(	_	0	SENT_556	[p13l190t320r196b347],
2	(	CD	NUMBER	(	num	1	SENT_556	[p13l190t355r196b382],
3	(	CD	NUMBER	(	num	4	SENT_556	[p13l190t390r196b417],
4	(	NN	O	(	amod	1	SENT_556	[p13l190t425r196b452],
5	(	CD	NUMBER	(	num	6	SENT_556	[p13l190t461r221b488],
6	F	NN	O	f	dep	4	SENT_556	[p13l190t461r221b488],
7	)	CD	NUMBER	)	num	8	SENT_556	[p13l190t461r221b488],
8	Stage	NN	O	stage	dep	6	SENT_556	[p13l235t461r311b491],
9	7	CD	NUMBER	7	dep	6	SENT_556	[p13l325t462r345b488],
10	,	,	O	,	_	0	SENT_556	[p13l325t462r345b488],
11	inability	NN	O	inability	appos	6	SENT_556	[p13l359t460r468b491],
12	of	IN	O	of	_	0	SENT_556	[p13l480t460r508b484],
13	patient	NN	O	patient	prep_of	11	SENT_556	[p13l520t461r617b491],
14	to	TO	O	to	aux	15	SENT_556	[p13l628t464r656b484],
15	perform	VB	O	perform	infmod	11	SENT_556	[p13l671t460r779b491],
16	daily	JJ	SET	daily	amod	17	SENT_556	[p13l793t460r857b491],
17	work	NN	O	work	dobj	15	SENT_556	[p13l869t460r943b484],
18	.	.	O	.	_	0	SENT_556	[p13l869t460r943b484],

1	DOI	NNP	O	DOI	_	0	SENT_557	[p13l190t496r246b519],
2	:	:	O	:	_	0	SENT_557	[p13l190t496r246b519],
3	10.1371	CD	NUMBER	10.1371	dep	1	SENT_557	[p13l262t495r747b526],
4	/	:	O	/	punct	6	SENT_557	[p13l262t495r747b526],
5	journa	NN	O	journa	nn	6	SENT_557	[p13l262t495r747b526],
6	|	NN	O	|	dep	3	SENT_557	[p13l262t495r747b526],
7	.	.	O	.	_	0	SENT_557	[p13l262t495r747b526],

1	ppat	NN	O	ppat	_	0	SENT_558	[p13l262t495r747b526],
2	.0020092	CD	NUMBER	.0020092	dep	1	SENT_558	[p13l262t495r747b526],
3	.	.	O	.	_	0	SENT_558	[p13l262t495r747b526],

1	g010	NN	O	g010	_	0	SENT_559	[p13l262t495r747b526],

1	mircoﬁlaraemia	NN	O	mircoﬁlaraemia	nsubjpass	20	SENT_560	[p13l190t598r422b621],
2	and	CC	O	and	_	0	SENT_560	[p13l447t598r499b621],
3	lack	NN	O	lack	conj_and	1	SENT_560	[p13l524t598r581b621],
4	of	IN	O	of	_	0	SENT_560	[p13l606t598r636b620],
5	circulating	VBG	O	circulate	prepc_of	1	SENT_560	[p13l658t598r816b629],
6	Og4C3	NN	O	og4c3	nn	8	SENT_560	[p13l840t598r939b629],
7	ﬁlarial	NN	O	ﬁlarial	nn	8	SENT_560	[p13l963t598r1057b621],
8	antigen	NN	O	antigen	dobj	5	SENT_560	[p13l1083t598r1198b629],
9	,	,	O	,	_	0	SENT_560	[p13l1083t598r1198b629],
10	despite	IN	O	despite	_	0	SENT_560	[p13l189t634r292b665],
11	exposure	NN	O	exposure	prep_despite	20	SENT_560	[p13l315t642r446b665],
12	to	TO	O	to	_	0	SENT_560	[p13l470t639r496b657],
13	infective	JJ	O	infective	amod	14	SENT_560	[p13l521t634r644b657],
14	larvae	NNS	O	larva	prep_to	11	SENT_560	[p13l667t634r752b657],
15	borne	VBN	O	bear	partmod	14	SENT_560	[p13l775t634r860b657],
16	by	IN	O	by	_	0	SENT_560	[p13l883t634r915b665],
17	mosquitoes	NNS	O	mosquito	agent	15	SENT_560	[p13l938t634r1109b665],
18	,	,	O	,	_	0	SENT_560	[p13l938t634r1109b665],
19	were	VBD	O	be	auxpass	20	SENT_560	[p13l1131t642r1199b657],
20	included	VBN	O	include	_	0	SENT_560	[p13l190t669r314b692],
21	as	IN	O	as	_	0	SENT_560	[p13l328t677r354b692],
22	controls	NNS	O	control	prep_as	20	SENT_560	[p13l367t669r492b692],
23	.	.	O	.	_	0	SENT_560	[p13l367t669r492b692],

1	Data	NN	O	datum	_	0	SENT_561	[p13l226t706r292b728],
2	analysis	NN	O	analysis	dep	1	SENT_561	[p13l307t705r428b736],
3	.	.	O	.	_	0	SENT_561	[p13l307t705r428b736],

1	Wolbachia	JJ	O	wolbachia	amod	2	SENT_562	[p13l447t705r577b728],
2	loads	NNS	O	load	nsubjpass	9	SENT_562	[p13l593t705r666b728],
3	in	IN	O	in	_	0	SENT_562	[p13l682t705r709b727],
4	worm	NN	O	worm	nn	5	SENT_562	[p13l724t713r806b727],
5	tissue	NN	O	tissue	prep_in	2	SENT_562	[p13l822t705r901b728],
6	and	CC	O	and	_	0	SENT_562	[p13l917t705r969b728],
7	microﬁlaremia	NN	O	microﬁlaremia	prep_in	2	SENT_562	[p13l985t705r1200b728],
8	were	VBD	O	be	auxpass	9	SENT_562	[p13l188t749r256b764],
9	summarized	VBN	O	summarize	_	0	SENT_562	[p13l274t741r448b764],
10	as	IN	O	as	mark	13	SENT_562	[p13l466t749r492b764],
11	geometric	JJ	O	geometric	amod	12	SENT_562	[p13l510t741r654b772],
12	means	NNS	O	means	nsubj	13	SENT_562	[p13l673t749r763b764],
13	(	VBP	O	(	advcl	9	SENT_562	[p13l782t741r859b770],
14	GM	NNP	ORGANIZATION	GM	dobj	13	SENT_562	[p13l782t741r859b770],
15	)	CD	NUMBER	)	num	14	SENT_562	[p13l782t741r859b770],
16	.	.	O	.	_	0	SENT_562	[p13l782t741r859b770],

1	Differences	NNS	O	difference	nsubjpass	10	SENT_563	[p13l877t741r1042b764],
2	in	IN	O	in	_	0	SENT_563	[p13l1061t741r1087b763],
3	GM	NNP	ORGANIZATION	GM	prep_in	1	SENT_563	[p13l1105t741r1155b764],
4	at	IN	O	at	_	0	SENT_563	[p13l1174t746r1199b764],
5	baseline	NN	O	baseline	nn	8	SENT_563	[p13l189t777r305b800],
6	and	CC	O	and	_	0	SENT_563	[p13l316t777r368b800],
7	subsequent	JJ	O	subsequent	conj_and	5	SENT_563	[p13l378t777r540b808],
8	follow-ups	NNS	O	follow-up	prep_at	3	SENT_563	[p13l549t777r699b808],
9	were	VBD	O	be	auxpass	10	SENT_563	[p13l709t785r777b800],
10	analyzed	VBN	O	analyze	_	0	SENT_563	[p13l787t777r911b808],
11	using	VBG	O	use	xcomp	10	SENT_563	[p13l921t777r997b808],
12	the	DT	O	the	det	13	SENT_563	[p13l1007t777r1051b800],
13	Wilcoxon	NNP	PERSON	Wilcoxon	nsubj	14	SENT_563	[p13l1061t777r1199b800],
14	signed	VBD	O	sign	ccomp	11	SENT_563	[p13l189t813r281b844],
15	rank	NN	O	rank	dobj	14	SENT_563	[p13l299t813r363b835],
16	and	CC	O	and	_	0	SENT_563	[p13l381t813r433b836],
17	Mann	NNP	PERSON	Mann	dobj	14	SENT_563	[p13l451t813r668b844],
18	.	.	O	.	_	0	SENT_563	[p13l451t813r668b844],

1	—	NN	O	—	_	0	SENT_564	[p13l451t813r668b844],
2	.	.	O	.	_	0	SENT_564	[p13l451t813r668b844],

1	Whitney	NNP	PERSON	Whitney	nn	2	SENT_565	[p13l451t813r668b844],
2	U	NNP	O	U	_	0	SENT_565	[p13l688t813r710b836],
3	tests	NNS	O	test	dep	2	SENT_565	[p13l725t818r794b836],
4	.	.	O	.	_	0	SENT_565	[p13l725t818r794b836],

1	Changes	NNS	O	change	nsubjpass	14	SENT_566	[p13l812t813r932b844],
2	in	IN	O	in	_	0	SENT_566	[p13l951t813r978b835],
3	the	DT	O	the	det	4	SENT_566	[p13l996t813r1040b836],
4	degree	NN	O	degree	prep_in	1	SENT_566	[p13l1057t813r1153b844],
5	of	IN	O	of	_	0	SENT_566	[p13l1171t813r1202b835],
6	antigenemia	NN	O	antigenemia	prep_of	4	SENT_566	[p13l189t848r370b879],
7	were	VBD	O	be	auxpass	8	SENT_566	[p13l393t856r461b871],
8	calculated	VBN	O	calculate	_	0	SENT_566	[p13l486t848r633b871],
9	as	IN	O	as	_	0	SENT_566	[p13l659t856r684b871],
10	percentages	NNS	O	percentage	prep_as	8	SENT_566	[p13l710t853r883b879],
11	from	IN	O	from	_	0	SENT_566	[p13l908t848r979b870],
12	baseline	NN	O	baseline	prep_from	10	SENT_566	[p13l1004t848r1121b871],
13	and	CC	O	and	_	0	SENT_566	[p13l1146t848r1199b871],
14	analyzed	VBN	O	analyze	conj_and	8	SENT_566	[p13l189t884r313b915],
15	between	IN	O	between	_	0	SENT_566	[p13l332t884r451b907],
16	treatment	NN	O	treatment	nn	17	SENT_566	[p13l471t889r615b907],
17	groups	NNS	O	group	prep_between	14	SENT_566	[p13l634t892r732b915],
18	at	IN	O	at	_	0	SENT_566	[p13l752t889r778b907],
19	subsequent	JJ	O	subsequent	amod	22	SENT_566	[p13l797t884r959b915],
20	follow-up	JJ	O	follow-up	amod	22	SENT_566	[p13l977t884r1115b915],
21	time	NN	O	time	nn	22	SENT_566	[p13l1136t884r1199b907],
22	points	NNS	O	point	prep_at	14	SENT_566	[p13l189t920r279b951],
23	by	IN	O	by	_	0	SENT_566	[p13l292t920r325b951],
24	the	DT	O	the	det	25	SENT_566	[p13l338t920r382b943],
25	Mann	NNP	PERSON	Mann	prep_by	14	SENT_566	[p13l396t920r613b951],
26	.	.	O	.	_	0	SENT_566	[p13l396t920r613b951],

1	—	NN	O	—	_	0	SENT_567	[p13l396t920r613b951],
2	.	.	O	.	_	0	SENT_567	[p13l396t920r613b951],

1	Whitney	NNP	PERSON	Whitney	nn	2	SENT_568	[p13l396t920r613b951],
2	U	NNP	O	U	nsubj	3	SENT_568	[p13l629t920r651b943],
3	test	NN	O	test	_	0	SENT_568	[p13l662t925r718b943],
4	.	.	O	.	_	0	SENT_568	[p13l662t925r718b943],

1	Proportions	NNS	O	proportion	nsubjpass	21	SENT_569	[p13l732t920r907b951],
2	of	IN	O	of	_	0	SENT_569	[p13l921t920r952b942],
3	MF-positive	JJ	O	mf-positive	prep_of	1	SENT_569	[p13l963t920r1133b951],
4	and	CC	O	and	_	0	SENT_569	[p13l1147t920r1199b943],
5	MF	NN	O	mf	conj_and	3	SENT_569	[p13l189t955r367b986],
6	—	CD	NUMBER	—	num	8	SENT_569	[p13l189t955r367b986],
7	negative	JJ	O	negative	amod	8	SENT_569	[p13l189t955r367b986],
8	individuals	NNS	O	individual	dep	5	SENT_569	[p13l390t955r547b978],
9	as	RB	O	as	_	0	SENT_569	[p13l569t963r595b978],
10	well	RB	O	well	_	0	SENT_569	[p13l617t955r673b978],
11	as	IN	O	as	_	0	SENT_569	[p13l695t963r721b978],
12	individuals	NNS	O	individual	conj_and	5	SENT_569	[p13l744t955r901b978],
13	showing	VBG	O	show	partmod	12	SENT_569	[p13l923t955r1041b986],
14	the	DT	O	the	det	15	SENT_569	[p13l1063t955r1107b978],
15	fFDS	NN	O	ffd	dobj	13	SENT_569	[p13l1128t955r1198b978],
16	before	IN	O	before	_	0	SENT_569	[p13l189t991r282b1014],
17	and	CC	O	and	_	0	SENT_569	[p13l296t991r348b1014],
18	after	IN	O	after	_	0	SENT_569	[p13l363t991r431b1014],
19	treatment	NN	O	treatment	prep_before	13	SENT_569	[p13l445t996r588b1014],
20	were	VBD	O	be	auxpass	21	SENT_569	[p13l601t999r668b1014],
21	compared	VBN	O	compare	_	0	SENT_569	[p13l682t991r828b1022],
22	using	VBG	O	use	xcomp	21	SENT_569	[p13l841t991r918b1022],
23	Fisher	NNP	PERSON	Fisher	dep	25	SENT_569	[p13l931t991r1026b1014],
24	’	CD	NUMBER	’	num	23	SENT_569	[p13l931t991r1026b1014],
25	exact	JJ	O	exact	amod	26	SENT_569	[p13l1041t996r1116b1014],
26	tests	NNS	O	test	dobj	22	SENT_569	[p13l1130t996r1198b1014],
27	.	.	O	.	_	0	SENT_569	[p13l1130t996r1198b1014],

1	Plasma	NN	O	plasma	nn	2	SENT_570	[p13l189t1027r290b1050],
2	levels	NNS	O	level	nsubjpass	8	SENT_570	[p13l309t1027r385b1050],
3	of	IN	O	of	_	0	SENT_570	[p13l405t1027r436b1049],
4	the	DT	O	the	det	6	SENT_570	[p13l453t1027r497b1050],
5	VEGF	NN	O	vegf	nn	6	SENT_570	[p13l516t1027r601b1050],
6	molecules	NNS	O	molecule	prep_of	2	SENT_570	[p13l621t1027r762b1050],
7	were	VBD	O	be	auxpass	8	SENT_570	[p13l781t1035r849b1050],
8	expressed	VBN	O	express	_	0	SENT_570	[p13l869t1027r1010b1058],
9	as	IN	O	as	_	0	SENT_570	[p13l1030t1035r1056b1050],
10	mean	NN	O	mean	prep_as	8	SENT_570	[p13l1077t1035r1154b1050],
11	:	:	O	:	_	0	SENT_570	[p13l1176t1029r1196b1048],
12	standard	JJ	O	standard	amod	13	SENT_570	[p13l189t1063r315b1086],
13	deviations	NNS	O	deviation	nsubj	14	SENT_570	[p13l330t1063r477b1086],
14	(	VBP	O	(	parataxis	8	SENT_570	[p13l493t1063r560b1092],
15	SD	NN	O	sd	nn	16	SENT_570	[p13l493t1063r560b1092],
16	)	NN	O	)	dobj	14	SENT_570	[p13l493t1063r560b1092],
17	,	,	O	,	_	0	SENT_570	[p13l493t1063r560b1092],
18	and	CC	O	and	_	0	SENT_570	[p13l576t1063r628b1086],
19	differences	NNS	O	difference	nsubjpass	42	SENT_570	[p13l643t1063r803b1086],
20	in	IN	O	in	_	0	SENT_570	[p13l819t1063r845b1085],
21	the	DT	O	the	det	22	SENT_570	[p13l861t1063r905b1086],
22	levels	NNS	O	level	prep_in	19	SENT_570	[p13l921t1063r997b1086],
23	of	IN	O	of	_	0	SENT_570	[p13l1012t1063r1043b1085],
24	the	DT	O	the	det	26	SENT_570	[p13l1056t1063r1100b1086],
25	VEGF	NN	MISC	vegf	nn	26	SENT_570	[p13l1114t1063r1199b1086],
26	molecules	NNS	O	molecule	prep_of	22	SENT_570	[p13l190t1098r331b1121],
27	between	IN	O	between	_	0	SENT_570	[p13l349t1098r468b1121],
28	endemic	JJ	O	endemic	amod	29	SENT_570	[p13l487t1098r608b1121],
29	normals	NNS	O	normal	prep_between	26	SENT_570	[p13l628t1098r751b1125],
30	,	,	O	,	_	0	SENT_570	[p13l628t1098r751b1125],
31	microﬁlaremic	JJ	O	microﬁlaremic	amod	36	SENT_570	[p13l770t1098r982b1121],
32	(	NN	O	(	nn	36	SENT_570	[p13l1002t1098r1198b1129],
33	MF	NN	O	mf	nn	36	SENT_570	[p13l1002t1098r1198b1129],
34	—	CD	NUMBER	—	num	36	SENT_570	[p13l1002t1098r1198b1129],
35	positive	JJ	O	positive	amod	36	SENT_570	[p13l1002t1098r1198b1129],
36	)	NN	O	)	prep_between	26	SENT_570	[p13l1002t1098r1198b1129],
37	,	,	O	,	_	0	SENT_570	[p13l1002t1098r1198b1129],
38	and	CC	O	and	_	0	SENT_570	[p13l189t1134r242b1157],
39	lymphedema	NN	O	lymphedema	nn	40	SENT_570	[p13l258t1134r444b1165],
40	patients	NNS	O	patient	prep_between	26	SENT_570	[p13l460t1134r575b1165],
41	were	VBD	O	be	auxpass	42	SENT_570	[p13l591t1142r659b1157],
42	analyzed	VBN	O	analyze	parataxis	8	SENT_570	[p13l676t1134r799b1165],
43	using	VBG	O	use	xcomp	42	SENT_570	[p13l815t1134r892b1165],
44	analysis	NN	O	analysis	dobj	43	SENT_570	[p13l908t1134r1017b1165],
45	of	IN	O	of	_	0	SENT_570	[p13l1034t1134r1064b1156],
46	variance	NN	O	variance	prep_of	44	SENT_570	[p13l1077t1134r1199b1157],
47	(	CD	NUMBER	(	num	46	SENT_570	[p13l190t1170r329b1199],
48	ANOVA	NNP	ORGANIZATION	ANOVA	dep	43	SENT_570	[p13l190t1170r329b1199],
49	)	CD	NUMBER	)	num	48	SENT_570	[p13l190t1170r329b1199],
50	with	IN	O	with	_	0	SENT_570	[p13l340t1170r402b1193],
51	the	DT	O	the	det	55	SENT_570	[p13l415t1170r458b1193],
52	Bonferroni/Dunn	NNP	O	Bonferroni/Dunn	nn	55	SENT_570	[p13l470t1170r722b1193],
53	post	NN	O	post	amod	55	SENT_570	[p13l734t1175r795b1201],
54	hoc	FW	O	hoc	dep	53	SENT_570	[p13l806t1170r856b1193],
55	test	NN	O	test	prep_with	43	SENT_570	[p13l869t1175r925b1193],
56	.	.	O	.	_	0	SENT_570	[p13l869t1175r925b1193],

1	Differences	NNS	O	difference	nsubjpass	44	SENT_571	[p13l938t1170r1103b1193],
2	in	IN	O	in	_	0	SENT_571	[p13l1116t1170r1142b1192],
3	the	DT	O	the	det	4	SENT_571	[p13l1155t1170r1199b1193],
4	levels	NNS	O	level	prep_in	1	SENT_571	[p13l189t1205r265b1228],
5	of	IN	O	of	_	0	SENT_571	[p13l281t1205r311b1227],
6	the	DT	O	the	det	7	SENT_571	[p13l324t1205r368b1228],
7	VEGFS	NN	O	vegf	prep_of	4	SENT_571	[p13l382t1205r479b1228],
8	within	IN	O	within	_	0	SENT_571	[p13l494t1205r585b1228],
9	the	DT	O	the	det	11	SENT_571	[p13l601t1205r645b1228],
10	treatment	NN	O	treatment	nn	11	SENT_571	[p13l661t1210r804b1228],
11	groups	NNS	O	group	prep_within	7	SENT_571	[p13l818t1213r916b1236],
12	before	IN	O	before	advmod	7	SENT_571	[p13l931t1205r1024b1228],
13	and	CC	O	and	_	0	SENT_571	[p13l1040t1205r1092b1228],
14	12	CD	DURATION	12	num	15	SENT_571	[p13l1110t1205r1139b1228],
15	mo	NN	DURATION	mo	conj_and	4	SENT_571	[p13l1155t1213r1198b1227],
16	after	IN	O	after	_	0	SENT_571	[p13l189t1241r258b1264],
17	treatment	NN	O	treatment	prep_after	15	SENT_571	[p13l270t1246r413b1264],
18	as	RB	O	as	_	0	SENT_571	[p13l425t1249r451b1264],
19	well	RB	O	well	_	0	SENT_571	[p13l463t1241r519b1264],
20	as	IN	O	as	_	0	SENT_571	[p13l532t1249r557b1264],
21	changes	NNS	O	change	conj_and	4	SENT_571	[p13l570t1241r683b1272],
22	in	IN	O	in	_	0	SENT_571	[p13l697t1241r723b1263],
23	lymphatic	JJ	O	lymphatic	amod	25	SENT_571	[p13l736t1241r878b1272],
24	vessel	NN	O	vessel	nn	25	SENT_571	[p13l890t1241r971b1264],
25	dilation	NN	O	dilation	prep_in	21	SENT_571	[p13l983t1241r1103b1268],
26	,	,	O	,	_	0	SENT_571	[p13l983t1241r1103b1268],
27	stages	NNS	O	stage	conj_and	25	SENT_571	[p13l1116t1246r1199b1272],
28	of	IN	O	of	_	0	SENT_571	[p13l189t1277r220b1299],
29	lymphedema	NN	O	lymphedema	prep_of	27	SENT_571	[p13l229t1277r421b1308],
30	,	,	O	,	_	0	SENT_571	[p13l229t1277r421b1308],
31	and	CC	O	and	_	0	SENT_571	[p13l433t1277r486b1300],
32	the	DT	O	the	det	33	SENT_571	[p13l498t1277r542b1300],
33	size	NN	O	size	conj_and	25	SENT_571	[p13l554t1277r603b1300],
34	of	IN	O	of	_	0	SENT_571	[p13l615t1277r646b1299],
35	affected	VBN	O	affect	amod	36	SENT_571	[p13l655t1277r770b1300],
36	limbs	NNS	O	limb	prep_of	33	SENT_571	[p13l782t1277r858b1300],
37	of	IN	O	of	_	0	SENT_571	[p13l870t1277r901b1299],
38	lymphedema	NN	O	lymphedema	prep_of	36	SENT_571	[p13l909t1277r1095b1308],
39	before	IN	O	before	_	0	SENT_571	[p13l1106t1277r1199b1300],
40	and	CC	O	and	_	0	SENT_571	[p13l189t1312r242b1335],
41	after	IN	O	after	_	0	SENT_571	[p13l266t1312r334b1335],
42	treatment	NN	O	treatment	prep_after	38	SENT_571	[p13l358t1317r501b1335],
43	were	VBD	O	be	auxpass	44	SENT_571	[p13l524t1320r592b1335],
44	assessed	VBN	O	assess	_	0	SENT_571	[p13l616t1312r731b1335],
45	using	VBG	O	use	xcomp	44	SENT_571	[p13l755t1312r832b1343],
46	paired	JJ	O	paired	amod	47	SENT_571	[p13l855t1312r948b1343],
47	t-tests	NNS	O	t-test	dobj	45	SENT_571	[p13l973t1316r1062b1335],
48	.	.	O	.	_	0	SENT_571	[p13l973t1316r1062b1335],

1	Positive	JJ	O	positive	amod	2	SENT_572	[p13l1088t1312r1199b1335],
2	relationships	NNS	O	relationship	nsubjpass	12	SENT_572	[p13l190t1348r376b1379],
3	between	IN	O	between	_	0	SENT_572	[p13l395t1348r515b1371],
4	the	DT	O	the	det	6	SENT_572	[p13l535t1348r579b1371],
5	disease	NN	O	disease	nn	6	SENT_572	[p13l598t1348r699b1371],
6	states	NNS	O	state	prep_between	2	SENT_572	[p13l718t1353r796b1371],
7	and	CC	O	and	_	0	SENT_572	[p13l817t1348r869b1371],
8	the	DT	O	the	det	10	SENT_572	[p13l889t1348r933b1371],
9	VEGF	NN	O	vegf	nn	10	SENT_572	[p13l952t1348r1037b1371],
10	molecules	NNS	O	molecule	prep_between	2	SENT_572	[p13l1057t1348r1198b1371],
11	were	VBD	O	be	auxpass	12	SENT_572	[p13l188t1392r256b1407],
12	assessed	VBN	O	assess	_	0	SENT_572	[p13l276t1384r391b1407],
13	by	IN	O	by	_	0	SENT_572	[p13l410t1384r442b1415],
14	the	DT	O	the	det	19	SENT_572	[p13l462t1384r506b1407],
15	Spearman	NNP	PERSON	Spearman	nn	19	SENT_572	[p13l526t1384r678b1415],
16	’	CD	NUMBER	’	num	19	SENT_572	[p13l526t1384r678b1415],
17	rank	NN	O	rank	nn	19	SENT_572	[p13l699t1384r764b1407],
18	correlation	NN	O	correlation	nn	19	SENT_572	[p13l783t1384r945b1407],
19	test	NN	O	test	agent	12	SENT_572	[p13l965t1389r1014b1407],
20	and	CC	O	and	_	0	SENT_572	[p13l1034t1384r1086b1407],
21	simple	JJ	O	simple	amod	23	SENT_572	[p13l1106t1384r1199b1415],
22	regression	NN	O	regression	nn	23	SENT_572	[p13l190t1419r337b1450],
23	analysis	NN	O	analysis	agent	12	SENT_572	[p13l355t1419r464b1450],
24	(	CD	NUMBER	(	num	25	SENT_572	[p13l483t1419r645b1447],
25	coefﬁcient	NN	O	coefﬁcient	nsubj	28	SENT_572	[p13l483t1419r645b1447],
26	of	IN	O	of	_	0	SENT_572	[p13l662t1419r693b1441],
27	determination	NN	O	determination	prep_of	25	SENT_572	[p13l708t1419r917b1442],
28	indicated	VBD	O	indicate	rcmod	23	SENT_572	[p13l936t1419r1070b1442],
29	as	IN	O	as	_	0	SENT_572	[p13l1088t1427r1114b1442],
30	T	NN	O	t	prep_as	28	SENT_572	[p13l1131t1420r1159b1448],
31	)	CD	NUMBER	)	num	30	SENT_572	[p13l1131t1420r1159b1448],
32	.	.	O	.	_	0	SENT_572	[p13l1131t1420r1159b1448],

1	A	DT	O	a	det	3	SENT_573	[p13l1177t1419r1200b1441],
2	two	CD	NUMBER	two	num	3	SENT_573	[p13l190t1455r338b1478],
3	—	NN	O	—	nsubj	4	SENT_573	[p13l190t1455r338b1478],
4	tailed	VBD	O	tail	_	0	SENT_573	[p13l190t1455r338b1478],
5	17-value	JJ	O	17-value	amod	6	SENT_573	[p13l360t1455r467b1486],
6	lower	JJR	O	lower	nsubjpass	10	SENT_573	[p13l493t1455r574b1478],
7	than	IN	O	than	_	0	SENT_573	[p13l599t1455r664b1478],
8	0.05	CD	NUMBER	0.05	prep_than	6	SENT_573	[p13l690t1455r749b1477],
9	was	VBD	O	be	auxpass	10	SENT_573	[p13l773t1463r823b1478],
10	considered	VBN	O	consider	ccomp	4	SENT_573	[p13l849t1455r1012b1478],
11	signiﬁcant	NN	O	signiﬁcant	dobj	10	SENT_573	[p13l1038t1455r1199b1486],
12	.	.	O	.	_	0	SENT_573	[p13l1038t1455r1199b1486],

1	Independence	NN	O	independence	nsubjpass	5	SENT_574	[p13l189t1491r395b1522],
2	of	IN	O	of	_	0	SENT_574	[p13l417t1491r448b1513],
3	data	NNS	O	datum	prep_of	1	SENT_574	[p13l466t1491r528b1514],
4	was	VBD	O	be	auxpass	5	SENT_574	[p13l548t1499r597b1514],
5	tested	VBN	O	test	_	0	SENT_574	[p13l620t1491r704b1514],
6	using	VBG	O	use	xcomp	5	SENT_574	[p13l726t1491r802b1522],
7	multivariate	JJ	O	multivariate	amod	8	SENT_574	[p13l824t1491r999b1514],
8	analysis	NN	O	analysis	dobj	6	SENT_574	[p13l1021t1491r1137b1522],
9	.	.	O	.	_	0	SENT_574	[p13l1021t1491r1137b1522],

1	All	DT	O	all	det	2	SENT_575	[p13l1158t1491r1199b1513],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_575	[p13l189t1527r304b1558],
3	were	VBD	O	be	auxpass	4	SENT_575	[p13l317t1535r385b1550],
4	done	VBN	O	do	_	0	SENT_575	[p13l398t1527r469b1550],
5	using	VBG	O	use	xcomp	4	SENT_575	[p13l483t1527r559b1558],
6	StatView	NNP	O	StatView	nn	8	SENT_575	[p13l572t1527r700b1550],
7	version	NN	O	version	nn	8	SENT_575	[p13l712t1527r817b1550],
8	X	NN	O	x	dobj	5	SENT_575	[p13l830t1528r852b1549],
9	for	IN	O	for	_	0	SENT_575	[p13l865t1527r908b1549],
10	Mac	NNP	O	Mac	prep_for	8	SENT_575	[p13l920t1528r977b1550],
11	OS	NNP	O	OS	tmod	5	SENT_575	[p13l992t1527r1034b1550],
12	9.5	CD	NUMBER	9.5	num	11	SENT_575	[p13l1048t1527r1094b1549],
13	.	.	O	.	_	0	SENT_575	[p13l1048t1527r1094b1549],

1	References	NNS	O	reference	_	0	SENT_576	[p13l188t1628r328b1648],
2	1	CD	NUMBER	1	num	1	SENT_576	[p13l191t1666r208b1685],
3	.	.	O	.	_	0	SENT_576	[p13l191t1666r208b1685],

1	World	NNP	ORGANIZATION	World	nn	3	SENT_577	[p13l238t1666r317b1686],
2	Health	NNP	ORGANIZATION	Health	nn	3	SENT_577	[p13l337t1666r422b1685],
3	Organization	NNP	ORGANIZATION	Organization	_	0	SENT_577	[p13l442t1666r609b1693],
4	(	CD	NUMBER	(	num	3	SENT_577	[p13l630t1666r705b1691],
5	2005	CD	DATE	2005	num	6	SENT_577	[p13l630t1666r705b1691],
6	)	CD	NUMBER	)	dep	3	SENT_577	[p13l630t1666r705b1691],
7	WHO	WP	O	who	rcmod	6	SENT_577	[p13l724t1666r797b1686],
8	annual	JJ	SET	annual	amod	9	SENT_577	[p13l817t1666r902b1685],
9	report	NN	O	report	dep	3	SENT_577	[p13l922t1670r1003b1693],
10	on	IN	O	on	_	0	SENT_577	[p13l1023t1672r1054b1685],
11	lymphatic	JJ	O	lymphatic	amod	12	SENT_577	[p13l1074t1666r1198b1693],
12	ﬁlariasis	NN	O	ﬁlariasis	prep_on	9	SENT_577	[p13l239t1700r342b1719],
13	2004	CD	DATE	2004	dep	9	SENT_577	[p13l363t1700r427b1720],
14	.	.	O	.	_	0	SENT_577	[p13l363t1700r427b1720],

1	Available	JJ	O	available	_	0	SENT_578	[p13l447t1700r570b1719],
2	:	:	O	:	_	0	SENT_578	[p13l447t1700r570b1719],
3	http	VB	O	http	dep	1	SENT_578	[p13l591t1700r892b1727],
4	:	:	O	:	_	0	SENT_578	[p13l591t1700r892b1727],
5	/	:	O	/	punct	6	SENT_578	[p13l591t1700r892b1727],
6	lwww.ﬁlariasis.org	NN	O	lwww.ﬁlariasis.org	dep	1	SENT_578	[p13l591t1700r892b1727],
7	.	.	O	.	_	0	SENT_578	[p13l591t1700r892b1727],

1	Accessed	VBN	O	access	_	0	SENT_579	[p13l912t1700r1026b1719],
2	12	CD	DATE	12	dobj	1	SENT_579	[p13l1048t1700r1074b1719],
3	October	NNP	DATE	October	tmod	1	SENT_579	[p13l1094t1700r1200b1720],
4	2005	CD	DATE	2005	num	3	SENT_579	[p13l239t1733r303b1752],
5	.	.	O	.	_	0	SENT_579	[p13l239t1733r303b1752],

1	Cox	NN	ORGANIZATION	cox	nn	2	SENT_580	[p13l239t1766r288b1786],
2	FE	NNP	ORGANIZATION	FE	nsubj	4	SENT_580	[p13l309t1766r341b1785],
3	(	CD	NUMBER	(	num	4	SENT_580	[p13l362t1766r437b1791],
4	2000	CD	DATE	2000	_	0	SENT_580	[p13l362t1766r437b1791],
5	)	CD	NUMBER	)	num	6	SENT_580	[p13l362t1766r437b1791],
6	Elimination	NN	O	elimination	dobj	4	SENT_580	[p13l458t1766r608b1785],
7	of	IN	O	of	_	0	SENT_580	[p13l629t1766r656b1785],
8	lymphatic	JJ	O	lymphatic	amod	9	SENT_580	[p13l674t1766r799b1793],
9	ﬁlariasis	NN	O	ﬁlariasis	prep_of	6	SENT_580	[p13l820t1766r923b1785],
10	as	IN	O	as	_	0	SENT_580	[p13l945t1772r967b1785],
11	a	DT	O	a	det	14	SENT_580	[p13l989t1773r1000b1785],
12	public	JJ	O	public	amod	14	SENT_580	[p13l1022t1766r1099b1793],
13	health	NN	O	health	nn	14	SENT_580	[p13l1121t1766r1199b1785],
14	problem	NN	O	problem	prep_as	4	SENT_580	[p13l239t1800r352b1827],
15	.	.	O	.	_	0	SENT_580	[p13l239t1800r352b1827],

1	Parasitol	NNP	O	Parasitol	nn	2	SENT_581	[p13l365t1800r475b1819],
2	Today	NNP	DATE	Today	_	0	SENT_581	[p13l487t1800r565b1827],
3	16	CD	DATE	16	num	2	SENT_581	[p13l579t1800r611b1819],
4	:	:	O	:	_	0	SENT_581	[p13l579t1800r611b1819],
5	135	CD	NUMBER	135	dep	2	SENT_581	[p13l626t1800r673b1819],
6	.	.	O	.	_	0	SENT_581	[p13l626t1800r673b1819],

1	Noroes	NNS	O	noro	_	0	SENT_582	[p13l239t1833r329b1853],
2	J	NN	O	j	dep	1	SENT_582	[p13l343t1833r362b1860],
3	,	,	O	,	_	0	SENT_582	[p13l343t1833r362b1860],
4	Dreyer	NNP	PERSON	Dreyer	nn	5	SENT_582	[p13l381t1833r469b1860],
5	G	NNP	PERSON	G	appos	2	SENT_582	[p13l487t1833r512b1856],
6	,	,	O	,	_	0	SENT_582	[p13l487t1833r512b1856],
7	Santos	NNP	PERSON	Santos	nn	8	SENT_582	[p13l532t1833r614b1853],
8	A	NNP	O	A	appos	2	SENT_582	[p13l633t1833r658b1856],
9	,	,	O	,	_	0	SENT_582	[p13l633t1833r658b1856],
10	Mendes	NNP	PERSON	Mendes	nn	11	SENT_582	[p13l678t1833r774b1852],
11	VG	NNP	O	VG	appos	2	SENT_582	[p13l792t1833r839b1856],
12	,	,	O	,	_	0	SENT_582	[p13l792t1833r839b1856],
13	Medeiros	NNP	PERSON	Medeiros	nn	14	SENT_582	[p13l859t1833r975b1852],
14	Z	NNP	O	Z	appos	2	SENT_582	[p13l995t1833r1016b1856],
15	,	,	O	,	_	0	SENT_582	[p13l995t1833r1016b1856],
16	et	FW	O	et	appos	2	SENT_582	[p13l1036t1837r1058b1852],
17	al.	FW	O	al.	nn	18	SENT_582	[p13l1077t1833r1103b1852],
18	(	FW	O	(	dep	1	SENT_582	[p13l1124t1831r1199b1858],
19	1997	CD	DATE	1997	num	20	SENT_582	[p13l1124t1831r1199b1858],
20	)	CD	NUMBER	)	dep	18	SENT_582	[p13l1124t1831r1199b1858],
21	Assessment	NNP	O	Assessment	dep	1	SENT_582	[p13l238t1866r382b1885],
22	of	IN	O	of	_	0	SENT_582	[p13l402t1866r429b1885],
23	the	DT	O	the	det	24	SENT_582	[p13l447t1866r485b1885],
24	efﬁcacy	NN	O	efﬁcacy	prep_of	21	SENT_582	[p13l506t1866r600b1893],
25	of	IN	O	of	_	0	SENT_582	[p13l621t1866r648b1885],
26	diethylcarbamazine	NN	O	diethylcarbamazine	prep_of	24	SENT_582	[p13l666t1866r914b1893],
27	on	IN	O	on	_	0	SENT_582	[p13l935t1872r966b1885],
28	adult	JJ	O	adult	prep_on	26	SENT_582	[p13l987t1866r1050b1885],
29	Wuchereria	FW	O	wuchereria	nn	30	SENT_582	[p13l1073t1866r1200b1885],
30	bancrofti	FW	O	bancrofti	dep	1	SENT_582	[p13l239t1900r337b1927],
31	in	FW	O	in	prep	30	SENT_582	[p13l348t1900r371b1919],
32	vivo	FW	O	vivo	pobj	31	SENT_582	[p13l383t1900r440b1919],
33	.	.	O	.	_	0	SENT_582	[p13l383t1900r440b1919],

1	Trans	NNP	O	Trans	nn	6	SENT_583	[p13l452t1900r524b1919],
2	R	NNP	O	R	nn	6	SENT_583	[p13l536t1900r554b1919],
3	Soc	NNP	O	Soc	nn	6	SENT_583	[p13l565t1900r608b1920],
4	Trop	NNP	O	Trop	nn	6	SENT_583	[p13l620t1900r684b1927],
5	Med	NNP	O	Med	nn	6	SENT_583	[p13l696t1900r750b1919],
6	Hyg	NNP	O	Hyg	_	0	SENT_583	[p13l762t1900r812b1927],
7	91	CD	NUMBER	91	num	6	SENT_583	[p13l824t1900r857b1919],
8	:	:	O	:	_	0	SENT_583	[p13l824t1900r857b1919],
9	78	CD	NUMBER	78	number	10	SENT_583	[p13l871t1898r949b1919],
10	—	CD	NUMBER	—	dep	6	SENT_583	[p13l871t1898r949b1919],
11	81	CD	NUMBER	81	dep	10	SENT_583	[p13l871t1898r949b1919],
12	.	.	O	.	_	0	SENT_583	[p13l871t1898r949b1919],

1	Bockarie	NNP	PERSON	Bockarie	nn	2	SENT_584	[p13l239t1933r350b1952],
2	MJ	NNP	PERSON	MJ	nsubj	21	SENT_584	[p13l363t1933r402b1960],
3	,	,	O	,	_	0	SENT_584	[p13l363t1933r402b1960],
4	Tisch	NNP	PERSON	Tisch	nn	5	SENT_584	[p13l415t1933r483b1952],
5	DJ	NNP	O	DJ	appos	2	SENT_584	[p13l496t1933r531b1960],
6	,	,	O	,	_	0	SENT_584	[p13l496t1933r531b1960],
7	Kastens	NNP	PERSON	Kastens	nn	8	SENT_584	[p13l545t1933r641b1952],
8	W	NNP	O	W	appos	2	SENT_584	[p13l654t1933r685b1956],
9	,	,	O	,	_	0	SENT_584	[p13l654t1933r685b1956],
10	Alexander	NNP	ORGANIZATION	Alexander	nn	11	SENT_584	[p13l698t1933r831b1952],
11	ND	NNP	ORGANIZATION	ND	appos	2	SENT_584	[p13l843t1933r890b1956],
12	,	,	O	,	_	0	SENT_584	[p13l843t1933r890b1956],
13	Dimber	NNP	O	Dimber	nn	14	SENT_584	[p13l904t1933r1001b1952],
14	Z	NNP	O	Z	appos	2	SENT_584	[p13l1013t1933r1034b1956],
15	,	,	O	,	_	0	SENT_584	[p13l1013t1933r1034b1956],
16	et	FW	O	et	appos	2	SENT_584	[p13l1048t1937r1070b1952],
17	al.	FW	O	al.	nn	18	SENT_584	[p13l1083t1933r1109b1952],
18	(	FW	O	(	dep	16	SENT_584	[p13l1124t1933r1199b1958],
19	2002	CD	DATE	2002	num	20	SENT_584	[p13l1124t1933r1199b1958],
20	)	CD	NUMBER	)	dep	2	SENT_584	[p13l1124t1933r1199b1958],
21	Mass	JJ	O	mass	_	0	SENT_584	[p13l239t1966r297b1985],
22	treatment	NN	O	treatment	nsubj	24	SENT_584	[p13l310t1970r435b1985],
23	to	TO	O	to	aux	24	SENT_584	[p13l447t1970r471b1985],
24	eliminate	VB	O	eliminate	xcomp	21	SENT_584	[p13l483t1966r601b1985],
25	ﬁlariasis	NN	O	ﬁlariasis	dobj	24	SENT_584	[p13l613t1966r717b1985],
26	in	IN	O	in	_	0	SENT_584	[p13l729t1966r752b1985],
27	Papua	NNP	LOCATION	Papua	nn	29	SENT_584	[p13l764t1966r841b1993],
28	New	NNP	LOCATION	New	nn	29	SENT_584	[p13l853t1966r907b1986],
29	Guinea	NNP	LOCATION	Guinea	prep_in	24	SENT_584	[p13l919t1966r1015b1986],
30	.	.	O	.	_	0	SENT_584	[p13l919t1966r1015b1986],

1	N	NN	O	n	nn	2	SENT_585	[p13l1027t1966r1047b1985],
2	EnglJ	NN	O	englj	nsubj	3	SENT_585	[p13l1059t1966r1134b1993],
3	Med	VBD	O	med	_	0	SENT_585	[p13l1145t1966r1199b1985],
4	347	CD	NUMBER	347	dobj	3	SENT_585	[p13l239t1998r288b2019],
5	:	:	O	:	_	0	SENT_585	[p13l239t1998r288b2019],
6	1841	CD	DATE	1841	number	7	SENT_585	[p13l303t2000r441b2019],
7	—	CD	DATE	—	dep	4	SENT_585	[p13l303t2000r441b2019],
8	1848	CD	DATE	1848	dep	7	SENT_585	[p13l303t2000r441b2019],
9	.	.	O	.	_	0	SENT_585	[p13l303t2000r441b2019],

1	Meyrowitsch	NNP	O	Meyrowitsch	nn	2	SENT_586	[p13l239t2033r398b2060],
2	DW	NNP	O	DW	_	0	SENT_586	[p13l415t2033r468b2056],
3	,	,	O	,	_	0	SENT_586	[p13l415t2033r468b2056],
4	Simonsen	NNP	ORGANIZATION	Simonsen	nn	5	SENT_586	[p13l485t2033r608b2053],
5	PE	NNP	ORGANIZATION	PE	appos	2	SENT_586	[p13l625t2033r663b2056],
6	,	,	O	,	_	0	SENT_586	[p13l625t2033r663b2056],
7	Magesa	NNP	O	Magesa	nn	8	SENT_586	[p13l681t2033r771b2060],
8	SM	NNP	O	SM	appos	2	SENT_586	[p13l788t2033r827b2053],
9	(	CD	NUMBER	(	num	10	SENT_586	[p13l844t2033r919b2058],
10	2004	CD	DATE	2004	dep	8	SENT_586	[p13l844t2033r919b2058],
11	)	CD	NUMBER	)	num	13	SENT_586	[p13l844t2033r919b2058],
12	Long-terin	NN	O	long-terin	nn	13	SENT_586	[p13l936t2033r1071b2060],
13	effect	NN	O	effect	dep	2	SENT_586	[p13l1088t2033r1158b2052],
14	of	IN	O	of	_	0	SENT_586	[p13l1175t2033r1202b2052],
15	three	CD	NUMBER	three	num	17	SENT_586	[p13l239t2066r304b2085],
16	different	JJ	O	different	amod	17	SENT_586	[p13l320t2066r431b2085],
17	strategies	NNS	O	strategy	prep_of	13	SENT_586	[p13l447t2066r565b2093],
18	for	IN	O	for	_	0	SENT_586	[p13l581t2066r618b2085],
19	mass	NN	O	mass	nn	21	SENT_586	[p13l633t2072r691b2085],
20	diethylcarbamazine	NN	O	diethylcarbamazine	nn	21	SENT_586	[p13l707t2066r955b2093],
21	administration	NN	O	administration	prep_for	17	SENT_586	[p13l971t2066r1159b2085],
22	in	IN	O	in	_	0	SENT_586	[p13l1176t2066r1199b2085],
23	bancroftian	JJ	O	bancroftian	amod	24	SENT_586	[p13l239t2100r387b2119],
24	ﬁlariasis	NN	O	ﬁlariasis	prep_in	21	SENT_586	[p13l401t2100r510b2119],
25	:	:	O	:	_	0	SENT_586	[p13l401t2100r510b2119],
26	Follow-up	JJ	O	follow-up	dep	13	SENT_586	[p13l525t2100r651b2127],
27	at	IN	O	at	_	0	SENT_586	[p13l666t2104r688b2119],
28	10	CD	DURATION	10	num	29	SENT_586	[p13l704t2100r729b2119],
29	years	NNS	NUMBER	year	prep_at	26	SENT_586	[p13l743t2106r806b2127],
30	after	IN	O	after	_	0	SENT_586	[p13l821t2100r880b2119],
31	treatment	NN	O	treatment	prep_after	29	SENT_586	[p13l893t2104r1024b2119],
32	.	.	O	.	_	0	SENT_586	[p13l893t2104r1024b2119],

1	Trans	NNP	O	Trans	nn	6	SENT_587	[p13l1038t2100r1111b2119],
2	R	NNP	O	R	nn	6	SENT_587	[p13l1125t2100r1143b2119],
3	Soc	NNP	O	Soc	nn	6	SENT_587	[p13l1155t2100r1198b2120],
4	Trop	NNP	O	Trop	nn	6	SENT_587	[p13l238t2133r302b2160],
5	Med	NNP	O	Med	nn	6	SENT_587	[p13l314t2133r368b2152],
6	Hyg	NNP	O	Hyg	_	0	SENT_587	[p13l380t2133r430b2160],
7	98	CD	NUMBER	98	num	6	SENT_587	[p13l441t2133r475b2152],
8	:	:	O	:	_	0	SENT_587	[p13l441t2133r475b2152],
9	627	CD	NUMBER	627	num	10	SENT_587	[p13l488t2131r597b2152],
10	—	NN	O	—	dep	6	SENT_587	[p13l488t2131r597b2152],
11	634	CD	NUMBER	634	dep	10	SENT_587	[p13l488t2131r597b2152],
12	.	.	O	.	_	0	SENT_587	[p13l488t2131r597b2152],

1	Meyrowitsch	NNP	O	Meyrowitsch	nn	2	SENT_588	[p13l239t2166r398b2193],
2	DW	NNP	O	DW	_	0	SENT_588	[p13l413t2166r466b2189],
3	,	,	O	,	_	0	SENT_588	[p13l413t2166r466b2189],
4	Simonsen	NNP	ORGANIZATION	Simonsen	nn	5	SENT_588	[p13l482t2166r604b2186],
5	PE	NNP	ORGANIZATION	PE	appos	2	SENT_588	[p13l620t2166r658b2189],
6	,	,	O	,	_	0	SENT_588	[p13l620t2166r658b2189],
7	Makunde	NNP	PERSON	Makunde	nn	14	SENT_588	[p13l674t2166r790b2185],
8	WH	NNP	PERSON	WH	nn	14	SENT_588	[p13l805t2166r854b2186],
9	(	NNP	O	(	nn	14	SENT_588	[p13l870t2166r945b2191],
10	1996	CD	DATE	1996	num	14	SENT_588	[p13l870t2166r945b2191],
11	)	NNP	O	)	nn	14	SENT_588	[p13l870t2166r945b2191],
12	Mass	NNP	O	Mass	nn	14	SENT_588	[p13l960t2166r1019b2185],
13	DEC	NNP	DATE	DEC	nn	14	SENT_588	[p13l1034t2166r1090b2186],
14	chemotherapy	NN	O	chemotherapy	appos	2	SENT_588	[p13l1105t2166r1199b2185, p13l239t2200r335b2227],
15	for	IN	O	for	_	0	SENT_588	[p13l348t2200r385b2219],
16	control	NN	O	control	prep_for	14	SENT_588	[p13l397t2200r489b2219],
17	of	IN	O	of	_	0	SENT_588	[p13l503t2200r530b2219],
18	bancroftian	JJ	O	bancroftian	amod	19	SENT_588	[p13l539t2200r688b2219],
19	ﬁlariasis	NN	O	ﬁlariasis	prep_of	16	SENT_588	[p13l701t2200r811b2219],
20	:	:	O	:	_	0	SENT_588	[p13l701t2200r811b2219],
21	Comparative	JJ	O	comparative	amod	22	SENT_588	[p13l825t2200r988b2227],
22	efﬁcacy	NN	O	efﬁcacy	dep	2	SENT_588	[p13l1001t2200r1096b2227],
23	of	IN	O	of	_	0	SENT_588	[p13l1109t2200r1136b2219],
24	four	CD	NUMBER	four	num	25	SENT_588	[p13l1145t2200r1200b2219],
25	strategies	NNS	O	strategy	prep_of	22	SENT_588	[p13l239t2233r357b2260],
26	two	CD	DURATION	two	num	27	SENT_588	[p13l368t2237r411b2252],
27	years	NNS	NUMBER	year	tmod	25	SENT_588	[p13l421t2239r484b2260],
28	after	IN	O	after	_	0	SENT_588	[p13l495t2233r554b2252],
29	start	NN	O	start	prep_after	25	SENT_588	[p13l564t2237r620b2252],
30	of	IN	O	of	_	0	SENT_588	[p13l629t2233r656b2252],
31	treatment	NN	O	treatment	prep_of	29	SENT_588	[p13l664t2237r795b2252],
32	.	.	O	.	_	0	SENT_588	[p13l664t2237r795b2252],

1	Trans	NNP	O	Trans	nn	6	SENT_589	[p13l805t2233r878b2252],
2	R	NNP	O	R	nn	6	SENT_589	[p13l888t2233r906b2252],
3	Soc	NNP	O	Soc	nn	6	SENT_589	[p13l915t2233r958b2253],
4	Trop	NNP	O	Trop	nn	6	SENT_589	[p13l968t2233r1031b2260],
5	Med	NNP	O	Med	nn	6	SENT_589	[p13l1041t2233r1095b2252],
6	Hyg	NNP	O	Hyg	_	0	SENT_589	[p13l1105t2233r1155b2260],
7	90	CD	NUMBER	90	num	6	SENT_589	[p13l1164t2233r1198b2252],
8	:	:	O	:	_	0	SENT_589	[p13l1164t2233r1198b2252],
9	423	CD	NUMBER	423	num	10	SENT_589	[p13l239t2266r348b2286],
10	—	NN	O	—	dep	6	SENT_589	[p13l239t2266r348b2286],
11	428	CD	NUMBER	428	dep	10	SENT_589	[p13l239t2266r348b2286],
12	.	.	O	.	_	0	SENT_589	[p13l239t2266r348b2286],

1	Bernhard	NNP	PERSON	Bernhard	nn	2	SENT_590	[p13l239t2300r359b2319],
2	P	NN	PERSON	p	nsubj	11	SENT_590	[p13l369t2300r390b2323],
3	,	,	O	,	_	0	SENT_590	[p13l369t2300r390b2323],
4	Magnussen	NNP	PERSON	Magnussen	nn	5	SENT_590	[p13l400t2300r539b2327],
5	P	NN	O	p	appos	2	SENT_590	[p13l548t2300r570b2323],
6	,	,	O	,	_	0	SENT_590	[p13l548t2300r570b2323],
7	Lemnge	NNP	ORGANIZATION	Lemnge	nn	8	SENT_590	[p13l580t2300r680b2327],
8	MM	NN	ORGANIZATION	mm	appos	2	SENT_590	[p13l690t2300r738b2319],
9	(	CD	NUMBER	(	num	10	SENT_590	[p13l748t2300r823b2325],
10	2001	CD	DATE	2001	dep	8	SENT_590	[p13l748t2300r823b2325],
11	)	NN	O	)	_	0	SENT_590	[p13l748t2300r823b2325],
12	A	DT	O	a	dep	11	SENT_590	[p13l832t2300r852b2319],
13	randomized	VBN	O	randomize	partmod	11	SENT_590	[p13l861t2300r1019b2323],
14	,	,	O	,	_	0	SENT_590	[p13l861t2300r1019b2323],
15	double-blind	JJ	O	double-blind	amod	18	SENT_590	[p13l1029t2300r1199b2323],
16	,	,	O	,	_	0	SENT_590	[p13l1029t2300r1199b2323],
17	placebo-controlled	JJ	O	placebo-controlled	amod	18	SENT_590	[p13l239t2333r480b2360],
18	study	NN	O	study	dobj	11	SENT_590	[p13l498t2333r564b2360],
19	with	IN	O	with	_	0	SENT_590	[p13l581t2333r635b2352],
20	diethylcarbamazine	NN	O	diethylcarbamazine	prep_with	18	SENT_590	[p13l653t2333r902b2360],
21	for	IN	O	for	_	0	SENT_590	[p13l920t2333r957b2352],
22	the	DT	O	the	det	23	SENT_590	[p13l975t2333r1013b2352],
23	treatment	NN	O	treatment	prep_for	18	SENT_590	[p13l1032t2337r1157b2352],
24	of	IN	O	of	_	0	SENT_590	[p13l1175t2333r1202b2352],
25	hydrocoele	NN	O	hydrocoele	prep_of	23	SENT_590	[p13l239t2366r378b2393],
26	in	IN	O	in	_	0	SENT_590	[p13l389t2366r412b2385],
27	an	DT	O	a	det	28	SENT_590	[p13l422t2373r451b2385],
28	area	NN	O	area	prep_in	25	SENT_590	[p13l461t2372r514b2385],
29	of	IN	O	of	_	0	SENT_590	[p13l523t2366r550b2385],
30	Tanzania	NNP	LOCATION	Tanzania	prep_of	28	SENT_590	[p13l557t2366r673b2385],
31	endemic	JJ	O	endemic	amod	18	SENT_590	[p13l682t2366r789b2385],
32	for	IN	O	for	_	0	SENT_590	[p13l799t2366r837b2385],
33	lymphatic	JJ	O	lymphatic	amod	34	SENT_590	[p13l845t2366r970b2393],
34	ﬁlariasis	NN	O	ﬁlariasis	prep_for	31	SENT_590	[p13l980t2366r1090b2385],
35	.	.	O	.	_	0	SENT_590	[p13l980t2366r1090b2385],

1	Trans	NNP	O	Trans	nn	6	SENT_591	[p13l1100t2366r1172b2385],
2	R	NNP	O	R	nn	6	SENT_591	[p13l1182t2366r1200b2385],
3	Soc	NNP	O	Soc	nn	6	SENT_591	[p13l239t2399r282b2419],
4	Trop	NNP	O	Trop	nn	6	SENT_591	[p13l294t2399r357b2426],
5	Med	NNP	O	Med	nn	6	SENT_591	[p13l370t2399r423b2418],
6	Hyg	NNP	O	Hyg	_	0	SENT_591	[p13l435t2399r485b2426],
7	95	CD	NUMBER	95	num	6	SENT_591	[p13l497t2399r530b2418],
8	:	:	O	:	_	0	SENT_591	[p13l497t2399r530b2418],
9	534	CD	NUMBER	534	num	10	SENT_591	[p13l544t2399r653b2418],
10	—	NN	O	—	dep	6	SENT_591	[p13l544t2399r653b2418],
11	536	CD	NUMBER	536	dep	10	SENT_591	[p13l544t2399r653b2418],
12	.	.	O	.	_	0	SENT_591	[p13l544t2399r653b2418],

1	.	.	O	.	_	0	SENT_592	[p13l205t2449r208b2452],

1	Joseph	NNP	PERSON	Joseph	nn	2	SENT_593	[p13l234t2433r322b2460],
2	A	NNP	PERSON	A	_	0	SENT_593	[p13l331t2433r357b2456],
3	,	,	O	,	_	0	SENT_593	[p13l331t2433r357b2456],
4	Mony	NNP	ORGANIZATION	Mony	nn	5	SENT_593	[p13l367t2433r437b2460],
5	P	NN	ORGANIZATION	p	appos	2	SENT_593	[p13l448t2433r469b2456],
6	,	,	O	,	_	0	SENT_593	[p13l448t2433r469b2456],
7	Prasad	NNP	O	Prasad	nn	8	SENT_593	[p13l479t2433r563b2452],
8	M	NNP	O	M	appos	2	SENT_593	[p13l573t2433r602b2456],
9	,	,	O	,	_	0	SENT_593	[p13l573t2433r602b2456],
10	John	NNP	PERSON	John	nn	11	SENT_593	[p13l608t2433r670b2460],
11	S	NNP	PERSON	S	appos	2	SENT_593	[p13l681t2433r701b2456],
12	,	,	O	,	_	0	SENT_593	[p13l681t2433r701b2456],
13	Srikanth	NNP	PERSON	Srikanth	appos	2	SENT_593	[p13l711t2433r826b2456],
14	,	,	O	,	_	0	SENT_593	[p13l711t2433r826b2456],
15	et	FW	O	et	appos	13	SENT_593	[p13l836t2437r859b2452],
16	al.	FW	O	al.	nn	17	SENT_593	[p13l869t2433r895b2452],
17	(	FW	O	(	dep	2	SENT_593	[p13l906t2433r981b2458],
18	2004	CD	DATE	2004	num	19	SENT_593	[p13l906t2433r981b2458],
19	)	CD	NUMBER	)	dep	17	SENT_593	[p13l906t2433r981b2458],
20	The	DT	O	the	det	21	SENT_593	[p13l991t2433r1039b2452],
21	efﬁcacies	NNS	O	efﬁcacies	dep	2	SENT_593	[p13l1050t2433r1164b2452],
22	of	IN	O	of	_	0	SENT_593	[p13l1175t2433r1202b2452],
23	affected-limb	JJ	O	affected-limb	amod	24	SENT_593	[p13l239t2466r407b2485],
24	care	NN	O	care	prep_of	21	SENT_593	[p13l420t2472r472b2485],
25	with	IN	O	with	_	0	SENT_593	[p13l484t2466r538b2485],
26	penicillin	NN	O	penicillin	nn	27	SENT_593	[p13l550t2466r670b2493],
27	diethylcarbamazine	NN	O	diethylcarbamazine	prep_with	24	SENT_593	[p13l682t2466r937b2493],
28	,	,	O	,	_	0	SENT_593	[p13l682t2466r937b2493],
29	the	DT	O	the	det	30	SENT_593	[p13l950t2466r988b2485],
30	combination	NN	O	combination	appos	2	SENT_593	[p13l1001t2466r1162b2485],
31	of	IN	O	of	_	0	SENT_593	[p13l1175t2466r1202b2485],
32	both	CC	O	both	preconj	33	SENT_593	[p13l239t2499r296b2518],
33	drugs	NNS	O	drug	prep_of	30	SENT_593	[p13l310t2499r378b2526],
34	or	CC	O	or	_	0	SENT_593	[p13l392t2505r419b2518],
35	antibiotic	JJ	O	antibiotic	amod	36	SENT_593	[p13l432t2499r554b2518],
36	ointment	NN	O	ointment	conj_or	33	SENT_593	[p13l568t2499r691b2522],
37	,	,	O	,	_	0	SENT_593	[p13l568t2499r691b2522],
38	in	IN	O	in	_	0	SENT_593	[p13l706t2499r729b2518],
39	the	DT	O	the	det	40	SENT_593	[p13l743t2499r781b2518],
40	prevention	NN	O	prevention	prep_in	2	SENT_593	[p13l795t2499r934b2526],
41	of	IN	O	of	_	0	SENT_593	[p13l948t2499r975b2518],
42	acute	JJ	O	acute	amod	43	SENT_593	[p13l986t2503r1052b2518],
43	adenolymphangitis	NN	O	adenolymphangitis	prep_of	40	SENT_593	[p13l1066t2499r1198b2526, p13l239t2533r355b2560],
44	during	IN	O	during	_	0	SENT_593	[p13l369t2533r454b2560],
45	bancroftian	JJ	O	bancroftian	amod	46	SENT_593	[p13l467t2533r616b2552],
46	ﬁlariasis	NN	O	ﬁlariasis	prep_during	43	SENT_593	[p13l630t2533r740b2552],
47	.	.	O	.	_	0	SENT_593	[p13l630t2533r740b2552],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_594	[p13l754t2533r807b2552],
2	Trop	NNP	PERSON	Trop	nn	4	SENT_594	[p13l821t2533r885b2560],
3	Med	NNP	PERSON	Med	nn	4	SENT_594	[p13l899t2533r953b2552],
4	Parasitol	NNP	PERSON	Parasitol	_	0	SENT_594	[p13l967t2533r1077b2552],
5	98	CD	NUMBER	98	num	4	SENT_594	[p13l1092t2533r1126b2552],
6	:	:	O	:	_	0	SENT_594	[p13l1092t2533r1126b2552],
7	685	CD	NUMBER	685	num	8	SENT_594	[p13l1141t2533r1198b2552],
8	—	NN	O	—	dep	4	SENT_594	[p13l1141t2533r1198b2552],
9	696	CD	NUMBER	696	dep	8	SENT_594	[p13l239t2566r288b2585],
10	.	.	O	.	_	0	SENT_594	[p13l239t2566r288b2585],

1	Freedman	NNP	O	Freedman	nn	2	SENT_595	[p13l239t2600r366b2619],
2	DO	NNP	O	DO	_	0	SENT_595	[p13l377t2600r426b2623],
3	,	,	O	,	_	0	SENT_595	[p13l377t2600r426b2623],
4	Bui	NNP	ORGANIZATION	Bui	nn	5	SENT_595	[p13l437t2600r479b2619],
5	T	NN	ORGANIZATION	t	appos	2	SENT_595	[p13l489t2600r513b2623],
6	,	,	O	,	_	0	SENT_595	[p13l489t2600r513b2623],
7	De	NNP	ORGANIZATION	De	nn	10	SENT_595	[p13l524t2600r557b2619],
8	Almeida	NNP	ORGANIZATION	Almeida	nn	10	SENT_595	[p13l567t2600r673b2619],
9	Filho	NNP	ORGANIZATION	Filho	nn	10	SENT_595	[p13l683t2600r747b2619],
10	PJ	NNP	ORGANIZATION	PJ	appos	2	SENT_595	[p13l758t2600r789b2627],
11	,	,	O	,	_	0	SENT_595	[p13l758t2600r789b2627],
12	Braga	NNP	ORGANIZATION	Braga	nn	13	SENT_595	[p13l800t2600r872b2627],
13	C	NNP	ORGANIZATION	C	appos	2	SENT_595	[p13l883t2600r907b2623],
14	,	,	O	,	_	0	SENT_595	[p13l883t2600r907b2623],
15	Maia	NNP	PERSON	Maia	appos	13	SENT_595	[p13l918t2600r978b2619],
16	e	LS	O	e	dep	18	SENT_595	[p13l988t2606r1000b2619],
17	Silva	NNP	PERSON	Silva	nn	18	SENT_595	[p13l1011t2600r1069b2620],
18	MC	NNP	O	MC	dep	2	SENT_595	[p13l1080t2600r1128b2623],
19	,	,	O	,	_	0	SENT_595	[p13l1080t2600r1128b2623],
20	et	FW	O	et	npadvmod	18	SENT_595	[p13l1139t2604r1162b2619],
21	al.	FW	O	al.	nn	22	SENT_595	[p13l1172t2600r1198b2619],
22	(	FW	O	(	dep	26	SENT_595	[p13l240t2633r314b2658],
23	1995	CD	DATE	1995	dep	22	SENT_595	[p13l240t2633r314b2658],
24	)	CD	NUMBER	)	dep	26	SENT_595	[p13l240t2633r314b2658],
25	Lymphoscintigraphic	JJ	O	lymphoscintigraphic	amod	26	SENT_595	[p13l324t2633r596b2660],
26	assessment	NN	O	assessment	dep	20	SENT_595	[p13l607t2637r743b2652],
27	of	IN	O	of	_	0	SENT_595	[p13l753t2633r780b2652],
28	the	DT	O	the	det	29	SENT_595	[p13l787t2633r826b2652],
29	effect	NN	O	effect	prep_of	26	SENT_595	[p13l836t2633r906b2652],
30	of	IN	O	of	_	0	SENT_595	[p13l916t2633r943b2652],
31	diethylcarbamazine	NN	O	diethylcarbamazine	nn	32	SENT_595	[p13l950t2633r1199b2660],
32	treatment	NN	O	treatment	prep_of	29	SENT_595	[p13l239t2670r365b2685],
33	on	IN	O	on	_	0	SENT_595	[p13l374t2672r405b2685],
34	lymphatic	JJ	O	lymphatic	amod	35	SENT_595	[p13l415t2666r540b2693],
35	damage	NN	O	damage	prep_on	18	SENT_595	[p13l550t2666r647b2693],
36	in	IN	O	in	_	0	SENT_595	[p13l657t2666r680b2685],
37	human	JJ	O	human	amod	39	SENT_595	[p13l690t2666r777b2685],
38	bancroftian	NN	O	bancroftian	nn	39	SENT_595	[p13l787t2666r936b2685],
39	ﬁlariasis	NN	O	ﬁlariasis	prep_in	35	SENT_595	[p13l945t2666r1055b2685],
40	.	.	O	.	_	0	SENT_595	[p13l945t2666r1055b2685],

1	AmJ	NNP	O	AmJ	nn	4	SENT_596	[p13l1065t2666r1126b2693],
2	Trop	NNP	O	Trop	nn	4	SENT_596	[p13l1135t2666r1199b2693],
3	Med	NNP	O	Med	nn	4	SENT_596	[p13l239t2699r293b2718],
4	Hyg	NNP	O	Hyg	_	0	SENT_596	[p13l305t2699r355b2726],
5	52	CD	NUMBER	52	num	4	SENT_596	[p13l367t2699r400b2718],
6	:	:	O	:	_	0	SENT_596	[p13l367t2699r400b2718],
7	258	CD	NUMBER	258	num	8	SENT_596	[p13l413t2699r522b2719],
8	—	NN	O	—	dep	4	SENT_596	[p13l413t2699r522b2719],
9	261	CD	NUMBER	261	dep	8	SENT_596	[p13l413t2699r522b2719],
10	.	.	O	.	_	0	SENT_596	[p13l413t2699r522b2719],

1	Kerketta	NNP	O	Kerketta	nn	2	SENT_597	[p13l239t2733r348b2752],
2	AS	NNP	O	AS	_	0	SENT_597	[p13l365t2733r406b2756],
3	,	,	O	,	_	0	SENT_597	[p13l365t2733r406b2756],
4	Babu	NNP	ORGANIZATION	Babu	nn	5	SENT_597	[p13l424t2733r488b2752],
5	BV	NN	ORGANIZATION	bv	appos	2	SENT_597	[p13l505t2733r549b2756],
6	,	,	O	,	_	0	SENT_597	[p13l505t2733r549b2756],
7	Rath	NN	PERSON	rath	nn	8	SENT_597	[p13l567t2733r625b2752],
8	K	NN	PERSON	k	appos	2	SENT_597	[p13l643t2733r668b2756],
9	,	,	O	,	_	0	SENT_597	[p13l643t2733r668b2756],
10	Jangid	NNP	O	Jangid	nn	11	SENT_597	[p13l681t2733r765b2760],
11	PK	NNP	O	PK	appos	2	SENT_597	[p13l783t2733r825b2756],
12	,	,	O	,	_	0	SENT_597	[p13l783t2733r825b2756],
13	Nayak	NNP	ORGANIZATION	Nayak	appos	2	SENT_597	[p13l843t2733r920b2760],
14	AN	DT	ORGANIZATION	a	dep	13	SENT_597	[p13l937t2733r984b2756],
15	,	,	O	,	_	0	SENT_597	[p13l937t2733r984b2756],
16	et	FW	O	et	appos	2	SENT_597	[p13l1003t2737r1025b2752],
17	al.	FW	O	al.	nn	18	SENT_597	[p13l1043t2733r1069b2752],
18	(	FW	O	(	dep	16	SENT_597	[p13l1088t2733r1163b2758],
19	2005	CD	DATE	2005	number	20	SENT_597	[p13l1088t2733r1163b2758],
20	)	CD	NUMBER	)	num	21	SENT_597	[p13l1088t2733r1163b2758],
21	A	DT	O	a	dep	18	SENT_597	[p13l1180t2733r1199b2752],
22	randomized	VBN	O	randomize	partmod	2	SENT_597	[p13l239t2766r390b2785],
23	clinical	JJ	O	clinical	amod	24	SENT_597	[p13l410t2766r500b2785],
24	trial	NN	O	trial	dobj	22	SENT_597	[p13l522t2766r572b2785],
25	to	TO	O	to	aux	26	SENT_597	[p13l594t2770r617b2785],
26	compare	VB	O	compare	xcomp	22	SENT_597	[p13l638t2772r748b2793],
27	the	DT	O	the	det	28	SENT_597	[p13l769t2766r807b2785],
28	efﬁcacy	NN	O	efﬁcacy	dobj	26	SENT_597	[p13l828t2766r922b2793],
29	of	IN	O	of	_	0	SENT_597	[p13l943t2766r970b2785],
30	three	CD	NUMBER	three	num	32	SENT_597	[p13l987t2766r1053b2785],
31	treatment	NN	O	treatment	nn	32	SENT_597	[p13l1073t2770r1199b2785],
32	regimens	NNS	O	regimen	prep_of	28	SENT_597	[p13l239t2799r353b2826],
33	along	IN	O	along	_	0	SENT_597	[p13l372t2799r441b2826],
34	with	IN	O	with	_	0	SENT_597	[p13l457t2799r511b2818],
35	footcare	NN	O	footcare	prep_along_with	32	SENT_597	[p13l529t2799r634b2818],
36	in	IN	O	in	_	0	SENT_597	[p13l653t2799r676b2818],
37	the	DT	O	the	det	39	SENT_597	[p13l694t2799r732b2818],
38	morbidity	NN	O	morbidity	nn	39	SENT_597	[p13l751t2799r876b2826],
39	management	NN	O	management	prep_in	26	SENT_597	[p13l895t2803r1058b2826],
40	of	IN	O	of	_	0	SENT_597	[p13l1076t2799r1103b2818],
41	ﬁlarial	JJ	O	ﬁlarial	amod	42	SENT_597	[p13l1118t2799r1198b2818],
42	lymphedema	NN	O	lymphedema	prep_of	39	SENT_597	[p13l239t2833r407b2860],
43	.	.	O	.	_	0	SENT_597	[p13l239t2833r407b2860],

1	Trop	NNP	O	Trop	nn	4	SENT_598	[p13l419t2833r483b2860],
2	Med	NNP	O	Med	nn	4	SENT_598	[p13l495t2833r549b2852],
3	Int	NNP	O	Int	nn	4	SENT_598	[p13l561t2833r597b2852],
4	Health	NNP	O	Health	_	0	SENT_598	[p13l609t2833r693b2852],
5	10	CD	NUMBER	10	num	4	SENT_598	[p13l708t2833r739b2852],
6	:	:	O	:	_	0	SENT_598	[p13l708t2833r739b2852],
7	698	CD	NUMBER	698	num	8	SENT_598	[p13l752t2831r861b2852],
8	—	NN	O	—	dep	4	SENT_598	[p13l752t2831r861b2852],
9	705	CD	NUMBER	705	dep	8	SENT_598	[p13l752t2831r861b2852],
10	.	.	O	.	_	0	SENT_598	[p13l752t2831r861b2852],

1	Melrose	NNP	O	Melrose	nn	2	SENT_599	[p13l239t2866r338b2885],
2	WD	NNP	O	WD	_	0	SENT_599	[p13l347t2866r393b2886],
3	(	CD	NUMBER	(	num	6	SENT_599	[p13l405t2866r480b2891],
4	2003	CD	DATE	2003	num	6	SENT_599	[p13l405t2866r480b2891],
5	)	NNP	O	)	nn	6	SENT_599	[p13l405t2866r480b2891],
6	Chemotherapy	NNP	O	Chemotherapy	dep	2	SENT_599	[p13l490t2866r679b2893],
7	for	IN	O	for	_	0	SENT_599	[p13l688t2866r725b2885],
8	lymphatic	JJ	O	lymphatic	amod	9	SENT_599	[p13l734t2866r859b2893],
9	ﬁlariasis	NN	O	ﬁlariasis	prep_for	6	SENT_599	[p13l870t2866r979b2885],
10	:	:	O	:	_	0	SENT_599	[p13l870t2866r979b2885],
11	Progress	NNP	O	Progress	dep	2	SENT_599	[p13l990t2866r1096b2893],
12	but	CC	O	but	_	0	SENT_599	[p13l1106t2866r1148b2885],
13	not	RB	O	not	_	0	SENT_599	[p13l1157t2870r1199b2885],
14	perfection	NN	O	perfection	conj_negcc	11	SENT_599	[p13l239t2899r377b2926],
15	.	.	O	.	_	0	SENT_599	[p13l239t2899r377b2926],

1	Expert	NN	O	expert	nn	5	SENT_600	[p13l389t2899r474b2926],
2	Rev	NN	O	rev	nn	5	SENT_600	[p13l486t2899r531b2918],
3	Anti	NNP	O	Anti	nn	5	SENT_600	[p13l542t2899r597b2918],
4	Infect	NNP	O	Infect	nn	5	SENT_600	[p13l609t2899r683b2918],
5	Ther	NNP	O	Ther	_	0	SENT_600	[p13l695t2899r756b2918],
6	1	CD	NUMBER	1	dep	5	SENT_600	[p13l770t2899r786b2918],
7	:	:	O	:	_	0	SENT_600	[p13l770t2899r786b2918],
8	571	CD	NUMBER	571	num	9	SENT_600	[p13l800t2897r908b2918],
9	—	NN	O	—	dep	5	SENT_600	[p13l800t2897r908b2918],
10	577	CD	NUMBER	577	dep	9	SENT_600	[p13l800t2897r908b2918],
11	.	.	O	.	_	0	SENT_600	[p13l800t2897r908b2918],

1	Das	NNS	MISC	da	nn	2	SENT_601	[p13l239t2933r283b2952],
2	L	NN	O	l	nsubj	10	SENT_601	[p13l298t2933r320b2956],
3	,	,	O	,	_	0	SENT_601	[p13l298t2933r320b2956],
4	Subramanyam	NNP	PERSON	Subramanyam	nn	6	SENT_601	[p13l335t2933r517b2960],
5	Reddy	NNP	PERSON	Reddy	nn	6	SENT_601	[p13l532t2933r611b2960],
6	G	NNP	PERSON	G	appos	2	SENT_601	[p13l625t2933r651b2956],
7	,	,	O	,	_	0	SENT_601	[p13l625t2933r651b2956],
8	Pani	NNP	PERSON	Pani	nn	9	SENT_601	[p13l666t2933r721b2952],
9	S	NNP	O	S	appos	6	SENT_601	[p13l736t2933r749b2953],
10	(	VBD	O	(	_	0	SENT_601	[p13l765t2933r840b2958],
11	2003	CD	DATE	2003	num	12	SENT_601	[p13l765t2933r840b2958],
12	)	CD	NUMBER	)	dobj	10	SENT_601	[p13l765t2933r840b2958],
13	Some	DT	O	some	det	14	SENT_601	[p13l855t2933r924b2953],
14	observations	NNS	O	observation	npadvmod	10	SENT_601	[p13l939t2933r1099b2952],
15	on	IN	O	on	_	0	SENT_601	[p13l1114t2939r1145b2952],
16	the	DT	O	the	det	17	SENT_601	[p13l1160t2933r1198b2952],
17	effect	NN	O	effect	prep_on	10	SENT_601	[p13l239t2966r310b2985],
18	of	IN	O	of	_	0	SENT_601	[p13l332t2966r359b2985],
19	Daflon	NNP	LOCATION	Daflon	prep_of	17	SENT_601	[p13l378t2966r463b2985],
20	(	CD	NUMBER	(	num	19	SENT_601	[p13l486t2966r639b2991],
21	micronized	VBN	O	micronize	partmod	17	SENT_601	[p13l486t2966r639b2991],
22	puriﬁed	JJ	O	puriﬁed	amod	24	SENT_601	[p13l661t2966r763b2993],
23	flavonoid	NN	O	flavonoid	nn	24	SENT_601	[p13l785t2966r905b2985],
24	fraction	NN	O	fraction	dobj	21	SENT_601	[p13l926t2966r1029b2985],
25	of	IN	O	of	_	0	SENT_601	[p13l1051t2966r1078b2985],
26	Rutaceae	FW	O	rutaceae	prep_of	24	SENT_601	[p13l1096t2966r1200b2986],
27	aumntiae	FW	O	aumntiae	nn	28	SENT_601	[p13l238t2999r355b3024],
28	)	FW	O	)	amod	24	SENT_601	[p13l238t2999r355b3024],
29	in	IN	O	in	_	0	SENT_601	[p13l367t2999r390b3018],
30	bancroftian	JJ	O	bancroftian	amod	32	SENT_601	[p13l402t2999r551b3018],
31	ﬁlarial	JJ	O	ﬁlarial	amod	32	SENT_601	[p13l563t2999r644b3018],
32	lymphedema	NN	O	lymphedema	prep_in	21	SENT_601	[p13l656t2999r824b3026],
33	.	.	O	.	_	0	SENT_601	[p13l656t2999r824b3026],

1	FilariaJ	NN	O	filariaj	_	0	SENT_602	[p13l837t2999r938b3026],
2	2	CD	NUMBER	2	num	1	SENT_602	[p13l950t2999r969b3019],
3	:	:	O	:	_	0	SENT_602	[p13l950t2999r969b3019],
4	5	CD	NUMBER	5	dep	1	SENT_602	[p13l982t2999r1000b3018],
5	.	.	O	.	_	0	SENT_602	[p13l982t2999r1000b3018],

1	xi	NN	O	xi	_	0	SENT_603	[p13l190t2298r202b2319],

1	؞	NN	O	؞	nsubj	4	SENT_604	[p13l188t3077r261b3136],
2	*	CD	NUMBER	*	num	3	SENT_604	[p13l188t3077r261b3136],
3	PLoS	NN	O	plo	dep	1	SENT_604	[p13l288t3093r352b3116],
4	Pathogens	VBD	O	pathogen	_	0	SENT_604	[p13l367t3092r511b3123],
5	|	CD	NUMBER	|	num	6	SENT_604	[p13l526t3091r528b3124],
6	www	NN	O	www	dobj	4	SENT_604	[p13l543t3092r882b3123],
7	.	.	O	.	_	0	SENT_604	[p13l543t3092r882b3123],

1	p	NN	O	p	nn	4	SENT_605	[p13l543t3092r882b3123],
2	|	CD	NUMBER	|	num	4	SENT_605	[p13l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	nn	4	SENT_605	[p13l543t3092r882b3123],
4	C	NN	O	c	_	0	SENT_605	[p13l198t355r224b382],
5	)	CD	NUMBER	)	num	6	SENT_605	[p13l198t355r224b382],
6	Stage	NN	O	stage	dep	4	SENT_605	[p13l238t355r314b385],
7	4	CD	NUMBER	4	dep	6	SENT_605	[p13l326t356r349b382],
8	,	,	O	,	_	0	SENT_605	[p13l326t356r349b382],
9	alteration	NN	O	alteration	appos	7	SENT_605	[p13l362t354r492b378],
10	of	IN	O	of	_	0	SENT_605	[p13l506t354r534b378],
11	skin	NN	O	skin	nn	12	SENT_605	[p13l545t354r596b378],
12	texture	NN	O	texture	prep_of	9	SENT_605	[p13l610t358r708b378],
13	and	CC	O	and	_	0	SENT_605	[p13l721t354r770b378],
14	formation	NN	O	formation	conj_and	12	SENT_605	[p13l784t354r918b378],
15	of	IN	O	of	_	0	SENT_605	[p13l933t354r961b378],
16	knobs	NNS	O	knob	prep_of	9	SENT_605	[p13l973t354r1054b378],
17	(	CD	NUMBER	(	num	18	SENT_605	[p13l1068t354r1253b382],
18	arrowheads	NNS	O	arrowhead	dep	4	SENT_605	[p13l1068t354r1253b382],
19	)	CD	NUMBER	)	dep	18	SENT_605	[p13l1068t354r1253b382],
20	.	.	O	.	_	0	SENT_605	[p13l1068t354r1253b382],

1	D	NN	O	d	tmod	10	SENT_606	[p13l199t390r226b417],
2	)	CD	NUMBER	)	num	1	SENT_606	[p13l199t390r226b417],
3	Stage	NN	O	stage	dep	1	SENT_606	[p13l241t390r317b420],
4	5	CD	NUMBER	5	num	3	SENT_606	[p13l330t391r351b417],
5	,	,	O	,	_	0	SENT_606	[p13l330t391r351b417],
6	presentation	NN	O	presentation	nsubj	10	SENT_606	[p13l366t390r538b420],
7	of	IN	O	of	_	0	SENT_606	[p13l552t389r580b413],
8	deep	JJ	O	deep	amod	9	SENT_606	[p13l591t389r660b420],
9	skin	NN	O	skin	prep_of	6	SENT_606	[p13l673t389r724b413],
10	folds	VBZ	O	fold	_	0	SENT_606	[p13l738t389r803b413],
11	in	IN	O	in	cc	15	SENT_606	[p13l817t390r839b413],
12	addition	NN	O	addition	_	0	SENT_606	[p13l854t389r966b413],
13	to	TO	O	to	_	0	SENT_606	[p13l980t393r1007b413],
14	the	DT	O	the	det	15	SENT_606	[p13l1020t389r1065b413],
15	alterations	NNS	O	alteration	dobj	10	SENT_606	[p13l1078t389r1221b413],
16	of	IN	O	of	_	0	SENT_606	[p13l1235t389r1263b413],
17	stage	NN	O	stage	prep_of	15	SENT_606	[p13l1274t393r1347b420],
18	4	CD	NUMBER	4	num	17	SENT_606	[p13l1359t391r1382b417],
19	;	:	O	;	_	0	SENT_606	[p13l1359t391r1382b417],
20	E	NN	O	e	dep	15	SENT_606	[p13l199t425r221b452],
21	)	CD	NUMBER	)	num	20	SENT_606	[p13l199t425r221b452],
22	Satge	NN	ORGANIZATION	satge	dep	20	SENT_606	[p13l235t425r311b455],
23	6	CD	NUMBER	6	num	22	SENT_606	[p13l324t426r345b452],
24	,	,	O	,	_	0	SENT_606	[p13l324t426r345b452],
25	presentation	NN	O	presentation	dep	15	SENT_606	[p13l360t425r532b455],
26	of	IN	O	of	_	0	SENT_606	[p13l546t424r574b448],
27	mossy	JJ	O	mossy	amod	28	SENT_606	[p13l586t431r671b455],
28	lesion	NN	O	lesion	prep_of	25	SENT_606	[p13l685t424r762b448],
29	in	IN	O	in	_	0	SENT_606	[p13l777t425r799b448],
30	addition	NN	O	addition	prep_in	28	SENT_606	[p13l813t424r926b448],
31	to	TO	O	to	_	0	SENT_606	[p13l939t428r967b448],
32	the	DT	O	the	det	33	SENT_606	[p13l980t424r1024b448],
33	alterations	NNS	O	alteration	prep_to	10	SENT_606	[p13l1037t424r1181b448],
34	of	IN	O	of	_	0	SENT_606	[p13l1194t424r1222b448],
35	stage	NN	O	stage	prep_of	33	SENT_606	[p13l1234t428r1307b455],
36	5	CD	NUMBER	5	num	35	SENT_606	[p13l1320t426r1341b448],
37	.	.	O	.	_	0	SENT_606	[p13l1320t426r1341b448],

1	Supporting	VBG	O	support	_	0	SENT_607	[p13l1277t596r1493b636],
2	Information	NN	O	information	nsubj	4	SENT_607	[p13l1513t595r1740b628],
3	Accession	NNP	O	Accession	nn	4	SENT_607	[p13l1275t653r1418b676],
4	Numbers	NNS	O	number	xcomp	1	SENT_607	[p13l1430t653r1564b676],

1	The	DT	O	the	det	4	SENT_608	[p13l1276t701r1331b724],
2	GenBank	NN	ORGANIZATION	genbank	nn	4	SENT_608	[p13l1344t701r1477b724],
3	(	CD	NUMBER	(	num	4	SENT_608	[p13l1490t701r2051b732],
4	http://www.ncbi.nlm.nih.gov/Genbank	NN	O	http://www.ncbi.nlm.nih.gov/genbank	nsubj	21	SENT_608	[p13l1490t701r2051b732],
5	)	CD	NUMBER	)	num	7	SENT_608	[p13l1490t701r2051b732],
6	accession	NN	O	accession	nn	7	SENT_608	[p13l2064t701r2198b724],
7	numbers	NNS	O	number	nsubj	14	SENT_608	[p13l2211t709r2286b723, p13l1276t740r1335b763],
8	for	IN	O	for	_	0	SENT_608	[p13l1353t740r1397b762],
9	the	DT	O	the	det	13	SENT_608	[p13l1415t740r1459b763],
10	gene	NN	O	gene	nn	13	SENT_608	[p13l1477t748r1544b771],
11	and	CC	O	and	_	0	SENT_608	[p13l1563t740r1615b763],
12	gene	NN	O	gene	conj_and	10	SENT_608	[p13l1633t748r1700b771],
13	products	NNS	O	product	prep_for	7	SENT_608	[p13l1719t740r1846b771],
14	discussed	VBN	O	discuss	rcmod	4	SENT_608	[p13l1865t740r1999b763],
15	in	IN	O	in	_	0	SENT_608	[p13l2018t740r2044b762],
16	this	DT	O	this	det	17	SENT_608	[p13l2064t740r2114b763],
17	paper	NN	O	paper	prep_in	14	SENT_608	[p13l2133t748r2217b771],
18	are	VBP	O	be	cop	21	SENT_608	[p13l2235t748r2286b763],
19	:	:	O	:	_	0	SENT_608	[p13l2235t748r2286b763],
20	soluble	JJ	O	soluble	amod	21	SENT_608	[p13l1277t780r1378b803],
21	VEGFR	NN	O	vegfr	_	0	SENT_608	[p13l1387t780r1522b803],
22	—	CD	NUMBER	—	number	23	SENT_608	[p13l1387t780r1522b803],
23	3	CD	NUMBER	3	dep	21	SENT_608	[p13l1387t780r1522b803],
24	(	NN	O	(	nn	26	SENT_608	[p13l1534t780r1748b809],
25	NM_002020	NN	O	nm_002020	nn	26	SENT_608	[p13l1534t780r1748b809],
26	)	NN	O	)	dep	23	SENT_608	[p13l1534t780r1748b809],
27	;	:	O	;	_	0	SENT_608	[p13l1534t780r1748b809],
28	VEGF-C	NN	O	vegf-c	nn	31	SENT_608	[p13l1757t780r1876b803],
29	(	CD	NUMBER	(	num	31	SENT_608	[p13l1887t778r2067b808],
30	CAA63907	NN	O	caa63907	nn	31	SENT_608	[p13l1887t778r2067b808],
31	)	NN	O	)	conj_and	21	SENT_608	[p13l1887t778r2067b808],
32	;	:	O	;	_	0	SENT_608	[p13l1887t778r2067b808],
33	and	CC	O	and	_	0	SENT_608	[p13l2078t780r2130b803],
34	Wuchereria	FW	O	wuchereria	nn	41	SENT_608	[p13l2143t780r2288b803],
35	brmcmfti	FW	O	brmcmfti	nn	41	SENT_608	[p13l1277t819r1388b850],
36	Wolba	FW	O	wolba	nn	41	SENT_608	[p13l1403t819r1601b850],
37	£	FW	O	£	nn	41	SENT_608	[p13l1403t819r1601b850],
38	hia	FW	O	hia	nn	41	SENT_608	[p13l1403t819r1601b850],
39	—	FW	O	—	nn	41	SENT_608	[p13l1403t819r1601b850],
40	ftsZ	NN	O	ftsz	nn	41	SENT_608	[p13l1403t819r1601b850],
41	gene	NN	O	gene	conj_and	21	SENT_608	[p13l1613t827r1679b850],
42	(	CD	NUMBER	(	num	44	SENT_608	[p13l1694t819r1863b848],
43	AF081198	NN	O	af081198	nn	44	SENT_608	[p13l1694t819r1863b848],
44	)	NN	O	)	dep	41	SENT_608	[p13l1694t819r1863b848],
45	.	.	O	.	_	0	SENT_608	[p13l1694t819r1863b848],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_609	[p13l1276t914r1636b954],

1	We	PRP	O	we	nsubj	2	SENT_610	[p13l1276t992r1321b1014],
2	thank	VBP	O	thank	_	0	SENT_610	[p13l1334t991r1415b1014],
3	the	DT	O	the	det	4	SENT_610	[p13l1428t991r1472b1014],
4	individuals	NNS	O	individual	dobj	2	SENT_610	[p13l1485t991r1641b1014],
5	of	IN	O	of	_	0	SENT_610	[p13l1654t991r1685b1013],
6	the	DT	O	the	det	10	SENT_610	[p13l1694t991r1738b1014],
7	District	NNP	ORGANIZATION	District	nn	10	SENT_610	[p13l1750t991r1859b1014],
8	Health	NNP	ORGANIZATION	Health	nn	10	SENT_610	[p13l1871t991r1968b1014],
9	Management	NNP	ORGANIZATION	Management	nn	10	SENT_610	[p13l1980t992r2167b1022],
10	team	NN	O	team	prep_of	4	SENT_610	[p13l2179t996r2249b1014],
11	at	IN	O	at	_	0	SENT_610	[p13l2261t996r2287b1014],
12	Axim	NNP	LOCATION	Axim	nn	17	SENT_610	[p13l1276t1031r1353b1053],
13	(	CD	NUMBER	(	num	17	SENT_610	[p13l1379t1032r1487b1059],
14	Nzema	NNP	LOCATION	Nzema	nn	17	SENT_610	[p13l1379t1032r1487b1059],
15	East	NNP	LOCATION	East	nn	17	SENT_610	[p13l1511t1032r1569b1054],
16	District	NNP	LOCATION	District	nn	17	SENT_610	[p13l1594t1031r1720b1059],
17	)	NNP	O	)	prep_at	10	SENT_610	[p13l1594t1031r1720b1059],
18	,	,	O	,	_	0	SENT_610	[p13l1594t1031r1720b1059],
19	Western	NNP	ORGANIZATION	Western	nn	20	SENT_610	[p13l1745t1032r1865b1054],
20	Region	NNP	ORGANIZATION	Region	appos	10	SENT_610	[p13l1890t1031r1999b1062],
21	,	,	O	,	_	0	SENT_610	[p13l1890t1031r1999b1062],
22	Ghana	NNP	LOCATION	Ghana	appos	10	SENT_610	[p13l2024t1031r2125b1058],
23	,	,	O	,	_	0	SENT_610	[p13l2024t1031r2125b1058],
24	for	IN	O	for	_	0	SENT_610	[p13l2150t1031r2194b1053],
25	their	PRP$	O	they	poss	26	SENT_610	[p13l2218t1031r2288b1054],
26	cooperation	NN	O	cooperation	prep_for	2	SENT_610	[p13l1276t1070r1460b1101],
27	.	.	O	.	_	0	SENT_610	[p13l1276t1070r1460b1101],

1	Author	NN	O	author	nn	2	SENT_611	[p13l1313t1112r1417b1134],
2	contributions	NNS	O	contribution	_	0	SENT_611	[p13l1432t1112r1634b1135],
3	.	.	O	.	_	0	SENT_611	[p13l1432t1112r1634b1135],

1	AH	RB	O	ah	advmod	7	SENT_612	[p13l1651t1112r1707b1139],
2	,	,	O	,	_	0	SENT_612	[p13l1651t1112r1707b1139],
3	MT	NNP	O	MT	nsubj	9	SENT_612	[p13l1724t1113r1779b1139],
4	,	,	O	,	_	0	SENT_612	[p13l1724t1113r1779b1139],
5	and	CC	O	and	_	0	SENT_612	[p13l1797t1112r1849b1135],
6	OA	NN	O	oa	conj_and	3	SENT_612	[p13l1866t1112r1914b1135],
7	conceived	VBD	O	conceive	_	0	SENT_612	[p13l1930t1112r2074b1135],
8	and	CC	O	and	_	0	SENT_612	[p13l2091t1112r2143b1135],
9	designed	VBD	O	design	conj_and	7	SENT_612	[p13l2160t1112r2286b1143],
10	the	DT	O	the	det	11	SENT_612	[p13l1277t1149r1321b1172],
11	experiments	NNS	O	experiment	dobj	9	SENT_612	[p13l1335t1149r1521b1180],
12	.	.	O	.	_	0	SENT_612	[p13l1335t1149r1521b1180],

1	AYD	NNP	O	AYD	nn	9	SENT_613	[p13l1535t1149r1610b1176],
2	,	,	O	,	_	0	SENT_613	[p13l1535t1149r1610b1176],
3	SM	NNP	O	SM	appos	9	SENT_613	[p13l1625t1149r1676b1176],
4	,	,	O	,	_	0	SENT_613	[p13l1625t1149r1676b1176],
5	SS	NNP	O	SS	appos	9	SENT_613	[p13l1691t1149r1731b1176],
6	,	,	O	,	_	0	SENT_613	[p13l1691t1149r1731b1176],
7	YMD	NNP	O	YMD	appos	9	SENT_613	[p13l1745t1150r1825b1176],
8	,	,	O	,	_	0	SENT_613	[p13l1745t1150r1825b1176],
9	LB	NNP	O	LB	nsubj	15	SENT_613	[p13l1839t1149r1886b1176],
10	,	,	O	,	_	0	SENT_613	[p13l1839t1149r1886b1176],
11	KP	NN	O	kp	conj_and	9	SENT_613	[p13l1901t1150r1948b1176],
12	,	,	O	,	_	0	SENT_613	[p13l1901t1150r1948b1176],
13	and	CC	O	and	_	0	SENT_613	[p13l1963t1149r2015b1172],
14	JL	NN	O	jl	conj_and	9	SENT_613	[p13l2024t1150r2059b1180],
15	performed	VBD	O	perform	_	0	SENT_613	[p13l2073t1149r2228b1180],
16	the	DT	O	the	det	17	SENT_613	[p13l2243t1149r2286b1172],
17	experiments	NNS	O	experiment	dobj	15	SENT_613	[p13l1276t1186r1463b1217],
18	.	.	O	.	_	0	SENT_613	[p13l1276t1186r1463b1217],

1	AYD	NNP	O	AYD	nsubj	9	SENT_614	[p13l1475t1186r1550b1213],
2	,	,	O	,	_	0	SENT_614	[p13l1475t1186r1550b1213],
3	SM	NNP	O	SM	nsubj	9	SENT_614	[p13l1563t1186r1614b1213],
4	,	,	O	,	_	0	SENT_614	[p13l1563t1186r1614b1213],
5	BL	NN	O	bl	nsubj	9	SENT_614	[p13l1626t1186r1673b1213],
6	,	,	O	,	_	0	SENT_614	[p13l1626t1186r1673b1213],
7	and	CC	O	and	_	0	SENT_614	[p13l1686t1186r1738b1209],
8	AH	NN	O	ah	conj_and	1	SENT_614	[p13l1749t1186r1798b1208],
9	analyzed	VBD	O	analyze	_	0	SENT_614	[p13l1811t1186r1934b1217],
10	the	DT	O	the	det	11	SENT_614	[p13l1947t1186r1990b1209],
11	data	NNS	O	datum	dobj	9	SENT_614	[p13l2003t1186r2070b1209],
12	.	.	O	.	_	0	SENT_614	[p13l2003t1186r2070b1209],

1	AYD	NNP	O	AYD	nn	3	SENT_615	[p13l2083t1186r2158b1213],
2	,	,	O	,	_	0	SENT_615	[p13l2083t1186r2158b1213],
3	SM	NNP	O	SM	nsubj	7	SENT_615	[p13l2170t1186r2221b1213],
4	,	,	O	,	_	0	SENT_615	[p13l2170t1186r2221b1213],
5	and	CC	O	and	_	0	SENT_615	[p13l2234t1186r2287b1209],
6	AH	NN	O	ah	conj_and	3	SENT_615	[p13l1276t1224r1324b1246],
7	wrote	VBD	O	write	_	0	SENT_615	[p13l1337t1229r1419b1247],
8	the	DT	O	the	det	9	SENT_615	[p13l1433t1224r1477b1247],
9	paper	NN	O	paper	dobj	7	SENT_615	[p13l1491t1232r1581b1255],
10	.	.	O	.	_	0	SENT_615	[p13l1491t1232r1581b1255],

1	Funding	NNP	O	Funding	_	0	SENT_616	[p13l1313t1265r1441b1296],
2	.	.	O	.	_	0	SENT_616	[p13l1313t1265r1441b1296],

1	We	PRP	O	we	nsubj	3	SENT_617	[p13l1454t1266r1499b1288],
2	are	VBP	O	be	cop	3	SENT_617	[p13l1512t1273r1555b1288],
3	grateful	JJ	O	grateful	_	0	SENT_617	[p13l1567t1265r1680b1296],
4	for	IN	O	for	_	0	SENT_617	[p13l1691t1265r1735b1287],
5	ﬁnancial	JJ	O	ﬁnancial	amod	6	SENT_617	[p13l1745t1265r1870b1288],
6	support	NN	O	support	prep_for	3	SENT_617	[p13l1882t1270r1995b1296],
7	from	IN	O	from	_	0	SENT_617	[p13l2006t1265r2077b1287],
8	the	DT	O	the	det	13	SENT_617	[p13l2090t1265r2134b1288],
9	European	JJ	ORGANIZATION	european	amod	13	SENT_617	[p13l2145t1266r2287b1296],
10	Commission	NNP	ORGANIZATION	Commission	nn	13	SENT_617	[p13l1277t1303r1455b1326],
11	(	CD	NUMBER	(	num	13	SENT_617	[p13l1472t1304r1524b1331],
12	EU	NNP	ORGANIZATION	EU	nn	13	SENT_617	[p13l1472t1304r1524b1331],
13	grant	NN	O	grant	prep_from	3	SENT_617	[p13l1540t1308r1616b1334],
14	ICA4	NN	O	ica4	dep	13	SENT_617	[p13l1632t1303r1955b1332],
15	.	.	O	.	_	0	SENT_617	[p13l1632t1303r1955b1332],

1	—	NN	O	—	_	0	SENT_618	[p13l1632t1303r1955b1332],
2	.	.	O	.	_	0	SENT_618	[p13l1632t1303r1955b1332],

1	CT-2002-10051	NN	O	ct-2002-10051	_	0	SENT_619	[p13l1632t1303r1955b1332],
2	)	NN	O	)	dep	1	SENT_619	[p13l1632t1303r1955b1332],
3	and	CC	O	and	_	0	SENT_619	[p13l1971t1303r2024b1326],
4	the	DT	O	the	det	9	SENT_619	[p13l2040t1303r2084b1326],
5	VWFoundation	NN	O	vwfoundation	nn	9	SENT_619	[p13l2100t1303r2286b1326, p13l1277t1340r1335b1363],
6	(	CD	NUMBER	(	num	9	SENT_619	[p13l1361t1341r1447b1371],
7	grant	NN	O	grant	nn	9	SENT_619	[p13l1361t1341r1447b1371],
8	I/7352	NN	O	i/7352	nn	9	SENT_619	[p13l1472t1338r1576b1368],
9	)	NN	O	)	conj_and	2	SENT_619	[p13l1472t1338r1576b1368],
10	.	.	O	.	_	0	SENT_619	[p13l1472t1338r1576b1368],

1	Pﬁzer	NNP	ORGANIZATION	Pﬁzer	nn	2	SENT_620	[p13l1602t1340r1685b1363],
2	Inc	NNP	ORGANIZATION	Inc	_	0	SENT_620	[p13l1708t1341r1761b1367],
3	,	,	O	,	_	0	SENT_620	[p13l1708t1341r1761b1367],
4	Karlsruhe	NNP	ORGANIZATION	Karlsruhe	nn	6	SENT_620	[p13l1787t1340r1937b1367],
5	,	,	O	,	_	0	SENT_620	[p13l1787t1340r1937b1367],
6	Germany	NNP	LOCATION	Germany	appos	2	SENT_620	[p13l1963t1340r2104b1371],
7	,	,	O	,	_	0	SENT_620	[p13l1963t1340r2104b1371],
8	generously	RB	O	generously	advmod	9	SENT_620	[p13l2129t1340r2287b1371],
9	provided	VBN	O	provide	partmod	6	SENT_620	[p13l1277t1377r1406b1408],
10	Vibramycin	NNP	PERSON	Vibramycin	dobj	9	SENT_620	[p13l1426t1377r1596b1408],
11	and	CC	O	and	_	0	SENT_620	[p13l1617t1377r1669b1400],
12	placebo	NN	O	placebo	nn	13	SENT_620	[p13l1690t1377r1801b1408],
13	tablets	NNS	O	tablet	dobj	9	SENT_620	[p13l1823t1377r1923b1400],
14	.	.	O	.	_	0	SENT_620	[p13l1823t1377r1923b1400],

1	AYD	NNP	O	AYD	nsubj	4	SENT_621	[p13l1944t1377r2011b1399],
2	is	VBZ	O	be	cop	4	SENT_621	[p13l2033t1377r2052b1399],
3	a	DT	O	a	det	4	SENT_621	[p13l2073t1385r2087b1400],
4	recipient	JJ	O	recipient	_	0	SENT_621	[p13l2108t1377r2239b1408],
5	of	IN	O	of	_	0	SENT_621	[p13l2259t1377r2290b1399],
6	scholarship	NN	O	scholarship	prep_of	4	SENT_621	[p13l1277t1414r1440b1445],
7	from	IN	O	from	_	0	SENT_621	[p13l1457t1414r1527b1436],
8	the	DT	O	the	det	15	SENT_621	[p13l1545t1414r1589b1437],
9	German	JJ	ORGANIZATION	german	amod	15	SENT_621	[p13l1606t1414r1723b1437],
10	Academic	NNP	ORGANIZATION	Academic	nn	15	SENT_621	[p13l1739t1414r1880b1437],
11	Exchange	NNP	ORGANIZATION	Exchange	nn	15	SENT_621	[p13l1898t1414r2036b1445],
12	Service	NNP	ORGANIZATION	Service	nn	15	SENT_621	[p13l2053t1414r2156b1437],
13	(	CD	NUMBER	(	num	15	SENT_621	[p13l2174t1414r2286b1443],
14	DAAD	NNP	ORGANIZATION	DAAD	nn	15	SENT_621	[p13l2174t1414r2286b1443],
15	)	NN	O	)	prep_from	6	SENT_621	[p13l2174t1414r2286b1443],
16	for	IN	O	for	_	0	SENT_621	[p13l1276t1452r1320b1474],
17	his	PRP$	O	he	poss	19	SENT_621	[p13l1332t1452r1370b1475],
18	PhD	NN	O	phd	nn	19	SENT_621	[p13l1384t1452r1444b1474],
19	work	NN	O	work	prep_for	15	SENT_621	[p13l1457t1452r1536b1474],
20	.	.	O	.	_	0	SENT_621	[p13l1457t1452r1536b1474],

1	Competing	VBG	O	compete	_	0	SENT_622	[p13l1314t1491r1474b1522],
2	interests	NNS	O	interest	dep	1	SENT_622	[p13l1483t1491r1615b1514],
3	.	.	O	.	_	0	SENT_622	[p13l1483t1491r1615b1514],

1	The	DT	O	the	det	2	SENT_623	[p13l1626t1491r1681b1514],
2	authors	NNS	O	author	nsubj	4	SENT_623	[p13l1692t1491r1800b1514],
3	have	VBP	O	have	aux	4	SENT_623	[p13l1811t1491r1875b1514],
4	declared	VBN	O	declare	_	0	SENT_623	[p13l1886t1491r2009b1514],
5	that	IN	O	that	complm	9	SENT_623	[p13l2020t1491r2076b1514],
6	no	DT	O	no	det	8	SENT_623	[p13l2087t1499r2122b1513],
7	competing	VBG	O	compete	amod	8	SENT_623	[p13l2132t1491r2288b1522],
8	interests	NNS	O	interest	nsubj	9	SENT_623	[p13l1277t1527r1398b1550],
9	exist	VBP	O	exist	ccomp	4	SENT_623	[p13l1412t1527r1484b1550],
10	.	.	O	.	_	0	SENT_623	[p13l1412t1527r1484b1550],

1	13	CD	NUMBER	13	_	0	SENT_624	[p13l1279t1629r1310b1648],
2	.	.	O	.	_	0	SENT_624	[p13l1279t1629r1310b1648],

1	Addiss	NNP	PERSON	Addiss	nn	2	SENT_625	[p13l1325t1629r1408b1648],
2	DG	NNS	O	dg	_	0	SENT_625	[p13l1428t1629r1475b1652],
3	,	,	O	,	_	0	SENT_625	[p13l1428t1629r1475b1652],
4	Mackenzie	NNP	PERSON	Mackenzie	nn	5	SENT_625	[p13l1495t1629r1627b1648],
5	C	NNP	O	C	appos	2	SENT_625	[p13l1646t1629r1664b1649],
6	(	JJ	O	(	amod	5	SENT_625	[p13l1684t1629r1759b1654],
7	2004	CD	DATE	2004	tmod	6	SENT_625	[p13l1684t1629r1759b1654],
8	)	CD	NUMBER	)	num	10	SENT_625	[p13l1684t1629r1759b1654],
9	LF	NN	O	lf	nn	10	SENT_625	[p13l1778t1629r1811b1648],
10	disease	NN	O	disease	dep	5	SENT_625	[p13l1830t1629r2045b1649],
11	.	.	O	.	_	0	SENT_625	[p13l1830t1629r2045b1649],

1	—	NN	O	—	_	0	SENT_626	[p13l1830t1629r2045b1649],
2	.	.	O	.	_	0	SENT_626	[p13l1830t1629r2045b1649],

1	Clinical	JJ	O	clinical	amod	2	SENT_627	[p13l1830t1629r2045b1649],
2	management	NN	O	management	_	0	SENT_627	[p13l2065t1633r2234b1656],
3	.	.	O	.	_	0	SENT_627	[p13l2065t1633r2234b1656],

1	In	IN	O	in	_	0	SENT_628	[p13l2254t1629r2286b1648],
2	:	:	O	:	_	0	SENT_628	[p13l2254t1629r2286b1648],
3	Towards	IN	O	towards	mark	10	SENT_628	[p13l1326t1663r1434b1682],
4	a	DT	O	a	det	6	SENT_628	[p13l1449t1670r1461b1682],
5	strategic	JJ	O	strategic	amod	6	SENT_628	[p13l1476t1663r1582b1690],
6	plan	NN	O	plan	nsubj	10	SENT_628	[p13l1598t1663r1652b1690],
7	for	IN	O	for	_	0	SENT_628	[p13l1667t1663r1704b1682],
8	research	NN	O	research	prep_for	6	SENT_628	[p13l1719t1663r1825b1682],
9	to	TO	O	to	aux	10	SENT_628	[p13l1841t1667r1864b1682],
10	support	VB	O	support	dep	1	SENT_628	[p13l1879t1667r1978b1690],
11	the	DT	O	the	det	13	SENT_628	[p13l1994t1663r2032b1682],
12	global	JJ	O	global	amod	13	SENT_628	[p13l2047t1663r2122b1690],
13	program	NN	O	program	dobj	10	SENT_628	[p13l2138t1669r2247b1690],
14	to	TO	O	to	aux	15	SENT_628	[p13l2263t1667r2286b1682],
15	eliminate	VB	O	eliminate	xcomp	10	SENT_628	[p13l1326t1697r1445b1716],
16	lymphatic	JJ	O	lymphatic	amod	17	SENT_628	[p13l1460t1697r1585b1724],
17	ﬁlariasis	NN	O	ﬁlariasis	dobj	15	SENT_628	[p13l1601t1697r1710b1716],
18	.	.	O	.	_	0	SENT_628	[p13l1601t1697r1710b1716],

1	Summary	NN	O	summary	_	0	SENT_629	[p13l1726t1697r1846b1724],
2	of	IN	O	of	_	0	SENT_629	[p13l1862t1697r1889b1716],
3	immediate	JJ	O	immediate	amod	4	SENT_629	[p13l1902t1697r2036b1716],
4	needs	NNS	O	need	prep_of	1	SENT_629	[p13l2052t1697r2122b1716],
5	and	CC	O	and	_	0	SENT_629	[p13l2138t1697r2184b1716],
6	opportunities	NNS	O	opportunity	prep_of	1	SENT_629	[p13l2199t1703r2286b1724, p13l1327t1731r1421b1750],
7	for	IN	O	for	_	0	SENT_629	[p13l1438t1731r1475b1750],
8	research	NN	O	research	prep_for	1	SENT_629	[p13l1492t1731r1598b1750],
9	on	IN	O	on	_	0	SENT_629	[p13l1615t1737r1646b1750],
10	lymphatic	JJ	O	lymphatic	amod	11	SENT_629	[p13l1663t1731r1788b1758],
11	ﬁlariasis	NN	O	ﬁlariasis	prep_on	1	SENT_629	[p13l1805t1731r1915b1750],
12	.	.	O	.	_	0	SENT_629	[p13l1805t1731r1915b1750],

1	Philadelphia	NNP	LOCATION	Philadelphia	nn	7	SENT_630	[p13l1933t1731r2097b1758],
2	,	,	O	,	_	0	SENT_630	[p13l1933t1731r2097b1758],
3	Pennsylvania	NNP	LOCATION	Pennsylvania	appos	7	SENT_630	[p13l2115t1731r2286b1758],
4	,	,	O	,	_	0	SENT_630	[p13l2115t1731r2286b1758],
5	USA	NNP	LOCATION	USA	appos	7	SENT_630	[p13l1326t1765r1388b1788],
6	,	,	O	,	_	0	SENT_630	[p13l1326t1765r1388b1788],
7	December	NNP	DATE	December	_	0	SENT_630	[p13l1401t1765r1531b1784],
8	9	CD	DATE	9	num	7	SENT_630	[p13l1542t1765r1607b1788],
9	—	NN	DATE	—	dep	7	SENT_630	[p13l1542t1765r1607b1788],
10	10	CD	DATE	10	num	9	SENT_630	[p13l1542t1765r1607b1788],
11	,	,	DATE	,	_	0	SENT_630	[p13l1542t1765r1607b1788],
12	2003	CD	DATE	2003	appos	9	SENT_630	[p13l1620t1765r1683b1785],
13	.	.	O	.	_	0	SENT_630	[p13l1620t1765r1683b1785],

1	AmJ	NNP	O	AmJ	nn	4	SENT_631	[p13l1695t1765r1759b1792],
2	Trop	NNP	O	Trop	nn	4	SENT_631	[p13l1771t1765r1834b1792],
3	Med	NNP	O	Med	nn	4	SENT_631	[p13l1846t1765r1900b1784],
4	Hyg	NNP	O	Hyg	_	0	SENT_631	[p13l1912t1765r1963b1792],
5	71	CD	NUMBER	71	number	6	SENT_631	[p13l1974t1763r1999b1784],
6	(	CD	NUMBER	(	num	8	SENT_631	[p13l2014t1765r2110b1792],
7	Suppl	NN	O	suppl	nn	8	SENT_631	[p13l2014t1765r2110b1792],
8	)	NN	O	)	dep	4	SENT_631	[p13l2014t1765r2110b1792],
9	:	:	O	:	_	0	SENT_631	[p13l2014t1765r2110b1792],
10	12	CD	NUMBER	12	number	11	SENT_631	[p13l2125t1765r2202b1785],
11	—	CD	NUMBER	—	dep	4	SENT_631	[p13l2125t1765r2202b1785],
12	15	CD	NUMBER	15	dep	11	SENT_631	[p13l2125t1765r2202b1785],
13	.	.	O	.	_	0	SENT_631	[p13l2125t1765r2202b1785],

1	Taylor	NNP	PERSON	Taylor	nn	2	SENT_632	[p13l1326t1800r1409b1827],
2	MJ	NNP	PERSON	MJ	nsubj	6	SENT_632	[p13l1427t1800r1466b1827],
3	,	,	O	,	_	0	SENT_632	[p13l1427t1800r1466b1827],
4	Hoerauf	NNP	O	Hoerauf	nn	5	SENT_632	[p13l1486t1800r1594b1819],
5	A	NNP	O	A	nsubj	6	SENT_632	[p13l1610t1800r1629b1819],
6	(	VBD	O	(	_	0	SENT_632	[p13l1649t1800r1723b1825],
7	1999	CD	DATE	1999	num	10	SENT_632	[p13l1649t1800r1723b1825],
8	)	CD	NUMBER	)	num	10	SENT_632	[p13l1649t1800r1723b1825],
9	Wolbachia	JJ	O	wolbachia	amod	10	SENT_632	[p13l1745t1800r1860b1819],
10	bacteria	NNS	O	bacterium	dobj	6	SENT_632	[p13l1878t1800r1980b1819],
11	of	IN	O	of	_	0	SENT_632	[p13l2000t1800r2027b1819],
12	ﬁlarial	JJ	O	ﬁlarial	amod	13	SENT_632	[p13l2043t1800r2124b1819],
13	nematodes	NNS	O	nematode	prep_of	10	SENT_632	[p13l2143t1800r2286b1819],
14	.	.	O	.	_	0	SENT_632	[p13l2143t1800r2286b1819],

1	Parasitol	NNP	O	Parasitol	nn	2	SENT_633	[p13l1326t1834r1436b1853],
2	Today	NNP	DATE	Today	_	0	SENT_633	[p13l1448t1834r1527b1861],
3	15	CD	DATE	15	num	2	SENT_633	[p13l1541t1834r1573b1853],
4	:	:	O	:	_	0	SENT_633	[p13l1541t1834r1573b1853],
5	437	CD	NUMBER	437	num	6	SENT_633	[p13l1585t1832r1695b1853],
6	—	NN	O	—	dep	2	SENT_633	[p13l1585t1832r1695b1853],
7	442	CD	NUMBER	442	dep	6	SENT_633	[p13l1585t1832r1695b1853],
8	.	.	O	.	_	0	SENT_633	[p13l1585t1832r1695b1853],

1	Saint	NNP	O	Saint	nn	3	SENT_634	[p13l1326t1869r1390b1889],
2	Andre	NNP	PERSON	Andre	nn	3	SENT_634	[p13l1400t1869r1479b1888],
3	A	NNP	PERSON	A	nsubj	19	SENT_634	[p13l1489t1869r1514b1892],
4	,	,	O	,	_	0	SENT_634	[p13l1489t1869r1514b1892],
5	Blackwell	NNP	ORGANIZATION	Blackwell	nn	6	SENT_634	[p13l1524t1869r1643b1888],
6	NM	NNP	ORGANIZATION	NM	appos	3	SENT_634	[p13l1653t1869r1705b1892],
7	,	,	O	,	_	0	SENT_634	[p13l1653t1869r1705b1892],
8	Hall	NNP	ORGANIZATION	Hall	nn	9	SENT_634	[p13l1715t1869r1767b1888],
9	LR	NNP	ORGANIZATION	LR	appos	6	SENT_634	[p13l1777t1869r1818b1892],
10	,	,	O	,	_	0	SENT_634	[p13l1777t1869r1818b1892],
11	Hoerauf	NNP	O	Hoerauf	nn	12	SENT_634	[p13l1829t1869r1937b1888],
12	A	NNP	O	A	appos	9	SENT_634	[p13l1944t1869r1969b1892],
13	,	,	O	,	_	0	SENT_634	[p13l1944t1869r1969b1892],
14	Brattig	NNP	O	Brattig	nn	15	SENT_634	[p13l1980t1869r2068b1896],
15	NW	NNP	O	NW	appos	6	SENT_634	[p13l2077t1869r2130b1892],
16	,	,	O	,	_	0	SENT_634	[p13l2077t1869r2130b1892],
17	et	FW	O	et	nn	19	SENT_634	[p13l2141t1873r2164b1888],
18	al.	FW	O	al.	nn	19	SENT_634	[p13l2174t1869r2200b1888],
19	(	FW	O	(	_	0	SENT_634	[p13l2211t1869r2286b1894],
20	2002	CD	DATE	2002	number	21	SENT_634	[p13l2211t1869r2286b1894],
21	)	CD	NUMBER	)	num	23	SENT_634	[p13l2211t1869r2286b1894],
22	The	DT	O	the	det	23	SENT_634	[p13l1326t1903r1374b1922],
23	role	NN	O	role	dobj	19	SENT_634	[p13l1387t1903r1435b1922],
24	of	IN	O	of	_	0	SENT_634	[p13l1448t1903r1475b1922],
25	endosymbiotic	JJ	O	endosymbiotic	amod	27	SENT_634	[p13l1485t1903r1670b1930],
26	Vl/olbachia	NN	O	vl/olbachia	nn	27	SENT_634	[p13l1685t1903r1801b1923],
27	bacteria	NNS	O	bacterium	prep_of	23	SENT_634	[p13l1812t1903r1914b1922],
28	in	IN	O	in	_	0	SENT_634	[p13l1927t1903r1950b1922],
29	the	DT	O	the	det	30	SENT_634	[p13l1964t1903r2002b1922],
30	pathogenesis	NN	O	pathogenesis	prep_in	19	SENT_634	[p13l2015t1903r2178b1930],
31	of	IN	O	of	_	0	SENT_634	[p13l2191t1903r2218b1922],
32	river	NN	O	river	nn	33	SENT_634	[p13l2227t1903r2287b1922],
33	blindness	NN	O	blindness	prep_of	30	SENT_634	[p13l1326t1937r1450b1956],
34	.	.	O	.	_	0	SENT_634	[p13l1326t1937r1450b1956],

1	Science	NNP	O	Science	_	0	SENT_635	[p13l1463t1937r1558b1957],
2	295	CD	NUMBER	295	num	1	SENT_635	[p13l1571t1937r1620b1957],
3	:	:	O	:	_	0	SENT_635	[p13l1571t1937r1620b1957],
4	1892	CD	DATE	1892	number	5	SENT_635	[p13l1634t1937r1772b1957],
5	—	CD	DATE	—	dep	1	SENT_635	[p13l1634t1937r1772b1957],
6	1895	CD	DATE	1895	dep	5	SENT_635	[p13l1634t1937r1772b1957],
7	.	.	O	.	_	0	SENT_635	[p13l1634t1937r1772b1957],

1	Taylor	NNP	PERSON	Taylor	nn	2	SENT_636	[p13l1326t1971r1409b1998],
2	MJ	NNP	PERSON	MJ	nsubj	3	SENT_636	[p13l1424t1971r1457b1998],
3	(	VBD	O	(	_	0	SENT_636	[p13l1474t1971r1548b1996],
4	2003	CD	DATE	2003	num	5	SENT_636	[p13l1474t1971r1548b1996],
5	)	CD	NUMBER	)	dobj	3	SENT_636	[p13l1474t1971r1548b1996],
6	Wolbachia	NNP	O	Wolbachia	dep	3	SENT_636	[p13l1567t1971r1682b1990],
7	in	IN	O	in	_	0	SENT_636	[p13l1698t1971r1721b1990],
8	the	DT	O	the	det	10	SENT_636	[p13l1737t1971r1776b1990],
9	inflammatory	JJ	O	inflammatory	amod	10	SENT_636	[p13l1792t1971r1964b1998],
10	pathogenesis	NN	O	pathogenesis	prep_in	3	SENT_636	[p13l1980t1971r2143b1998],
11	of	IN	O	of	_	0	SENT_636	[p13l2159t1971r2186b1990],
12	human	JJ	O	human	amod	13	SENT_636	[p13l2199t1971r2286b1990],
13	ﬁlariasis	NN	O	ﬁlariasis	prep_of	10	SENT_636	[p13l1326t2005r1436b2024],
14	.	.	O	.	_	0	SENT_636	[p13l1326t2005r1436b2024],

1	Ann	NNP	PERSON	Ann	nn	5	SENT_637	[p13l1447t2005r1501b2024],
2	N	NNP	PERSON	N	nn	5	SENT_637	[p13l1513t2005r1532b2025],
3	Y	NN	PERSON	y	nn	5	SENT_637	[p13l1545t2005r1562b2024],
4	Acad	NNP	PERSON	Acad	nn	5	SENT_637	[p13l1573t2005r1636b2024],
5	Sci	NNP	PERSON	Sci	_	0	SENT_637	[p13l1648t2005r1684b2025],
6	990	CD	NUMBER	990	num	5	SENT_637	[p13l1696t2005r1745b2024],
7	:	:	O	:	_	0	SENT_637	[p13l1696t2005r1745b2024],
8	444	CD	NUMBER	444	num	9	SENT_637	[p13l1758t2005r1868b2024],
9	—	NN	O	—	dep	5	SENT_637	[p13l1758t2005r1868b2024],
10	449	CD	NUMBER	449	dep	9	SENT_637	[p13l1758t2005r1868b2024],
11	.	.	O	.	_	0	SENT_637	[p13l1758t2005r1868b2024],

1	Hise	NNP	ORGANIZATION	Hise	nn	2	SENT_638	[p13l1326t2040r1381b2059],
2	AG	NNP	ORGANIZATION	AG	nsubj	9	SENT_638	[p13l1395t2040r1442b2063],
3	,	,	O	,	_	0	SENT_638	[p13l1395t2040r1442b2063],
4	Gillette-Ferguson	NNP	O	Gillette-Ferguson	nn	5	SENT_638	[p13l1456t2040r1678b2067],
5	I	NNP	O	I	appos	2	SENT_638	[p13l1692t2040r1707b2063],
6	,	,	O	,	_	0	SENT_638	[p13l1692t2040r1707b2063],
7	Pearlman	NNP	PERSON	Pearlman	nn	8	SENT_638	[p13l1721t2040r1841b2059],
8	E	NNP	O	E	appos	5	SENT_638	[p13l1855t2040r1871b2059],
9	(	VBD	O	(	_	0	SENT_638	[p13l1885t2040r1960b2065],
10	2003	CD	DATE	2003	num	12	SENT_638	[p13l1885t2040r1960b2065],
11	)	CD	NUMBER	)	num	12	SENT_638	[p13l1885t2040r1960b2065],
12	Immunopathogenesis	NN	O	immunopathogenesis	dobj	9	SENT_638	[p13l1974t2040r2248b2067],
13	of	IN	O	of	_	0	SENT_638	[p13l2262t2040r2289b2059],
14	Onchocerca	NN	O	onchocerca	nn	19	SENT_638	[p13l1327t2074r1452b2094],
15	vol-uulm	NN	O	vol-uulm	nn	19	SENT_638	[p13l1465t2074r1560b2093],
16	keratitis	NN	O	keratitis	nn	19	SENT_638	[p13l1574t2074r1677b2093],
17	(	NN	O	(	nn	19	SENT_638	[p13l1693t2074r1761b2099],
18	river	NN	O	river	nn	19	SENT_638	[p13l1693t2074r1761b2099],
19	blindness	NN	O	blindness	prep_of	12	SENT_638	[p13l1775t2074r1909b2098],
20	)	CD	NUMBER	)	dep	19	SENT_638	[p13l1775t2074r1909b2098],
21	:	:	O	:	_	0	SENT_638	[p13l1775t2074r1909b2098],
22	A	DT	O	a	det	24	SENT_638	[p13l1924t2074r1943b2093],
23	novel	JJ	O	novel	amod	24	SENT_638	[p13l1958t2074r2025b2093],
24	role	NN	O	role	dep	19	SENT_638	[p13l2041t2074r2089b2093],
25	for	IN	O	for	_	0	SENT_638	[p13l2104t2074r2142b2093],
26	TLR4	NN	O	tlr4	nn	30	SENT_638	[p13l2155t2074r2226b2093],
27	and	CC	O	and	_	0	SENT_638	[p13l2241t2074r2287b2093],
28	endosymbiotic	JJ	O	endosymbiotic	conj_and	26	SENT_638	[p13l1326t2108r1511b2135],
29	I/Volbachia	NN	O	i/volbachia	nn	30	SENT_638	[p13l1526t2108r1641b2128],
30	bacteria	NNS	O	bacterium	prep_for	24	SENT_638	[p13l1652t2108r1781b2135],
31	.	.	O	.	_	0	SENT_638	[p13l1652t2108r1781b2135],

1	J	NNP	O	J	nn	3	SENT_639	[p13l1652t2108r1781b2135],
2	Endotoxin	NN	O	endotoxin	nn	3	SENT_639	[p13l1793t2108r1926b2127],
3	Res	NNP	O	Res	_	0	SENT_639	[p13l1938t2108r1980b2127],
4	9	CD	NUMBER	9	dep	3	SENT_639	[p13l1993t2108r2011b2127],
5	:	:	O	:	_	0	SENT_639	[p13l1993t2108r2011b2127],
6	390	CD	NUMBER	390	num	7	SENT_639	[p13l2024t2108r2133b2127],
7	—	NN	O	—	dep	3	SENT_639	[p13l2024t2108r2133b2127],
8	394	CD	NUMBER	394	dep	7	SENT_639	[p13l2024t2108r2133b2127],
9	.	.	O	.	_	0	SENT_639	[p13l2024t2108r2133b2127],

1	Dreyer	NNP	PERSON	Dreyer	nn	2	SENT_640	[p13l1326t2143r1413b2170],
2	G	NNP	PERSON	G	nsubj	18	SENT_640	[p13l1424t2143r1450b2166],
3	,	,	O	,	_	0	SENT_640	[p13l1424t2143r1450b2166],
4	Ottesen	NNP	PERSON	Ottesen	nn	5	SENT_640	[p13l1462t2143r1560b2163],
5	EA	NN	PERSON	ea	appos	2	SENT_640	[p13l1572t2143r1614b2166],
6	,	,	O	,	_	0	SENT_640	[p13l1572t2143r1614b2166],
7	Galdino	NNP	PERSON	Galdino	nn	8	SENT_640	[p13l1627t2143r1727b2163],
8	E	NNP	PERSON	E	appos	5	SENT_640	[p13l1739t2143r1760b2166],
9	,	,	O	,	_	0	SENT_640	[p13l1739t2143r1760b2166],
10	Andrade	NNP	PERSON	Andrade	nn	11	SENT_640	[p13l1772t2143r1882b2162],
11	L	NNP	PERSON	L	appos	8	SENT_640	[p13l1894t2143r1916b2166],
12	,	,	O	,	_	0	SENT_640	[p13l1894t2143r1916b2166],
13	Rocha	NNP	PERSON	Rocha	nn	14	SENT_640	[p13l1928t2143r2006b2162],
14	A	NNP	O	A	appos	5	SENT_640	[p13l2017t2143r2043b2166],
15	,	,	O	,	_	0	SENT_640	[p13l2017t2143r2043b2166],
16	et	FW	O	et	nn	18	SENT_640	[p13l2055t2147r2077b2162],
17	al.	FW	O	al.	nn	18	SENT_640	[p13l2089t2143r2115b2162],
18	(	FW	O	(	_	0	SENT_640	[p13l2128t2143r2203b2168],
19	1992	CD	DATE	1992	num	22	SENT_640	[p13l2128t2143r2203b2168],
20	)	CD	NUMBER	)	num	22	SENT_640	[p13l2128t2143r2203b2168],
21	Renal	JJ	O	renal	amod	22	SENT_640	[p13l2215t2143r2286b2162],
22	abnormalities	NNS	O	abnormality	dobj	18	SENT_640	[p13l1326t2177r1501b2196],
23	in	IN	O	in	_	0	SENT_640	[p13l1515t2177r1538b2196],
24	microﬁlaremic	JJ	O	microﬁlaremic	amod	25	SENT_640	[p13l1552t2177r1738b2196],
25	patients	NNS	O	patient	prep_in	22	SENT_640	[p13l1753t2177r1853b2204],
26	with	IN	O	with	_	0	SENT_640	[p13l1866t2177r1920b2196],
27	Bancroftian	JJ	O	bancroftian	amod	28	SENT_640	[p13l1934t2177r2085b2196],
28	ﬁlariasis	NN	O	ﬁlariasis	prep_with	18	SENT_640	[p13l2098t2177r2208b2196],
29	.	.	O	.	_	0	SENT_640	[p13l2098t2177r2208b2196],

1	Am	VBP	O	be	_	0	SENT_641	[p13l2221t2177r2265b2196],
2	J	NN	O	j	nn	3	SENT_641	[p13l2274t2177r2287b2204],
3	Trop	NN	O	trop	nsubj	4	SENT_641	[p13l1326t2211r1389b2238],
4	Med	VBD	O	med	ccomp	1	SENT_641	[p13l1402t2211r1455b2230],
5	Hyg	NN	O	hyg	dobj	4	SENT_641	[p13l1467t2211r1518b2238],
6	46	CD	NUMBER	46	num	5	SENT_641	[p13l1529t2211r1562b2230],
7	:	:	O	:	_	0	SENT_641	[p13l1529t2211r1562b2230],
8	745	CD	NUMBER	745	num	9	SENT_641	[p13l1576t2209r1685b2230],
9	—	NN	O	—	dep	5	SENT_641	[p13l1576t2209r1685b2230],
10	751	CD	NUMBER	751	dep	9	SENT_641	[p13l1576t2209r1685b2230],
11	.	.	O	.	_	0	SENT_641	[p13l1576t2209r1685b2230],

1	Addiss	NNP	PERSON	Addiss	nn	2	SENT_642	[p13l1325t2246r1410b2265],
2	DG	NNS	O	dg	_	0	SENT_642	[p13l1432t2246r1480b2269],
3	,	,	O	,	_	0	SENT_642	[p13l1432t2246r1480b2269],
4	Dimock	NNP	ORGANIZATION	Dimock	nn	5	SENT_642	[p13l1502t2246r1603b2265],
5	KA	NN	ORGANIZATION	ka	appos	2	SENT_642	[p13l1625t2246r1671b2269],
6	,	,	O	,	_	0	SENT_642	[p13l1625t2246r1671b2269],
7	Eberhard	NNP	PERSON	Eberhard	nn	8	SENT_642	[p13l1693t2246r1814b2265],
8	ML	NNP	PERSON	ML	appos	2	SENT_642	[p13l1836t2246r1884b2269],
9	,	,	O	,	_	0	SENT_642	[p13l1836t2246r1884b2269],
10	Lammie	NNP	PERSON	Lammie	nn	12	SENT_642	[p13l1906t2246r2010b2265],
11	PJ	NNP	PERSON	PJ	nn	12	SENT_642	[p13l2033t2246r2058b2273],
12	(	NNP	O	(	appos	2	SENT_642	[p13l2081t2246r2158b2271],
13	1995	CD	DATE	1995	num	14	SENT_642	[p13l2081t2246r2158b2271],
14	)	CD	NUMBER	)	dep	12	SENT_642	[p13l2081t2246r2158b2271],
15	Clinical	JJ	O	clinical	amod	21	SENT_642	[p13l2180t2246r2286b2269],
16	,	,	O	,	_	0	SENT_642	[p13l2180t2246r2286b2269],
17	parasitologic	JJ	O	parasitologic	amod	21	SENT_642	[p13l1326t2280r1496b2307],
18	,	,	O	,	_	0	SENT_642	[p13l1326t2280r1496b2307],
19	and	CC	O	and	_	0	SENT_642	[p13l1513t2280r1559b2299],
20	immunologic	JJ	O	immunologic	conj_and	17	SENT_642	[p13l1576t2280r1742b2307],
21	observations	NNS	O	observation	dep	2	SENT_642	[p13l1759t2280r1919b2299],
22	of	IN	O	of	_	0	SENT_642	[p13l1935t2280r1962b2299],
23	patients	NNS	O	patient	prep_of	21	SENT_642	[p13l1976t2280r2076b2307],
24	with	IN	O	with	_	0	SENT_642	[p13l2092t2280r2146b2299],
25	hydrocele	NN	O	hydrocele	prep_with	23	SENT_642	[p13l2162t2280r2286b2307],
26	and	CC	O	and	_	0	SENT_642	[p13l1326t2314r1372b2333],
27	elephantiasis	NN	O	elephantiasis	conj_and	25	SENT_642	[p13l1384t2314r1547b2341],
28	in	IN	O	in	_	0	SENT_642	[p13l1560t2314r1583b2333],
29	an	DT	O	a	det	30	SENT_642	[p13l1595t2321r1624b2333],
30	area	NN	O	area	prep_in	21	SENT_642	[p13l1636t2320r1688b2333],
31	with	IN	O	with	_	0	SENT_642	[p13l1699t2314r1753b2333],
32	endemic	JJ	O	endemic	amod	34	SENT_642	[p13l1765t2314r1872b2333],
33	lymphatic	JJ	O	lymphatic	amod	34	SENT_642	[p13l1884t2314r2009b2341],
34	ﬁlariasis	NN	O	ﬁlariasis	prep_with	30	SENT_642	[p13l2021t2314r2151b2341],
35	.	.	O	.	_	0	SENT_642	[p13l2021t2314r2151b2341],

1	J	NNP	O	J	nn	3	SENT_643	[p13l2021t2314r2151b2341],
2	Infect	NNP	O	Infect	nn	3	SENT_643	[p13l2162t2314r2236b2333],
3	Dis	NNP	O	Dis	_	0	SENT_643	[p13l2247t2314r2286b2333],
4	171	CD	NUMBER	171	num	3	SENT_643	[p13l1328t2346r1375b2367],
5	:	:	O	:	_	0	SENT_643	[p13l1328t2346r1375b2367],
6	755	CD	NUMBER	755	num	7	SENT_643	[p13l1389t2346r1497b2367],
7	—	NN	O	—	dep	3	SENT_643	[p13l1389t2346r1497b2367],
8	758	CD	NUMBER	758	dep	7	SENT_643	[p13l1389t2346r1497b2367],
9	.	.	O	.	_	0	SENT_643	[p13l1389t2346r1497b2367],

1	Dreyer	NNP	PERSON	Dreyer	nn	2	SENT_644	[p13l1326t2382r1413b2409],
2	G	NNP	PERSON	G	dep	15	SENT_644	[p13l1425t2382r1450b2405],
3	,	,	O	,	_	0	SENT_644	[p13l1425t2382r1450b2405],
4	Noroes	NNP	O	Noroes	nn	5	SENT_644	[p13l1463t2382r1553b2402],
5	J	NNP	O	J	appos	2	SENT_644	[p13l1561t2382r1580b2409],
6	,	,	O	,	_	0	SENT_644	[p13l1561t2382r1580b2409],
7	Figueredo-Silva	NNP	O	Figueredo-Silva	nn	8	SENT_644	[p13l1592t2382r1791b2409],
8	J	NNP	O	J	appos	2	SENT_644	[p13l1798t2382r1817b2409],
9	,	,	O	,	_	0	SENT_644	[p13l1798t2382r1817b2409],
10	Piessens	NNP	O	Piessens	nn	11	SENT_644	[p13l1830t2382r1932b2401],
11	WF	NNP	O	WF	appos	2	SENT_644	[p13l1944t2382r1986b2402],
12	(	CD	NUMBER	(	dep	15	SENT_644	[p13l1999t2382r2074b2407],
13	2000	CD	DATE	2000	num	15	SENT_644	[p13l1999t2382r2074b2407],
14	)	CD	NUMBER	)	num	15	SENT_644	[p13l1999t2382r2074b2407],
15	Pathogenesis	NN	O	pathogenesis	dep	25	SENT_644	[p13l2087t2382r2250b2409],
16	of	IN	O	of	_	0	SENT_644	[p13l2262t2382r2289b2401],
17	lymphatic	JJ	O	lymphatic	amod	18	SENT_644	[p13l1326t2417r1451b2444],
18	disease	NN	O	disease	prep_of	15	SENT_644	[p13l1463t2417r1551b2436],
19	in	IN	O	in	_	0	SENT_644	[p13l1563t2417r1586b2436],
20	bancroftian	JJ	O	bancroftian	amod	21	SENT_644	[p13l1598t2417r1747b2436],
21	ﬁlariasis	NN	O	ﬁlariasis	prep_in	18	SENT_644	[p13l1758t2417r1868b2436],
22	:	:	O	:	_	0	SENT_644	[p13l1758t2417r1868b2436],
23	A	DT	O	a	det	25	SENT_644	[p13l1880t2417r1899b2436],
24	clinical	JJ	O	clinical	amod	25	SENT_644	[p13l1911t2417r2000b2436],
25	perspective	NN	O	perspective	_	0	SENT_644	[p13l2013t2417r2163b2444],
26	.	.	O	.	_	0	SENT_644	[p13l2013t2417r2163b2444],

1	Parasitol	NNP	O	Parasitol	nn	2	SENT_645	[p13l2176t2417r2286b2436],
2	Today	NNP	DATE	Today	_	0	SENT_645	[p13l1326t2451r1404b2478],
3	16	CD	DATE	16	num	2	SENT_645	[p13l1418t2451r1450b2470],
4	:	:	O	:	_	0	SENT_645	[p13l1418t2451r1450b2470],
5	544	CD	NUMBER	544	num	6	SENT_645	[p13l1464t2451r1572b2470],
6	—	NN	O	—	dep	2	SENT_645	[p13l1464t2451r1572b2470],
7	548	CD	NUMBER	548	dep	6	SENT_645	[p13l1464t2451r1572b2470],
8	.	.	O	.	_	0	SENT_645	[p13l1464t2451r1572b2470],

1	Ravindran	NN	PERSON	ravindran	nn	2	SENT_646	[p13l1326t2485r1458b2504],
2	B	NN	PERSON	b	_	0	SENT_646	[p13l1473t2485r1490b2504],
3	(	CD	NUMBER	(	num	4	SENT_646	[p13l1506t2485r1581b2510],
4	2003	CD	DATE	2003	dep	2	SENT_646	[p13l1506t2485r1581b2510],
5	)	NNP	O	)	nn	8	SENT_646	[p13l1506t2485r1581b2510],
6	Aping	NNP	O	Aping	nn	8	SENT_646	[p13l1596t2485r1674b2512],
7	Jane	NNP	PERSON	Jane	nn	8	SENT_646	[p13l1684t2485r1742b2512],
8	Goodall	NNP	PERSON	Goodall	dep	2	SENT_646	[p13l1758t2485r1863b2505],
9	:	:	O	:	_	0	SENT_646	[p13l1758t2485r1863b2505],
10	Insights	NNPS	O	Insights	dep	2	SENT_646	[p13l1879t2485r1976b2512],
11	into	IN	O	into	_	0	SENT_646	[p13l1993t2485r2042b2504],
12	human	JJ	O	human	amod	14	SENT_646	[p13l2058t2485r2145b2504],
13	lymphatic	JJ	O	lymphatic	amod	14	SENT_646	[p13l2161t2485r2286b2512],
14	ﬁlariasis	NN	O	ﬁlariasis	prep_into	10	SENT_646	[p13l1326t2519r1436b2538],
15	.	.	O	.	_	0	SENT_646	[p13l1326t2519r1436b2538],

1	Trends	NNS	O	trend	_	0	SENT_647	[p13l1448t2519r1537b2538],
2	Parasitol	NNP	O	Parasitol	dep	1	SENT_647	[p13l1549t2519r1659b2538],
3	19	CD	NUMBER	19	num	2	SENT_647	[p13l1674t2519r1705b2538],
4	:	:	O	:	_	0	SENT_647	[p13l1674t2519r1705b2538],
5	105	CD	NUMBER	105	num	6	SENT_647	[p13l1720t2519r1828b2538],
6	—	NN	O	—	dep	1	SENT_647	[p13l1720t2519r1828b2538],
7	109	CD	NUMBER	109	dep	6	SENT_647	[p13l1720t2519r1828b2538],
8	.	.	O	.	_	0	SENT_647	[p13l1720t2519r1828b2538],

1	Saharinen	JJ	PERSON	saharinen	amod	2	SENT_648	[p13l1326t2554r1455b2574],
2	P	NN	PERSON	p	tmod	12	SENT_648	[p13l1473t2554r1495b2577],
3	,	,	O	,	_	0	SENT_648	[p13l1473t2554r1495b2577],
4	Tammela	NN	ORGANIZATION	tammelum	nn	5	SENT_648	[p13l1513t2554r1631b2573],
5	T	NN	ORGANIZATION	t	nsubj	12	SENT_648	[p13l1650t2554r1674b2577],
6	,	,	O	,	_	0	SENT_648	[p13l1650t2554r1674b2577],
7	Karkkainen	JJ	PERCENT	karkkainen	quantmod	8	SENT_648	[p13l1693t2554r1839b2573],
8	%	NN	PERCENT	%	appos	5	SENT_648	[p13l1859t2554r1898b2581],
9	*	CD	NUMBER	*	num	11	SENT_648	[p13l1859t2554r1898b2581],
10	Alitalo	NNP	O	Alitalo	nn	11	SENT_648	[p13l1916t2554r2001b2573],
11	K	NNP	O	K	dep	8	SENT_648	[p13l2020t2554r2038b2573],
12	(	VBD	O	(	_	0	SENT_648	[p13l2058t2554r2133b2579],
13	2004	CD	DATE	2004	num	14	SENT_648	[p13l2058t2554r2133b2579],
14	)	CD	NUMBER	)	dobj	12	SENT_648	[p13l2058t2554r2133b2579],
15	Lymphatic	JJ	O	lymphatic	amod	16	SENT_648	[p13l2151t2554r2286b2581],
16	vasculature	NN	O	vasculature	dep	12	SENT_648	[p13l1326t2588r1475b2607],
17	:	:	O	:	_	0	SENT_648	[p13l1326t2588r1475b2607],
18	development	NN	O	development	dep	16	SENT_648	[p13l1490t2588r1661b2615],
19	,	,	O	,	_	0	SENT_648	[p13l1490t2588r1661b2615],
20	molecular	JJ	O	molecular	amod	21	SENT_648	[p13l1676t2588r1803b2607],
21	regulation	NN	O	regulation	conj_and	18	SENT_648	[p13l1817t2588r1947b2615],
22	and	CC	O	and	_	0	SENT_648	[p13l1962t2588r2007b2607],
23	role	NN	O	role	conj_and	18	SENT_648	[p13l2022t2588r2070b2607],
24	in	IN	O	in	_	0	SENT_648	[p13l2085t2588r2108b2607],
25	tumor	NN	O	tumor	nn	26	SENT_648	[p13l2123t2592r2202b2607],
26	metastasis	NN	O	metastasis	prep_in	12	SENT_648	[p13l2215t2592r2286b2607, p13l1326t2622r1390b2641],
27	and	CC	O	and	_	0	SENT_648	[p13l1402t2622r1448b2641],
28	inflammation	NN	O	inflammation	prep_in	12	SENT_648	[p13l1460t2622r1638b2641],
29	.	.	O	.	_	0	SENT_648	[p13l1460t2622r1638b2641],

1	Trends	NNS	O	trend	_	0	SENT_649	[p13l1650t2622r1739b2641],
2	Immunol	NNP	O	Immunol	dep	1	SENT_649	[p13l1751t2622r1867b2641],
3	25	CD	NUMBER	25	num	2	SENT_649	[p13l1880t2622r1913b2642],
4	:	:	O	:	_	0	SENT_649	[p13l1880t2622r1913b2642],
5	387	CD	NUMBER	387	num	6	SENT_649	[p13l1926t2620r2035b2641],
6	—	NN	O	—	dep	1	SENT_649	[p13l1926t2620r2035b2641],
7	395	CD	NUMBER	395	dep	6	SENT_649	[p13l1926t2620r2035b2641],
8	.	.	O	.	_	0	SENT_649	[p13l1926t2620r2035b2641],

1	Takahashi	NNP	PERSON	Takahashi	nn	2	SENT_650	[p13l1326t2657r1454b2676],
2	M	NNP	O	M	_	0	SENT_650	[p13l1473t2657r1502b2680],
3	,	,	O	,	_	0	SENT_650	[p13l1473t2657r1502b2680],
4	Yoshimoto	NNP	PERSON	Yoshimoto	nn	5	SENT_650	[p13l1521t2657r1659b2676],
5	T	NN	O	t	appos	2	SENT_650	[p13l1678t2657r1702b2680],
6	,	,	O	,	_	0	SENT_650	[p13l1678t2657r1702b2680],
7	Kubo	NN	PERSON	kubo	nn	8	SENT_650	[p13l1721t2657r1788b2676],
8	H	NN	PERSON	h	appos	2	SENT_650	[p13l1808t2657r1829b2676],
9	(	CD	NUMBER	(	dep	8	SENT_650	[p13l1849t2657r1924b2682],
10	2004	CD	DATE	2004	num	13	SENT_650	[p13l1849t2657r1924b2682],
11	)	CD	NUMBER	)	num	13	SENT_650	[p13l1849t2657r1924b2682],
12	Molecular	JJ	O	molecular	amod	13	SENT_650	[p13l1943t2657r2071b2676],
13	mechanisms	NNS	O	mechanism	dep	2	SENT_650	[p13l2089t2657r2243b2676],
14	of	IN	O	of	_	0	SENT_650	[p13l2262t2657r2289b2676],
15	lymphangiogenesis	NN	O	lymphangiogenesis	prep_of	13	SENT_650	[p13l1326t2691r1572b2718],
16	.	.	O	.	_	0	SENT_650	[p13l1326t2691r1572b2718],

1	IntJ	NN	O	intj	nn	2	SENT_651	[p13l1585t2691r1641b2718],
2	Hematol	NN	O	hematol	_	0	SENT_651	[p13l1653t2691r1761b2710],
3	80	CD	NUMBER	80	dep	2	SENT_651	[p13l1774t2691r1808b2710],
4	:	:	O	:	_	0	SENT_651	[p13l1774t2691r1808b2710],
5	29	CD	NUMBER	29	number	6	SENT_651	[p13l1821t2691r1900b2711],
6	—	CD	NUMBER	—	dep	2	SENT_651	[p13l1821t2691r1900b2711],
7	34	CD	NUMBER	34	dep	6	SENT_651	[p13l1821t2691r1900b2711],
8	.	.	O	.	_	0	SENT_651	[p13l1821t2691r1900b2711],

1	Witte	NNP	PERSON	Witte	nn	2	SENT_652	[p13l1326t2725r1394b2744],
2	MH	NNP	O	MH	dep	16	SENT_652	[p13l1406t2725r1458b2748],
3	,	,	O	,	_	0	SENT_652	[p13l1406t2725r1458b2748],
4	Bernas	NNP	PERSON	Bernas	nn	6	SENT_652	[p13l1470t2725r1555b2744],
5	M	NNP	O	M	nn	6	SENT_652	[p13l1567t2725r1606b2752],
6	]	NN	O	]	appos	2	SENT_652	[p13l1567t2725r1606b2752],
7	,	,	O	,	_	0	SENT_652	[p13l1567t2725r1606b2752],
8	Martin	NNP	PERSON	Martin	nn	9	SENT_652	[p13l1617t2725r1703b2744],
9	CP	NNP	O	CP	appos	2	SENT_652	[p13l1714t2725r1755b2748],
10	,	,	O	,	_	0	SENT_652	[p13l1714t2725r1755b2748],
11	Witte	NNP	ORGANIZATION	Witte	appos	2	SENT_652	[p13l1766t2725r1835b2745],
12	CL	NN	ORGANIZATION	cl	dep	16	SENT_652	[p13l1846t2725r1882b2745],
13	(	CD	NUMBER	(	num	12	SENT_652	[p13l1893t2725r1968b2750],
14	2001	CD	DATE	2001	num	16	SENT_652	[p13l1893t2725r1968b2750],
15	)	NN	O	)	nn	16	SENT_652	[p13l1893t2725r1968b2750],
16	Lymphangiogenesis	NN	O	lymphangiogenesis	dep	20	SENT_652	[p13l1979t2725r2229b2752],
17	and	CC	O	and	_	0	SENT_652	[p13l2241t2725r2286b2744],
18	lymphangiodysplasia	NN	O	lymphangiodysplasium	conj_and	16	SENT_652	[p13l1326t2760r1597b2787],
19	:	:	O	:	_	0	SENT_652	[p13l1326t2760r1597b2787],
20	From	IN	O	from	_	0	SENT_652	[p13l1609t2760r1677b2779],
21	molecular	JJ	O	molecular	pobj	20	SENT_652	[p13l1690t2760r1816b2779],
22	to	TO	O	to	_	0	SENT_652	[p13l1828t2764r1852b2779],
23	clinical	JJ	O	clinical	amod	24	SENT_652	[p13l1865t2760r1954b2779],
24	lymphology	NN	O	lymphology	prep_to	21	SENT_652	[p13l1967t2760r2121b2787],
25	.	.	O	.	_	0	SENT_652	[p13l1967t2760r2121b2787],

1	Microsc	NNP	ORGANIZATION	Microsc	nn	3	SENT_653	[p13l2134t2760r2231b2779],
2	Res	NNP	ORGANIZATION	Res	nn	3	SENT_653	[p13l2244t2760r2286b2779],
3	Tech	NNP	ORGANIZATION	Tech	_	0	SENT_653	[p13l1326t2794r1388b2813],
4	55	CD	NUMBER	55	num	3	SENT_653	[p13l1401t2794r1434b2813],
5	:	:	O	:	_	0	SENT_653	[p13l1401t2794r1434b2813],
6	122	CD	NUMBER	122	num	7	SENT_653	[p13l1449t2794r1556b2814],
7	—	NN	O	—	dep	3	SENT_653	[p13l1449t2794r1556b2814],
8	145	CD	NUMBER	145	dep	7	SENT_653	[p13l1449t2794r1556b2814],
9	.	.	O	.	_	0	SENT_653	[p13l1449t2794r1556b2814],

1	Ruocco	NNP	PERSON	Ruocco	nn	2	SENT_654	[p13l1326t2828r1420b2847],
2	V	NNP	O	V	_	0	SENT_654	[p13l1433t2828r1458b2851],
3	,	,	O	,	_	0	SENT_654	[p13l1433t2828r1458b2851],
4	Schwartz	NNP	PERSON	Schwartz	nn	5	SENT_654	[p13l1472t2828r1585b2848],
5	RA	NN	O	ra	appos	2	SENT_654	[p13l1599t2828r1643b2851],
6	,	,	O	,	_	0	SENT_654	[p13l1599t2828r1643b2851],
7	Ruocco	NNP	PERSON	Ruocco	nn	9	SENT_654	[p13l1657t2828r1750b2847],
8	E.	NNP	PERSON	E.	nn	9	SENT_654	[p13l1764t2828r1785b2847],
9	(	NNP	O	(	appos	2	SENT_654	[p13l1800t2828r1875b2853],
10	2002	CD	DATE	2002	num	12	SENT_654	[p13l1800t2828r1875b2853],
11	)	NNP	O	)	nn	12	SENT_654	[p13l1800t2828r1875b2853],
12	Lymphedema	NNP	O	Lymphedema	dep	9	SENT_654	[p13l1889t2828r2067b2855],
13	:	:	O	:	_	0	SENT_654	[p13l1889t2828r2067b2855],
14	An	DT	O	a	det	17	SENT_654	[p13l2081t2828r2117b2847],
15	immunologically	RB	O	immunologically	advmod	16	SENT_654	[p13l2131t2828r2286b2855, p13l1327t2862r1391b2889],
16	vulnerable	JJ	O	vulnerable	amod	17	SENT_654	[p13l1402t2862r1536b2881],
17	site	NN	O	site	dep	2	SENT_654	[p13l1548t2862r1590b2881],
18	for	IN	O	for	_	0	SENT_654	[p13l1602t2862r1640b2881],
19	development	NN	O	development	prep_for	17	SENT_654	[p13l1651t2862r1817b2889],
20	of	IN	O	of	_	0	SENT_654	[p13l1829t2862r1856b2881],
21	neoplasms	NNS	O	neoplasm	prep_of	19	SENT_654	[p13l1865t2862r2003b2889],
22	.	.	O	.	_	0	SENT_654	[p13l1865t2862r2003b2889],

1	J	NNP	O	J	nn	4	SENT_655	[p13l2011t2862r2024b2889],
2	Am	NNP	O	Am	nn	4	SENT_655	[p13l2035t2862r2079b2881],
3	Acad	NNP	O	Acad	nn	4	SENT_655	[p13l2091t2862r2154b2881],
4	Dermatol	NNP	O	Dermatol	_	0	SENT_655	[p13l2166t2862r2286b2881],
5	47	CD	NUMBER	47	num	4	SENT_655	[p13l1326t2894r1360b2915],
6	:	:	O	:	_	0	SENT_655	[p13l1326t2894r1360b2915],
7	124	CD	NUMBER	124	num	8	SENT_655	[p13l1375t2894r1482b2916],
8	—	NN	O	—	dep	4	SENT_655	[p13l1375t2894r1482b2916],
9	127	CD	NUMBER	127	dep	8	SENT_655	[p13l1375t2894r1482b2916],
10	.	.	O	.	_	0	SENT_655	[p13l1375t2894r1482b2916],

1	Saaristo	NNP	MISC	Saaristo	nn	2	SENT_656	[p13l1326t2931r1427b2951],
2	A	NNP	MISC	A	nsubj	9	SENT_656	[p13l1442t2931r1467b2954],
3	,	,	O	,	_	0	SENT_656	[p13l1442t2931r1467b2954],
4	Karkkainen	NNP	PERSON	Karkkainen	nn	5	SENT_656	[p13l1483t2931r1630b2950],
5	MJ	NNP	PERSON	MJ	appos	2	SENT_656	[p13l1646t2931r1685b2958],
6	,	,	O	,	_	0	SENT_656	[p13l1646t2931r1685b2958],
7	Alitalo	NNP	PERSON	Alitalo	nn	8	SENT_656	[p13l1700t2931r1785b2950],
8	K	NNP	PERSON	K	appos	5	SENT_656	[p13l1801t2931r1820b2950],
9	(	VBD	O	(	_	0	SENT_656	[p13l1836t2931r1911b2956],
10	2002	CD	DATE	2002	number	11	SENT_656	[p13l1836t2931r1911b2956],
11	)	CD	NUMBER	)	num	12	SENT_656	[p13l1836t2931r1911b2956],
12	Insights	NNPS	O	Insights	dobj	9	SENT_656	[p13l1926t2931r2024b2958],
13	into	IN	O	into	_	0	SENT_656	[p13l2040t2931r2089b2950],
14	the	DT	O	the	det	16	SENT_656	[p13l2106t2931r2144b2950],
15	molecular	JJ	O	molecular	amod	16	SENT_656	[p13l2160t2931r2287b2950],
16	pathogenesis	NN	O	pathogenesis	prep_into	9	SENT_656	[p13l1326t2965r1489b2992],
17	and	CC	O	and	_	0	SENT_656	[p13l1504t2965r1549b2984],
18	targeted	VBN	O	target	conj_and	9	SENT_656	[p13l1564t2965r1668b2992],
19	treatment	NN	O	treatment	dobj	18	SENT_656	[p13l1683t2969r1808b2984],
20	of	IN	O	of	_	0	SENT_656	[p13l1822t2965r1849b2984],
21	lymphedema	NN	O	lymphedema	prep_of	19	SENT_656	[p13l1860t2965r2028b2992],
22	.	.	O	.	_	0	SENT_656	[p13l1860t2965r2028b2992],

1	Ann	NNP	PERSON	Ann	nn	5	SENT_657	[p13l2042t2965r2095b2984],
2	N	NNP	O	N	nn	5	SENT_657	[p13l2109t2965r2129b2984],
3	Y	NN	O	y	nn	5	SENT_657	[p13l2143t2965r2161b2984],
4	Acad	NNP	O	Acad	nn	5	SENT_657	[p13l2173t2965r2237b2984],
5	Sci	NNP	O	Sci	_	0	SENT_657	[p13l2250t2965r2286b2985],
6	979	CD	NUMBER	979	num	5	SENT_657	[p13l1326t2997r1375b3018],
7	:	:	O	:	_	0	SENT_657	[p13l1326t2997r1375b3018],
8	94	CD	NUMBER	94	num	9	SENT_657	[p13l1388t2999r1482b3018],
9	—	NN	O	—	dep	5	SENT_657	[p13l1388t2999r1482b3018],
10	110	CD	NUMBER	110	dep	9	SENT_657	[p13l1388t2999r1482b3018],
11	.	.	O	.	_	0	SENT_657	[p13l1388t2999r1482b3018],

1	14	CD	NUMBER	14	_	0	SENT_658	[p13l1279t1800r1310b1819],
2	.	.	O	.	_	0	SENT_658	[p13l1279t1800r1310b1819],

1	52	CD	NUMBER	52	num	3	SENT_659	[p14l190t2999r217b3019],
2	Korpelainen	NN	O	korpelainen	nn	3	SENT_659	[p14l239t207r397b234],
3	EI	NN	O	eus	nsubj	7	SENT_659	[p14l411t207r442b230],
4	,	,	O	,	_	0	SENT_659	[p14l411t207r442b230],
5	Alitalo	NNP	PERSON	Alitalo	nn	6	SENT_659	[p14l456t207r540b226],
6	K	NNP	PERSON	K	nsubj	7	SENT_659	[p14l555t207r573b226],
7	(	VBD	O	(	_	0	SENT_659	[p14l587t207r662b232],
8	1998	CD	DATE	1998	num	9	SENT_659	[p14l587t207r662b232],
9	)	CD	NUMBER	)	dobj	7	SENT_659	[p14l587t207r662b232],
10	Signaling	NN	O	signaling	nn	11	SENT_659	[p14l676t207r794b234],
11	angiogenesis	NN	O	angiogenesis	tmod	7	SENT_659	[p14l807t207r966b234],
12	and	CC	O	and	_	0	SENT_659	[p14l980t207r1026b226],
13	lymphangiogenesis	NN	O	lymphangiogenesis	tmod	7	SENT_659	[p14l1039t207r1199b234, p14l239t240r333b267],
14	.	.	O	.	_	0	SENT_659	[p14l1039t207r1199b234, p14l239t240r333b267],

1	Curr	NNP	O	Curr	nn	4	SENT_660	[p14l346t240r406b260],
2	Opin	NNP	O	Opin	nn	4	SENT_660	[p14l417t240r482b267],
3	Cell	NNP	O	Cell	nn	4	SENT_660	[p14l494t240r542b260],
4	Biol	NNP	O	Biol	_	0	SENT_660	[p14l554t240r603b259],
5	10	CD	NUMBER	10	num	4	SENT_660	[p14l618t240r650b259],
6	:	:	O	:	_	0	SENT_660	[p14l618t240r650b259],
7	159464	CD	NUMBER	159464	dep	4	SENT_660	[p14l665t240r772b259],
8	.	.	O	.	_	0	SENT_660	[p14l665t240r772b259],

1	Achen	NNP	O	Achen	nn	2	SENT_661	[p14l238t274r319b293],
2	MG	NN	O	mg	_	0	SENT_661	[p14l332t274r382b297],
3	,	,	O	,	_	0	SENT_661	[p14l332t274r382b297],
4	Jeltsch	NNP	O	Jeltsch	nn	5	SENT_661	[p14l391t274r477b301],
5	M	NNP	O	M	appos	2	SENT_661	[p14l491t274r520b297],
6	,	,	O	,	_	0	SENT_661	[p14l491t274r520b297],
7	Kukk	NNP	PERSON	Kukk	nn	8	SENT_661	[p14l534t274r599b293],
8	E	NNP	PERSON	E	appos	2	SENT_661	[p14l611t274r633b297],
9	,	,	O	,	_	0	SENT_661	[p14l611t274r633b297],
10	Makinen	NNP	ORGANIZATION	Makinen	nn	11	SENT_661	[p14l647t274r756b293],
11	T	NN	ORGANIZATION	t	appos	2	SENT_661	[p14l769t274r793b297],
12	,	,	O	,	_	0	SENT_661	[p14l769t274r793b297],
13	Vitali	NNP	PERSON	Vitali	nn	14	SENT_661	[p14l805t274r875b294],
14	A	NNP	PERSON	A	nsubj	31	SENT_661	[p14l887t274r913b297],
15	,	,	O	,	_	0	SENT_661	[p14l887t274r913b297],
16	et	FW	O	et	dep	24	SENT_661	[p14l926t278r949b293],
17	al.	FW	O	al.	nn	18	SENT_661	[p14l962t274r988b293],
18	(	FW	O	(	dep	16	SENT_661	[p14l1002t274r1077b299],
19	1998	CD	DATE	1998	dep	24	SENT_661	[p14l1002t274r1077b299],
20	)	CD	NUMBER	)	num	24	SENT_661	[p14l1002t274r1077b299],
21	Vascular	JJ	O	vascular	amod	24	SENT_661	[p14l1089t274r1199b293],
22	endothelial	JJ	O	endothelial	amod	24	SENT_661	[p14l239t307r381b326],
23	growth	NN	O	growth	nn	24	SENT_661	[p14l394t307r482b334],
24	factor	NN	O	factor	dep	31	SENT_661	[p14l495t307r570b326],
25	D	NN	O	d	dep	24	SENT_661	[p14l582t307r601b326],
26	(	CD	NUMBER	(	num	28	SENT_661	[p14l615t307r737b332],
27	VEGF-D	NN	O	vegf-d	nn	28	SENT_661	[p14l615t307r737b332],
28	)	NN	O	)	nsubj	31	SENT_661	[p14l615t307r737b332],
29	is	VBZ	O	be	cop	31	SENT_661	[p14l750t307r767b326],
30	a	DT	O	a	det	31	SENT_661	[p14l780t314r792b326],
31	ligand	NN	O	ligand	dep	2	SENT_661	[p14l804t307r882b334],
32	for	IN	O	for	_	0	SENT_661	[p14l894t307r932b326],
33	the	DT	O	the	det	37	SENT_661	[p14l944t307r982b326],
34	tyrosine	NN	O	tyrosine	nn	37	SENT_661	[p14l996t307r1097b334],
35	kinases	NNS	O	kinase	nn	37	SENT_661	[p14l1109t307r1199b326],
36	VEGF	NN	ORGANIZATION	vegf	nn	37	SENT_661	[p14l238t341r312b361],
37	receptor	NN	O	receptor	prep_for	31	SENT_661	[p14l322t345r431b368],
38	2	CD	NUMBER	2	number	39	SENT_661	[p14l441t341r454b360],
39	(	CD	NUMBER	(	num	41	SENT_661	[p14l464t341r534b366],
40	Flkl	NN	O	flkl	nn	41	SENT_661	[p14l464t341r534b366],
41	)	NN	O	)	dep	37	SENT_661	[p14l464t341r534b366],
42	and	CC	O	and	_	0	SENT_661	[p14l544t341r590b360],
43	VEGF	NN	O	vegf	nn	44	SENT_661	[p14l599t341r673b361],
44	receptor	NN	O	receptor	dep	37	SENT_661	[p14l684t345r793b368],
45	3	CD	NUMBER	3	num	48	SENT_661	[p14l802t341r815b360],
46	(	NN	O	(	nn	48	SENT_661	[p14l825t341r896b366],
47	Flt4	NN	O	flt4	nn	48	SENT_661	[p14l825t341r896b366],
48	)	NN	O	)	dep	41	SENT_661	[p14l825t341r896b366],
49	.	.	O	.	_	0	SENT_661	[p14l825t341r896b366],

1	Proc	NNP	O	Proc	nn	7	SENT_662	[p14l907t341r964b360],
2	Natl	NNP	O	Natl	nn	7	SENT_662	[p14l974t341r1026b361],
3	Acad	NNP	O	Acad	nn	7	SENT_662	[p14l1036t341r1100b360],
4	Sci	NNP	O	Sci	nn	7	SENT_662	[p14l1110t341r1145b361],
5	U	NNP	O	U	nn	7	SENT_662	[p14l1156t341r1175b361],
6	S	NNP	O	S	nn	7	SENT_662	[p14l1185t341r1198b361],
7	A	NNP	O	A	_	0	SENT_662	[p14l238t375r257b394],
8	95	CD	NUMBER	95	num	7	SENT_662	[p14l269t375r303b394],
9	:	:	O	:	_	0	SENT_662	[p14l269t375r303b394],
10	548-553	CD	NUMBER	548-553	dep	7	SENT_662	[p14l316t375r426b394],
11	.	.	O	.	_	0	SENT_662	[p14l316t375r426b394],

1	Veikkola	JJ	ORGANIZATION	veikkola	amod	2	SENT_663	[p14l238t409r349b429],
2	T	NN	ORGANIZATION	t	_	0	SENT_663	[p14l366t409r390b432],
3	,	,	O	,	_	0	SENT_663	[p14l366t409r390b432],
4	Jussila	NN	PERSON	jussilum	nn	5	SENT_663	[p14l402t409r485b436],
5	L	NN	PERSON	l	appos	2	SENT_663	[p14l502t409r524b432],
6	,	,	O	,	_	0	SENT_663	[p14l502t409r524b432],
7	Makinen	NN	ORGANIZATION	makinen	nn	8	SENT_663	[p14l542t409r651b428],
8	T	NN	ORGANIZATION	t	appos	2	SENT_663	[p14l668t409r692b432],
9	,	,	O	,	_	0	SENT_663	[p14l668t409r692b432],
10	Karpanen	NN	ORGANIZATION	karpanen	nn	11	SENT_663	[p14l710t409r835b436],
11	T	NN	ORGANIZATION	t	appos	2	SENT_663	[p14l852t409r876b432],
12	,	,	O	,	_	0	SENT_663	[p14l852t409r876b432],
13	Jeltsch	NN	O	jeltsch	nn	14	SENT_663	[p14l889t409r975b436],
14	M	NN	O	m	appos	2	SENT_663	[p14l993t409r1022b432],
15	,	,	O	,	_	0	SENT_663	[p14l993t409r1022b432],
16	et	FW	O	et	appos	2	SENT_663	[p14l1039t413r1062b428],
17	al.	FW	O	al.	nn	18	SENT_663	[p14l1079t409r1105b428],
18	(	FW	O	(	dep	16	SENT_663	[p14l1124t409r1199b434],
19	2001	CD	DATE	2001	num	21	SENT_663	[p14l1124t409r1199b434],
20	)	CD	NUMBER	)	num	21	SENT_663	[p14l1124t409r1199b434],
21	Signalling	NN	O	signalling	nsubj	29	SENT_663	[p14l239t442r365b469],
22	via	IN	O	via	_	0	SENT_663	[p14l373t442r408b461],
23	vascular	JJ	O	vascular	amod	27	SENT_663	[p14l418t442r521b461],
24	endothelial	JJ	O	endothelial	amod	27	SENT_663	[p14l530t442r672b461],
25	growth	NN	O	growth	nn	27	SENT_663	[p14l682t442r770b469],
26	factor	NN	O	factor	nn	27	SENT_663	[p14l780t442r856b461],
27	receptor-3	NN	O	receptor-3	prep_via	21	SENT_663	[p14l865t442r998b469],
28	is	VBZ	O	be	cop	29	SENT_663	[p14l1009t442r1026b461],
29	sufﬁcient	JJ	O	sufﬁcient	rcmod	2	SENT_663	[p14l1036t442r1153b461],
30	for	IN	O	for	_	0	SENT_663	[p14l1162t442r1200b461],
31	lymphangiogenesis	NN	O	lymphangiogenesis	prep_for	29	SENT_663	[p14l239t476r479b503],
32	in	IN	O	in	_	0	SENT_663	[p14l492t476r515b495],
33	transgenic	JJ	O	transgenic	amod	34	SENT_663	[p14l527t476r657b503],
34	mice	NNS	O	mouse	prep_in	31	SENT_663	[p14l671t476r735b495],
35	.	.	O	.	_	0	SENT_663	[p14l671t476r735b495],

1	EMBO	NNP	ORGANIZATION	EMBO	nn	2	SENT_664	[p14l748t476r830b496],
2	J	NNP	O	J	_	0	SENT_664	[p14l838t476r851b503],
3	20	CD	NUMBER	20	num	2	SENT_664	[p14l863t476r896b496],
4	:	:	O	:	_	0	SENT_664	[p14l863t476r896b496],
5	12234231	CD	NUMBER	12234231	dep	2	SENT_664	[p14l911t476r1049b496],
6	.	.	O	.	_	0	SENT_664	[p14l911t476r1049b496],

1	Cao	NNP	O	Cao	nn	2	SENT_665	[p14l239t509r287b529],
2	Y	NN	O	y	nsubj	26	SENT_665	[p14l303t509r327b532],
3	,	,	O	,	_	0	SENT_665	[p14l303t509r327b532],
4	Linden	NNP	PERSON	Linden	nn	5	SENT_665	[p14l344t509r434b528],
5	P	NN	PERSON	p	appos	2	SENT_665	[p14l451t509r472b532],
6	,	,	O	,	_	0	SENT_665	[p14l451t509r472b532],
7	Farnebo	NNP	PERSON	Farnebo	nn	8	SENT_665	[p14l489t509r594b528],
8	J	NNP	PERSON	J	appos	2	SENT_665	[p14l606t509r625b536],
9	,	,	O	,	_	0	SENT_665	[p14l606t509r625b536],
10	Cao	NNP	O	Cao	nn	11	SENT_665	[p14l643t509r691b529],
11	R	NNP	O	R	appos	2	SENT_665	[p14l708t509r731b532],
12	,	,	O	,	_	0	SENT_665	[p14l708t509r731b532],
13	Eriksson	NNP	PERSON	Eriksson	nn	14	SENT_665	[p14l748t509r855b528],
14	A	NNP	O	A	appos	2	SENT_665	[p14l872t509r897b532],
15	,	,	O	,	_	0	SENT_665	[p14l872t509r897b532],
16	et	FW	O	et	appos	2	SENT_665	[p14l915t513r937b528],
17	al.	FW	O	al.	nn	18	SENT_665	[p14l954t509r980b528],
18	(	FW	O	(	dep	16	SENT_665	[p14l998t509r1073b534],
19	1998	CD	DATE	1998	dep	16	SENT_665	[p14l998t509r1073b534],
20	)	CD	NUMBER	)	num	25	SENT_665	[p14l998t509r1073b534],
21	Vascular	JJ	O	vascular	amod	25	SENT_665	[p14l1089t509r1199b528],
22	endothelial	JJ	O	endothelial	amod	25	SENT_665	[p14l239t543r381b562],
23	growth	NN	O	growth	nn	25	SENT_665	[p14l394t543r482b570],
24	factor	NN	O	factor	nn	25	SENT_665	[p14l495t543r571b562],
25	C	NN	O	c	dep	2	SENT_665	[p14l583t543r600b563],
26	induces	VBZ	O	induce	_	0	SENT_665	[p14l614t543r709b562],
27	angiogenesis	NN	O	angiogenesis	dobj	26	SENT_665	[p14l722t543r881b570],
28	in	FW	O	in	prep	27	SENT_665	[p14l895t543r918b562],
29	vivo	FW	O	vivo	pobj	28	SENT_665	[p14l931t543r987b562],
30	.	.	O	.	_	0	SENT_665	[p14l931t543r987b562],

1	Proc	NNP	O	Proc	nn	7	SENT_666	[p14l1000t543r1057b562],
2	Natl	NNP	O	Natl	nn	7	SENT_666	[p14l1070t543r1123b562],
3	Acad	NNP	O	Acad	nn	7	SENT_666	[p14l1135t543r1199b562],
4	Sci	NNP	O	Sci	nn	7	SENT_666	[p14l239t577r274b597],
5	U	NNP	O	U	nn	7	SENT_666	[p14l286t577r306b597],
6	S	NNP	O	S	nn	7	SENT_666	[p14l318t577r331b597],
7	A	NNP	O	A	_	0	SENT_666	[p14l343t577r362b596],
8	95	CD	NUMBER	95	num	7	SENT_666	[p14l374t577r408b596],
9	:	:	O	:	_	0	SENT_666	[p14l374t577r408b596],
10	1438944394	CD	NUMBER	1438944394	dep	7	SENT_666	[p14l423t577r591b596],
11	.	.	O	.	_	0	SENT_666	[p14l423t577r591b596],

1	Baldwin	NNP	PERSON	Baldwin	nn	2	SENT_667	[p14l239t610r340b629],
2	ME	NNP	O	ME	nsubj	32	SENT_667	[p14l357t610r403b633],
3	,	,	O	,	_	0	SENT_667	[p14l357t610r403b633],
4	Catimel	NNP	O	Catimel	nn	5	SENT_667	[p14l420t610r518b630],
5	B	NNP	O	B	appos	2	SENT_667	[p14l534t610r557b633],
6	,	,	O	,	_	0	SENT_667	[p14l534t610r557b633],
7	Nice	NNP	ORGANIZATION	Nice	nn	8	SENT_667	[p14l574t610r630b630],
8	EC	NNP	ORGANIZATION	EC	appos	2	SENT_667	[p14l646t610r688b633],
9	,	,	O	,	_	0	SENT_667	[p14l646t610r688b633],
10	Roufail	NNP	O	Roufail	nn	11	SENT_667	[p14l704t610r796b629],
11	S	NNP	O	S	appos	2	SENT_667	[p14l812t610r832b633],
12	,	,	O	,	_	0	SENT_667	[p14l812t610r832b633],
13	Hall	NNP	O	Hall	nn	14	SENT_667	[p14l849t610r900b629],
14	NE	NNS	O	ne	appos	2	SENT_667	[p14l917t610r960b633],
15	,	,	O	,	_	0	SENT_667	[p14l917t610r960b633],
16	et	FW	O	et	nn	18	SENT_667	[p14l977t614r999b629],
17	al.	FW	O	al.	nn	18	SENT_667	[p14l1016t610r1042b629],
18	(	FW	O	(	dep	32	SENT_667	[p14l1060t610r1134b635],
19	2001	CD	DATE	2001	number	20	SENT_667	[p14l1060t610r1134b635],
20	)	CD	NUMBER	)	num	22	SENT_667	[p14l1060t610r1134b635],
21	The	DT	O	the	det	22	SENT_667	[p14l1150t610r1199b629],
22	speciﬁcity	NN	O	speciﬁcity	dobj	18	SENT_667	[p14l239t644r365b671],
23	of	IN	O	of	_	0	SENT_667	[p14l378t644r405b663],
24	receptor	NN	O	receptor	nn	25	SENT_667	[p14l416t648r525b671],
25	binding	NN	O	binding	prep_of	22	SENT_667	[p14l537t644r636b671],
26	by	IN	O	by	_	0	SENT_667	[p14l648t644r676b671],
27	vascular	JJ	O	vascular	amod	29	SENT_667	[p14l689t644r792b663],
28	endothelial	JJ	O	endothelial	amod	29	SENT_667	[p14l804t644r947b663],
29	growth	NN	O	growth	prep_by	18	SENT_667	[p14l960t644r1048b671],
30	factor-D	NN	O	factor-d	nsubj	32	SENT_667	[p14l1062t644r1167b663],
31	is	VBZ	O	be	cop	32	SENT_667	[p14l1182t644r1199b663],
32	different	JJ	O	different	_	0	SENT_667	[p14l239t678r350b697],
33	in	IN	O	in	_	0	SENT_667	[p14l363t678r386b697],
34	mouse	NN	O	mouse	prep_in	32	SENT_667	[p14l398t684r479b697],
35	and	CC	O	and	_	0	SENT_667	[p14l491t678r537b697],
36	man	NN	O	man	prep_in	32	SENT_667	[p14l549t678r629b705],
37	.	.	O	.	_	0	SENT_667	[p14l549t678r629b705],

1	J	NNP	O	J	nn	3	SENT_668	[p14l549t678r629b705],
2	Biol	NNP	O	Biol	nn	3	SENT_668	[p14l641t678r691b697],
3	Chem	NNP	O	Chem	_	0	SENT_668	[p14l703t678r776b698],
4	276	CD	NUMBER	276	num	3	SENT_668	[p14l789t676r837b698],
5	:	:	O	:	_	0	SENT_668	[p14l789t676r837b698],
6	19166	CD	NUMBER	19166	number	7	SENT_668	[p14l852t676r1021b697],
7	—	CD	NUMBER	—	dep	3	SENT_668	[p14l852t676r1021b697],
8	19171	CD	NUMBER	19171	dep	7	SENT_668	[p14l852t676r1021b697],
9	.	.	O	.	_	0	SENT_668	[p14l852t676r1021b697],

1	.	.	O	.	_	0	SENT_669	[p14l220t727r223b730],

1	Jeltsch	NNP	O	Jeltsch	nn	2	SENT_670	[p14l234t711r320b738],
2	M	NNP	O	M	nsubj	18	SENT_670	[p14l342t711r371b734],
3	,	,	O	,	_	0	SENT_670	[p14l342t711r371b734],
4	Kaipainen	NNP	PERSON	Kaipainen	nn	5	SENT_670	[p14l394t711r524b738],
5	A	NNP	O	A	appos	2	SENT_670	[p14l545t711r570b734],
6	,	,	O	,	_	0	SENT_670	[p14l545t711r570b734],
7	Joukov	NNP	PERSON	Joukov	nn	8	SENT_670	[p14l588t711r679b738],
8	V	NNP	PERSON	V	appos	5	SENT_670	[p14l700t711r725b734],
9	,	,	O	,	_	0	SENT_670	[p14l700t711r725b734],
10	Meng	NNP	O	Meng	nn	11	SENT_670	[p14l747t711r817b738],
11	X	NNP	O	X	appos	8	SENT_670	[p14l838t711r863b734],
12	,	,	O	,	_	0	SENT_670	[p14l838t711r863b734],
13	Lakso	NNP	PERSON	Lakso	nn	14	SENT_670	[p14l885t711r957b730],
14	M	NNP	O	M	appos	5	SENT_670	[p14l979t711r1008b734],
15	,	,	O	,	_	0	SENT_670	[p14l979t711r1008b734],
16	et	FW	O	et	nn	18	SENT_670	[p14l1030t715r1053b730],
17	al.	FW	O	al.	nn	18	SENT_670	[p14l1075t711r1101b730],
18	(	FW	O	(	_	0	SENT_670	[p14l1124t709r1199b736],
19	1997	CD	DATE	1997	num	21	SENT_670	[p14l1124t709r1199b736],
20	)	CD	NUMBER	)	num	21	SENT_670	[p14l1124t709r1199b736],
21	Hyperplasia	NN	PERSON	hyperplasium	dobj	18	SENT_670	[p14l239t745r391b772],
22	of	IN	O	of	_	0	SENT_670	[p14l403t745r430b764],
23	lymphatic	JJ	O	lymphatic	amod	24	SENT_670	[p14l439t745r564b772],
24	vessels	NNS	O	vessel	prep_of	21	SENT_670	[p14l576t745r657b764],
25	in	IN	O	in	_	0	SENT_670	[p14l670t745r693b764],
26	VEGF-C	NN	O	vegf-c	nn	28	SENT_670	[p14l704t745r808b765],
27	transgenic	JJ	O	transgenic	amod	28	SENT_670	[p14l821t745r951b772],
28	mice	NNS	O	mouse	prep_in	18	SENT_670	[p14l964t745r1029b764],
29	.	.	O	.	_	0	SENT_670	[p14l964t745r1029b764],

1	Science	NNP	O	Science	_	0	SENT_671	[p14l1042t745r1137b765],
2	276	CD	NUMBER	276	num	1	SENT_671	[p14l1150t743r1198b765],
3	:	:	O	:	_	0	SENT_671	[p14l1150t743r1198b765],
4	14234425	CD	NUMBER	14234425	dep	1	SENT_671	[p14l241t779r379b799],
5	.	.	O	.	_	0	SENT_671	[p14l241t779r379b799],

1	Kaipainen	NNP	MISC	Kaipainen	nn	2	SENT_672	[p14l239t812r369b839],
2	A	NNP	MISC	A	_	0	SENT_672	[p14l379t812r404b835],
3	,	,	O	,	_	0	SENT_672	[p14l379t812r404b835],
4	KorhonenJ	NNP	O	KorhonenJ	appos	2	SENT_672	[p14l415t812r568b839],
5	,	,	O	,	_	0	SENT_672	[p14l415t812r568b839],
6	Mustonen	NNP	PERSON	Mustonen	nn	7	SENT_672	[p14l580t812r705b831],
7	T	NN	PERSON	t	appos	2	SENT_672	[p14l715t812r739b835],
8	,	,	O	,	_	0	SENT_672	[p14l715t812r739b835],
9	van	NN	O	van	nn	11	SENT_672	[p14l749t819r792b831],
10	Hinsbergh	NNP	ORGANIZATION	Hinsbergh	nn	11	SENT_672	[p14l803t812r935b839],
11	VW	NNP	ORGANIZATION	VW	appos	2	SENT_672	[p14l945t812r998b835],
12	,	,	O	,	_	0	SENT_672	[p14l945t812r998b835],
13	Fang	NNP	PERSON	Fang	nn	14	SENT_672	[p14l1009t812r1070b839],
14	GH	NN	PERSON	gh	nsubj	30	SENT_672	[p14l1079t812r1129b835],
15	,	,	O	,	_	0	SENT_672	[p14l1079t812r1129b835],
16	et	FW	O	et	dep	21	SENT_672	[p14l1139t816r1162b831],
17	al.	FW	O	al.	nn	18	SENT_672	[p14l1172t812r1198b831],
18	(	FW	O	(	dep	16	SENT_672	[p14l240t846r314b871],
19	1995	CD	DATE	1995	dep	21	SENT_672	[p14l240t846r314b871],
20	)	CD	NUMBER	)	num	21	SENT_672	[p14l240t846r314b871],
21	Expression	NN	O	expression	dep	30	SENT_672	[p14l325t846r463b873],
22	of	IN	O	of	_	0	SENT_672	[p14l473t846r500b865],
23	the	DT	O	the	det	26	SENT_672	[p14l508t846r546b865],
24	fms-like	JJ	O	fms-like	amod	26	SENT_672	[p14l557t846r656b865],
25	tyrosine	NN	O	tyrosine	nn	26	SENT_672	[p14l667t846r768b873],
26	kinase	NN	O	kinase	prep_of	21	SENT_672	[p14l778t846r857b865],
27	4	CD	NUMBER	4	num	28	SENT_672	[p14l867t846r881b865],
28	gene	NN	O	gene	nsubj	30	SENT_672	[p14l890t852r948b873],
29	becomes	VBZ	O	become	cop	30	SENT_672	[p14l958t846r1067b865],
30	restricted	JJ	O	restricted	dep	2	SENT_672	[p14l1077t846r1199b865],
31	to	TO	O	to	_	0	SENT_672	[p14l239t884r263b899],
32	lymphatic	JJ	O	lymphatic	amod	33	SENT_672	[p14l275t880r400b907],
33	endothelium	NN	O	endothelium	prep_to	30	SENT_672	[p14l412t880r574b899],
34	during	IN	O	during	_	0	SENT_672	[p14l586t880r671b907],
35	development	NN	O	development	prep_during	30	SENT_672	[p14l683t880r854b907],
36	.	.	O	.	_	0	SENT_672	[p14l683t880r854b907],

1	Proc	NNP	O	Proc	nn	7	SENT_673	[p14l866t880r923b899],
2	Natl	NNP	O	Natl	nn	7	SENT_673	[p14l935t880r988b899],
3	Acad	NNP	O	Acad	nn	7	SENT_673	[p14l1000t880r1063b899],
4	Sci	NNP	O	Sci	nn	7	SENT_673	[p14l1075t880r1111b900],
5	U	NNP	O	U	nn	7	SENT_673	[p14l1123t880r1143b900],
6	S	NNP	O	S	nn	7	SENT_673	[p14l1155t880r1168b900],
7	A	NNP	O	A	_	0	SENT_673	[p14l1180t880r1199b899],
8	92	CD	NUMBER	92	num	7	SENT_673	[p14l239t913r273b932],
9	:	:	O	:	_	0	SENT_673	[p14l239t913r273b932],
10	3566-3570	CD	DURATION	3566-3570	dep	7	SENT_673	[p14l286t911r426b932],
11	.	.	O	.	_	0	SENT_673	[p14l286t911r426b932],

1	Kukk	NNP	PERSON	Kukk	nn	2	SENT_674	[p14l239t947r304b966],
2	E	NNP	O	E	nsubj	30	SENT_674	[p14l313t947r335b970],
3	,	,	O	,	_	0	SENT_674	[p14l313t947r335b970],
4	Lymboussaki	NNP	PERSON	Lymboussaki	nn	5	SENT_674	[p14l344t947r508b974],
5	A	NNP	O	A	appos	2	SENT_674	[p14l517t947r542b970],
6	,	,	O	,	_	0	SENT_674	[p14l517t947r542b970],
7	Taira	NNP	PERSON	Taira	nn	8	SENT_674	[p14l551t947r619b966],
8	S	NNP	PERSON	S	appos	2	SENT_674	[p14l628t947r648b970],
9	,	,	O	,	_	0	SENT_674	[p14l628t947r648b970],
10	Kaipainen	NNP	PERSON	Kaipainen	nn	11	SENT_674	[p14l658t947r788b974],
11	A	NNP	O	A	appos	2	SENT_674	[p14l797t947r913b974],
12	,	,	O	,	_	0	SENT_674	[p14l797t947r913b974],
13	Jeltsch	NNP	O	Jeltsch	nn	14	SENT_674	[p14l797t947r913b974],
14	M	NNP	O	M	appos	2	SENT_674	[p14l923t947r952b970],
15	,	,	O	,	_	0	SENT_674	[p14l923t947r952b970],
16	et	FW	O	et	dep	2	SENT_674	[p14l962t951r985b966],
17	al.	FW	O	al.	nn	18	SENT_674	[p14l994t947r1020b966],
18	(	FW	O	(	dep	2	SENT_674	[p14l1031t947r1106b972],
19	1996	CD	DATE	1996	num	20	SENT_674	[p14l1031t947r1106b972],
20	)	CD	NUMBER	)	dep	18	SENT_674	[p14l1031t947r1106b972],
21	VEGFC	NN	O	vegfc	nn	23	SENT_674	[p14l1114t947r1198b967, p14l239t980r256b1000],
22	receptor	NN	O	receptor	nn	23	SENT_674	[p14l266t984r375b1007],
23	binding	NN	O	binding	dep	18	SENT_674	[p14l384t980r482b1007],
24	and	CC	O	and	_	0	SENT_674	[p14l491t980r537b999],
25	pattern	NN	O	pattern	nsubj	30	SENT_674	[p14l547t984r640b1007],
26	of	IN	O	of	_	0	SENT_674	[p14l650t980r677b999],
27	expression	NN	O	expression	prep_of	25	SENT_674	[p14l683t980r818b1007],
28	with	IN	O	with	_	0	SENT_674	[p14l827t980r881b999],
29	VEGFR-3	NN	MISC	vegfr-3	prep_with	2	SENT_674	[p14l890t980r1009b1000],
30	suggests	VBZ	O	suggest	_	0	SENT_674	[p14l1018t984r1119b1007],
31	a	DT	O	a	det	32	SENT_674	[p14l1129t987r1140b999],
32	role	NN	O	role	dobj	30	SENT_674	[p14l1150t980r1199b999],
33	in	IN	O	in	_	0	SENT_674	[p14l239t1014r262b1033],
34	lymphatic	JJ	O	lymphatic	amod	36	SENT_674	[p14l274t1014r399b1041],
35	vascular	JJ	O	vascular	amod	36	SENT_674	[p14l411t1014r514b1033],
36	development	NN	O	development	prep_in	32	SENT_674	[p14l525t1014r696b1041],
37	.	.	O	.	_	0	SENT_674	[p14l525t1014r696b1041],

1	Development	NNP	O	Development	_	0	SENT_675	[p14l709t1014r879b1041],
2	122	CD	NUMBER	122	num	1	SENT_675	[p14l893t1014r940b1034],
3	:	:	O	:	_	0	SENT_675	[p14l893t1014r940b1034],
4	3829	CD	NUMBER	3829	number	5	SENT_675	[p14l953t1012r1092b1033],
5	—	CD	NUMBER	—	dep	1	SENT_675	[p14l953t1012r1092b1033],
6	3837	CD	NUMBER	3837	dep	5	SENT_675	[p14l953t1012r1092b1033],
7	.	.	O	.	_	0	SENT_675	[p14l953t1012r1092b1033],

1	.	.	O	.	_	0	SENT_676	[p14l220t1064r223b1067],

1	Taylor	NNP	ORGANIZATION	Taylor	nn	2	SENT_677	[p14l238t1048r321b1075],
2	MJ	NNP	ORGANIZATION	MJ	dep	18	SENT_677	[p14l339t1048r378b1075],
3	,	,	O	,	_	0	SENT_677	[p14l339t1048r378b1075],
4	Cross	NNP	ORGANIZATION	Cross	nn	5	SENT_677	[p14l397t1048r465b1068],
5	HF	NN	O	hf	appos	2	SENT_677	[p14l483t1048r527b1071],
6	,	,	O	,	_	0	SENT_677	[p14l483t1048r527b1071],
7	Ford	NNP	ORGANIZATION	Ford	nn	8	SENT_677	[p14l546t1048r605b1067],
8	L	NNP	ORGANIZATION	L	appos	2	SENT_677	[p14l623t1048r645b1071],
9	,	,	O	,	_	0	SENT_677	[p14l623t1048r645b1071],
10	Makunde	NNP	ORGANIZATION	Makunde	nn	11	SENT_677	[p14l664t1048r781b1067],
11	WH	NNP	ORGANIZATION	WH	appos	2	SENT_677	[p14l799t1048r854b1071],
12	,	,	O	,	_	0	SENT_677	[p14l799t1048r854b1071],
13	Prasad	NNP	O	Prasad	nn	14	SENT_677	[p14l873t1048r956b1067],
14	GB	NNP	O	GB	appos	2	SENT_677	[p14l974t1048r1019b1071],
15	,	,	O	,	_	0	SENT_677	[p14l974t1048r1019b1071],
16	et	FW	O	et	appos	2	SENT_677	[p14l1038t1052r1060b1067],
17	al.	FW	O	al.	nn	18	SENT_677	[p14l1078t1048r1104b1067],
18	(	FW	O	(	_	0	SENT_677	[p14l1124t1048r1199b1073],
19	2001	CD	DATE	2001	num	22	SENT_677	[p14l1124t1048r1199b1073],
20	)	CD	NUMBER	)	num	22	SENT_677	[p14l1124t1048r1199b1073],
21	Wolbachia	JJ	O	wolbachia	amod	22	SENT_677	[p14l241t1081r356b1100],
22	bacteria	NNS	O	bacterium	dep	18	SENT_677	[p14l369t1081r471b1100],
23	in	IN	O	in	_	0	SENT_677	[p14l485t1081r508b1100],
24	ﬁlarial	JJ	O	ﬁlarial	amod	25	SENT_677	[p14l522t1081r602b1100],
25	immunity	NN	O	immunity	prep_in	22	SENT_677	[p14l617t1081r740b1108],
26	and	CC	O	and	_	0	SENT_677	[p14l753t1081r799b1100],
27	disease	NN	O	disease	prep_in	22	SENT_677	[p14l812t1081r906b1100],
28	.	.	O	.	_	0	SENT_677	[p14l812t1081r906b1100],

1	Parasite	NN	O	parasite	_	0	SENT_678	[p14l921t1081r1020b1100],
2	Immunol	NNP	O	Immunol	dep	1	SENT_678	[p14l1034t1081r1150b1100],
3	23	CD	NUMBER	23	num	2	SENT_678	[p14l1165t1081r1198b1101],
4	:	:	O	:	_	0	SENT_678	[p14l1165t1081r1198b1101],
5	401-409	CD	NUMBER	401-409	dep	1	SENT_678	[p14l239t1115r348b1134],
6	.	.	O	.	_	0	SENT_678	[p14l239t1115r348b1134],

1	Makinen	NN	PERSON	makinen	nn	2	SENT_679	[p14l239t1149r348b1168],
2	T	NN	PERSON	t	_	0	SENT_679	[p14l361t1149r385b1172],
3	,	,	O	,	_	0	SENT_679	[p14l361t1149r385b1172],
4	Jussila	NN	PERSON	jussilum	nn	5	SENT_679	[p14l394t1149r477b1176],
5	L	NN	PERSON	l	appos	2	SENT_679	[p14l490t1149r512b1172],
6	,	,	O	,	_	0	SENT_679	[p14l490t1149r512b1172],
7	Veikkola	JJ	ORGANIZATION	veikkola	amod	8	SENT_679	[p14l524t1149r636b1169],
8	T	NN	ORGANIZATION	t	appos	2	SENT_679	[p14l649t1149r673b1172],
9	,	,	O	,	_	0	SENT_679	[p14l649t1149r673b1172],
10	Karpanen	NN	ORGANIZATION	karpanen	nn	11	SENT_679	[p14l687t1149r811b1176],
11	T	NN	ORGANIZATION	t	appos	2	SENT_679	[p14l824t1149r848b1172],
12	,	,	O	,	_	0	SENT_679	[p14l824t1149r848b1172],
13	Kettunen	NNP	PERSON	Kettunen	nn	14	SENT_679	[p14l862t1149r981b1168],
14	MI	NNP	O	MI	appos	2	SENT_679	[p14l994t1149r1033b1172],
15	,	,	O	,	_	0	SENT_679	[p14l994t1149r1033b1172],
16	et	FW	O	et	appos	2	SENT_679	[p14l1047t1153r1070b1168],
17	al.	FW	O	al.	nn	18	SENT_679	[p14l1083t1149r1109b1168],
18	(	FW	O	(	dep	16	SENT_679	[p14l1124t1149r1199b1174],
19	2001	CD	DATE	2001	num	21	SENT_679	[p14l1124t1149r1199b1174],
20	)	CD	NUMBER	)	num	21	SENT_679	[p14l1124t1149r1199b1174],
21	Inhibition	NN	O	inhibition	dep	16	SENT_679	[p14l239t1182r367b1201],
22	of	IN	O	of	_	0	SENT_679	[p14l380t1182r407b1201],
23	lymphangiogenesis	NN	O	lymphangiogenesis	prep_of	21	SENT_679	[p14l416t1182r656b1209],
24	with	IN	O	with	dep	2	SENT_679	[p14l668t1182r721b1201],
25	resulting	VBG	O	result	pcomp	24	SENT_679	[p14l734t1182r846b1209],
26	lymphedema	NN	O	lymphedema	dobj	25	SENT_679	[p14l857t1182r1019b1209],
27	in	IN	O	in	_	0	SENT_679	[p14l1032t1182r1055b1201],
28	transgenic	JJ	O	transgenic	amod	29	SENT_679	[p14l1068t1182r1198b1209],
29	mice	NNS	O	mouse	prep_in	25	SENT_679	[p14l239t1216r298b1235],
30	expressing	VBG	O	express	partmod	29	SENT_679	[p14l310t1216r444b1243],
31	soluble	JJ	O	soluble	amod	33	SENT_679	[p14l455t1216r544b1235],
32	VEGF	NN	O	vegf	nn	33	SENT_679	[p14l555t1216r629b1236],
33	receptor-3	NN	O	receptor-3	dobj	30	SENT_679	[p14l642t1216r781b1243],
34	.	.	O	.	_	0	SENT_679	[p14l642t1216r781b1243],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_680	[p14l794t1216r838b1236],
2	Med	NNP	PERSON	Med	_	0	SENT_680	[p14l850t1216r904b1235],
3	7	CD	NUMBER	7	num	2	SENT_680	[p14l917t1214r935b1235],
4	:	:	O	:	_	0	SENT_680	[p14l917t1214r935b1235],
5	199	CD	NUMBER	199	num	6	SENT_680	[p14l950t1216r1057b1235],
6	—	NN	O	—	dep	2	SENT_680	[p14l950t1216r1057b1235],
7	205	CD	NUMBER	205	dep	6	SENT_680	[p14l950t1216r1057b1235],
8	.	.	O	.	_	0	SENT_680	[p14l950t1216r1057b1235],

1	Ristimaki	NNP	MISC	Ristimaki	nn	2	SENT_681	[p14l239t1250r357b1269],
2	A	NNP	MISC	A	nsubj	15	SENT_681	[p14l368t1250r394b1273],
3	,	,	O	,	_	0	SENT_681	[p14l368t1250r394b1273],
4	Narko	NNP	PERSON	Narko	nn	5	SENT_681	[p14l405t1250r483b1269],
5	K	NNP	PERSON	K	appos	2	SENT_681	[p14l496t1250r520b1273],
6	,	,	O	,	_	0	SENT_681	[p14l496t1250r520b1273],
7	Enholm	NNP	PERSON	Enholm	nn	8	SENT_681	[p14l532t1250r630b1269],
8	B	NNP	O	B	appos	2	SENT_681	[p14l641t1250r762b1277],
9	,	,	O	,	_	0	SENT_681	[p14l641t1250r762b1277],
10	Joukov	NNP	PERSON	Joukov	nn	11	SENT_681	[p14l641t1250r762b1277],
11	V	NNP	PERSON	V	appos	2	SENT_681	[p14l773t1250r798b1273],
12	,	,	O	,	_	0	SENT_681	[p14l773t1250r798b1273],
13	Alitalo	NNP	PERSON	Alitalo	nn	14	SENT_681	[p14l810t1250r894b1269],
14	K	NNP	PERSON	K	appos	2	SENT_681	[p14l906t1250r925b1269],
15	(	VBD	O	(	_	0	SENT_681	[p14l937t1250r1012b1275],
16	1998	CD	DATE	1998	num	19	SENT_681	[p14l937t1250r1012b1275],
17	)	CD	NUMBER	)	num	19	SENT_681	[p14l937t1250r1012b1275],
18	Proinflammatory	JJ	O	proinflammatory	amod	19	SENT_681	[p14l1024t1250r1198b1269, p14l239t1287r289b1310],
19	cytokines	NNS	O	cytokine	dobj	15	SENT_681	[p14l304t1283r422b1310],
20	regulate	VBP	O	regulate	rcmod	19	SENT_681	[p14l437t1283r539b1310],
21	expression	NN	O	expression	dobj	20	SENT_681	[p14l554t1283r689b1310],
22	of	IN	O	of	_	0	SENT_681	[p14l704t1283r731b1302],
23	the	DT	O	the	det	26	SENT_681	[p14l744t1283r782b1302],
24	lymphatic	JJ	O	lymphatic	amod	26	SENT_681	[p14l797t1283r922b1310],
25	endothelial	JJ	O	endothelial	amod	26	SENT_681	[p14l937t1283r1080b1302],
26	mitogen	NN	O	mitogen	nn	30	SENT_681	[p14l1095t1283r1199b1310],
27	vascular	JJ	O	vascular	amod	28	SENT_681	[p14l238t1317r341b1336],
28	endothelial	JJ	O	endothelial	amod	30	SENT_681	[p14l352t1317r495b1336],
29	growth	NN	O	growth	nn	30	SENT_681	[p14l507t1317r595b1344],
30	factor-C	NN	O	factor-c	prep_of	21	SENT_681	[p14l607t1317r738b1344],
31	.	.	O	.	_	0	SENT_681	[p14l607t1317r738b1344],

1	J	NNP	O	J	nn	3	SENT_682	[p14l607t1317r738b1344],
2	Biol	NNP	O	Biol	nn	3	SENT_682	[p14l750t1317r800b1336],
3	Chem	NNP	O	Chem	_	0	SENT_682	[p14l812t1317r885b1337],
4	273	CD	NUMBER	273	num	3	SENT_682	[p14l898t1315r947b1337],
5	:	:	O	:	_	0	SENT_682	[p14l898t1315r947b1337],
6	8413	CD	NUMBER	8413	number	7	SENT_682	[p14l960t1317r1099b1336],
7	—	CD	NUMBER	—	dep	3	SENT_682	[p14l960t1317r1099b1336],
8	8418	CD	NUMBER	8418	dep	7	SENT_682	[p14l960t1317r1099b1336],
9	.	.	O	.	_	0	SENT_682	[p14l960t1317r1099b1336],

1	Taylor	NNP	ORGANIZATION	Taylor	nn	2	SENT_683	[p14l238t1351r321b1378],
2	MJ	NNP	ORGANIZATION	MJ	nsubjpass	22	SENT_683	[p14l332t1351r370b1378],
3	,	,	O	,	_	0	SENT_683	[p14l332t1351r370b1378],
4	Cross	NNP	ORGANIZATION	Cross	nn	5	SENT_683	[p14l382t1351r450b1371],
5	HF	NN	ORGANIZATION	hf	appos	2	SENT_683	[p14l461t1351r505b1374],
6	,	,	O	,	_	0	SENT_683	[p14l461t1351r505b1374],
7	Bilo	NNP	PERSON	Bilo	nn	8	SENT_683	[p14l516t1351r565b1370],
8	K	NNP	PERSON	K	nsubj	9	SENT_683	[p14l577t1351r595b1370],
9	(	VBD	O	(	parataxis	22	SENT_683	[p14l606t1351r681b1376],
10	2000	CD	DATE	2000	num	13	SENT_683	[p14l606t1351r681b1376],
11	)	CD	NUMBER	)	num	13	SENT_683	[p14l606t1351r681b1376],
12	Inflammatory	JJ	O	inflammatory	amod	13	SENT_683	[p14l692t1351r866b1378],
13	responses	NNS	O	response	dobj	9	SENT_683	[p14l876t1357r998b1378],
14	induced	VBN	O	induce	partmod	13	SENT_683	[p14l1010t1351r1111b1370],
15	by	IN	O	by	_	0	SENT_683	[p14l1121t1351r1149b1378],
16	the	DT	O	the	det	18	SENT_683	[p14l1161t1351r1199b1370],
17	ﬁlarial	JJ	O	ﬁlarial	amod	18	SENT_683	[p14l239t1384r319b1403],
18	nematode	NN	O	nematode	agent	14	SENT_683	[p14l338t1384r463b1403],
19	Brugia	NN	O	brugium	nn	20	SENT_683	[p14l480t1384r558b1411],
20	mulayi	NNS	O	mulayus	nsubjpass	22	SENT_683	[p14l575t1384r649b1411],
21	are	VBP	O	be	auxpass	22	SENT_683	[p14l666t1390r704b1403],
22	mediated	VBN	O	mediate	_	0	SENT_683	[p14l722t1384r840b1403],
23	by	IN	O	by	_	0	SENT_683	[p14l857t1384r885b1411],
24	lipopolysaccharide-like	JJ	O	lipopolysaccharide-like	amod	25	SENT_683	[p14l903t1384r1199b1411],
25	activity	NN	O	activity	agent	22	SENT_683	[p14l239t1418r330b1445],
26	from	IN	O	from	_	0	SENT_683	[p14l340t1418r402b1437],
27	endosymbiotic	JJ	O	endosymbiotic	amod	28	SENT_683	[p14l413t1418r598b1445],
28	VVolbachz	NN	O	vvolbachz	prep_from	22	SENT_683	[p14l611t1418r727b1438],
29	'	''	O	'	_	0	SENT_683	[p14l611t1418r727b1438],
30	a	DT	O	a	det	31	SENT_683	[p14l611t1418r727b1438],
31	bacteria	NNS	O	bacterium	dep	28	SENT_683	[p14l737t1418r864b1445],
32	.	.	O	.	_	0	SENT_683	[p14l737t1418r864b1445],

1	J	NNP	O	J	nn	3	SENT_684	[p14l737t1418r864b1445],
2	Exp	NNP	O	Exp	nn	3	SENT_684	[p14l875t1418r922b1445],
3	Med	NNP	O	Med	_	0	SENT_684	[p14l933t1418r987b1437],
4	191	CD	NUMBER	191	num	3	SENT_684	[p14l1000t1418r1047b1437],
5	:	:	O	:	_	0	SENT_684	[p14l1000t1418r1047b1437],
6	14294436	CD	NUMBER	14294436	dep	3	SENT_684	[p14l1060t1418r1198b1438],
7	.	.	O	.	_	0	SENT_684	[p14l1060t1418r1198b1438],

1	Raman	NNP	PERSON	Raman	nn	2	SENT_685	[p14l239t1452r326b1471],
2	U	NNP	PERSON	U	nsubj	20	SENT_685	[p14l347t1452r373b1475],
3	,	,	O	,	_	0	SENT_685	[p14l347t1452r373b1475],
4	Eswaran	NNP	ORGANIZATION	Eswaran	nn	5	SENT_685	[p14l393t1452r497b1471],
5	D	NNP	ORGANIZATION	D	appos	2	SENT_685	[p14l518t1452r543b1475],
6	,	,	O	,	_	0	SENT_685	[p14l518t1452r543b1475],
7	Narayanan	NNP	PERSON	Narayanan	nn	8	SENT_685	[p14l564t1452r701b1479],
8	RB	NN	O	rb	appos	2	SENT_685	[p14l722t1452r764b1475],
9	,	,	O	,	_	0	SENT_685	[p14l722t1452r764b1475],
10	Jayaraman	NNP	PERSON	Jayaraman	nn	11	SENT_685	[p14l780t1452r917b1479],
11	K	NNP	PERSON	K	appos	2	SENT_685	[p14l938t1452r962b1475],
12	,	,	O	,	_	0	SENT_685	[p14l938t1452r962b1475],
13	Kaliraj	NNP	PERSON	Kaliraj	nn	14	SENT_685	[p14l983t1452r1066b1479],
14	P	NN	PERSON	p	appos	2	SENT_685	[p14l1088t1452r1103b1471],
15	(	CD	NUMBER	(	num	19	SENT_685	[p14l1124t1452r1199b1477],
16	1999	CD	DATE	1999	num	19	SENT_685	[p14l1124t1452r1199b1477],
17	)	CD	NUMBER	)	num	19	SENT_685	[p14l1124t1452r1199b1477],
18	Proinflammatory	JJ	O	proinflammatory	amod	19	SENT_685	[p14l239t1485r457b1512],
19	cytokines	NNS	O	cytokine	dep	14	SENT_685	[p14l477t1485r595b1512],
20	secreted	VBN	O	secrete	_	0	SENT_685	[p14l616t1485r720b1504],
21	by	IN	O	by	_	0	SENT_685	[p14l741t1485r769b1512],
22	monocytes	NNS	O	monocyte	prep_by	20	SENT_685	[p14l789t1489r924b1512],
23	of	IN	O	of	_	0	SENT_685	[p14l945t1485r972b1504],
24	ﬁlarial	JJ	O	ﬁlarial	amod	25	SENT_685	[p14l989t1485r1070b1504],
25	patients	NNS	O	patient	prep_of	22	SENT_685	[p14l1091t1485r1198b1512],
26	.	.	O	.	_	0	SENT_685	[p14l1091t1485r1198b1512],

1	Microbiol	NNP	O	Microbiol	nn	2	SENT_686	[p14l239t1519r362b1538],
2	Immunol	NNP	O	Immunol	_	0	SENT_686	[p14l374t1519r490b1538],
3	43	CD	NUMBER	43	num	2	SENT_686	[p14l503t1519r537b1538],
4	:	:	O	:	_	0	SENT_686	[p14l503t1519r537b1538],
5	279	CD	NUMBER	279	num	6	SENT_686	[p14l550t1517r659b1539],
6	—	NN	O	—	dep	2	SENT_686	[p14l550t1517r659b1539],
7	283	CD	NUMBER	283	dep	6	SENT_686	[p14l550t1517r659b1539],
8	.	.	O	.	_	0	SENT_686	[p14l550t1517r659b1539],

1	Brattig	NNP	ORGANIZATION	Brattig	nn	2	SENT_687	[p14l239t1553r327b1580],
2	NW	NNP	ORGANIZATION	NW	nsubj	34	SENT_687	[p14l345t1553r399b1576],
3	,	,	O	,	_	0	SENT_687	[p14l345t1553r399b1576],
4	Rathjens	NNP	PERSON	Rathjens	nn	5	SENT_687	[p14l419t1553r528b1580],
5	U	NNP	PERSON	U	appos	2	SENT_687	[p14l548t1553r574b1576],
6	,	,	O	,	_	0	SENT_687	[p14l548t1553r574b1576],
7	Ernst	NNP	ORGANIZATION	Ernst	nn	8	SENT_687	[p14l594t1553r660b1572],
8	M	NNP	ORGANIZATION	M	appos	2	SENT_687	[p14l680t1553r709b1576],
9	,	,	O	,	_	0	SENT_687	[p14l680t1553r709b1576],
10	Geisinger	NNP	PERSON	Geisinger	nn	11	SENT_687	[p14l729t1553r850b1580],
11	F	NN	PERSON	f	appos	2	SENT_687	[p14l869t1553r889b1576],
12	,	,	O	,	_	0	SENT_687	[p14l869t1553r889b1576],
13	Renz	NNP	PERSON	Renz	nn	14	SENT_687	[p14l909t1553r970b1572],
14	A	NNP	O	A	appos	2	SENT_687	[p14l989t1553r1014b1576],
15	,	,	O	,	_	0	SENT_687	[p14l989t1553r1014b1576],
16	et	FW	O	et	appos	2	SENT_687	[p14l1034t1557r1057b1572],
17	al.	FW	O	al.	nn	18	SENT_687	[p14l1077t1553r1103b1572],
18	(	FW	O	(	dep	16	SENT_687	[p14l1124t1553r1199b1578],
19	2000	CD	DATE	2000	num	22	SENT_687	[p14l1124t1553r1199b1578],
20	)	CD	NUMBER	)	num	22	SENT_687	[p14l1124t1553r1199b1578],
21	Lipopolysaccharide-like	JJ	O	lipopolysaccharide-like	amod	22	SENT_687	[p14l239t1586r544b1613],
22	molecules	NNS	O	molecule	dep	16	SENT_687	[p14l555t1586r680b1605],
23	derived	VBN	O	derive	partmod	2	SENT_687	[p14l691t1586r786b1605],
24	from	IN	O	from	_	0	SENT_687	[p14l797t1586r858b1605],
25	VI/olbachzn	NN	O	vi/olbachzn	nn	26	SENT_687	[p14l871t1586r987b1606],
26	endobacteria	NN	O	endobacterium	prep_from	23	SENT_687	[p14l997t1586r1164b1605],
27	of	IN	O	of	_	0	SENT_687	[p14l1175t1586r1202b1605],
28	the	DT	O	the	det	31	SENT_687	[p14l239t1620r277b1639],
29	ﬁlaria	NN	O	ﬁlaria	nn	31	SENT_687	[p14l291t1620r365b1639],
30	Onchocerca	NN	O	onchocerca	nn	31	SENT_687	[p14l379t1620r504b1640],
31	vol-uulm	NN	O	vol-uulm	prep_of	26	SENT_687	[p14l517t1620r611b1639],
32	are	VBP	O	be	cop	34	SENT_687	[p14l625t1626r663b1639],
33	candidate	NN	O	candidate	nn	34	SENT_687	[p14l677t1620r801b1639],
34	mediators	NNS	O	mediator	_	0	SENT_687	[p14l815t1620r941b1639],
35	in	IN	O	in	_	0	SENT_687	[p14l956t1620r979b1639],
36	the	DT	O	the	det	37	SENT_687	[p14l993t1620r1031b1639],
37	sequence	NN	O	sequence	prep_in	34	SENT_687	[p14l1046t1626r1161b1647],
38	of	IN	O	of	_	0	SENT_687	[p14l1175t1620r1202b1639],
39	inflammatory	JJ	O	inflammatory	amod	42	SENT_687	[p14l239t1653r412b1680],
40	and	CC	O	and	_	0	SENT_687	[p14l433t1653r479b1672],
41	anti-inflammatory	JJ	O	anti-inflammatory	conj_and	39	SENT_687	[p14l501t1653r735b1680],
42	responses	NNS	O	response	prep_of	37	SENT_687	[p14l756t1659r879b1680],
43	of	IN	O	of	_	0	SENT_687	[p14l901t1653r928b1672],
44	human	JJ	O	human	amod	45	SENT_687	[p14l947t1653r1034b1672],
45	monocytes	NNS	O	monocyte	prep_of	42	SENT_687	[p14l1056t1657r1198b1680],
46	.	.	O	.	_	0	SENT_687	[p14l1056t1657r1198b1680],

1	Microbes	NNS	O	microbe	nsubj	2	SENT_688	[p14l239t1687r354b1706],
2	Infect	VBP	O	infect	_	0	SENT_688	[p14l366t1687r440b1706],
3	2	CD	NUMBER	2	dobj	2	SENT_688	[p14l452t1687r471b1706],
4	:	:	O	:	_	0	SENT_688	[p14l452t1687r471b1706],
5	11474157	CD	NUMBER	11474157	dobj	2	SENT_688	[p14l485t1685r623b1706],
6	.	.	O	.	_	0	SENT_688	[p14l485t1685r623b1706],

1	Taylor	NNP	PERSON	Taylor	nn	3	SENT_689	[p14l238t1721r321b1748],
2	l\/I	NNP	O	l\/I	nn	3	SENT_689	[p14l331t1721r370b1748],
3	]	NNP	O	]	_	0	SENT_689	[p14l331t1721r370b1748],
4	,	,	O	,	_	0	SENT_689	[p14l331t1721r370b1748],
5	Bandi	NNP	PERSON	Bandi	nn	6	SENT_689	[p14l380t1721r453b1740],
6	C	NNP	O	C	appos	3	SENT_689	[p14l463t1721r487b1744],
7	,	,	O	,	_	0	SENT_689	[p14l463t1721r487b1744],
8	HoeraufA	NNP	O	HoeraufA	appos	3	SENT_689	[p14l498t1721r631b1740],
9	(	CD	NUMBER	(	num	8	SENT_689	[p14l642t1721r717b1746],
10	2005	CD	DATE	2005	dep	8	SENT_689	[p14l642t1721r717b1746],
11	)	CD	NUMBER	)	num	14	SENT_689	[p14l642t1721r717b1746],
12	Wolbachia	JJ	O	wolbachia	amod	14	SENT_689	[p14l729t1721r844b1740],
13	bacterial	JJ	O	bacterial	amod	14	SENT_689	[p14l853t1721r963b1740],
14	endosymbionts	NNS	O	endosymbiont	dep	3	SENT_689	[p14l973t1721r1165b1748],
15	of	IN	O	of	_	0	SENT_689	[p14l1175t1721r1202b1740],
16	ﬁlarial	JJ	O	ﬁlarial	amod	17	SENT_689	[p14l239t1754r319b1773],
17	nematodes	NNS	O	nematode	prep_of	14	SENT_689	[p14l332t1754r474b1773],
18	.	.	O	.	_	0	SENT_689	[p14l332t1754r474b1773],

1	Adv	NNP	O	Adv	nn	2	SENT_690	[p14l486t1754r536b1773],
2	Parasitol	NNP	O	Parasitol	_	0	SENT_690	[p14l548t1754r658b1773],
3	60	CD	NUMBER	60	num	2	SENT_690	[p14l671t1754r704b1773],
4	:	:	O	:	_	0	SENT_690	[p14l671t1754r704b1773],
5	245	CD	NUMBER	245	num	6	SENT_690	[p14l717t1754r827b1774],
6	—	NN	O	—	dep	2	SENT_690	[p14l717t1754r827b1774],
7	284	CD	NUMBER	284	dep	6	SENT_690	[p14l717t1754r827b1774],
8	.	.	O	.	_	0	SENT_690	[p14l717t1754r827b1774],

1	Taylor	NNP	ORGANIZATION	Taylor	nn	2	SENT_691	[p14l238t1788r321b1815],
2	MJ	NNP	ORGANIZATION	MJ	nsubj	18	SENT_691	[p14l335t1788r374b1815],
3	,	,	O	,	_	0	SENT_691	[p14l335t1788r374b1815],
4	Makunde	NNP	PERSON	Makunde	nn	5	SENT_691	[p14l389t1788r505b1807],
5	WH	NNP	PERSON	WH	appos	2	SENT_691	[p14l519t1788r574b1811],
6	,	,	O	,	_	0	SENT_691	[p14l519t1788r574b1811],
7	McGarry	NNP	PERSON	McGarry	nn	8	SENT_691	[p14l589t1788r700b1815],
8	HF	NN	O	hf	appos	5	SENT_691	[p14l714t1788r758b1811],
9	,	,	O	,	_	0	SENT_691	[p14l714t1788r758b1811],
10	Turner	NNP	ORGANIZATION	Turner	nn	11	SENT_691	[p14l772t1788r863b1807],
11	JD	NNP	ORGANIZATION	JD	appos	8	SENT_691	[p14l871t1788r912b1815],
12	,	,	O	,	_	0	SENT_691	[p14l871t1788r912b1815],
13	Mand	NNP	O	Mand	nn	14	SENT_691	[p14l927t1788r998b1807],
14	S	NNP	O	S	appos	5	SENT_691	[p14l1012t1788r1031b1811],
15	,	,	O	,	_	0	SENT_691	[p14l1012t1788r1031b1811],
16	et	FW	O	et	nn	18	SENT_691	[p14l1046t1792r1068b1807],
17	al.	FW	O	al.	nn	18	SENT_691	[p14l1082t1788r1108b1807],
18	(	FW	O	(	_	0	SENT_691	[p14l1124t1788r1199b1813],
19	2005	CD	DATE	2005	num	20	SENT_691	[p14l1124t1788r1199b1813],
20	)	CD	NUMBER	)	dobj	18	SENT_691	[p14l1124t1788r1199b1813],
21	Macroﬁlaricidal	JJ	O	macroﬁlaricidal	amod	22	SENT_691	[p14l239t1822r440b1841],
22	activity	NN	O	activity	dep	20	SENT_691	[p14l452t1822r543b1849],
23	after	IN	O	after	_	0	SENT_691	[p14l554t1822r613b1841],
24	doxycycline	NN	O	doxycycline	nn	25	SENT_691	[p14l624t1822r772b1849],
25	treatment	NN	O	treatment	prep_after	18	SENT_691	[p14l784t1826r910b1841],
26	of	IN	O	of	_	0	SENT_691	[p14l921t1822r948b1841],
27	Wuchereria	FW	LOCATION	wuchereria	nn	28	SENT_691	[p14l958t1822r1085b1842],
28	bzmcrofti	FW	O	bzmcrofti	prep_of	25	SENT_691	[p14l1095t1822r1199b1849],
29	:	:	O	:	_	0	SENT_691	[p14l1095t1822r1199b1849],
30	A	DT	O	a	det	35	SENT_691	[p14l238t1855r257b1874],
31	double-blind	JJ	O	double-blind	amod	35	SENT_691	[p14l273t1855r443b1878],
32	,	,	O	,	_	0	SENT_691	[p14l273t1855r443b1878],
33	randomised	JJ	O	randomised	amod	35	SENT_691	[p14l460t1855r610b1874],
34	placebo-controlled	JJ	O	placebo-controlled	amod	35	SENT_691	[p14l626t1855r868b1882],
35	trial	NN	O	trial	dep	25	SENT_691	[p14l884t1855r941b1874],
36	.	.	O	.	_	0	SENT_691	[p14l884t1855r941b1874],

1	Lancet	NNP	O	Lancet	_	0	SENT_692	[p14l958t1855r1044b1874],
2	365	CD	NUMBER	365	num	1	SENT_692	[p14l1060t1855r1109b1874],
3	:	:	O	:	_	0	SENT_692	[p14l1060t1855r1109b1874],
4	2116	CD	DATE	2116	number	5	SENT_692	[p14l1126t1855r1198b1875],
5	—	CD	DATE	—	dep	1	SENT_692	[p14l1126t1855r1198b1875],
6	2121	CD	DATE	2121	dep	5	SENT_692	[p14l239t1889r303b1908],
7	.	.	O	.	_	0	SENT_692	[p14l239t1889r303b1908],

1	Hoerauf	NNP	O	Hoerauf	nn	2	SENT_693	[p14l239t1923r347b1942],
2	A	NNP	O	A	nsubj	18	SENT_693	[p14l359t1923r385b1946],
3	,	,	O	,	_	0	SENT_693	[p14l359t1923r385b1946],
4	Volkmann	NNP	PERSON	Volkmann	nn	5	SENT_693	[p14l401t1923r533b1943],
5	L	NNP	O	L	appos	2	SENT_693	[p14l549t1923r571b1946],
6	,	,	O	,	_	0	SENT_693	[p14l549t1923r571b1946],
7	Hamelmann	NNP	ORGANIZATION	Hamelmann	nn	8	SENT_693	[p14l588t1923r744b1942],
8	C	NNP	ORGANIZATION	C	appos	5	SENT_693	[p14l761t1923r785b1946],
9	,	,	O	,	_	0	SENT_693	[p14l761t1923r785b1946],
10	Adjei	NNP	PERSON	Adjei	nn	11	SENT_693	[p14l801t1923r867b1950],
11	O	NNP	PERSON	O	appos	8	SENT_693	[p14l884t1923r912b1946],
12	,	,	O	,	_	0	SENT_693	[p14l884t1923r912b1946],
13	Autenrieth	NNP	ORGANIZATION	Autenrieth	nn	14	SENT_693	[p14l927t1923r1067b1942],
14	IB	NNP	ORGANIZATION	IB	appos	5	SENT_693	[p14l1084t1923r1117b1946],
15	,	,	O	,	_	0	SENT_693	[p14l1084t1923r1117b1946],
16	et	FW	O	et	nn	18	SENT_693	[p14l1134t1927r1156b1942],
17	al.	FW	O	al.	nn	18	SENT_693	[p14l1172t1923r1198b1942],
18	(	FW	O	(	_	0	SENT_693	[p14l240t1956r314b1981],
19	2000	CD	DATE	2000	num	22	SENT_693	[p14l240t1956r314b1981],
20	)	CD	NUMBER	)	num	22	SENT_693	[p14l240t1956r314b1981],
21	Endosymbiotic	JJ	O	endosymbiotic	amod	22	SENT_693	[p14l331t1956r520b1983],
22	bacteria	NNS	O	bacterium	dobj	18	SENT_693	[p14l537t1956r640b1975],
23	in	IN	O	in	_	0	SENT_693	[p14l657t1956r680b1975],
24	worms	NNS	O	worm	prep_in	22	SENT_693	[p14l697t1962r779b1975],
25	as	IN	O	as	_	0	SENT_693	[p14l797t1962r820b1975],
26	targets	NNS	O	target	prep_as	18	SENT_693	[p14l837t1960r921b1983],
27	for	IN	O	for	_	0	SENT_693	[p14l938t1956r976b1975],
28	a	DT	O	a	det	30	SENT_693	[p14l992t1963r1004b1975],
29	novel	JJ	O	novel	amod	30	SENT_693	[p14l1021t1956r1088b1975],
30	chemotherapy	NN	O	chemotherapy	prep_for	26	SENT_693	[p14l1105t1956r1199b1975, p14l239t1990r335b2017],
31	in	IN	O	in	_	0	SENT_693	[p14l348t1990r371b2009],
32	ﬁlariasis	NN	O	ﬁlariasis	prep_in	30	SENT_693	[p14l383t1990r493b2009],
33	.	.	O	.	_	0	SENT_693	[p14l383t1990r493b2009],

1	Lancet	NNP	O	Lancet	_	0	SENT_694	[p14l505t1990r591b2009],
2	355	CD	NUMBER	355	num	1	SENT_694	[p14l603t1990r651b2009],
3	:	:	O	:	_	0	SENT_694	[p14l603t1990r651b2009],
4	12424243	CD	NUMBER	12424243	dep	1	SENT_694	[p14l666t1990r804b2010],
5	.	.	O	.	_	0	SENT_694	[p14l666t1990r804b2010],

1	Hoerauf	NNP	O	Hoerauf	nn	2	SENT_695	[p14l239t2024r347b2043],
2	A	NNP	O	A	nsubj	18	SENT_695	[p14l355t2024r380b2047],
3	,	,	O	,	_	0	SENT_695	[p14l355t2024r380b2047],
4	Mand	NNP	O	Mand	nn	5	SENT_695	[p14l392t2024r463b2043],
5	S	NNP	O	S	appos	2	SENT_695	[p14l475t2024r494b2047],
6	,	,	O	,	_	0	SENT_695	[p14l475t2024r494b2047],
7	Fischer	NNP	PERSON	Fischer	nn	8	SENT_695	[p14l506t2024r598b2043],
8	K	NNP	PERSON	K	appos	5	SENT_695	[p14l609t2024r633b2047],
9	,	,	O	,	_	0	SENT_695	[p14l609t2024r633b2047],
10	Kruppa	NNP	PERSON	Kruppa	nn	11	SENT_695	[p14l645t2024r741b2051],
11	T	NN	O	t	appos	8	SENT_695	[p14l752t2024r776b2047],
12	,	,	O	,	_	0	SENT_695	[p14l752t2024r776b2047],
13	Marfo-Debrekyei	NNP	O	Marfo-Debrekyei	nn	14	SENT_695	[p14l788t2024r1004b2051],
14	Y	NN	O	y	appos	5	SENT_695	[p14l1016t2024r1039b2047],
15	,	,	O	,	_	0	SENT_695	[p14l1016t2024r1039b2047],
16	et	FW	O	et	nn	18	SENT_695	[p14l1051t2028r1073b2043],
17	al.	FW	O	al.	nn	18	SENT_695	[p14l1085t2024r1111b2043],
18	(	FW	O	(	_	0	SENT_695	[p14l1124t2024r1199b2049],
19	2003	CD	DATE	2003	num	20	SENT_695	[p14l1124t2024r1199b2049],
20	)	CD	NUMBER	)	dobj	18	SENT_695	[p14l1124t2024r1199b2049],
21	Doxycycline	NNP	O	Doxycycline	dep	20	SENT_695	[p14l239t2057r392b2084],
22	as	IN	O	as	_	0	SENT_695	[p14l403t2063r426b2076],
23	a	DT	O	a	det	25	SENT_695	[p14l437t2064r449b2076],
24	novel	JJ	O	novel	amod	25	SENT_695	[p14l459t2057r526b2076],
25	strategy	NN	O	strategy	prep_as	18	SENT_695	[p14l537t2061r636b2084],
26	against	IN	O	against	_	0	SENT_695	[p14l646t2057r734b2084],
27	bancroftian	JJ	O	bancroftian	amod	28	SENT_695	[p14l744t2057r893b2076],
28	ﬁlariasis	NN	O	ﬁlariasis	prep_against	25	SENT_695	[p14l904t2057r1164b2084],
29	.	.	O	.	_	0	SENT_695	[p14l904t2057r1164b2084],

1	—	NN	O	—	_	0	SENT_696	[p14l904t2057r1164b2084],
2	.	.	O	.	_	0	SENT_696	[p14l904t2057r1164b2084],

1	Depletion	NN	O	depletion	_	0	SENT_697	[p14l904t2057r1164b2084],
2	of	IN	O	of	_	0	SENT_697	[p14l1175t2057r1202b2076],
3	Wolbachia	JJ	LOCATION	wolbachia	amod	4	SENT_697	[p14l241t2091r356b2110],
4	endosymbionts	NNS	O	endosymbiont	prep_of	1	SENT_697	[p14l365t2091r557b2118],
5	from	IN	O	from	_	0	SENT_697	[p14l567t2091r628b2110],
6	Wuchereria	FW	LOCATION	wuchereria	nn	7	SENT_697	[p14l640t2091r767b2111],
7	buncmfti	FW	O	buncmfti	prep_from	4	SENT_697	[p14l776t2091r874b2118],
8	and	CC	O	and	_	0	SENT_697	[p14l884t2091r929b2110],
9	stop	VB	O	stop	prep_of	1	SENT_697	[p14l939t2095r992b2118],
10	of	IN	O	of	_	0	SENT_697	[p14l1002t2091r1029b2110],
11	microﬁlariae	NN	O	microﬁlariae	nn	12	SENT_697	[p14l1036t2091r1199b2110],
12	production	NN	O	production	prep_of	9	SENT_697	[p14l239t2125r388b2152],
13	.	.	O	.	_	0	SENT_697	[p14l239t2125r388b2152],

1	Med	NNP	O	Med	nn	3	SENT_698	[p14l401t2125r455b2144],
2	Microbiol	NNP	O	Microbiol	nn	3	SENT_698	[p14l467t2125r590b2144],
3	Immunol	NNP	O	Immunol	_	0	SENT_698	[p14l602t2125r718b2144],
4	5	CD	NUMBER	5	num	3	SENT_698	[p14l731t2125r749b2144],
5	:	:	O	:	_	0	SENT_698	[p14l731t2125r749b2144],
6	261	CD	NUMBER	261	num	7	SENT_698	[p14l763t2123r872b2145],
7	—	NN	O	—	dep	3	SENT_698	[p14l763t2123r872b2145],
8	273	CD	NUMBER	273	dep	7	SENT_698	[p14l763t2123r872b2145],
9	.	.	O	.	_	0	SENT_698	[p14l763t2123r872b2145],

1	.	.	O	.	_	0	SENT_699	[p14l220t2174r223b2177],

1	Turner	NNP	O	Turner	nn	2	SENT_700	[p14l238t2158r330b2177],
2	JD	NNP	O	JD	nsubj	21	SENT_700	[p14l342t2158r382b2185],
3	,	,	O	,	_	0	SENT_700	[p14l342t2158r382b2185],
4	Mand	NNP	LOCATION	Mand	nn	5	SENT_700	[p14l401t2158r471b2177],
5	S	NNP	LOCATION	S	appos	2	SENT_700	[p14l489t2158r509b2181],
6	,	,	O	,	_	0	SENT_700	[p14l489t2158r509b2181],
7	Debrah	NNP	ORGANIZATION	Debrah	nn	8	SENT_700	[p14l527t2158r620b2177],
8	AY	NNP	O	AY	appos	2	SENT_700	[p14l637t2158r681b2181],
9	,	,	O	,	_	0	SENT_700	[p14l637t2158r681b2181],
10	Muehlfeld	NNP	PERSON	Muehlfeld	nn	11	SENT_700	[p14l700t2158r827b2177],
11	J	NNP	PERSON	J	appos	2	SENT_700	[p14l840t2158r859b2185],
12	,	,	O	,	_	0	SENT_700	[p14l840t2158r859b2185],
13	Pfarr	NNP	O	Pfarr	nn	14	SENT_700	[p14l877t2158r942b2177],
14	K	NNP	O	K	appos	2	SENT_700	[p14l960t2158r984b2181],
15	,	,	O	,	_	0	SENT_700	[p14l960t2158r984b2181],
16	et	FW	O	et	appos	2	SENT_700	[p14l1002t2162r1025b2177],
17	al.	FW	O	al.	nn	18	SENT_700	[p14l1043t2158r1068b2177],
18	(	FW	O	(	dep	16	SENT_700	[p14l1088t2158r1163b2183],
19	2006	CD	DATE	2006	number	20	SENT_700	[p14l1088t2158r1163b2183],
20	)	CD	NUMBER	)	num	21	SENT_700	[p14l1088t2158r1163b2183],
21	A	DT	O	a	_	0	SENT_700	[p14l1180t2158r1199b2177],
22	randomized	VBN	O	randomize	partmod	21	SENT_700	[p14l239t2192r396b2215],
23	,	,	O	,	_	0	SENT_700	[p14l239t2192r396b2215],
24	double-blind	JJ	O	double-blind	amod	26	SENT_700	[p14l410t2192r573b2211],
25	clinical	JJ	O	clinical	amod	26	SENT_700	[p14l587t2192r676b2211],
26	trial	NN	O	trial	nn	43	SENT_700	[p14l691t2192r741b2211],
27	of	IN	O	of	_	0	SENT_700	[p14l755t2192r782b2211],
28	a	DT	O	a	det	30	SENT_700	[p14l793t2199r805b2211],
29	3-week	JJ	DURATION	3-week	amod	30	SENT_700	[p14l818t2192r904b2211],
30	course	NN	O	course	prep_of	26	SENT_700	[p14l918t2198r999b2211],
31	of	IN	O	of	_	0	SENT_700	[p14l1013t2192r1040b2211],
32	doxycycline	NN	O	doxycycline	prep_of	30	SENT_700	[p14l1050t2192r1198b2219],
33	plus	CC	O	plus	_	0	SENT_700	[p14l239t2225r289b2252],
34	albendazole	NN	O	albendazole	nn	43	SENT_700	[p14l304t2225r453b2244],
35	and	CC	O	and	_	0	SENT_700	[p14l468t2225r514b2244],
36	ivermectin	NN	O	ivermectin	conj_and	34	SENT_700	[p14l528t2225r663b2244],
37	for	IN	O	for	_	0	SENT_700	[p14l677t2225r715b2244],
38	the	DT	O	the	det	39	SENT_700	[p14l729t2225r767b2244],
39	treatment	NN	O	treatment	prep_for	34	SENT_700	[p14l782t2229r908b2244],
40	of	IN	O	of	_	0	SENT_700	[p14l921t2225r948b2244],
41	Wuchereria	FW	O	wuchereria	nn	42	SENT_700	[p14l962t2225r1089b2244],
42	bancrofti	FW	O	bancrofti	prep_of	39	SENT_700	[p14l1102t2225r1200b2252],
43	infection	NN	O	infection	dobj	21	SENT_700	[p14l239t2259r359b2278],
44	.	.	O	.	_	0	SENT_700	[p14l239t2259r359b2278],

1	Clin	NNP	O	Clin	nn	3	SENT_701	[p14l372t2259r423b2279],
2	Infect	NNP	O	Infect	nn	3	SENT_701	[p14l435t2259r509b2278],
3	Dis	NNP	O	Dis	_	0	SENT_701	[p14l521t2259r560b2278],
4	42	CD	NUMBER	42	num	3	SENT_701	[p14l572t2259r606b2279],
5	:	:	O	:	_	0	SENT_701	[p14l572t2259r606b2279],
6	10814089	CD	NUMBER	10814089	dep	3	SENT_701	[p14l621t2259r759b2278],
7	.	.	O	.	_	0	SENT_701	[p14l621t2259r759b2278],

1	Mand	NN	O	mand	nn	2	SENT_702	[p14l239t2293r310b2312],
2	S	NN	O	s	nsubj	15	SENT_702	[p14l328t2293r348b2316],
3	,	,	O	,	_	0	SENT_702	[p14l328t2293r348b2316],
4	Debrah	NNP	ORGANIZATION	Debrah	nn	5	SENT_702	[p14l367t2293r460b2312],
5	A	NNP	O	A	appos	2	SENT_702	[p14l478t2293r503b2316],
6	,	,	O	,	_	0	SENT_702	[p14l478t2293r503b2316],
7	Batsa	NNP	ORGANIZATION	Batsa	nn	8	SENT_702	[p14l522t2293r588b2312],
8	L	NNP	ORGANIZATION	L	appos	2	SENT_702	[p14l606t2293r628b2316],
9	,	,	O	,	_	0	SENT_702	[p14l606t2293r628b2316],
10	Adjei	NNP	PERSON	Adjei	nn	11	SENT_702	[p14l646t2293r713b2320],
11	O	NNP	PERSON	O	appos	2	SENT_702	[p14l732t2293r759b2316],
12	,	,	O	,	_	0	SENT_702	[p14l732t2293r759b2316],
13	Hoerauf	NNP	O	Hoerauf	nn	14	SENT_702	[p14l778t2293r887b2312],
14	A	NNP	O	A	appos	2	SENT_702	[p14l901t2293r920b2312],
15	(	VBD	O	(	_	0	SENT_702	[p14l940t2293r1014b2318],
16	2004	CD	DATE	2004	dobj	15	SENT_702	[p14l940t2293r1014b2318],
17	)	CD	NUMBER	)	number	18	SENT_702	[p14l940t2293r1014b2318],
18	Reliable	JJ	O	reliable	dep	16	SENT_702	[p14l1033t2293r1134b2312],
19	and	CC	O	and	_	0	SENT_702	[p14l1153t2293r1199b2312],
20	frequent	JJ	O	frequent	amod	21	SENT_702	[p14l239t2326r348b2353],
21	detection	NN	O	detection	conj_and	18	SENT_702	[p14l365t2326r484b2345],
22	of	IN	O	of	prep	18	SENT_702	[p14l502t2326r529b2345],
23	adult	JJ	O	adult	amod	25	SENT_702	[p14l543t2326r607b2345],
24	Wuchereria	FW	O	wuchereria	nn	25	SENT_702	[p14l626t2326r753b2346],
25	bzmcrofti	FW	O	bzmcrofti	dep	22	SENT_702	[p14l769t2326r867b2353],
26	in	IN	O	in	_	0	SENT_702	[p14l884t2326r907b2345],
27	Ghanaian	JJ	MISC	ghanaian	amod	28	SENT_702	[p14l925t2326r1046b2346],
28	women	NNS	O	woman	prep_in	25	SENT_702	[p14l1063t2332r1154b2345],
29	by	IN	O	by	_	0	SENT_702	[p14l1171t2326r1199b2353],
30	ultrasonography	NN	O	ultrasonography	prep_by	15	SENT_702	[p14l239t2360r454b2387],
31	.	.	O	.	_	0	SENT_702	[p14l239t2360r454b2387],

1	Trop	NNP	O	Trop	nn	4	SENT_703	[p14l466t2360r530b2387],
2	Med	NNP	O	Med	nn	4	SENT_703	[p14l542t2360r596b2379],
3	Int	NNP	O	Int	nn	4	SENT_703	[p14l607t2360r643b2379],
4	Health	NNP	O	Health	_	0	SENT_703	[p14l655t2360r740b2379],
5	9	CD	NUMBER	9	num	4	SENT_703	[p14l752t2360r771b2379],
6	:	:	O	:	_	0	SENT_703	[p14l752t2360r771b2379],
7	11114114	CD	NUMBER	11114114	dep	4	SENT_703	[p14l786t2360r923b2379],
8	.	.	O	.	_	0	SENT_703	[p14l786t2360r923b2379],

1	Dreyer	NNP	PERSON	Dreyer	nn	2	SENT_704	[p14l239t2394r327b2421],
2	G	NNP	PERSON	G	dep	14	SENT_704	[p14l348t2394r374b2417],
3	,	,	O	,	_	0	SENT_704	[p14l348t2394r374b2417],
4	Addiss	NNP	PERSON	Addiss	nn	5	SENT_704	[p14l396t2394r480b2413],
5	D	NNP	O	D	appos	2	SENT_704	[p14l502t2394r528b2417],
6	,	,	O	,	_	0	SENT_704	[p14l502t2394r528b2417],
7	Dreyer	NNP	PERSON	Dreyer	nn	8	SENT_704	[p14l550t2394r639b2421],
8	P	NN	PERSON	p	appos	2	SENT_704	[p14l660t2394r681b2417],
9	,	,	O	,	_	0	SENT_704	[p14l660t2394r681b2417],
10	Noroes	NNPS	O	Noroes	nn	11	SENT_704	[p14l704t2394r795b2413],
11	J	NNP	O	J	appos	2	SENT_704	[p14l813t2394r826b2421],
12	(	CD	NUMBER	(	dep	14	SENT_704	[p14l848t2394r925b2419],
13	2002	CD	DATE	2002	num	14	SENT_704	[p14l848t2394r925b2419],
14	)	CD	NUMBER	)	dep	19	SENT_704	[p14l848t2394r925b2419],
15	Basic	JJ	O	basic	amod	17	SENT_704	[p14l947t2394r1011b2413],
16	lymphedema	NN	O	lymphedema	nn	17	SENT_704	[p14l1034t2394r1199b2421],
17	management	NN	O	management	dep	14	SENT_704	[p14l239t2431r408b2454],
18	:	:	O	:	_	0	SENT_704	[p14l239t2431r408b2454],
19	Treatment	NN	O	treatment	_	0	SENT_704	[p14l429t2427r565b2446],
20	and	CC	O	and	_	0	SENT_704	[p14l586t2427r632b2446],
21	prevention	NN	O	prevention	conj_and	19	SENT_704	[p14l653t2427r792b2454],
22	of	IN	O	of	_	0	SENT_704	[p14l813t2427r840b2446],
23	problems	NNS	O	problem	prep_of	19	SENT_704	[p14l858t2427r976b2454],
24	associated	VBN	O	associate	partmod	19	SENT_704	[p14l997t2427r1125b2446],
25	with	IN	O	with	_	0	SENT_704	[p14l1145t2427r1199b2446],
26	lymphatic	JJ	O	lymphatic	amod	27	SENT_704	[p14l239t2461r363b2488],
27	ﬁlariasis	NN	O	ﬁlariasis	prep_with	24	SENT_704	[p14l376t2461r485b2480],
28	.	.	O	.	_	0	SENT_704	[p14l376t2461r485b2480],

1	Hollis	NNP	PERSON	Hollis	nn	5	SENT_705	[p14l498t2461r572b2480],
2	(	NNP	O	(	nn	5	SENT_705	[p14l585t2461r647b2486],
3	New	NNP	LOCATION	New	nn	5	SENT_705	[p14l585t2461r647b2486],
4	Hampshire	NNP	LOCATION	Hampshire	nn	5	SENT_705	[p14l659t2461r814b2488],
5	)	NN	O	)	_	0	SENT_705	[p14l659t2461r814b2488],
6	:	:	O	:	_	0	SENT_705	[p14l659t2461r814b2488],
7	Hollis	NNP	ORGANIZATION	Hollis	nn	8	SENT_705	[p14l827t2461r900b2480],
8	Publishing	NNP	ORGANIZATION	Publishing	dep	5	SENT_705	[p14l913t2461r1052b2488],
9	.	.	O	.	_	0	SENT_705	[p14l913t2461r1052b2488],

1	112	CD	NUMBER	112	num	2	SENT_706	[p14l1067t2461r1107b2481],
2	p.	NN	O	p.	tmod	8	SENT_706	[p14l1120t2468r1141b2488],
3	Bradley	NNP	O	Bradley	nn	4	SENT_706	[p14l239t2495r335b2522],
4	MH	NNP	O	MH	dep	2	SENT_706	[p14l351t2495r403b2518],
5	,	,	O	,	_	0	SENT_706	[p14l351t2495r403b2518],
6	Kumaraswami	NNP	O	Kumaraswami	nn	7	SENT_706	[p14l420t2495r599b2514],
7	V	NNP	O	V	nsubj	8	SENT_706	[p14l614t2495r634b2515],
8	(	VBD	O	(	_	0	SENT_706	[p14l650t2495r725b2520],
9	2004	CD	DATE	2004	num	12	SENT_706	[p14l650t2495r725b2520],
10	)	CD	NUMBER	)	num	12	SENT_706	[p14l650t2495r725b2520],
11	Essential	JJ	O	essential	amod	12	SENT_706	[p14l740t2495r850b2514],
12	tools	NNS	O	tool	dobj	8	SENT_706	[p14l867t2495r1031b2522],
13	.	.	O	.	_	0	SENT_706	[p14l867t2495r1031b2522],

1	—	NN	O	—	_	0	SENT_707	[p14l867t2495r1031b2522],
2	.	.	O	.	_	0	SENT_707	[p14l867t2495r1031b2522],

1	Drugs	NNS	O	drug	_	0	SENT_708	[p14l867t2495r1031b2522],
2	and	CC	O	and	_	0	SENT_708	[p14l1047t2495r1093b2514],
3	clinical	JJ	O	clinical	amod	5	SENT_708	[p14l1108t2495r1198b2514],
4	drug	NN	O	drug	nn	5	SENT_708	[p14l239t2528r298b2555],
5	trials	NNS	O	trial	conj_and	1	SENT_708	[p14l309t2528r377b2547],
6	.	.	O	.	_	0	SENT_708	[p14l309t2528r377b2547],

1	In	IN	O	in	_	0	SENT_709	[p14l389t2528r420b2547],
2	:	:	O	:	_	0	SENT_709	[p14l389t2528r420b2547],
3	Towards	IN	O	towards	mark	10	SENT_709	[p14l432t2528r540b2547],
4	a	DT	O	a	det	6	SENT_709	[p14l552t2535r564b2547],
5	strategic	JJ	O	strategic	amod	6	SENT_709	[p14l575t2528r682b2555],
6	plan	NN	O	plan	nsubj	10	SENT_709	[p14l694t2528r748b2555],
7	for	IN	O	for	_	0	SENT_709	[p14l760t2528r798b2547],
8	research	NN	O	research	prep_for	6	SENT_709	[p14l809t2528r915b2547],
9	to	TO	O	to	aux	10	SENT_709	[p14l927t2532r950b2547],
10	support	VB	O	support	dep	1	SENT_709	[p14l962t2532r1061b2555],
11	the	DT	O	the	det	13	SENT_709	[p14l1073t2528r1111b2547],
12	global	JJ	O	global	amod	13	SENT_709	[p14l1123t2528r1198b2555],
13	program	NN	O	program	dobj	10	SENT_709	[p14l239t2568r348b2589],
14	to	TO	O	to	aux	15	SENT_709	[p14l364t2566r388b2581],
15	eliminate	VB	O	eliminate	xcomp	10	SENT_709	[p14l403t2562r522b2581],
16	lymphatic	JJ	O	lymphatic	amod	17	SENT_709	[p14l537t2562r662b2589],
17	ﬁlariasis	NN	O	ﬁlariasis	dobj	15	SENT_709	[p14l678t2562r787b2581],
18	.	.	O	.	_	0	SENT_709	[p14l678t2562r787b2581],

1	Summary	NN	O	summary	_	0	SENT_710	[p14l803t2562r923b2589],
2	of	IN	O	of	_	0	SENT_710	[p14l939t2562r966b2581],
3	immediate	JJ	O	immediate	amod	4	SENT_710	[p14l979t2562r1112b2581],
4	needs	NNS	O	need	prep_of	1	SENT_710	[p14l1128t2562r1199b2581],
5	and	CC	O	and	_	0	SENT_710	[p14l239t2596r285b2615],
6	opportunities	NNS	O	opportunity	prep_of	1	SENT_710	[p14l307t2596r484b2623],
7	for	IN	O	for	_	0	SENT_710	[p14l506t2596r544b2615],
8	research	NN	O	research	prep_for	1	SENT_710	[p14l565t2596r672b2615],
9	on	IN	O	on	_	0	SENT_710	[p14l695t2602r726b2615],
10	lymphatic	JJ	O	lymphatic	amod	11	SENT_710	[p14l748t2596r874b2623],
11	ﬁlariasis	NN	O	ﬁlariasis	prep_on	1	SENT_710	[p14l897t2596r1008b2615],
12	.	.	O	.	_	0	SENT_710	[p14l897t2596r1008b2615],

1	Philadelphia	NNP	LOCATION	Philadelphia	nn	3	SENT_711	[p14l1031t2596r1199b2623],
2	,	,	O	,	_	0	SENT_711	[p14l1031t2596r1199b2623],
3	Pennsylvania	NNP	LOCATION	Pennsylvania	_	0	SENT_711	[p14l239t2629r409b2656],
4	,	,	O	,	_	0	SENT_711	[p14l239t2629r409b2656],
5	USA	NNP	LOCATION	USA	nn	7	SENT_711	[p14l421t2629r484b2652],
6	,	,	O	,	_	0	SENT_711	[p14l421t2629r484b2652],
7	December	NNP	DATE	December	appos	3	SENT_711	[p14l495t2629r625b2648],
8	940	CD	DATE	940	num	7	SENT_711	[p14l636t2629r700b2652],
9	,	,	DATE	,	_	0	SENT_711	[p14l636t2629r700b2652],
10	2003	CD	DATE	2003	num	7	SENT_711	[p14l713t2629r776b2649],
11	.	.	O	.	_	0	SENT_711	[p14l713t2629r776b2649],

1	AmJ	NNP	O	AmJ	nn	4	SENT_712	[p14l788t2629r851b2656],
2	Trop	NNP	O	Trop	nn	4	SENT_712	[p14l862t2629r925b2656],
3	Med	NNP	O	Med	nn	4	SENT_712	[p14l937t2629r990b2648],
4	Hyg	NNP	O	Hyg	_	0	SENT_712	[p14l1002t2629r1052b2656],
5	71	CD	NUMBER	71	number	6	SENT_712	[p14l1063t2627r1088b2648],
6	(	CD	NUMBER	(	num	8	SENT_712	[p14l1103t2629r1198b2656],
7	Suppl	NN	O	suppl	nn	8	SENT_712	[p14l1103t2629r1198b2656],
8	)	NN	O	)	dep	4	SENT_712	[p14l1103t2629r1198b2656],
9	:	:	O	:	_	0	SENT_712	[p14l1103t2629r1198b2656],
10	741	CD	NUMBER	741	dep	4	SENT_712	[p14l240t2661r303b2682],
11	.	.	O	.	_	0	SENT_712	[p14l240t2661r303b2682],

1	Molyneux	NNP	PERSON	Molyneux	nn	2	SENT_713	[p14l239t2696r363b2723],
2	DH	NNP	O	DH	nsubj	15	SENT_713	[p14l378t2696r427b2719],
3	,	,	O	,	_	0	SENT_713	[p14l378t2696r427b2719],
4	Bradley	NNP	PERSON	Bradley	nn	5	SENT_713	[p14l442t2696r538b2723],
5	M	NNP	O	M	appos	2	SENT_713	[p14l553t2696r582b2719],
6	,	,	O	,	_	0	SENT_713	[p14l553t2696r582b2719],
7	Hoerauf	NNP	O	Hoerauf	nn	8	SENT_713	[p14l597t2696r705b2715],
8	A	NNP	O	A	appos	2	SENT_713	[p14l716t2696r741b2719],
9	,	,	O	,	_	0	SENT_713	[p14l716t2696r741b2719],
10	Kyelem	NNP	ORGANIZATION	Kyelem	nn	11	SENT_713	[p14l757t2696r850b2723],
11	D	NNP	ORGANIZATION	D	appos	2	SENT_713	[p14l864t2696r890b2719],
12	,	,	O	,	_	0	SENT_713	[p14l864t2696r890b2719],
13	Taylor	NNP	PERSON	Taylor	nn	14	SENT_713	[p14l905t2696r988b2723],
14	MJ	NNP	PERSON	MJ	appos	2	SENT_713	[p14l1002t2696r1035b2723],
15	(	VBD	O	(	_	0	SENT_713	[p14l1050t2696r1125b2721],
16	2003	CD	DATE	2003	number	17	SENT_713	[p14l1050t2696r1125b2721],
17	)	CD	NUMBER	)	num	20	SENT_713	[p14l1050t2696r1125b2721],
18	Mass	JJ	O	mass	amod	20	SENT_713	[p14l1140t2696r1199b2715],
19	drug	NN	O	drug	nn	20	SENT_713	[p14l239t2730r298b2757],
20	treatment	NN	O	treatment	dobj	15	SENT_713	[p14l306t2734r432b2749],
21	for	IN	O	for	_	0	SENT_713	[p14l441t2730r478b2749],
22	lymphatic	JJ	O	lymphatic	amod	23	SENT_713	[p14l487t2730r612b2757],
23	ﬁlariasis	NN	O	ﬁlariasis	prep_for	20	SENT_713	[p14l621t2730r725b2749],
24	and	CC	O	and	_	0	SENT_713	[p14l734t2730r780b2749],
25	onchocerciasis	NN	O	onchocerciasis	prep_for	20	SENT_713	[p14l789t2730r981b2749],
26	.	.	O	.	_	0	SENT_713	[p14l789t2730r981b2749],

1	Trends	NNS	O	trend	_	0	SENT_714	[p14l990t2730r1079b2749],
2	Parasitol	NNP	O	Parasitol	dep	1	SENT_714	[p14l1089t2730r1198b2749],
3	19	CD	NUMBER	19	num	2	SENT_714	[p14l241t2763r273b2782],
4	:	:	O	:	_	0	SENT_714	[p14l241t2763r273b2782],
5	516-522	CD	NUMBER	516-522	dep	1	SENT_714	[p14l286t2763r395b2782],
6	.	.	O	.	_	0	SENT_714	[p14l286t2763r395b2782],

1	Dadzie	NNP	PERSON	Dadzie	nn	2	SENT_715	[p14l239t2797r324b2816],
2	Y	NN	PERSON	y	_	0	SENT_715	[p14l333t2797r356b2820],
3	,	,	O	,	_	0	SENT_715	[p14l333t2797r356b2820],
4	Neira	NNP	PERSON	Neira	nn	5	SENT_715	[p14l366t2797r436b2816],
5	M	NNP	O	M	appos	2	SENT_715	[p14l446t2797r475b2820],
6	,	,	O	,	_	0	SENT_715	[p14l446t2797r475b2820],
7	Hopkins	NNP	PERSON	Hopkins	nn	8	SENT_715	[p14l485t2797r592b2824],
8	D	NNP	PERSON	D	appos	2	SENT_715	[p14l602t2797r620b2816],
9	(	CD	NUMBER	(	num	12	SENT_715	[p14l632t2797r707b2822],
10	2003	CD	DATE	2003	num	12	SENT_715	[p14l632t2797r707b2822],
11	)	NNP	O	)	nn	12	SENT_715	[p14l632t2797r707b2822],
12	Final	NNP	O	Final	dep	8	SENT_715	[p14l716t2797r779b2816],
13	report	NN	O	report	dep	2	SENT_715	[p14l789t2801r870b2824],
14	of	IN	O	of	_	0	SENT_715	[p14l879t2797r906b2816],
15	the	DT	O	the	det	16	SENT_715	[p14l914t2797r952b2816],
16	Conference	NN	O	conference	prep_of	13	SENT_715	[p14l962t2797r1109b2817],
17	on	IN	O	on	_	0	SENT_715	[p14l1119t2803r1150b2816],
18	the	DT	O	the	det	19	SENT_715	[p14l1161t2797r1199b2816],
19	Eradicability	NN	O	eradicability	prep_on	16	SENT_715	[p14l239t2831r400b2858],
20	of	IN	O	of	_	0	SENT_715	[p14l412t2831r439b2850],
21	Onchocerciasis	NN	O	onchocerciasis	prep_of	19	SENT_715	[p14l448t2831r647b2851],
22	.	.	O	.	_	0	SENT_715	[p14l448t2831r647b2851],

1	FilariaJ	NN	O	filariaj	_	0	SENT_716	[p14l659t2831r760b2858],
2	2	CD	NUMBER	2	num	1	SENT_716	[p14l772t2831r791b2850],
3	:	:	O	:	_	0	SENT_716	[p14l772t2831r791b2850],
4	2	CD	NUMBER	2	dep	1	SENT_716	[p14l804t2831r822b2851],
5	.	.	O	.	_	0	SENT_716	[p14l804t2831r822b2851],

1	Hoerauf	NNP	O	Hoerauf	nn	2	SENT_717	[p14l239t2865r347b2884],
2	A	NNP	O	A	nsubj	18	SENT_717	[p14l358t2865r384b2888],
3	,	,	O	,	_	0	SENT_717	[p14l358t2865r384b2888],
4	Mand	NNP	O	Mand	nn	5	SENT_717	[p14l400t2865r471b2884],
5	S	NNP	O	S	appos	2	SENT_717	[p14l486t2865r506b2888],
6	,	,	O	,	_	0	SENT_717	[p14l486t2865r506b2888],
7	Volkmann	NNP	PERSON	Volkmann	nn	8	SENT_717	[p14l520t2865r653b2885],
8	L	NNP	PERSON	L	appos	5	SENT_717	[p14l668t2865r690b2888],
9	,	,	O	,	_	0	SENT_717	[p14l668t2865r690b2888],
10	Buttner	NNP	PERSON	Buttner	nn	11	SENT_717	[p14l706t2865r805b2884],
11	M	NNP	O	M	appos	8	SENT_717	[p14l820t2865r848b2888],
12	,	,	O	,	_	0	SENT_717	[p14l820t2865r848b2888],
13	Marfo-Debrekyei	NNP	O	Marfo-Debrekyei	nn	14	SENT_717	[p14l864t2865r1080b2892],
14	Y	NN	O	y	appos	5	SENT_717	[p14l1096t2865r1119b2888],
15	,	,	O	,	_	0	SENT_717	[p14l1096t2865r1119b2888],
16	et	FW	O	et	nn	18	SENT_717	[p14l1135t2869r1157b2884],
17	al.	FW	O	al.	nn	18	SENT_717	[p14l1172t2865r1198b2884],
18	(	FW	O	(	_	0	SENT_717	[p14l240t2898r314b2923],
19	2003	CD	DATE	2003	num	20	SENT_717	[p14l240t2898r314b2923],
20	)	CD	NUMBER	)	conj_and	20	SENT_717	[p14l240t2898r314b2923],
21	Doxycycline	NNP	O	Doxycycline	prep_in	20	SENT_717	[p14l327t2898r480b2925],
22	in	IN	O	in	_	0	SENT_717	[p14l494t2898r517b2917],
23	the	DT	O	the	det	24	SENT_717	[p14l530t2898r568b2917],
24	treatment	NN	O	treatment	pobj	20	SENT_717	[p14l581t2902r707b2917],
25	of	IN	O	of	_	0	SENT_717	[p14l719t2898r746b2917],
26	human	JJ	O	human	amod	27	SENT_717	[p14l755t2898r843b2917],
27	onchocerciasis	NN	O	onchocerciasis	prep_of	24	SENT_717	[p14l855t2898r1047b2917],
28	:	:	O	:	_	0	SENT_717	[p14l855t2898r1047b2917],
29	Kinetics	NNS	O	kinetics	dep	24	SENT_717	[p14l1060t2898r1162b2917],
30	of	IN	O	of	_	0	SENT_717	[p14l1175t2898r1202b2917],
31	Wolbachia	JJ	LOCATION	wolbachia	amod	33	SENT_717	[p14l241t2932r356b2951],
32	endobacteria	NNS	O	endobacterium	nn	33	SENT_717	[p14l370t2932r537b2951],
33	reduction	NN	O	reduction	prep_of	29	SENT_717	[p14l552t2932r676b2951],
34	and	CC	O	and	_	0	SENT_717	[p14l692t2932r737b2951],
35	of	IN	O	of	_	0	SENT_717	[p14l752t2932r780b2951],
36	inhibition	NN	O	inhibition	prep_of	20	SENT_717	[p14l792t2932r919b2951],
37	of	IN	O	of	_	0	SENT_717	[p14l934t2932r961b2951],
38	embryogenesis	NN	O	embryogenesis	prep_of	36	SENT_717	[p14l973t2932r1160b2959],
39	in	IN	O	in	_	0	SENT_717	[p14l1176t2932r1199b2951],
40	female	JJ	O	female	amod	42	SENT_717	[p14l239t2965r322b2984],
41	Onchocerm	NN	O	onchocerm	nn	42	SENT_717	[p14l335t2965r460b2985],
42	worms	NNS	O	worm	prep_in	18	SENT_717	[p14l471t2971r559b2984],
43	.	.	O	.	_	0	SENT_717	[p14l471t2971r559b2984],

1	Microbes	NNS	O	microbe	nsubj	2	SENT_718	[p14l572t2965r687b2984],
2	Infect	VBP	O	infect	_	0	SENT_718	[p14l699t2965r773b2984],
3	5	CD	NUMBER	5	dobj	2	SENT_718	[p14l786t2965r804b2984],
4	:	:	O	:	_	0	SENT_718	[p14l786t2965r804b2984],
5	261	CD	NUMBER	261	num	6	SENT_718	[p14l817t2963r926b2985],
6	—	NN	O	—	dep	3	SENT_718	[p14l817t2963r926b2985],
7	273	CD	NUMBER	273	dep	6	SENT_718	[p14l817t2963r926b2985],
8	.	.	O	.	_	0	SENT_718	[p14l817t2963r926b2985],

1	.	.	O	.	_	0	SENT_719	[p14l220t3015r223b3018],

1	Hoerauf	NNP	O	Hoerauf	nn	2	SENT_720	[p14l239t2999r347b3018],
2	A	NNP	O	A	nsubj	15	SENT_720	[p14l355t2999r380b3022],
3	,	,	O	,	_	0	SENT_720	[p14l355t2999r380b3022],
4	Mand	NNP	O	Mand	nn	5	SENT_720	[p14l392t2999r463b3018],
5	S	NNP	O	S	appos	2	SENT_720	[p14l474t2999r494b3022],
6	,	,	O	,	_	0	SENT_720	[p14l474t2999r494b3022],
7	Adjei	NNP	PERSON	Adjei	nn	8	SENT_720	[p14l505t2999r572b3026],
8	O	NNP	PERSON	O	appos	2	SENT_720	[p14l584t2999r611b3022],
9	,	,	O	,	_	0	SENT_720	[p14l584t2999r611b3022],
10	Fleischer	NNP	PERSON	Fleischer	nn	11	SENT_720	[p14l623t2999r737b3018],
11	B	NNP	O	B	appos	2	SENT_720	[p14l748t2999r771b3022],
12	,	,	O	,	_	0	SENT_720	[p14l748t2999r771b3022],
13	Buttner	NNP	PERSON	Buttner	nn	14	SENT_720	[p14l782t2999r881b3018],
14	DW	NNP	O	DW	appos	2	SENT_720	[p14l892t2999r939b3019],
15	(	VBD	O	(	_	0	SENT_720	[p14l951t2999r1026b3024],
16	2001	CD	DATE	2001	num	18	SENT_720	[p14l951t2999r1026b3024],
17	)	CD	NUMBER	)	num	18	SENT_720	[p14l951t2999r1026b3024],
18	Depletion	NN	O	depletion	dobj	15	SENT_720	[p14l1037t2999r1163b3026],
19	of	IN	O	of	prep	15	SENT_720	[p14l1175t2999r1202b3018],

1	2	CD	NUMBER	2	num	3	SENT_721	[p14l188t3077r261b3136],
2	d	NN	O	d	nn	3	SENT_721	[p14l188t3077r261b3136],
3	PLoS	NN	O	plo	nsubj	4	SENT_721	[p14l288t3093r352b3116],
4	Pathogens	VBD	O	pathogen	_	0	SENT_721	[p14l367t3092r511b3123],
5	|	CD	NUMBER	|	num	6	SENT_721	[p14l526t3091r528b3124],
6	www	NN	O	www	dobj	4	SENT_721	[p14l543t3092r882b3123],
7	.	.	O	.	_	0	SENT_721	[p14l543t3092r882b3123],

1	p	NN	O	p	_	0	SENT_722	[p14l543t3092r882b3123],
2	|	CD	NUMBER	|	num	3	SENT_722	[p14l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	dep	1	SENT_722	[p14l543t3092r882b3123],

1	Wolbachia	JJ	O	wolbachia	amod	2	SENT_723	[p14l1328t207r1443b227],
2	endobacteria	NN	O	endobacterium	_	0	SENT_723	[p14l1459t207r1625b226],
3	in	IN	O	in	_	0	SENT_723	[p14l1642t207r1665b226],
4	Onchocerca	NN	LOCATION	onchocerca	nn	5	SENT_723	[p14l1682t207r1807b227],
5	volvulus	NN	O	volvulus	prep_in	2	SENT_723	[p14l1822t207r1916b226],
6	by	IN	O	by	_	0	SENT_723	[p14l1932t207r1960b234],
7	doxycycline	NN	O	doxycycline	prep_by	2	SENT_723	[p14l1976t207r2124b234],
8	and	CC	O	and	_	0	SENT_723	[p14l2141t207r2187b226],
9	microﬁlaridermia	NN	O	microﬁlaridermia	prep_by	2	SENT_723	[p14l2203t207r2286b226, p14l1326t240r1476b259],
10	after	IN	O	after	_	0	SENT_723	[p14l1488t240r1548b259],
11	ivermectin	NN	O	ivermectin	nn	12	SENT_723	[p14l1559t240r1694b259],
12	treatment	NN	O	treatment	prep_after	2	SENT_723	[p14l1707t244r1838b259],
13	.	.	O	.	_	0	SENT_723	[p14l1707t244r1838b259],

1	Lancet	NNP	O	Lancet	_	0	SENT_724	[p14l1851t240r1937b259],
2	357	CD	NUMBER	357	num	1	SENT_724	[p14l1949t238r1998b259],
3	:	:	O	:	_	0	SENT_724	[p14l1949t238r1998b259],
4	14154416	CD	NUMBER	14154416	dep	1	SENT_724	[p14l2013t240r2150b259],
5	.	.	O	.	_	0	SENT_724	[p14l2013t240r2150b259],

1	Debrah	NNP	ORGANIZATION	Debrah	nn	2	SENT_725	[p14l1326t273r1419b292],
2	AY	NNP	O	AY	nsubj	18	SENT_725	[p14l1434t273r1479b296],
3	,	,	O	,	_	0	SENT_725	[p14l1434t273r1479b296],
4	Mand	NNP	O	Mand	nn	5	SENT_725	[p14l1495t273r1566b292],
5	S	NNP	O	S	appos	2	SENT_725	[p14l1582t273r1602b296],
6	,	,	O	,	_	0	SENT_725	[p14l1582t273r1602b296],
7	Marfo-Debrekyei	NNP	O	Marfo-Debrekyei	nn	8	SENT_725	[p14l1618t273r1834b300],
8	Y	NN	O	y	appos	5	SENT_725	[p14l1850t273r1873b296],
9	,	,	O	,	_	0	SENT_725	[p14l1850t273r1873b296],
10	Larbi	NNP	PERSON	Larbi	nn	11	SENT_725	[p14l1889t273r1957b292],
11	J	NNP	PERSON	J	appos	8	SENT_725	[p14l1968t273r1987b300],
12	,	,	O	,	_	0	SENT_725	[p14l1968t273r1987b300],
13	Adjei	NNP	PERSON	Adjei	nn	14	SENT_725	[p14l2003t273r2069b300],
14	O	NNP	O	O	appos	5	SENT_725	[p14l2086t273r2113b296],
15	,	,	O	,	_	0	SENT_725	[p14l2086t273r2113b296],
16	et	FW	O	et	nn	18	SENT_725	[p14l2130t277r2152b292],
17	al.	FW	O	al.	nn	18	SENT_725	[p14l2168t273r2194b292],
18	(	FW	O	(	_	0	SENT_725	[p14l2211t273r2286b298],
19	2006	CD	DATE	2006	number	20	SENT_725	[p14l2211t273r2286b298],
20	)	CD	NUMBER	)	num	21	SENT_725	[p14l2211t273r2286b298],
21	Assessment	NNP	O	Assessment	dobj	18	SENT_725	[p14l1325t306r1469b325],
22	of	IN	O	of	_	0	SENT_725	[p14l1486t306r1513b325],
23	microﬁlarial	JJ	O	microﬁlarial	amod	24	SENT_725	[p14l1526t306r1683b325],
24	loads	NNS	O	load	prep_of	21	SENT_725	[p14l1700t306r1764b325],
25	in	IN	O	in	_	0	SENT_725	[p14l1781t306r1804b325],
26	the	DT	O	the	det	27	SENT_725	[p14l1821t306r1859b325],
27	skin	NN	O	skin	prep_in	24	SENT_725	[p14l1876t306r1926b325],
28	of	IN	O	of	_	0	SENT_725	[p14l1943t306r1970b325],
29	onchocerciasis	NN	O	onchocerciasis	nn	30	SENT_725	[p14l1983t306r2169b325],
30	patients	NNS	O	patient	prep_of	27	SENT_725	[p14l2186t306r2286b333],
31	after	IN	O	after	_	0	SENT_725	[p14l1326t340r1386b359],
32	treatment	NN	O	treatment	prep_after	18	SENT_725	[p14l1402t344r1527b359],
33	with	IN	O	with	_	0	SENT_725	[p14l1543t340r1596b359],
34	different	JJ	O	different	amod	35	SENT_725	[p14l1613t340r1724b359],
35	regimens	NNS	O	regimen	prep_with	32	SENT_725	[p14l1741t340r1856b367],
36	of	IN	O	of	_	0	SENT_725	[p14l1872t340r1899b359],
37	doxycycline	NN	O	doxycycline	prep_of	35	SENT_725	[p14l1912t340r2061b367],
38	plus	CC	O	plus	prep	37	SENT_725	[p14l2077t340r2127b367],
39	ivermectin	NN	O	ivermectin	dep	38	SENT_725	[p14l2144t340r2286b359],
40	.	.	O	.	_	0	SENT_725	[p14l2144t340r2286b359],

1	FilariaJ	NN	O	filariaj	_	0	SENT_726	[p14l1326t373r1427b400],
2	5	CD	NUMBER	5	num	1	SENT_726	[p14l1439t373r1457b392],
3	:	:	O	:	_	0	SENT_726	[p14l1439t373r1457b392],
4	1	CD	NUMBER	1	dep	1	SENT_726	[p14l1472t373r1489b392],
5	.	.	O	.	_	0	SENT_726	[p14l1472t373r1489b392],

1	Lammie	NNP	PERSON	Lammie	nn	3	SENT_727	[p14l1326t406r1429b425],
2	PJ	NNP	PERSON	PJ	nn	3	SENT_727	[p14l1439t406r1464b433],
3	(	NNP	O	(	_	0	SENT_727	[p14l1475t406r1550b431],
4	2004	CD	DATE	2004	num	7	SENT_727	[p14l1475t406r1550b431],
5	)	CD	NUMBER	)	num	7	SENT_727	[p14l1475t406r1550b431],
6	Essential	JJ	O	essential	amod	7	SENT_727	[p14l1560t406r1669b425],
7	tools	NNS	O	tool	dep	3	SENT_727	[p14l1681t406r1922b433],
8	.	.	O	.	_	0	SENT_727	[p14l1681t406r1922b433],

1	—	NN	O	—	_	0	SENT_728	[p14l1681t406r1922b433],
2	.	.	O	.	_	0	SENT_728	[p14l1681t406r1922b433],

1	Diagnostics	NNPS	O	Diagnostics	_	0	SENT_729	[p14l1681t406r1922b433],
2	.	.	O	.	_	0	SENT_729	[p14l1681t406r1922b433],

1	In	IN	O	in	_	0	SENT_730	[p14l1932t406r1964b425],
2	:	:	O	:	_	0	SENT_730	[p14l1932t406r1964b425],
3	Towards	IN	O	towards	mark	10	SENT_730	[p14l1974t406r2082b425],
4	a	DT	O	a	det	6	SENT_730	[p14l2093t413r2104b425],
5	strategic	JJ	O	strategic	amod	6	SENT_730	[p14l2114t406r2221b433],
6	plan	NN	O	plan	nsubj	10	SENT_730	[p14l2232t406r2286b433],
7	for	IN	O	for	_	0	SENT_730	[p14l1326t439r1363b458],
8	research	NN	O	research	prep_for	6	SENT_730	[p14l1372t439r1478b458],
9	to	TO	O	to	aux	10	SENT_730	[p14l1488t443r1511b458],
10	support	VB	O	support	dep	1	SENT_730	[p14l1521t443r1620b466],
11	the	DT	O	the	det	13	SENT_730	[p14l1629t439r1668b458],
12	global	JJ	O	global	amod	13	SENT_730	[p14l1677t439r1752b466],
13	program	NN	O	program	dobj	10	SENT_730	[p14l1762t445r1872b466],
14	to	TO	O	to	aux	15	SENT_730	[p14l1881t443r1905b458],
15	eliminate	VB	O	eliminate	xcomp	10	SENT_730	[p14l1914t439r2032b458],
16	lymphatic	JJ	O	lymphatic	amod	17	SENT_730	[p14l2042t439r2166b466],
17	ﬁlariasis	NN	O	ﬁlariasis	dobj	15	SENT_730	[p14l2176t439r2286b458],
18	.	.	O	.	_	0	SENT_730	[p14l2176t439r2286b458],

1	Summary	NN	O	summary	_	0	SENT_731	[p14l1326t473r1446b500],
2	of	IN	O	of	_	0	SENT_731	[p14l1456t473r1483b492],
3	immediate	JJ	O	immediate	amod	4	SENT_731	[p14l1491t473r1625b492],
4	needs	NNS	O	need	prep_of	1	SENT_731	[p14l1635t473r1706b492],
5	and	CC	O	and	_	0	SENT_731	[p14l1716t473r1762b492],
6	opportunities	NNS	O	opportunity	prep_of	1	SENT_731	[p14l1772t473r1946b500],
7	for	IN	O	for	_	0	SENT_731	[p14l1956t473r1994b492],
8	research	NN	O	research	prep_for	1	SENT_731	[p14l2003t473r2109b492],
9	on	IN	O	on	_	0	SENT_731	[p14l2120t479r2151b492],
10	lymphatic	JJ	O	lymphatic	amod	11	SENT_731	[p14l2161t473r2286b500],
11	ﬁlariasis	NN	O	ﬁlariasis	prep_on	1	SENT_731	[p14l1326t506r1436b525],
12	.	.	O	.	_	0	SENT_731	[p14l1326t506r1436b525],

1	Philadelphia	NNP	LOCATION	Philadelphia	nn	7	SENT_732	[p14l1454t506r1619b533],
2	,	,	O	,	_	0	SENT_732	[p14l1454t506r1619b533],
3	Pennsylvania	NNP	LOCATION	Pennsylvania	appos	7	SENT_732	[p14l1637t506r1808b533],
4	,	,	O	,	_	0	SENT_732	[p14l1637t506r1808b533],
5	USA	NNP	LOCATION	USA	appos	7	SENT_732	[p14l1826t506r1888b529],
6	,	,	O	,	_	0	SENT_732	[p14l1826t506r1888b529],
7	December	NNP	DATE	December	_	0	SENT_732	[p14l1906t506r2036b525],
8	9	CD	DATE	9	num	7	SENT_732	[p14l2053t506r2117b529],
9	—	NN	DATE	—	dep	7	SENT_732	[p14l2053t506r2117b529],
10	10	CD	DATE	10	num	9	SENT_732	[p14l2053t506r2117b529],
11	,	,	DATE	,	_	0	SENT_732	[p14l2053t506r2117b529],
12	2003	CD	DATE	2003	appos	9	SENT_732	[p14l2136t506r2200b526],
13	.	.	O	.	_	0	SENT_732	[p14l2136t506r2200b526],

1	Am	VBP	O	be	cop	5	SENT_733	[p14l2217t506r2261b525],
2	d	NN	O	d	nn	5	SENT_733	[p14l2274t506r2287b533],
3	Trop	NNP	O	Trop	nn	5	SENT_733	[p14l1326t539r1389b566],
4	Med	NNP	O	Med	nn	5	SENT_733	[p14l1402t539r1455b558],
5	Hyg	NNP	O	Hyg	_	0	SENT_733	[p14l1467t539r1518b566],
6	71	CD	NUMBER	71	number	7	SENT_733	[p14l1529t537r1554b558],
7	(	CD	NUMBER	(	num	9	SENT_733	[p14l1569t539r1665b566],
8	Suppl	NN	O	suppl	nn	9	SENT_733	[p14l1569t539r1665b566],
9	)	NN	O	)	dep	5	SENT_733	[p14l1569t539r1665b566],
10	:	:	O	:	_	0	SENT_733	[p14l1569t539r1665b566],
11	2	CD	NUMBER	2	number	12	SENT_733	[p14l1678t539r1727b558],
12	—	CD	NUMBER	—	dep	5	SENT_733	[p14l1678t539r1727b558],
13	5	CD	NUMBER	5	dep	12	SENT_733	[p14l1678t539r1727b558],
14	.	.	O	.	_	0	SENT_733	[p14l1678t539r1727b558],

1	Dunyo	NNP	O	Dunyo	nn	2	SENT_734	[p14l1326t572r1409b599],
2	SK	NNP	O	SK	nsubj	9	SENT_734	[p14l1422t572r1462b595],
3	,	,	O	,	_	0	SENT_734	[p14l1422t572r1462b595],
4	Nkrumah	NNP	ORGANIZATION	Nkrumah	nn	5	SENT_734	[p14l1474t572r1594b591],
5	FK	NN	ORGANIZATION	fk	appos	2	SENT_734	[p14l1607t572r1648b595],
6	,	,	O	,	_	0	SENT_734	[p14l1607t572r1648b595],
7	Simonsen	NNP	ORGANIZATION	Simonsen	nn	8	SENT_734	[p14l1661t572r1783b592],
8	PE	NNP	ORGANIZATION	PE	appos	5	SENT_734	[p14l1796t572r1829b591],
9	(	VBD	O	(	_	0	SENT_734	[p14l1841t572r1916b597],
10	2000	CD	DATE	2000	num	11	SENT_734	[p14l1841t572r1916b597],
11	)	CD	NUMBER	)	dobj	9	SENT_734	[p14l1841t572r1916b597],
12	A	DT	O	a	det	31	SENT_734	[p14l1928t572r1947b591],
13	randomized	VBN	O	randomize	dep	31	SENT_734	[p14l1960t572r2111b591],
14	double-blind	JJ	O	double-blind	amod	17	SENT_734	[p14l2123t572r2286b591],
15	placebo-controlled	JJ	O	placebo-controlled	amod	17	SENT_734	[p14l1326t606r1568b633],
16	ﬁeld	JJ	O	ﬁeld	amod	17	SENT_734	[p14l1581t606r1635b625],
17	trial	NN	O	trial	dobj	13	SENT_734	[p14l1649t606r1700b625],
18	of	IN	O	of	_	0	SENT_734	[p14l1713t606r1741b625],
19	ivermectin	NN	O	ivermectin	prep_of	17	SENT_734	[p14l1751t606r1886b625],
20	and	CC	O	and	_	0	SENT_734	[p14l1900t606r1946b625],
21	albendazole	NN	O	albendazole	prep_of	17	SENT_734	[p14l1959t606r2109b625],
22	alone	RB	O	alone	advmod	13	SENT_734	[p14l2123t606r2190b625],
23	and	CC	O	and	_	0	SENT_734	[p14l2204t606r2249b625],
24	in	IN	O	in	dep	31	SENT_734	[p14l2263t606r2286b625],
25	combination	NN	O	combination	pobj	24	SENT_734	[p14l1326t639r1488b658],
26	for	IN	O	for	_	0	SENT_734	[p14l1502t639r1540b658],
27	the	DT	O	the	det	28	SENT_734	[p14l1554t639r1592b658],
28	treatment	NN	O	treatment	prep_for	25	SENT_734	[p14l1607t643r1732b658],
29	of	IN	O	of	_	0	SENT_734	[p14l1747t639r1774b658],
30	lymphatic	JJ	O	lymphatic	prep_of	28	SENT_734	[p14l1785t639r1910b666],
31	ﬁlariasis	NN	O	ﬁlariasis	npadvmod	9	SENT_734	[p14l1924t639r2028b658],
32	in	IN	O	in	_	0	SENT_734	[p14l2043t639r2066b658],
33	Ghana	NNP	LOCATION	Ghana	prep_in	9	SENT_734	[p14l2080t639r2168b659],
34	.	.	O	.	_	0	SENT_734	[p14l2080t639r2168b659],

1	Trans	NNP	O	Trans	nn	6	SENT_735	[p14l2182t639r2255b658],
2	R	NNP	O	R	nn	6	SENT_735	[p14l2269t639r2287b658],
3	Soc	NNP	O	Soc	nn	6	SENT_735	[p14l1326t672r1369b692],
4	Trop	NNP	O	Trop	nn	6	SENT_735	[p14l1381t672r1444b699],
5	Med	NNP	O	Med	nn	6	SENT_735	[p14l1457t672r1511b691],
6	Hyg	NNP	O	Hyg	_	0	SENT_735	[p14l1523t672r1573b699],
7	94	CD	NUMBER	94	num	6	SENT_735	[p14l1584t672r1618b691],
8	:	:	O	:	_	0	SENT_735	[p14l1584t672r1618b691],
9	205	CD	NUMBER	205	num	10	SENT_735	[p14l1631t672r1740b692],
10	—	NN	O	—	dep	6	SENT_735	[p14l1631t672r1740b692],
11	211	CD	NUMBER	211	dep	10	SENT_735	[p14l1631t672r1740b692],
12	.	.	O	.	_	0	SENT_735	[p14l1631t672r1740b692],

1	Simonsen	NNP	ORGANIZATION	Simonsen	nn	2	SENT_736	[p14l1326t705r1449b725],
2	PE	NNP	ORGANIZATION	PE	nsubj	15	SENT_736	[p14l1468t705r1506b728],
3	,	,	O	,	_	0	SENT_736	[p14l1468t705r1506b728],
4	Magesa	NNP	ORGANIZATION	Magesa	nn	5	SENT_736	[p14l1525t705r1616b732],
5	SM	NNP	ORGANIZATION	SM	appos	2	SENT_736	[p14l1635t705r1679b728],
6	,	,	O	,	_	0	SENT_736	[p14l1635t705r1679b728],
7	Dunyo	NNP	ORGANIZATION	Dunyo	nn	8	SENT_736	[p14l1698t705r1781b732],
8	SK	NNP	ORGANIZATION	SK	appos	2	SENT_736	[p14l1800t705r1840b728],
9	,	,	O	,	_	0	SENT_736	[p14l1800t705r1840b728],
10	Malecela-Lazaro	NNP	O	Malecela-Lazaro	nn	11	SENT_736	[p14l1859t705r2066b724],
11	MN	NN	O	mn	appos	2	SENT_736	[p14l2085t705r2136b728],
12	,	,	O	,	_	0	SENT_736	[p14l2085t705r2136b728],
13	Michael	NNP	PERSON	Michael	nn	14	SENT_736	[p14l2155t705r2253b724],
14	E	NNP	PERSON	E	appos	2	SENT_736	[p14l2271t705r2287b724],
15	(	VBD	O	(	_	0	SENT_736	[p14l1327t739r1402b764],
16	2004	CD	DATE	2004	num	17	SENT_736	[p14l1327t739r1402b764],
17	)	CD	NUMBER	)	dobj	15	SENT_736	[p14l1327t739r1402b764],
18	The	DT	O	the	det	19	SENT_736	[p14l1415t739r1463b758],
19	effect	NN	O	effect	npadvmod	15	SENT_736	[p14l1477t739r1547b758],
20	of	IN	O	of	_	0	SENT_736	[p14l1560t739r1587b758],
21	single	JJ	O	single	amod	23	SENT_736	[p14l1597t739r1668b766],
22	dose	NN	O	dose	nn	23	SENT_736	[p14l1682t739r1737b758],
23	ivermectin	NN	O	ivermectin	prep_of	19	SENT_736	[p14l1751t739r1886b758],
24	alone	RB	O	alone	dep	19	SENT_736	[p14l1900t739r1968b758],
25	or	CC	O	or	_	0	SENT_736	[p14l1981t745r2009b758],
26	in	IN	O	in	dep	19	SENT_736	[p14l2021t739r2044b758],
27	combination	NN	O	combination	pobj	26	SENT_736	[p14l2058t739r2219b758],
28	with	IN	O	with	_	0	SENT_736	[p14l2233t739r2286b758],
29	albendazole	NN	O	albendazole	prep_with	15	SENT_736	[p14l1326t772r1476b791],
30	on	IN	O	on	_	0	SENT_736	[p14l1488t778r1519b791],
31	Wuchereria	FW	O	wuchereria	nn	33	SENT_736	[p14l1533t772r1659b791],
32	bancmfti	FW	O	bancmfti	nn	33	SENT_736	[p14l1670t772r1768b799],
33	infection	NN	O	infection	prep_on	15	SENT_736	[p14l1780t772r1893b791],
34	in	IN	O	in	_	0	SENT_736	[p14l1906t772r1929b791],
35	primary	JJ	O	primary	amod	37	SENT_736	[p14l1941t772r2042b799],
36	school	NN	O	school	nn	37	SENT_736	[p14l2054t772r2133b791],
37	children	NNS	O	child	prep_in	33	SENT_736	[p14l2145t772r2251b791],
38	in	IN	O	in	_	0	SENT_736	[p14l2263t772r2286b791],
39	Tanzania	NNP	LOCATION	Tanzania	prep_in	37	SENT_736	[p14l1326t805r1448b824],
40	.	.	O	.	_	0	SENT_736	[p14l1326t805r1448b824],

1	Trans	NNP	O	Trans	nn	6	SENT_737	[p14l1460t805r1532b824],
2	R	NNP	O	R	nn	6	SENT_737	[p14l1544t805r1562b824],
3	Soc	NNP	O	Soc	nn	6	SENT_737	[p14l1573t805r1616b825],
4	Trop	NNP	O	Trop	nn	6	SENT_737	[p14l1628t805r1691b832],
5	Med	NNP	O	Med	nn	6	SENT_737	[p14l1704t805r1758b824],
6	Hyg	NNP	O	Hyg	_	0	SENT_737	[p14l1770t805r1820b832],
7	98	CD	NUMBER	98	num	6	SENT_737	[p14l1831t805r1865b824],
8	:	:	O	:	_	0	SENT_737	[p14l1831t805r1865b824],
9	462	CD	NUMBER	462	num	10	SENT_737	[p14l1878t803r1988b825],
10	—	NN	O	—	dep	6	SENT_737	[p14l1878t803r1988b825],
11	472	CD	NUMBER	472	dep	10	SENT_737	[p14l1878t803r1988b825],
12	.	.	O	.	_	0	SENT_737	[p14l1878t803r1988b825],

1	Critchley	NNP	PERSON	Critchley	nn	2	SENT_738	[p14l1326t838r1443b865],
2	J	NNP	PERSON	J	_	0	SENT_738	[p14l1460t838r1479b865],
3	,	,	O	,	_	0	SENT_738	[p14l1460t838r1479b865],
4	Addiss	NNP	PERSON	Addiss	nn	5	SENT_738	[p14l1501t838r1585b857],
5	D	NNP	O	D	appos	2	SENT_738	[p14l1607t838r1633b861],
6	,	,	O	,	_	0	SENT_738	[p14l1607t838r1633b861],
7	Ejere	NNP	O	Ejere	nn	8	SENT_738	[p14l1655t838r1720b865],
8	H	NNP	O	H	appos	2	SENT_738	[p14l1742t838r1770b861],
9	,	,	O	,	_	0	SENT_738	[p14l1742t838r1770b861],
10	Gamble	NNP	O	Gamble	nn	11	SENT_738	[p14l1792t838r1890b858],
11	C	NNP	O	C	appos	2	SENT_738	[p14l1912t838r1937b861],
12	,	,	O	,	_	0	SENT_738	[p14l1912t838r1937b861],
13	Garner	NNP	PERSON	Garner	nn	14	SENT_738	[p14l1959t838r2051b858],
14	P	NN	O	p	appos	2	SENT_738	[p14l2072t838r2093b861],
15	,	,	O	,	_	0	SENT_738	[p14l2072t838r2093b861],
16	et	FW	O	et	dep	2	SENT_738	[p14l2116t842r2138b857],
17	al.	FW	O	al.	nn	18	SENT_738	[p14l2160t838r2187b857],
18	(	FW	O	(	dep	2	SENT_738	[p14l2210t838r2286b863],
19	2005	CD	DATE	2005	num	20	SENT_738	[p14l2210t838r2286b863],
20	)	CD	NUMBER	)	dep	18	SENT_738	[p14l2210t838r2286b863],
21	Albendazole	NNP	O	Albendazole	dep	18	SENT_738	[p14l1325t872r1484b891],
22	for	IN	O	for	_	0	SENT_738	[p14l1506t872r1544b891],
23	the	DT	O	the	det	24	SENT_738	[p14l1565t872r1604b891],
24	control	NN	O	control	prep_for	21	SENT_738	[p14l1626t872r1719b891],
25	and	CC	O	and	_	0	SENT_738	[p14l1742t872r1788b891],
26	elimination	NN	O	elimination	conj_and	2	SENT_738	[p14l1810t872r1958b891],
27	of	IN	O	of	_	0	SENT_738	[p14l1980t872r2007b891],
28	lymphatic	JJ	O	lymphatic	amod	29	SENT_738	[p14l2026t872r2152b899],
29	ﬁlariasis	NN	O	ﬁlariasis	prep_of	26	SENT_738	[p14l2174t872r2286b891],
30	:	:	O	:	_	0	SENT_738	[p14l2174t872r2286b891],
31	systematic	JJ	O	systematic	amod	32	SENT_738	[p14l1326t905r1455b932],
32	review	NN	O	review	dep	2	SENT_738	[p14l1468t905r1555b924],
33	.	.	O	.	_	0	SENT_738	[p14l1468t905r1555b924],

1	Trop	NNP	O	Trop	nn	4	SENT_739	[p14l1567t905r1630b932],
2	Med	NNP	O	Med	nn	4	SENT_739	[p14l1643t905r1696b924],
3	Int	NNP	O	Int	nn	4	SENT_739	[p14l1708t905r1744b924],
4	Health	NNP	O	Health	_	0	SENT_739	[p14l1756t905r1841b924],
5	10	CD	NUMBER	10	num	4	SENT_739	[p14l1855t905r1887b924],
6	:	:	O	:	_	0	SENT_739	[p14l1855t905r1887b924],
7	818	CD	NUMBER	818	num	8	SENT_739	[p14l1900t905r2009b925],
8	—	NN	O	—	dep	4	SENT_739	[p14l1900t905r2009b925],
9	825	CD	NUMBER	825	dep	8	SENT_739	[p14l1900t905r2009b925],
10	.	.	O	.	_	0	SENT_739	[p14l1900t905r2009b925],

1	Ramzy	NNP	PERSON	Ramzy	nn	2	SENT_740	[p14l1326t938r1408b965],
2	RM	NN	PERSON	rm	nsubj	12	SENT_740	[p14l1421t938r1469b961],
3	,	,	O	,	_	0	SENT_740	[p14l1421t938r1469b961],
4	Gad	NNP	PERSON	Gad	nn	5	SENT_740	[p14l1482t938r1533b958],
5	AM	NNP	O	AM	appos	2	SENT_740	[p14l1545t938r1595b961],
6	,	,	O	,	_	0	SENT_740	[p14l1545t938r1595b961],
7	Faris	NNP	PERSON	Faris	nn	8	SENT_740	[p14l1608t938r1668b957],
8	R	NNP	PERSON	R	appos	2	SENT_740	[p14l1681t938r1705b961],
9	,	,	O	,	_	0	SENT_740	[p14l1681t938r1705b961],
10	Weil	NNP	PERSON	Weil	nn	11	SENT_740	[p14l1717t938r1773b958],
11	GJ	NNP	O	GJ	appos	2	SENT_740	[p14l1787t938r1816b965],
12	(	VBD	O	(	_	0	SENT_740	[p14l1829t938r1904b963],
13	1991	CD	DATE	1991	num	15	SENT_740	[p14l1829t938r1904b963],
14	)	CD	NUMBER	)	num	15	SENT_740	[p14l1829t938r1904b963],
15	Evaluation	NN	O	evaluation	dobj	12	SENT_740	[p14l1917t938r2051b957],
16	of	IN	O	of	_	0	SENT_740	[p14l2065t938r2092b957],
17	a	DT	O	a	det	18	SENT_740	[p14l2101t945r2113b957],
18	monoclonalantibody	NN	O	monoclonalantibody	prep_of	15	SENT_740	[p14l2126t938r2286b957, p14l1326t971r1438b998],
19	based	VBN	O	base	partmod	18	SENT_740	[p14l1449t971r1520b990],
20	antigen	NN	O	antigen	nn	21	SENT_740	[p14l1532t971r1625b998],
21	assay	NN	O	assay	dobj	19	SENT_740	[p14l1638t977r1699b998],
22	for	IN	O	for	_	0	SENT_740	[p14l1711t971r1748b990],
23	diagnosis	NN	O	diagnosis	prep_for	19	SENT_740	[p14l1759t971r1875b998],
24	of	IN	O	of	_	0	SENT_740	[p14l1887t971r1914b990],
25	VI/ucherevria	NN	O	vi/ucherevria	nn	27	SENT_740	[p14l1925t971r2052b991],
26	bancmfti	NN	O	bancmftus	nn	27	SENT_740	[p14l2063t971r2161b998],
27	infection	NN	O	infection	prep_of	23	SENT_740	[p14l2173t971r2286b990],
28	in	IN	O	in	_	0	SENT_740	[p14l1327t1004r1350b1023],
29	Egypt	NNP	LOCATION	Egypt	prep_in	27	SENT_740	[p14l1362t1004r1439b1031],
30	.	.	O	.	_	0	SENT_740	[p14l1362t1004r1439b1031],

1	Am	VBP	O	be	dep	6	SENT_741	[p14l1451t1004r1494b1023],
2	ڊ	NN	O	ڊ	nn	6	SENT_741	[p14l1502t1004r1515b1031],
3	d	NN	O	d	nn	6	SENT_741	[p14l1502t1004r1515b1031],
4	Trop	NNP	O	Trop	nn	6	SENT_741	[p14l1526t1004r1589b1031],
5	Med	NNP	O	Med	nn	6	SENT_741	[p14l1602t1004r1655b1023],
6	Hyg	NNP	O	Hyg	_	0	SENT_741	[p14l1667t1004r1718b1031],
7	44	CD	NUMBER	44	dep	6	SENT_741	[p14l1729t1004r1763b1023],
8	:	:	O	:	_	0	SENT_741	[p14l1729t1004r1763b1023],
9	691	CD	NUMBER	691	num	10	SENT_741	[p14l1776t1004r1885b1023],
10	—	NN	O	—	dep	6	SENT_741	[p14l1776t1004r1885b1023],
11	695	CD	NUMBER	695	rcmod	10	SENT_741	[p14l1776t1004r1885b1023],
12	.	.	O	.	_	0	SENT_741	[p14l1776t1004r1885b1023],

1	.	.	O	.	_	0	SENT_742	[p14l1307t1038r1412b1065],

1	Joukov	NNP	PERSON	Joukov	nn	2	SENT_743	[p14l1307t1038r1412b1065],
2	V	NNP	PERSON	V	nsubj	32	SENT_743	[p14l1425t1038r1451b1061],
3	,	,	O	,	_	0	SENT_743	[p14l1425t1038r1451b1061],
4	Pajusola	NNP	PERSON	Pajusola	nn	5	SENT_743	[p14l1466t1038r1569b1065],
5	K	NNP	PERSON	K	appos	2	SENT_743	[p14l1584t1038r1608b1061],
6	,	,	O	,	_	0	SENT_743	[p14l1584t1038r1608b1061],
7	Kaipainen	NNP	PERSON	Kaipainen	nn	8	SENT_743	[p14l1623t1038r1753b1065],
8	A	NNP	O	A	appos	2	SENT_743	[p14l1767t1038r1792b1061],
9	,	,	O	,	_	0	SENT_743	[p14l1767t1038r1792b1061],
10	Chilov	NNP	PERSON	Chilov	nn	11	SENT_743	[p14l1807t1038r1888b1058],
11	D	NNP	PERSON	D	appos	2	SENT_743	[p14l1902t1038r1928b1061],
12	,	,	O	,	_	0	SENT_743	[p14l1902t1038r1928b1061],
13	Lahtinen	NNP	O	Lahtinen	appos	2	SENT_743	[p14l1942t1038r2057b1057],
14	I	PRP	O	I	nn	13	SENT_743	[p14l2071t1038r2086b1061],
15	,	,	O	,	_	0	SENT_743	[p14l2071t1038r2086b1061],
16	et	FW	O	et	dep	13	SENT_743	[p14l2100t1042r2123b1057],
17	al.	FW	O	al.	nn	18	SENT_743	[p14l2137t1038r2163b1057],
18	(	FW	O	(	dep	13	SENT_743	[p14l2179t1038r2254b1063],
19	1996	CD	DATE	1996	num	20	SENT_743	[p14l2179t1038r2254b1063],
20	)	CD	NUMBER	)	dep	13	SENT_743	[p14l2179t1038r2254b1063],
21	A	DT	O	a	det	26	SENT_743	[p14l2267t1038r2286b1057],
22	novel	JJ	O	novel	amod	23	SENT_743	[p14l1326t1071r1393b1090],
23	vascular	JJ	O	vascular	amod	26	SENT_743	[p14l1406t1071r1509b1090],
24	endothelial	JJ	O	endothelial	amod	26	SENT_743	[p14l1520t1071r1663b1090],
25	growth	NN	O	growth	nn	26	SENT_743	[p14l1676t1071r1764b1098],
26	factor	NN	O	factor	dep	20	SENT_743	[p14l1776t1071r1858b1094],
27	,	,	O	,	_	0	SENT_743	[p14l1776t1071r1858b1094],
28	VEGF-C	NN	O	vegf-c	appos	2	SENT_743	[p14l1870t1071r1980b1094],
29	,	,	O	,	_	0	SENT_743	[p14l1870t1071r1980b1094],
30	is	VBZ	O	be	cop	32	SENT_743	[p14l1994t1071r2011b1090],
31	a	DT	O	a	det	32	SENT_743	[p14l2024t1078r2036b1090],
32	ligand	NN	O	ligand	_	0	SENT_743	[p14l2048t1071r2125b1098],
33	for	IN	O	for	_	0	SENT_743	[p14l2138t1071r2175b1090],
34	the	DT	O	the	det	38	SENT_743	[p14l2188t1071r2226b1090],
35	Flt4	NN	O	flt4	nn	38	SENT_743	[p14l2238t1071r2287b1090],
36	(	CD	NUMBER	(	num	38	SENT_743	[p14l1327t1104r1462b1129],
37	VEGFR-3	NN	O	vegfr-3	nn	38	SENT_743	[p14l1327t1104r1462b1129],
38	)	NN	O	)	prep_for	32	SENT_743	[p14l1327t1104r1462b1129],
39	and	CC	O	and	_	0	SENT_743	[p14l1479t1104r1525b1123],
40	KDR	NN	O	kdr	nn	43	SENT_743	[p14l1542t1104r1602b1123],
41	(	CD	NUMBER	(	num	43	SENT_743	[p14l1619t1104r1753b1129],
42	VEGFR-2	NN	O	vegfr-2	nn	43	SENT_743	[p14l1619t1104r1753b1129],
43	)	NN	O	)	prep_for	32	SENT_743	[p14l1619t1104r1753b1129],
44	receptor	NN	O	receptor	nn	46	SENT_743	[p14l1771t1108r1880b1131],
45	tyrosine	NN	O	tyrosine	nn	46	SENT_743	[p14l1896t1104r1997b1131],
46	kinases	NNS	O	kinase	dep	43	SENT_743	[p14l2014t1104r2110b1123],
47	.	.	O	.	_	0	SENT_743	[p14l2014t1104r2110b1123],

1	EMBO	NNP	O	EMBO	nn	2	SENT_744	[p14l2127t1104r2210b1124],
2	J	NNP	O	J	_	0	SENT_744	[p14l2222t1104r2235b1131],
3	15	CD	NUMBER	15	num	2	SENT_744	[p14l2254t1104r2286b1123],
4	:	:	O	:	_	0	SENT_744	[p14l2254t1104r2286b1123],
5	1751	CD	DATE	1751	dep	2	SENT_744	[p14l1328t1135r1390b1156],
6	.	.	O	.	_	0	SENT_744	[p14l1328t1135r1390b1156],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_745	[p14l1326t1171r1370b1190],
2	J	NNP	PERSON	J	dep	18	SENT_745	[p14l1385t1171r1404b1198],
3	,	,	O	,	_	0	SENT_745	[p14l1385t1171r1404b1198],
4	Gray	NNP	O	Gray	nn	5	SENT_745	[p14l1423t1171r1483b1198],
5	A	NNP	O	A	appos	2	SENT_745	[p14l1502t1171r1527b1194],
6	,	,	O	,	_	0	SENT_745	[p14l1502t1171r1527b1194],
7	Yuan	NNP	O	Yuan	nn	8	SENT_745	[p14l1546t1171r1611b1190],
8	J	NNP	O	J	appos	2	SENT_745	[p14l1626t1171r1644b1198],
9	,	,	O	,	_	0	SENT_745	[p14l1626t1171r1644b1198],
10	Luoh	NNP	O	Luoh	nn	11	SENT_745	[p14l1664t1171r1729b1190],
11	SM	NNP	O	SM	appos	2	SENT_745	[p14l1749t1171r1794b1194],
12	,	,	O	,	_	0	SENT_745	[p14l1749t1171r1794b1194],
13	Avraham	NNP	PERSON	Avraham	nn	14	SENT_745	[p14l1813t1171r1928b1190],
14	H	NNP	PERSON	H	appos	2	SENT_745	[p14l1948t1171r1975b1194],
15	,	,	O	,	_	0	SENT_745	[p14l1948t1171r1975b1194],
16	et	FW	O	et	appos	2	SENT_745	[p14l1995t1175r2017b1190],
17	al.	FW	O	al.	nn	18	SENT_745	[p14l2037t1171r2062b1190],
18	(	FW	O	(	_	0	SENT_745	[p14l2083t1171r2158b1196],
19	1996	CD	DATE	1996	dep	18	SENT_745	[p14l2083t1171r2158b1196],
20	)	CD	NUMBER	)	num	25	SENT_745	[p14l2083t1171r2158b1196],
21	Vascular	JJ	O	vascular	amod	25	SENT_745	[p14l2177t1171r2287b1191],
22	endothelial	JJ	O	endothelial	amod	25	SENT_745	[p14l1326t1204r1469b1223],
23	growth	NN	O	growth	nn	25	SENT_745	[p14l1479t1204r1567b1231],
24	factor-related	JJ	O	factor-related	amod	25	SENT_745	[p14l1577t1204r1752b1223],
25	protein	NN	O	protein	dep	19	SENT_745	[p14l1762t1204r1862b1231],
26	:	:	O	:	_	0	SENT_745	[p14l1762t1204r1862b1231],
27	a	DT	O	a	det	31	SENT_745	[p14l1873t1211r1885b1223],
28	ligand	NN	O	ligand	nn	31	SENT_745	[p14l1894t1204r1972b1231],
29	and	CC	O	and	_	0	SENT_745	[p14l1982t1204r2028b1223],
30	speciﬁc	NN	O	speciﬁc	conj_and	28	SENT_745	[p14l2037t1204r2130b1231],
31	activator	NN	O	activator	dep	19	SENT_745	[p14l2141t1204r2253b1223],
32	of	IN	O	of	_	0	SENT_745	[p14l2262t1204r2289b1223],
33	the	DT	O	the	det	37	SENT_745	[p14l1327t1237r1365b1256],
34	tyrosine	NN	O	tyrosine	nn	37	SENT_745	[p14l1378t1237r1478b1264],
35	kinase	NN	O	kinase	nn	37	SENT_745	[p14l1490t1237r1569b1256],
36	receptor	NN	O	receptor	nn	37	SENT_745	[p14l1581t1241r1691b1264],
37	Flt4	NN	O	flt4	prep_of	31	SENT_745	[p14l1701t1237r1755b1256],
38	.	.	O	.	_	0	SENT_745	[p14l1701t1237r1755b1256],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_746	[p14l1768t1237r1825b1256],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_746	[p14l1837t1237r1890b1256],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_746	[p14l1901t1237r1965b1256],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_746	[p14l1977t1237r2012b1257],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_746	[p14l2025t1237r2081b1257],
6	93	CD	NUMBER	93	num	5	SENT_746	[p14l2093t1237r2127b1256],
7	:	:	O	:	_	0	SENT_746	[p14l2093t1237r2127b1256],
8	19884992	CD	NUMBER	19884992	dep	5	SENT_746	[p14l2142t1237r2280b1257],
9	.	.	O	.	_	0	SENT_746	[p14l2142t1237r2280b1257],

1	Skobe	NN	O	skobe	nn	2	SENT_747	[p14l1326t1270r1402b1290],
2	M	NN	O	m	nsubj	27	SENT_747	[p14l1422t1270r1451b1293],
3	,	,	O	,	_	0	SENT_747	[p14l1422t1270r1451b1293],
4	Hawighorst	NN	ORGANIZATION	hawighorst	nn	5	SENT_747	[p14l1471t1270r1617b1297],
5	T	NN	ORGANIZATION	t	appos	2	SENT_747	[p14l1635t1270r1659b1293],
6	,	,	O	,	_	0	SENT_747	[p14l1635t1270r1659b1293],
7	Jackson	NNP	ORGANIZATION	Jackson	nn	8	SENT_747	[p14l1674t1270r1774b1297],
8	DG	NNS	ORGANIZATION	dg	appos	2	SENT_747	[p14l1794t1270r1841b1293],
9	,	,	O	,	_	0	SENT_747	[p14l1794t1270r1841b1293],
10	Prevo	NNP	ORGANIZATION	Prevo	nn	11	SENT_747	[p14l1861t1270r1933b1289],
11	R	NNP	ORGANIZATION	R	appos	2	SENT_747	[p14l1953t1270r1976b1293],
12	,	,	O	,	_	0	SENT_747	[p14l1953t1270r1976b1293],
13	Janes	NNP	PERSON	Janes	nn	14	SENT_747	[p14l1991t1270r2060b1297],
14	L	NNP	O	L	appos	2	SENT_747	[p14l2080t1270r2102b1293],
15	,	,	O	,	_	0	SENT_747	[p14l2080t1270r2102b1293],
16	et	FW	O	et	nn	18	SENT_747	[p14l2122t1274r2144b1289],
17	al.	FW	O	al.	nn	18	SENT_747	[p14l2164t1270r2190b1289],
18	(	FW	O	(	rcmod	14	SENT_747	[p14l2211t1270r2286b1295],
19	2001	CD	DATE	2001	num	21	SENT_747	[p14l2211t1270r2286b1295],
20	)	CD	NUMBER	)	num	21	SENT_747	[p14l2211t1270r2286b1295],
21	Induction	NN	O	induction	dobj	18	SENT_747	[p14l1326t1304r1451b1323],
22	of	IN	O	of	_	0	SENT_747	[p14l1461t1304r1488b1323],
23	tumor	NN	O	tumor	nn	24	SENT_747	[p14l1496t1308r1575b1323],
24	lymphangiogenesis	NN	O	lymphangiogenesis	prep_of	21	SENT_747	[p14l1584t1304r1824b1331],
25	by	IN	O	by	_	0	SENT_747	[p14l1835t1304r1863b1331],
26	VEGF-C	NN	O	vegf-c	prep_by	18	SENT_747	[p14l1872t1304r1975b1324],
27	promotes	VBZ	O	promote	_	0	SENT_747	[p14l1986t1308r2107b1331],
28	breast	NN	O	breast	nn	30	SENT_747	[p14l2117t1304r2193b1323],
29	cancer	NN	O	cancer	nn	30	SENT_747	[p14l2203t1310r2287b1323],
30	metastasis	NN	O	metastasis	dobj	27	SENT_747	[p14l1326t1337r1460b1356],
31	.	.	O	.	_	0	SENT_747	[p14l1326t1337r1460b1356],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_748	[p14l1472t1337r1517b1356],
2	Med	NNP	PERSON	Med	_	0	SENT_748	[p14l1529t1337r1583b1356],
3	7	CD	NUMBER	7	num	2	SENT_748	[p14l1595t1335r1613b1356],
4	:	:	O	:	_	0	SENT_748	[p14l1595t1335r1613b1356],
5	192498	CD	NUMBER	192498	dep	2	SENT_748	[p14l1628t1337r1735b1357],
6	.	.	O	.	_	0	SENT_748	[p14l1628t1337r1735b1357],

1	.	.	O	.	_	0	SENT_749	[p14l1307t1386r1310b1389],

1	Jussila	NNP	PERSON	Jussila	nn	2	SENT_750	[p14l1321t1370r1404b1397],
2	L	NNP	PERSON	L	_	0	SENT_750	[p14l1423t1370r1445b1393],
3	,	,	O	,	_	0	SENT_750	[p14l1423t1370r1445b1393],
4	Valtola	NNP	ORGANIZATION	Valtola	nn	5	SENT_750	[p14l1463t1370r1554b1390],
5	R	NNP	ORGANIZATION	R	appos	2	SENT_750	[p14l1574t1370r1597b1393],
6	,	,	O	,	_	0	SENT_750	[p14l1574t1370r1597b1393],
7	Partanen	NNP	ORGANIZATION	Partanen	nn	8	SENT_750	[p14l1617t1370r1732b1389],
8	TA	NNP	ORGANIZATION	TA	appos	2	SENT_750	[p14l1751t1370r1795b1393],
9	,	,	O	,	_	0	SENT_750	[p14l1751t1370r1795b1393],
10	Salven	NNP	PERSON	Salven	nn	11	SENT_750	[p14l1815t1370r1896b1390],
11	P	NN	PERSON	p	appos	2	SENT_750	[p14l1915t1370r1937b1393],
12	,	,	O	,	_	0	SENT_750	[p14l1915t1370r1937b1393],
13	Heikkila	NNP	PERSON	Heikkila	nn	14	SENT_750	[p14l1957t1370r2062b1389],
14	P	NN	O	p	appos	2	SENT_750	[p14l2082t1370r2103b1393],
15	,	,	O	,	_	0	SENT_750	[p14l2082t1370r2103b1393],
16	et	FW	O	et	dep	2	SENT_750	[p14l2123t1374r2145b1389],
17	al.	FW	O	al.	nn	18	SENT_750	[p14l2165t1370r2190b1389],
18	(	FW	O	(	dep	2	SENT_750	[p14l2211t1370r2286b1395],
19	1998	CD	DATE	1998	num	20	SENT_750	[p14l2211t1370r2286b1395],
20	)	CD	NUMBER	)	dep	18	SENT_750	[p14l2211t1370r2286b1395],
21	Lymphatic	JJ	O	lymphatic	amod	22	SENT_750	[p14l1326t1403r1461b1430],
22	endothelium	NN	O	endothelium	dep	18	SENT_750	[p14l1477t1403r1639b1422],
23	and	CC	O	and	_	0	SENT_750	[p14l1656t1403r1702b1422],
24	Kaposi	NN	PERSON	kaposus	poss	26	SENT_750	[p14l1718t1403r1821b1430],
25	’s	POS	O	’s	_	0	SENT_750	[p14l1718t1403r1821b1430],
26	sarcoma	NN	O	sarcoma	conj_and	2	SENT_750	[p14l1837t1409r1942b1422],
27	spindle	NN	O	spindle	nn	28	SENT_750	[p14l1958t1403r2049b1430],
28	cells	NNS	O	cell	dep	26	SENT_750	[p14l2065t1403r2118b1422],
29	detected	VBN	O	detect	partmod	2	SENT_750	[p14l2135t1403r2242b1422],
30	by	IN	O	by	_	0	SENT_750	[p14l2259t1403r2287b1430],
31	antibodies	NNS	O	antibody	agent	29	SENT_750	[p14l1326t1437r1458b1456],
32	against	IN	O	against	_	0	SENT_750	[p14l1480t1437r1568b1464],
33	the	DT	O	the	det	38	SENT_750	[p14l1590t1437r1629b1456],
34	vascular	JJ	O	vascular	amod	38	SENT_750	[p14l1650t1437r1753b1456],
35	endothelial	JJ	O	endothelial	amod	38	SENT_750	[p14l1774t1437r1917b1456],
36	growth	NN	O	growth	nn	38	SENT_750	[p14l1939t1437r2027b1464],
37	factor	NN	O	factor	nn	38	SENT_750	[p14l2049t1437r2125b1456],
38	receptor-3	NN	O	receptor-3	prep_against	31	SENT_750	[p14l2146t1437r2286b1464],
39	.	.	O	.	_	0	SENT_750	[p14l2146t1437r2286b1464],

1	Cancer	NN	O	cancer	_	0	SENT_751	[p14l1326t1470r1417b1490],
2	Res	NNP	O	Res	dep	1	SENT_751	[p14l1428t1470r1470b1489],
3	58	CD	NUMBER	58	num	2	SENT_751	[p14l1483t1470r1516b1489],
4	:	:	O	:	_	0	SENT_751	[p14l1483t1470r1516b1489],
5	15994604	CD	NUMBER	15994604	dep	1	SENT_751	[p14l1531t1470r1669b1489],
6	.	.	O	.	_	0	SENT_751	[p14l1531t1470r1669b1489],

1	Mandriota	NN	O	mandriota	nn	2	SENT_752	[p14l1326t1503r1459b1522],
2	SJ	NN	O	sj	nsubj	26	SENT_752	[p14l1474t1503r1504b1530],
3	,	,	O	,	_	0	SENT_752	[p14l1474t1503r1504b1530],
4	Jussila	NN	PERSON	jussilum	nn	5	SENT_752	[p14l1515t1503r1597b1530],
5	L	NN	PERSON	l	appos	2	SENT_752	[p14l1612t1503r1634b1526],
6	,	,	O	,	_	0	SENT_752	[p14l1612t1503r1634b1526],
7	Jeltsch	NN	O	jeltsch	nn	8	SENT_752	[p14l1645t1503r1731b1530],
8	M	NN	O	m	appos	2	SENT_752	[p14l1747t1503r1776b1526],
9	,	,	O	,	_	0	SENT_752	[p14l1747t1503r1776b1526],
10	Compagni	NNP	MISC	Compagni	nn	11	SENT_752	[p14l1791t1503r1922b1530],
11	A	NNP	O	A	appos	2	SENT_752	[p14l1937t1503r1962b1526],
12	,	,	O	,	_	0	SENT_752	[p14l1937t1503r1962b1526],
13	Baetens	NNP	PERSON	Baetens	nn	14	SENT_752	[p14l1977t1503r2075b1522],
14	D	NNP	O	D	appos	2	SENT_752	[p14l2090t1503r2116b1526],
15	,	,	O	,	_	0	SENT_752	[p14l2090t1503r2116b1526],
16	et	FW	O	et	appos	2	SENT_752	[p14l2131t1507r2154b1522],
17	al.	FW	O	al.	nn	18	SENT_752	[p14l2169t1503r2195b1522],
18	(	FW	O	(	dep	16	SENT_752	[p14l2211t1503r2286b1528],
19	2001	CD	DATE	2001	dep	16	SENT_752	[p14l2211t1503r2286b1528],
20	)	CD	NUMBER	)	num	25	SENT_752	[p14l2211t1503r2286b1528],
21	Vascular	JJ	O	vascular	amod	25	SENT_752	[p14l1325t1536r1435b1555],
22	endothelial	JJ	O	endothelial	amod	25	SENT_752	[p14l1453t1536r1596b1555],
23	growth	NN	O	growth	nn	25	SENT_752	[p14l1614t1536r1702b1563],
24	factor-C-mediated	JJ	O	factor-c-mediated	amod	25	SENT_752	[p14l1721t1536r1955b1556],
25	lymphangiogenesis	NN	O	lymphangiogenesis	dep	2	SENT_752	[p14l1974t1536r2214b1563],
26	promotes	VBZ	O	promote	_	0	SENT_752	[p14l2233t1542r2286b1563, p14l1326t1574r1401b1589],
27	tumour	NN	O	tumour	nn	28	SENT_752	[p14l1413t1574r1508b1589],
28	metastasis	NN	O	metastasis	dobj	26	SENT_752	[p14l1520t1570r1653b1589],
29	.	.	O	.	_	0	SENT_752	[p14l1520t1570r1653b1589],

1	EMBOJ	NN	ORGANIZATION	emboj	_	0	SENT_753	[p14l1665t1570r1768b1597],
2	20	CD	NUMBER	20	num	1	SENT_753	[p14l1780t1570r1814b1589],
3	:	:	O	:	_	0	SENT_753	[p14l1780t1570r1814b1589],
4	672-682	CD	NUMBER	672-682	dep	1	SENT_753	[p14l1827t1568r1936b1590],
5	.	.	O	.	_	0	SENT_753	[p14l1827t1568r1936b1590],

1	Pollitt	NNP	PERSON	Pollitt	dep	5	SENT_754	[p14l1326t1603r1403b1622],
2	l	NN	O	l	dep	1	SENT_754	[p14l1422t1603r1461b1630],
3	\	CD	NUMBER	\	dep	5	SENT_754	[p14l1422t1603r1461b1630],
4	’	CD	NUMBER	’	num	5	SENT_754	[p14l1422t1603r1461b1630],
5	IJ	NN	O	ij	dep	21	SENT_754	[p14l1422t1603r1461b1630],
6	,	,	O	,	_	0	SENT_754	[p14l1422t1603r1461b1630],
7	Hanby	NNP	ORGANIZATION	Hanby	nn	8	SENT_754	[p14l1480t1603r1562b1630],
8	AM	NNP	ORGANIZATION	AM	appos	5	SENT_754	[p14l1580t1603r1630b1626],
9	,	,	O	,	_	0	SENT_754	[p14l1580t1603r1630b1626],
10	Horgan	NNP	PERSON	Horgan	nn	11	SENT_754	[p14l1649t1603r1745b1630],
11	K	NNP	PERSON	K	appos	5	SENT_754	[p14l1764t1603r1788b1626],
12	,	,	O	,	_	0	SENT_754	[p14l1764t1603r1788b1626],
13	Murphy	NNP	PERSON	Murphy	nn	14	SENT_754	[p14l1807t1603r1906b1630],
14	CE	NNP	O	CE	appos	5	SENT_754	[p14l1924t1603r1965b1626],
15	,	,	O	,	_	0	SENT_754	[p14l1924t1603r1965b1626],
16	Jones	NNP	PERSON	Jones	nn	17	SENT_754	[p14l1979t1603r2050b1630],
17	PF	NNP	O	PF	appos	5	SENT_754	[p14l2069t1603r2106b1626],
18	,	,	O	,	_	0	SENT_754	[p14l2069t1603r2106b1626],
19	et	FW	O	et	appos	5	SENT_754	[p14l2125t1607r2148b1622],
20	al.	FW	O	al.	nn	21	SENT_754	[p14l2166t1603r2192b1622],
21	(	FW	O	(	dep	24	SENT_754	[p14l2211t1603r2286b1628],
22	2005	CD	DATE	2005	num	23	SENT_754	[p14l2211t1603r2286b1628],
23	)	CD	NUMBER	)	dep	21	SENT_754	[p14l2211t1603r2286b1628],
24	Angiogenesis	NNP	O	Angiogenesis	_	0	SENT_754	[p14l1325t1636r1492b1663],
25	in	IN	O	in	_	0	SENT_754	[p14l1511t1636r1534b1655],
26	breast	NN	O	breast	nn	27	SENT_754	[p14l1553t1636r1629b1655],
27	cancer	NN	O	cancer	prep_in	24	SENT_754	[p14l1648t1642r1737b1655],
28	:	:	O	:	_	0	SENT_754	[p14l1648t1642r1737b1655],
29	how	WRB	O	how	advmod	32	SENT_754	[p14l1755t1636r1806b1655],
30	should	MD	O	should	aux	32	SENT_754	[p14l1825t1636r1908b1655],
31	we	PRP	O	we	nsubj	32	SENT_754	[p14l1926t1642r1958b1655],
32	measure	VB	O	measure	dep	27	SENT_754	[p14l1977t1642r2082b1655],
33	this	DT	O	this	dobj	32	SENT_754	[p14l2101t1636r2155b1655],
34	?	.	O	?	_	0	SENT_754	[p14l2101t1636r2155b1655],

1	(	NN	O	(	_	0	SENT_755	[p14l2175t1636r2286b1661],
2	Review	NN	O	review	nn	3	SENT_755	[p14l2175t1636r2286b1661],
3	)	NN	O	)	dep	1	SENT_755	[p14l2175t1636r2286b1661],
4	.	.	O	.	_	0	SENT_755	[p14l2175t1636r2286b1661],

1	Oncol	NNP	MISC	Oncol	nn	2	SENT_756	[p14l1326t1669r1403b1689],
2	Rep	NNP	MISC	Rep	_	0	SENT_756	[p14l1415t1669r1463b1696],
3	13	CD	NUMBER	13	num	2	SENT_756	[p14l1478t1669r1510b1688],
4	:	:	O	:	_	0	SENT_756	[p14l1478t1669r1510b1688],
5	931	CD	NUMBER	931	num	6	SENT_756	[p14l1522t1669r1632b1688],
6	—	NN	O	—	dep	2	SENT_756	[p14l1522t1669r1632b1688],
7	936	CD	NUMBER	936	dep	6	SENT_756	[p14l1522t1669r1632b1688],
8	.	.	O	.	_	0	SENT_756	[p14l1522t1669r1632b1688],

1	Duff	NNP	O	Duff	nn	2	SENT_757	[p14l1326t1703r1385b1722],
2	SE	NN	O	se	_	0	SENT_757	[p14l1396t1703r1432b1726],
3	,	,	O	,	_	0	SENT_757	[p14l1396t1703r1432b1726],
4	Li	NNP	PERSON	Li	nn	5	SENT_757	[p14l1446t1703r1470b1722],
5	C	NNP	PERSON	C	appos	2	SENT_757	[p14l1484t1703r1508b1726],
6	,	,	O	,	_	0	SENT_757	[p14l1484t1703r1508b1726],
7	Jeziorska	NNP	O	Jeziorska	nn	8	SENT_757	[p14l1517t1703r1634b1730],
8	M	NNP	O	M	appos	5	SENT_757	[p14l1647t1703r1676b1726],
9	,	,	O	,	_	0	SENT_757	[p14l1647t1703r1676b1726],
10	Kumar	NNP	PERSON	Kumar	nn	11	SENT_757	[p14l1690t1703r1777b1722],
11	S	NNP	PERSON	S	appos	5	SENT_757	[p14l1790t1703r1809b1726],
12	,	,	O	,	_	0	SENT_757	[p14l1790t1703r1809b1726],
13	Saunders	NNP	PERSON	Saunders	nn	14	SENT_757	[p14l1823t1703r1939b1723],
14	MP	NNP	O	MP	appos	5	SENT_757	[p14l1953t1703r1999b1726],
15	,	,	O	,	_	0	SENT_757	[p14l1953t1703r1999b1726],
16	et	FW	O	et	dep	5	SENT_757	[p14l2013t1707r2035b1722],
17	al.	FW	O	al.	nn	18	SENT_757	[p14l2049t1703r2074b1722],
18	(	FW	O	(	dep	5	SENT_757	[p14l2089t1703r2164b1728],
19	2003	CD	DATE	2003	number	20	SENT_757	[p14l2089t1703r2164b1728],
20	)	CD	NUMBER	)	num	25	SENT_757	[p14l2089t1703r2164b1728],
21	Vascular	JJ	O	vascular	amod	25	SENT_757	[p14l2177t1703r2287b1723],
22	endothelial	JJ	O	endothelial	amod	25	SENT_757	[p14l1326t1736r1469b1755],
23	growth	NN	O	growth	nn	25	SENT_757	[p14l1487t1736r1575b1763],
24	factors	NNS	O	factor	nn	25	SENT_757	[p14l1593t1736r1679b1755],
25	C	NN	O	c	dep	18	SENT_757	[p14l1697t1736r1715b1756],
26	and	CC	O	and	_	0	SENT_757	[p14l1734t1736r1779b1755],
27	D	NN	O	d	appos	2	SENT_757	[p14l1797t1736r1816b1755],
28	and	CC	O	and	_	0	SENT_757	[p14l1835t1736r1881b1755],
29	lymphangiogenesis	NN	O	lymphangiogenesis	conj_and	27	SENT_757	[p14l1899t1736r2139b1763],
30	in	IN	O	in	_	0	SENT_757	[p14l2158t1736r2181b1755],
31	gastrointestinal	JJ	O	gastrointestinal	amod	33	SENT_757	[p14l2200t1740r2286b1763, p14l1327t1769r1444b1788],
32	tract	NN	O	tract	nn	33	SENT_757	[p14l1457t1773r1515b1788],
33	malignancy	NN	O	malignancy	prep_in	27	SENT_757	[p14l1527t1769r1677b1796],
34	.	.	O	.	_	0	SENT_757	[p14l1527t1769r1677b1796],

1	BrJ	NN	O	brj	nn	2	SENT_758	[p14l1690t1769r1739b1796],
2	Cancer	NN	O	cancer	_	0	SENT_758	[p14l1751t1769r1841b1789],
3	89	CD	NUMBER	89	dep	2	SENT_758	[p14l1852t1769r1886b1788],
4	:	:	O	:	_	0	SENT_758	[p14l1852t1769r1886b1788],
5	426	CD	NUMBER	426	num	6	SENT_758	[p14l1899t1769r2008b1789],
6	—	NN	O	—	dep	2	SENT_758	[p14l1899t1769r2008b1789],
7	430	CD	NUMBER	430	dep	6	SENT_758	[p14l1899t1769r2008b1789],
8	.	.	O	.	_	0	SENT_758	[p14l1899t1769r2008b1789],

1	Mitsuhashi	NNP	MISC	Mitsuhashi	nn	2	SENT_759	[p14l1326t1802r1463b1821],
2	A	NNP	MISC	A	nsubj	18	SENT_759	[p14l1473t1802r1498b1825],
3	,	,	O	,	_	0	SENT_759	[p14l1473t1802r1498b1825],
4	Suzuka	NNP	ORGANIZATION	Suzuka	nn	5	SENT_759	[p14l1509t1802r1597b1822],
5	K	NNP	ORGANIZATION	K	appos	2	SENT_759	[p14l1608t1802r1632b1825],
6	,	,	O	,	_	0	SENT_759	[p14l1608t1802r1632b1825],
7	Yamazawa	NNP	PERSON	Yamazawa	nn	8	SENT_759	[p14l1642t1802r1773b1821],
8	K	NNP	PERSON	K	appos	5	SENT_759	[p14l1784t1802r1808b1825],
9	,	,	O	,	_	0	SENT_759	[p14l1784t1802r1808b1825],
10	Matsui	NNP	PERSON	Matsui	nn	11	SENT_759	[p14l1819t1802r1902b1821],
11	H	NNP	O	H	appos	8	SENT_759	[p14l1913t1802r1941b1825],
12	,	,	O	,	_	0	SENT_759	[p14l1913t1802r1941b1825],
13	Seki	NNP	PERSON	Seki	nn	14	SENT_759	[p14l1952t1802r2003b1822],
14	K	NNP	PERSON	K	appos	5	SENT_759	[p14l2014t1802r2038b1825],
15	,	,	O	,	_	0	SENT_759	[p14l2014t1802r2038b1825],
16	et	FW	O	et	nn	18	SENT_759	[p14l2049t1806r2071b1821],
17	al.	FW	O	al.	nn	18	SENT_759	[p14l2082t1802r2108b1821],
18	(	FW	O	(	_	0	SENT_759	[p14l2119t1802r2194b1827],
19	2005	CD	DATE	2005	num	24	SENT_759	[p14l2119t1802r2194b1827],
20	)	CD	NUMBER	)	num	21	SENT_759	[p14l2119t1802r2194b1827],
21	Serum	NN	O	serum	npadvmod	22	SENT_759	[p14l2205t1802r2286b1822],
22	vascular	JJ	O	vascular	amod	24	SENT_759	[p14l1326t1836r1429b1855],
23	endothelial	JJ	O	endothelial	amod	24	SENT_759	[p14l1444t1836r1586b1855],
24	growth	NN	O	growth	dobj	18	SENT_759	[p14l1603t1836r1691b1863],
25	factor	NN	O	factor	nn	28	SENT_759	[p14l1707t1836r1782b1855],
26	(	CD	NUMBER	(	num	28	SENT_759	[p14l1798t1836r1888b1861],
27	VEGF	NN	O	vegf	nn	28	SENT_759	[p14l1798t1836r1888b1861],
28	)	NN	O	)	dep	24	SENT_759	[p14l1798t1836r1888b1861],
29	and	CC	O	and	_	0	SENT_759	[p14l1905t1836r1951b1855],
30	VEGF-C	NN	O	vegf-c	nn	31	SENT_759	[p14l1966t1836r2069b1856],
31	levels	NNS	O	level	dobj	18	SENT_759	[p14l2086t1836r2153b1855],
32	as	IN	O	as	_	0	SENT_759	[p14l2169t1842r2192b1855],
33	tumor	NN	O	tumor	nn	34	SENT_759	[p14l2208t1840r2287b1855],
34	markers	NNS	O	marker	prep_as	31	SENT_759	[p14l1326t1869r1428b1888],
35	in	IN	O	in	_	0	SENT_759	[p14l1441t1869r1464b1888],
36	patients	NNS	O	patient	prep_in	18	SENT_759	[p14l1476t1869r1577b1896],
37	with	IN	O	with	_	0	SENT_759	[p14l1588t1869r1642b1888],
38	cervical	JJ	O	cervical	amod	39	SENT_759	[p14l1654t1869r1750b1888],
39	carcinoma	NN	O	carcinoma	prep_with	36	SENT_759	[p14l1763t1869r1902b1888],
40	.	.	O	.	_	0	SENT_759	[p14l1763t1869r1902b1888],

1	Cancer	NN	O	cancer	_	0	SENT_760	[p14l1915t1869r2005b1889],
2	1032	CD	DATE	1032	number	3	SENT_760	[p14l2018t1869r2065b1888],
3	724	CD	NUMBER	724	dep	1	SENT_760	[p14l2079t1867r2188b1889],
4	—	NN	O	—	dep	3	SENT_760	[p14l2079t1867r2188b1889],
5	730	CD	NUMBER	730	num	4	SENT_760	[p14l2079t1867r2188b1889],
6	.	.	O	.	_	0	SENT_760	[p14l2079t1867r2188b1889],

1	Peixoto	NNP	PERSON	Peixoto	nn	2	SENT_761	[p14l1326t1902r1423b1921],
2	CA	NNP	O	CA	nsubj	6	SENT_761	[p14l1446t1902r1491b1925],
3	,	,	O	,	_	0	SENT_761	[p14l1446t1902r1491b1925],
4	Figueiredo-Silva	NNP	O	Figueiredo-Silva	nn	5	SENT_761	[p14l1513t1902r1724b1929],
5	J	NNP	O	J	nsubj	6	SENT_761	[p14l1741t1902r1754b1929],
6	(	VBD	O	(	_	0	SENT_761	[p14l1777t1902r1852b1927],
7	2001	CD	DATE	2001	num	8	SENT_761	[p14l1777t1902r1852b1927],
8	)	CD	NUMBER	)	dobj	6	SENT_761	[p14l1777t1902r1852b1927],
9	Fine	JJ	O	fine	amod	10	SENT_761	[p14l1875t1902r1929b1921],
10	structure	NN	O	structure	dep	6	SENT_761	[p14l1952t1906r2069b1921],
11	of	IN	O	of	_	0	SENT_761	[p14l2091t1902r2118b1921],
12	intrascrotal	JJ	O	intrascrotal	amod	14	SENT_761	[p14l2138t1902r2286b1921],
13	lymphatic	JJ	O	lymphatic	amod	14	SENT_761	[p14l1326t1935r1451b1962],
14	vessels	NNS	O	vessel	prep_of	10	SENT_761	[p14l1461t1935r1542b1954],
15	infected	VBN	O	infect	partmod	14	SENT_761	[p14l1553t1935r1655b1954],
16	by	IN	O	by	_	0	SENT_761	[p14l1665t1935r1693b1962],
17	VI/uchereria	NN	O	vi/uchereria	nn	20	SENT_761	[p14l1705t1935r1832b1955],
18	bancmfti	NN	O	bancmftus	nn	20	SENT_761	[p14l1842t1935r1939b1962],
19	adult	JJ	O	adult	amod	20	SENT_761	[p14l1949t1935r2013b1954],
20	worms	NNS	O	worm	agent	15	SENT_761	[p14l2022t1935r2130b1962],
21	.	.	O	.	_	0	SENT_761	[p14l2022t1935r2130b1962],

1	J	NNP	O	J	nn	4	SENT_762	[p14l2022t1935r2130b1962],
2	Submicrosc	NNP	O	Submicrosc	nn	4	SENT_762	[p14l2139t1935r2286b1955],
3	Cytol	NNP	O	Cytol	nn	4	SENT_762	[p14l1326t1969r1392b1996],
4	Pathol	NNP	O	Pathol	_	0	SENT_762	[p14l1404t1969r1485b1988],
5	33	CD	NUMBER	33	num	4	SENT_762	[p14l1497t1969r1531b1988],
6	:	:	O	:	_	0	SENT_762	[p14l1497t1969r1531b1988],
7	125431	CD	NUMBER	125431	dep	4	SENT_762	[p14l1546t1969r1653b1988],
8	.	.	O	.	_	0	SENT_762	[p14l1546t1969r1653b1988],

1	Noroes	NNS	O	noro	nn	2	SENT_763	[p14l1326t2002r1416b2022],
2	J	NN	O	j	_	0	SENT_763	[p14l1430t2002r1449b2029],
3	,	,	O	,	_	0	SENT_763	[p14l1430t2002r1449b2029],
4	Addiss	NNP	PERSON	Addiss	nn	5	SENT_763	[p14l1468t2002r1550b2021],
5	D	NNP	O	D	appos	2	SENT_763	[p14l1569t2002r1595b2025],
6	,	,	O	,	_	0	SENT_763	[p14l1569t2002r1595b2025],
7	Amaral	NNP	PERSON	Amaral	nn	8	SENT_763	[p14l1613t2002r1706b2021],
8	F	NN	O	f	appos	5	SENT_763	[p14l1725t2002r1746b2025],
9	,	,	O	,	_	0	SENT_763	[p14l1725t2002r1746b2025],
10	Coutinho	NNP	PERSON	Coutinho	nn	11	SENT_763	[p14l1765t2002r1885b2022],
11	A	NNP	O	A	appos	5	SENT_763	[p14l1903t2002r1929b2025],
12	,	,	O	,	_	0	SENT_763	[p14l1903t2002r1929b2025],
13	Medeiros	NNP	PERSON	Medeiros	nn	14	SENT_763	[p14l1948t2002r2064b2021],
14	Z	NNP	O	Z	appos	5	SENT_763	[p14l2083t2002r2104b2025],
15	,	,	O	,	_	0	SENT_763	[p14l2083t2002r2104b2025],
16	et	FW	O	et	dep	2	SENT_763	[p14l2124t2006r2146b2021],
17	al.	FW	O	al.	nn	18	SENT_763	[p14l2165t2002r2191b2021],
18	(	FW	O	(	dep	2	SENT_763	[p14l2211t2002r2286b2027],
19	1996	CD	DATE	1996	num	21	SENT_763	[p14l2211t2002r2286b2027],
20	)	CD	NUMBER	)	num	21	SENT_763	[p14l2211t2002r2286b2027],
21	Occurrence	NN	O	occurrence	dep	18	SENT_763	[p14l1326t2035r1475b2055],
22	of	IN	O	of	_	0	SENT_763	[p14l1490t2035r1517b2054],
23	living	VBG	O	live	prepc_of	18	SENT_763	[p14l1527t2035r1597b2062],
24	adult	JJ	O	adult	amod	26	SENT_763	[p14l1610t2035r1674b2054],
25	Wuchemria	NNP	O	Wuchemria	nn	26	SENT_763	[p14l1690t2035r1816b2054],
26	bzmcmfti	NNS	O	bzmcmftus	dobj	23	SENT_763	[p14l1829t2035r1927b2062],
27	in	IN	O	in	_	0	SENT_763	[p14l1941t2035r1964b2054],
28	the	DT	O	the	det	30	SENT_763	[p14l1978t2035r2016b2054],
29	scrotal	JJ	O	scrotal	amod	30	SENT_763	[p14l2030t2035r2114b2054],
30	area	NN	O	area	prep_in	23	SENT_763	[p14l2128t2041r2181b2054],
31	of	IN	O	of	_	0	SENT_763	[p14l2195t2035r2222b2054],
32	men	NNS	O	man	prep_of	30	SENT_763	[p14l2233t2041r2286b2054],
33	with	IN	O	with	_	0	SENT_763	[p14l1326t2068r1379b2087],
34	microﬁlaremia	NN	O	microﬁlaremia	prep_with	32	SENT_763	[p14l1392t2068r1585b2087],
35	.	.	O	.	_	0	SENT_763	[p14l1392t2068r1585b2087],

1	Trans	NNP	O	Trans	nn	6	SENT_764	[p14l1598t2068r1670b2087],
2	R	NNP	O	R	nn	6	SENT_764	[p14l1682t2068r1700b2087],
3	Soc	NNP	O	Soc	nn	6	SENT_764	[p14l1711t2068r1754b2088],
4	Trop	NNP	O	Trop	nn	6	SENT_764	[p14l1766t2068r1830b2095],
5	Med	NNP	O	Med	nn	6	SENT_764	[p14l1842t2068r1896b2087],
6	Hyg	NNP	O	Hyg	_	0	SENT_764	[p14l1908t2068r1958b2095],
7	90	CD	NUMBER	90	num	6	SENT_764	[p14l1969t2068r2003b2087],
8	:	:	O	:	_	0	SENT_764	[p14l1969t2068r2003b2087],
9	55	CD	NUMBER	55	number	10	SENT_764	[p14l2017t2068r2095b2087],
10	—	CD	NUMBER	—	dep	6	SENT_764	[p14l2017t2068r2095b2087],
11	56	CD	NUMBER	56	dep	10	SENT_764	[p14l2017t2068r2095b2087],
12	.	.	O	.	_	0	SENT_764	[p14l2017t2068r2095b2087],

1	Shenoy	NNP	PERSON	Shenoy	nn	2	SENT_765	[p14l1326t2102r1418b2129],
2	RK	NNP	O	RK	nsubj	12	SENT_765	[p14l1428t2102r1472b2125],
3	,	,	O	,	_	0	SENT_765	[p14l1428t2102r1472b2125],
4	Suma	NNP	ORGANIZATION	Suma	nn	5	SENT_765	[p14l1482t2102r1551b2122],
5	TK	NN	ORGANIZATION	tk	appos	2	SENT_765	[p14l1561t2102r1605b2125],
6	,	,	O	,	_	0	SENT_765	[p14l1561t2102r1605b2125],
7	Rajan	NNP	PERSON	Rajan	nn	8	SENT_765	[p14l1616t2102r1687b2129],
8	K	NNP	PERSON	K	appos	2	SENT_765	[p14l1697t2102r1722b2125],
9	,	,	O	,	_	0	SENT_765	[p14l1697t2102r1722b2125],
10	Kumaraswami	NNP	O	Kumaraswami	nn	11	SENT_765	[p14l1732t2102r1911b2121],
11	V	NNP	O	V	appos	2	SENT_765	[p14l1921t2102r1940b2122],
12	(	VBD	O	(	_	0	SENT_765	[p14l1951t2102r2026b2127],
13	1998	CD	DATE	1998	num	14	SENT_765	[p14l1951t2102r2026b2127],
14	)	CD	NUMBER	)	dobj	12	SENT_765	[p14l1951t2102r2026b2127],
15	Prevention	NNP	O	Prevention	dep	14	SENT_765	[p14l2036t2102r2175b2121],
16	of	IN	O	of	_	0	SENT_765	[p14l2186t2102r2213b2121],
17	acute	JJ	O	acute	amod	18	SENT_765	[p14l2220t2106r2286b2121],
18	adenolymphangitis	NN	O	adenolymphangitis	prep_of	15	SENT_765	[p14l1326t2135r1568b2162],
19	in	IN	O	in	_	0	SENT_765	[p14l1587t2135r1610b2154],
20	brugian	JJ	O	brugian	amod	21	SENT_765	[p14l1629t2135r1727b2162],
21	ﬁlariasis	NN	O	ﬁlariasis	prep_in	18	SENT_765	[p14l1746t2135r1855b2154],
22	:	:	O	:	_	0	SENT_765	[p14l1746t2135r1855b2154],
23	Comparison	NN	O	comparison	dep	14	SENT_765	[p14l1874t2135r2030b2162],
24	of	IN	O	of	_	0	SENT_765	[p14l2049t2135r2076b2154],
25	the	DT	O	the	det	26	SENT_765	[p14l2092t2135r2130b2154],
26	efﬁcacy	NN	O	efﬁcacy	prep_of	23	SENT_765	[p14l2149t2135r2244b2162],
27	of	IN	O	of	_	0	SENT_765	[p14l2262t2135r2289b2154],
28	ivermectin	NN	O	ivermectin	prep_of	26	SENT_765	[p14l1327t2168r1462b2187],
29	and	CC	O	and	_	0	SENT_765	[p14l1472t2168r1518b2187],
30	diethylcarbamazine	NN	O	diethylcarbamazine	conj_and	28	SENT_765	[p14l1528t2168r1783b2195],
31	,	,	O	,	_	0	SENT_765	[p14l1528t2168r1783b2195],
32	each	DT	O	each	advmod	33	SENT_765	[p14l1793t2168r1849b2187],
33	combined	VBN	O	combine	prep	12	SENT_765	[p14l1859t2168r1985b2187],
34	with	IN	O	with	pcomp	33	SENT_765	[p14l1994t2168r2048b2187],
35	local	JJ	O	local	amod	36	SENT_765	[p14l2058t2168r2116b2187],
36	treatment	NN	O	treatment	pobj	34	SENT_765	[p14l2127t2172r2252b2187],
37	of	IN	O	of	_	0	SENT_765	[p14l2262t2168r2289b2187],
38	the	DT	O	the	det	40	SENT_765	[p14l1327t2201r1365b2220],
39	affected	VBN	O	affect	amod	40	SENT_765	[p14l1377t2201r1478b2220],
40	limb	NN	O	limb	prep_of	36	SENT_765	[p14l1490t2201r1552b2220],
41	.	.	O	.	_	0	SENT_765	[p14l1490t2201r1552b2220],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_766	[p14l1564t2201r1617b2220],
2	Trop	NNP	PERSON	Trop	nn	4	SENT_766	[p14l1629t2201r1692b2228],
3	Med	NNP	PERSON	Med	nn	4	SENT_766	[p14l1705t2201r1758b2220],
4	Parasitol	NNP	PERSON	Parasitol	_	0	SENT_766	[p14l1770t2201r1880b2220],
5	92	CD	NUMBER	92	num	4	SENT_766	[p14l1893t2201r1927b2221],
6	:	:	O	:	_	0	SENT_766	[p14l1893t2201r1927b2221],
7	587-594	CD	NUMBER	587-594	dep	4	SENT_766	[p14l1940t2199r2049b2220],
8	.	.	O	.	_	0	SENT_766	[p14l1940t2199r2049b2220],

1	Shenoy	NNP	PERSON	Shenoy	nn	2	SENT_767	[p14l1326t2235r1418b2262],
2	RK	NNP	O	RK	_	0	SENT_767	[p14l1427t2235r1471b2258],
3	,	,	O	,	_	0	SENT_767	[p14l1427t2235r1471b2258],
4	Kumaraswami	NNP	O	Kumaraswami	nn	5	SENT_767	[p14l1481t2235r1660b2254],
5	V	NNP	O	V	appos	2	SENT_767	[p14l1668t2235r1694b2258],
6	,	,	O	,	_	0	SENT_767	[p14l1668t2235r1694b2258],
7	Suma	NNP	LOCATION	Suma	nn	8	SENT_767	[p14l1703t2235r1773b2255],
8	TK	NN	LOCATION	tk	appos	2	SENT_767	[p14l1781t2235r1826b2258],
9	,	,	O	,	_	0	SENT_767	[p14l1781t2235r1826b2258],
10	Rajan	NN	PERSON	rajan	nn	11	SENT_767	[p14l1835t2235r1906b2262],
11	K	NN	PERSON	k	appos	2	SENT_767	[p14l1916t2235r1940b2258],
12	,	,	O	,	_	0	SENT_767	[p14l1916t2235r1940b2258],
13	Radhakuttyamma	NN	O	radhakuttyamma	nn	14	SENT_767	[p14l1950t2235r2173b2262],
14	G	NN	O	g	appos	2	SENT_767	[p14l2182t2235r2202b2255],
15	(	CD	NUMBER	(	num	17	SENT_767	[p14l2211t2235r2286b2260],
16	1999	CD	DATE	1999	num	17	SENT_767	[p14l2211t2235r2286b2260],
17	)	NN	O	)	dep	14	SENT_767	[p14l2211t2235r2286b2260],
18	A	DT	O	a	det	22	SENT_767	[p14l1325t2268r1345b2287],
19	double-blind	JJ	O	double-blind	amod	22	SENT_767	[p14l1356t2268r1526b2291],
20	,	,	O	,	_	0	SENT_767	[p14l1356t2268r1526b2291],
21	placebo-controlled	JJ	O	placebo-controlled	amod	22	SENT_767	[p14l1539t2268r1780b2295],
22	study	NN	O	study	dep	14	SENT_767	[p14l1792t2268r1858b2295],
23	of	IN	O	of	_	0	SENT_767	[p14l1870t2268r1897b2287],
24	the	DT	O	the	det	25	SENT_767	[p14l1906t2268r1944b2287],
25	efﬁcacy	NN	O	efﬁcacy	prep_of	22	SENT_767	[p14l1956t2268r2051b2295],
26	of	IN	O	of	_	0	SENT_767	[p14l2063t2268r2090b2287],
27	oral	JJ	O	oral	amod	28	SENT_767	[p14l2099t2268r2147b2287],
28	penicillin	NN	O	penicillin	prep_of	25	SENT_767	[p14l2160t2268r2286b2295],
29	,	,	O	,	_	0	SENT_767	[p14l2160t2268r2286b2295],
30	diethylcarbamazine	NN	O	diethylcarbamazine	nn	33	SENT_767	[p14l1326t2301r1575b2328],
31	or	CC	O	or	_	0	SENT_767	[p14l1588t2307r1615b2320],
32	local	JJ	O	local	conj_or	30	SENT_767	[p14l1628t2301r1686b2320],
33	treatment	NN	O	treatment	appos	2	SENT_767	[p14l1700t2305r1825b2320],
34	of	IN	O	of	_	0	SENT_767	[p14l1839t2301r1866b2320],
35	the	DT	O	the	det	37	SENT_767	[p14l1876t2301r1915b2320],
36	affected	VBN	O	affect	amod	37	SENT_767	[p14l1928t2301r2029b2320],
37	limb	NN	O	limb	prep_of	33	SENT_767	[p14l2042t2301r2098b2320],
38	in	IN	O	in	_	0	SENT_767	[p14l2112t2301r2135b2320],
39	preventing	VBG	O	prevent	prepc_in	37	SENT_767	[p14l2149t2301r2287b2328],
40	acute	JJ	O	acute	amod	41	SENT_767	[p14l1326t2338r1393b2353],
41	adenolymphangitis	NN	O	adenolymphangitis	dobj	39	SENT_767	[p14l1405t2334r1646b2361],
42	in	IN	O	in	_	0	SENT_767	[p14l1659t2334r1682b2353],
43	lymphedema	NN	O	lymphedema	prep_in	39	SENT_767	[p14l1693t2334r1856b2361],
44	caused	VBN	O	cause	partmod	43	SENT_767	[p14l1867t2334r1951b2353],
45	by	IN	O	by	_	0	SENT_767	[p14l1963t2334r1991b2361],
46	brugian	JJ	O	brugian	amod	47	SENT_767	[p14l2002t2334r2100b2361],
47	ﬁlariasis	NN	O	ﬁlariasis	agent	44	SENT_767	[p14l2112t2334r2221b2353],
48	.	.	O	.	_	0	SENT_767	[p14l2112t2334r2221b2353],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_768	[p14l2233t2334r2286b2353],
2	Trop	NNP	PERSON	Trop	nn	4	SENT_768	[p14l1326t2368r1389b2395],
3	Med	NNP	PERSON	Med	nn	4	SENT_768	[p14l1402t2368r1455b2387],
4	Parasitol	NNP	PERSON	Parasitol	_	0	SENT_768	[p14l1467t2368r1577b2387],
5	93	CD	NUMBER	93	num	4	SENT_768	[p14l1590t2368r1623b2387],
6	:	:	O	:	_	0	SENT_768	[p14l1590t2368r1623b2387],
7	367	CD	NUMBER	367	num	8	SENT_768	[p14l1636t2366r1746b2387],
8	—	NN	O	—	dep	4	SENT_768	[p14l1636t2366r1746b2387],
9	377	CD	NUMBER	377	dep	8	SENT_768	[p14l1636t2366r1746b2387],
10	.	.	O	.	_	0	SENT_768	[p14l1636t2366r1746b2387],

1	Pani	NNP	PERSON	Pani	_	0	SENT_769	[p14l1326t2401r1381b2420],
2	SP	NN	O	sp	dep	1	SENT_769	[p14l1399t2401r1436b2424],
3	,	,	O	,	_	0	SENT_769	[p14l1399t2401r1436b2424],
4	Yuvaraj	NNP	PERSON	Yuvaraj	nn	5	SENT_769	[p14l1453t2401r1548b2428],
5	J	NNP	PERSON	J	dep	1	SENT_769	[p14l1561t2401r1580b2428],
6	,	,	O	,	_	0	SENT_769	[p14l1561t2401r1580b2428],
7	Vanamail	NNP	O	Vanamail	nn	8	SENT_769	[p14l1597t2401r1718b2421],
8	P	NN	O	p	conj_and	2	SENT_769	[p14l1735t2401r1756b2424],
9	,	,	O	,	_	0	SENT_769	[p14l1735t2401r1756b2424],
10	Dhanda	NNP	O	Dhanda	nn	11	SENT_769	[p14l1774t2401r1872b2420],
11	V	NNP	O	V	conj_and	2	SENT_769	[p14l1888t2401r1914b2424],
12	,	,	O	,	_	0	SENT_769	[p14l1888t2401r1914b2424],
13	Michael	NNP	PERSON	Michael	nn	14	SENT_769	[p14l1932t2401r2029b2420],
14	E	NNP	PERSON	E	conj_and	2	SENT_769	[p14l2047t2401r2068b2424],
15	,	,	O	,	_	0	SENT_769	[p14l2047t2401r2068b2424],
16	(	CD	NUMBER	(	num	17	SENT_769	[p14l2087t2401r2162b2426],
17	1995	CD	DATE	1995	conj_and	2	SENT_769	[p14l2087t2401r2162b2426],
18	)	CD	NUMBER	)	num	20	SENT_769	[p14l2087t2401r2162b2426],
19	Episodic	JJ	MISC	episodic	amod	20	SENT_769	[p14l2179t2401r2286b2428],
20	adenolymphagitis	NN	O	adenolymphagitis	dep	17	SENT_769	[p14l1326t2434r1551b2461],
21	and	CC	O	and	_	0	SENT_769	[p14l1564t2434r1610b2453],
22	lymphedema	NN	O	lymphedema	dep	1	SENT_769	[p14l1622t2434r1785b2461],
23	in	IN	O	in	_	0	SENT_769	[p14l1798t2434r1821b2453],
24	patients	NNS	O	patient	prep_in	1	SENT_769	[p14l1835t2434r1935b2461],
25	with	IN	O	with	_	0	SENT_769	[p14l1948t2434r2002b2453],
26	bancroftian	JJ	O	bancroftian	amod	27	SENT_769	[p14l2015t2434r2163b2453],
27	ﬁlariasis	NN	O	ﬁlariasis	prep_with	24	SENT_769	[p14l2176t2434r2286b2453],
28	.	.	O	.	_	0	SENT_769	[p14l2176t2434r2286b2453],

1	Trans	NNP	O	Trans	nn	6	SENT_770	[p14l1326t2467r1398b2486],
2	R	NNP	O	R	nn	6	SENT_770	[p14l1410t2467r1428b2486],
3	Soc	NNP	O	Soc	nn	6	SENT_770	[p14l1439t2467r1482b2487],
4	Trop	NNP	O	Trop	nn	6	SENT_770	[p14l1494t2467r1558b2494],
5	Med	NNP	O	Med	nn	6	SENT_770	[p14l1570t2467r1624b2486],
6	Hyg	NNP	O	Hyg	dep	26	SENT_770	[p14l1636t2467r1686b2494],
7	89	CD	NUMBER	89	dep	6	SENT_770	[p14l1697t2467r1731b2486],
8	:	:	O	:	_	0	SENT_770	[p14l1697t2467r1731b2486],
9	72	CD	NUMBER	72	num	13	SENT_770	[p14l1744t2465r1818b2486],
10	—	CD	NUMBER	—	num	13	SENT_770	[p14l1744t2465r1818b2486],
11	74	CD	NUMBER	74	num	13	SENT_770	[p14l1744t2465r1818b2486],
12	Gyapong	NNP	ORGANIZATION	Gyapong	nn	13	SENT_770	[p14l1326t2501r1440b2528],
13	JO	NNP	ORGANIZATION	JO	dep	6	SENT_770	[p14l1454t2501r1496b2528],
14	,	,	O	,	_	0	SENT_770	[p14l1454t2501r1496b2528],
15	Gyapong	NNP	O	Gyapong	nn	16	SENT_770	[p14l1516t2501r1630b2528],
16	M	NNP	O	M	appos	13	SENT_770	[p14l1649t2501r1678b2524],
17	,	,	O	,	_	0	SENT_770	[p14l1649t2501r1678b2524],
18	Evans	NNP	PERSON	Evans	nn	19	SENT_770	[p14l1698t2501r1769b2520],
19	DB	NNP	O	DB	appos	13	SENT_770	[p14l1789t2501r1834b2524],
20	,	,	O	,	_	0	SENT_770	[p14l1789t2501r1834b2524],
21	Aikins	NNP	ORGANIZATION	Aikins	nn	22	SENT_770	[p14l1853t2501r1933b2520],
22	MK	NNP	ORGANIZATION	MK	appos	13	SENT_770	[p14l1953t2501r2003b2524],
23	,	,	O	,	_	0	SENT_770	[p14l1953t2501r2003b2524],
24	Adjei	NNP	PERSON	Adjei	nn	25	SENT_770	[p14l2022t2501r2089b2528],
25	S	NNP	PERSON	S	nsubj	26	SENT_770	[p14l2109t2501r2122b2521],
26	(	VBD	O	(	_	0	SENT_770	[p14l2143t2501r2218b2526],
27	1996	CD	DATE	1996	num	28	SENT_770	[p14l2143t2501r2218b2526],
28	)	CD	NUMBER	)	dobj	26	SENT_770	[p14l2143t2501r2218b2526],
29	The	DT	O	the	det	31	SENT_770	[p14l2238t2501r2286b2520],
30	economic	JJ	O	economic	amod	31	SENT_770	[p14l1326t2534r1449b2553],
31	burden	NN	O	burden	tmod	26	SENT_770	[p14l1459t2534r1550b2553],
32	of	IN	O	of	_	0	SENT_770	[p14l1560t2534r1587b2553],
33	lymphatic	JJ	O	lymphatic	amod	34	SENT_770	[p14l1593t2534r1718b2561],
34	ﬁlariasis	NN	O	ﬁlariasis	prep_of	31	SENT_770	[p14l1728t2534r1832b2553],
35	in	IN	O	in	_	0	SENT_770	[p14l1842t2534r1865b2553],
36	northern	JJ	O	northern	amod	37	SENT_770	[p14l1875t2534r1989b2553],
37	Ghana	NNP	LOCATION	Ghana	prep_in	34	SENT_770	[p14l1999t2534r2087b2554],
38	.	.	O	.	_	0	SENT_770	[p14l1999t2534r2087b2554],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_771	[p14l2096t2534r2150b2553],
2	Trop	NNP	PERSON	Trop	nn	4	SENT_771	[p14l2159t2534r2223b2561],
3	Med	NNP	PERSON	Med	nn	4	SENT_771	[p14l2233t2534r2286b2553],
4	Parasitol	NNP	PERSON	Parasitol	_	0	SENT_771	[p14l1326t2567r1436b2586],
5	90	CD	NUMBER	90	num	4	SENT_771	[p14l1449t2567r1483b2586],
6	:	:	O	:	_	0	SENT_771	[p14l1449t2567r1483b2586],
7	39	CD	NUMBER	39	number	8	SENT_771	[p14l1495t2567r1574b2586],
8	—	CD	NUMBER	—	dep	4	SENT_771	[p14l1495t2567r1574b2586],
9	48	CD	NUMBER	48	dep	8	SENT_771	[p14l1495t2567r1574b2586],
10	.	.	O	.	_	0	SENT_771	[p14l1495t2567r1574b2586],

1	Ramaiah	NNP	ORGANIZATION	Ramaiah	nn	2	SENT_772	[p14l1326t2600r1436b2619],
2	KD	NN	ORGANIZATION	kd	nsubj	18	SENT_772	[p14l1450t2600r1495b2623],
3	,	,	O	,	_	0	SENT_772	[p14l1450t2600r1495b2623],
4	Radhamani	NNP	O	Radhamani	nn	5	SENT_772	[p14l1509t2600r1653b2619],
5	MP	NNP	O	MP	appos	2	SENT_772	[p14l1666t2600r1713b2623],
6	,	,	O	,	_	0	SENT_772	[p14l1666t2600r1713b2623],
7	John	NNP	PERSON	John	nn	8	SENT_772	[p14l1721t2600r1784b2627],
8	KR	NNP	PERSON	KR	appos	5	SENT_772	[p14l1797t2600r1841b2623],
9	,	,	O	,	_	0	SENT_772	[p14l1797t2600r1841b2623],
10	Evans	NNP	ORGANIZATION	Evans	nn	11	SENT_772	[p14l1854t2600r1926b2619],
11	DB	NNP	ORGANIZATION	DB	appos	8	SENT_772	[p14l1939t2600r1983b2623],
12	,	,	O	,	_	0	SENT_772	[p14l1939t2600r1983b2623],
13	Guyatt	NNP	PERSON	Guyatt	nn	14	SENT_772	[p14l1997t2600r2081b2627],
14	H	NNP	O	H	appos	5	SENT_772	[p14l2094t2600r2122b2623],
15	,	,	O	,	_	0	SENT_772	[p14l2094t2600r2122b2623],
16	et	FW	O	et	nn	18	SENT_772	[p14l2135t2604r2158b2619],
17	al.	FW	O	al.	nn	18	SENT_772	[p14l2171t2600r2197b2619],
18	(	FW	O	(	_	0	SENT_772	[p14l2211t2600r2286b2625],
19	2000	CD	DATE	2000	num	20	SENT_772	[p14l2211t2600r2286b2625],
20	)	CD	NUMBER	)	dobj	18	SENT_772	[p14l2211t2600r2286b2625],
21	The	DT	O	the	det	22	SENT_772	[p14l1326t2634r1374b2653],
22	impact	NN	O	impact	dep	20	SENT_772	[p14l1392t2634r1478b2661],
23	of	IN	O	of	_	0	SENT_772	[p14l1495t2634r1523b2653],
24	lymphatic	JJ	O	lymphatic	amod	25	SENT_772	[p14l1537t2634r1662b2661],
25	ﬁlariasis	NN	O	ﬁlariasis	prep_of	22	SENT_772	[p14l1679t2634r1783b2653],
26	on	IN	O	on	_	0	SENT_772	[p14l1800t2641r1831b2653],
27	labour	NN	O	labour	nn	28	SENT_772	[p14l1849t2634r1931b2653],
28	inputs	NNS	O	input	prep_on	18	SENT_772	[p14l1948t2634r2026b2661],
29	in	IN	O	in	_	0	SENT_772	[p14l2044t2634r2067b2653],
30	southern	JJ	O	southern	amod	31	SENT_772	[p14l2085t2634r2197b2653],
31	India	NNP	LOCATION	India	prep_in	28	SENT_772	[p14l2215t2634r2286b2653],
32	:	:	O	:	_	0	SENT_772	[p14l2215t2634r2286b2653],
33	Results	NNS	O	result	dep	28	SENT_772	[p14l1326t2667r1414b2686],
34	of	IN	O	of	_	0	SENT_772	[p14l1426t2667r1454b2686],
35	a	DT	O	a	det	37	SENT_772	[p14l1463t2674r1475b2686],
36	multi-site	JJ	O	multi-site	amod	37	SENT_772	[p14l1487t2667r1607b2686],
37	study	NN	O	study	prep_of	33	SENT_772	[p14l1619t2667r1691b2694],
38	.	.	O	.	_	0	SENT_772	[p14l1619t2667r1691b2694],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_773	[p14l1703t2667r1756b2686],
2	Trop	NNP	PERSON	Trop	nn	4	SENT_773	[p14l1768t2667r1832b2694],
3	Med	NNP	PERSON	Med	nn	4	SENT_773	[p14l1844t2667r1898b2686],
4	Parasitol	NNP	PERSON	Parasitol	_	0	SENT_773	[p14l1909t2667r2020b2686],
5	94	CD	NUMBER	94	num	4	SENT_773	[p14l2032t2667r2066b2686],
6	:	:	O	:	_	0	SENT_773	[p14l2032t2667r2066b2686],
7	353	CD	NUMBER	353	num	8	SENT_773	[p14l2079t2667r2188b2686],
8	—	NN	O	—	dep	4	SENT_773	[p14l2079t2667r2188b2686],
9	364	CD	NUMBER	364	dep	8	SENT_773	[p14l2079t2667r2188b2686],
10	.	.	O	.	_	0	SENT_773	[p14l2079t2667r2188b2686],

1	Ottesen	NNP	PERSON	Ottesen	nn	2	SENT_774	[p14l1326t2700r1425b2720],
2	EA	NN	PERSON	ea	_	0	SENT_774	[p14l1435t2700r1471b2719],
3	(	CD	NUMBER	(	num	7	SENT_774	[p14l1482t2700r1557b2725],
4	1993	CD	DATE	1993	num	7	SENT_774	[p14l1482t2700r1557b2725],
5	)	CD	NUMBER	)	num	7	SENT_774	[p14l1482t2700r1557b2725],
6	Filarial	JJ	O	filarial	amod	7	SENT_774	[p14l1568t2700r1656b2719],
7	infections	NNS	O	infection	dep	2	SENT_774	[p14l1668t2700r1799b2719],
8	.	.	O	.	_	0	SENT_774	[p14l1668t2700r1799b2719],

1	Infect	VB	O	infect	_	0	SENT_775	[p14l1810t2700r1884b2719],
2	Dis	NNP	O	Dis	nn	3	SENT_775	[p14l1894t2700r1933b2719],
3	Clin	NNP	O	Clin	nsubj	6	SENT_775	[p14l1943t2700r1995b2720],
4	North	NNP	O	North	dep	6	SENT_775	[p14l2006t2700r2081b2720],
5	Am	VBP	O	be	dep	6	SENT_775	[p14l2092t2700r2135b2719],
6	7	CD	NUMBER	7	xcomp	1	SENT_775	[p14l2147t2698r2165b2719],
7	:	:	O	:	_	0	SENT_775	[p14l2147t2698r2165b2719],
8	619	CD	NUMBER	619	num	9	SENT_775	[p14l2176t2700r2286b2719],
9	—	NN	O	—	dep	6	SENT_775	[p14l2176t2700r2286b2719],
10	633	CD	NUMBER	633	dep	9	SENT_775	[p14l2176t2700r2286b2719],
11	.	.	O	.	_	0	SENT_775	[p14l2176t2700r2286b2719],

1	Addiss	NNP	PERSON	Addiss	nn	2	SENT_776	[p14l1325t2733r1408b2752],
2	DG	NNS	O	dg	_	0	SENT_776	[p14l1421t2733r1468b2756],
3	,	,	O	,	_	0	SENT_776	[p14l1421t2733r1468b2756],
4	Eberhard	NNP	PERSON	Eberhard	nn	5	SENT_776	[p14l1481t2733r1599b2752],
5	ML	NNP	PERSON	ML	appos	2	SENT_776	[p14l1612t2733r1659b2756],
6	,	,	O	,	_	0	SENT_776	[p14l1612t2733r1659b2756],
7	Lammie	NNP	PERSON	Lammie	appos	2	SENT_776	[p14l1672t2733r1775b2752],
8	d	NN	O	d	prep	7	SENT_776	[p14l1787t2733r1813b2760],
9	(	CD	NUMBER	(	num	10	SENT_776	[p14l1826t2733r1901b2758],
10	1994	CD	DATE	1994	dep	8	SENT_776	[p14l1826t2733r1901b2758],
11	)	CD	NUMBER	)	num	12	SENT_776	[p14l1826t2733r1901b2758],
12	“	NN	O	“	dep	2	SENT_776	[p14l1914t2732r2031b2752],
13	Filarial	JJ	O	filarial	dep	12	SENT_776	[p14l1914t2732r2031b2752],
14	"	``	O	"	punct	15	SENT_776	[p14l1914t2732r2031b2752],
15	adenolymphangitis	NN	O	adenolymphangitis	dep	2	SENT_776	[p14l2045t2733r2286b2760],
16	without	IN	O	without	_	0	SENT_776	[p14l1326t2767r1423b2786],
17	ﬁlarial	JJ	O	ﬁlarial	amod	18	SENT_776	[p14l1435t2767r1515b2786],
18	infection	NN	O	infection	prep_without	15	SENT_776	[p14l1529t2767r1648b2786],
19	.	.	O	.	_	0	SENT_776	[p14l1529t2767r1648b2786],

1	Lancet	NNP	O	Lancet	_	0	SENT_777	[p14l1661t2767r1746b2786],
2	343	CD	NUMBER	343	num	1	SENT_777	[p14l1759t2767r1807b2786],
3	:	:	O	:	_	0	SENT_777	[p14l1759t2767r1807b2786],
4	597	CD	NUMBER	597	dep	1	SENT_777	[p14l1821t2765r1869b2786],
5	.	.	O	.	_	0	SENT_777	[p14l1821t2765r1869b2786],

1	Casley-Smith	JJ	O	casley-smith	amod	2	SENT_778	[p14l1326t2800r1491b2827],
2	JR	NN	O	jr	nsubj	9	SENT_778	[p14l1506t2800r1544b2827],
3	,	,	O	,	_	0	SENT_778	[p14l1506t2800r1544b2827],
4	Jamal	NNP	PERSON	Jamal	nn	5	SENT_778	[p14l1559t2800r1633b2827],
5	S	NNP	PERSON	S	appos	2	SENT_778	[p14l1653t2800r1673b2823],
6	,	,	O	,	_	0	SENT_778	[p14l1653t2800r1673b2823],
7	Casley-Smith	NNP	PERSON	Casley-Smith	nn	8	SENT_778	[p14l1693t2800r1858b2827],
8	J	NNP	PERSON	J	appos	5	SENT_778	[p14l1873t2800r1886b2827],
9	(	VBD	O	(	_	0	SENT_778	[p14l1906t2800r1981b2825],
10	1993	CD	DATE	1993	num	12	SENT_778	[p14l1906t2800r1981b2825],
11	)	CD	NUMBER	)	num	12	SENT_778	[p14l1906t2800r1981b2825],
12	Reduction	NN	O	reduction	dobj	9	SENT_778	[p14l2001t2800r2132b2819],
13	of	IN	O	of	_	0	SENT_778	[p14l2151t2800r2178b2819],
14	ﬁlaritic	JJ	O	ﬁlaritic	amod	15	SENT_778	[p14l2195t2800r2286b2819],
15	lymphedema	NN	O	lymphedema	prep_of	12	SENT_778	[p14l1326t2833r1489b2860],
16	and	CC	O	and	_	0	SENT_778	[p14l1500t2833r1546b2852],
17	elephantiasis	NN	O	elephantiasis	prep_of	12	SENT_778	[p14l1557t2833r1721b2860],
18	by	IN	O	by	_	0	SENT_778	[p14l1731t2833r1759b2860],
19	5,6	CD	NUMBER	5,6	num	20	SENT_778	[p14l1771t2833r1805b2856],
20	benzo-alpha-pyrone	NN	O	benzo-alpha-pyrone	prep_by	9	SENT_778	[p14l1816t2833r2072b2860],
21	(	CD	NUMBER	(	num	23	SENT_778	[p14l2084t2833r2229b2858],
22	coumarin	NN	O	coumarin	nn	23	SENT_778	[p14l2084t2833r2229b2858],
23	)	NN	O	)	dep	20	SENT_778	[p14l2084t2833r2229b2858],
24	,	,	O	,	_	0	SENT_778	[p14l2084t2833r2229b2858],
25	and	CC	O	and	_	0	SENT_778	[p14l2241t2833r2287b2852],
26	the	DT	O	the	det	27	SENT_778	[p14l1327t2866r1365b2885],
27	effects	NNS	O	effect	conj_and	20	SENT_778	[p14l1376t2866r1457b2885],
28	of	IN	O	of	_	0	SENT_778	[p14l1469t2866r1496b2885],
29	diethylcarbamazine	NN	O	diethylcarbamazine	prep_of	27	SENT_778	[p14l1504t2866r1753b2893],
30	(	CD	NUMBER	(	num	29	SENT_778	[p14l1765t2866r1844b2891],
31	DEC	NNP	DATE	DEC	tmod	9	SENT_778	[p14l1765t2866r1844b2891],
32	)	CD	NUMBER	)	num	31	SENT_778	[p14l1765t2866r1844b2891],
33	.	.	O	.	_	0	SENT_778	[p14l1765t2866r1844b2891],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_779	[p14l1856t2866r1909b2885],
2	Trop	NNP	PERSON	Trop	nn	4	SENT_779	[p14l1920t2866r1983b2893],
3	Med	NNP	PERSON	Med	nn	4	SENT_779	[p14l1995t2866r2049b2885],
4	Parasitol	NNP	PERSON	Parasitol	_	0	SENT_779	[p14l2060t2866r2170b2885],
5	87	CD	NUMBER	87	num	4	SENT_779	[p14l2182t2864r2216b2885],
6	:	:	O	:	_	0	SENT_779	[p14l2182t2864r2216b2885],
7	247	CD	NUMBER	247	num	8	SENT_779	[p14l2229t2864r2286b2886],
8	—	NN	O	—	dep	4	SENT_779	[p14l2229t2864r2286b2886],
9	258	CD	NUMBER	258	dep	8	SENT_779	[p14l1327t2900r1375b2920],
10	.	.	O	.	_	0	SENT_779	[p14l1327t2900r1375b2920],

1	World	NNP	ORGANIZATION	World	nn	3	SENT_780	[p14l1326t2933r1405b2952],
2	Health	NNP	ORGANIZATION	Health	nn	3	SENT_780	[p14l1426t2933r1510b2952],
3	Organization	NNP	ORGANIZATION	Organization	_	0	SENT_780	[p14l1531t2933r1698b2960],
4	(	CD	NUMBER	(	num	5	SENT_780	[p14l1720t2933r1795b2958],
5	1996	CD	DATE	1996	dep	3	SENT_780	[p14l1720t2933r1795b2958],
6	)	NNP	O	)	nn	10	SENT_780	[p14l1720t2933r1795b2958],
7	Coumarin	NNP	O	Coumarin	nn	10	SENT_780	[p14l1815t2933r1943b2953],
8	(	NNP	O	(	nn	10	SENT_780	[p14l1965t2933r2089b2958],
9	Lodema	NNP	O	Lodema	nn	10	SENT_780	[p14l1965t2933r2089b2958],
10	)	NN	O	)	dep	5	SENT_780	[p14l1965t2933r2089b2958],
11	.	.	O	.	_	0	SENT_780	[p14l1965t2933r2089b2958],

1	WHO	WP	ORGANIZATION	who	dep	3	SENT_781	[p14l2110t2933r2182b2953],
2	Pharm	NNP	ORGANIZATION	Pharm	nn	3	SENT_781	[p14l2203t2933r2286b2952],
3	Newsl	NNP	ORGANIZATION	Newsl	_	0	SENT_781	[p14l1326t2966r1399b2986],
4	10	CD	NUMBER	10	num	3	SENT_781	[p14l1414t2966r1445b2985],
5	:	:	O	:	_	0	SENT_781	[p14l1414t2966r1445b2985],
6	2	CD	NUMBER	2	dep	3	SENT_781	[p14l1458t2966r1477b2985],
7	.	.	O	.	_	0	SENT_781	[p14l1458t2966r1477b2985],

1	.	.	O	.	_	0	SENT_782	[p14l1307t3015r1310b3018],

1	Lalitha	NNP	PERSON	Lalitha	nn	2	SENT_783	[p14l1326t2999r1414b3018],
2	P	NN	PERSON	p	_	0	SENT_783	[p14l1427t2999r1448b3022],
3	,	,	O	,	_	0	SENT_783	[p14l1427t2999r1448b3022],
4	Ravichandran	NN	O	ravichandran	nn	5	SENT_783	[p14l1461t2999r1637b3018],
5	M	NN	O	m	appos	2	SENT_783	[p14l1651t2999r1679b3022],
6	,	,	O	,	_	0	SENT_783	[p14l1651t2999r1679b3022],
7	Suba	NNP	LOCATION	Suba	nn	8	SENT_783	[p14l1693t2999r1753b3019],
8	S	NNP	LOCATION	S	appos	2	SENT_783	[p14l1766t2999r1786b3022],
9	,	,	O	,	_	0	SENT_783	[p14l1766t2999r1786b3022],
10	Kaliraj	NNP	PERSON	Kaliraj	nn	11	SENT_783	[p14l1799t2999r1882b3026],
11	P	NN	PERSON	p	appos	2	SENT_783	[p14l1896t2999r1917b3022],
12	,	,	O	,	_	0	SENT_783	[p14l1896t2999r1917b3022],
13	Narayanan	NNP	PERSON	Narayanan	nn	14	SENT_783	[p14l1930t2999r2067b3026],
14	RB	NN	O	rb	appos	2	SENT_783	[p14l2081t2999r2123b3022],
15	,	,	O	,	_	0	SENT_783	[p14l2081t2999r2123b3022],
16	et	FW	O	et	appos	2	SENT_783	[p14l2136t3003r2158b3018],
17	al.	FW	O	al.	nn	18	SENT_783	[p14l2171t2999r2197b3018],
18	(	FW	O	(	dep	2	SENT_783	[p14l2211t2999r2286b3024],
19	1998	CD	DATE	1998	num	20	SENT_783	[p14l2211t2999r2286b3024],
20	)	CD	NUMBER	)	dep	18	SENT_783	[p14l2211t2999r2286b3024],

1	Quantitative	JJ	O	quantitative	amod	2	SENT_784	[p15l239t207r400b233],
2	assessment	NN	O	assessment	nsubj	20	SENT_784	[p15l423t211r561b226],
3	of	IN	O	of	_	0	SENT_784	[p15l582t207r609b226],
4	circulating	VBG	O	circulate	prepc_of	2	SENT_784	[p15l628t207r767b234],
5	antigens	NNS	O	antigen	dobj	4	SENT_784	[p15l788t207r894b234],
6	in	IN	O	in	_	0	SENT_784	[p15l917t207r940b226],
7	human	JJ	O	human	amod	9	SENT_784	[p15l962t207r1050b226],
8	lymphatic	JJ	O	lymphatic	amod	9	SENT_784	[p15l1072t207r1198b234],
9	ﬁlariasis	NN	O	ﬁlariasis	prep_in	5	SENT_784	[p15l239t240r348b259],
10	:	:	O	:	_	0	SENT_784	[p15l239t240r348b259],
11	A	DT	O	a	det	13	SENT_784	[p15l365t240r384b259],
12	ﬁeld	JJ	O	ﬁeld	amod	13	SENT_784	[p15l400t240r454b259],
13	evaluation	NN	O	evaluation	dep	5	SENT_784	[p15l471t240r602b259],
14	of	IN	O	of	_	0	SENT_784	[p15l619t240r646b259],
15	monoclonal	JJ	O	monoclonal	amod	17	SENT_784	[p15l660t240r810b259],
16	antibody-based	JJ	O	antibody-based	amod	17	SENT_784	[p15l827t240r1021b267],
17	ELISA	NN	O	elisa	prep_of	13	SENT_784	[p15l1037t240r1117b260],
18	using	VBG	O	use	partmod	17	SENT_784	[p15l1133t240r1200b267],
19	blood	NN	O	blood	dobj	18	SENT_784	[p15l239t273r310b292],
20	collected	VBN	O	collect	_	0	SENT_784	[p15l322t273r435b292],
21	on	IN	O	on	_	0	SENT_784	[p15l448t279r479b292],
22	ﬁlter	NN	O	ﬁlter	nn	23	SENT_784	[p15l491t273r552b292],
23	strips	NNS	O	strip	prep_on	20	SENT_784	[p15l563t273r637b300],
24	.	.	O	.	_	0	SENT_784	[p15l563t273r637b300],

1	Trop	NNP	O	Trop	nn	4	SENT_785	[p15l649t273r713b300],
2	Med	NNP	O	Med	nn	4	SENT_785	[p15l725t273r779b292],
3	Int	NNP	O	Int	nn	4	SENT_785	[p15l790t273r826b292],
4	Health	NNP	O	Health	_	0	SENT_785	[p15l839t273r923b292],
5	3	CD	NUMBER	3	dep	4	SENT_785	[p15l936t273r954b292],
6	:	:	O	:	_	0	SENT_785	[p15l936t273r954b292],
7	4l	CD	NUMBER	4l	dep	4	SENT_785	[p15l967t273r1046b292],
8	—	CD	NUMBER	—	number	9	SENT_785	[p15l967t273r1046b292],
9	45	CD	NUMBER	45	dep	7	SENT_785	[p15l967t273r1046b292],
10	.	.	O	.	_	0	SENT_785	[p15l967t273r1046b292],

1	.	.	O	.	_	0	SENT_786	[p15l220t322r223b325],

1	Ewert	NNP	PERSON	Ewert	nn	2	SENT_787	[p15l239t306r310b325],
2	A	NNP	O	A	_	0	SENT_787	[p15l320t306r346b329],
3	,	,	O	,	_	0	SENT_787	[p15l320t306r346b329],
4	Reitmeyer	NNP	O	Reitmeyer	nn	6	SENT_787	[p15l357t306r530b333],
5	]	CD	NUMBER	]	num	6	SENT_787	[p15l357t306r530b333],
6	C	NN	O	c	appos	2	SENT_787	[p15l357t306r530b333],
7	,	,	O	,	_	0	SENT_787	[p15l357t306r530b333],
8	Folse	NN	PERSON	folse	nn	9	SENT_787	[p15l541t306r604b325],
9	D	NN	PERSON	d	appos	2	SENT_787	[p15l615t306r633b325],
10	(	CD	NUMBER	(	num	11	SENT_787	[p15l646t306r720b331],
11	1980	CD	DATE	1980	dep	9	SENT_787	[p15l646t306r720b331],
12	)	CD	NUMBER	)	num	14	SENT_787	[p15l646t306r720b331],
13	Chronic	JJ	O	chronic	amod	14	SENT_787	[p15l731t306r832b326],
14	infection	NN	O	infection	dep	2	SENT_787	[p15l844t306r957b325],
15	of	IN	O	of	_	0	SENT_787	[p15l968t306r995b325],
16	cats	NNS	O	cat	prep_of	14	SENT_787	[p15l1003t310r1049b325],
17	with	IN	O	with	_	0	SENT_787	[p15l1059t306r1113b325],
18	Brugia	NN	O	brugium	nn	20	SENT_787	[p15l1123t306r1200b333],
19	malayiand	NN	O	malayiand	nn	20	SENT_787	[p15l238t339r363b366],
20	streptococcus	NN	O	streptococcus	prep_with	16	SENT_787	[p15l369t343r548b366],
21	.	.	O	.	_	0	SENT_787	[p15l369t343r548b366],

1	Southeast	JJ	MISC	southeast	amod	7	SENT_788	[p15l555t339r677b359],
2	Asian	JJ	MISC	asian	amod	7	SENT_788	[p15l683t339r767b366],
3	]	NN	O	]	nn	7	SENT_788	[p15l683t339r767b366],
4	Trop	NNP	O	Trop	nn	7	SENT_788	[p15l773t339r837b366],
5	Med	NNP	O	Med	nn	7	SENT_788	[p15l843t339r897b358],
6	Public	NNP	O	Public	nn	7	SENT_788	[p15l903t339r981b358],
7	Health	NNP	O	Health	_	0	SENT_788	[p15l988t339r1072b358],
8	11	CD	NUMBER	11	num	7	SENT_788	[p15l1081t339r1112b358],
9	:	:	O	:	_	0	SENT_788	[p15l1081t339r1112b358],
10	32	CD	NUMBER	32	number	11	SENT_788	[p15l1120t339r1198b359],
11	—	CD	NUMBER	—	dep	7	SENT_788	[p15l1120t339r1198b359],
12	?	.	O	?	_	0	SENT_788	[p15l1120t339r1198b359],

1	>	JJR	O	>	_	0	SENT_789	[p15l1120t339r1198b359],
2	9	CD	NUMBER	9	dep	1	SENT_789	[p15l1120t339r1198b359],
3	.	.	O	.	_	0	SENT_789	[p15l1120t339r1198b359],

1	Olszewski	NNP	PERSON	Olszewski	nn	2	SENT_790	[p15l239t373r360b393],
2	WL	NNP	O	WL	_	0	SENT_790	[p15l371t373r501b400],
3	,	,	O	,	_	0	SENT_790	[p15l371t373r501b400],
4	Jamal	NNP	PERSON	Jamal	nn	5	SENT_790	[p15l371t373r501b400],
5	S	NNP	PERSON	S	appos	2	SENT_790	[p15l513t373r533b396],
6	,	,	O	,	_	0	SENT_790	[p15l513t373r533b396],
7	Manokaran	NNP	O	Manokaran	nn	8	SENT_790	[p15l545t373r688b392],
8	G	NNP	O	G	appos	2	SENT_790	[p15l700t373r725b396],
9	,	,	O	,	_	0	SENT_790	[p15l700t373r725b396],
10	Lukomska	NNP	LOCATION	Lukomska	nn	11	SENT_790	[p15l737t373r866b392],
11	B	NNP	O	B	appos	2	SENT_790	[p15l877t373r900b396],
12	,	,	O	,	_	0	SENT_790	[p15l877t373r900b396],
13	Kubicka	NNP	PERSON	Kubicka	nn	15	SENT_790	[p15l912t373r1015b392],
14	U	NNP	PERSON	U	nn	15	SENT_790	[p15l1026t373r1046b393],
15	(	NNP	O	(	appos	2	SENT_790	[p15l1058t373r1133b398],
16	1993	CD	DATE	1993	dep	15	SENT_790	[p15l1058t373r1133b398],
17	)	CD	NUMBER	)	num	19	SENT_790	[p15l1058t373r1133b398],
18	Skin	NN	O	skin	nn	19	SENT_790	[p15l1144t373r1199b393],
19	changes	NNS	O	change	dep	2	SENT_790	[p15l239t406r338b433],
20	in	IN	O	in	_	0	SENT_790	[p15l352t406r375b425],
21	ﬁlarial	JJ	O	ﬁlarial	amod	24	SENT_790	[p15l389t406r470b425],
22	and	CC	O	and	_	0	SENT_790	[p15l485t406r530b425],
23	non-ﬁlarial	JJ	O	non-ﬁlarial	conj_and	21	SENT_790	[p15l544t406r686b425],
24	lymphedema	NN	O	lymphedema	prep_in	19	SENT_790	[p15l700t406r863b433],
25	of	IN	O	of	_	0	SENT_790	[p15l877t406r904b425],
26	the	DT	O	the	det	28	SENT_790	[p15l915t406r953b425],
27	lower	JJR	O	lower	amod	28	SENT_790	[p15l967t406r1037b425],
28	extremities	NNS	O	extremity	prep_of	19	SENT_790	[p15l1050t406r1198b425],
29	.	.	O	.	_	0	SENT_790	[p15l1050t406r1198b425],

1	Trop	NNP	O	Trop	nn	3	SENT_791	[p15l238t439r302b466],
2	Med	NNP	O	Med	nn	3	SENT_791	[p15l314t439r368b458],
3	Parasitol	NNP	O	Parasitol	_	0	SENT_791	[p15l380t439r490b458],
4	44	CD	NUMBER	44	num	3	SENT_791	[p15l502t439r536b458],
5	:	:	O	:	_	0	SENT_791	[p15l502t439r536b458],
6	40	CD	NUMBER	40	number	7	SENT_791	[p15l549t439r628b458],
7	—	CD	NUMBER	—	dep	3	SENT_791	[p15l549t439r628b458],
8	44	CD	NUMBER	44	dep	7	SENT_791	[p15l549t439r628b458],
9	.	.	O	.	_	0	SENT_791	[p15l549t439r628b458],

1	Esterre	JJ	O	esterre	amod	2	SENT_792	[p15l239t472r328b491],
2	P	NN	O	p	_	0	SENT_792	[p15l338t472r359b495],
3	,	,	O	,	_	0	SENT_792	[p15l338t472r359b495],
4	Plichart	NN	O	plichart	nn	5	SENT_792	[p15l369t472r468b491],
5	C	NN	O	c	appos	2	SENT_792	[p15l478t472r502b495],
6	,	,	O	,	_	0	SENT_792	[p15l478t472r502b495],
7	Huin-Blondey	NNP	O	Huin-Blondey	nn	8	SENT_792	[p15l512t472r691b499],
8	MO	NNP	DURATION	MO	appos	2	SENT_792	[p15l701t472r753b495],
9	,	,	O	,	_	0	SENT_792	[p15l701t472r753b495],
10	Nguyen	NNP	ORGANIZATION	Nguyen	nn	11	SENT_792	[p15l763t472r859b499],
11	LN	NN	ORGANIZATION	ln	appos	2	SENT_792	[p15l869t472r906b492],
12	(	CD	NUMBER	(	num	13	SENT_792	[p15l918t472r993b497],
13	2005	CD	DATE	2005	dep	11	SENT_792	[p15l918t472r993b497],
14	)	NNP	O	)	dep	2	SENT_792	[p15l918t472r993b497],
15	Soluble	JJ	O	soluble	amod	18	SENT_792	[p15l1002t472r1095b492],
16	cellular	JJ	O	cellular	amod	18	SENT_792	[p15l1105t472r1200b491],
17	adhesion	NN	O	adhesion	nn	18	SENT_792	[p15l239t505r351b524],
18	molecules	NNS	O	molecule	dep	14	SENT_792	[p15l370t505r500b528],
19	,	,	O	,	_	0	SENT_792	[p15l370t505r500b528],
20	selectins	NNS	O	selectin	appos	2	SENT_792	[p15l519t505r631b528],
21	,	,	O	,	_	0	SENT_792	[p15l519t505r631b528],
22	VEGF	NN	O	vegf	appos	2	SENT_792	[p15l648t505r723b525],
23	and	CC	O	and	_	0	SENT_792	[p15l741t505r787b524],
24	endothelin-l	NN	O	endothelin-l	appos	2	SENT_792	[p15l804t505r965b524],
25	in	IN	O	in	_	0	SENT_792	[p15l986t505r1009b524],
26	patients	NNS	O	patient	prep_in	22	SENT_792	[p15l1027t505r1127b532],
27	with	IN	O	with	_	0	SENT_792	[p15l1145t505r1199b524],
28	Wuchevreria	NN	O	wuchevrerium	nn	29	SENT_792	[p15l241t539r367b558],
29	bancrofti	NN	O	bancroftus	prep_with	26	SENT_792	[p15l381t539r479b566],
30	infection	NN	O	infection	dep	2	SENT_792	[p15l493t539r606b558],
31	and	CC	O	and	_	0	SENT_792	[p15l621t539r667b558],
32	association	NN	O	association	conj_and	30	SENT_792	[p15l681t539r820b558],
33	with	IN	O	with	_	0	SENT_792	[p15l834t539r888b558],
34	clinical	JJ	O	clinical	amod	35	SENT_792	[p15l902t539r992b558],
35	status	NN	O	status	prep_with	30	SENT_792	[p15l1007t543r1084b558],
36	.	.	O	.	_	0	SENT_792	[p15l1007t543r1084b558],

1	Parasite	NN	O	parasite	_	0	SENT_793	[p15l1099t539r1199b558],
2	Immunol	NNP	O	Immunol	dep	1	SENT_793	[p15l239t572r354b591],
3	27	CD	NUMBER	27	num	2	SENT_793	[p15l367t570r401b591],
4	:	:	O	:	_	0	SENT_793	[p15l367t570r401b591],
5	9	CD	NUMBER	9	num	6	SENT_793	[p15l414t572r478b591],
6	—	NN	O	—	dep	1	SENT_793	[p15l414t572r478b591],
7	l6	NN	O	l6	dep	6	SENT_793	[p15l414t572r478b591],
8	.	.	O	.	_	0	SENT_793	[p15l414t572r478b591],

1	n	NN	O	n	nsubj	5	SENT_794	[p15l188t3077r261b3136],
2	>	JJR	O	>	amod	4	SENT_794	[p15l188t3077r261b3136],
3	PLoS	NN	O	plo	nn	4	SENT_794	[p15l288t3093r352b3116],
4	Pathogens	NNS	O	pathogen	dep	1	SENT_794	[p15l367t3092r511b3123],
5	|	VBP	O	|	_	0	SENT_794	[p15l526t3091r528b3124],
6	www	NN	O	www	dobj	5	SENT_794	[p15l543t3092r882b3123],
7	.	.	O	.	_	0	SENT_794	[p15l543t3092r882b3123],

1	p	NN	O	p	_	0	SENT_795	[p15l543t3092r882b3123],
2	|	CD	NUMBER	|	num	3	SENT_795	[p15l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	dep	1	SENT_795	[p15l543t3092r882b3123],

1	Irrthum	NNP	MISC	Irrthum	nn	2	SENT_796	[p15l1326t207r1427b226],
2	A	NNP	MISC	A	nsubj	16	SENT_796	[p15l1446t207r1471b230],
3	,	,	O	,	_	0	SENT_796	[p15l1446t207r1471b230],
4	Karkkainen	NNP	PERSON	Karkkainen	nn	6	SENT_796	[p15l1491t207r1637b226],
5	M	NNP	O	M	nn	6	SENT_796	[p15l1657t207r1696b234],
6	]	NN	O	]	appos	2	SENT_796	[p15l1657t207r1696b234],
7	,	,	O	,	_	0	SENT_796	[p15l1657t207r1696b234],
8	Devriendt	JJ	PERSON	devriendt	amod	9	SENT_796	[p15l1715t207r1842b226],
9	K	NN	PERSON	k	appos	2	SENT_796	[p15l1862t207r1886b230],
10	,	,	O	,	_	0	SENT_796	[p15l1862t207r1886b230],
11	Alitalo	NNP	PERSON	Alitalo	nn	12	SENT_796	[p15l1905t207r1989b226],
12	K	NNP	PERSON	K	appos	2	SENT_796	[p15l2009t207r2033b230],
13	,	,	O	,	_	0	SENT_796	[p15l2009t207r2033b230],
14	Vikkula	NNP	O	Vikkula	nn	15	SENT_796	[p15l2052t207r2149b226],
15	M	NNP	O	M	appos	2	SENT_796	[p15l2169t207r2191b226],
16	(	VBD	O	(	_	0	SENT_796	[p15l2211t207r2286b232],
17	2000	CD	DATE	2000	num	18	SENT_796	[p15l2211t207r2286b232],
18	)	CD	NUMBER	)	dobj	16	SENT_796	[p15l2211t207r2286b232],
19	Congenital	JJ	O	congenital	amod	21	SENT_796	[p15l1326t243r1465b270],
20	hereditary	JJ	O	hereditary	amod	21	SENT_796	[p15l1478t243r1609b270],
21	lymphedema	NN	O	lymphedema	dep	16	SENT_796	[p15l1623t243r1785b270],
22	caused	VBN	O	cause	partmod	21	SENT_796	[p15l1798t243r1882b262],
23	by	IN	O	by	_	0	SENT_796	[p15l1895t243r1923b270],
24	a	DT	O	a	det	25	SENT_796	[p15l1936t250r1948b262],
25	mutation	NN	O	mutation	agent	22	SENT_796	[p15l1961t243r2077b262],
26	that	WDT	O	that	nsubj	27	SENT_796	[p15l2091t243r2139b262],
27	inactivates	VBZ	O	inactivate	rcmod	25	SENT_796	[p15l2153t243r2286b262],
28	VEGFR3	NN	O	vegfr3	nn	30	SENT_796	[p15l1325t279r1434b299],
29	tyrosine	NN	O	tyrosine	nn	30	SENT_796	[p15l1447t279r1548b306],
30	kinase	NN	O	kinase	dobj	27	SENT_796	[p15l1559t279r1644b298],
31	.	.	O	.	_	0	SENT_796	[p15l1559t279r1644b298],

1	Am	VBP	O	be	cop	4	SENT_797	[p15l1656t279r1720b306],
2	]	CD	NUMBER	]	num	4	SENT_797	[p15l1656t279r1720b306],
3	Hum	NNP	PERSON	Hum	nn	4	SENT_797	[p15l1732t279r1794b298],
4	Genet	NNP	PERSON	Genet	_	0	SENT_797	[p15l1806t279r1882b299],
5	67	CD	NUMBER	67	num	4	SENT_797	[p15l1894t277r1928b298],
6	:	:	O	:	_	0	SENT_797	[p15l1894t277r1928b298],
7	2954301	CD	NUMBER	2954301	dep	4	SENT_797	[p15l1941t279r2050b299],
8	.	.	O	.	_	0	SENT_797	[p15l1941t279r2050b299],

1	Mand	NN	O	mand	nn	2	SENT_798	[p15l1326t316r1397b335],
2	S	NN	O	s	_	0	SENT_798	[p15l1411t316r1431b339],
3	,	,	O	,	_	0	SENT_798	[p15l1411t316r1431b339],
4	Marfo-Debrekyei	NNP	O	Marfo-Debrekyei	nn	5	SENT_798	[p15l1445t316r1661b343],
5	Y	NN	O	y	appos	2	SENT_798	[p15l1675t316r1698b339],
6	,	,	O	,	_	0	SENT_798	[p15l1675t316r1698b339],
7	Dittrich	NNP	PERSON	Dittrich	nn	8	SENT_798	[p15l1712t316r1812b335],
8	M	NNP	O	M	appos	2	SENT_798	[p15l1826t316r1855b339],
9	,	,	O	,	_	0	SENT_798	[p15l1826t316r1855b339],
10	Fischer	NNP	PERSON	Fischer	nn	11	SENT_798	[p15l1869t316r1961b335],
11	K	NNP	PERSON	K	appos	2	SENT_798	[p15l1974t316r1998b339],
12	,	,	O	,	_	0	SENT_798	[p15l1974t316r1998b339],
13	Adjei	NNP	PERSON	Adjei	nn	14	SENT_798	[p15l2011t316r2078b343],
14	O	NNP	PERSON	O	appos	2	SENT_798	[p15l2092t316r2120b339],
15	,	,	O	,	_	0	SENT_798	[p15l2092t316r2120b339],
16	et	FW	O	et	appos	14	SENT_798	[p15l2134t320r2157b335],
17	al.	FW	O	al.	nn	18	SENT_798	[p15l2170t316r2196b335],
18	(	FW	O	(	dep	2	SENT_798	[p15l2211t316r2286b341],
19	2003	CD	DATE	2003	num	20	SENT_798	[p15l2211t316r2286b341],
20	)	CD	NUMBER	)	dep	18	SENT_798	[p15l2211t316r2286b341],
21	Animated	JJ	O	animated	amod	22	SENT_798	[p15l1325t352r1451b371],
22	documentation	NN	O	documentation	dep	2	SENT_798	[p15l1467t352r1661b371],
23	of	IN	O	of	_	0	SENT_798	[p15l1677t352r1704b371],
24	the	DT	O	the	det	27	SENT_798	[p15l1717t352r1755b371],
25	ﬁlaria	JJ	O	ﬁlaria	amod	27	SENT_798	[p15l1771t352r1844b371],
26	dance	NN	O	dance	nn	27	SENT_798	[p15l1860t352r1933b371],
27	sign	NN	O	sign	prep_of	22	SENT_798	[p15l1949t352r1998b379],
28	(	CD	NUMBER	(	num	30	SENT_798	[p15l2015t352r2083b377],
29	FDS	NN	O	fd	nn	30	SENT_798	[p15l2015t352r2083b377],
30	)	NN	O	)	dep	2	SENT_798	[p15l2015t352r2083b377],
31	in	IN	O	in	_	0	SENT_798	[p15l2099t352r2122b371],
32	bancroftian	JJ	O	bancroftian	amod	33	SENT_798	[p15l2138t352r2286b371],
33	ﬁlariasis	NN	O	ﬁlariasis	prep_in	30	SENT_798	[p15l1326t389r1436b408],
34	.	.	O	.	_	0	SENT_798	[p15l1326t389r1436b408],

1	Filaria	NNP	O	Filaria	nn	2	SENT_799	[p15l1448t389r1549b416],
2	]	NN	O	]	_	0	SENT_799	[p15l1448t389r1549b416],
3	2	CD	NUMBER	2	num	2	SENT_799	[p15l1561t389r1579b409],
4	:	:	O	:	_	0	SENT_799	[p15l1561t389r1579b409],
5	3	CD	NUMBER	3	dep	2	SENT_799	[p15l1593t389r1611b408],
6	.	.	O	.	_	0	SENT_799	[p15l1593t389r1611b408],

1	Moller	NNP	PERSON	Moller	nn	2	SENT_800	[p15l1326t426r1409b445],
2	R	NNP	PERSON	R	nsubj	3	SENT_800	[p15l1419t426r1437b445],
3	(	VBD	O	(	_	0	SENT_800	[p15l1447t426r1522b451],
4	1980	CD	DATE	1980	num	6	SENT_800	[p15l1447t426r1522b451],
5	)	CD	NUMBER	)	num	6	SENT_800	[p15l1447t426r1522b451],
6	Arrangement	NN	O	arrangement	dobj	3	SENT_800	[p15l1532t426r1703b453],
7	and	CC	O	and	_	0	SENT_800	[p15l1713t426r1759b445],
8	ﬁne	NN	O	ﬁne	nn	9	SENT_800	[p15l1769t426r1816b445],
9	structure	NN	O	structure	dobj	3	SENT_800	[p15l1826t430r1942b445],
10	of	IN	O	of	_	0	SENT_800	[p15l1952t426r1979b445],
11	lymphatic	JJ	O	lymphatic	amod	12	SENT_800	[p15l1986t426r2111b453],
12	vessels	NNS	O	vessel	prep_of	9	SENT_800	[p15l2122t426r2203b445],
13	in	IN	O	in	_	0	SENT_800	[p15l2214t426r2237b445],
14	the	DT	O	the	det	17	SENT_800	[p15l2248t426r2286b445],
15	human	JJ	O	human	amod	17	SENT_800	[p15l1326t462r1413b481],
16	spermatic	JJ	O	spermatic	amod	17	SENT_800	[p15l1426t462r1549b489],
17	cord	NN	O	cord	prep_in	3	SENT_800	[p15l1562t462r1625b481],
18	.	.	O	.	_	0	SENT_800	[p15l1562t462r1625b481],

1	Adrologia	NNP	O	Adrologia	_	0	SENT_801	[p15l1637t462r1763b489],
2	6	CD	NUMBER	6	num	1	SENT_801	[p15l1776t462r1794b481],
3	:	:	O	:	_	0	SENT_801	[p15l1776t462r1794b481],
4	564	CD	NUMBER	564	num	5	SENT_801	[p15l1807t460r1917b481],
5	—	NN	O	—	dep	1	SENT_801	[p15l1807t460r1917b481],
6	576	CD	NUMBER	576	dep	5	SENT_801	[p15l1807t460r1917b481],
7	.	.	O	.	_	0	SENT_801	[p15l1807t460r1917b481],

1	Kumaraswami	NNP	O	Kumaraswami	nn	2	SENT_802	[p15l1326t500r1505b519],
2	V	NNP	O	V	nsubj	3	SENT_802	[p15l1518t500r1537b520],
3	(	VBD	O	(	_	0	SENT_802	[p15l1550t500r1625b525],
4	2000	CD	DATE	2000	num	5	SENT_802	[p15l1550t500r1625b525],
5	)	CD	NUMBER	)	dobj	3	SENT_802	[p15l1550t500r1625b525],
6	The	DT	O	the	det	8	SENT_802	[p15l1638t500r1686b519],
7	clinical	JJ	O	clinical	amod	8	SENT_802	[p15l1699t500r1789b519],
8	manifestations	NNS	O	manifestation	tmod	3	SENT_802	[p15l1802t500r1988b519],
9	of	IN	O	of	_	0	SENT_802	[p15l2001t500r2028b519],
10	lymphatic	JJ	O	lymphatic	amod	11	SENT_802	[p15l2038t500r2163b527],
11	ﬁlariasis	NN	O	ﬁlariasis	prep_of	8	SENT_802	[p15l2176t500r2286b519],
12	.	.	O	.	_	0	SENT_802	[p15l2176t500r2286b519],

1	In	IN	O	in	dep	4	SENT_803	[p15l1326t536r1357b555],
2	:	:	O	:	_	0	SENT_803	[p15l1326t536r1357b555],
3	Nutman	NNP	O	Nutman	nn	4	SENT_803	[p15l1369t536r1472b556],
4	TB	NN	O	tb	_	0	SENT_803	[p15l1482t536r1525b559],
5	,	,	O	,	_	0	SENT_803	[p15l1482t536r1525b559],
6	editor	NN	O	editor	amod	4	SENT_803	[p15l1536t536r1618b555],
7	.	.	O	.	_	0	SENT_803	[p15l1536t536r1618b555],

1	Tropical	JJ	MISC	tropical	amod	2	SENT_804	[p15l1630t536r1737b563],
2	medicine	NN	O	medicine	_	0	SENT_804	[p15l1749t536r1865b555],
3	in	IN	O	in	_	0	SENT_804	[p15l1876t536r1899b555],
4	science	NN	O	science	prep_in	2	SENT_804	[p15l1910t536r2000b555],
5	and	CC	O	and	_	0	SENT_804	[p15l2012t536r2057b555],
6	practice	NN	O	practice	prep_in	2	SENT_804	[p15l2068t536r2176b563],
7	.	.	O	.	_	0	SENT_804	[p15l2068t536r2176b563],

1	Volume	NN	O	volume	_	0	SENT_805	[p15l2187t536r2286b556],
2	1	CD	NUMBER	1	dep	1	SENT_805	[p15l1328t572r1345b591],
3	.	.	O	.	_	0	SENT_805	[p15l1328t572r1345b591],

1	London	NNP	LOCATION	London	_	0	SENT_806	[p15l1358t572r1463b591],
2	:	:	O	:	_	0	SENT_806	[p15l1358t572r1463b591],
3	Imperial	NNP	ORGANIZATION	Imperial	nn	5	SENT_806	[p15l1476t572r1584b599],
4	College	NNP	ORGANIZATION	College	nn	5	SENT_806	[p15l1596t572r1689b599],
5	Press	NNP	ORGANIZATION	Press	dep	1	SENT_806	[p15l1701t572r1771b591],
6	.	.	O	.	_	0	SENT_806	[p15l1701t572r1771b591],

1	pp	NN	O	pp	_	0	SENT_807	[p15l1784t578r1822b599],
2	.	.	O	.	_	0	SENT_807	[p15l1784t578r1822b599],

1	l03	NN	O	l03	_	0	SENT_808	[p15l1837t572r1938b591],
2	—	CD	NUMBER	—	num	3	SENT_808	[p15l1837t572r1938b591],
3	l25	NN	O	l25	dep	1	SENT_808	[p15l1837t572r1938b591],

